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Abstract  
 
HIV transmission remains ongoing among men who have sex with men (MSM). Depressive 
symptomatology has been linked to sexual risk-taking among sexually active MSM in the U.S. 
Data in Europe are lacking. The aim of this thesis was to investigate the role of depressive 
symptoms in sexual behaviours linked to STI/HIV transmission among gay, bisexual, and other 
MSM in the UK, using data from two studies. AURAH (Attitudes to, and Understanding of, Risk 
of Acquisition of HIV) was a cross-sectional study of HIV-negative MSM attending 20 
genitourinary medicine (GUM) clinics across England (2013-2014). Men reporting recent sex 
were included in analysis (N=1340). PROUD was a randomized trial to assess the effectiveness 
of pre-exposure prophylaxis among MSM reporting condomless sex (CLS), and therefore at 
high-risk for HIV acquisition, in England (2012-2014, N=540 at baseline). Across studies/time-
points, prevalence of depressive symptoms (PHQ-9≥10) ranged from 12.4%-14.4%; associated 
factors included lower socio-economic status, lower supportive network, concealment of 
sexuality, bisexual-identity, anti-gay attitudes, recreational drug use, and intimate partner 
violence. Among sexually active men in AURAH, depressive symptoms were associated with all 
measures of CLS, including previous sexually transmitted infection and post-exposure 
prophylaxis (PEP) use, even after adjusting for socio-demographics and recreational drug use 
(adjusted prevalence ratio for ≥2 CLS partners: 1.28 95% CI: 1.05, 1.56; p=0.013). In structural 
equation modelling, depression was associated with CLS indirectly via low self-efficacy 
(perceived inability to ensure condom-use when desired) (p<0.001). Among the PROUD sample 
of men reporting CLS, depressive symptoms were associated with PEP use, but not with 
greater versus lower levels of CLS. Among samples with high levels of sexual risk, factors with 
disinhibiting effects (i.e. drug use) may better explain differences in behaviour. Among sexually 
active GUM clinic attendees, management of depression alongside interventions surrounding 
self-efficacy may play an important role in HIV/STI prevention. 
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1 Introduction  
 
This thesis addresses the relationship between depression and sexual behaviour linked to HIV 
and STI transmission among individuals at highest risk of sexual acquisition of HIV in high-
income countries: men who engage in anal sex with other men. The introduction has nine parts. 
In part one, the overall thesis aims and objectives are stated. In part two, the mechanisms of 
sexual transmission of HIV and reasons for increased risk of HIV acquisition among men who 
have sex with men (MSM) are described. This thesis focuses on data from the United Kingdom 
(UK) and in part three the current epidemiology of HIV among MSM in the UK is presented. This 
is followed by the rationale for continued HIV prevention research in part four. In part five, the 
population of interest in this thesis is further defined by describing associated 
identities/communities. Key events in the HIV/AIDS epidemic are presented together with 
changing perceptions of HIV within gay and bisexual communities. Epidemiological trends over 
time in sexual risk behaviour, STIs, and HIV in high-income countries are presented. In part six, 
the minority stress theory is described. Depression is defined in part seven and in part eight the 
prevalence of depression and its association with sexual risk behaviour among sexual minority 
men is presented. Possible mechanisms by which depression might influence sexual behaviour 
are described. Part nine concludes the introduction by presenting the rationale for this PhD 
thesis, the thesis hypothesis, and the sources of data for analysis. 
 
1.1 Thesis aims and objectives 
 
The overall aim of this PhD thesis is to investigate prevalence and correlates of clinically 
significant depressive symptoms and the relationship of depressive symptoms with HIV/STI 
sexual transmission risk behaviours among gay, bisexual, and other men who have sex with 
men (MSM). This is in order to inform clinical care and HIV prevention, and thus provide insight 
into the extent to which addressing/managing depressive symptoms may play a role in HIV/STI 
prevention. This thesis uses data from two UK studies: ‘The Attitudes to, and Understanding of, 
Risk of Acquisition of HIV’ (AURAH) cross-sectional observational study and from the PROUD 
randomized trial. 
 
1.1.1 Objectives 
 
Among HIV-negative gay, bisexual, and other MSM in the UK investigate: 
(i) Prevalence of depressive symptoms and treatment for depression 
(ii) Association of socio-demographic and lifestyle factors with depressive symptoms 
(iii) Association of psychosocial factors with depressive symptoms 
Chapter 1 
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(iv) Association of depressive symptoms with sexual risk behaviour 
(v) Association of depressive symptoms with self-efficacy for sexual safety 
(vi) Association of self-efficacy for sexual safety with sexual risk behaviour 
(vii) Indirect association of depressive symptoms with sexual risk behaviour via self-efficacy 
for sexual safety 
 
As described in detail in the following section, objectives (i) and (ii) are addressed in Chapters 4 
and 7. Objective (iii) is addressed in Chapter 7. Objectives (iv), (v), and (vi) are addressed in 
Chapters 5 and 8. Objective (vii) is addressed in Chapter 6. In each results chapter, findings are 
discussed in the context of existing literature and the limitations of the findings are discussed. 
The implications of the thesis findings are discussed in the final conclusion (Chapter 9).  
 
1.1.2 Specific objectives of thesis chapters 
 
Chapter 1: (a) introduce HIV and describe reasons for increased risk of HIV acquisition among 
MSM; (b) describe the epidemiology of HIV among MSM in the UK; (c) present rationale for 
continued HIV prevention research; (d) define sexual minority populations; (e) describe key 
events in the HIV/AIDS epidemic together with changing perceptions of HIV within gay and 
bisexual communities, and present epidemiological trends in sexual risk behaviour and 
STIs/HIV in high-income countries; (f) describe the minority stress theory; (g) define depression; 
(h) describe the existing literature on the prevalence of depression and association with sexual 
risk behaviour and possible mechanisms for association among MSM; (i) present the thesis 
rationale and hypothesis. 
 
Chapter 2: conduct two literature reviews. 
Literature review (i): review studies that have investigated the relationship between depression 
and sexual risk behaviours among samples of MSM or HIV-negative MSM in high-income 
countries (North America, Australia, New Zealand, and countries in Western Europe) in order to: 
(a) describe instruments used to measure depression and associated prevalence; (b) review the 
relationships found between depression and sexual behaviour measures, according to study 
recruitment setting and in the context of key sample characteristics. 
 
Literature review (ii): review all studies that have investigated HIV sexual transmission risk 
behaviours in samples of MSM or HIV-negative MSM in the UK, in order to: (a) evaluate 
differences in the prevalence of sexual behaviour across study recruitment settings; (b) assess 
correlates of sexual behaviour, considering factors other than depression. 
 
Chapter 3: (a) describe the methodology of the AURAH study and the PROUD trial; (b) define 
the variables used in the thesis; (c) make explicit the hypothesized causal connection between 
depressive symptoms and sexual behaviour using a directed acyclical graph (DAG), whereby 
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the hypothesized relationships between psychosocial variables of relevance to both depression 
and sexual behaviour among sexual minority men are presented; (d) describe the statistical 
methods used in the thesis; (e) describe the methodological weaknesses of AURAH and 
PROUD. 
 
Chapter 4: using data from the AURAH study: (a) describe the prevalence of depressive 
symptom measures, treatment for depression, and psychological co-morbidities; (b) investigate 
the cross-sectional association of socio-demographic (age, country of birth and ethnicity, sexual 
identity, markers of socio-economic status, relationship status, and study region) and 
lifestyle/psychosocial factors (smoking, alcohol consumption, recreational drug use, supportive 
networks, and disclosure of sexual orientation) with depressive symptoms. 
 
Chapter 5: using data from the AURAH study to investigate: (a) the relationship of depression 
measures with condomless sex and other sexual behaviour measures, and the potential 
confounding/moderating effects of recreational drug use; (b) the relationship between 
depressive symptoms and measures of low self-efficacy for sexual safety; (c) the relationship 
between measures of low self-efficacy for sexual safety and sexual behaviour measures; (d) the 
potential mediating effects of low self-efficacy on the relationship between depressive 
symptoms and sexual behaviour. 
 
Chapter 6: using data from the AURAH study, develop a structural equation model (SEM) 
based on the DAG presented in Chapter 3, in order to examine the indirect effect of depressive 
symptoms on sexual behaviour through the mechanism of self-efficacy for sexual safety. 
 
Chapter 7: using data from the PROUD trial to investigate across study time-points: (a) the 
prevalence of depression measures; (b) the association of socio-demographic (age, country of 
birth and ethnicity, sexual identity, markers of socio-economic status, relationship status, and 
study region) and lifestyle/psychosocial factors (alcohol consumption, recreational drug use, 
intimate partner violence, age at first sexual debut, negative attitudes towards gay sexuality, 
and disclosure of sexual orientation) with depressive symptoms. 
 
Chapter 8: using data from the PROUD trial to investigate across study time-points: (a) the 
relationship of depression measures with condomless sex and other sexual behaviour 
measures, and the potential confounding/moderating effects of psychosocial factors; (b) the 
relationship between depressive symptoms and measures of low self-efficacy for sexual safety; 
(c) the relationship between measures of low self-efficacy for sexual safety and sexual 
behaviour measures; (d) the potential mediating effects of low self-efficacy on the relationship 
between depressive symptoms and sexual behaviour. 
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Chapter 9: discuss the implications of the thesis, comparing and bringing together the AURAH 
and PROUD study findings, and make recommendations for clinical and prevention policy and 
future research. 
 
I conceptualized the hypothesis investigated in this thesis, conducted both literature reviews, 
conducted all data-analyses and interpretation, and undertook for AURAH, all data 
management and for PROUD, variable derivation. I lead the design of a short survey that was 
distributed to PROUD participants.  
 
Publications and presentations arising from this thesis, to date, are listed in Appendix section 
11.1. 
 
1.2 Human immunodeficiency virus 
 
The human immunodeficiency virus (HIV) pandemic was first recognized in the early 1980s. The 
HIV virus was isolated in 1983 
(1, 2)
 and confirmed to be the causative agent associated with the 
acquired immunodeficiency syndrome (AIDS) in 1984 
(3, 4)
. HIV is a retrovirus that belongs to the 
Retroviridae family and genus Lentivirus. HIV is transmitted through three main routes: sexual 
transmission, blood contact, and mother-to-child transmission. HIV attacks the immune system 
of the infected individual, causing progressive immunosuppression, and increasing risk of 
opportunistic infections, cancers, and death. Prior to the advent of effective treatment, the 
median survival time from HIV infection was around ten years 
(5)
. Effective treatment for HIV -
triple combination antiretroviral treatment (ART) - was introduced in the mid-1990s. The 
prognosis of HIV has been transformed since the introduction of ART. HIV-positive individuals 
with access to treatment now have greatly improved life expectancy, nearing that of the general 
population 
(6-12)
. The plasma HIV viral load, which is a measure of the level of HIV replication in 
circulating blood, is one of the primary markers used to monitor the success of treatment. 
Effective treatment of HIV results in reduction of the plasma viral load, the aim being the 
reduction of viral load to a level undetectable with standard assays. Suppression of HIV viral 
load is usually associated with restoration of immune function to a level that is comparable with 
that seen in individuals not infected with HIV. An undetectable viral load is also associated with 
a dramatically reduced risk of HIV transmission to a sexual partner 
(13-17)
. Until recently, 
treatment policy for HIV recommended that initiation of ART be delayed until the level of 
immunosuppression, of the HIV-infected individual, posed a significant risk to health. This was 
done in order to balance the treatment benefit with its potential risk of side-effects. However, in 
2015, it was demonstrated in a large international randomized controlled trial (START) that 
starting ART earlier confers a reduction in risk of serious illness 
(18)
. Given the potential public 
health and individual clinical benefit, new guidelines recommend treating individuals with HIV 
from the time of their diagnosis 
(19-21)
. 
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1.2.1 Sexual transmission of HIV 
Sexual transmission of HIV usually takes place via condomless sex i.e. sexual intercourse 
without a condom, referred to throughout this thesis as CLS 
(15)
. HIV crosses the epithelial 
barriers that cover the mucosal surfaces of the genital track and anus/rectum 
(22)
. Genital and 
rectal tissues are populated with dendritic cells, macrophages, T cells and other cells that 
participate in immune responses. These cells express chemokine receptors (mainly CD4 and 
CCR5) that are susceptible to HIV infection 
(23, 24)
. In addition to the vaginal/cervical epithelia, 
the rectal canal represents the most efficient route for HIV transmission 
(22)
. The rectal canal 
consists of only a single layer of epithelium covering mucosal tissue, where activated innate 
immune cells are plentiful 
(25)
. Any destruction to epithelial integrity enables direct access to 
target cells and establishment of infection in the mucosa 
(23)
. Receptive anal sex (i.e. having a 
partner insert their penis into one’s rectum with ejaculation) is the most efficient sexual practice 
for transmitting HIV, at an estimated 1.4% (95% CI: 0.2%, 2.5%) per act probability and 40.4% 
(95% CI: 6.0%, 74.9%) per partner probability (18-fold higher than for vaginal sex) 
(26)
. The 
depletion of CD4+ lymphocytes, a type of white blood cell that is crucial to fighting infection, 
plays a critical role in the pathogenesis of HIV 
(25, 27, 28)
. 
 
1.2.2 Men who have sex with men and HIV 
The first indication of the global HIV/AIDS pandemic was recognized in October of 1981, when 
the number of cases of Kaposi sarcoma, a rare type of cancer in North America and Europe, 
was occurring among young gay-identified men in New York and San Francisco with alarming 
frequency 
(29)
. On the heels of this report, it became clear that a number of gay-identified men 
were suffering from an unusual number of opportunistic infections and immunodeficiency 
(30, 31)
.  
 
The term men who have sex with men has been used since at least 1990, with the abbreviation 
MSM coined in 1994 by public health researchers 
(32)
. The purpose of the term MSM was to 
acknowledge that behaviours not identities conferred risk for HIV. The term MSM has since 
become the status quo in HIV epidemiological research. Essentially, MSM is a broader 
category, including gay- and bisexual-identified men, heterosexual-identified men who have sex 
with men, male sex workers, and men who have sex with men in all male settings such as 
prisons. As a result, it endeavours to encompass diverse identities and terms that may exist 
across cultures, social class, and ethnicity 
(33, 34)
. Use of this term is discussed further in section 
1.5.2. 
 
1.2.3 MSM, risk of HIV, and vulnerability to other STIs 
MSM continue to be one of the population groups with the greatest risk of sexual transmission 
of HIV in many parts of the world 
(35, 36)
. If the transmission probability of receptive condomless 
anal sex was similar to that of condomless vaginal sex, the five year cumulative incidence of 
HIV in MSM would be reduced by an estimated 80-90% 
(37)
. MSM are unique sexual beings in 
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that they can acquire HIV through receptive CLS and then pass it on through insertive CLS. In 
addition, MSM are vulnerable to rectal sexually transmitted infections (STIs) including Neisseria 
gonorrhoea, Chlamydia trachomatis, Treponema pallidum (syphilis), lymphogranuloma 
venereum (LGV), and Herpes simplex virus (HSV). Rectal STIs can present on the perianal skin 
and anal canal, causing inflammation of the rectal mucosa (clinical proctitis), anal discharge and 
pain, and sores in and/or on the anus. Rectal STIs and their treatment have important 
implications in the control of HIV as they are implicit in both transmission and susceptibility 
(38-40)
 
(41)
.  
 
1.3 Epidemiology of HIV among MSM in the United Kingdom  
 
At the time of writing this thesis, national HIV surveillance data was available up to 2015 in the 
UK.  
 
1.3.1 Prevalence of HIV in the UK 
Figure 1 presents the estimated number of individuals living with HIV (diagnosed and 
undiagnosed) in 2015 across exposure groups (MSM, black African ethnicity, injection drug 
users), calculated using the multi-parameter evidence synthesis model (MPES), which takes 
into account multiple data sources 
(42)
. In total, 101200 (95% credible interval: 97500, 105700) 
individuals were estimated to be living with HIV. Of these individuals, an estimated 47000 (95% 
credible interval: 44200, 50900) were MSM (Figure 1). Based on the assumption that 3.3% of 
men in the UK have had sex with a man in the past five years, it was estimated that the 
prevalence of HIV among MSM was one in 17 (58.7 [95% credible interval: 51.2, 68.0] per 
1000). In London, the prevalence was estimated to be higher at one in seven MSM (135 [95% 
credible interval: 101, 184] per 1000). Of the 47000 MSM estimated to be living with HIV, 12% 
(95% credible interval
i
: 7-19%) were estimated to have an undiagnosed HIV infection 
(42)
.  
 
 
 
 
 
 
 
 
 
 
                                                     
i
 95% credible interval presents the statistical uncertainty surrounding estimates from a Bayesian analysis 
(i.e. from the MPES model) 42. Kirwan PD, Chau C, Brown AE, Gill ON, Delpech VC. HIV in the UK- 
2016 report. London: Public Health England, 2016. 
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Figure 1: Estimated number of people living with HIV (both diagnosed and undiagnosed), 
using MPES, by exposure group (all ages): UK, 2015, from Public Health England 2016 
report: Kirwan et al. 2016 
(42)
  
 
 
 
1.3.2 Incidence of HIV in the UK 
In 2015, 6095 men and women were diagnosed with HIV
ii
. Figure 2 shows the number of new 
HIV diagnoses over the period of 2006-2015, according to exposure group (sex between men, 
heterosexual contact, injecting drug use). For MSM, observed estimates and estimates adjusted 
according to the distribution of exposure groups from data with complete information, are shown 
in green. In 2015, 3320 new HIV diagnoses were reported among MSM
iii
 (1307 new diagnoses 
among MSM resident in London); constituting 54% of all new HIV diagnoses in the UK 
(43)
. 
Although the number of new HIV diagnoses was slightly higher in 2014 (N=3360), it appears 
that numbers remained high in 2015 among MSM, despite initiatives to counter new infections 
and the ready availability of ART over the past decade. An individual-based stochastic computer 
simulation model 
(44-47)
 has reconstructed the HIV epidemic among MSM in the UK (1980-2012) 
to model the relative influences of sexual risk behaviour change, rates of HIV testing, and ART-
induced virologic suppression on HIV incidence (diagnosed and undiagnosed cases) 
(15)
. This 
model suggests that it is the counter-effect of concomitant increases in CLS amongst MSM as a 
whole that has resulted in a net increase in HIV incidence over a period in which ART coverage 
                                                     
ii
 Of note, the decline in number of new diagnoses of HIV via heterosexual contact, as shown in Figure 2 
, is attributed to changing migration patterns, as more men and women born in sub-Saharan Africa have 
an HIV infection diagnosed in their respective countries rather than after having migrated to the UK 43.
 Chau C, Kirwan P, Brown A, Gill N, Delpech V. HIV diagnoses, late diagnoses and numbers 
accessing treatment and care. London: Public Health England, 2016. 
iii
 The incidence of HIV (i.e. number of new cases/total population at risk) among MSM in the UK is not 
reported. 
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and viral suppression has been increasing. Furthermore, studies suggest that the majority of 
new HIV infections are from people unaware of their HIV status 
(14, 15, 48-52)
. In 2015, 30% of 
MSM (n=777/2628) were diagnosed at late stage of infection 
(43)
.  
 
Figure 2: New HIV diagnoses by exposure group over time; 2006-2015, from Public Health 
England 2016 report: Chau et al. 2016 
(43)
 
 
 
 
1.3.3 Changes in HIV diagnosis in 2016 
Prior to submitting this thesis, a short report was published 
(53)
 suggesting that compared to 
observations made in 2015, a substantial decrease in the number of new HIV diagnoses was 
seen at five genitourinary medicine (GUM) clinics in London at the end of 2016. The drop was 
considered to reflect a decrease in incidence given the concomitant increase in median CD4 
count at diagnosis. Smaller declines, however, were seen at other GUM clinics in London and 
elsewhere in England. It was suggested that use of pre-exposure prophylaxis (PrEP) was likely 
to have contributed to the observed decrease in new diagnoses. PrEP is discussed in section 
1.4.2. 
 
1.4 HIV prevention  
 
Although the prognosis of HIV infection has dramatically improved 
(6-9)
, living with HIV and 
taking lifelong treatment can substantially impact on quality of life. For many individuals an HIV 
diagnosis can be deeply disenfranchising. There is evidence that HIV continues to impact on 
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mental health and well-being even in the era of successful treatment 
(15, 54, 55)
. Efforts need to 
remain focused on reducing new HIV infections. 
 
1.4.1 Sexual healthcare provision in the UK 
GUM clinics provide open access, confidential, high-quality, and free STI and HIV testing and 
care on the UK National Health Service (NHS) 
(53)
. The British Association for Sexual Health and 
HIV (BASHH) sets national guidelines and standards for specialists in genitourinary medicine 
(56)
. Guidelines suggest that all sexually active MSM should test for HIV and other STIs at least 
annually and those considered to be at high-risk should test every three months 
(57)
. Testing on 
a three monthly basis is recommended for MSM following CLS with a new partner, diagnosis of 
a new STI, and recreational drug use, which may be a marker of high-risk behaviour 
(57)
.  
 
1.4.2 Prevention interventions 
Promotion of condom-use and HIV testing is the backbone of HIV prevention 
(58-63)
. Behavioural 
interventions to increase condom-use encompass a range of educational, motivational, peer-
group, skills-building, and community normative approaches 
(64)
. A recent review shows that 
although a large number of behavioural interventions have been evaluated, the majority 
demonstrated modest reductions in self-reported sexual risk behaviour, and often no effects on 
HIV incidence 
(64)
. Studies have mostly been conducted in the U.S. Of note, treatment of STIs is 
also a strong public health intervention in its own right but has had mixed results in trials in 
which the effect on prevention of HIV acquisition was assessed 
(65)
. 
 
Novel biomedical interventions include the use of oral ART for post-exposure prophylaxis 
(PEP), pre-exposure prophylaxis (PrEP) and to reduce infectiousness among HIV-positive 
individuals (i.e. Treatment as Prevention, TasP) 
(16, 66-74)
. Individuals can take PEP soon after 
possible exposure to HIV in order to reduce their risk of acquiring HIV.  A follow-up HIV test is 
required. BASHH guidelines for use of PEP were published in 2006 
(75-78)
. PEP is increasingly 
being recommended for MSM following CLS 
(79)
. Efficacy of PEP is dependent on accurate 
perceptions of risk, engagement in sexual health care, and willingness to report sexual risk-
taking.  
 
Individuals who test negative for HIV can take PrEP (daily or intermittently) prior to potential HIV 
exposure, in order to reduce their risk of acquiring HIV.  There are several studies showing that 
Truvada-based PrEP is efficacious at preventing HIV acquisition through sex: iPrEx 
(67)
, 
IPERGAY 
(74)
, and PROUD 
(80)
 (86% reduction in HIV incidence among MSM). PrEP was 
approved in the U.S. by the FDA in 2012 
(81)
 and in France in 2015 
(82)
. In May 2016, BASHH 
together with the British HIV Association (BHIVA) issued a statement that PrEP should be made 
available within a comprehensive HIV prevention package to MSM in the UK 
(83)
. PrEP was 
authorized by the European Medicines Agency in July 2016 
(84)
 and on April 10
th
 2017, the 
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decision was made to make PrEP available on the NHS in Scotland 
(85)
. At the time of writing 
this thesis, PrEP was not available in England on the NHS. The Court of Appeal established 
that NHS England has the legal power to commission PrEP services in England and Wales 
(86)
. 
Private clinics are able to prescribe PrEP, but not without significant cost to the user, which has 
led to many individuals buying generic versions of the drug online from overseas 
(87)
. 
 
TasP is the use of immediate/early HIV treatment to be taken by individuals diagnosed with HIV, 
in order to reduce the risk of transmission to their sero-different partners (i.e. HIV-negative 
partners) 
(16, 68, 88, 89)
. As described above in section 1.3.2, results from UK modeling work 
suggests that although novel biomedical interventions such as TasP (which requires high levels 
of HIV testing) may have an appreciable effect on reducing HIV incidence among populations at 
risk, concomitant increases in CLS may greatly undermine the positive impact of TaSP 
(15)
. It is 
possible that these findings may also apply to interventions involving PrEP, especially given that 
not all potentially at-risk individuals will be willing or able to take PrEP consistently. Therefore, 
efforts need to remain focused on promotion of condom-use and further investigating potentially 
effective behavioural interventions, particularly in the UK, is required. 
 
1.5 Sexual minority men, sexual behaviour, and HIV 
 
1.5.1 Biological sex, gender identity, and sexual orientation 
The interface between biological sex, gender identity, and sexual orientation can be complex. 
Sex is a function of biological characteristics of males and females, whereas, gender is a 
separate construct which refers to socially constructed roles, attributes, and behaviours. Gender 
identity is based on self-conception and experience as being female, male, another gender, or 
no gender 
(90-92)
. Gender minorities include individuals who identify as transgender (who 
experience little or no connection between their biological sex assigned at birth and their gender 
identify), intersex (biological characteristics at birth do not fit into a binary measure of male or 
female), and non-binary/gender queer 
(90-92)
. Sexual orientation is defined by sexual attraction, 
sex of sexual partners, and sexual identity. Sexual minority men include individuals who identify 
as monosexual (gay/homosexual), plurisexual (bisexual, pansexual [sexual attraction to 
members of any biological sex or gender identity], fluid, queer), or asexual. Queer is an 
umbrella term used by individuals in the LGBTQA (lesbian, gay, bisexual, transgender, queer, 
asexual) community to indicate an identity that is not straight/heterosexual and incorporates 
complex dynamics of gender identity 
(90-92)
.  
 
1.5.2 Defining this population for research purposes 
The indiscriminate use of the term MSM has received criticism. Young and Meyer 
(32)
 have 
suggested that use of the term MSM takes an ahistorical view of sexual minority communities, 
can obscure the complex dynamics of sexual orientation and gender identity, and removes from 
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the sexual minority man his power to name himself. Furthermore, they suggest that the term 
MSM disregards the fact that while some men may have sex with men, others may also engage 
in long-term, committed, emotional relationships with men. These relationships may occur in the 
context of communities and social networks in which sexual identity is shared. 
 
Although the term MSM is often used for simplicity throughout this thesis when reviewing 
previous research, I have decided to recognize that the vast majority of ‘MSM’ participating in 
HIV research are gay-identified (and to a lesser extent bisexual-identified). Identity related 
factors are meaningful and powerful forces in people’s lives. Treating MSM as a homogenous 
group (a phenomena known as the out-group homogeneity bias 
(93)
) denies individuals the 
importance of their unique experiences of growing up, coming out, and finding themselves 
amongst a community of individuals united by their identity and lifestyles.  
 
The nomenclature of research populations at risk of HIV is clearly complex. In this thesis, I hope 
to capture the role of sexual identity in behaviours leading to HIV transmission by carefully 
naming the population under study, which comprises different communities/groups at risk of 
HIV, as ‘gay, bisexual, and other MSM’, and as far as numbers allow, assessing differences 
according to sexual identity within this population. When describing a conceptual model, 
presented in the Methods chapter and investigated in Chapter 6, the relationships are 
hypothesized for a population group referred to as sexual minority men. Bisexual men are 
referred to specifically, but this includes men of other plurisexual identity labels. The section 
below specifically examines the impact that key events in the HIV/AIDS epidemic have had on 
the gay community. 
 
This thesis addresses literature from North America, Western Europe, Australia, and New 
Zealand. Factors that drive trends in HIV epidemiology may be very different between low- and 
middle-income countries, and high-income countries. When studies are described in the 
following sections of this introduction, it is important to be cognizant that research among sexual 
minorities is complicated by the lack of a contact list for all members of the population (the 
sampling frame). Accordingly, it is not feasible to select a random sample of sexual minority 
men. Instead, most studies recruit men from community/commercial gay venues, producing 
samples which may not be fully representative of the sexual minority population in the country of 
study. This issue is discussed further in Chapter 2. 
 
1.5.3 Gay community and sexual behaviour in the context of HIV 
Gay and bisexual communities have had a unique experience with regard to HIV and as a result 
have had a unique socio-cultural response to the epidemic. Gay and bisexual men have been in 
the highest HIV/AIDS risk group since the very beginning of the epidemic. At this time virtually 
nothing was known about the pathology of the virus and its transmission routes. Gay sexuality 
(and bisexuality) was, and still is in some respects, a stigmatized identity. The appearance of a 
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deadly virus with no known means of prevention or cure had a profound impact on gay and 
bisexual men, many of whom lost partners and peers, experiencing a substantial reduction in 
their social support networks 
(94, 95)
. The impact of the AIDS epidemic on gay (and bisexual) 
communities cannot be overstated. Perhaps no other group of people is more equipped to deal 
with the shifting challenges that have occurred over the last decade in the epidemic. With that 
said, section 1.5.3.1 presents landmark events in the history of the HIV epidemic and their 
impact on perceptions of HIV transmission within gay (and bisexual) communities.  
 
1.5.3.1 Changing perceptions of risk 
This section draws predominantly on findings from a qualitative study of 37 gay men recruited 
from community/commercial gay venues and GUM clinics across Scotland in the late 90’s to 
explore the role of new HIV-related health technologies on changing HIV risk management for 
the gay community 
(96-98)
. Prior to the isolation of HIV in 1983 and against the backdrop of 
unprecedented sexual freedom of the 1970s, the threat of HIV/AIDS swept through the gay (and 
bisexual) community unhindered. Since any sexual partner could potentially be infected, the 
necessity to indiscriminately use condoms became paramount 
(96, 99)
. The initial death and 
destruction wrought by the epidemic stirred a robust community safe sex ethos. Universal 
condom-use became the prescribed status quo 
(96, 99)
.   
 
With the identification of HIV and introduction of HIV antibody testing, however, men could for 
the first time, discern the HIV status of their sexual partners and determine their risk of 
transmission from or to a partner. As a result, indiscriminate condom-use was no longer 
perceived to be of absolute necessity 
(96)
. If arrived upon through a process of mutual HIV 
testing, disclosure, and selection of practices that matched the HIV serostatus discordancy or 
concordancy of partnerships, CLS no longer lay outside the realm of what was acceptable 
sexual behaviour. These behavioural changes are commonly referred to as ‘relapse’, but 
controversially so. The natural shift in understanding of and capacity to deal with HIV galvanized 
the grass roots movement of ‘risk reduction’, to balance the gains and losses of ‘bareback’ sex 
i.e. intentional CLS 
(96)
. Common risk reduction practices include sero-sorting, whereby 
individuals only have CLS with partners of the same HIV status as themselves. Seropositioning 
involves active allocation of sexual positioning during anal sex i.e. taking an insertive or 
receptive position, based on HIV status. A known HIV-positive partner would assume the 
receptive rather than insertive role to protect their partner from ejaculation. Other practices 
include withdrawal and the concept of negotiated safety, whereby partners practicing CLS come 
to an agreement to use condoms with other sexual partners 
(96, 100-102)
. 
 
With enduring fear in the background, HIV antibody testing also created distinct categories of 
men for the first time: those who were negative, those who were positive, and those whose HIV 
status was unknown. With this came a sense of ‘Othering’ of those in the community who were 
known to be HIV-positive, upon whom, all of a sudden, ‘risk’ and responsibility was attributed. At 
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this time motivation to test and disclose was tenuous 
(98)
. Against this backdrop of sparse 
testing, an assumption that sero-negativity accompanied non-disclosure of an HIV status was 
documented 
(103-105)
.  
 
The introduction of ART in 1996 was met with a significant decrease in HIV associated 
morbidity and mortality 
(6-12)
. It was widely felt that the advent of ART had profoundly changed 
attitudes to HIV within the gay community 
(97)
. The perception of HIV shifted from it being a 
death sentence to a chronic, long-term, yet manageable infection. Following the introduction of 
ART, HIV testing was encouraged within gay communities 
(106)
. Furthermore, in 2008, a group of 
Swiss HIV clinicians and researchers issued a statement indicating that the risk of 
transmitting HIV through CLS was extremely low if the HIV diagnosed partner has a suppressed 
HIV plasma viral load for at least six months and no other STI 
(107)
. It was widely felt that this 
new HIV-related information had once again changed perceptions of HIV risk within the gay 
community 
(108)
. Information from The Swiss HIV Cohort Study suggested that sexual behaviour 
patterns may have changed among HIV diagnosed individuals in Switzerland. There was some 
evidence to suggest that participants on ART reported higher levels of CLS with sero-different 
partners following the publication of the ‘Swiss Statement’ 
(109)
. Yet even before this statement 
was released, studies from outside Europe suggested that HIV-negative MSM perceived a 
number of sexual practices with HIV diagnosed MSM on ART as less risky than with men not on 
ART 
(110)
. More recent data has noted an increased likelihood in HIV-negative MSM to engage 
in CLS in sero-different relationships (i.e. with an HIV-positive partner) where their partner 
reports an undetectable viral load 
(111)
.  However, it is of note that the number of studies 
investigating this association among HIV-negative men is limited.  
 
1.5.4 Epidemiological trends in condomless sex and STIs/HIV in high-income countries 
This section gives an overview of HIV surveillance data from MSM in high-income countries 
from the late 1970s onwards. The methodological details of UK studies are described in 
Chapter 2. There is some evidence from England to suggest that diagnoses of syphilis began to 
decrease in the late 1970s and continued to fall during the early ’80s 
(112)
. However, research 
carried out in the late 1980s and early 1990s noted an increase in CLS 
(113)
, perhaps reflecting 
the gay community response to HIV antibody testing with risk reduction strategies. Similarly, in 
the post-ART era, during the late 1990s and into early 2000, studies in the UK, France, 
Germany, Switzerland 
(114-129)
, Australia, Canada, and the U.S. 
(130-142)
 found a substantial 
increase in self-reported sexual risk behaviour, namely CLS with a partner of unknown or sero-
different HIV status, regardless of age or HIV status. In San Francisco, the proportion of MSM 
reporting CLS with one or more partners doubled between 1994 and 1999 and continued to 
increase into early 2000 
(130, 138)
. In London, the proportion of MSM reporting CLS with one or 
more casual partners more than doubled between 1998 and 2001 
(126)
. Rectal STI incidence 
(gonorrhoea, syphilis, and LGV) also increased significantly during the late 1990s and into early 
2000 across Western European countries and in the U.S. 
(112, 127, 128, 143-156)
. The first syphilis 
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outbreak among MSM was reported in Hamburg in 1997 
(157)
 and was followed by large 
outbreaks in London, Paris, and Dublin 
(158-160)
. The first outbreak of LGV among MSM was 
reported in Rotterdam in 2003 
(161)
 and subsequent large outbreaks were reported in the UK and 
France 
(162-173)
. Most cases of LGV and syphilis were among older, white, and HIV-positive MSM 
(162-173)
.  
 
Mirroring the rise in CLS and STI incidence, an increase in HIV incidence was observed in 
Amsterdam 
(52)
, Vancouver 
(174)
, Ontario 
(175)
, London 
(176)
, and Rome 
(177)
 up to mid-2000. In 
Amsterdam, London, and San Francisco, although STI incidence increased overall among 
MSM, the increase in HIV incidence was only found among older (34 years or older), but not 
younger men 
(52, 148, 176, 178)
. In London, the observed increase in HIV incidence from 1997-2004 
among older men was not significant 
(176)
. In any case, an increase in the uptake of HIV testing 
was observed during this period in London. It was suggested that this was most likely as a 
result of both newfound HIV treatment optimism and introduction of opt-out testing, whereby all 
patients were offered a test regardless of symptoms or risk factors 
(179, 180)
. The number of HIV 
tests among MSM attending GUM clinics in London increased from 5114 in 1997 to 9387 in 
2002 (84% increase). Elsewhere in England, Wales, and Northern Ireland, the number of tests 
increased from 5030 to 8864 (76% increase) and in Scotland from 1040 in 1997 to 2513 in 
2004. Improvements in HIV reporting systems may have also contributed to the increase in 
number of diagnoses among MSM in the UK and elsewhere 
(176)
. Furthermore, there is some 
evidence to suggest that men continued to practice HIV risk reduction strategies after 1996 
(119)
. 
Serosorting was widely reported among HIV-positive gay-identified men in New York, San 
Francisco, Montreal, Sydney, and London 
(100, 126, 181-184)
. More men effectively practicing risk 
reduction may have explained the stable incidence of HIV among younger men, and at the 
same time, the rise in other STIs, for which transmission risk remained. Furthermore, 
surveillance data from the UK and Belgium suggested that a significant proportion of MSM 
diagnosed with syphilis were reporting recent oral sex without a condom 
(158, 159, 185, 186)
. Although 
syphilis can be acquired through this sexual practice, it carries a substantially lower risk of HIV 
transmission than CLS. Together with the disproportionate circulation of syphilis and LGV 
among diagnosed HIV-positive MSM, these factors might help to further explain the stable 
incidence of HIV and also the rise in STI incidence observed among younger men between the 
period 1996 to mid-2000 
(187)
. The increase in sexual risk behaviour and STI incidence observed 
during the decade following the introduction of ART, reportedly began to stabilize in London 
(126)
, 
Sydney 
(188)
, and San Francisco 
(189)
.  
 
Following the ‘Swiss Statement’ in 2008, there has been a clear and persisting increase in STIs 
and HIV diagnoses in Western Europe, the U.S., Canada, New Zealand, and Australia 
(15, 64, 142, 
190-195)
. Diagnosis of gonorrhea among MSM in England increased 32% from 2013 to 2014 (from 
13,629 to 18,029) 
(193)
, and this increase is highly concerning given the risk for emergence of 
resistant strains of gonorrhea 
(196)
. Furthermore, from 2013 to 2014, syphilis, chlamydia, and 
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genital herpes diagnoses among MSM in England increased by 46%, 26%, and 10% 
respectively 
(193)
. In the U.S., the estimated number of new diagnoses of HIV infection among 
MSM rose from 27,001 in 2011 to 27,588 in 2012, 27,642 in 2013, and 29,418 in 2014 
(194)
. 
Increased uptake of STI and HIV testing cannot fully explain the rise in incidence 
(197)
. It is of 
note, the apparent decline in HIV incidence observed among MSM in the UK in 2015 and 
steeper decline in some GUM clinics in London at the end of 2016, may reflect the use of PrEP 
(see section 1.3.3). Similarly in the U.S. the number of new diagnoses of HIV among MSM has 
declined slightly in 2015 to 26376 
(198, 199)
. In San Francisco, a free
iv
 and easy-to-access PrEP 
programme has been rolled-out since 2014. The number of new HIV diagnoses dropped 
substantially to 255 in 2015 (17% decrease since 2014) and 223 in 2016 in San Francisco 
(200)
. 
 
1.5.4.1 Quantifying the impact of changing community perceptions of HIV risk on condomless 
sex and HIV/STI transmission 
Historically, trends in sexual risk behaviour have been attributed to the changed perception of 
HIV as a chronic and manageable rather than terminal illness and changed perception of 
transmission risk with HIV-positive sexual partners on treatment 
(106)
. However, a number of 
longitudinal studies conducted in the Netherlands and U.S. reported conflicting results as to 
whether HIV treatment and transmission optimism is associated with sexual risk behaviour 
(131, 
201-205)
. Therefore, although it appears that gay communities reacted to the advent of ART and 
release of the Swiss Statement with changing perceptions of and methods of dealing with HIV, it 
is now generally accepted that at a population-level, HIV optimism alone is insufficient by itself 
to explain increases in sexual risk behaviour and STI/HIV incidence 
(129, 205-208)
. It is perhaps 
possible, that even in the upcoming era of PrEP, trends in sexual risk behaviour may not be fully 
explained by changing perceptions of HIV transmission.  
  
1.6 Sexual minority men and minority stress theory 
 
The emergence of the HIV epidemic in the 1980s prompted an unprecedented medical and 
social interest into the sexual behaviour of sexual minority men, and sexual minority lifestyles in 
general, to assess the profound burden of HIV in these communities. One aspect of the new 
research agenda was the investigation of the impact of sexual minority status itself on health. 
The most widely used theoretical framework to culminate from this work is Meyer’s minority 
stress theory 
(209-211)
, which describes stress processes in sexual minority populations. Key 
features of the minority stress theory are described below. The initiation of research into 
depression, its association with sexual risk behaviour, and possible mechanisms of association 
among sexual minority men, is presented in section 1.8. Of note, in-depth research into other 
psychosocial factors, which are recreational drug use and intimate partner violence, was also 
initiated as a result of the minority stress theory. Evidence for elevated prevalence of these 
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psychosocial factors among sexual minority men and a link with sexual minority stress is 
presented in Appendix section 11.4. These psychosocial factors are defined and their 
association with sexual risk behaviour is described in the literature review of Chapter 2 (sections 
2.5.3, 2.5.4, and 2.6.3.2). 
 
1.6.1 Minority stress and its origins 
 
1.6.1.1 History of violence against sexual minority men in high-income countries 
Antigay state-sanctioned violence and discrimination has been perpetrated throughout history; 
from Nazi extermination of homosexuals to violent and often fatal enforcement of ‘sodomy laws’ 
(212)
. Textbox 1 presents the timeline of political events concerning sexual minority men in the 
UK 
(213, 214)
. Of note, until 1973, gay sexuality was characterised as a mental health disorder in 
the Diagnostic and Statistical Manual (DSM) of mental disorders, devised by the American 
Psychiatric Association for use in clinical practice. Men with ‘homosexual tendencies’ were 
sometimes subjected to shock/aversion therapy. These conditioning-based approaches, so-
called ‘reparative therapy’, were proven unsuccessful and highly harmful in the 1980’s 
(209, 215-
217)
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
Textbox 1: Time-line of political events concerning sexual minority men in the UK up to 
2014
v
 
 
 
 
1.6.1.2 Conflict and prejudice 
From the early days of Durkheim to the works of Pearlin, Merton, and Moss in the 20
th
 century, 
social theorists have described the profound stress that occurs when an individual’s values and 
experiences in the world are incompatible with social structures, norms and institutions. Minority 
persons are likely to feel conflicted, as mainstream cultural norms do not usually reflect those of 
the minority group 
(219-222)
. Social comparison and symbolic interaction theorists describe the 
adverse consequences of negative social interactions. Perpetual negative feedback from 
others, such as stereotyping and prejudice, has the potential to lead to deep seeded negativity 
about the self, which may lead to poor mental health outcomes 
(223-225)
. Prejudice is a noxious 
environment for minority individuals. In Meyer’s minority stress model, homophobic taunts can 
lead to: (i) internalized homophobia, (ii) pervasive expectations of rejection, and (iii) non-
disclosure of one’s sexual orientation 
(209, 226-228)
. These three elements will be discussed in 
more detail in the next section. In essence, to be in continual conflict with a discriminatory social 
environment is considered the source of minority stress 
(210, 229)
. Minority stress is classified as 
unique, that is not a feature of stresses common to the general population, such as finances, 
but an additional, pervasive layer of stress that requires additional coping mechanisms. It is also 
                                                     
v
 On 31
st
 January 2017 an amendment to the Policing and Crime Bill was passed (‘Turings Law’), which 
posthumously pardoned thousands of gay and bisexual men convicted of consensual same-sex 
relationships. As part of this bill, statutory pardons will also be granted to the living.218. Gyimah S. 
Thousands officially pardoned under 'Turing's Law'. Ministry of Justice; 2017. 
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considered to be chronic and socially biased as it stems from social processes rather than 
individual events, such as losing a business 
(210, 230-234)
. 
 
1.6.2 Objective and subjective stressors: the role of personal identification in Meyer’s minority 
stress model 
The social and personal meanings that are attached to sexual identities and the stress they 
entail varies from person to person. Stress may also be independent of self-identification with 
an assigned minority status. For instance, a man may have a male sexual partner but identity as 
heterosexual. If this man is perceived to be associated with gay sexuality, he may experience 
the same prejudices that self-identified gay/bisexual men are subjected to. In the minority stress 
model these have been termed as objective stressors. They are independent of an individual’s 
perceptions and appraisals, as opposed to subjective stressors which are associated with self-
identity as a sexual minority, and are characterised by the three cornerstones of the minority 
stress model: (i) internalized homophobia, (ii) expectations of rejection, and (iii) concealment 
(209, 226-228)
. 
 
Internalized homophobia is a process of self-stigmatization by directing negative antigay social 
values/attitudes towards the self. It is internal and insidious, often resulting in deep conflict and 
poor self-regard, with negative consequences such as pervasive expectations of rejection in 
one’s life.  Due to the significance of early life socialization experiences, residual internalized 
homophobia may be a permanent fixture throughout a sexual minority individual’s life-course. If 
individuals integrate a high degree of antigay attitudes into their perception of self, mental health 
problems may follow 
(211, 235-239)
. 
 
Concealment of and secrecy around one’s identity is often adopted as a coping strategy out of 
fear of the perceived negative consequences of disclosing a stigmatized identity. Although a 
common coping strategy, it is one that has the potential to backfire, as the constant 
preoccupation and cognitive effort involved in hiding one’s identity is a heavy burden to bear, 
and can become highly stressful 
(227)
. Expressing emotions and disclosing important aspects of 
oneself is profoundly important in maintaining physical and mental health. Inhibition and 
repression of one’s thoughts and feelings have been shown to impact immune functioning and 
other health outcomes 
(240, 241)
. Furthermore, concealment adds to mental distress by disallowing 
individuals to affiliate with others who are of the same sexual identity. Smart and Wegner (2000) 
describe the experience of concealment as a “Private hell” (page 229 
(242)
). Although in many 
regions of the world acceptance of sexual minority individuals has evolved considerably over 
the last few decades, concealment of sexual identity is not necessarily restricted to 
adolescence, but may be pervasive throughout adulthood as well. Concealment of sexual 
orientation is often prevalent in the work place for instance, with adverse consequences for 
psychological functioning and job-related outcomes 
(243, 244)
. 
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1.6.3 Minority stress and resilience  
“Stress and resilience interact in predicting mental disorder” (page 679 
(209)
). The process of 
coming out for a sexual minority individual, which among this generation may often occur during 
adolescence, can be a highly stressful experience. In the minority stress model, there are three 
main factors which can ameliorate the effects of stress on psychological functioning through 
self-acceptance: (i) family support, (ii) personal resources including personality characteristics, 
and (iii) group resources/social structural factors including community solidarity and 
cohesiveness. Sexual minority communities counteract stress by establishing a social 
environment with alternative structures and values that validate the experiences and feelings of 
minority individuals. In social evaluation theory, group affiliation allows members to appraise 
themselves in comparison to other like-minded members, rather than members of the dominant 
culture 
(225, 245-247)
. Therefore, identifying with a minority status, in itself, can ameliorate stress 
through opportunities for affiliation, social support, and coping. For individuals who do not 
identify as a sexual minority, but do engage in non-heteronormative behaviour, these 
opportunities for positive coping may not be available. Of note, factors (ii) and (iii) are greatly 
intertwined, since accessing community facilities greatly depends on personality variables. 
Similarly, where certain communities are forbidden and community services are hidden, as in 
many regions of the world, even highly resourceful persons will struggle with coping as a 
minority.  
 
Stress related to sexual minority status does occur within the broader context of environmental 
circumstance, including the advantages or disadvantages related to an individual’s socio-
economic status. Therefore, socio-economic factors may also be a strong determinant of the 
degree of exposure to stresses and coping resources 
(248, 249)
.  
 
1.6.4 Current social climate for sexual minority men in high-income countries 
In many countries steps have been taken to abolish state-sanctioned discrimination against 
sexual minority individuals, including the Equalities Act in 2010 and approval of marriage 
between same-sex partners in 2013 in England and Wales (see Textbox 1). This legislation has 
most likely helped in reducing a climate of stigmatization and devaluation. However, ‘coming 
out’ may still remain a highly stressful experience for some sexual minority individuals due to 
rejection or fear of rejection by friends and family- reflecting that mainstream culture remains 
relatively heterosexist 
(250, 251)
. Therefore, while the social and political environment may have 
changed dramatically over recent decades, reducing prejudice and conflict, there are certainly 
indicators that some individuals still experience discrimination and denigration in various 
contexts based on their sexual orientation (see section 1.8.1). 
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1.7 Depression: definition, prevalence, and management 
 
1.7.1 Defining depression 
This section (1.7.1.1 to 1.7.3.2) deals with a general definition of depression. The measuring of 
depression for research purposes is discussed in Chapter 2 (section 2.4.2).  
 
1.7.1.1 Cognitive model of depression 
Support for Aaron Beck’s cognitive model of depression
vi
 has gathered over the past 40 years of 
systematic research 
(252, 257-264)
. The model proposed that the meaning assigned to early life 
stress such as parental loss or childhood abuse/maltreatment, can transform into durable 
negative attitudes and biases about the self, regarding personal adequacy, acceptability and 
worth. For instance, ‘If I lose an important person, I am helpless’ 
(262, 265, 266)
. Dysfunctional 
attitudes/beliefs (unlovable, inadequate, worthless, helpless) are thought to become embedded 
within cognitive structures labelled cognitive schemas
vii
 in the meaning assignment system. This 
results in cognitive vulnerability i.e. sensitization of individuals to later negative events 
(266)
. 
When cognitive schemas are activated by an event, they distort the information processing 
system, producing an attentional bias, whereby, attentional resources are directed towards 
negative stimuli and negatively biased interpretations. The result is a systematic cognitive bias 
in information processing, leading to the symptoms of depression: sadness, hopelessness, loss 
of motivation, and regressive behaviours such as social withdrawal and inactivity 
(257, 262, 267, 268)
. 
 
The impact of activated schemas depends on the intensity of a negative experience and the 
threshold for activation. Systematic stressful events can lower the threshold 
(267)
. A full-blown 
major depression characterized by profound anhedonia (inability to feel pleasure in normally 
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 Of note, a number of other models of depression have been theorized. Extending the cognitive model of 
depression, the model of triadic reciprocal causation dictates that individuals with depression tend to 
create depressing environments by constantly interpreting life events in pessimistic ways. This in turn often 
elicits negative reactions and evaluations from other individuals with whom they interact, ultimately 
validating the depressed individuals negative outlook on life. In the diathesis-stress model of depression, 
individuals are carriers of inherent vulnerabilities that under taxing stressors give rise to depression. Other 
models of depression include the biased causal explanations theory. Essentially, this theory is similar to 
the cognitive model of depression and observes that depression is a function of ascribing failures to 
personal deficiencies. Treatments based on these theories have not been widely developed, but instead 
rely on cognitive behavioural therapy 252. Young J, Rygh JL, Weinberger AD, Beck AT. Cognitive 
Therapy for Depression. In: Barlow DH, editor. Clinical Handbook of Psychological Disorders A step-by-
step treatment manual. 4th ed. New York: Guilford Press; 2008, 253. Coyne JC. Essential papers on 
depression. New York: New York University Press; 1985, 254. Joiner TE, Jr. Contagious depression: 
existence, specificity to depressed symptoms, and the role of reassurance seeking. Journal of personality 
and social psychology. 1994;67(2):287-96, 255. Peterson C, Seligman ME. Causal explanations as a 
risk factor for depression: theory and evidence. Psychol Rev. 1984;91(3):347-74, 256. Bandura A. 
Self-efficacy. The exercise of control. New York: W.H. Freeman and Company; 1997.. 
vii
 Cognitive schemas are mental concepts in cognitive psychology that represent constructions of reality 
(which are profoundly entrenched emotion-based beliefs) through early life experiences with significant 
others. Schemas remain dormant in the subconscious memory until activated by a life event. Stimulated 
schemas inform an individual about what to expect from a variety of experiences and situations 252.
 Young J, Rygh JL, Weinberger AD, Beck AT. Cognitive Therapy for Depression. In: Barlow DH, 
editor. Clinical Handbook of Psychological Disorders A step-by-step treatment manual. 4th ed. New York: 
Guilford Press; 2008. 
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pleasurable activities) and sleep and appetite disturbance, is different from that of depressive 
symptom episodes. Dysfunctional attitudes/beliefs may become integrated into affective 
(relating to mood and feelings), motivational, behavioural, and physiological, as well as, 
cognitive schemas. As a result of systematic activation, these schemas may become organized 
into a depressive mode, a network of negative schemas 
(257, 269)
. A severe adverse event or 
accumulation of negative events may trigger the cognitive schemas that activate the other 
schemas. The activated mode takes complete control of the information processing system, 
which is evidenced by increased negative appraisals and rumination. At this time, resources are 
taken away from adaptive schemas such as coping and problem solving. When fully activated, 
the mode becomes relatively autonomous and is no longer sensitive to external events i.e. 
positive events do not attenuate negative thinking. The result is total immersion of the 
personality in a full-blown major depression. It has been suggested that adaptive schemas can 
be reactivated in cognitive behavioural therapy (CBT), as discussed below 
(262)
. 
 
1.7.1.2 Parallels between biological and psychological concepts: genetic vulnerability 
and data from neurophysiological studies 
Not all individuals subjected to traumatic experiences become depressed. There is some 
evidence to suggest that the presence of certain gene variations and their impact on neural 
functioning greatly influences the degree of cognitive vulnerability to depression. Figure 3 
presents biological mechanisms which may predispose individuals to depression. In summary, 
biological predisposition may operate through the presence of genetic variants 
(270-282)
, 
suboptimal serotonergic neurotransmission, hyperactivity of the amygdala 
(283, 284)
 as well as 
changes to many other brain regions 
(256, 283, 285-294)
, sustained high blood concentrations of 
stress hormones 
(295-300)
, and inhibition of new brain cell formation together with metabolic/ 
endocrinological mechanisms 
(297, 301, 302)
 leading to a reorganizing of neural structures. For 
instance, studies have shown that the presence of the short variant of the 5-HTTLPR gene and 
subsequent neural functioning may sensitize individuals to life experiences and result in the 
formation of negative attitudes 
(265, 303-306)
. In the cognitive model of depression, frequent 
activation of dysfunctional attitudes can lead to the symptoms of depression. A number of 
studies have found that individuals with the short variant of the 5-HTTLPR gene experience 
higher levels of clinically significant depression and suicidality 
(297, 307-312)
. Questions have been 
raised however, about the generalizability of these findings 
(313)
. Regardless, findings from 
genetic, neuroimaging, and neuroendocrine studies, do appear to complement the cognitive 
model of depression dictated by Aaron Beck decades previously. That is, the relationships 
between external stimuli, biological predisposition, neural dysfunction and depression 
established in the neuroscience literature appear to run parallel to the cognitive model of 
external stimuli, cognitive factors and depression established in the cognitive psychology 
literature. 
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Figure 3: Possible elements involved in biological predisposition to depression* 
* References of studies from which this information was derived are presented in section 1.7.1.2 above. 
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1.7.1.3 Categories of depression 
The most common form of depression is called unipolar depression. It is characterised by the 
presence of a number of typical symptoms for at least two weeks: feeling down, having difficulty 
enjoying things, feeling like one has to push oneself to get anything done, difficulty sleeping, 
exhaustion, loss of appetite, trouble concentrating, and feeling pessimistic about the future 
(252, 
314)
. The severity of the depression is determined based on how many symptoms are present 
and how severely an individual experiences them. Accordingly, depression can then be 
classified as mild, moderate, or severe 
(252, 314, 315)
.  
 
There are chronic and non-chronic forms of depression 
(252, 314)
. The latter may include a single 
episode or recurrent episodes with full recovery between episodes. Dysthymia is a chronic 
depressive disorder characterised as a milder change in mood, which is similar to depression, 
and lasts at least two years. Symptoms often include feelings of being unsettled, unhappy or 
down, but unlike depression, dysthymia does not affect everyday life- the symptoms may 
change from day to day and week to week 
(252, 314)
. Clinical opinion suggests that the onset of 
dysthymia around mid-adolescence often determines the chronic nature of the depression 
(316, 
317)
. Furthermore, evidence from the U.S. National Comorbidity Survey (N=5877) suggests that 
chronic depression is more evident in individuals who experience a traumatic event in 
childhood/adolescence 
(318)
. In a U.S. study of individuals with early-onset dysthymia (N=97), 
which incorporated annual semistructured interviews over a period of eight years, those who 
experienced early-onset dysthymia and early life trauma were more likely to present with an 
increase in depression severity over time compared to individuals with dysthymia and no early 
life trauma 
(317)
. 
 
Some individuals may be particularly affected by depression during the darker winter months, 
known as seasonal affective disorder. Some mothers may experience depression after giving 
birth to a child (postnatal depression). Depression may also be a consequence of bipolar 
disorder. Bipolar disorder is characterised by alternating phases of extreme mood, with typical 
symptoms of depression in one phase and manic euphoria
viii
 in another 
(252, 314)
. 
 
1.7.2 Prevalence of depression in the UK 
Depression is widespread and deeply debilitating. In the Adult Psychiatric Morbidity Survey 
(2014), 3.3% of 7500 adults (16 years and older) residing in private households in England were 
classified as having clinically significant symptoms of depression in the week prior to an 
interviewer administered structured interview using the Clinical Interview Schedule-Revised 
(CIS-R). Of the 15.7% of adults who were classified as having a common mental health disorder 
of clinical significance by CIS-R (including depression, generalized anxiety disorder, phobias, 
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 Characterized by extreme activity with little sleep, self-confidence to the point of delusion, and irritability. 
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obsessive compulsive disorder, or panic disorder), 67.2% self-reported that they had 
experienced depression at some point in their lives 
(319, 320)
.  
 
1.7.3 Managing depression 
Professional help is most often needed to overcome the symptoms of depression and to assess 
possible suicide risk, safeguarding concerns, and adherence and response to treatment 
(315, 321)
.  
 
1.7.3.1 Psychopharmacological interventions 
The pharmacotherapist intervenes at the neurochemical level. In the UK, antidepressants are 
prescribed for individuals with moderate to severe depression, often in combination with 
psychosocial treatment. Textbox 2 presents common antidepressants prescribed in the UK 
(315, 
321)
.  
 
Textbox 2: Common antidepressants prescribed in the UK 
 
 
 
 
Although antidepressant treatment is widespread, there are some significant concerns. Many 
antidepressants are cardiotoxic and weaken the heart 
(322, 323)
. It is also estimated that even 
among individuals who initially respond to an antidepressant, about one in three patients will 
experience a worsening of their symptoms over the subsequent six months 
(324)
. In a recent 
meta-analysis of four trials, in which all participants were initially treated with SSRIs and were 
then randomized to placebo or continued SSRI treatment, SSRIs were found to have a modest 
(13% higher) protective effect against relapse compared to placebo 
(324)
. 
 
1.7.3.2 Psychosocial interventions 
The psychotherapist intervenes at the cognitive, affective, and behavioural levels 
(256, 325)
. In 
general, psychotherapy seeks to restore a sense of personal capability to do the things that 
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provide satisfaction and purpose to one’s life 
(326, 327)
. Beck’s development of CBT, based on the 
cognitive model of depression described in section 1.7.1.1, is the most studied, validated and 
clinically applied work on depression psychotherapy 
(252, 263, 264)
. CBT includes two major 
components: (i) analysis of erroneous assumptions, inferences, and conclusions in the 
routinized faulty habits of thinking and (ii) graded behavioural assignments to disconfirm 
misbeliefs, provide mastery experiences that affirm personal capabilities, and restore positive 
self-evaluations. In a U.S. controlled trial, where outpatient individuals aged 18 to 70 years with 
major depressive disorder (N=240) were randomized to receive an SSRI, CBT, or placebo 
(double blinding in the treatment arm), therapy was found to be as effective as medication in 
terms of depression severity and rates of remission. It was noted that the degree of 
effectiveness of therapy depended on the level of therapist experience/expertise 
(328)
. CBT is not 
however without its controversies 
(252)
. In a meta-analysis, CBT was not found to be superior to 
non-cognitive psychotherapy treatments on child and adolescent depression 
(329)
. Nevertheless, 
the risk of depression relapse has been found to be highest for individuals who respond to 
antidepressants without the support of any form of psychotherapy 
(330, 331)
. 
 
1.8 Sexual minority men and depression  
 
In this section (1.8.1 to 1.8.2), evidence regarding the prevalence of depression among sexual 
minority men and its association with sexual risk behaviour is described. In sections 1.8.3 to 
1.8.4, the possible mechanisms by which depression might lead to sexual risk behaviour are 
presented. 
 
1.8.1 Studies comparing the prevalence of depression between sexual minorities and their 
heterosexual counterparts in high-income countries 
There appears to be consistent evidence that depression prevalence is elevated among sexual 
minority men compared to their heterosexual counterparts in high-income countries. One meta-
analysis has investigated studies conducted from 1996-2005. Among 160 gay, bisexual, and 
other MSM, the lifetime prevalence of depression was found to be higher compared to that in 
6010 other men (pooled prevalence ratio [PR] 2.58 95% CI: 1.92, 3.47), and the prevalence of 
depression in the past year was similarly elevated (pooled PR 2.41 95% CI: 1.80, 3.23). Studies 
included three population-based surveys from the U.S. and one population-based survey from 
Western Europe: the third National Health and Nutrition Examination Survey, National 
Comorbidity Survey, McArthur Foundation National Survey of Midlife Development in the United 
States, and the Netherlands Mental Health Survey and Incidence Study 
(332)
.  
 
A recent systematic review has synthesised findings from 199 studies (using a range of 
measures of depression), the vast majority of which were from the U.S. Studies of adults 
residing in private households in the U.S. included the Behavioral Risk Factor Surveillance 
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Study 
(333)
, California Quality of Life Survey
(334)
, National Health Interview 
(335)
, National 
Epidemiologic Survey on Alcohol and Related Conditions 
(336)
, and National Health and Nutrition 
Examination Survey 
(337)
. The review reported elevated levels of depression (as well as 
generalized anxiety disorder) among lesbian, gay- and bisexual-identified individuals in the vast 
majority of their reviewed studies. Elevated prevalence was observed across these different 
orientations compared to heterosexual 
(338)
. 
 
A number of recent studies of adults residing in private households in Western European 
countries have also investigated the prevalence of depressive symptoms among sexual minority 
individuals: the 2007-2009 Netherlands Mental Health Survey and Incidence Study (NMHSIS, 
N=6646) 
(339)
, the 2006 Context of Sexuality in France study (CSF, N=9622) 
(340)
, the 2007 Adult 
Psychiatric Morbidity Survey (APMS, N=7403) 
(341)
, and the 2010-2012 British National Survey 
of Sexual Attitudes and Lifestyles (Natsal-3, N=6293 men) 
(342)
. The sample size of the sexual 
minority sub-group ranged from 60 in NMHSIS 
(339)
  to 190 individuals in Natsal-3 
(342)
. 
Depression was measured using the Composite International Diagnostic Interview (symptoms in 
the past year) in NMHSIS 
(339)
, self-report of feeling depressed in the past year in CSF 
(340)
, the 
CIS-R (symptoms in the past week) in APMS 
(341)
, and a shortened version of the Patient Health 
Questionnaire (PHQ-2, symptoms in the past two weeks) in Natsal-3 
(342)
. The prevalence of 
depression was found to be significantly higher among sexual minority individuals, including 
after adjustment for socio-demographic factors in APMS 
(341)
. For instance, the prevalence was 
39.0% among gay-identified men and 28.1% among bisexual-identified men for self-reported 
depression in CSF 
(340)
, and 4.1% among gay- and bisexual-identified men and women on the 
CIS-R in APMS 
(341)
. The comparable prevalence of depression among heterosexual identified 
individuals was 17.0% 
(340)
 and 2.7% 
(341)
 in CSF and APMS respectively. Furthermore, the 
prevalence of major depression on the Composite International Diagnostic Interview was 
elevated among men who reported sex with men in the past year (at 9.0%) in NMHSIS 
(339)
 and 
the prevalence of depression on the CIS-R was elevated among individuals who reported any 
same-sex partners (at 4.0%) in APMS 
(341)
. In Natsal-3, although the prevalence of depressive 
symptoms on the PHQ-2 was similar among men who reported sex with a man in the past five 
years compared to men who did not, the MSM group was more likely to self-report having 
received treatment for depression in the past year, including after adjusting for age (14.0% vs. 
5.8%, OR 2.75 95% CI: 1.69, 4.47; p<0.001) 
(342)
. 
 
1.8.1.1 Minority stress and depression 
Although certain factors described above in section 1.6.3 can ameliorate the effects of stress on 
psychological functioning, the minority stress theory may explain why the prevalence of 
depression is elevated among sexual minority men 
(339, 340)
 
(338, 343-345)
. In the 2007 APMS, 4.9% 
of sexual minority individuals reported discrimination on the grounds of sexuality, compared to 
1.6% of heterosexual identified individuals (p<0.001). Among sexual minorities, unfair treatment 
perceived to be due to sexual orientation was associated with depression (OR 6.95 95% CI: 
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2.74, 17.67). The same was true among individuals reporting any same-sex partners (OR 7.91 
95% CI: 2.90, 21.58) 
(341)
. Studies of U.S. MSM have also found associations between 
perceived discrimination on the basis of sexual orientation and depressive symptoms 
(346, 347)
. 
 
Although MSM may be at increased risk for mental health disorders, it is possible that the gap 
will close over time as the legal and social landscape of sexual minority communities progress 
and stigma diminishes. It may then be that the major factors associated with depressive 
symptoms mirror those found for heterosexuals, namely, socio-economic hardship 
(348-351)
. 
 
1.8.2 Association between depression and sexual risk behaviour 
One meta-analysis of studies published up to 1999, has examined the association between 
depression and CLS among MSM 
(352)
. Findings across studies were inconsistent and in 
combined estimates there was no significant relationship of depression with measures of CLS. 
The vast majority of included studies were conducted in the U.S. In studies conducted up to 
2014, there was evidence that depressive symptoms were associated with higher prevalence of 
CLS (including with multiple partners and partners of an unknown or sero-different status) 
(353-
368)
 and with HIV seroconversion 
(369)
 among samples of MSM. A number of studies failed to find 
an association 
(346, 347, 370-373)
. Two studies were conducted in Europe; one in the UK (1999) 
(355)
 
and the other in Belgium (2008) 
(358)
, both studies finding an association between depressive 
symptoms and measures of CLS. These studies were identified via a comprehensive literature 
search of all high-income country studies (in the regions investigated in this thesis) on sexual 
behaviour among MSM samples including HIV-negative MSM. The purpose and findings of the 
thesis literature review are presented and discussed in detail in Chapter 2. 
 
 
1.8.3 Mechanisms by which depression leads to sexual risk behaviour 
There may be a number of explanations for how depression may lead to sexual risk. The main 
explanations involve elements of feeling unable to maintain or ‘not caring’ about sexual safety. 
The behavioural consequences of depression have been described in two theories: social 
cognitive theory and cognitive escape theory, described below.  
 
1.8.3.1 Depression and behaviour: social cognitive theory 
Albert Bandura began to publish work on his social cognitive theory in the 1980s. Social 
cognitive theory aimed to describe how cognitive activities can be used to explain and 
encourage behavioural adaptation and change
ix
. Personal agency is the capacity to create 
                                                     
ix
 Of note, in addition to social cognitive theory there are two other models commonly used to theorize 
pathways leading to behavioural change. These are the health belief model and the theory of reasoned 
action/planned behaviour. The health belief model explains behavioural choice as a function of the 
perceived gains and losses, whereby attitudes to and perceptions of the outcome of this behaviour are 
emphasised. In the theory of reasoned action/planned behaviour, behaviour is a function of intentions, 
which are governed by behavioural and social norms and attitudes 374. Fisher WA, Fisher JD, Rye BJ. 
Understanding and promoting AIDS-preventive behavior: insights from the theory of reasoned action. 
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action. Social cognitive theory rejects the dualistic notion of the self, whereby one is considered 
an agent only when acting or managing one’s environment. This theory dictates that individuals 
are also agents when they are “reflecting on their experiences and exerting self-influence” (page 
5 
(256)
). The latter is termed ‘beliefs of personal efficacy’ or simply, ‘self-efficacy’, and it is said to 
constitute the key factor of agency. Essentially, if an individual does not perceive that they have 
the capacity to produce a certain outcome, then they will not attempt to make it happen
x
. How 
one judges one’s personal efficacy is thought to come about through a complex interaction of 
“microsensory, perceptual, and information processing activities” (page 4 
(256)
). 
 
Feeling hopeless about the future is one of the key features of depression. Hopelessness runs 
in parallel to perceived inefficacy in gaining highly valued outcomes. In line with the cognitive 
model of depression, in social cognitive theory, depression is thought to stem from a perceived 
inefficacy to change adverse/traumatic life circumstances 
(256, 262)
. Depression may also 
perpetuate a feeling of being incapable of influencing events and social conditions that 
significantly impact on one’s life. Bandura suggests that repeated self-devaluation and 
demoralizing/disparaging thoughts breed depression, which in turn further diminishes an 
appreciation of one’s better qualities and enhances self-critical reactions and reduces self-
rewarding ones, leading to a lower sense of self-efficacy 
(256)
. 
 
1.8.3.2 Self-efficacy for sexual safety 
When navigating sexual risk reduction, individuals have to exercise control over themselves as 
well as their partners. Although sexual knowledge and favourable attitudes towards condom-use 
are important, following a social cognitive perspective on behavioural management, the main 
requirement for effective sexual risk reduction is perceived self-efficacy to exercise control in 
interpersonal relationships 
(379, 380)
. There are a number of psychosocial factors that may lower 
one’s sense of efficacy to exercise self-protective control in sexual situations; drug and alcohol 
use, experiences of sexual coercion/abuse, and perhaps most commonly, depression 
(256, 381-
387)
. 
                                                                                                                                                           
Health psychology : official journal of the Division of Health Psychology, American Psychological 
Association. 1995;14(3):255-64.  
375. Carmel S. The Health Belief Model in the research of AIDS-related preventive behavior. Public 
health reviews. 1990;18(1):73-85, 376. Aggleton P, O'Reilly K, Slutkin G, Davies P. Risking 
everything? Risk behavior, behavior change, and AIDS. Science (New York, NY). 1994;265(5170):341-5.  
377. Mustanski BS, Newcomb ME, Du Bois SN, Garcia SC, Grov C. HIV in young men who have sex 
with men: a review of epidemiology, risk and protective factors, and interventions. J Sex Res. 2011;48(2-
3):218-53, 378. Wulfert E, Wan CK. Safer sex intentions and condom use viewed from a health belief, 
reasoned action, and social cognitive perspective. Ibid. 1995;4:293-305. 
x
 Of note, Bandura states that the concept of self-efficacy is not the same as the concept of self-esteem, 
as feelings of self-worth and value do not always equate to positive beliefs of personal efficacy, and 
similarly, perceived inefficacy to produce a certain outcome is not always associated with a low self-
esteem. Therefore, these concepts although similar are not the same. 256. Bandura A. Self-efficacy. 
The exercise of control. New York: W.H. Freeman and Company; 1997. 
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1.8.3.3 Interventions to improve self-efficacy for sexual safety 
There is some evidence to suggest that learning self-regulative skills greatly improves one’s 
sense of efficacy to resist peer pressures and exert control in interpersonal relationships i.e. 
negotiate condom-use. Self-regulation is a function of internal standards and evaluative 
reactions to behaviour. Self-regulation may include motivation through self-incentives or other 
such forms of cognitive self-guidance. Obtaining self-regulative skills may involve learning how 
to cope with/successfully manage potentially adverse situations. Bandura suggests this is best 
achieved by being guided through experiences and equipped with the knowledge and skills 
needed to effectively exercise control over risky situations, thereby fostering a sense of mastery 
(256)
. Research by Kelly (1995) 
(388)
 produced formative work on the effectiveness of self-
regulatory programmes for self-protective sexuality through improvement of perceived efficacy 
to exercise personal control over sexual practices. 
 
1.8.3.4 Depression and behaviour: cognitive escape theory 
In cognitive escape theory, individuals turn their attention away from threatening cues, 
completely or partially escaping from personal self-awareness. The cognitive escape model 
suggests that for behaviours that are desirable, such as sex (for reasons of physical pleasure as 
well as seeking connectedness and acceptance), the rational process by which perceived risk of 
HIV/STIs might result in subsequent behavioural response such as condom-use, may be 
reversed.  
 
Sensation-seeking and HIV-related worry may represent two pathways leading to sexual risk-
taking via cognitive escape coping. Sensation-seeking (and sexual compulsivity) is a personality 
characteristic that is associated with impulsive behaviour 
(389, 390)
, as described in Appendix 
section 11.4.1.1,  and has been established as a theoretical precursor to cognitive escape 
(391)
. 
Men with this personality trait may be ‘determined’ to perceive themselves to be at low risk 
irrespective of the circumstances, and as such may avoid or be unable to adequately respond to 
information to the contrary, in order to escape from restrictive sexual norms 
(392, 393)
. This first 
pathway takes the form of suppression of and/or distraction from any thoughts that extend too 
far into the future.  
 
Many gay and bisexual men enter and conduct their sexual life-course against the backdrop of 
HIV. HIV related worry is facilitated by pervasive prevention messages. The lack of a cure or 
vaccine means that there is no imminent end to demands for sexual safety. It has been posited 
that fear may make some men ‘determined’ to perceive the threat of HIV infection to be 
uncontrollable, in order to escape from worry and conduct their sex lives unhindered by stress 
(394-396)
. This second pathway takes the form of fatalistic beliefs about HIV- the notion that 
acquiring HIV is inevitable. 
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Cognitively escaping from awareness of HIV risk and sexual norms may make men particularly 
vulnerable to STI/HIV transmission 
(397)
. Cognitive escape has been linked, theoretically, to CLS 
(396, 398)
. Cognitive escape may be facilitated by highly stimulating sexual contexts and drug use. 
The relationship between drug use and cognitive disengagement (including both thought 
suppression/short-term thinking and fatalistic beliefs) is most likely bi-directional 
(397, 399)
.  
 
1.8.3.5 Depression, lowered self-efficacy for sexual safety, and engagement in 
cognitive escape: implications for sexual risk-taking 
Conceptually, cognitive escape and self-efficacy are linked. Low self-efficacy for coping is 
thought to make escape tendencies more likely. The perceived lack of control in interpersonal 
relationships (low self-efficacy for sexual safety) may translate into the belief that failure to 
protect oneself is inevitable. The threat of sexual transmission of HIV, which is viewed as 
personally uncontrollable is then tuned out (cognitive escape) 
(400)
. In the self-regulation and 
coping literature on sexual minority men, an established hypothesis is that those who 
experience depressive symptoms may be more likely to engage in escapism as a coping 
strategy, characterised by fatalistic beliefs such as helplessness or powerlessness in the face of 
the HIV threat 
(397, 401-404)
. The thesis hypothesis is presented in detail in section 1.9.1. 
 
1.8.4 Investigating mechanisms of association between depression and CLS in 
epidemiological studies 
Project Mix (2004-2006) is the only high-income country study (U.S.) of MSM (N=1540) 
(362)
 to 
have investigated mechanisms of effect for the relationship between depression and CLS. 
There was support from this study for lowered self-efficacy and cognitive escape as such 
mechanisms. Findings from Project Mix are discussed in detail in Chapter 2 section 2.4.8 and 
Chapter 6 section 6.4.2. 
 
1.8.5 Anxiety and thoughts of suicide/self-harm  
This thesis focuses on depression, and as such, the literature review presented in Chapter 2 
examines studies of depression. However, findings on the association between generalized 
anxiety disorder (GAD) and sexual risk behaviour, and suicidal ideation (thoughts/planning of 
suicide)/thoughts of self-harm and sexual risk behaviour are also presented in this thesis. These 
findings will be discussed in the context of the findings on depression.  
 
Historically, GAD has received very little clinical and research attention compared to other 
common anxiety disorders (including panic disorder and post-traumatic stress disorder) and 
depression. GAD was first described in the third edition of the DSM in 1980. Since this time, the 
definition of GAD has undergone frequent revision. GAD was originally associated with fairly 
minimal impairment in psychological functioning. It is now understood that some individuals 
have a temperamental predisposition to worry, which may be exacerbated by stressful life 
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events resulting in excessive, uncontrollable, and chronic worry 
(252, 405)
. Based on data from the 
World Mental Health (WMH) surveys in the U.S., Australia, and New Zealand (N=30532), the 
lifetime prevalence of GAD was estimated to be around 8% 
(405)
. Based on data collected from 
WMH surveys in 26 countries between 2001-2012 (N=147261), the majority of individuals with 
lifetime (81.9%) and 12-month (70.8%) GAD had at least one comorbid mental health disorder. 
Major depression was the most common comorbidity, found in 52.6% of lifetime GAD cases and 
40.9% of 12-month GAD cases 
(405)
. 
 
Literature on self-harm and suicide is vast. Briefly, self-harm tends to first occur during 
adolescence. In a systematic review of studies of adolescent samples, published between 2005 
to 2011, the mean life-time prevalence of self-inflicted injury was 18.0% across studies 
(406)
. 
Based on data collected from WMH surveys in 17 countries (N=84850), the prevalence of 
suicidal ideation was estimated to be around 9.2% 
(407)
. Recurrent thoughts of death are a 
common symptom in a major depressive episode 
(408)
. Depression is the psychiatric diagnosis 
most commonly associated with suicidal ideation and suicide 
(409)
. 
  
1.9 Thesis rationale 
 
The literature review conducted in Chapter 2 demonstrates some evidence of a relationship 
between depressive symptoms and sexual behaviour among MSM. The association and 
magnitude of effect may vary according to the setting and specific sample of MSM under study. 
It remains unclear in which samples of MSM the relationship is present and there is no general 
consensus on the magnitude of the effect. Furthermore, the vast majority of studies have been 
conducted in the U.S. There is a lack of data in Europe, including the UK. Psychological 
symptom distress has been found to be associated with CLS among HIV outpatients in the UK 
(410-414)
. Although HIV prevention has been a public health priority among MSM in the 
UK/Europe, mental health has not generally been a focus of European studies of HIV/STI risk 
and prevention among sexual minority men. The health care infrastructure is different in the 
U.S. and UK and mental health facilities and services may also differ, with implications for the 
treatment and prevalence of depression. The potential role of depression in sexual health and 
transmission of HIV is not well understood in the UK.  
 
Additionally, there is a lack of research in the U.S. and no UK/European studies into the 
mechanisms by which the relationship between depressive symptoms and sexual behaviour 
operates. Therefore, implications for intervention remain uncertain. Current research into the 
mechanisms through which the association between depression and CLS operates is needed. 
 
Only recently a small number of UK studies have begun to examine the prevalence of 
depressive symptoms among sexual minority men: Natsal-3 (2010-2012; N=190) 
(342)
, The 
Stonewall Gay & Bisexual Men’s Health Survey (2011; N=5416) 
(415)
, survey of MSM recruited 
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online (2016; N=179) 
(416)
, and survey of MSM recruited from a GUM clinic (1999; N=122) 
(355)
. 
In most of these studies, the sample size was too small to allow for meaningful analysis of 
associated factors. Until 1973, gay sexuality was cited in the DSM as constituting a mental 
health disorder. Research into psychological distress among sexual minority men has been a 
politically charged area, so as not to perpetuate the pathologizing of gay men. This may account 
for the lack of research into the prevalence of mental health conditions and associated factors 
among sexual minority men in the UK. However, in recent years there has been a visible shift in 
the UK research agenda to address mental health & wellbeing among the general population 
and sexual minorities in particular, for whom it is being increasingly recognized that the burden 
of psychological distress may be higher. The prevalence of depressive symptoms and 
association with socio-demographic, lifestyle, and psychosocial factors needs to be further 
investigated among sexual minority men in the UK. The specific objectives for each of the 
remaining chapters included in this thesis are presented in section 1.1.2. 
 
1.9.1 Thesis hypothesis 
Given the self-regulation and coping literature on depressive symptoms, it is hypothesized that 
among a group of gay, bisexual, and other MSM, depressive symptoms would be associated 
with increased sexual risk behaviour, in other words increased levels of CLS. This relationship 
is hypothesized to be partially but not fully confounded by recreational drug use, childhood 
sexual abuse, and intimate partner violence (as discussed in section 3.5 of Chapter 3). Low 
self-efficacy for sexual safety is hypothesized to be on the casual pathway between depression 
and sexual risk behaviour. More specifically, a depressive syndrome (be it chronic or episodic) 
is often associated with feelings of personal inadequacy, worthlessness, and hopelessness/loss 
of motivation. In terms of one’s sex life, it is hypothesized here that depressive symptoms lower 
one’s perceived ability to exercise self-protective control in sexual situations where this is 
desired. Furthermore, it is thought that this perception may for some individuals translate into 
the notion that acquiring HIV is inevitable- a fatalism towards one’s sexual health. This form of 
‘escape coping’ and resultant lack of self-regulation, may increase the chances of potentially 
risky sexual situations. 
  
1.9.2 The AURAH and PROUD studies 
This thesis investigates two studies, firstly, the Attitudes to, and Understanding of, Risk of 
Acquisition of HIV (AURAH) study and secondly, the PROUD trial. AURAH is a cross-sectional 
study of HIV-negative or unknown status individuals attending 20 GUM clinics across England 
from 2013 to 2014 
(417)
. It is the largest study of HIV-negative MSM attending GUM clinics in the 
UK (N=1484). Findings will be useful in informing intervention and prevention programmes that 
aim to reach these target populations. Participants were asked to self-complete a confidential 
questionnaire that collected detailed information on socio-demographic, lifestyle, health, and 
sexual behaviour measures. Included as part of this questionnaire, was the PHQ-9, a common 
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instrument used to measure self-reported depressive symptoms in clinical and research 
settings.  
 
The Pre-exposure Option for reducing HIV in the UK, the PROUD trial, assessed the 
effectiveness of PrEP 
(80)
. PROUD was an open-label, randomized controlled trial at 13 GUM 
clinics across England. To be enrolled, men had to be HIV-negative and report a specific 
behavioural profile: CLS in the previous three months and be of the opinion that they would 
have CLS in the next three months. From 2012-2014, men were randomly assigned (1:1) to 
receive PrEP (245mg of tenofovir disoproxil and 200mg of emtricitabine) at enrolment (n=275) 
or after a period of one year (n=269). Follow-up continued for at least two years, until 2016. At 
baseline, socio-demographic, lifestyle, and sexual behaviour data was collected. The PROUD 
trial also incorporated the PHQ-9 at baseline and as part of the subsequent annual 
questionnaires. At follow-up, psychosocial data, including that on internalized homophobia, age 
at anal sex debut (sex at a very young age may include experiences of childhood sexual abuse 
[CSA]), and intimate partner violence (IPV), was collected. As described in detail in Chapters 2 
(section 2.6.3.2) and 3 (section 3.5), the latter two of these factors together with recreational 
drug use are hypothesized in this thesis to confound the relationship between depressive 
symptoms and sexual risk behaviour. 
 
Measurement of depressive symptoms in two large MSM samples of differing behavioural 
profiles in England over a recent time period, in AURAH and PROUD, offers the fortuitous 
opportunity to investigate prevalence and correlates of depression, and the relationship with 
sexual risk behaviour in both studies, and to compare findings. PROUD also adds to findings 
from AURAH by allowing an investigation into the association between markers of internalized 
homophobia and depression, and the relationship between depressive symptoms and sexual 
behaviour adjusted for recreational drug use, a young age at anal sex debut, and IPV. In 
addition, as a longitudinal study, PROUD also provides the opportunity to investigate changes in 
depression prevalence over time. The weaknesses of AURAH and PROUD in addressing the 
thesis hypothesis are discussed in Chapter 3. 
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2 Literature review 
 
2.1 Aims 
This chapter presents a review of quantitative studies, for which the aim was two-fold. Firstly, to 
investigate the relationship between depression measures and sexual behaviour among 
samples of MSM including HIV-negative MSM in North America, Western Europe, Australia, and 
New Zealand. Secondly, to investigate the prevalence of CLS measures and their association 
with other factors among MSM in UK studies including HIV-negative MSM. 
 
2.2 Introduction 
 
2.2.1 Rationale for literature review 
As stated in section 1.9, the relationship between depression and sexual behaviour remains 
unclear. In particular, there is a need for systematic documentation of relevant studies, to 
investigate in which samples of MSM the relationship between depressive symptoms and 
sexual behaviour is present and to assess the magnitude of the effect, and to gain insights into 
mechanisms of effect. All studies that have investigated the link between depression and sexual 
behaviour among MSM in high-income countries will be reviewed in the first section of this 
chapter (review i). Studies will be reviewed according to recruitment site and in the context of 
key sample characteristics, including the prevalence of sexual behaviour, in order to better 
understand in which contexts the relationship is present.  
 
For the second section of this chapter (review ii), all UK studies that have investigated sexual 
behaviour among HIV-negative MSM will be further reviewed. The aim of this section is to: (i) 
describe differences in the prevalence of CLS measures across recruitment sites, in order to 
suggest, based on information from review (i), in which UK samples depressive symptoms may 
be associated with increased sexual risk behaviour, and (ii) describe factors that have been 
investigated and found to be associated with sexual behaviour among MSM in the UK. This is 
useful in identifying potential confounding or mediating factors when assessing the relationship 
between depression and sexual behaviour. 
 
In the proceeding sections, study designs, sampling strategies, and methods of data collection 
that have been commonly used in survey studies of MSM are presented, as this is crucial to 
understanding the terminology used throughout reviews (i) and (ii).  
 
Chapter 2 
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2.2.2 Rationale for quantitative studies of MSM 
MSM remain the group at greatest risk of sexual acquisition of HIV in high-income countries 
(15, 
43, 64, 142, 190-197)
. There is a need for systematic quantitative research on large groups of MSM in 
order to gather information on self-reported sexual risk behaviour that is relatively precisely 
estimated. This is required to guide public health planning, programming, and funding for HIV 
prevention efforts. It is of note however, that quantitative research is limited in its capacity to 
elicit deeper insights into behaviour, perceptions, feelings, and understanding. For this, 
qualitative approaches to research may be required, whereby texts and images, alongside 
numbers and statistics, are analysed in order to decode, translate, and come to terms with the 
meaning of social phenomena 
(418)
.  
 
2.2.3 Study design 
Different study designs can be chosen in order to satisfy the research question. Broadly 
speaking, if the research question concerns the prevalence of a behavioural/biological factor, 
then a cross-sectional design is satisfactory. In a cross-sectional study, all factors are measured 
at one time. Such a study gives a ‘snapshot’ of a population and involves no follow-up. If the 
research question concerns incidence, a longitudinal study (cohort or interventional) is required.  
In a longitudinal study participants are followed over time. In the simplest design, two cohorts of 
participants without the outcome of interest, one with the exposure of interest and one without, 
are followed over time with repeated or continuous monitoring of the outcome. The incidence 
rate of the outcome is then compared between the exposed and unexposed cohorts. 
Confounding can be accounted for by matching the unexposed cohort to the exposed cohort on 
key socio-demographic factors or by measuring known confounders and adjusting for measures 
in statistical analysis. In interventional longitudinal studies, confounding can be controlled for via 
the randomization of participants to the intervention or control group. The occurrence of 
confounding factors would theoretically be equally distributed between groups 
(419)
. Cross-
sectional designs usually require fewer resources and are less time constraining than 
longitudinal study designs. Cross-sectional studies have been most commonly used to assess 
sexual behaviour among MSM 
(419)
. 
 
When interpreting findings from different study designs, it is important to consider temporality. If 
a study aims to assess the relationship between an exposure and an outcome, ideally it should 
be known that the exposure was present before the outcome occurred. A cross-sectional survey 
cannot usually evaluate the temporality of an association as it is often not possible to conclude 
with confidence that the exposure preceded the outcome, since both the exposure and outcome 
were measured at the same time. The exception being, for exposures that are fixed from birth or 
those that are likely to be fixed from a relatively early age, including ethnicity, sexual identity, 
and level of education.  
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2.2.4 Sampling strategies for studies of sexual behaviour among MSM 
In the context of survey research, MSM constitute a ‘hard-to-reach’ population. A ‘hard-to-reach’ 
population is often made up of relatively few individuals and sampling is complicated by the lack 
of a contact list or register of some kind for all members (the sampling frame). Population-based 
research requires a sampling frame and provides the most unbiased estimates at a population 
level. Sampling strategies that involve recruiting a representative sample of MSM from the 
general population cannot be done since no such contact lists are available. It is possible to use 
a large population-based research study in order to obtain a subset of MSM. However, this 
approach may not be feasible, as a very large sample needs to be recruited to obtain a 
sufficient number of individuals with relatively uncommon characteristics 
(420, 421)
. Researchers 
can also use a general population sample but actively boost the number of participants with 
certain characteristics.  
 
2.2.4.1 Study setting  
The most common approach to sampling a ‘hard-to-reach’ population is for the researcher to 
identify a location in which individuals of interest are conveniently available. A convenience 
sample is one that is easily accessible i.e. attendees at an event or venue or a self-selection of 
individuals volunteering to participate. Volunteer samples are ones in which individuals respond 
to study advertisements such as on posters, in newspapers, or on the Internet 
(422-424)
.  
 
In research related to MSM, a common approach is the recruitment of men who have contact 
with sexual health services. Another approach is to recruit men from gay cafes, bars, clubs, 
saunas, and other venues on the gay scene, or from community events/venues associated with 
sexual minority communities 
(120)
. These approaches to recruitment only reach men who attend 
the particular recruitment site and are more likely to recruit those who are regular attenders. The 
emergence of the Internet provides another common way of recruiting MSM for behavioural 
research. Large numbers of men can be recruited in this way. However, the major disadvantage 
to Internet studies is that the number of men who came into contact with the online 
advertisement but chose not to self-select for participation, and as such the characteristics of 
these individuals, is unknown.  
 
2.2.4.2 Sampling method 
There are a number of methods that can be used to select a sample, not all of which are equal 
in their ability to select samples that are representative of the target population. They fall into 
one of two categories: probability or non-probability sampling methods. Probability sampling 
methods require a sampling frame. There are a number of ways in which a probability sample 
can be selected from a sampling frame, including simple random sampling in which every 
individual has the same probability of being selected for the sample. Simple random sampling is 
the gold-standard but may be impractical or too expensive. In some instances researchers may 
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want to include individuals with relatively rare characteristics in the sampling frame, for which 
the research question is of particular interest. In this case, a random selection method called 
stratified random sampling is employed. Researchers assign a greater than simple random 
probability of selecting units with particular characteristics i.e. different sampling probabilities 
are employed across strata. Another method, called systematic random sampling is similar to 
simple random sampling but does not involve separate random selection of each unit. A 
sampling interval is first calculated. For instance, if the sampling frame consisted of households, 
the number of households in the population divided by the number of households required for 
the sample would be calculated to generate the sampling interval. A random household number 
would then be selected between one and the sampling interval as the starting point. The 
sampling interval number is repeatedly added to select subsequent households 
(422)
. Stratified 
and systematic random sampling methods can be combined in a two stage process i.e. a 
sampling frame can be separated into strata and units then systematically sampled from the 
strata. This is called multistage sampling and can include various other random sampling 
methods, through two or more stages 
(422)
. Since probability samples can assign probability 
values of being selected for the study, the strength of the study sample with regards to 
generalizability i.e. the external validity, can be assessed 
(422)
. 
 
Non-probability sampling does not require a sampling frame. Selecting a convenience sample 
involves non-probability sampling methods, with the exception being that two techniques are 
able to approximate probability-based sampling methods. These two techniques are discussed 
after the non-probability forms of sampling. In a convenience sample, one common method of 
selection is consecutive selection of participants. Another form of non-probability sampling, 
which allows for a number of different techniques, is purposive sampling. This method selects 
members of a convenience sample who have particular characteristics of interest to the 
research question. Selected participants can be asked to recommend people they know with the 
desired study criteria, called ‘snow-ball sampling’. Purposive sampling can also be used to 
include an array of subject characteristics in predefined proportions, called quota sampling. 
Taking measures to over (or under) represent particular individuals may reflect a need to 
simulate the actual proportion in the target population (proportional) or, more commonly, may be 
used for analytic reasons (disproportionate).  
 
There are two techniques which are sometimes used in research on MSM that can approximate 
probability-based sampling methods. These are time-location sampling (TLS) and respondent-
driven sampling (RDS) 
(425, 426)
. In TLS and RDS, the probability of selection is not known a 
priori, however weightings are calculated after data collection in order to determine, a posteriori, 
the probability of selection 
(424, 427)
. For instance, in TLS, a complete list of venues visited by the 
target population and the times at which they are visited is drawn up 
(424)
. These are called 
venue-day-time units (VDTs). 
(421)
 These units make up a sampling frame. A simple random 
sample (or stratified sample) of the VDTs is selected. Individuals at these VDTs are 
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consecutively sampled. In order to approximate a probability-based sample, weightings that 
correct for differences between individuals in terms of the frequency with which they attend 
venues are then calculated.
(425)
 The RDS method begins with a small number of peers, recruited 
purposively from the target population, called ‘seeds’. The ‘seeds’ recruit the first wave of 
participants who in turn recruits the second wave.
(428)
 The survey ends when the desired size of 
the sample is reached. To establish weightings it is necessary to collect information on the size 
of each individuals network 
(424, 429)
.  
 
Regardless of whether probability or non-probability methods of sample selection are utilized, a 
convenience sample is biased since the members of it have self-selected and are all similar in 
at least one way. Therefore, any results will only be truly generalizable to those individuals 
reachable in a convenience sample 
(422)
. 
 
2.2.5 Method of data collection 
The only feasible method of collecting data on sexual behaviour in quantitative research is by 
questionnaire, which may be administered or self-completed. Capturing sexual behaviours on a 
questionnaire is subject to social desirability bias i.e. participants may respond in a way that is 
deemed favourable by others, which may result in an underestimation of behaviours. Self-
completion of questionnaires is often used in studies of sexual behaviour to ensure greater 
privacy of responses and encourage more accurate reporting of stigmatized behaviours. A 
number of computerized survey instruments are now commonly used in studies of MSM. These 
include audio computer-assisted self-interviewing (ACASI), computer-assisted self-interviewing 
(CASI), and computer-assisted telephone interviewing (CATI). The advantages of these 
methods include the ability to automate the branching of questions, directly check for missing 
responses and consistency, and provide tailored feedback based on responses, as well as cost 
advantages 
(430)
.  
 
2.3 Methodology for literature review (i) and (ii) 
 
2.3.1 Location of literature  
The following electronic databases were searched: Pubmed, the Cochrane Database of 
Systematic Reviews and the Cochrane Central Register of Controlled Trials. The search 
strategy is presented in Appendix section 11.5 Table 45. A single initial search strategy was 
used for both reviews. Sexual and HIV testing behaviour terms were searched for including 
PrEP and PEP. The reference lists of eligible studies were also searched. The literature was 
reviewed up to 15/11/2017. Studies conducted after 2014 were not reviewed in this chapter, but 
are included in the discussion of AURAH and PROUD results chapters. 
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2.3.2 Inclusion and exclusion criteria 
For review (i), studies were included if they were conducted from 1996 to 2014
xi
 and 
investigated the link between any measure of depression and any measure of sexual behaviour 
or HIV incidence among HIV-negative MSM in North America, Western Europe, Australia, or 
New Zealand. Studies were also eligible if they investigated a composite measure of depression 
and anxiety, although studies which just investigated anxiety were not eligible for this review. A 
search of reference lists of eligible studies was also undertaken. Studies that recruited only 
individuals known to be HIV-positive were excluded. For review (ii), studies were included if they 
were conducted from 1996 to 2014 and investigated HIV sexual transmission risk behaviours 
among HIV-negative MSM in the UK. Studies that recruited only individuals known to be HIV-
positive were excluded. In both reviews, for studies that investigated online samples of men, 
only those that included men resident in the appropriate countries under review (i.e. only UK for 
review ii) were eligible for inclusion. Both observational and interventional studies were eligible 
for inclusion. Longitudinal studies which began prior to 1996 were still eligible for inclusion if 
follow-up data collection took place after 1996 and findings were presented for the post 1996 
period. Only studies that included a quantitative component were eligible for inclusion.   
 
2.3.3 Data extraction 
Results from all studies identified as eligible were reviewed. All eligible studies were organized 
and summarized according to their recruitment setting. If a mixed method approach to 
recruitment was utilized, for instance if men were recruited from sexual health clinics, gay 
venues, and online, then studies were described under the site at which the largest proportion 
of the sample was recruited. For studies that used mixed approaches to recruitment and did not 
report the proportion recruited from each site, the following rules were considered to be 
appropriate: (i) if online sampling was reported, this method of recruitment was assumed to 
have generated the largest number of men for study participation and (ii) if a number of 
community/commercial gay venues were sited together with clinics as sites of recruitment, the 
former was assumed to have generated the largest number of men for study participation. 
Studies that recruited only from sexual health clinics were described in the clinic section. Of 
note, GUM clinics and LGBT health care facilities are referred to collectively as sexual health 
clinics in review (i). When individuals who were previously diagnosed as HIV-positive were 
included, data for the remainder of the sample was extracted where possible.  
 
 
 
                                                     
xi
 These dates were chosen as a result of the introduction of ART in 1996 and since AURAH and PROUD 
recruited men up to 2014.  
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2.4 Results review (i): studies that have investigated depression and sexual behaviour 
among HIV-negative MSM in high-income countries 
 
2.4.1 Relevant studies 
In total, 22 studies (26 publications) and one meta-analysis were identified that recruited a 
sample of MSM or HIV-negative MSM from North America or Western Europe between 1996 
and 2014, and investigated the relationship between depressive symptoms and a measure of 
CLS or HIV incidence. No studies that fit these criteria were identified from Canada, Australia, 
or New Zealand. Two of the 22 studies were conducted in Europe; one in the UK 
(355)
 and the 
other in Belgium 
(358)
. The remaining studies were conducted in the U.S. 
(41, 346, 347, 353, 354, 356, 357, 
359-373, 431)
. In terms of recruitment site, two studies recruited men from the general U.S. 
population. One UK study recruited men from a GUM clinic. Two U.S. studies recruited men 
from an LGBT health and research facility specializing in HIV care (including HIV/STI testing). 
Nine studies recruited men from community or commercial gay venues, and eight studies 
recruited men online. One meta-analysis of studies conducted up to 1999 was identified. The 
findings from this meta-analysis are discussed in section 2.4.4.1. Of note, at the time of 
submitting this thesis (December 2017), no studies were identified that would have been eligible 
for this review but recruited men from 2015 onwards.  
 
In section 2.4.1.1 to 2.4.1.4 below, each study is described in terms of sampling strategy, 
inclusion criteria, method of data collection, and sample size, according to recruitment setting.  
 
2.4.1.1 General population 
The Urban Men’s Health Study (UMHS) 
(41, 354)
  recruited MSM in Chicago, Los Angeles, New 
York, and San Francisco (1996-1998) via household probability telephone sampling (referred to 
as a random digit-dial sample) of areas identified to be of moderate to high MSM residential 
density. Men were eligible for study inclusion if they self-identified as gay or bisexual, or 
reported sexual contact with other men since age 14. CATI was utilized for data collection. The 
sample size was 2674 MSM. It is of note that obtaining a population-based sample of MSM of 
this size is unusual for reasons stated in section 2.2.4 above. However, the sample size was 
achieved by including in the sampling frame, neighborhoods known to be of high sexual minority 
residential density.  
 
The Chicago Male Drug Use and Health Survey (CMDUHS) 
(359)
 was a supplement to a general 
population study that used a probability sampling method to select men and women resident in 
households in Chicago (2002-2003). The CMDUHS sampled areas identified to be of high MSM 
residential density. In a face-to-face screening of individuals from randomly selected 
households, in predetermined neighborhoods, men were deemed eligible for study inclusion if 
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they self-identified as gay or bisexual, or reported a history of consensual sex with other men. 
ACASI was utilized for data collection. The sample size was 216 MSM. 
 
2.4.1.2 Sexual health clinics 
Beck et al. 2003 
(355)
 recruited a convenience sample of MSM in east London (1999), who were 
attending a weekly gay men’s GUM clinic. All men were asked to self-complete a questionnaire. 
The sample size was 122 MSM. 
 
Reisner et al. 2009 
(366)
 recruited a convenience sample of MSM in Boston (2006-2009), who 
were attending the Fenway Community Health center, a health and research facility specializing 
in HIV care among the LGBT community. The study was advertised in the Fenway center, and 
MSM who self-completed a questionnaire volunteered for study participation. The sample size 
was 189 MSM. 
 
The iPrEx clinical trial 
(67, 360)
 was conducted in six countries (U.S., South Africa, Thailand, Peru, 
Ecuador, and Brazil) and randomized MSM (and transgender women) to daily oral PrEP or 
placebo, plus a comprehensive package of prevention services. In the U.S., men were recruited 
from the Fenway center (2007-2009). To be included in the trial men had to report one of the 
following behaviours in the six months prior to the initial study screening visit: (i) anal sex with 
three or more male partners, (ii) diagnosis of STI, (iii) transactional sexual activity, or (iv) CLS 
with an unknown or HIV-positive status partner. Enrolled men were asked to fill out a 
behavioural survey using CASI. The majority of U.S participants identified as Hispanic/Latino 
ethnicity. Of note, from July 2009 onwards, men were asked to provide regular data on 
symptoms of depression. It has been investigated based on U.S. data from 2009 onwards 
(N=2131), whether depressive symptoms were associated with sexual risk-taking.  
 
2.4.1.3 Community and commercial gay venues  
The Young Men’s Survey (YMS) 
(347)
 recruited a probability sample of MSM in Seattle (1998), 
who were attending bars, clubs, businesses, parks, and social organizations (time-location 
sampling). Men were eligible for study inclusion if they were aged between 23-29 years and 
reported having sex with men. An interviewer administered the survey to participants. The 
sample size was 429 MSM. 
 
The EXPLORE study 
(368, 369)
 was conducted in Boston, Chicago, Denver, New York, San 
Francisco, and Seattle, and randomized HIV-negative MSM to receive a behavioural 
intervention or standard risk reduction counseling. EXPLORE had mixed methods of 
recruitment: venue-based, clinic-based, and Internet-based. Men recruited from 
community/commercial gay venues represented the largest proportion of the sample (data not 
shown). Specifically, a consecutive sample of MSM who were attending clubs, bars, 
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bathhouses, sex clubs, health clubs, and video arcades, were recruited (1999-2001). EXPLORE 
also recruited MSM through referrals from other cohort studies, community agencies and clinics 
(purposive sampling), and current study participants were asked to refer other men (snowball 
sampling). EXPLORE also recruited MSM online. Men were eligible for study inclusion if they 
reported having had anal sex with a man in the past year and had not been involved in a 
mutually monogamous relationship in the past two years with an HIV-negative male partner. 
ACASI was utilized for data collection. The sample size was 4295 MSM.  
 
Dudley et al. 2004 
(370)
 promoted a study on sexual decision making among MSM to LGBT 
youth groups and advertised the study on posters and fliers distributed to gay venues, in five 
cities in Midwestern U.S. (exact recruitment period not published, assumed to take place around 
2002-2003). Men were eligible for study inclusion if they were aged between 13-21 years and 
self-identified as gay or reported having had sex with a man. Men who volunteered for study 
participation were asked to self-complete a pen-and-paper questionnaire. The sample size was 
154 MSM. 
 
The Multicenter AIDS Cohort Study (MACS) 
(431)
 was conducted in Baltimore, Pittsburgh, 
Chicago, and Los Angeles, and consisted of a prospective (20 years of follow-up) study among 
initially HIV-negative MSM. MACS was advertised in gay magazines and in gay medical 
practices. Initial assessments took place from 1984 to 1991. MSM who completed a 
questionnaire volunteered for study participation. MACS also recruited a smaller convenience 
sample of MSM attending gay bars and baths and through referrals from gay activists 
(purposive sampling). Current study participants were also asked to refer other men (snowball 
sampling). ACASI was utilized for data collection. The sample size was 4003 MSM. 
 
The Sex and Love Study (version 2.0) 
(371)
, recruited a convenience sample of MSM in New 
York (2003-2004), who were attending a series of LGBT community events. All men who 
walked past the research booth at each community event were asked to self-complete a pen-
and-paper questionnaire. Men were eligible for study inclusion if they self-identified as gay or 
bisexual. The sample size was 669 MSM. 
 
Project MIX 
(362)
 was conducted in New York, Chicago, San Francisco, and Los Angeles, and 
consisted of a behavioural intervention for MSM. Project MIX had mixed methods of recruitment: 
venue-based and Internet-based. Men recruited from community/commercial gay venues 
represented the largest proportion of the sample (data not shown). Specifically, a consecutive 
sample of MSM who were attending bars, clubs, and gay businesses and agencies, were 
recruited (2004-2006). Project MIX also recruited MSM through referrals from local 
agencies/organizations and community advisory board members (purposive sampling). Current 
study participants were also asked to refer other men (snowball sampling). Since the study was 
also advertised on flyers and information cards distributed to community and commercial gay 
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venues, some men who were included in the study volunteered to participate. Project MIX also 
recruited MSM online. Men were eligible for study inclusion if they reported two or more 
occasions of alcohol use or one or more occasions of non-injection drug use during or 
immediately before sex, and reported CLS with an unknown or HIV sero-different status male 
partner in the past six months. ACASI was utilized for data collection. The sample size was 
1540 MSM. 
 
The HONOR project 
(372)
 recruited a convenience sample of MSM in Seattle, San Francisco, Los 
Angeles, Denver, Minneapolis, and New York, who were attending gay venues at which 
individuals of American Indian, Alaska Native or First Nation heritage/identity reside, work, or 
socialize (2005-2007). Since the HONOR project was also advertised in newsletters, brochures, 
and posters distributed to community and commercial gay venues, some men who were 
included in the study volunteered to participate. Finally, HONOR also used partial network 
sampling
xii
 and respondent-driven sampling techniques to recruit an additional small sample of 
men. Men were eligible for study inclusion if they identified as American Indian or Alaska 
Native/First Nations ethnicity, and self-identified as gay, bisexual, or transgender, or reported 
having engaged in same-sex sexual behaviour in the past year. CASI was utilized for data 
collection. The sample size was 173 MSM. 
 
De Santis et al. 2008 
(356)
 recruited a convenience sample of MSM in South Florida (exact 
recruitment period not published, assumed to take place around 2006-2007). This study had 
mixed methods of recruitment: venue-based and clinic-based. Men recruited from 
community/commercial gay venues represented the largest proportion of the sample (data not 
shown). Specifically, MSM who were attending bars, clubs, parties/social events, and places of 
worship, were recruited. This study also recruited men who were attending sexual health clinics. 
A consecutive sample of men was asked to self-complete a pen-and-paper questionnaire. The 
majority of participants identified as Hispanic/Latino ethnicity. The sample size was 205 MSM. 
 
San Francisco’s fourth implementation of the National HIV Behavioral Surveillance System 
(NHBS) 
(363)
 recruited a probability sample of MSM in San Francisco (2014), who were attending 
a range of community and commercial gay venues (time-location sampling). All men were asked 
to participate in the study. Men were eligible for study inclusion if they reported having had sex 
with a man in the past year. An interviewer administered the survey to participants. The sample 
size was 322 MSM. Analyses were conducted separately for HIV-negative (N=240) and HIV-
positive men (N=82).  
 
                                                     
xii
 Network sampling in household surveys involves individuals being linked to households of relatives and 
others with whom they have well-defined relationships, and who could serve as good proxy respondents 
432. Shimizu I, Sirken M. Network Sampling for Rare Trait Inference ASA Section on Survey Research 
Methods: National Center for Health Statistics;  [8th July 2016]. Available from: 
www.amstat.org/sections/srms/proceedings/y2006/files/jsm2006-000397.pdf. 
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2.4.1.4 Online 
Frontiers in Prevention (FIP) 
(353)
 recruited an online sample of MSM residing in New York 
(2005-2006). Men were eligible for study inclusion if they reported using the Internet to meet 
men at least twice per month, self-identified as a barebacker or as someone who practices 
barebacking, had intentional anal CLS during the previous two months with a man met over the 
Internet, and used at least one of six identified popular Internet sites for barebacking. CASI was 
utilized for data collection. The sample size was 120 MSM. Analyses were conducted 
separately for HIV-negative (N=89) and HIV-positive men (N=31). 
 
Men of Asia Prevention Study (MAPS) 
(357)
 recruited a sample of MSM residing in Washington 
and Philadelphia (2004-2007). MAPS had mixed methods of recruitment: Internet-based and 
venue-based. Men recruited online represented the largest proportion of the sample (data not 
shown). A smaller sample of MSM was recruited through referral from community-based 
organizations and by actively approaching potentially eligible men attending bars, public sex 
areas, Pride events, and ethnic specific gay events (purposive sampling). Men were eligible for 
study inclusion if they self-identified as Asian/Pacific ethnicity and reported sex with a man in 
the past year. CASI was utilized for data collection. The sample size was 319 MSM. 
 
Vanden Berghe et al. 2014 
(358)
  recruited a sample of MSM residing in Belgium (2008). This 
study had mixed methods of recruitment: Internet-based and venue-based. Men recruited online 
represented the largest proportion of the sample (data not shown). A smaller, volunteer sample 
of MSM was recruited via advertisement on posters distributed to gay venues. Men were eligible 
for study inclusion if they reported anal sex with a casual partner in the past six months and a 
negative HIV status. Participants were given a link to the survey online. The sample size was 
591 MSM. 
 
The Bareback Project 
(346)
 recruited a probability sample of MSM across the U.S. (2008-2009), 
who were using one of 16 websites (around half of men were recruited from bareback sex 
websites). Men were consecutively asked to participate in a telephone interview if the first letter 
of their username and ethnicity matched a randomly selected profile utilized by different 
recruiters on different days. Recruitment took place during all hours of the day and night. The 
sample size was 332 MSM. 
 
P18 Cohort Study 
(365)
 recruited a sample of MSM residing in New York (2009-2011). The P18 
Cohort had mixed methods of recruitment: Internet-based and venue-based. Men recruited 
online represented the largest proportion of the sample (data not shown). A smaller sample of 
MSM who were attending gay venues and community centres, or were present at parks, and 
college campuses and dormitories, was recruited. Men were eligible for study inclusion if they 
were aged 18 or 19 years old, reported having been sexually active with a man in the past six 
months, and reported a negative or unknown HIV status. Multiracial men and men of black, 
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Latino, and Asian-Pacific Islander ethnicity were over-sampled. ACASI was utilized for data 
collection. Of note, sexual behaviour was measured using the interviewer-administered ‘Time 
Line Follow Back (TLFB) calendar method’, in which participants were asked to provide a 
retrospective account of their sexual behaviour over the past four weeks on a calendar. At 
baseline, the sample size was 598 MSM and at the six months follow-up the sample size was 
509 MSM.  
 
Maksut et al. 2016 
(373)
 recruited a sample of MSM residing in Atlanta (2012-2014). This study 
had mixed methods of recruitment: Internet-based and venue-based. Men recruited online 
represented the largest proportion of the sample (data not shown). A smaller sample of MSM 
who were attending bars, clubs, and bathhouses, and were present in parks and street 
locations, was also recruited. Men were eligible for study inclusion if they identified as black or 
African American ethnicity, reported CLS with a man in the past year, and a negative HIV 
status. ACASI was utilized for data collection.  The sample size was 450 MSM. 
 
The One Thousand Strong panel 
(364)
 recruited an online sample of MSM across the U.S. The 
exact recruitment period was not published, given that the first report was published in 2015, the 
study is assumed to have taken place around 2013-2014. Men who were recruited were existing 
members of the Community Marketing and Insight panel, which consisted of over 22000 gay 
and bisexual men from across the U.S. Men were recruited online, as well as, to a lesser 
degree, from LGBT organizations and events, and via advertisements in LGBT media. Panelists 
were invited to complete a short screening questionnaire online. Men were eligible for study 
inclusion if they self-identified as male and as gay or bisexual, and reported a negative HIV 
status. Participants were given a link to the full survey online. The sample size was 1071 MSM. 
Of note, the association between depressive symptoms and sexual risk behaviour was 
investigated among 1033 men who did not report PrEP use. 
 
Martinez et al. 2016 
(433)
 recruited a sample of Latino MSM residing in New York (2014). This 
study had mixed methods of recruitment: Internet-based and venue-based. Men recruited online 
represented the largest proportion of the sample (data not shown). A smaller sample of MSM 
who were attending community-based organizations was also recruited. Current study 
participants were also asked to refer other men (snowball sampling). Men were eligible for study 
inclusion if they were aged 18 years or older and identified as Latino ethnicity. An interviewer 
administered the survey. The sample size was 176 MSM. 
 
2.4.2 Measures of depression 
Table 1 presents the measures of depression used among the 22 studies that recruited a 
sample of MSM or HIV-negative MSM from North America or Western Europe between 1996 
and 2014. In all studies, symptom questionnaires were utilized for measuring depression. These 
were the Center for Epidemiological Studies-Depressed Mood Scale (CES-D), the Beck 
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Depression Inventory-II (BDI-II), the Patient Health Questionnaire (PHQ-9), the Hospital Anxiety 
and Depression Scale (HADS), and the SF-36 Health survey. In Textbox 3 a description of 
these symptom questionnaires is presented. Internal consistency reflects the coherence of the 
components of a questionnaire scale 
(434)
. Coefficient alpha is the most common measure of 
internal consistency and is routinely reported in psychological research on personality and 
mood assessment 
(435)
. Alphas below .70 are considered to be indicative of poor reliability and 
predictive validity
xiii
 
(437)
. The alpha coefficient for each of the five depression symptom 
questionnaires utilized in studies identified in this review, is presented in Textbox 3. References 
for the studies in which these alpha coefficients were derived, are as follows: CES-D 
(438-440)
, 
BDI-II 
(353, 441)
, PHQ-9 
(442-445)
, HADS 
(446)
, and the SF-36 Health Survey 
(370)
.  
 
Seventeen studies (20 publications) measured depressive symptoms using the CES-D (see 
Table 1). The cut-off for depression was considered to be a score of >22 in two studies, >21 in 
one study, ≥16 in eight studies, >16 in one study, and >10 in another study. Two studies 
investigated categories of depressive symptom severity (‘low, middle, high’ or ‘none, mild, 
major’), two studies split the CES-D score into quartiles, and two studies treated the score as 
continuous. Furthermore, three studies investigated a shortened version of the CES-D; one 
study used a 9-item questionnaire and the other two studies used a 10-item questionnaire. Even 
though the CES-D was the most commonly used depressive symptom questionnaire in studies 
identified in this review, the definitions and classifications of depression varied widely across 
studies. Of the remaining five studies, depressive symptoms were measured using the BDI-II in 
two studies 
(353, 365)
, the PHQ-9 in one study 
(363)
, HADS in one study 
(355)
, and the SF-36 Health 
survey in the final study 
(370)
.  
 
2.4.3 Prevalence of depression 
Table 1 shows the prevalence of depression among the 22 identified studies. Five studies 
across recruitment settings presented the prevalence of depression according to CES-D≥16 and 
estimates ranged from 22.8% to 54.9% (both of these estimates were from men recruited from 
community/commercial gay venues). In the one publication that presented the prevalence of 
depression according to CES-D>22, the estimate was 47.4%. The mean depression score was 
10.7 
(353)
 and 9.8 
(365)
 in the two studies which used the BDI-II, and 3.0 
(370)
 in the one study that 
used the SF-36 Health survey. The prevalence of major and other depressive syndromes was 
13.0% in the one study that used the PHQ-9 
(363)
. Finally, the prevalence of ‘case level’ 
depression was 6.9% in the one study that used HADS 
(355)
. It appears there was no clear 
pattern in prevalence of depressive symptoms according to recruitment setting or study 
selection criteria. Of note, the prevalence of clinically significant depressive symptoms on the 
                                                     
xiii
 It is of note that there are some limitations to the coefficient alpha. For instance, it has been suggested 
that a higher alpha may be obtained via use of almost identical content in the scale. In this instance, 
although the alpha coefficient suggests higher consistency, in reality, with item redundancy, this scale may 
not be very useful 436. Loevinger J. The attenuation paradox in test theory. Psychological bulletin. 
1954;51(5):493-504.  
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PHQ-9 (score of ≥10) has been investigated in the general UK population and this is presented 
and discussed in section 4.4.3 of Chapter 4. 
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Textbox 3: Symptom questionnaires for measuring depression 
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2.4.4 Relationship between depressive symptoms and sexual behaviour measures  
 
2.4.4.1 Meta-analysis 
Crepaz and Marks conducted a meta-analysis of studies assessing the association between 
depressive symptoms and sexual risk behaviour up to 1999 
(352)
. The review did not restrict to 
MSM populations. The vast majority of included studies were conducted in the U.S. Findings 
across studies were inconsistent (and statistically heterogeneous). In combined estimates, there 
was no significant relationship of depression (or anxiety) with measures of CLS (including 
condomless penetrative or oral sex, frequency of condom-use, numbers of sex partners, or their 
composite indices). Stratifying by sample population (MSM, substance users, or other) or HIV 
status did not significantly moderate the association (estimates not published). Of the studies 
included in this meta-analysis, five investigated the relationship between depression and sexual 
risk behaviour among HIV-negative MSM: Coping in Health and Illness Project, N=53 MSM 
recruited from community/commercial gay venues, unadjusted association found 
(447)
; Dilley et 
al. 1998, N=55 MSM recruited from community/commercial gay venues, no unadjusted 
association found 
(448)
; Strathdee et al. 1998, N=371 MSM recruited from sexual health clinics, 
unadjusted association found (disappeared after adjusting for education, substance use, and 
social support) 
(449)
; Amsterdam cohort study, N=118 MSM recruited from 
community/commercial gay venues, no unadjusted association found 
(450)
; University of 
California, San Francisco (UCSF) Coping Project, N=66 MSM recruited from 
community/commercial gay venues, no unadjusted association found 
(451)
. In addition, two 
studies investigated a sample of MSM which included both HIV-positive and HIV-negative men; 
one study finding the reverse association (i.e. depression was associated with less sexual risk-
taking) in unadjusted and adjusted analysis (N=384) 
(452)
 and the other finding no association in 
unadjusted analysis (N=381) 
(453)
. All of these studies recruited MSM before or up to 1996. The 
sample size was small in each study. 
 
Crepaz and Marks suggested that there may be two opposing associations of depressive 
symptoms. In some individuals, depression may lead to increased sexual risk behaviour and in 
others to no sexual activity as a result of lowered libido and interest in sex. If the association 
operates in both directions, assessment of this relationship is problematic since opposing trends 
can result in an observed overall lack of association. For instance, if a study population includes 
participants who report recent sex and those who do not, and if the prevalence of depressive 
symptoms is highest among men who report no sex and among men who report sexual risk-
taking, then investigating the relationship of depression with CLS versus no CLS in this sample 
may result in no association being found. Any difference in prevalence of depressive symptoms 
that exists between men who report CLS and men who report condom-protected sex would be 
obscured due to the fact that the ‘no sex’ and ‘condom-protected sex’ groups had been 
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combined as the comparator group. This hypothesis has informed the presentation of results in 
this review, as described in section 2.4.4.2 below. 
 
2.4.4.2 Classification of studies conducted from 1996 to 2014 in high-income 
countries and study findings 
Table 1 presents findings from the 22 studies (1996 to 2014) identified in the review, relating to 
the association between depression and sexual risk behaviour. The classification of study 
findings is somewhat complicated by the investigation of a number of different sexual behaviour 
measures in most studies and a significant and independent relationship observed for some 
measures but not others. In order to summarize the findings, presented first in the table are 
studies for which an unadjusted and/or adjusted association between depression and at least 
one measure of sexual behaviour (or HIV incidence) was found. Presented after this, are the 
studies that found no unadjusted or adjusted association with any measure of sexual behaviour 
considered. If unadjusted and adjusted results were reported, an association was considered to 
be present if the adjusted results were statistically significant. Accordingly, studies which found 
a significant unadjusted association that disappeared after adjustment were not considered to 
present an association, with the exception of one study (see section 2.4.7). The limitations of 
this approach are discussed in section 2.4.9. 
 
In Table 1, the studies are documented according to recruitment setting. In addition, in view of 
the hypothesis discussed above, results are shown in the context of the prevalence of sexual 
behaviour reported by the sample. In the section below, the unadjusted and adjusted study 
results presented in Table 1 are discussed in relation to: (i) recruitment setting, (ii) measure of 
sexual behaviour, (iii) socio-demographic characteristics, and (iv) prevalence of recent sex. 
When reporting recent sex this refers to anal sex with a man within the recall period used in 
each study, which could be up to 12 months. In section 2.4.5.5 the sexual behaviour profile of 
samples is discussed in the context of the study recruitment setting. Identifying whether certain 
behavioural profiles occur more frequently in certain study settings and thus, whether any 
patterns exist in terms of the study setting and association found, may be useful in 
understanding in which populations targeted interventions addressing depression and sexual 
risk may be most effective/beneficial. Describing patterns, if they do exist, may also be useful in 
order to extrapolate to other similar yet understudied regions such as Europe.   
 
2.4.5 Overall study findings 
Of the 22 identified studies, 20 had a cross-sectional design and two were longitudinal. The 
implications of study design are discussed in section 2.4.6. Overall, 15 studies (68%) found at 
least one significant association between depression and sexual risk behaviour. In each of the 
15 studies, the association was in the same direction; participants who had depressive 
symptoms were more likely to report sexual risk behaviour than those without depressive 
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symptoms. The impact of adjusting for variables on the magnitude of the association found is 
discussed in section 2.4.7 below.  
 
Seven studies did not find evidence for an association between depressive symptoms and 
sexual behaviour. Two studies observed an association before adjustment which disappeared 
after adjusting for socio-demographic factors 
(372)
, poly-drug use, childhood sexual abuse (CSA), 
intimate partner violence (IPV), and sexual compulsivity 
(371)
. One study did not find an 
association in unadjusted or adjusted analysis 
(347)
, two studies investigated the association in 
unadjusted analysis only 
(373, 433)
, and two studies investigated the association in adjusted 
analysis only 
(346, 370)
. Across these seven studies, the sample size was small, ranging from 154 
men 
(370)
 to 669 men 
(371)
. The possible lack of statistical power may explain the lack of 
association observed. However, a number of very small studies were still able to detect a 
difference between men with depressive symptoms and men without in terms of sexual risk-
taking: MAPS (N=62) 
(357)
, FIP (N=89) 
(353)
, Beck et al 2003 (N=122) 
(355)
, De Santis et al 2008 
(N=205) 
(356)
, including in adjusted analysis: CMDUHS (N=177) 
(359)
, Reisner et al 2009 (N=189) 
(366)
, and NHBS (N=240) 
(363)
.  
 
2.4.5.1 Findings according to recruitment setting 
Of 22 studies identified in this review, two recruited men from the general population, three from 
sexual health clinics, nine from community and/or commercial gay venues, and eight from 
online. Of the two general population-based studies, both found an association between 
depressive symptoms and a measure of sexual risk behaviour. Similarly, all three studies of 
sexual health clinic attendees found an association between depression and a measure of 
sexual risk behaviour. Of the nine gay venue-based studies, five found an association with a 
measure of sexual risk behaviour and four did not. Of the eight studies which recruited men 
online, five found an association with a measure of sexual risk behaviour and three did not. It is 
difficult to conclude from these findings whether the association between depression and sexual 
behaviour is more consistently demonstrated in samples recruited from certain settings. The 
implications of recruitment site are discussed in the context of sexual behaviour profiles of 
samples in section 2.4.5.5 below.  
 
2.4.5.2 Findings according to measures of sexual behaviour 
In the 22 studies identified in this review, the most common measure of sexual behaviour 
collected was CLS with one or more partners (recall periods included the past month [n=2], past 
two months [n=1], past three months [n=5], past six months [n=1], and past year [n=2]), followed 
by CLS with an unknown or HIV sero-different status partner (recall periods included the four 
most recent sex partners [n=1], past month [n=1], past three months [n=1], past six months 
[n=2], and past year [n=1]). Other studies investigated CLS with one or more casual/non-
monogamous/non-primary partners (N=4), receptive CLS with one or more partners (N=2), 
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receptive CLS with an unknown or HIV sero-different status partner (N=2), receptive CLS with 
one or more casual/non-monogamous/non-primary partners (N=3), insertive CLS with one or 
more casual/non-monogamous/non-primary partners (N=2), and HIV seroconversion (N=2). 
Investigated in one study only, were the following measures: insertive CLS with one or more 
partners, CLS with a non-primary partner or two or more partners, insertive and/or receptive 
CLS with multiple, casual, or unknown/HIV sero-different status partners, number of acts of CLS 
(including with an HIV-positive partner), the Safer Sex Behaviour Questionnaire (SSBQ), and 
composite measures of risk/risk reduction.  
 
Of the six studies that investigated the association between depressive symptoms and CLS with 
one or more partners, one found an association with depressive symptoms and five did not. Of 
the six studies that investigated the association with CLS with an unknown/sero-different status 
partner, four found an association and two did not. There does appear to be a pattern whereby 
the relationship with depression was more consistently found for CLS with an unknown/sero-
different status partner compared to CLS with one or more partners. However, it is difficult to 
make any firm conclusions given the range of different recall periods investigated and the fact 
that although a number of studies investigated report of ‘any CLS’, half of these studies did not 
investigate the association with depressive symptoms.  
 
2.4.5.3 Findings according to participant socio-demographic characteristics 
Of the 22 studies identified in this review, 18 reported the proportion of participants who had 
previously received an HIV diagnosis. In Project MIX 
(362)
, separate analyses were conducted 
among samples including (47%) and excluding men who self-reported an HIV-positive status. 
Of the ten studies that included only HIV-negative or unknown status men, nine found evidence 
of an association between depressive symptoms and a measure of sexual risk behaviour 
(including Project MIX). Of the nine studies that included HIV-positive men, five found evidence 
of an association between depressive symptoms and a measure of sexual risk behaviour 
(including Project MIX). This could be taken to indicate evidence to suggest that the relationship 
between depressive symptoms and sexual risk behaviour is more consistent among samples of 
HIV-negative/unknown status MSM. However, this comparison is unfortunately complicated by 
the very wide range in prevalence of HIV sero-positivity reported by participants: 9.8% to 59.0%. 
The prevalence of self-reported HIV sero-positivity ranged from 10-51% among studies that 
found an association between depressive symptoms and a measure of sexual risk behaviour 
and from 11-59% among studies that did not find an association. It is difficult to conclude from 
these findings whether the association between depression and sexual behaviour differs by HIV 
status.  
 
Of the 22 studies, seven (predominantly) recruited men of BAME (black, Asian, or other minority 
ethnicity). De Santis et al 2008 
(356)
 recruited mainly Hispanic and Latino men, MAPS
(357)
 
recruited only Asian men, the P18 Cohort 
(365)
 recruited mainly ethnic minority men, HONOR 
(372)
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recruited only men who identified as American Indian/Alaskan Native, Maksut et al 2016 
(373)
 
recruited only men of black ethnicity, Martinez et al 2016 
(433)
 recruited only men of Latino 
ethnicity, and the majority of U.S. participants in the iPrEx trial 
(67, 360)
 identified as 
Hispanic/Latino ethnicity. Of these seven studies, four found an association between depressive 
symptoms and a measure of sexual risk behaviour. Of the 15 studies that did not predominantly 
recruit men of BAME, 11 found an association between depressive symptoms and a measure of 
sexual risk behaviour. There does not appear to be any obvious pattern whereby the 
relationship with depression was more consistent in certain ethnic groups.  
 
Of the 22 studies, three recruited young MSM. The P18 Cohort 
(365)
 recruited only men aged 18-
19 years, Dudley et al 2004 
(370)
 recruited only men aged 13-21 years, and YMS 
(347)
 recruited 
only men aged 23-29 years. Of these three studies, one (P18 Cohort) found an association 
between depressive symptoms and a measure of sexual risk behaviour. Of the 19 studies that 
did not predominantly recruit younger MSM, 14 found an association between depressive 
symptoms and a measure of sexual risk behaviour. Although it appears that the association was 
more consistent in samples including older MSM, it is difficult to conclude the presence of such 
a pattern given the small number of studies which investigated young MSM.   
 
2.4.5.4 Findings according to prevalence of recent sex 
In line with Crepaz and Marks’ theory of opposing associations, there is some evidence to 
suggest that the relationship between depressive symptoms and sexual behaviour is affected by 
the prevalence of recent sex in the sample. Of the 22 studies identified in this review, eleven 
reported the proportion of men reporting recent anal sex with a man (either in the results or 
implicit as part of the inclusion criteria). In nine out of these eleven studies, all or almost all 
participants (98-100%) reported recent sex 
(353, 357-359, 362, 363, 365, 367-369, 373)
. In the remaining two 
studies, <98% of participants reported recent sex- the prevalence was 59.9% (past three 
months) 
(370)
 and 72.0% (past year) 
(372)
. Of the nine studies in which all or almost all participants 
reported recent sex, eight studies (88.9%) found evidence of an association between 
depressive symptoms and a measure of sexual risk behaviour. Of the two studies in which the 
prevalence of recent sex was lower, neither found evidence of an association between 
depressive symptoms and a measure of sexual risk behaviour. Interpreting these findings may 
however, be complicated by the relatively small number of studies presenting the prevalence of 
anal sex and the different recall periods among studies that did.  
 
2.4.5.5 Sexual behaviour profile of samples and recruitment site 
Of all 22 studies identified in this review, six reported both the prevalence of recent sex and 
CLS with one or more partners (either in the results or implicit as part of the inclusion criteria). 
Of the four studies which reported the prevalence of recent sex to be ≥98%, the prevalence of 
CLS with one or more partners was 21.0% (past month) 
(365)
, 96.0% (past two months) 
(353)
, 
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69.1% (past six months) 
(367-369)
, and 100% (past year). Of the two studies which reported a 
lower prevalence of recent sex, the prevalence of CLS with one or more partners was 22.1% 
(past three months) 
(370)
 and 48.6% (past year) 
(372)
. The prevalence of CLS appears to be 
higher in studies with a higher prevalence of recent anal sex
xiv
.  
 
When considering the recruitment setting of the ten studies that reported the prevalence of CLS 
with one or more partners, three recruited men from sexual health clinics, three from 
community/commercial gay venues, and four from online.  The prevalence of CLS with one or 
more partners was 56.0% (past month) 
(355)
, 60.0% (past three months) 
(360)
, and 79.9% (past 
year) 
(366)
 in studies of sexual health clinic attendees. In studies of community/commercial gay 
venue attendees the prevalence was 22.1% (past three months) 
(370)
, 69.1% (past six months) 
(367-369)
, and 48.6% (past year) 
(372)
. Finally, in studies of men recruited online the prevalence 
was 21.0% (past month) 
(365)
, 96.0% (past two months) 
(353)
, 50.6% (past three months) 
(433)
, and 
100% (past year) 
(373)
. It appears that the prevalence of CLS with one or more partners is higher 
in studies which recruited men from sexual health clinics and online compared to studies which 
recruited men from community/commercial gay venues. However, as a result of the differing 
recall periods investigated, it is difficult to directly compare the prevalence of sexual behaviour 
between studies. Furthermore, it is of note, two of the online recruited samples 
(353, 373)
, that 
reported the prevalence of CLS with one or more partners, incorporated inclusion criteria 
requiring men to report recent CLS. These inclusion criteria explain the CLS prevalence of 96-
100%.  
 
2.4.6 Temporality of association 
The vast majority of studies identified in this review incorporated a cross-sectional design. As a 
result, it is not possible to conclude the direction of causality. It is possible that the associations 
observed between depressive symptoms and increased sexual risk behaviour may operate in 
the opposite direction; it could be that in some men sexual risk-taking leads to symptoms of 
depression. It is also possible that the association operates in both directions. There is a large 
body of theoretical work, however, suggesting that depression can lead to CLS (see section 
1.8.3). Two studies were identified in this review that incorporated a longitudinal design and 
investigated the association between depressive symptoms and HIV incidence (EXPLORE 
(367-
369)
 and MACS 
(361, 431)
). Although an association with HIV incidence was only observed in 
EXPLORE, men with depressive symptoms at baseline of MACS were more likely to be placed 
in the high sexual risk trajectory group than the low sexual risk trajectory group after eleven 
years of observation, including after adjustment for socio-demographic factors and substance 
use. These findings provide some evidence in favour of concluding that depression leads to 
CLS.  
 
                                                     
xiv
 Although this is as expected, it was also possible that samples of sexually active men may not report 
(high levels of) CLS. 
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It is of note, of the 22 studies identified in this review, none investigated whether the prevalence 
of sexual risk behaviour was lower among men who were receiving treatment for depression 
and did not report depressive symptoms. It is therefore, not possible to comment based on 
findings from this review, as to whether the effect of depression on sexual behaviour was 
reversed with the removal of symptoms with treatment. Such an investigation would be helpful 
in providing further evidence of causality. Criteria for concluding evidence of causality is 
discussed in section 3.4.4 of Chapter 3 and further explored in the final conclusion chapter of 
this thesis. 
 
2.4.7 Magnitude of effect 
Unfortunately, it is very difficult to compare the magnitude of associations found given that 
multiple measures of depression and sexual behaviour were investigated, using various 
statistical methodologies. Depression measures on CES-D were most commonly investigated 
with sexual behaviour measures in logistic regression models, producing odds ratios, ORs 
(N=12) 
(41, 347, 358-362, 364, 366, 367, 371, 372)
. Of these 12 studies, eight found an association with a 
measure of sexual risk behaviour 
(358-362, 364, 366, 367)
. The magnitude of these ORs ranged from 
1.3 for the association between CES-D≥16 and CLS with an unknown/HIV-positive status 
partner at last episode of sex (EXPLORE, men recruited from community/ commercial gay 
venues)
(367)
, to 5.72 for the association between high scores on CES-D versus low scores and 
report of both insertive and receptive CLS with multiple, casual, or unknown/HIV sero-different 
status partners in the past six months (CMDUHS, general population study)
(359)
. In both studies 
these ORs were adjusted for socio-demographic factors and alcohol and drug use. 
 
Of the 15 studies that found an association with a measure of sexual risk behaviour, three 
reported the association in unadjusted and adjusted analysis 
(353, 366, 367)
 (Table 1). In two out of 
these three studies, the association was somewhat attenuated after adjusting for a set of 
variables. In FIP (N=89) 
(353)
, a depressive symptom score was investigated as the dependent 
variable and the association with CLS with an HIV-positive partner in the past two months was 
attenuated after adjustment for socio-demographic factors (ethnicity, income, and educational 
attainment) 
(353)
. In EXPLORE (N=4295) 
(367)
, the association between depressive symptoms 
and CLS with an unknown/HIV-positive status partner at last episode of sex was attenuated 
after adjustment for socio-demographic and lifestyle factors (age, ethnicity, educational 
attainment, income, and substance use). In the remaining study (Reisner et al 2009, N=189 
(366)
) 
the association between depressive symptoms and a composite measure of risk increased after 
adjustment for socio-demographic and lifestyle factors (age, ethnicity, educational attainment, 
income, disclosure of sexual orientation, HIV status, STI history, drug and alcohol use, and 
sexual partner meeting venues). It is of note, that one other study (Vanden Berghe et al 2014, 
N=591 
(358)
) reported the association in unadjusted and adjusted analysis. The following factors 
were included in adjusted analysis: age, education, alcohol use, drug use, markers of sensation 
seeking, risk perception regarding insertive CLS, risk perception regarding receptive CLS, 
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perceived social norm for condom-use, and markers of unsupportive social interactions. The 
significant unadjusted association disappeared after adjusting for these factors. However, levels 
of social support are thought to be highly correlated with depression 
(358, 454, 455)
. As a result, this 
study was classified as having found an association between depression and sexual risk 
behaviour. It is possible that the association between depressive symptoms and sexual risk 
behaviour is not independent of socio-demographic and lifestyle factors. With so few studies in 
this review presenting unadjusted and adjusted model estimates, it is difficult to examine this 
further. 
 
In most epidemiological studies, it is a matter of debate which factors should be adjusted for in 
analysis. Some socio-demographic factors are fixed from birth or from a relatively early age 
(e.g. ethnicity, sexual identity, level of education), whereas recreational drug use may be a 
consequence or prederminant of depresssion. One study in this review was considered not to 
show a relationship since the association disappeared after adjusting for socio-demographic 
factors, poly-drug use, CSA, IPV, and sexual compulsivity. Since it is possible that one or more 
of these factors is on the causal pathway, it is difficult to judge the extent to which this study 
provides evidence for depression being a risk factor for sexual risk behaviour.  
 
2.4.8 Mechanisms of effect 
Of the 22 studies identified in this review, one (Project MIX 
(362)
) investigated potential factors on 
the causal pathway between depression and sexual risk behaviour using mediational analysis. 
Mediational analysis investigates whether the association between an exposure and outcome 
operates fully or partially via an intermediate factor(s) within a hypothesized causal chain 
(456)
. 
Mediational analysis is revisited in further detail in Chapter 3 section 3.4.2. In Project MIX, it 
was hypothesized that the relationship between depression and sexual risk behaviour would be 
partially mediated by self-efficacy for sexual safety, cognitive escape, and avoidant coping 
(avoidance of situations/thoughts that trigger anxiety) 
(362)
. Adjusting for age, income, education 
level, ethnicity, HIV status, and research site, depressive symptoms were found to be 
associated with higher numbers of CLS partners of unknown or HIV sero-different status in the 
past three months indirectly via low self-efficacy for sexual safety or cognitive escape 
tendencies. As a result, it was reported in this study that psychological vulnerabilities and 
dysfunctional coping processes may be possible mechanisms of effect for the relationship of 
depression with sexual risk behaviour. Further details of the mediational analysis in Project MIX 
are presented in Chapter 6 in the context of findings in this thesis. 
 
2.4.9 Summary 
There was considerable evidence based on this review of 22 high-income country studies of 
MSM (1996-2014) for an association between depression and increased sexual risk behaviour, 
but with varying estimates of magnitude of effect. There was little evidence to suggest that the 
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presence of an effect varied according to study recruitment setting, socio-demographic 
characteristics of the sample, or the measure of sexual behaviour investigated. However, the 
number of studies with certain socio-demographic characteristics (i.e. a younger age group) 
was too small to allow for more meaningful comparisons. There was some evidence to suggest 
that the presence of an effect was dependent on the proportion of the study population that was 
sexually active. There are, however, a number of limitations to interpreting findings from this 
review. Whether an association between depressive symptoms and sexual risk behaviour 
remained statistically significant after adjustment was subject to which set of variables was 
adjusted for. Where sets of adjusted variables differed, studies may be estimating a different 
effect/answering a different question. Furthermore, examining whether associations are 
statistically significant is subject to the study sample size and whether adjustment takes place at 
all is subject to the sample size. Finally, there is the issue of publication bias, whereby studies 
that report an association between depression and sexual behaviour may be more likely to be 
submitted or accepted for publication compared to studies that report weaker or no 
associations. Therefore, it is possible that the interpretation of study findings for review in this 
thesis was subject to bias. It is perhaps reassuring however, that the pattern of overall study 
findings appeared to be in line with that hypothesized by Crepaz and Marks decades previously. 
Findings from review (i) and potential implications will be discussed in detail together with the 
findings from review (ii), at the end of this chapter.
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting  
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs. no 
depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
UMHS  
(41, 354)
, U.S. 
(N=2881), 
general 
population 
 
17%
 ii
 
 
CES-D<16 
CES-D≥16 
 
/ / CLS 2+/ 
any CLS (no 
primary partner) 
12 
months 
 
/ 19.0% 
25.6% 
χ
2 
test p<0.001 
/ / 
 
 
/ 
Receptive CLS 
with unknown/ 
sero-different 
partner 
12 
months 
/ 3.2% 
3.6% 
χ
2 
test p>0.100 
/ / 
 
 
 
/ 
CES-D≤22 
CES-D>22 
/ / CLS with 
unknown/ sero-
different partner 
4 most 
recent 
sex 
partners 
/ / OR 1 
1.1 [0.8, 1.5] 
Age, 
education, 
ethnicity, 
income, HIV 
status 
CMDUHS 
(359)
, U.S. 
(N=177), 
general 
population 
15% 
 
CES-D: 
Low≤2 
Middle≤7  
High≥8 
(23.2%) 
 
 
6 
months 
100% Only insertive
xxviii 
CLS & risky 
partner
n 
6 
months 
 
14.7% 
 
/ OR
o
 1 
0.94 [0.41, 2.19] 
0.41 [0.11, 1.44] 
Drug use, 
drinking, HIV 
status, race 
Only receptive
xxix
 
CLS & risky 
partner
n 
6 
months 
 
15.8% 
 
/ OR
o
 1 
0.69 [0.22, 2.21] 
0.50 [0.13, 1.97] 
Drug use, 
drinking, HIV 
status, race 
Insertive & 
receptive CLS & 
risky partner
n 
6 
months 
9.6% / OR
o
 1 
2.99 [0.65, 1.37] 
5.72 [1.76, 18.9] 
Drug use, 
drinking, HIV 
status, race 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs no 
depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
Beck et al 
2003
(355)
, UK 
(N=122), 
sexual health 
clinics 
9.8% 
 
HADS<11 
HADS≥11 
(6.9%
k
) 
 
 
/ 
 
/ 
 
CLS 1+ partners 1 month 56.0%
l
 / / / / 
CLS with 
unknown/sero-
different partner: 
Yes 
No 
1 month 43.6%
m
 
% reporting: 
HADS≥11
p
 
13.6% 
2.7% 
χ
2 
test p=0.010 
/ / / 
Reisner et al 
2009
(366)
, 
U.S. 
(N=189),  
sexual health 
clinc 
51% 
 
CES-D<16 
CES-D≥16 
(43.4%) 
/ / CLS with 1+ 
partners 
12 
months 
79.9% 
 
/ / / / 
Composite 
measure of 
sexual risk-taking
z
 
12 
months 
20.1% 1 
2.08 [0.99, 4.55] 
p<0.050 
OR 1 
3.13 [1.09, 9.09] 
p<0.050 
Socio-
demographic 
and lifestyle 
factors
xii
 
iPrEx
(360)
, 6 
countries 
(N=2131
xxiii
),  
sexual health 
clinics 
0% / / / Baseline: 
CLS with 1+ 
partners 
3 
months 
60.0% / / / / 
CES-D  
quartiles: 
≤7 
8-12 
13-19 
>19  
Median=12 
Mean=14 
Receptive CLS 
with 1+ 
partners
xxiii
 
3 
months 
61.0% / OR
xxii 
 
1 
1.17 [0.88, 1.57] 
1.21 [0.90, 1.61] 
1.46 [1.09, 1.94] 
p=0.012 
Age, study 
site, anti-
depressants, 
number of 
sexual 
partners 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample 
size of 
MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs no 
depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
EXPLORE 
(367-369)
, 
U.S. 
(N=4295), 
community/ 
commercial 
gay venues  
0%
 t
 
 
CES-D  
quartiles: 
7-12 
13-17 
18-22  
>23  
(14.2% for 
score 18+) 
 
6 
months  
98% CLS 1+ partners
 t
 6 
months 
69.1% 
 
/ 
 
/ / 
 
/ 
Receptive CLS 1+ 
partner 
6 
months 
48.0% 
 
/ 
 
/ / 
 
/ 
 
Insertive CLS 1+ 
partner 
6 
months 
54.9% 
 
/ / / 
 
/ 
 
HIV 
seroconversion 
 
4 year 
follow-
up  
2.1 per 
100 
person 
years
va 
n=258 
1 
1.94 [1.45, 2.56] 
1.96 [1.33, 2.89] 
2.44 [1.47, 4.03] 
HR
x
 1 
1.48 [1.12, 1.96] 
w 
w 
Socio-
demographic, 
lifestyle, and 
sexual 
behaviour 
measures
xi
 
CLS with 
unknown/HIV+ 
partner 
6 
months 
/ / RR 
(GEE
y
) 
Higher CLS with 
higher depression 
score (estimate 
not shown) 
p<0.001
 
Age, 
education, 
ethnicity, 
randomization 
arm, study site 
CES-D<16 
CES-D≥16 
(47.0%) 
CLS with 
unknown/HIV+ 
partner  
Most 
recent 
episode 
of sex 
16% 1 
1.5 [1.3, 1.7] 
p<0.001 
OR (GEE) 1 
1.3 [1.2, 1.5] 
p<0.001 
Age, ethnicity, 
education, 
income, 
substance use 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs no 
depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
MACS  
(361, 431)
, U.S. 
(N=4003 
from 1984-
2004; 
N=419 from 
2003-2004), 
community/ 
commercial 
gay venues 
0%
t
 1984-2004: 
CES-D<16 
CES-D≥16 
/ / HIV 
seroconversion 
 
30 year 
follow-
up 
n=436 1 
0.83 [0.64, 1.08] 
HR
xa
 1 
0.83 [0.63, 1.09] 
Socio-
demographics, 
lifestyle 
factors, sexual 
behaviour
iii
 
0% 2003-2004: 
CES-D<16 
CES-D≥16 
(54.9%) 
/ 
 
/ 
 
Risk group 
xviii
: 
Moderate (vs. 
low) 
 
Sexual 
risk 
trajecto-
ries 
(2003-
2011) 
22.9% 
 
/ OR
xix
 1 
1.37 [0.73, 2.55] 
 
Study site, 
age, ethnicity, 
education, 
income, 
substance use 
Risk group 
xviii
: 
High  
(vs. low) 
Sexual 
risk 
trajecto-
ries 
(2003-
2011) 
14.1% / OR
xix
 1 
2.36 [1.14, 4.92] 
Study site, 
age, ethnicity, 
education, 
income, 
substance use 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, country, 
sample size of 
MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs no 
depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
Project 
MIX
(362)
,  
U.S. (N=1540 
full sample
xb
; 
N=599 HIV-
negative 
sample), 
community/ 
commercial 
gay venues  
47%  CES-D9:  
mean 
severity 
score
b 
Moderate 
(39.0%)  
High (22.0%) 
6 
months  
100% CLS with 
unknown/sero-
different partner
c
 
3 
months 
72.5% F(1, 1.523)=10.45 
β=0.084 
R
2
=0.007 
p<0.010 
RR
d
 F(2, 1522)=26.22
e
 
β=0.060 
R
2
=0.032 
p<0.001 
Self-
efficacy for 
sexual 
safety 
 
0%
h
 CES-D9 
symptoms: 
≤at times 
>at times 
(score>2: 
39.0%) 
CLS with 1+ non-
primary partners 
3 
months 
60% / OR 1 
1.27 [0.90, 1.80] 
Age, 
education, 
ethnicity, 
city 
Receptive CLS 
with 1+ non-
primary partners 
3 
months 
27% / OR 1 
1.58 [1.07, 2.33] 
Insertive CLS with 
1+ non-primary 
partners 
3 
months 
39% / OR 1 
0.86 [0.59, 1.23] 
De Santis et al 
2008
(356)
,  
U.S. (N=205), 
community/ 
commercial 
gay venues  
/ CES-D≤16 
CES-D>16 
(33.7%) 
/ / SSBQ
a
 score<78 
(indication of 
lower levels of 
safer sex 
behaviour) 
/ 52.2% F(1, 203)= 
4.312 
R
2
=0.144 
p=0.039 
RR
d
 / / 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs 
no depression 
Variables 
adjusted for 
Association found (for each study significant associations are shown in red) 
NHBS 
(363)
, 
U.S. 
(N=240) 
community/ 
commercial 
gay venues 
0%
h
 PHQ-9 major 
& other 
depressive 
syndromes: 
No
xxvii
 
Yes (13.0%) 
12 
months  
100% CLS with 
unknown/HIV+ 
partner 
6 
months 
/ / Marginal 
risk 
difference
 
xiv
 
Reference 
-16.5 [-22.7,  
-10.2] 
Age, ethnicity, 
poverty, social 
support, 
discrimination, 
alcohol 
Receptive CLS 
with unknown/ 
sero-different 
partner 
6 
months 
/ / Marginal 
risk 
difference
 
xiv
 
Reference 
-6.4 [-10.8, -2.1] 
Age, ethnicity, 
poverty, social 
support, 
discrimination, 
alcohol 
FIP 
(353)
 
U.S.  
(N=89 HIV- 
men; N=120 
overall, 26% 
HIV+),  
online 
0% 
 
BDI-II mean 
score  
(10.7; SD=1) 
2 
months  
100%
s
 CLS 1+ occasions 2 
months 
96%
q 
 
/ 
 
/ / 
 
/ 
Frequency of CLS 
with HIV+ partner 
2 
months 
 
Media
n=1,IQ
R=3
 
0.23 
Spearman's rho 
p<0.05 
/ / / 
Any CLS with 
HIV+ partner: 
Yes 
No 
2 
months 
49.4% % reporting high BDI-II
  
scores
p
; 
13.5% 
7.9%  
Mann-Whitney U
 
test 
p=0.016 
RR
r
 BDI-II
  
as 
dependent 
variable: Wald 
(1, n= 83)=4.49; 
p=0.034 
Ethnicity, 
income, 
education 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual 
intercourse  
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of 
sexual behaviour in 
those without and 
with depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs 
no depression 
Variables adjusted 
for 
Association found (for each study significant associations are shown in red) 
MAPS
(357)
, 
U.S. 
(N=62
xxvi
), 
online 
/ CES-D: 
None (≤15) 
Mild 
Major (27+) 
12 
months  
100% CLS with 1+ 
partners 
3 months / 15.8% 
25.0% 
62.5% 
χ
2 
test p=0.04 
/ / / 
Vanden 
Berghe et al 
2014
(358)
, 
Belgium 
(N=591), 
online 
0%
h
 CES-D≤21 
CES-D>21
f
 
(29.3%) 
 
6 
months  
100%
g
 CLS with 
casual 
partner 
6 months 34.0%  1 
1.66 [1.16, 2.37] 
p=0.006 
OR 1 
0.94 [0.58, 1.54] 
p=0.806
i
 
Socio-demographic 
and lifestyle factors
j
 
P18 Cohort 
(365)
, U.S. 
(N=509), 
online 
0%
xv
 BDI-II score: 
Minimal 0-9 
Mild 10-18 
Moderate 
19-29 
Severe  
30-36 
12 
months  
100%
 
xvi
 
Acts of CLS: 
0 
1 
>1 
4 weeks 4.6 
mean 
acts 
SD=7 
0.09 
Spearman's rho 
p<0.05 
/ / / 
BDI-II mean 
score  
(9.8; SD=8.7) 
CLS with 1+ 
partners 
4 weeks 21.0% / IRR
xvii
 0.99 [0.97, 1.01] 
p=0.228 
Drugs, alcohol, 
relationship, 
education, SES, 
compulsive sexual 
behaviour 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of sexual 
behaviour in those 
without and with 
depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs 
no depression 
Variables 
adjusted 
for 
Association found (for each study significant associations are shown in red) 
One 
Thousand 
Strong 
(364)
, 
U.S. 
(N=1033),  
online 
0%
h
 CES-D
xx
 
mean score  
(16.3; 
SD=11.5) 
 
/ / CLS with a casual 
partner 
3 
months 
 
 
32.0% / OR 1.21 [0.96, 1.54] 
p=0.11 
Age, 
ethnicity, 
education, 
relationship 
Receptive CLS 
with a casual 
partner 
/ / OR 1.43 [1.08, 1.90] 
p<0.01 
Insertive CLS with 
a casual partner 
/ / OR 1.17 [0.90, 1.51] 
p=0.24 
CLS events with 
casual partners 
/ / RR
xxi
 1.40 [1.23, 1.60] 
p<0.001 
Receptive CLS 
events with 
casual partners 
/ / RR
xxi
 1.97 [1.67, 2.32] 
p<0.001 
Insertive CLS 
events with 
casual partners 
/ / RR
xxi
 1.19 [1.02, 1.38] 
p=0.02 
CES-D: 
Quadratic 
term 
CLS events with 
casual partners 
/ / RR
xxi
 1.32 [1.08, 1.63] 
p<0.01 
Receptive CLS 
events with 
casual partners 
/ / RR
xxi
 1.63 [1.25, 2.12] 
p<0.001 
Insertive CLS 
events with 
casual partners 
/ / RR
xxi
 1.09 [0.87, 1.36] 
p=0.44 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual 
intercourse  
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, 
country, 
sample size 
of MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of 
sexual behaviour in 
those without and 
with depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs 
no depression 
Variables 
adjusted for 
Association not found 
YMS 
(347)
,  
U.S. (N=429), 
community/ 
commercial 
gay venues  
 
/ CES-D<16 
CES-D≥16 
(22.8%) 
/ / CLS with non- 
monogamous 
partner 
 
6 
months 
 
8.9% 
 
1 
1.57 [0.80, 3.10] 
 
OR 1 
1.08 [0.51, 2.30] 
 
Education, 50+ 
lifetime sex 
partners, age at 
first anal sex<18 
Receptive CLS 
with non-
monogamous 
partner 
6 
months 
 
6.1% 1 
1.23 [0.66, 2.27] 
OR 1 
0.86 [0.43, 1.71] 
Education, 50+ 
sex partners, age 
at first anal 
sex<18, age at 
first oral sex<18, 
forced sex 
Dudley et al 
2004
(370)
, U.S. 
(N=154), 
community/ 
commercial 
gay venues 
/ SF-36 Health 
Survey
 iv 
mean score 
(3.0, SD=1.1) 
3 
months  
59.9% CLS with 1+ 
partners 
3 
months 
22.1% 
vb
 
39.2% 
vi
 
/ RR
vii
 β=0.04 
p>0.05 
Age, relationship, 
personality traits, 
risk behaviour
vii
 
Sex and Love 
(371)
, U.S. 
(N=669), 
community/ 
commercial 
gay venues  
11% CES-D≤22 
CES-D>22 
(47.4%) 
/ / CLS with non-
primary partner 
of unknown/ 
sero-different 
status 
3 
months 
11.5% 1 
2.04 [1.23, 3.37] 
OR 1 
1.62 [0.89, 2.96] 
Age, education, 
ethnicity, income, 
HIV status, poly-
drug use, CSA, 
IPV, sexual 
compulsivity 
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Table 1: Studies conducted from 1996 that have investigated the association between depression and sexual risk behaviour among samples of 
MSM, including HIV-negative MSM, in North America and Western Europe, according to whether an association was found and recruitment setting 
(continued) 
 HIV+ 
(self-
report) 
Prevalence 
of depression 
Prevalence of 
sexual intercourse 
(with a man) 
Prevalence of CLS (with a man) Association of depression with sexual risk behaviour 
Study, country, 
sample size of 
MSM, 
recruitment 
setting
 xiii
: 
% Measure  
%depressed 
Recall 
period 
% Measure  Recall 
period 
% Prevalence of 
sexual behaviour in 
those without and 
with depression 
and unadjusted 
association  
Measure 
of effect 
size 
Adjusted 
association for  
depression vs 
no depression 
Variables 
adjusted for 
Association not found 
HONOR 
(372)
,  
U.S. (N=173)
ix
, 
community/ 
commercial 
gay venues 
34% CES-D<10 
CES-D≥10 
(54.1%) 
12 
months  
72% CLS with 1+ 
partners 
12 
months  
48.6% 
 
1 
1.5 [0.8, 2.8] 
OR 1 
1.0 [0.5, 2.1] 
Age, housing 
status 
CLS with 
unknown/sero-
different partner 
12 
months  
20.0% 1 
2.3 [1.0, 5.0] 
OR 1 
1.8 [0.7, 4.3] 
Age, housing 
status 
Bareback 
Project 
(346)
, 
U.S. 
(N=332)
viii
, 
online 
59% CES-D<16 
CES-D≥16 
(26.7%) 
/ / Proportion of anal 
sex acts that 
involve condoms 
3 
months 
/ / Beta 
values 
from SEM 
p=0.370 Demographic 
and 
psychosocial 
factors
xxx
 
Maksut et al 
2016
(373)
, U.S. 
(N=230 
YBMSM; 
N=220 
OBMSM
 xxiv
),  
online 
0%
h
 YBMSM: 
CES-D10<10 
CES-D10≥10 
(45.0%) 
12 
months 
 
100%
 xxv
 
 
CLS with 1+ 
partners 
3 
months 
/ 
(100% 
past 
year) 
1 
1.02 [0.99, 1.04] 
RR
xxi
 / / 
OBMSM: 
CES-D10<10 
CES-D10≥10 
(50.8%) 
CLS with 1+ 
partners 
3 
months 
/ 
(100% 
past 
year) 
1 
1.01 [0.99, 1.03] 
RR
xxi
 / / 
Martinez et al 
2016
(433)
, U.S. 
(N=176), 
online 
34% CES-D10<10 
CES-D10≥10 
(69.4%) 
/ / CLS with 1+ 
partners 
3 
months 
50.6% χ
2
= 3.48, p>0.05 
(proportions not 
shown) 
/ / / 
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2.5 Results review (ii): UK studies that have investigated sexual behaviour among HIV-
negative MSM 
 
2.5.1 Relevant UK studies 
In total, 27 UK studies conducted from 1996-2014, comprising of 68 separate surveys, that 
recruited a sample of MSM or HIV-negative MSM and investigated measures of HIV sexual 
transmission risk behaviour, were identified. Most of these studies consisted of a serial cross-
sectional design, whereby the recruitment of men for survey completion was repeated over a 
number of years. A brief summary of all studies identified is given below according to 
recruitment setting. Table 2 presents each study with the year of recruitment and sample size, 
according to recruitment setting. Table 2 also shows in which surveys sexual behaviour 
measures considered to be most frequently collected in behavioural surveillance studies of HIV 
transmission among MSM, were measured. The most common measures of CLS were 
considered to be: (i) CLS with one or more partners, (ii) CLS with two or more partners, and (iii) 
CLS with a partner of unknown or sero-different HIV status. For measure (iii), a sero-different 
partner includes both HIV-negative and HIV-positive men, depending on the HIV status of the 
man reporting the CLS. It is of note however, that determining whether a partner is of a sero-
different HIV status is complicated by the fact that, depending on the timing of the last HIV test, 
an individual who may consider himself to be HIV-negative may in fact be HIV-positive. Where 
studies collected information on measures (i), (ii), or (iii), a tick is shown in Table 2. The CLS 
measures presented in Table 2 do not cover all sexual behaviour measures that each study 
collected. The prevalence of CLS measures (i)-(iii) are presented and discussed in section 
2.5.2. 
 
In addition, Table 2 shows in which surveys socio-demographic and psychosocial factors 
defined a priori to be of greatest relevance to sexual behaviour, as well as mental health, 
among MSM, were measured. Key socio-demographic factors were considered to be: age, 
ethnicity, sexual identity, education, and relationship status. These variables were considered to 
constitute the major demographic factors and the most common socio-economic measures. Key 
psychosocial factors were considered to be: depression, recreational drug and alcohol use, 
childhood sexual abuse (CSA), and intimate partner violence (IPV). Where information on a 
factor was collected, a tick is shown in Table 2. The measures presented in Table 2 do not 
cover all socio-demographic and psychosocial variables that each study collected. Of note, one 
of the studies in Table 2 that measured depression 
(355)
, was also included in review (i). The 
other studies in Table 2 that measured depression were not included in review (i) since they did 
not investigate the association between depression and sexual behaviour. A review of socio-
demographic and psychosocial factors investigated and found to be associated with sexual 
behaviour measures, is presented in section 2.5.4. 
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2.5.1.1 General population 
Only the British National Survey of Sexual Attitudes and Lifestyles (Natsal) recruited MSM from 
the British general population. Natsal uses a multistage probability sampling method to select 
men and women resident in private households in Britain and consists of a cross-sectional 
survey, which has been conducted three times to date 
(457, 458)
.  
 
2.5.1.2 Sexual health clinics 
Ten studies recruited convenience samples of men from GUM clinics, mostly for one-off 
surveys. Seven studies recruited MSM from GUM clinics in London 
(102, 355, 459-466)
 or Brighton 
(467)
, including one randomized controlled trial (RCT) of a cognitive behavioural intervention to 
reduce STIs among gay-identified men in London 
(461)
. Three studies recruited MSM from GUM 
clinics in several cities across the UK 
(35, 468, 469)
. These included two annual behavioural 
surveillance surveys: the Lymphogranuloma venereum (LGV) Enhanced Surveillance system 
(468)
 and the GUM clinic activity dataset (GUMCADv2) 
(469)
. GUMCADv2 is an anonymized, 
patient-level, electronic dataset which collects information on STI diagnoses from all patients 
attending GUM clinics and other sexual health services in England 
(470)
. The socio-demographic 
characteristics of each patient is collected for GUMCAD at the first clinic attendance. 
Information on sexual orientation is ascertained as part of sexual history taking in clinic and is 
incorporated into the GUMCAD dataset. 
 
2.5.1.3 Community and commercial gay venues 
Eight studies recruited a convenience sample of men from community or commercial gay 
venues. Of these studies, five used time-location sampling (TLS) to recruit men visiting gay 
bars, clubs, and saunas: The Gay Men’s Sexual Health Survey (GMSHS) in England 
(conducted 14 times to date) 
(117, 120, 144, 471-473)
, the GMSHS in Glasgow and Edinburgh 
(conducted six times to date)
(180, 474-476)
, Testing Barriers project in Glasgow and Edinburgh 
(conducted three times to date) 
(96-98, 103-105, 477)
, and two one-off cross-sectional surveys in 
Edinburgh 
(478)
 and Glasgow (Make Your Position Clear, MYPC) 
(479, 480)
. One study, the Gay 
Men’s Survey, recruited a consecutive sample of men visiting gay bars, clubs, and saunas in 
London (one-off survey) 
(481)
, and another study, the 4 gym project, recruited a consecutive 
sample of MSM attending gyms in central London (conducted seven times to date) 
(116, 129, 482-
487)
. The final study recruited a volunteer sample of MSM reading gay magazines for an HIV risk 
reduction intervention addressing sadomasochistic sex (the ‘SM’ sex study) in London. An RCT 
was set up to establish its efficacy 
(488)
. 
 
2.5.1.4 Online 
Finally, eight studies recruited a volunteer sample of men online, predominantly from gay dating 
websites: The Gay Men’s Sex Survey (GMSS) across the UK (conducted 13 times to date) 
(489-
497)
, The Sigma Panel in England (monthly programme of focused questions) 
(414)
, The Internet 
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and HIV Study in London (conducted twice to date) 
(464-466)
, The Men and Sexual Health (MESH) 
Project of BAME and migrant MSM across the UK (one-off survey) 
(498, 499)
, the Sexual Attitudes 
and Lifestyles of London’s Eastern Europeans (SALLEE) Project in London (one-off survey) 
(500)
, the Social Media, MSM and Sexual Health (SMMASH) Survey in Scotland, Wales, 
Northern Ireland, and the Republic of Ireland (one-off survey) 
(481, 501, 502)
, the Dean Street at 
Home (DS@H) study across the UK (one-off survey) 
(503)
, and a one-off survey of young MSM 
(aged 18-25 years) across the UK 
(504)
. 
 
The majority of studies in this review included men known to be HIV-positive. Across studies, 
the proportion of men reporting a positive HIV status ranged from 6.4% (SMMASH) 
(501)
 to 22% 
(4 gym project) 
(116)
. The vast majority of studies incorporated self-completion questionnaires. 
With the exception of two studies (the ‘SM’ sex study 
(488)
 and an RCT of GUM clinic attendees 
(461)
), all consisted of a cross-sectional design and most carried out serial (repeated) surveys, 
which did not include the linking of participants between surveys. At the time of submitting this 
thesis (December 2017), one study was identified that would have been eligible for this review 
but recruited men from 2015 onwards 
(416)
. In this cross-sectional survey study, users of a 
popular geosocial-networking smartphone app for gay, bisexual, and other MSM were recruited 
in January 2016 (N=179). Advertisements were limited to users in London. Information was 
collected on a range of socio-demographic, health, and lifestyle factors, as well as sexual 
behaviours including HIV testing and PEP use. Of note, depressive symptoms were measured 
on the PHQ-2 and the prevalence observed is described in Chapter 4. The association between 
depressive symptoms and sexual behaviour measures was not investigated, only factors 
associated with PEP awareness and use has been assessed. The key measures of CLS 
investigated in this review were not collected 
(416)
. 
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Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
General population: 
Natsal-1 1990 (N=90
f
)
(115)
                    
Natsal-2 2000 (N=133
f
)
(115)
                    
Natsal-3 2010-2012 (N=190
f
)
(342)
        i              
GUM clinics: 
Clinic survey 1995-1996 
(N=285)
(462)
 
                   
Clinic survey 1997-1998 
(N=470)
(102)
 
                   
Clinic-based RCT 1995-1997
 
 
(Baseline N=361)
(461)
 
                   
Clinic-based intervention 
1999 (N=65 HIV testing) 
2000 (N=292 HIV testing)
(460)
 
                   
Clinic-based survey 1999 
(N=122)
(355)
 
      h              
The Internet and HIV Study (HIV 
testing clinics) 2002-2003 
(N=404)
(465)
 
                   
LGV Enhanced Surveillance 
System 2004-2010 (N=1281)
(468)
 
                   
Clinic survey 2005 (N=2162)
(35)
                    
Clinic survey 2005-2007 
(N=301)
(467)
 
                   
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Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
(continued) 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
GUM clinics: 
Clinic surveillance data 2011-
2014 (N=16422)
(469)
 
                   
Community/commercial gay venues: 
GMSHS England 1996
b
  
(N=2482)
(144)
  
                   
GMSHS England 1997
b
  
(N=2121)
(144)
 
                   
GMSHS England 1998
b
  
(N=2068)
(144)
 
                   
GMSHS England 1999
c
 
(N=2030)
(117)
 
                   
GMSHS England 2000
c
 
(N=1058
d
)
(117, 473)
 
                   
GMSHS England 2001 
(N=1138
d
)
(473)
 
                   
GMSHS England 2002 
(N=907
d
)
(473)
 
                   
GMSHS England 2003 
(N=1235
d
)
(473)
 
                   
GMSHS England 2004 
(N=1173
d
)
(473)
 
                   
GMSHS England 2005 
(N=1291
d
)
(473)
 
                   
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Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
(continued) 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
Community/commercial gay venues: 
GMSHS England 2006 
(N=927
d
)
(473)
 
                   
GMSHS England 2008 
(N=920
d
)
(473)
 
                   
GMSHS England 2011 
(N=842
d
)
(472, 505)
 
                   
GMSHS England 2013 (N=647
d
) 
(473)
 
                   
GMSHS Scotland 1996 
(N=2276)
(475)
 
                   
GMSHS Scotland 1999 
(N=2498)
(475)
 
                   
GMSHS Scotland 2002 
(N=1734)
(118)
 
                   
GMSHS Scotland 2005 
(N=1744)
(506)
  
                   
GMSHS Scotland 2008 
(N=1330)
(477, 507, 508)
 
                   
GMSHS Scotland 2011
e
 
(N=1515)
(509)
 
                   
Testing Barriers 1999-2000 
(N=713)
(104, 477)
 
                   
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Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
(continued) 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
Community/commercial gay venues: 
Testing Barriers 2002 (N=283)
(104, 
477)
 
                   
Testing Barriers 2003 (N=275)
(105, 
477)
 
                   
Community-based survey 1998 
(N=506)
(478)
 
                   
MYPC intervention 2010 (10-
month follow-up N=784) 
(479, 480)
 
                   
Gay Men’s Survey 2011 (N=1216) 
(481)
 
                   
Gym-based intervention 1997 
(Baseline N=1004)
(482-484)
 
                   
4 gym project 1998 (N=834)
(116)
                    
4 gym project 1999 (N=630)
(116)
                    
4 gym project 2000 (N=739)
(487)
       g              
4 gym project 2001 (N=735)
(116)
                    
4 gym project 2002 (N=828)
(116)
                    
4 gym project 2003 (N=498)
(116)
                    
Community-based RCT (‘SM sex’ 
Study) 2003 (N=50)
(488)
 
                   
Online: 
GMSS
a
 1998 (N=6315)
(510)
                    
 
 
 
78 
 
Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
(continued) 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
Online: 
GMSS
a
 1999 (N=9322)
(511)
                    
GMSS
a
 2000 (N=9789)
(489)
                    
GMSS
a
 2001 (N=14616)
(490)
                    
GMSS
a
 2002 (N=16871)
(492)
                    
GMSS
a
 2003 (N=14551)
(493)
                    
GMSS
a
 2004 (N=16002)
(494)
                    
GMSS
a
 2005 (N=16426)
(495)
                    
GMSS
a
 2006 (N=12155)
(496)
                    
GMSS
a
 2007 (N=8716)
(497)
                    
GMSS
a
 2008 (N=7461)
(512)
                    
GMSS
a
 2010 (EMIS) 
(N=15456)
(505, 513)
 
                   
GMSS 2014 (N=15360)
(514)
                    
The Internet and HIV Study 
(online) 2002 (N=4974)
(464, 466)
 
                   
The Internet and HIV Study 
(online) 2003 (N=2539)
(465)
 
                   
MESH 2007-2008 (N=13278) 
(498, 499)
 
                   
SALLEE 2009 (N=691)
(500, 515)
                    
The Sigma Panel 2011- 2012  
(9 ‘Blasts’ N=224-1823)
(414, 516-523)
 
                   
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Table 2: UK studies of sexual behaviour among MSM and collection of key socio-demographic, psychosocial, and sexual behaviour measures 
(continued) 
 Age Ethnicity Sexual 
identity 
Education Relation-
ship 
status 
Depression Drug 
use 
Drinking CSA
j
 IPV
k
 CLS with 
1+ partner 
 
 
 
 
Recal 
period in 
months: 
CLS with 
2+ 
partners  
 
 
 
Recal 
period in 
months: 
CLS with 
unknown/ 
sero-
different 
partner 
 
Recal 
period in 
months: 
Study           3 6 12  3 6 12  3  6 12  
Online: 
SMMASH 2012-2013 
(N=2668)
(481, 501)
 
                   
Online survey 2012-2013 
(N=702)
(504)
 
                   
DS@H 
l
 2012-2014 (N=17361) 
(503)
 
                   
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2.5.2 Prevalence of CLS across UK recruitment settings 
Of all 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 58 presented a prevalence estimate for: (i) CLS with one or more partners, (ii) CLS with 
two or more partners, or (iii) CLS with a partner of unknown or sero-different HIV status. Of 
these 58 studies, 41 presented the prevalence of CLS measures in the past year, two presented 
the prevalence in the past six months, and 15 presented the prevalence in the past three 
months (see Table 2). Of the remaining ten studies, two asked questions about insertive and 
receptive CLS separately 
(490, 493)
, one asked whether participants considered their past sexual 
practices to be risky and if so to describe why they considered this to be the case 
(494)
, and three 
focused entirely on HIV testing rates 
(460, 503)
 and acceptability of home sampling kits for STI/HIV 
(467)
. Furthermore, two studies investigated episodes of LGV 
(468)
 and PEP prescription
(469)
, 
another focused entirely on attitudes to, experiences of and access to condom-use
(414, 516-523)
, 
and finally, Natsal-1 did not ask about condom-use during sex 
(115)
.  
 
Given the amount of data collected on this recall period, the prevalence of CLS measures (i), 
(ii), and (iii) in the past year is presented in Figure 4 below, Figure 29 (in Appendix section 
11.6), and Figure 30 (in Appendix section 11.6) respectively. The prevalence of CLS measures 
(i) and (iii) in the past three months is also presented in Figure 31 and Figure 32 (in Appendix 
section 11.6) respectively. Repeated surveys were treated as separate studies. All relevant 
estimates found for each study were included. Figures are colour coded according to 
recruitment setting. The dashed reference lines provided demarcate whether the prevalence 
estimates are below or above 25% or 50% depending on whether the scale went up to 50% 
(Figure 29, Figure 30, and Figure 32) or 100% (Figure 4 and Figure 31) respectively. No test of 
significance is implied by these reference lines, they are used only as a visual aid to compare 
estimates. 
 
The differences observed between studies in prevalence estimates of CLS measures may 
reflect differences in study recruitment, bearing in mind that some studies used mixed 
approaches to recruitment (GMSS and GMSHS England). Differences may, however, also 
reflect variation in study population characteristics, inherent differences in different cities, 
method of ascertainment of information (i.e. self-report versus interviewer administered; CASI 
versus paper), and trends in behaviour over calendar time. It is not possible to disentangle 
these effects. That being said, there does appear to be a pattern in the differences observed 
between prevalence estimates according to study recruitment site for each measure of CLS and 
across both recall periods presented. This is briefly discussed for the measure of CLS with one 
or more partners in the past year (Figure 4). 
 
Natsal represents a gold standard as it is a representative sample of the general population. 
The prevalence estimates in Figure 4 were 37.6% and 56.8% in Natsal-2 and Natsal-3. 
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Unfortunately, estimates derived from the Natsal MSM sub-sample are relatively imprecise 
given the small sample size (Natsal-2 N=133; Natsal-3 N=190). The estimates derived from 
clinic samples come from one RCT of the same men surveyed at baseline (1995-1997) and 12-
months later. Since some men were randomized to a cognitive behavioural intervention to 
reduce STIs, the baseline prevalence estimate of 61.8% may be more relevant when comparing 
with other studies. This baseline prevalence of CLS among men attending GUM clinics appears 
to be the highest estimate found. The confidence interval is however somewhat wide given the 
relatively small sample size of 361 men. Men recruited online also appear to report a slightly 
higher prevalence of CLS in the past year (range from: 39.4%-60.1%) compared to men 
recruited from community and commercial gay venues (range from: 29.7%-56.0%). Of note, 
similar patterns were observed when investigating CLS with one or more partners in the past 
three months (see Appendix section 11.6 Figure 31). 
 
In Figure 4, within the recruitment category of community and commercial gay venues, men 
recruited from Pride events appear to report a somewhat higher prevalence of CLS (range from: 
39.0%-46.3%) compared to men recruited from bars, clubs, and saunas (range from: 29.7%-
55.1%). Due to the transitory nature of Pride events and elevated celebratory tone, it is perhaps 
possible that these events elicit greater opportunity for risk-taking. Furthermore, bars, clubs, and 
saunas may serve as intervention sites, and men who regularly attend these venues may be 
more likely to be exposed to health promotion messages. Although men who attend Pride 
events are most likely to be community attached gay or bisexual-identified men, Pride events 
may also attract men who are not particularly active on the scene. Online sampling may also 
recruit a broader cross-section of men, some of whom may have fewer connections to the gay 
community, with fewer opportunities to be exposed to health interventions and lower levels of 
community affiliation and social support. Lower levels of social support may have negative 
consequences for health and wellbeing, as discussed in detail in section 1.6.3. Finally, the high 
prevalence observed in the SM sex Study (56.0%) which consisted of a volunteer sample of 
men reading gay magazines, may not be surprising given that men volunteered for an 
intervention addressing sadomasochistic sex, which may as a sexual practice involve greater 
risk-taking. As seen in the very wide confidence interval (95% CI: 42.2%, 69.8%), the number of 
men participating in this study was very small (N=50), making it difficult to accurately compare 
this particular prevalence estimate.  
 
Finally, it is notable in Figure 4, that the prevalence of CLS appears to increase over time 
(1996-2011) within the repeated GMSHS England surveys. Trends in sexual behaviour may to 
some extent reflect changed perceptions of HIV following the introduction of ART in the late 
1990s and dissemination of new HIV related information, namely the release of the Swiss 
Statement in 2008, as discussed in sections 1.5.3.1-1.5.4 of the thesis introduction. The 
apparent increase over time may reflect increased engagement in CLS or increased reporting of 
CLS on behavioural surveys. 
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Figure 4: Proportion of MSM reporting anal CLS with one or more male partners in the 
past year, from UK studies
a
 which include HIV-negative men (1996-2014) and according 
to study recruitment site 
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2.5.3 Defining other key factors in the context of sexual behaviour among MSM  
 
2.5.3.1 Defining recreational drug use 
Recreational drug use refers to the use of chemical substances for leisure, to intentionally get 
‘high’, rather than medical purposes. Most drugs used for recreational purposes are illicit and 
fall into one of three categories: hallucinogens (affecting what one sees, feels, and hears, 
including acid/LSD), ‘downers’ (affecting thought processes, heart rate, and breathing, including 
cannabis/marijuana), and ‘uppers’ (affecting speed of speech, reactions, and heart rate, 
including methamphetamine/crystal meth, amphetamine/speed, ecstasy/E, cocaine/crack) 
(524)
.  
 
2.5.3.2 Defining childhood sexual abuse and intimate partner violence 
CSA is defined as sexual victimization perpetrated during childhood and adolescence, whether 
perpetrated by caregivers, adults or peers 
(525)
. IPV is defined as violent behaviour, which is not 
restricted to physical force but may also encompass emotional/psychological and/or sexual 
harm, carried out by or directed towards a spouse or other intimate partner 
(526)
. One may be 
either a victim or perpetrator of IPV, or both receive and carry out abuse with a partner
xv
. 
 
Many theories have postulated the mechanisms leading to IPV, both as a victim and 
perpetrator, for which there are four main schools of thought: (i) psychoanalytic theories 
(530-545)
, 
(ii) social theories 
(545-547)
, (iii) cognitive behavioural theories 
(545, 548-560)
, and (iv) family and 
systems theories 
(545, 561, 562)
. Textbox 4 provides a brief description of these theories. In 
summary, although the theories are rooted in disciplines of varying perspective on social 
phenomena, dysfunctional relationships formed with primary caregivers in early childhood and 
the ameliorating effects of socio-economic advantage and social support are clearly pivotal 
themes. 
                                                     
xv
 In Johnson’s categorization of IPV dynamics, violence between partners often occurs in the form of: (i) 
intimate terrorism, whereby one partner carries out abuse via a range of control tactics that are likely to 
escalate over time in a cyclical pattern of abuse, remorse, pursuit, tension build-up and abuse (cycle of 
violence theory), (ii) mutual violent control, whereby both partners are abusive and controlling, (iii) violent 
resistance, whereby one partner is violent and the other responds in violent self-defence, or (iv) situational 
couple violence, whereby one or both partners are abusive but the abuse is not attached to a pattern of 
escalating control 527. Johnson MP. A typology of domestic violence. Intimate terrorism, violent 
resistance, and situational couple violence. United States of America: Northeastern University Press; 
2008, 528. Melander LA, Noel H, Tyler KA. Bidirectional, unidirectional, and nonviolence: a 
comparison of the predictors among partnered young adults. Violence and victims. 2010;25(5):617-30, 
529. Cycle of Violence: Women's Center. Youth & Family Services; 2017 [May 3rd 2017]. Available 
from: http://www.womenscenteryfs.org/index.php/get-info/prevention/education/14-cycle-of-violence. 
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Textbox 4: Theories predicting the onset and maintenance of IPV 
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2.5.4 Factors associated with CLS measures among MSM in the UK 
Of the 68 UK studies identified in review (ii), data was collected in 66 studies for age, 52 for 
ethnicity, 30 for sexual identity, 53 for educational attainment, 28 for relationship status, 19 for 
recreational drug use, and in ten studies for alcohol use (Table 2). A small sub-set of these 
studies, some of which combined a number of repeated surveys (across different studies), have 
investigated the association of these factors with common measures of CLS: nine studies for 
age 
(118, 477, 482, 489, 509-512, 563)
, seven for ethnicity 
(482, 489, 496, 498, 499, 510-512)
, two for sexual identity 
(509, 510)
, eight for educational attainment 
(118, 482, 489, 496, 509, 510, 512, 563)
, four for relationship status 
(482, 496, 510, 512)
, five for recreational drug use 
(478, 484, 487, 509, 511)
, and two studies for alcohol use 
(478, 509)
. Table 46- Table 52 in Appendix section 11.7 presents all unadjusted and/or adjusted 
associations of key socio-demographic and psychosocial factors with CLS measures (i) to (iii). 
Findings are summarized below.  
 
Report of CLS with one or more partners was found to be associated with younger age 
(482, 489)
, 
lower levels of education 
(510)
, being in an ongoing relationship 
(482, 496, 510)
, substance use 
(511)
, 
and anabolic steriod use 
(484)
 in unadjusted and/or adjusted analysis. However, other studies 
failed to find an association with age 
(510, 511)
, education 
(482, 489)
, and anabolic steriod use 
(487)
 in 
unadjusted analysis, or with education 
(496)
 after adjusting for other socio-demographic factors.  
 
Report of CLS with two or more partners was found to be associated with younger age 
(118, 477, 
512, 563)
, lower levels of education 
(512)
 and any recreational drug use 
(509)
 in unadjusted and/or 
adjusted analysis. However, other studies failed to find an association with age  
(509)
 and 
education 
(509)
, as well as relationship status 
(512)
 in unadjusted analysis, or with education 
(118, 
563)
, use of poppers (inhaled drug consisting of nitrites with euphoria-inducing effects) 
(509)
, or 
use of viagra 
(509)
 after adjusting for socio-demographic factors 
(118, 563)
 and substance use 
(509)
. 
 
Report of CLS with a partner of unknown/sero-different HIV status was found to be associated 
with younger age 
(563)
, use of marijuana before or during sex 
(478)
, use of poppers before or 
during sex 
(478)
, and use of party drugs (ecstasy, LSD, amphetamine, and cocaine) before or 
during sex 
(478)
 in unadjusted and/or adjusted analysis. Other studies failed to find an 
association with education 
(509, 563)
 as well as use of any recreational drugs 
(509)
 in unadjusted 
analysis, or with age 
(509)
, use of poppers 
(509)
, or use of viagra 
(509)
 after adjusting for socio-
demographic factors and recreational drug use. 
 
Of note, for each factor and across CLS measures, there was no pattern whereby studies that 
failed to find an association had a smaller sample size (Table 46- Table 52 in Appendix section 
11.7). A lack of statistical power does not appear to account for the lack of associations found in 
some studies. 
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Ethnicity 
(482, 489, 496, 498, 510-512)
, sexual identity 
(509, 510)
, and alcohol use (including 
‘always/sometimes drunk on alcohol’ and ‘drinking before/during sex’) 
(478, 509)
 was not found to 
be associated with measures of CLS in unadjusted and/or adjusted analysis. In one study 
(509)
, 
an unadjusted association was observed between bisexual identity and CLS with two or more 
partners in the past year, but this relationship disappeared after adjusting for socio-demographic 
factors, frequency of gay scene use, and alcohol and drug use. Only two studies investigated 
associations with sexual identity and alcohol use. 
 
Of the 68 UK studies of sexual behaviour among MSM (if repeated surveys are considered as 
separate studies), three collected data on depression (Table 2) 
(342, 355, 564)
. Of these three 
studies, one, a GUM clinic sample in 1999 (N=122), investigated the association between 
depressive symptoms and sexual risk behaviour. The results of this study were discussed in 
review (i). A higher prevalence of depressive symptoms (HADS score ≥11) was observed 
among men who reported CLS with an unknown/HIV-positive status partner than men who did 
not, in unadjusted analysis (see Table 1) 
(355)
. Similarly, the association between CSA and 
common measures of CLS has not been investigated, as measures of CSA have not been 
explicitly collected. It was investigated whether sexual assualt and non-consensual sex in 
childhood and adulthood was associated with CLS with one or more partners in the past year in 
two studies (see Appendix section 11.7 Table 53) 
(355, 510)
. Both studies investigated unadjusted 
associations only, one study finding that men who reported sexual assualt in childhood and/or 
adulthood were more likely to report CLS 
(510)
, and the other finding no association with non-
consensual sex 
(355)
. No UK studies of sexual behaviour among MSM have collected data on 
IPV (Table 2).  
 
2.6 Discussion 
 
2.6.1 Relationship between depressive symptoms and sexual behaviour measures  
Of the 22 eligible studies identified in review (i), the majority (68%) found an association 
between a measure of depressive symptoms and increased sexual risk behaviour 
(353-368)
 (or 
HIV seroconversion 
(369)
), including after adjustment for socio-demographic factors and 
recreational drug use 
(366, 367, 369)
. Unfortunately, it is difficult to draw conclusions on the 
magnitude of the association given the various measures of depressive symptoms and sexual 
behaviours investigated across different statistical methodologies. There does appear to be 
some evidence to suggest that the association between depressive symptoms and sexual risk 
behaviour is attenuated after adjusting for socio-demographic factors and substance use. 
However, the number of studies which presented unadjusted and adjusted estimates was small 
(N=3 
(353, 366, 367)
). Small sample sizes and a lack of statistical power may explain why an 
association was not found between depressive symptoms and any measure of sexual behaviour 
investigated in seven studies 
(346, 347, 370-373, 433)
. Two of these studies observed an unadjusted 
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association which disappeared after adjusting for socio-demographic factors 
(372)
, poly-drug use, 
CSA, IPV, and sexual compulsivity 
(371)
. 
 
2.6.2 Theory of opposing associations between depression and sexual behaviour: 
implications of prevalence of recent sex  
The association between depressive symptoms and sexual behaviour did not appear to be 
more consistently demonstrated in samples investigating certain measures of sexual risk-taking 
or in samples with certain socio-demographic profiles (including HIV status, age, and ethnicity). 
However, there was some evidence that the association was more consistently demonstrated in 
samples where almost all men reported (recent) sexual intercourse compared to samples which 
included a higher proportion of men who did not report (recent) sex.  
 
Crepaz and Marks’ theory of opposing associations of depressive symptoms suggests that 
depression may result in increased sexual risk behaviour in some individuals and in others in 
sexual inactivity due to lowered libido and interest in sex. Opposing trends may result in an 
observed overall lack of association. In line with this theory, findings from review (i) suggest that 
studies that did not separate MSM who were not sexually active from those having condom-
protected sex may have underestimated the effect of depression on condom-use. It is of note, 
however, that only half of identified studies presented the prevalence of recent anal sex 
(n=11/22) and different recall periods were utilized among studies that did. 
 
2.6.2.1 Reasons for opposing associations between depression and sexual behaviour 
Crepaz and Marks hypothesized that although the presence of moderate/chronic low-level 
depressive symptoms may be associated with sexual risk-taking, acute or chronic symptoms 
may have the opposite effect by reducing sexual interest and libido 
(352)
. They also made a case 
for investigating an inverted U-shape relationship whereby the likelihood of engaging in sexual 
activity decreases as depressive symptoms become more severe. In the cognitive model of 
depression (see section 1.7.1.1), a total immersion of the personality in a full-blown major 
depression is characterized by profound anhedonia (inability to feel pleasure in normally 
pleasurable activities) and sleep and appetite disturbance  
(257, 269)
. However, in the five studies 
identified in review (i) that investigated categories of depressive symptom severity, the highest 
level of depression was associated with increased reporting of CLS measures compared to 
lower but still clinically significant levels of depression 
(357, 359, 360, 365, 367-369)
.  
 
It has also been suggested by Alvy et al 2011 
(362)
, in Project Mix, that the type of coping 
mechanism employed by individuals with depression may determine the direction of 
association. Some individuals with depression may be more likely to engage in escape coping 
processes characterised by externalizing responses such as sexual risk-taking and substance 
use. Other individuals with depression may be more likely to engage in alternative coping 
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mechanisms characterised by internalizing responses, such as social withdrawal and sexual 
inactivity. Collecting samples of men with certain behavioural profiles such as high levels of 
sexual activity and drug use may therefore include only men who are more likely to react to 
depression with externalising responses. This explanation of opposing associations was 
described in the framework of the cognitive escape model. For a description of the theory of 
cognitive escape, see section 1.8.3.4. 
 
Further evidence for the different responses to depression theory described above, may come 
from the internalizing-externalizing model. The internalizing-externalizing model is often used as 
a theoretical framework for understanding the co-occurrence of psychosocial phenomena 
(565, 
566)
. In this model, internalization is defined as the expression of distress inwards. Internalizing 
disorders include those of depression and anxiety. Externalization is defined as the expression 
of distress outwards and disorders include attention deficit/hyperactivity disorder (ADHD), 
antisocial personality disorder, and substance use disorders. Following this theoretical 
framework, it has been suggested in genetic studies that: (i) the presence of certain genes 
encoding impulse regulation and behavioural disinhibition may explain the co-occurrence of 
sensation seeking, substance use, and ADHD 
(567)
, and (ii) the presence of certain genes
xvi
 may 
confer risk for the co-occurrence of internalizing (in particular major depression) and 
externalizing disorders such as substance use 
(307, 566, 568-573)
. It has also been suggested that 
environmental factors may confer risk for the co-occurrence of depression and externalizing 
disorders 
(566)
. Therefore, depending on genetic/environmental predisposition, it is possible that 
some individuals may cope with depression with more externalising responses, whereas, others 
may cope with more internalizing responses.  
 
2.6.2.2 Recruitment setting 
Based on findings in review (i), there appears to be some evidence to suggest that recruitment 
of men from certain settings, including sexual health clinics and possibly online, may elicit 
samples with unique behavioural profiles. Among sexually active samples of men reporting a 
high prevalence of CLS, the association between depressive symptoms and sexual risk 
behaviour may be more likely to be observed. This does not necessarily mean that a sexual 
                                                     
xvi
 This includes the serotonin transporter gene, serotonin 2A receptor gene, and dopamine D4 receptor 
gene. 307. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life 
stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (New York, NY). 
2003;301(5631):386-9, 568. Sakai JT, Young SE, Stallings MC, Timberlake D, Smolen A, Stetler 
GL, et al. Case-control and within-family tests for an association between conduct disorder and 5HTTLPR. 
American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the 
International Society of Psychiatric Genetics. 2006;141B(8):825-32, 569. Eley TC, Sugden K, 
Corsico A, Gregory AM, Sham P, McGuffin P, et al. Gene-environment interaction analysis of serotonin 
system markers with adolescent depression. Molecular psychiatry. 2004;9(10):908-15, 570. Mik 
HM, Ehtesham S, Baldassarra L, De Luca V, Davidge K, Bender D, et al. Serotonin system genes and 
childhood-onset aggression. Psychiatric genetics. 2007;17(1):11, 571. Lopez Leon S, Croes EA, Sayed-
Tabatabaei FA, Claes S, Van Broeckhoven C, van Duijn CM. The dopamine D4 receptor gene 48-base-
pair-repeat polymorphism and mood disorders: a meta-analysis. Biological psychiatry. 2005;57(9):999-
1003, 572. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. Two dopamine 
genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Molecular 
psychiatry. 2001;6(4):429-33. 
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health clinic or online sample has to be recruited in order to find an association. The recruitment 
or analysis of men from the general population or from community/commercial gay venues may 
be restricted so as to obtain a sexually active sample. For instance, among studies that 
recruited men from community/commercial gay venues in review (i), compared to YMS 
(347)
, 
Dudley et al 2004
(370)
, Sex and Love 
(371)
, and HONOR 
(372)
, a number of studies including 
EXPLORE 
(367-369)
, Project MIX
(362)
, and NHBS 
(363)
, restricted the recruitment of men to those 
reporting recent anal sex. The latter studies found an association between depressive 
symptoms and sexual risk behaviour. Furthermore, an association between depressive 
symptoms and sexual risk behaviour was also found in a general population sample which 
restricted the analysis to men reporting recent anal sex 
(359)
. However, there may be implications 
for intervention in understanding which sites may be more likely to consist of men of certain 
behavioural profiles.  
 
When investigating the 68 UK studies of sexual behaviour among MSM identified in review (ii), 
the prevalence of CLS measures appeared to be higher in studies which recruited men from 
sexual health clinics and online, compared to the general population and community/ 
commercial gay venues. These findings appear to reiterate those found in review (i). Given that 
the primary purpose of attending sexual health clinics is to screen for HIV and other STIs, it 
follows that the vast majority of attendees will be sexually active and have engaged in CLS. 
Recruitment of MSM online compared to in gay venues, may produce samples of men who are 
less likely to be affiliated to sexual minority communities and less likely to have been exposed to 
health interventions. This may have implications for psychological functioning and sexual risk-
taking respectively. Findings from mostly U.S. studies in review (i), suggest that the association 
between depressive symptoms and sexual behaviour may be more consistently demonstrated 
in sexually active samples reporting a high prevalence of CLS. It is possible that this 
relationship may also be observed among MSM recruited from GUM clinics and online in the 
UK. The only UK study to investigate the association between depressive symptoms and sexual 
behaviour was conducted among a GUM clinic sample of 122 MSM in 1999 
(355)
. This study 
found an association between depressive symptoms and increased sexual risk-taking in 
unadjusted analysis. Therefore, based on findings from review (i) and (ii), it may be that 
targeted interventions in the UK addressing depression and sexual risk may be most effective in 
a GUM clinic setting and possibly online. However, the UK, and European region as a whole, 
still remains understudied. As stated in section 1.9, findings from the U.S. may not be 
generalizable to a UK/European setting given the potential impact of the differing health care 
infrastructure on treatment and prevalence of depression. Further studies investigating the 
association between depressive symptoms and sexual behaviour are needed in the UK. 
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2.6.3 Other factors associated with CLS measures among MSM in the UK: a comparison with 
studies in other high-income countries 
 
2.6.3.1 Socio-demographic factors 
There appears to be some evidence to suggest that among MSM in the UK, younger age, lower 
levels of educational attainment, and being in an ongoing relationship (for any CLS) is 
associated with CLS measures including with multiple partners and partners of an 
unknown/sero-different HIV status. However, associations with age and educational attainment 
were not consistently demonstrated. Studies from other high-income countries, mainly the U.S., 
do appear to support evidence for an association of younger age and socio-economic 
disadvantage with sexual risk behaviour 
(491, 574-577)
.  
 
2.6.3.2 Psychosocial factors 
Measures of recreational drug use were consistently associated with CLS measures across UK 
studies. Associations with some individual drugs including poppers and Viagra, disappeared 
after adjusting for use of other recreational drugs. It is of note that, ‘chemsex’ is a recently 
described phenomenon in the UK 
(578-584)
. Chemsex is the intentional use of novel psychoactive 
substances (usually one or more of mephedrone, gamma-hydroxybutrate/gamma-butyrolactone 
[GHB/GBL] and methamphetamine) during or immediately before sex. Chemsex appears to 
occur among self-identified gay men to stimulate sexual arousal and prolonged sexual 
episodes. It typically occurs in private homes or commercial sex-on-premises venues such as 
saunas or sex clubs and as a group sexual activity. Qualitative work (2013-2014) among a 
volunteer sample of MSM suggests that serosorting practices are common among HIV-positive 
men who engage in chemsex. At the same time, it suggests that a number of men whose last 
HIV test was negative had unintentional CLS as a direct result of ‘chem’ use. 
 
The relationship between recreational drug use and sexual risk behaviour has also been 
consistently and strongly demonstrated in studies of MSM from other high-income countries 
(397, 
585-600)
, mainly the U.S. These include two separate literature reviews of drugs used in dance 
clubs/rave parties (‘club-drugs’) published up to 2005 
(598, 599)
 and a recent meta-analysis of 
amphetamine-type stimulants (including methamphetamine and ecstasy) and HIV seropositivity 
(600)
. The association may be due to direct autonomic or central nervous system mechanisms 
that increase arousal, decrease anxiety, and disinhibit sexual activity 
(397, 601-603)
. Men may also 
use substances strategically to induce a state of cognitive release and escape from rational self-
awareness, which then results in risk 
(397, 597)
. Sexually-oriented settings on the gay scene may 
present opportunities for drug-induced cognitive disengagement and sexual risk 
(397)
. Drug use 
may become associated with sexuality through social learning of gay bars, clubs, and saunas 
as settings where gay sexuality is sanctioned and celebrated 
(120)
.  
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Although this data has not been collected in UK studies of sexual behaviour among MSM, two 
meta-analyses of mainly U.S. studies, up to 2014, have investigated the association of CSA 
(604)
 
and IPV 
(605)
 with CLS and HIV seropositivity, both finding strong overall associations.  
 
It is noteworthy, that among MSM (most studies conducted in U.S.) recreational drug use 
(41, 346, 
358, 454, 564, 606-609)
, CSA 
(368, 610)
, and IPV 
(605)
 has also been found to be independently associated 
with depressive symptoms, including in a meta-analysis of studies up to 2013 
(605)
. CSA has 
also been linked to IPV 
(611)
 and substance use 
(604)
, and IPV to substance use in a meta-
analysis of studies up to 2013 
(605)
. It has been suggested in syndemic theory that it is the 
synergistic interactions of two or more co-occurring psychosocial health problems that 
compound the risk of HIV infection among MSM 
(371, 612-614)
. The hypothesized relationships in 
this thesis are presented in a conceptual model in the next chapter (Figure 8). Of note, 
recreational drug use, CSA, and IPV are considered to be possible confounders of the 
association between depressive symptoms and sexual risk behaviour, and self-efficacy for 
sexual safety is considered to be a possible mediator of this relationship.  
 
2.6.4 AURAH and PROUD studies: implications for intervention in a UK setting 
Data from the AURAH study and PROUD trial is investigated in this thesis. The methodologies 
of these studies are described in detail in the next chapter. The AURAH study provides an 
opportunity to examine the relationship between depressive symptoms on PHQ-9 and 
measures of sexual behaviour among MSM attendees of GUM clinics across England from 
2013-2014. The PROUD trial provides an opportunity to investigate this relationship among a 
volunteer sample of MSM who were required to have reported CLS in the previous three 
months and be of the opinion that they would have CLS in the next three months. Therefore, it 
will be possible to conclude in this thesis, whether depressive symptoms are associated with 
increased reporting of sexual behaviours linked to HIV and STI transmission, among current 
samples of sexually active MSM in the UK. The thesis hypothesis is presented in section 1.9.1. 
 
In Chapters 4 and 7 of this thesis, the prevalence of depression measures on PHQ-9 and 
associated factors are investigated using data from AURAH and PROUD respectively. Findings 
from AURAH and PROUD relating to the association of depressive symptoms with sexual 
behaviour are presented in Chapters 5 and 8 respectively and are discussed in the context of 
findings from this literature review. The potential mechanisms through which depression might 
lead to CLS, for which there is a dearth of research in high-income countries, is examined in 
Chapter 6. The potential implications of these findings for targeted interventions are discussed 
in the final conclusion chapter of this thesis. 
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3 Thesis methods 
 
This chapter presents an overview of the data management tasks undertaken as part of this 
thesis and the AURAH and PROUD study methods and selection of participants for analysis. In 
addition, the definition of variables used in analysis and epidemiological concepts and the 
statistical methodology employed in this thesis, are described. To conclude this chapter, the 
methodological limitations of the AURAH and PROUD studies are discussed. Full details of the 
AURAH study methods are presented in Appendix section 11.8 and of the PROUD trial 
methods in Appendix section 11.9. These appendix sections contain detailed information on the 
identification of the sample population, method of sample selection, sample power calculation, 
questionnaire, statement of ethical approval, and data processing 
(80, 417, 615)
.  
 
3.1 Data management 
 
At the time of starting this PhD (07/2014), data collection procedures for AURAH were complete 
and baseline data collection was complete for PROUD. This section gives an overview of my 
involvement in the data management of AURAH and PROUD. 
 
Data cleaning and derivation of variables for the AURAH study was solely my responsibility. The 
raw AURAH dataset was received in eight batches over a period of one year (July 2014-July 
2015). During this year, I checked the data for errors and inconsistencies, including use of 
automated data checking terms in Stata: ‘assert’ 
(616)
. Any errors were corrected and attempts 
were made to resolve inconsistencies by investigating the original individual scanned 
questionnaires and defining rules for multiple responses and implausible combinations of 
variables. A set of derived variables was created for analysis. Appendix section 11.8.5 (Table 
58-Table 62) includes a detailed description of these processes. 
 
The PROUD baseline and 12-month questionnaire datasets were received in Stata on 
September 6
th
 2016. Following discussion with the MRC CTU team on November 2
nd 
2016, 
where I presented preliminary findings at the CTU team meeting, it was decided that data from 
the 24-month questionnaire (n=333) should also be incorporated. This data was received on 
December 16
th
 2016. The PROUD trial data has been managed by Dr Ellen White and Dr David 
Dunn based at the MRC CTU. All data management procedures that I have carried out and are 
relevant to this thesis are described in detail in Appendix section 11.9.5. These predominantly 
involved dealing with inconsistent responses to sexual behaviour and variable derivation.  
 
 
Chapter 3 
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3.2 Study methods/participants 
 
3.2.1 The AURAH study methods 
The AURAH (Attitudes to, and Understanding of, Risk of Acquisition of HIV) study is a cross-
sectional questionnaire study that recruited men and women from 20 GUM clinics in England. 
Men and women were eligible for inclusion in the study if they met the following criteria: aged 18 
years or over without diagnosed HIV. The questionnaire was only provided in the English 
language. Clinic attendees were consecutively sampled. After five months of consecutive 
sampling, it became clear that the proportion of the populations of interest (MSM and black 
African men and women) was not reaching the targets set for analytic purposes. Accordingly, 
sampling switched to disproportionate quota purposive methods, in order to ‘over represent’ and 
recruit until the required proportion of the populations of interest were enrolled. Over the 17 
month study period (June 2013 and November 2014) a total of 4380 eligible patients were 
approached and asked to participate in this study. Of those approached, 3340 (76%) gave 
consent to take part in the study by self-completing a confidential questionnaire that sought 
detailed information on socio-demographic factors, health and well-being, lifestyle factors, HIV-
related information, and sexual risk behaviour. A description of all questions asked is presented 
in Appendix section 11.8.4. The number of completed questionnaires finally collected was 2630 
and thus, the response rate was 60% (2630/4380) of eligible patients approached and 79% 
(2630/3340) of those who gave consent. Information on gender and clinic site was noted for all 
GUM clinic attendees approached as part of the AURAH study. Information on HIV/STI testing 
and results of HIV testing was collected from clinic records for all consenting study participants. 
The possibility of response bias among all men and women who were approached and all those 
consenting to participate was investigated in Appendix section 11.8.6.1 Table 63 and Table 64. 
Findings appear to suggest minimal response bias. However, it was only possible to investigate 
whether consent to participate and survey completion differed according to a very limited 
number of factors collected (gender, clinic site, HIV/STI testing, and results of HIV testing). 
 
3.2.2 AURAH study participants 
 
3.2.2.1 Selection of MSM sample  
This thesis focuses solely on MSM recruited for study participation, the remainder of the 
AURAH study sample will not be investigated here. Men were included in the analyses 
presented in this thesis if they met at least one of the following criteria: (i) reported being gay or 
bisexual including other plurisexual identity labels: pansexual, omnisexual, open, queer, and 
other identities that are not explicitly based on attractions to one sex/gender 
(617)
, or (ii) reported 
anal sex with a man in the past three months, or (iii) reported having disclosed to their family, 
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friends, or workmates as being gay, bisexual, and/or attracted to men. In total, 1484 men were 
defined as MSM, see Figure 5. 
 
3.2.2.2 Restricting to men who reported recent sex 
Crepaz and Marks authored the only meta-analysis which has included samples of MSM in an 
assessment of the association between depressive symptoms and sexual risk behaviour 
(352)
. 
As a result of this work, Crepaz and Marks suggested that there may be two opposing 
associations of depressive symptoms. In some individuals, depression may result in increased 
sexual risk behaviour and in others in lowered libido/interest in sex and sexual inactivity (see 
section 2.4.4.1). Accordingly, assessment of this relationship may be problematic since 
opposing trends can result in an observed overall lack of association. Findings from review (i) of 
this thesis provide some support in favour of this theory of opposing trends (see section 
2.4.5.4). Informed by these findings and as a result of the overall aim being to inform HIV 
prevention in the UK, this thesis focused on the distinction between men who reported sexual 
risk behaviour and men who were sexually active but did not report risk behaviour. Therefore, 
only MSM who reported recent sex were included in the main AURAH analyses. However, 
levels of depression among MSM who were not sexually active were also investigated, in order 
to better understand the potentially complex relationship of depressive symptoms with sexual 
behaviour. In line with findings from review (i) and (ii) of this thesis, the proportion of AURAH 
GUM clinic attendees who did not report recent sex was small (N=144; 9.7%).  
 
In order to acknowledge the inclusion of plurisexual identified men in our definition of MSM, men 
were eligible for inclusion regardless of whether they reported recent anal sex with a man or 
recent vaginal or anal sex with a woman. In total, 1340 MSM reported anal and/or vaginal sex in 
the past three months, see Figure 5. Of note, Figure 6 presents the overlap between the three 
inclusion criteria for MSM categorization (based on sexual identity, sexual behaviour, and 
disclosure of sexual orientation) among a) all 1484 MSM and b) 1340 MSM reporting recent 
sex. The vast majority of MSM investigated in this thesis, identified as gay or bisexual (including 
other plurisexual identities), reported anal sex with a man in the past three months, and 
reported having disclosed their sexual orientation to family, friends, and/or work colleagues. 
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Figure 5: Inclusion criteria for MSM in the AURAH study 
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a) 
 
 
 
Figure 6: Intersection of inclusion criteria for MSM in the AURAH study 
 
 
* One man specified “Straight but occasionally play with men”, see footnote 
a
 under Figure 5. 
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b) 
 
 
 
* Reported sex with a woman in the past three months. 
 
3.2.2.3 Diagnosis of HIV, socio-demographic characteristics, clinic site, and reasons 
for attendance 
Overall, 1112 of 1484 MSM (83.1%) had an HIV test on the day of the AURAH questionnaire. 
Four men tested HIV-positive (0.3% overall), all of whom were included in the 1340 MSM who 
reported recent sex. These HIV-positive men were retained in the sample for analyses, as they 
were not diagnosed with HIV at the time of questionnaire completion. The socio-demographic 
factors investigated in this thesis are defined below in section 3.3.5. The prevalence of these 
socio-demographic factors is presented in Chapter 4 (Table 5). Briefly, of the 1340 MSM, 89% 
identified as gay, 10% as bisexual or another plurisexual identity label, and 1% as straight. 
Eighty-two percent of men were of white ethnicity; median age was 31 years. Overall, 57% were 
born in the UK, 67% had a university degree, and 76% were attending a clinic in London. In 
London, a large proportion of men were recruited from 56 Dean Street clinic (n=478) and the 
Mortimer Market Centre (n=240). Outside of London, a large proportion of men were recruited 
from a clinic in Brighton (Claude Nicol Centre, n=173) (see Appendix section 11.8.1 Table 54). 
The majority of men (68.1%) reported attending the clinic for a routine screening test. A small 
number of men (N=154) specified reasons other than routine screening, getting a symptom 
checked or treated, and getting contraception or contraceptive advice. These other reasons 
included: clinical trial (n=50), Hepatitis B vaccination (n=41), PEP (get/follow-up) (n=32), 
collecting results/treatment (n=17), and counselling/information (n=3).  
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3.2.3 The PROUD trial methods 
The PROUD trial (Pre-exposure Option for reducing HIV in the UK) was a multi-centre, open 
label RCT, at 13 GUM clinics across England 
(80)
, evaluating the benefit of PrEP as part of a 
package of HIV risk reduction interventions for HIV-negative gay men. Recruitment took place 
between November 2012 and April 2014, and participants had the opportunity to remain in 
follow-up for at least two years. Men, and transgender women
xvii
, aged 18 years or older who 
were attending one of the recruiting clinics for a routine visit and reported CLS on more than 
one occasion with a man in the past three months, were asked if they were interested in PrEP, 
and if so were provided with information sheets on the PROUD trial. Posters and electronic 
screens in participating GUM clinics, advertisements on social media, and distribution of 
business cards and leaflets by community organizations during outreach activities were also 
used to promote the study. Individuals who were interested in the study could download the 
information sheet from the study website. Individuals from clinic and non-clinic recruitment were 
eligible for inclusion if at the enrolment visit, they had an HIV-negative test result, reported anal 
CLS with a man on more than one occasion within the past three months, and reported that 
they were likely to have anal CLS with a man in the next three months. A total of 544 men 
underwent randomization; 275 to the immediate arm and 269 to the deferred arm. Given the 
nature of the non-clinic recruitment, it was difficult to determine the response rate of all eligible 
men. Of note, deferral of PrEP was initially set until the 12 month point, however, an 
unexpectedly high incidence of HIV observed during the deferral period (9.0 per 100 person-
years, 90 CI: 6.1, 12.8), led to a recommendation from the Trial Steering Committee in October 
2014 that all participants should be offered PrEP 
(80)
.  
 
The PROUD trial collected information on socio-demographic factors, lifestyles, health and well-
being, and sexual behaviour at baseline. A similar version of the questionnaire, excluding socio-
demographics and including psychosocial factors, was given to participants on an 
approximately annual basis thereafter; the 12-month questionnaire was completed between 
November 2013 and June 2015 and the 24-month questionnaire was completed between 
November 2014 and June 2016. A description of all questions asked is presented in Appendix 
section 11.9.4. 
 
 
 
 
 
                                                     
xvii
 Of note, transgender women were included in PROUD eligibility. In total, three transgender women 
enrolled in PROUD. Of these three women, none identified as transgender on the baseline questionnaire. 
Questions on gender identity were not asked about on the follow-up questionnaires (anecdotal information 
from Dr Mitzy Gafos, social science lead on the PROUD team). For simplicity sake, PROUD participants 
are referred to as ‘men’ throughout this thesis. 
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3.2.4 PROUD trial participants 
Figure 7 shows the inclusion of men in analyses presented in this thesis. Overall, 540 men 
completed a questionnaire at baseline. Only data from men who remained HIV-negative at the 
time of filling out the follow-up questionnaire was analysed at the 12- and 24-month time-points, 
since this thesis focused on men at risk of HIV acquisition. This included 410 HIV-negative men 
who completed a 12-month questionnaire and 333 HIV-negative men who completed a 24-
month questionnaire. Of the 130 men who did not contribute data for analysis at month-12, 124 
did not complete the follow-up questionnaire, of whom 20 had received an HIV-positive 
diagnosis since baseline. The remaining six men completed a 12-month questionnaire but were 
diagnosed with HIV at or before the follow-up visit and were excluded from analysis
xviii
. An 
additional 103 men did not complete the 24-month questionnaire. Of these men, two had 
received an HIV-positive diagnosis since the 12-month questionnaire. 
 
Due to the loss of individuals completing behavioural questionnaires at follow-up, see Figure 7, 
it was deemed important to investigate whether depression, as well as socio-demographic 
factors, was associated with loss-to-follow-up. This was in order to determine the possibility of 
response bias. There was no difference between men with depressive symptoms and men 
without symptoms at baseline in terms of completing the 12-month questionnaire (22.5% vs. 
24.2%; χ
2
 test p=0.780) and at the 12-month questionnaire in terms of completing the 24-month 
questionnaire (27.1% vs. 24.8%; χ
2
 test p=0.702). Findings were similar when stratifying by trial 
arm, for 12-month questionnaire completion (immediate arm [24.1 vs. 20.5%; χ
2
 test p=0.648]; 
deferred arm [20.0% vs. 27.9%; χ
2
 test p=0.444]) and 24-month questionnaire completion 
(immediate arm [27.8% vs. 22.8%; χ
2
 test p=0.519]; deferred arm [26.1% vs. 26.9%; χ
2
 test 
p=0.934]). At baseline, younger men ([<25 years] χ
2
 test p=0.002), men who were born in the 
UK and BAME (χ
2
 test p=0.015), and men who reported a non-university degree level of 
education (χ
2
 test p=0.008) were less likely to complete a 12-month questionnaire. The 
association with age and UK born/ethnicity was only present among men randomized to the 
immediate PrEP arm. The association with education was only present among men randomized 
to the deferred arm.  
 
 
 
 
 
 
 
                                                     
xviii
 In total 26 study participants received an HIV-positive diagnosis after baseline questionnaire 
completion, 21 men in the deferred arm and five men in the immediate group. Three men, one in the 
deferred and two in the immediate arm, had a reactive HIV antigen-antibody test result but non-reactive 
point-of-care test result at baseline, and were not aware of their status at this time. 
 
 
 
100 
 
Figure 7: Inclusion of PROUD participants for data analysis at each time-point 
 
 
 
3.2.4.1 Socio-demographic characteristics  
Information on socio-demographic factors was collected at baseline of the PROUD trial. The 
socio-demographic factors investigated in this thesis are defined below in section 3.3.10. The 
prevalence of these socio-demographic factors is presented in Chapter 7 (Table 22). Briefly, 
96% of men identified as gay, 3% as bisexual or another plurisexual identity label (one man 
identified as queer), and 1% as straight. Eighty-two percent of men were of white ethnicity; 
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median age was 35 years. Overall, 60% were born in the UK, 61% had a university degree, and 
69% participated at a site in London at baseline. 
 
3.3 Definition of variables 
 
3.3.1 Variable definitions in the AURAH study 
 
3.3.2 Symptoms of depression and other mental health disorders 
This thesis focuses on clinically significant depressive symptoms assessed using a symptom 
questionnaire and categorised using a cut-off point, but it also investigates depressive symptom 
severity, two criteria-based depressive syndromes, and self-report of receiving treatment for 
depression, as well as briefly examining GAD, and suicidal ideation/self-harm. The definition of 
these measures is described in detail below.  
 
3.3.2.1 Measures of depression on PHQ-9 based on standard algorithms 
The PHQ-9 is a nine-item screening tool based on the Diagnostic and Statistical Manual of 
Mental Disorders version four. The internal consistency of items on the PHQ-9 has been 
described in detail in Textbox 3. The PHQ-9 was used to measure the prevalence of clinically 
significant depressive symptoms in AURAH and PROUD. In the PHQ-9, participants are asked 
to rate how often over the past two weeks they have been bothered by nine specific problems 
(Textbox 5).
(443)
 A depressive symptom score is generated by summing responses for each 
question coded as follows: ‘not at all’ (0), ‘several days’ (1), ‘more than half the days’ (2), and 
‘nearly every day’ (3), resulting in a total score with a possible range from 0 to 27. Of note, in 
this thesis, a missing response was included in the ‘not at all’ category with a score of 0. The 
handling of missing data is discussed in section 3.3.11 below. The depressive symptom score is 
categorized as follows: No symptoms of depression/minimal (0-4), mild (5-9), moderate (10-14), 
moderately severe (15-19), and severe (20-27). A cut-off point of 10 or greater is considered a 
‘yellow flag’ on the PHQ-9, to indicate a possible clinically significant depressive condition. This 
is the most commonly used measure of depression based on the PHQ-9, and was the main 
measure of depressive symptoms investigated in this thesis. Questionnaire-based measures of 
depression may be limited in that they do not encompass a full evaluation of symptoms by a 
mental health professional. However, in a validation study when the distribution of PHQ-9 
scores were investigated according to depression diagnostic status in U.S. primary care and 
obstetrics/gynaecology patients interviewed by a (blinded) mental health professional, the vast 
majority of patients (93%) with no depressive disorder had a PHQ-9 score less than 10, while 
88% with major depression had scores of 10 or greater 
(443)
. Additional validation studies have 
been conducted, all of which have reported similar findings, across geographical locations 
(444, 
618-627)
. 
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A diagnostic algorithm for a major depressive syndrome was defined as a total score of at least 
five ‘positive’ responses, including either question 1 or question 2. With the exception of 
question 9, a ‘positive’ response was defined as having the symptom ‘more than half the days’ 
or ‘nearly every day’. For question 9, a ‘positive’ response was defined as having the symptom 
‘several days’ or more frequently 
(442)
. A diagnostic algorithm for major and other depressive 
syndromes (dysthymia, seasonal affective disorder, bipolar disorder) was defined as a total 
score of at least two ‘positive’ responses, including either question 1 or question 2 
(442)
. 
 
Of note, following the nine problems presented on the PHQ-9, AURAH participants were asked 
‘If you were bothered by any of these problems, how difficult have they made it for you to do 
your work, take care of things at home, or get along with other people?’ 
 
Textbox 5: PHQ-9 and GAD-7 scales  
 
 
3.3.2.2 Receiving treatment for depression 
Participants were asked whether they were receiving medical treatment or therapy for 
depression, and/or for any other mental health condition. Participants were also asked whether 
they had ever been told by a doctor that they have a mental health condition and, if so, to 
specify their condition. Finally, participants were asked ‘which statements best describe your 
own state of health today’ on EuroQoL 5D (questionnaire on health-related quality of life 
(628)
); 
one of the five domains is anxiety/depression with the following response options: ‘I am not 
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anxious or depressed’, ‘I am moderately anxious or depressed’, and ‘I am extremely anxious or 
depressed’. For the measure of treatment for depression and anxiety/depression on EuroQoL 
5D, a missing response was included in the no treatment and no anxiety/depression categories. 
 
3.3.2.3 Generalized anxiety disorder 
The GAD-7 scale is a standard seven item questionnaire used to measure symptoms of anxiety, 
with response options for each symptom: not at all (0), several days (1), more than half the days 
(2), and nearly every day (3) (Textbox 5) 
(629)
. In this thesis, a missing response was included in 
the ‘not at all’ category with a score of 0. Although the GAD-7 was originally developed to 
diagnose GAD, it also has good sensitivity and specificity as a screening tool of panic disorder, 
social anxiety disorder, and post-traumatic stress disorder (PTSD) 
(630)
. An anxiety symptom 
score was generated by summing responses for each of the seven questions. The standard 
definition of a total score of ≥10 (from potential range 0 to 21) was used to define GAD. As for 
the PHQ-9, a cut-off point of 10 or greater is considered a ‘yellow flag’ on GAD-7. 
 
3.3.2.4 Suicidal ideation/self-harm 
Suicidal ideation/self-harm, referred to as suicidal ideation for simplicity throughout this thesis, 
was defined as a positive response to the final PHQ-9 question: ‘Thoughts that you would be 
better off dead, or of hurting yourself in some way’. Participants were considered to screen 
positive if they answered ‘several days’, ‘more than half the days’, or ‘nearly every day’ to this 
question. A missing response was included in the ‘not at all’ category. 
 
3.3.3 Sexual behaviour measures  
Eight sexual behaviour measures were considered for analysis: six were related to CLS 
(regardless of the sex of the partner) and two were related to partner numbers. Participants 
were asked questions about anal and vaginal sex in the past three months. Four measures of 
CLS (anal or vaginal) in the past three months were defined:  
i) CLS with one or more partners  
ii) CLS with two or more partners 
iii) CLS with at least one unknown and/or HIV-positive status partner (excludes men 
who reported no partners of unknown HIV status and only one HIV-positive CLS 
partner who was a long-term partner and with whom they ‘thought the risks of 
catching HIV were low because their partner was taking ART’) 
iv) Receptive CLS with an unknown HIV status partner  
 
Measure (iv) included men who reported always being the receptive partner and those who 
reported being sometimes the receptive and sometimes the insertive partner. Only men who 
reported that they did not know the HIV status of any of their partners could be included, as for 
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those who reported knowing some or all of their partners’ HIV status, it was not possible to 
distinguish whether this was the HIV-positive partner with whom the participant had insertive or 
receptive CLS. Furthermore, it is of note that although measure (i) CLS with one or more 
partners was investigated in this thesis, it is acknowledged that CLS should not in itself be 
pathologized since the act of CLS will often occur within the context of loving and mutually 
supportive relationships, and that strategies may also be used to try and reduce any perceived 
risk of HIV transmission. The limitations of investigating measure (i) in the context of STI/HIV 
transmission, are discussed in Chapter 5. 
 
Participants were asked whether they had been diagnosed with an STI in the past year. 
Although the site of infection was not specified, a rectal STI diagnosis was defined as report of 
one of four bacterial infections: (i) gonorrhoea, (ii) chlamydia, (iii) syphilis, or (iv) LGV. As 
described in section 1.2.3, rectal STIs and their treatment have important implications in the 
control of HIV and are often taken as a proxy measure for CLS. Participants were asked about 
the diagnosis of genital herpes and as such HSV was not included as part of the definition of 
rectal STIs.  
 
Finally, PEP use in the past year, having eleven or more new sexual partners in the past year, 
and group sex (sex with more than one person on the same occasion) in the past three months, 
was also ascertained. For each of the measures described above, a missing response was 
included in the no CLS or no high partner number category. 
 
3.3.4 Self-efficacy for sexual safety and reasons for non-condom-use 
The following statement was used to measure self-efficacy: ‘I feel confident that, if I want to, I 
can make sure a condom is used during sex with any partner, in any situation.’ If a participant 
strongly agreed with this statement this was considered to indicate high self-efficacy for sexual 
safety; all other responses (tend to agree, tend to disagree, strongly disagree, undecided/no 
opinion/not relevant to me, and missing) were not considered to indicate high self-efficacy. This 
categorisation was chosen for high self-efficacy for sexual safety due to the very high proportion 
of participants who agreed with this statement, therefore, it was believed appropriate to 
separate participants who specified ‘tend to agree’ from those who specified ‘strongly agree’. 
 
Participants were also asked the degree to which they agreed with the following statement: ‘I 
find it difficult to discuss condom use with any new sexual partner’. If a participant agreed (tend 
to or strongly) with this statement, this was considered to indicate difficulty in negotiating 
condom-use. All other responses (tend to disagree, strongly disagree, undecided/no opinion/not 
relevant to me, and missing) were not considered to indicate difficulty in negotiating condom-
use. 
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Men were also asked reasons for non-condom-use, for which the following options were given 
(one or more could be chosen): ‘Didn’t think about using a condom or did not have a condom’, 
‘Don’t like using condoms or it’s more enjoyable/close without a condom’, ‘My partner didn’t 
want to use a condom’, ‘Felt unable to discuss condom use’, ‘Got carried away or was under the 
influence of alcohol or drugs’, and ‘Difficult for me/partner to keep erection or ejaculate when 
using a condom’.  
 
3.3.5 Other covariates 
The other (self-reported) variables investigated in Chapters 4 and 5 include:  
 
- Age group in six categories: <25, 25-29, 30-34, 35-39, 40-44, or ≥45 years  
 
- Country of birth and ethnicity: UK born & white ethnicity, UK born & BAME (black, 
Asian, and minority ethnicity), non-UK born & white ethnicity, or non-UK born & BAME  
 
- Study region: London, South, or Midlands/Yorkshire and the Humber (the study clinics 
within each region are presented in Appendix section 11.8.1 Table 54) 
 
- Education: educated to university degree level or not (including a missing response) 
 
- Employment status: employed full- or part-time or other (unemployed, student, 
permanently/temporarily sick, looking after home, retired, other, or a missing response) 
 
- Financial hardship: having enough money to cover basic needs (e.g. for food and 
heating) all of the time, most of the time, or none/some of the time 
 
- Housing status: home-owner, renting (private or council), or unstable/other (homeless, 
temporary accommodation, staying with partner, friends, family, or other) 
 
- Sexual identity: gay, bisexual (including other plurisexual identities that are not explicitly 
based on attractions to one sex/gender 
(617)
), or straight/heterosexual 
 
Men, who did not select the ‘straight/heterosexual’ option when asked about their sexuality, 
were asked ‘what proportion of the following groups know that you are gay, bisexual and/or 
attracted men?’ The groups included: (i) close family, (ii) friends, and (iii) workmates. Response 
options for each group included: all/almost all, >half, half, <half, and few/none. Five variables 
regarding disclosure of sexual orientation were derived. 
- Disclosure of sexual orientation to close family: all/almost all, some (<half, half, or 
>half), or few/none 
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- Disclosure of sexual orientation to friends: all/almost all, some (<half, half, or >half), or 
few/none 
- Disclosure of sexual orientation to workmates: all/almost all, some (<half, half, or >half), 
or few/none 
- ‘Out’ to all/almost all friends, work colleagues, and close family: all/almost all or less 
(including a missing response) 
- ‘Out’ to few/no friends, work colleagues, and close family: few/none or more (including a 
missing response) 
 
- Relationship status: ongoing relationship with a partner (wife or civil partner or 
girlfriend/boyfriend) or not (including a missing response) 
 
Based on a modified version of the Duke-UNC Functional Social Support Questionnaire 
(631)
, 
participants were asked the level (as much as I would like; almost as much as I would like; 
some, but would like more; less than I would like; much less than I would like) at which they 
received the following help/support from other people: ‘I have people who care what happens to 
me’, ‘I get love and affection’, ‘I get chances to talk to someone I trust about my personal 
problems’, ‘I get invitations to go out and do things with other people’, and ‘I get help when I am 
sick in bed’. The response options were coded as 1 to 5, starting with as much as I would like 
(coded as 1). The total score across the five questions for each participant was generated. A 
total score of 5-10 was coded as 5 (low levels of a supportive network), 10-15 as 4, 15-20 as 3, 
20-24 as 2 and 25 as 1 (high levels of a supportive network). 
- Supportive network: social support score based on a modified version of the Duke-UNC 
Functional Social Support Questionnaire; 1 (highest), 2, 3, 4, or 5 (lowest) 
(631)
  
 
-  Regular smoking: current cigarette smoker or otherwise (including a missing response) 
 
Participants were asked the first two questions of the WHO AUDIT-C questionnaire: (i) ‘How 
often do you have a drink that contains alcohol?’ and (ii) ‘How many units of alcohol do you 
drink on a typical day when you are drinking?’ An alcohol use score was generated by summing 
responses for each question. Question (i) was coded as follows: ‘never’ (0), ‘monthly or less’ (1), 
‘2-4 times per month’ (2), ‘2-3 times per week’ (3), and ‘4+ times per week’ (4). Question (ii) was 
coded as follows: ‘1-2’ (0), ‘3-4’ (1), ‘5-6’ (2), ‘7-9’ (3), and ‘10+’ (4). The total score had a 
possible range from 0 to 8 
(632)
. Given that the AUDIT-C questionnaire incorporated a third 
question (how often have you had 8 or more units if male on a single occasion in the last year), 
which was not included in AURAH, a total score of less than six (instead of less than five) was 
considered to indicate lower risk drinking and a score of six or more (instead of five or more) 
was considered to indicate higher-risk drinking in this thesis. 
- Higher-risk alcohol consumption: higher-risk score of ≥6 or lower risk/no alcohol 
consumption score of <6 (including a missing response to both questions (i) and (ii)) 
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All participants were asked to report whether they had used recreational drugs in the past three 
months and, if so, to select which drug or drugs from the following list of 18 options; acid, 
lysergic acid diethylamide (LSD), or magic mushrooms (all grouped as psychedelics); anabolic 
steroids; cannabis (marijuana, grass); cocaine (coke); crack; codeine; crystal meth 
(methamphetamine); ecstasy (MDMA or E); GHB (GBL or liquid ecstasy); heroin, ketamine (k); 
khat (chat); mephedrone; morphine; opium; poppers (amyl nitrites); speed (amphetamine); 
erectile dysfunction drugs (Viagra); and other (whereby participants were asked to specify the 
drug). Other drugs specified were coded to the above categories where appropriate (in most 
cases participants specified one of the drug options under a different or street name).  
- Number of recreational drugs used in the past three months: none (including a missing 
response), 1, 2-4, or ≥5.  
- Poly-drug use: use of three or more recreational drugs or not (including a missing 
response) 
- Chemsex-associated drug use
xix
: use of at least one psychoactive substance that is 
commonly used before/during sex (crystal methamphetamine, mephedrone or 
GHB/GBL
(578-580)
) or not (including a missing response) 
- Club-drug use
xx
: use of at least one club-drug (mephedrone, GHB/GBL, ketamine, 
cocaine or ecstasy/MDMA) or not (including a missing response) 
 
The specification of variables in Chapter 6 differs slightly. These variables are described in 
Chapter 6 section 6.2.3.1. 
 
3.3.6 Variable definitions in the PROUD trial 
 
3.3.7 Symptoms of depression  
The definition of PHQ-9 depression measures, including suicidal ideation/self-harm, is 
described in detail in section 3.3.2. Information on symptoms of anxiety was not collected as 
part of PROUD questionnaires.  
 
                                                     
xix
 There may be other drugs that are used for chemsex, including Viagra, ketamine, ecstasy, cocaine, 
poppers, and alcohol, but these drugs do not cause the same degree of sexual disinhibition nor the same 
amount of harm that is possible with crystal methamphetamine, mephedrone and GHB/GBL (based on 
anecdotal report from David Stuart, the substance use lead at 56 Dean Street, 18/09/2015). 
xx
 This measure was developed in consultation with David Stuart, the substance use lead at 56 Dean 
Street (18/09/2015). At this time, these drugs were thought to be most commonly used by gay men on the 
clubbing scene, based on interviews conducted by David Stuart with over 1500 MSM seeking support from 
ChemSex clinics at 56 Dean Street, and anecdotal reports from the LGBT drug/alcohol service ‘Antidote’ 
at the charity London Friend, as relayed by David Stuart. Although it was thought to be of interest to 
investigate ‘club-drug use’, it is acknowledged, that there is a great deal of cross-over between club-drugs 
and chemsex-drugs. Therefore, these measures are not compared in any way throughout this thesis, but 
rather examined together as measures of drug use which may be relevant to MSM in the context of HIV 
prevention research. Furthermore, it is also acknowledged that trends in club-drug use may have changed 
since the conception of the club-drug variable in 2015. 
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3.3.7.1 Receiving treatment for depression 
At the baseline visit men were asked by study staff to note down any medication they were 
taking. I identified all men who specified that they were taking a medication that has been 
licensed for treatment of depression. Two members of the PROUD trial team (Professor 
McCormack and Dr White) independently reviewed participants’ responses, in order to ensure 
that all appropriate treatments specified had been identified. Responses included; amitriptyline, 
bupropion, sertraline, citalopram, duloxetine, escitalopram, fluoxetine, mirtazapine, sertraline, 
venlafaxine, as well as ‘antidepressant’ and ‘serotonin’. 
 
3.3.8 Sexual behaviour measures  
Ten sexual behaviour measures were considered for analysis: seven were related to CLS and 
three were related to partner numbers. PROUD trial participants were asked about the number 
of partners (any and new) with whom the participant had anal sex in the past three months, with 
how many of these partners a condom was used and whether the participant was the insertive 
or receptive partner, as well as information about the most recent episode of anal sex and 
knowledge of partner HIV status. Five measures of CLS in the past three months were defined:  
(i) CLS with at least two receptive and/or insertive CLS partners (of note, this measure 
is phrased in such a way to acknowledge the difficulty in distinguishing whether 
men who reported one receptive CLS partner and one insertive CLS partner [n=61 
at baseline, n=37 at month-12, and n=29 at month-24] were referring to the same 
partner or two different partners) 
(ii) CLS with at least five receptive and/or insertive CLS partners (derived due to the 
very high proportion of men reporting at least two CLS partners) 
(iii) CLS with at least one partner with whom they knew were HIV-positive but did not 
know  whether treatment was being taken 
(iv) Receptive CLS with an HIV-positive partner not known to be on treatment 
(v) Last CLS with an unknown/HIV-positive partner not known to be on treatment 
 
At baseline, participants were asked whether they had been diagnosed with an STI in the past 
year. A rectal STI diagnosis was defined as report of one of four (rectal) bacterial infections: (i) 
rectal gonorrhoea, (ii) rectal chlamydia, (iii) syphilis, and (iv) LGV. Furthermore, at baseline self-
reported PEP use in the past year was also ascertained.  
 
The three measures of partner numbers included:  
(i) Ten or more new anal sex partners in the past three months 
(ii) Receptive anal sex with ten or more partners in the past three months 
(iii) Group sex in the past three months (collected as part of the 12- and 24-month 
questionnaires only) 
 
 
 
 
109 
 
Of note, for each of the measures described above, a missing response was included in the no 
CLS or no high partner number category. Although it was originally planned to investigate HIV 
and STI incidence, and PrEP adherence, it become clear that collection of this data was not 
sufficient/the sample size was too limited to allow for meaningful analysis.  
 
3.3.9 Self-efficacy for sexual safety and reasons for non-condom-use 
At the 12- and 24-month follow-up, men were asked the extent to which they agreed or 
disagreed with a series of statements on condom-use and sexual satisfaction. The following 
statement was used to measure self-efficacy: ‘The sex I have is always as safe as I want it to 
be’. If a participant strongly agreed with this statement this was considered to indicate high self-
efficacy for sexual safety, all other responses (agree, disagree, strongly disagree, 
neural/uncertain, and missing) were not considered to indicate high self-efficacy. Participants 
were also asked the degree to which they agreed with the following statement: ‘I find it easy to 
say ‘no’ to sex I don’t want’. If a participant disagreed (disagree or strongly disagree) with this 
statement they were considered to indicate difficulty in saying no to unwanted sex, again all 
other responses (agree, strongly agree, neutral/uncertain, and missing) were not considered to 
indicate difficulty in saying no to unwanted sex. Of note, although one’s ability to say no to 
unwanted sex is a component of self-efficacy for sexual safety, one may theoretically have high 
self-efficacy for sexual safety (i.e. always have sex that is as safe as one wants it to be) but 
difficulty in saying no to unwanted sex. Finally, participants were asked the degree to which they 
agreed with the following statement: ‘I am happy with my sex life’. If a participant disagreed 
(disagree or strongly disagree) with this statement they were considered to indicate being 
unhappy with their sex life. All other responses (agree, strongly agree, neutral/uncertain, and 
missing) were not considered to indicate unhappiness with one’s sex life.  
 
Men were also asked reasons for non-condom-use, for which the following options were given 
(and one or more could be chosen): ‘I don’t like using condoms’, ‘He doesn’t like using 
condoms’, ‘Condoms weren’t discussed’, ‘We don’t use condoms with each other but do with 
other partners’, ‘Neither of us had any condoms’, ‘I didn’t consider myself at risk of HIV’, ‘I was 
under the influence of alcohol’, ‘I was under the influence of drugs’, ‘I am faithful to him’, ‘He is 
faithful to me’, ‘It is more enjoyable without a condom’, ‘I was only dipping’, ‘I lose erections with 
condoms’ (only asked in the annual follow-up questionnaires) and ‘Other’. 
 
3.3.10 Other covariates 
The other (self-reported) variables investigated in Chapters 7 and 8 include:  
 
- Age group in six categories: <25, 25-29, 30-34, 35-39, 40-44, or ≥45 years  
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Baseline only;  
 
- Country of birth and ethnicity: UK born & white ethnicity, UK born & BAME (black, 
Asian, and minority ethnicity), non-UK born & white ethnicity, or non-UK born & BAME  
 
- Study region: London or outside London 
 
- Education: educated to university degree level or not (including a missing response) 
 
- Employment status: employed full- or part-time or other (unemployed, student, retired, 
other, or a missing response) 
 
- Sexual identity: gay, bisexual (including other plurisexual identities that are not explicitly 
based on attractions to one sex/gender 
(617)
), or straight/heterosexual 
 
- Relationship status: ongoing relationship with a partner (wife/husband or civil partner or 
girlfriend/boyfriend) or not (including a missing response) 
 
- Higher-risk alcohol consumption based on the first two questions of the WHO AUDIT-C 
questionnaire 
(632)
 (questions and scoring are described above in section 3.3.5): higher-
risk score of ≥6 or lower risk/no alcohol consumption score of <6 (including a missing 
response to both questions). Of note, the response options included in PROUD for the 
first WHO AUDIT-C question (‘How often have you had a drink containing alcohol in the 
last 90 days?’) were 1 frequency lower than that specified in the WHO questionnaire, for 
instance, ‘2 or 3 times a month’ instead of ‘2 to 4 times a month’, and ‘once or twice a 
week’ instead of ‘2 to 3 times a week’. It is therefore possible, that the higher-risk 
alcohol consumption variable examined in PROUD constitutes a different measure to 
that investigated in AURAH, whereby the prevalence may be slightly overestimated in 
PROUD. The potential difference in measures is discussed in the limitations section of 
PROUD results chapters.  
 
All participants were asked to report whether they had used recreational drugs in the past three 
months and, if so, to select which drug or drugs from a list of 19 options including ‘other’ (see 
section 3.3.5). 
- Number of recreational drugs used in the past three months: none (including a missing 
response), 1, 2-4, or ≥5 
- Poly-drug use: use of three or more recreational drugs or not (including a missing 
response) 
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- Chemsex-associated drug use: use of at least one psychoactive substance that is 
commonly used before/during sex (crystal methamphetamine, mephedrone or 
GHB/GBL
(578-580)
) or not (including a missing response) 
- Club-drug use: use of at least one club-drug (mephedrone, GHB/GBL, ketamine, 
cocaine or ecstasy/MDMA) or not (including a missing response) 
 
12- and 24-month questionnaires only; 
 
Participants were given a set of circumstances in which individuals might have sex and were 
asked when last they had had sex under these circumstances (if ever) even if it is not typical. 
One of these circumstances included ‘sex after using recreational drugs’. Response options 
included: never, >six months ago, within the last six months, within the last three months, and 
within the last four weeks. Sex after using recreational drugs is referred to throughout this thesis 
as sexualized drug use. 
- Recently had sex after using recreational drugs (sexualized drug use): yes (within the 
last four weeks/last three months) or no (within last six months, >six months ago, never, 
or a missing response) 
 
Participants were asked ‘How old were you the very first time you had any sexual contact with a 
male, or a male had any sexual contact with you?’ and ‘How old were you the very first time you 
had anal intercourse (top or bottom) with a male?’ The UK Sexual Offences Act 2003 stipulates 
the legal age of sexual consent to be 16 and that children under age 13 have no legal capacity 
to consent to any form of sexual activity since they cannot fully comprehend nor are they 
developmentally prepared for it 
(633)
. Two measures of age at anal sex debut were investigated, 
including cut-offs of age <13 and age ≤15. Reports of sexual intercourse before age 13 may 
include experiences of CSA, however, since information was not collected on the age of the 
sexual partner and whether they felt forced, it is possible that some participants may not have 
experienced forced/coerced sex. Furthermore, experiences of CSA may occur at ages older 
than 13 years. Therefore, although it was of interest in this thesis to investigate a very young 
age at sexual debut as this measure may include many cases of CSA, it may not reflect or pick 
up all sexual abuse experienced. The limitation of considering this measure to be indicative of 
CSA is discussed in Chapters 7 and 8. Of note, a third measure was derived in order to 
investigate the time delay between first sexual contact and anal sex.  
-  Age <13 at first anal sex: yes or no (age ≥13 at first anal sex) 
 
- Age ≤15 at first anal sex: yes or no (age >15) 
 
- Time between any sexual contact and anal sex with a male: same time, 1-2 years, 3-4 
years, or 5+ years 
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Participants were asked five questions about IPV victimization and five questions about IPV 
perpetration. Each question had the following four response options: never, yes- more than 1 
year ago, yes within the last year with former partner, and yes within the last year with current 
partner. The five IPV victimization questions included the following: ‘Have you ever felt 
frightened of the behaviour of a partner’, ‘Have you ever needed to ask a partner’s permission 
to work, go shopping, visit relatives, or visit friends (i.e. beyond the usual of being considerate to 
and checking with a partner)’, ‘Have you ever been hit, slapped, kicked or otherwise physically 
hurt by a partner’, ‘Have you ever been forced to have sex or made to engage in some sexual 
activity when you did not want to’, and ‘Have you ever been forced to have sex without a 
condom when you did not want to’. Similarly, the five IPV perpetration questions included the 
following: ‘Have you ever behaved in a manner that has made a partner feel frightened’, ‘Has a 
partner ever needed to ask your permission to work, go shopping, visit relatives, or visit friends 
(i.e. beyond the usual of being considerate to and checking with a partner)’, ‘Have you ever hit, 
slapped, kicked or otherwise physically hurt a partner’, ‘Have you ever forced a partner to have 
sex or engage in some sexual activity when he did not want to’, and ‘Have you ever forced a 
partner to have sex without a condom when he did not want to’. Responding with ‘yes’ (more 
than 1 year ago, within the last year with former partner, or within the last year with current 
partner) to at least one of the five IPV victimization questions was considered to indicate any 
IPV victimization and responding with ‘yes’ to at least one of the five IPV perpetration questions 
was considered to indicate any IPV perpetration. Of note, following the ten IPV questions, 
participants were asked ‘If you answered yes in the last year to any question above, do you 
think joining PROUD has influenced these behaviours?’, with response options; no, yes in a 
positive way, or yes in a negative way. 
- Any IPV victimization: reported any form of IPV victimization or not (including a missing 
response) 
- IPV victimization in the past year: reported any form of IPV victimization in the past year 
or not (including a missing response) 
- Any IPV perpetration: reported any form of IPV perpetration or not (including a missing 
response) 
- IPV perpetration in the past year: reported any form of IPV perpetration in the past year 
or not (including a missing response) 
  
Participants were asked eight questions surrounding attitudes towards gay sexuality based on 
the 26-item Internalized Homophobia Scale (IHS) 
(634)
. Each question had the following five 
response options: strongly agree, agree, neutral or uncertain, disagree, and strongly disagree. 
The eight questions included the following: (i) ‘I feel comfortable in gay bars’, (ii) ‘I feel 
comfortable being seen in public with an obviously transgender/gay person’, (iii) ‘I feel 
comfortable discussing homosexuality in a public situation’, (iv)‘I feel comfortable being a 
transgender/gay man’, (v) ‘Homosexuality is morally acceptable to me’, (vi) ‘Even if I could 
change my sexual orientation I wouldn’t’, (vii) ‘Obviously effeminate homosexual men make me 
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feel uncomfortable’ and (viii) ‘Social situations with transgender/gay men make me feel 
uncomfortable’. Responding with ‘strongly agree’ or ‘agree’ to questions (vii) or (viii), or with 
‘strongly disagree’ or ‘disagree’ to questions (i), (ii), (iii), (iv), (v), or (vi) was considered to 
indicate having negative attitudes towards gay sexuality. 
- Internalized homophobia: negative attitudes towards gay sexuality or not (including a 
missing response) 
 
Participants were asked how many of their (i) work colleagues, (ii) friends, and (iii) close family, 
know that they are gay/transgender/have sex with men. Response options for groups (i)-(iii) 
included: all/almost all, >half, <half, few, and none. Five variables regarding disclosure of sexual 
orientation were derived. 
- Disclosure of sexual orientation to work colleagues: all/almost all, some (<half or >half), 
few, or none 
- Disclosure of sexual orientation to friends: all/almost all, some (<half or >half), few, or 
none 
- Disclosure of sexual orientation to close family: all/almost all, some (<half or >half), few, 
or none 
-  ‘Out’ to all/almost all work colleagues, friends, and close family: all/almost or less 
(including a missing response) 
- ‘Out’ to few/no work colleagues, friends, and close family: few/none or more (including a 
missing response) 
 
3.3.11 Handling of missing data 
Where non-response to a question was considered to indicate non-occurrence of a measure, 
this is included in the definition of variables above. For instance, a missing response for 
education was considered to indicate non-university education and a missing response for 
recreational drug use was considered to indicate that zero drugs had been taken. Similarly, for 
the PHQ-9 and GAD-7, non-response to an item on the inventory was considered as absence of 
that specific symptom. This was done as there appeared to be a common response pattern in 
which only those symptoms that had been experienced were ticked. Where missing responses 
were included in the definition of variables, the proportion of missing values is provided when 
reporting the prevalence of measures in results chapters. The proportion of missing values was 
≤5% for all variables used in analyses. Initial analyses that were undertaken to investigate 
whether excluding missing values (when defining each variable) had an impact on findings, 
demonstrated that this was not the case.  
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3.4 Epidemiological concepts: hypothesized causal effects 
 
3.4.1 Directed acyclical graphs 
In epidemiological studies, it is important to define the hypothesized causal effects of exposures 
on the outcome of interest. Directed acyclical graphs (DAG) provide a framework in which a set 
of hypothesized causal effects can be generated, producing a conceptual model. In a DAG, 
arrows are drawn between variables of interest in order to make explicit the hypothesis made 
about the causal connection 
(635-637)
. Only one causal direction can be specified. For instance, 
either factor A is causing factor B or factor B is causing factor A, or neither of these is true. 
Hypothesized relationships can be either positive or negative. 
 
Defining a set of hypothesized causal effects is useful in order to clarify which variables may be 
potential confounders, effect modifiers, and mediators of the relationship between the exposure 
of interest and outcome. This will inform the analysis. In addition, it is possible to generate 
analyses to assess how consistent or otherwise the data are with the conceptual model. These 
concepts are discussed below. Of note, in most studies it is not possible to prove that observed 
relationships are in fact causal. Investigating evidence for causality is discussed in section 
3.4.4. 
 
3.4.2 Investigating confounding, effect modification, and mediation 
A confounding factor is associated with both the exposure variable and the outcome variable 
and is not considered to be an intermediary step in the hypothesized causal pathway. 
Confounding can be adjusted for in the analysis if information on the potential confounding 
factor is available. If a potential confounding factor is distributed unequally among the exposure 
variable categories, it may completely or partially reduce, or increase, the observed association 
between the exposure and outcome when added to a regression model 
(638)
. 
 
Effect modification occurs when the association between the exposure variable and the 
outcome variable differs depending on the level of a third variable. Dealing with effect 
modification involves examining the association between the exposure and the outcome 
separately for each level of the effect modifying variable in a regression model. Effect 
modification is sometimes referred to as interaction and an effect modifier as an interactor 
(638)
.  
 
Mediation occurs when the association between the exposure and outcome operates fully or 
partially through an intermediate factor(s) within a hypothesized causal chain 
(456)
. If a factor is 
found to be a mediating variable this would mean that in order for the exposure to lead to the 
outcome, it must first cause the mediating variable(s), which then in turn leads to the outcome. 
The most common approach to mediated analysis stems from the work of Kenny and 
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colleagues and is referred to as the ‘causal steps’ approach 
(639, 640)
. A series of four steps, using 
regression modelling, are required to reasonably conclude potential mediation: 
1. The exposure must be significantly associated with the outcome 
2. The exposure must be significantly associated with the mediating variable 
3. The mediating variable must be significantly associated with the outcome 
4. The association between the exposure and outcome should be reduced (or completely 
blocked) when the mediating variable is added to the model 
 
It has been suggested that this approach is insufficient on its own to allow conclusions to be 
made regarding potential mediation, as it does not provide estimates of the mediated effect and 
standard errors. It is therefore, not possible to assess the significance of the mediated effect 
and any conclusions drawn may be subject to type I or II errors 
(456)
. There are two other 
common approaches to mediational analysis, which extend the causal steps approach: the 
difference of coefficients method and the product of coefficients method. In both methods, the 
difference between the effect of the exposure on the outcome with and without the mediating 
variable in the model is measured 
(456)
. Under most circumstances, these approaches will 
produce identical estimates of the mediated effect.  
 
3.4.2.1 Investigating mediation using structural equation modelling 
The product of coefficients method is often used in a structural equation model (SEM) 
framework. SEM produces estimates of the direct effect of the exposure on the outcome, the 
indirect effect of the exposure on the outcome via the mediating variable (or multiple variables in 
complex mediational chains), and the total effects in a single model 
(456)
. A significant indirect 
effect suggests that the hypothesized intermediate factor may be on the causal pathway. The 
Sobel formula is used to test the significance of the indirect effect by dividing the estimate of the 
mediated effect by one of several standard error estimates 
(641)
.  
 
3.4.3 Investigating the conceptual model 
SEM is also a means by which to assess whether the data are consistent with a given set of 
causal relationships, since it allows for more flexible specification of relationships. Nearly any 
variable can be allowed to be correlated, or constrained to be uncorrelated, with another 
variable. It is helpful to examine more than one conceptual model in SEM in order to investigate 
which hypothesis the data are more consistent with. In this way, SEM is also a means by which 
to generate further hypotheses.  
 
3.4.4 Evidence for causality 
In 1965, Sir Austin Bradford Hill proposed nine ‘aspects of association’ that should be 
considered when evaluating epidemiological data and concluding causation 
(642)
. These nine 
aspects of association were integrated into the so called Bradford Hill Criteria, which is to this 
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day commonly used as a guide to causal inference. The strongest evidence for causality comes 
from longitudinal study designs in which temporality can be inferred. In particular, evidence is 
more robust for randomized trials as they also control for confounding. Other criteria for 
determining whether a relationship is causal include strength of association, consistency, 
specificity, biological gradient, biological plausibility, coherence, experiment, and analogy. 
These criteria are defined in Textbox 6.
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Textbox 6: Bradford Hill Criteria; adapted from research by Fedak et al 2015 
(642)
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3.5 Causal pathways hypothesized in this thesis 
 
In order to make explicit the hypotheses made about the causal connections between socio-
demographics, psychosocial factors and depressive symptoms, and between depressive 
symptoms and CLS in this thesis, a DAG 
(635-637)
 was drawn using DAGitty software 
(643)
. The 
DAG is presented in Figure 8 below. All arrows shown leading to depression and CLS were 
derived from observed relationships based on previous literature presented in Chapters 1 and 2 
(and in Appendix sections 11.4.1- 11.4.2.1), although such relationships have not been proved 
to be causal. It is of note that implicit within this conceptual model, is that CLS is often a 
desirable behaviour for reasons of intimacy and pleasure. Where the sex is desired, perceived 
risk of STIs/HIV may result in behavioural adaptation via condom-use for some individuals but 
not others, reflected in the factors shown leading to CLS in the DAG. All arrows shown leading 
to psychosocial factors (CSA, IPV, recreational drug use, and sexual minority stress) and 
psychological constructs (self-efficacy and cognitive escape) were informed by previous 
literature. The arrows shown between the following factors were hypothesized causal 
relationships which were not informed by findings from previous studies: age and relationship 
status, structural factors (socio-cultural norms regarding sexuality, as described in section 
1.6.1.2 of Chapter 1, which may be supported by religious doctrines) and lack of knowledge 
about HIV, having been born outside the UK and low socio-economic status, low socio-
economic status and lack of knowledge about HIV, and relationship status and lack of 
supportive network. 
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Figure 8: Directed acyclical graph of hypothesized causal connections between socio-demographics, psychosocial factors and depressive 
symptoms****, and between depression and CLS, among sexual minority men  
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All the factors represented by pink squares in Figure 8, including sexual minority stress, lower 
supportive network, and sensation seeking/sexual compulsivity, are hypothesized to be 
ancestors of the primary exposure of interest and of the outcome i.e.to indirectly cause both 
depression and CLS, or directly cause one and indirectly cause the other. There are five factors 
in Figure 8 that are hypothesized to directly cause both depression and CLS. These are 
recreational drug use, CSA, IPV, younger age, and being in an ongoing relationship. Since 
these factors are not hypothesized to be on the causal pathway between depressive symptoms 
and CLS, they are potential confounders of this relationship. The inclusion of these factors in 
adjusted models is described in the next section. Of note, recreational drug use, a very young 
age at anal sex debut, which may include experiences of CSA, and IPV were also investigated 
as potential effect modifiers of the relationship between depressive symptoms and CLS.  
 
Low self-efficacy for sexual safety is hypothesized to be the main mechanism mediating the 
association between depressive symptoms and CLS in Figure 8. Lack of self-efficacy is 
hypothesized to lead directly to CLS and indirectly via a process of cognitive escape. Since only 
one causal pathway can be presented in the DAG, the green arrow is only shown from 
depression to self-efficacy and not self-efficacy to CLS. It is of note that AURAH did not ask 
questions surrounding CSA or IPV, and neither AURAH nor PROUD collected information on 
knowledge of HIV
xxi
, markers of cognitive escape coping, personality traits associated with 
sensation seeking/sexual compulsivity, or fear of HIV due to pervasive prevention messages 
(HIV-related worry). The PROUD trial collected information on age at anal sex debut but as 
discussed above in section 3.3.10, although reports of sexual intercourse before age 13 may 
include experiences of CSA, this measure may not reflect or pick up all sexual abuse 
experienced. Furthermore, structural factors cannot be extrapolated from the AURAH or 
PROUD questionnaire, and a comprehensive measure of minority stress was not investigated in 
either study. Modelling of the DAG is described in the next section. This includes depicting the 
hypothesized relationships between factors collected, in a SEM, in order to investigate the 
indirect effect of self-efficacy for sexual safety and examine consistency of the conceptual 
model with the data. 
 
3.6 Statistical methodology 
 
This section describes the main statistical methods used in analysis in this thesis, further details 
are given in individual chapters. 
 
 
 
                                                     
xxi
 Knowledge of HIV refers to awareness and understanding of HIV transmission routes, susceptibility (i.e. 
with a concurrent STI), and prevention and risk reduction strategies (biomedical interventions and 
community approaches to risk reduction such as sero-sorting and sero-positioning). This includes an 
understanding of the implications of an HIV viral load in terms of infectiousness. 
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3.6.1 Analyses based on cross-sectional data from the AURAH study 
 
3.6.2 Modified Poisson regression 
Logistic regression is often used when the outcome is binary, in order to produce odds ratios 
(ORs) to describe the association between an exposure and the binary outcome variable. 
However, ORs can be somewhat difficult to interpret, as they are not intuitive, do not relate 
directly to percentages, and may be misinterpreted as risk ratios or prevalence ratios. Modified 
Poisson regression, so termed by Zou (2004), can be used in order to produce risk ratios or 
prevalence ratios when the outcome (dependent variable) is binary. Poison regression is a 
generalized linear model with a log link and a Poisson distribution 
(644)
. Ordinary Poisson 
regression is usually used for analysis of count outcomes, the counts being non-negative 
integer values, usually describing the occurrence of certain events
xxii
. Use of Poisson regression 
with a binary outcome will result in underdispersed data, since the data exhibits less variation 
than expected by a model based on a Poisson distribution. Underdispersion will result in 
standard errors
xxiii
, p-values, and confidence intervals that are too large, since the error term is 
miss-specified when the underlying data are binomially distributed 
(644)
. Zou (2004) found that 
this issue can be solved via the use of a robust error variance procedure, called a sandwich 
estimator. The sandwich error term can correct the variance overestimation by relaxing the 
assumption that the data are from a Poisson distribution 
(645)
. Accordingly, modified Poisson 
regression, was used for unadjusted and adjusted analysis of binary outcomes for cross-
sectional analyses in Chapters 4 and 5 of this thesis, in order to produce prevalence ratios 
(PRs). Of note, overall p-values for heterogeneity based on the Wald test in modified Poisson 
regression and p-values for tests for linear trend, whereby categorical variables are treated as 
continuous in the model, are presented. Effect modification via use of interaction terms and the 
causal steps approach to mediation was investigated in modified Poisson models in Chapter 5. 
Analyses were performed using STATA statistical software 
(646)
. One disadvantage of the use of 
PRs rather than ORs is that, when investigating the association between depressive symptoms 
and sexual risk behaviour, the magnitude of the PRs cannot be directly compared across sexual 
behaviours of different prevalence. For a common outcome measure, whereby the underlying 
prevalence may be high, the PR is likely to be of smaller magnitude compared to that for rare 
outcomes. For instance, a prevalence of 10% may be doubled resulting in a PR of 2, but a 
prevalence of 60% cannot be doubled and therefore cannot result in a PR of 2. Accordingly, 
PRs should be considered together with the prevalence of the outcome. 
 
                                                     
xxii
 The dependent variable has the probability of being 0, 1, 2, 3, 4, 5 etc. 
xxiii
 The standard error is the accuracy with which a sample represents a population. The calculation for the 
standard error is based on the sample size and standard deviation. The standard deviation is how much 
the members of a group differ/deviate from the mean value for the group. The calculation for the standard 
deviation is based on the value for each member of the group, the mean value, and the sample size. 644.
 Cummings P. Methods for estimating adjusted risk ratios. The Stata Journal. 2009;9(2):175-96. 
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3.6.3 Structural equation modelling 
SEM has been introduced in sections 3.4.2 and 3.4.2.1 above. Of further note, SEM allows 
unobserved (latent) variables to be treated as if they were observed. Latent variables are 
defined as constructs that are not real, but come from the ‘imagination of the researcher’, as 
opposed to traits, which exist in people. For latent variables, a hypothetical variable attempts to 
measure real phenomena. For instance, the construct of self-efficacy is not real, but there are 
real phenomena or personality traits to which researchers apply this term 
(647-650)
. 
Acknowledging variables as latent rather than observed can have clear advantages. Latent 
variables account for unreliability of measurement but in regression analysis/SEM, the 
regression coefficients/path coefficients will be biased for unreliable observed variables 
(456, 651)
. 
In addition, SEM can be used to correct for non-normality in the data and for missing data 
problems. Finally, as Bryan et al (2007) put it, “it is more satisfying to simultaneously test the 
validity of the entire theory as hypothesized in the context of a structural model” 
(456)
 (page 366).  
 
The same DAG as that presented above in Figure 8 but depicting the hypothesized 
relationships between factors collected in the AURAH questionnaire, is presented in Chapter 6 
Figure 16. SEM was used to explore the conceptual model (DAG) in Chapter 6 in order to 
investigate mediation and examine consistency of the model with the data. Mplus is the main 
SEM software capable of handling categorical data and as such, all analyses were performed 
using MPlus statistical software 
(652, 653)
. 
 
3.6.4 Dealing with hierarchical data 
In Chapter 5, when investigating the association between depressive symptoms and sexual 
behaviour, a variable describing the region of GUM clinic site recruitment, referred to as the 
study region, was investigated as a random-effect (with random intercepts) in a multilevel 
mixed-effects Poisson regression model. This was in order to take into account the hierarchical 
structure of the data. When comparing this model
xxiv
 to a model that incorporated study clinic 
site as a fixed-effect in a Poisson regression, the pseudo R
2
 was identical. This was the case at 
each stage of the model building procedure described below, and for each outcome. As a result, 
and since it was not of interest in this thesis to compare the within-group variance with the 
between group variance, it was decided that the study region would be investigated as a fixed-
effect in a Poisson model with a robust variance estimator. 
 
3.6.5 Adjustment for confounders  
When investigating the association between depressive symptoms and sexual risk behaviour, 
depressive symptoms and self-efficacy for sexual safety, and self-efficacy for sexual safety and 
sexual risk behaviour, in Chapter 5, factors were adjusted for in two stages. In the first stage, 
                                                     
xxiv
 As well as a Poisson model incorporating a clustered sandwich estimator, which relaxes the 
assumption that observations are independent and allows for intragroup correlation. 
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socio-demographic factors assumed not to be on the causal pathway were adjusted for. These 
included hypothesized confounders in the DAG in Figure 8 with a direct causal link to sexual 
behaviour (age and relationship status) as well as factors that may be proxy measures for 
knowledge about HIV (UK born and educational attainment). In the second stage, these same 
socio-demographic factors were adjusted for plus lifestyle factors hypothesized to be 
confounders, in order to assess the extent to which the association was attenuated. The two 
models are shown below. Of note, when investigating socio-demographic and lifestyle factors 
associated with depressive symptoms in Chapter 4, adjustment for factors in Model 1 was 
investigated only. 
 
1. Model 1 with socio-demographic variables: age group in four categories (<25, 25-34, 
35-39, or 40+), university education (yes or no/missing), born in the UK (yes or no), self-
reported sexual identity (gay or bisexual/straight), ongoing relationship (yes or 
no/missing), and study region (London, South, or Midlands/Yorkshire & the Humber). 
 
2. Model 2 with the same socio-demographic variables shown above plus lifestyle 
variables: number of recreational drugs used (0/missing, 1, 2-4, or 5+), higher-risk 
alcohol consumption (modified WHO AUDIT-C higher-risk score of ≥6 or lower risk/no 
alcohol consumption score of <6/missing), and regular smoking (yes or no/missing). 
 
Initial analyses undertaken to investigate whether adjusting for age grouped into six categories 
(<25; 25-29; 30-34; 35-39; 40-44; ≥45 years) or adjusting for age as a continuous variable had 
an impact on findings, demonstrated that this was not the case.  
 
3.6.6 Longitudinal data from the PROUD trial 
For reasons described above in section 3.3.8, although originally planned it was not possible to 
investigate HIV/STI incidence in this thesis using longitudinal data from the PROUD trial. As a 
result, cross-sectional associations with depressive symptoms and sexual risk behaviour 
measures were investigated in this thesis, at each PROUD time-point and by pooling data from 
each time-point. The statistical methods used to do this, are described below. 
 
3.6.7  Generalised estimating equations 
Standard regression modelling assumes that all observations are independent of each other. 
Longitudinal data contains repeated measures from the same individual over time. In general, 
observations from the same individual are more similar to each other than observations from 
different individuals. Use of standard regression models to analyse data with correlated 
observations tends to produce standard errors that will underestimate the true sample-to-
 
 
 
125 
 
sample variation and hypothesis test probabilities
xxv
 that will be too low. Confidence intervals will 
also be unrealistically narrow 
(644, 645)
. Generalized estimating equations (GEEs) treat the data 
as if it were cross-sectional, while dealing with variance underestimation for correlated 
observations in longitudinal studies. This is achieved via the use of a robust estimation of 
standard error procedure. In GEEs, the estimated coefficients are based on variations within 
and between individuals, and it is possible to investigate the effects of time-invariant and time-
variant independent variables on the dependent variable. GEEs were chosen for analysis of 
longitudinal data from the PROUD trial, since the prevalence rather than incidence of outcomes 
was investigated in this thesis. Compound symmetry was used for the correlational structure via 
use of the ‘exchangeable’ option in STATA, since it was assumed that the observations on a 
given participant were more correlated than those between different participants. A Poisson 
model with a log link was fitted in GEEs in order to produce PRs in Chapters 7 and 8 
(655, 656)
. As 
described in section 3.6.2 for modified Poisson regression, estimates are presented with overall 
p-values for heterogeneity (based on the Wald test) and p-values for tests for linear trend. Effect 
modification via use of interaction terms was investigated in GEEs in Chapter 8. Although 
originally planned, based on initial findings it was deemed unnecessary to investigate mediation 
via the causal steps approach or SEM. All analyses were performed using STATA statistical 
software 
(646)
. It is of note that cross-sectional data from PROUD at each time-point (baseline, 
12-month, and 24-month questionnaire) was also investigated using modified Poisson 
regression, as described in section 3.6.2. 
 
3.6.8 Adjustment for confounders  
The PROUD trial collected longitudinal data. With the exception of age, information on socio-
demographic and lifestyle factors was only collected at the baseline questionnaire. When 
investigating associations at month-12 and month-24 in modified Poisson models, and when 
combining data from each study time-point using GEEs, it was necessary to decide which of 
these socio-demographic and lifestyle factors were likely to remain the same over the course of 
the two year study and which factors were likely to change. It was considered appropriate to 
assume that information on country of birth, study region, education, employment status, and 
sexual identity would most likely not change over the course of the study, and as such, the 
baseline value of these variables was included in modified Poisson models at follow-up and in 
GEE models. It was however, considered inappropriate to assume that relationship status, 
higher-risk drinking, and recreational drug use in the past three months would not change over 
the two year period of the study, and as such, these variables were not included in modified 
Poisson models at follow-up or in GEE models. 
 
                                                     
xxv
 Hypothesis tests consist of testing the probability that the null hypothesis, that there is no difference 
between two population proportions for instance, is true.654. Kohler U, Kreuter F. Data Analysis Using 
Stata. 3rd ed. Texas: StataCorp LP; 2009.  
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In Chapter 8, investigating the association between depressive symptoms and sexual risk 
behaviour, at baseline, month-12, and month-24 in modified Poisson models, and when 
combining data from each study time-point using GEEs, different factors were adjusted for in 
two stages given the collection of data at different time-points. In the first stage, socio-
demographic factors assumed not to be on the causal pathway were adjusted for. These 
included hypothesized confounders in the DAG in Figure 8 with a direct causal link to sexual 
behaviour (age and relationship status) as well as factors that may be proxy measures for 
knowledge about HIV (UK born and educational attainment). In the second stage, these same 
socio-demographic factors were adjusted for plus psychosoical factors hypothesized to be 
confounders, in order to assess the extent to which the association was attenuated. The two 
stages of adjustment at each study time-point are presented below. Of note, when investigating 
socio-demographic and psychosocial factors associated with depressive symptoms in Chapter 
7, adjustment for factors in Model 1 was investigated only. Furthermore, in Chapter 8, when 
examining associations at month-12 and month-24 in modified Poisson models, adjustment for 
factors in Model 1 was investigated only. Adjustment for psychosocial factors in Model 2 was 
investigated in GEEs given the increased statistical power associated with combining 
observations from baseline, month-12, and month-24. 
 
1. Model 1 with socio-demographic variables: 
- Baseline; age group in four categories (<25, 25-34, 35-39, or 40+), university 
education (yes or no/missing), born in the UK (yes or no), self-reported sexual 
identity (gay or bisexual/straight), ongoing relationship (yes or no/missing), and 
study region (London or outside London). 
- 12- and 24-month questionnaire; same as above excluding ongoing 
relationship. 
- GEEs; same as above excluding ongoing relationship. 
 
2. Model 2 with the same socio-demographic variables shown above plus psychosocial 
variables:  
- Baseline; number of recreational drugs used (0/missing, 1, 2-4, or 5+), and 
higher-risk alcohol consumption (WHO AUDIT-C higher-risk score of ≥6 or 
lower risk/no alcohol consumption score of <6/missing). 
- GEEs; any IPV victimization (yes or no/missing) and age <13 years at anal sex 
debut (yes or no). 
 
Of note, when investigating the association between depressive symptoms and self-efficacy for 
sexual safety, and self-efficacy for sexual safety and sexual risk behaviour at the 12- and/or 24-
month questionnaire, in Chapter 8, the same two-stage adjustment procedure as that described 
above was investigated, with the exception of any IPV victimization, which was excluded from 
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Model 2. In Figure 8, only recreational drug use and CSA were hypothesized to be confounders 
of these associations. 
 
Initial analyses undertaken to investigate whether adjusting for age grouped into six categories 
(<25; 25-29; 30-34; 35-39; 40-44; ≥45 years) or adjusting for age as a continuous variable had 
an impact on findings, demonstrated that this was not the case.  
 
3.6.9 Patient and Public Involvement in PROUD findings 
Given findings in this thesis from the PROUD trial, and the usual practice of Patient and Public 
Involvement (PPI) in the interpretation of PROUD findings, in conjunction with PROUD 
investigators, I designed a short PPI survey that was distributed to PROUD participants. This 
was interpreted using a qualitative analytic approach. The methodology and findings are 
presented in Chapters 7 and 8.  
 
3.6.10 Evidence for causality in this thesis 
In the final conclusion chapter, the Bradford Hill criteria are evaluated based on findings from 
this thesis, in order to provide a framework to consider whether the observed association 
between depressive symptoms and sexual behaviour measures is likely to be causal. 
 
3.7 Methodological limitations 
 
3.7.1 General weaknesses of the AURAH study 
The AURAH study is important in the context of GUM services but it does not necessarily allow 
us to generalize to all MSM in the UK. The use of non-probability sampling methods may also 
call into question the external validity of the sample i.e. the men recruited for AURAH may not 
be representative of all men attending GUM clinics in England. Some attempts were made to try 
and improve external validity; at study start, all sites were asked to identify different clinic 
days/times each week for recruitment. 
 
The cross-sectional design of the study is another potential weakness. As mentioned in section 
3.4.4, although it is often not possible to definitively conclude causality, longitudinal study 
designs provide the strongest evidence in favour of concluding an observed relationship to be 
causal. Whereas, making inferences as to whether observed relationships in cross-sectional 
study designs are causal, is particularly difficult as it is not possible to be assured of the 
direction of association. For example, unemployment and substance use may be causal factors 
in the development of depression. On the other hand, those with depressive symptoms may be 
more likely to be unable to work, or to use substances to cope with negative life stresses. 
Similarly, it may be the case that CLS leads to symptoms of depression, rather than occurring 
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as a result of such symptoms, or that the association operates in both directions. Finally, a 
number of important additional factors that may have a bearing on the link between depressive 
symptoms and sexual behaviour were not collected in the AURAH study. These include CSA 
and IPV in adulthood. 
 
3.7.1.1 Potential sources of bias 
In the AURAH study, behaviours that are thought to be socially unacceptable may have been 
under-reported, resulting in reporting bias/social desirability bias. Bias may have been reduced 
via the use of self-completion questionnaires, attempts to create a private space for survey 
completion, provision of an envelope to create a sense of anonymity, and by not allowing clinic 
staff to see the questionnaire. Additionally there were a number of inconsistent responses to the 
sexual lifestyle section in the AURAH questionnaire (see Appendix section 11.8.5.3). Therefore, 
it is important to be mindful throughout this thesis that self-reported sexual behaviour may be 
subject to errors and biases.  
 
Furthermore, the AURAH study nurse coordinator identified 15 clinical centres for study 
participation based on previously successful research collaborations and on the understanding 
that the centre could facilitate access to large numbers of HIV-negative MSM and black African 
men and women. It is therefore possible, that selection bias may have affected the choice of 
venues for the survey. Bias may have been reduced by incorporating into the study a large 
number of GUM clinic sites (N=20) across England. 
 
3.7.2 General weaknesses of the PROUD trial 
In the context of consistent PrEP use, CLS may no longer place an individual at higher-risk for 
HIV acquisition. Therefore, in the immediate PrEP arm of the PROUD trial, it is PrEP adherence 
that is the risk behaviour of interest. Some men may use PrEP intermittently, and in such 
circumstances, CLS during a non-PrEP use period, may place an individual at risk. As such 
measuring ‘unprotected sex’ whereby an individual is not on PrEP and reports CLS, may be the 
most appropriate measure of sexual risk. However, due to the lack of data on PrEP adherence, 
it was not possible to investigate how participants matched PrEP adherence to sexual risk 
behaviour. Furthermore, PROUD was initially designed as a pilot study to investigate feasibility, 
and therefore, the sample size is limited. This may affect the precision of the estimates and 
increase the chances of a type II error (a false negative finding). Findings must therefore, be 
interpreted with caution. Finally, the PROUD study population did not include bisexual men 
reporting recent sex with women only. Excluding these men may not provide a full picture of the 
role of depression in sexual behaviour among sexual minority men. 
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3.7.2.1 Potential sources of bias 
Social desirability bias may also be relevant to the PROUD trial, since information on sexual 
behaviour, age at anal sex debut, and intimate partner violence was requested. Ways in which 
this form of bias may have been overcome in PROUD are similar to that for AURAH (section 
3.7.1.1). Three additional types of bias may have been operating during the PROUD trial and 
require consideration: (i) performance bias, (ii) attrition bias, and (iii) contamination bias. Firstly, 
performance bias occurs when one study arm receives more attention from investigators of the 
trial than the other study arm. In PROUD, individuals in the immediate arm received a greater 
number of screening tests for STIs as a result of more regular study clinic attendance than men 
in the deferred arm (mean 4.2 versus 3.6), biasing the randomized comparison between the two 
arms with regards to STI incidence. However, this potential source of bias does not affect the 
findings presented in this thesis given that STI incidence was not investigated and STI 
diagnosis in the past year was only investigated at baseline.  
 
Secondly, attrition bias occurs when there are systematic differences between groups in terms 
of loss-to-follow-up from a study. In PROUD, 130 men who completed a baseline questionnaire 
did not complete a 12-month questionnaire and 103 men who completed a 12-month 
questionnaire did not complete a 24-month questionnaire. Upon investigation (see section 
3.2.4), it appears that men without a 12-month questionnaire may have differed significantly in 
baseline socio-demographic factors (age, country born/ethnicity, education) to men with a 12-
month questionnaire. Perhaps combining data from each time-point in GEEs, as described 
above (section 3.6.7), may have, to some extent, addressed this source of bias.  
 
Thirdly, contamination bias occurs when members of the control arm of a trial are exposed to 
the intervention. In PROUD, it is possible that men in the deferred arm were taking PrEP from 
study start. Two men enrolled twice in the PROUD trial in order to access PrEP, after first being 
randomized to the deferred group. It has been suggested that other men in the deferred arm 
may have co-enrolled without being detected. It is also possible that men accessed PrEP 
through the Internet or used someone else’s PrEP or HIV antiretroviral medication as PrEP, for 
instance if obtained as PEP. In the context of this thesis, this emphasises the need to address 
the PROUD sample in the context of biomedical intervention (both PEP and PrEP). 
 
3.7.3 Considering type I error  
A maximum probability of making a type I error (a false positive finding), was set at 0.05, 
indicating that there was no greater than a 5% chance of making a type I error. The AURAH 
study consisted of a large sample of men (N=1340), in which multiple exposures and multiple 
outcomes were addressed. It is possible that this may have increased the likelihood of finding 
an effect due to chance. However, the analyses in this thesis investigated a clear, pre-defined 
hypothesis about depression and sexual risk. Furthermore, emphasis is placed on the pattern of 
results rather than solely on significance testing. Several different sexual behaviour measures 
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were assessed in order to examine whether the pattern of results was consistent across 
measures of CLS and higher partner numbers.  
 
Multiple testing also took place when investigating the relationship between depression 
measures and sexual behaviour measures at each time-point of the PROUD trial. It is inevitable 
that some significant findings will appear just by chance, resulting in type I error. However, 
merging data from each time-point in GEE models should have reduced the occurrence of any 
possible type I errors. 
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4 Prevalence of depressive symptoms and associated factors among gay, bisexual, 
and other men who have sex with men in the AURAH study 
 
 
4.1 Introduction 
 
As described in the thesis introduction (section 1.8.1), the prevalence of depression appears to 
be elevated among sexual minority men compared to their heterosexual counterparts in high-
income countries 
(332, 338-342)
. Stress associated with a sexual minority status, as described in 
Meyer’s minority stress model, may account for the elevated prevalence of depression 
(211, 223-
225, 235-239, 245-247)
. Among sexual minority men, socio-economic status 
(248, 249)
 and social support 
(225, 245-247)
, as well as other psychosocial factors, such as recreational drug use, CSA, and IPV 
(41, 368, 454, 605, 610, 657, 658)
 
(604, 605, 611, 658-666)
, may be associated with depressive symptoms.  
 
In the first three results chapters of this thesis, data from the AURAH study is investigated. The 
AURAH study questionnaire incorporated the PHQ-9, a standard instrument that is commonly 
used to measure self-reported depressive symptoms in clinical and research settings, as 
described in section 3.3.2.1 of Chapter 3. The AURAH questionnaire also incorporated the 
GAD-7 (assessing anxiety symptoms) and asked participants about mental health diagnoses 
and treatments, including specifically treatment for depression, see sections 3.3.2.2-3.3.2.3. 
The aim of this chapter was to investigate among HIV-negative (or unknown status) gay, 
bisexual, and other MSM, who reported recent anal or vaginal sex, the prevalence of depressive 
symptoms on PHQ-9 and the association with socio-demographic and lifestyle factors. The 
second aim of this chapter was to present the prevalence of anxiety on GAD-7, mental health 
diagnoses, and treatment for mental health conditions.  
 
4.2 Statistical methods 
 
A detailed description of the variables investigated in analyses presented in this Chapter, is 
included in Chapter 3 section 3.3.1. 
 
The prevalence of each of the nine individual PHQ-9 depressive symptoms is presented. The 
prevalence of depressive symptoms according to PHQ-9 criteria is presented using three 
definitions: (score of ≥10, major depressive syndrome, major and other depressive syndromes). 
The prevalence of suicidal ideation and medical treatment/therapy for depression is also 
presented. Of note, in order to more accurately present the prevalence of men with depression 
who were receiving treatment, men with either depressive symptoms (PHQ-9≥10) or who 
Chapter 4 
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reported receiving treatment for depression were considered to account for all men with any 
evidence of current depression, since treatment in the absence of symptoms may indicate 
successfully treated depression. The prevalence of GAD on GAD-7, as well as the diagnosis 
and treatment of any mental health disorder, was also assessed.  
 
Associations of socio-demographic and lifestyle factors (see section 3.3.5) with depressive 
symptoms (PHQ-9≥10) were assessed using χ
2 
tests, χ
2
 tests for trend, and Fisher’s exact test 
(when expected numbers were small) for univariable analysis. Associations are presented 
unadjusted and adjusted for key socio-demographic factors (see section 3.6.5) using modified 
Poisson regression with a robust variance estimator, see section 3.6.2 
(645)
. An additional 
analysis was undertaken to assess the relationship of socio-demographic and lifestyle factors 
with depressive symptoms when including the 144 men who did not report recent sex (N=1484 
MSM). A sensitivity analysis was undertaken using different PHQ-9-based definitions of 
depressive symptoms (major depressive syndrome and major and other depressive 
syndromes). 
 
4.3 Results 
 
4.3.1 Prevalence of depressive symptom measures on PHQ-9 
Table 3 presents the prevalence of the nine depressive symptoms on PHQ-9. The proportion of 
individuals who had missing responses to symptoms is presented as a footnote under Table 3. 
As described in section 3.3.11 of Chapter 3, missing responses were considered to indicate that 
the symptom was not present. Overall, the most commonly experienced symptom, for at least 
several days over the past two weeks, was ‘feeling tired or having little energy’, followed by 
‘trouble falling or staying asleep, or sleeping too much’, and ‘feeling down, depressed, or 
hopeless’.  
 
Following the PHQ-9 depressive symptoms, participants were asked ‘If you were bothered by 
any of these problems, how difficult have they made it for you to do your work, take care of 
things at home, or get along with other people?’ Of the 1099 participants who had responded 
‘several days’ or more to at least one symptom, 53.5% said ‘not at all’ difficult to the question 
posed above, 35.6% said somewhat difficult, 4.4% said very difficult, and 1.6% said extremely 
difficult (4.9% did not respond).  
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Table 3: Prevalence of PHQ-9 depressive symptoms in AURAH N=1340 
  Not at 
all
a
 
% 
Several 
days 
% 
>half the 
days 
% 
Nearly 
every day 
% 
PHQ-9 1) Little interest or pleasure 
in doing things 
70.1% 
 
23.7% 
 
3.9% 
 
2.4% 
 
PHQ-9 2) Feeling down, 
depressed, or hopeless 
61.0% 
 
30.0% 
 
5.9% 
 
3.1% 
 
PHQ-9 3) Trouble falling or staying 
asleep, or sleeping too much 
52.8% 
 
30.5% 
 
10.1% 
 
6.6% 
 
PHQ-9 4) Feeling tired or having 
little energy 
46.6% 
 
38.0% 
 
10.1% 
 
5.4% 
 
PHQ-9 5) Poor appetite or 
overeating 
75.2% 
 
16.0% 
 
5.8% 
 
3.0% 
 
PHQ-9 6) Feeling bad about 
yourself-or that you are a failure or 
have let yourself or your family 
down 
61.2% 
 
26.2% 
 
7.8% 
 
4.8% 
 
PHQ-9 7) Trouble concentrating on 
things, such as reading the 
newspaper or watching television 
75.7% 
 
15.8% 
 
5.7% 
 
2.8% 
 
PHQ-9 8) Moving or speaking so 
slowly that other people could have 
noticed/being so restless that it is 
hard to sit still 
76.2% 
 
17.2% 
 
4.8% 
 
1.8% 
 
PHQ-9 9) Thoughts that you would 
be better off dead, or of hurting 
yourself in some way 
88.3% 
 
8.1% 
 
2.5% 
 
1.2% 
 
 
Table 4 presents the prevalence of depressive symptom measures on PHQ-9. The prevalence 
of clinically significant depressive symptoms (PHQ-9≥10) was 12.4% (166/1340). Of these 166 
men, 54.8% had moderate depressive symptom severity, 30.1% of men had moderately severe 
symptoms, and 15.1% had severe symptoms of depression. When considering the full 
distribution of the PHQ-9 score among all 1340 men, 66.7% had no/minimal symptoms of 
depression and 20.9% had mild symptoms, and were not considered to indicate clinically 
significant depressive symptoms. Furthermore, 6.8% had moderate symptoms, 3.7% had 
moderately severe symptoms, and 1.9% had severe symptoms of depression, and were 
considered to indicate clinically significant depressive symptoms. 
 
In total, 6.3% of men met the diagnostic algorithm for major depression (n=85), and 10.2% of 
men met the diagnostic algorithm for major and other depressive syndromes (n=136). As 
expected, all 85 men who were classified as having a major depressive disorder screened 
positive for clinically significant depressive symptoms. An additional 81 men screened positive 
for the measure of clinically significant depressive symptoms. Of these 81 men, the vast 
majority (85.2%) was classified as having moderate depressive symptoms, 13.6% as having 
moderately severe symptoms, and one man as having severe symptoms. Of 136 men who were 
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classified as having a major or other depressive syndrome, 105 (77.2%) screened positive for 
clinically significant depressive symptoms and 31 (22.8%) did not.  
 
The prevalence of suicidal ideation on PHQ-9 was 11.7% (n=157). Of men who scored positive 
for depressive symptoms (≥10) more than half, 57.2% (n=95/166) screened positive for suicidal 
ideation. 
 
Table 4: Prevalence of depressive symptom measures
a
 on PHQ-9 in AURAH 
 MSM reporting anal or vaginal sex in the 
past three months [N=1340] 
 n (%)  
95% CI 
Clinically significant depressive 
symptoms (score of ≥10) 
166 (12.4%) 
10.7%, 14.3% 
Depression severity: 
None/minimal  
Mild 
Moderate 
Moderately severe 
Severe 
 
894 (66.7% 95% CI: 64.1%, 69.2%) 
280 (20.9% 95% CI: 18.8%, 23.2%) 
91 (6.8% 95% CI: 5.6%, 8.3%) 
50 (3.7% 95% CI: 2.8%, 4.9%) 
25 (1.9% 95% CI: 1.3%, 2.7%) 
Major depressive syndrome  85 (6.3%) 
5.2%, 7.8% 
Major and other depressive 
syndromes  
136 (10.2%) 
8.6%, 11.9% 
Suicidal ideation  157 (11.7%) 
10.1%, 13.6% 
 
 
4.3.2 Receiving medical treatment or therapy for depression 
Overall, the proportion of men who reported receiving treatment for depression (medical or 
other) was 9.2% (123/1340). Of the 166 men with depressive symptoms (PHQ-9≥10), treatment 
for depression was reported by 28.9% (n=48). Of the 1174 men without depressive symptoms 
(PHQ-9<10), 6.4% (n=75) reported treatment for depression. Among the 241 men with any 
evidence of current depression (PHQ-9≥10 and/or receiving treatment for depression), 51.0% 
(n=123) reported receiving treatment for depression.  
 
4.3.3 Anxiety, depression, and other mental health disorders 
 
4.3.3.1 Generalized anxiety disorder on GAD-7 
The prevalence of generalized anxiety disorder on GAD-7 (score of ≥10) was 10.2% (n=137). Of 
men who scored positive for depressive symptoms (PHQ-9≥10), 60.8% (n=101/166) also 
scored positive for GAD on GAD-7 (≥10). Similarly, men who scored positive for GAD were 
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much more likely than men who did not to score positive for depressive symptoms on PHQ-9 
(73.7% vs. 5.4%; χ
2 
p-value<0.001). 
 
4.3.3.2 Anxiety and depression on EuroQoL 5D 
The prevalence of moderate/extreme anxiety or depression on EuroQoL 5D, which asks about 
one’s state of health today, was 34.8% (n=466), much higher than the proportion positive for 
depressive symptoms on PHQ-9. Of these 466 men, 30.9% (n=144) screened positive for 
depressive symptoms on PHQ-9 (≥10). Of the 166 men who screened positive for depressive 
symptoms, the vast majority (86.8%) reported being anxious or depressed on EuroQoL 5D. 
 
4.3.3.3 Anxiety/depression diagnosis and other mental health disorders 
When participants were asked whether a doctor had ever told them that they have a mental 
health condition, 18.5% (n=248/1340) of men responded that a doctor had. The prevalence of 
conditions specified is presented in Figure 9. The prevalence of anxiety and depression is 
presented together given that a number of men specified both conditions. Of the 248 men who 
reported having ever been told by a doctor that they have a mental health condition, 196 men 
(79.0%) specified anxiety and/or depression. A smaller proportion of men specified the following 
conditions: bipolar disorder (n=7; 2.8%), personality disorder
xxvi
 (n=4; 1.6%), psychosis
xxvii
 (n=2; 
0.8%), and learning disorder
xxviii
 (n=2; 0.8%) 
(667-669)
. One man specified an eating disorder and 
one man specified PTSD. Although bipolar disorder and PTSD may fall under the categories of 
depression and anxiety respectively, given that these conditions were specifically cited, they are 
presented separately here. Nineteen men (7.7%) specified multiple conditions.   
 
Of note, of the 166 men who screened positive for depressive symptoms (PHQ-9≥10), 75 men 
(45.2%) reported ever having been told by a doctor that they have a mental health condition. Of 
these 75 men, 59 (78.7%) specified depression and/or anxiety, ten (13.3%) specified multiple 
diagnoses, one man had a missing response, and the five remaining men specified bipolar, 
personality disorder, psychosis, learning disorder, or PTSD. 
 
 
 
 
 
 
 
 
 
                                                     
xxvi
 All men specified borderline personality disorder. 
xxvii
 This includes one man who specified schizophrenia. 
xxviii
 This includes men who specified ADHD and Asperger syndrome. 
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Figure 9: Prevalence of mental health conditions among those ever diagnosed by a 
doctor in AURAH 
 
 
4.3.3.4 Treatment of anxiety and other mental health disorders 
Overall, 3.7% (n=49) of men reported receiving medical treatment or therapy for a mental health 
condition other than depression at the time of the questionnaire. In Figure 10, the mental health 
conditions for which participants reported receiving treatment are presented. Of the 49 men who 
reported receiving treatment for a mental health condition other than depression, 28 men 
(57.1%) specified anxiety; 24 men specified anxiety/GAD, two men specified PTSD, one man 
specified panic attacks, and one man specified stress. Furthermore, 6 men (12.2%) had a 
missing response, 4 men (8.2%) specified bipolar, and three men (6.1%) specified OCD, 
psychosis (schizophrenia), and a learning disorder (ADHD). One man specified a borderline 
personality disorder and one man specified an eating disorder.  
 
Of note, of the 166 men who screened positive for depressive symptoms (PHQ-9≥10), 20 men 
(12.0%) reported receiving treatment for a mental health condition other than depression. Of 
these 20 men, treatment was reported by ten men (50.0%) specifying anxiety/stress/PTSD/ 
panic attacks, three men (15.0%) specifying OCD, two men (10.0%) specifying a learning 
disorder, bipolar, and a missing response, and one man specifying psychosis.  
 
 
 
 
 
79% 
3% 
2% 
1% 
1% 
<1% 
<1% 
8% 
6% 
Anxiety/depression
Bipolar disorder
Personality disorder
Learning disorder
Psychosis
Eating disorder
PTSD
Multiple (≥2) 
diagnoses 
Unknown
N=248 MSM who reported having been told by 
a doctor that they have a mental health 
condition 
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Figure 10: Prevalence of currently receiving treatment/therapy for a mental health 
condition other than depression in AURAH 
 
 
4.3.4 Prevalence of other psychosocial factors 
The prevalence of socio-demographic factors is described in Chapter 3 section 3.2.2.3, and is 
presented below in Table 5, together with the prevalence of lifestyle/psychosocial factors. Of the 
1340 men, the prevalence of reporting using 0, 1, 2-4, and 5 or more recreational drugs in the 
past three months was 43.2%, 20.1%, 22.5%, and 14.2% respectively; 56.8% reported recent 
recreational drug use. The prevalence of chemsex-associated drug use was 23.4%. Higher-risk 
alcohol consumption was reported by 19.3% of men. Overall, 48.7% of men reported having 
disclosed their sexual orientation to all or almost all of their close family, friends, and work 
colleagues, whereas, 4.2% reported having disclosed to few or none of these individuals. Thirty 
percent of men reported very high levels of a supportive network. 
 
4.3.5 Socio-demographic and lifestyle factors associated with depressive symptoms (PHQ-
9≥10) 
Table 5 shows the association of socio-demographic and lifestyle factors with depressive 
symptoms (PHQ-9 ≥10) among the 1340 men. There were very strong associations between 
depressive symptoms and indicators of lower socio-economic status (financial hardship, non-
employment, non-home-ownership, and non-university education), with prevalence of 
depressive symptoms increasing from 7% to 50% with increasing level of financial hardship. 
Depression was also very strongly associated with lower levels of a supportive network: 
prevalence increased from 4% to 49% from high to low categories of social support. Depressive 
symptoms were also associated with younger age, identifying as bisexual, Midlands/ 
Yorkshire/Humber region of recruitment, lower levels of disclosure of sexual orientation to work 
57% 
8% 
2% 
6% 
6% 
6% 
2% 12% 
Anxiety/stress/PTSD/panic
attacks
Bipolar
Personality disorder
Psychosis
OCD
Learning disorder
Eating disorder
Unknown
N=49 MSM who reported receiving medical 
treatment/therapy for a mental health condition 
other than depression  
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colleagues, smoking, higher-risk drinking, and greater number of recreational drugs used. A 
significant trend was observed between lower levels of disclosure of sexual orientation to 
friends and higher prevalence of depressive symptoms, and the overall association was of 
borderline significance. The following factors were not associated with depressive symptoms: 
having been born in the UK and ethnicity, disclosure of sexual orientation to close family, being 
‘out’ to all/almost all or few/no friends, work colleagues, and close family, and ongoing 
relationship status. After adjusting for key socio-demographic factors (see footnote under Table 
5), the factors listed above remained significantly associated with depression, with some 
attenuation in the magnitude of effect, with the exception of study region, disclosure of sexual 
orientation to friends, and smoking, which were no longer significant. The strongest associations 
remained with socio-economic factors and supportive network, for instance the adjusted relative 
difference in prevalence across categories of financial hardship and levels of a supportive 
network was five-fold and ten-fold respectively.  
  
When investigating the relationship of socio-demographic and lifestyle factors with depressive 
symptoms (PHQ-9≥10) among all 1484 MSM in AURAH (prevalence: 12.5%, n=185/1484), an 
identical pattern of associations was observed (Appendix section 11.10, Table 65), the only 
exception being that smoking remained associated with depressive symptoms after adjustment 
for key socio-demographic factors. Of note, the prevalence of depressive symptoms (PHQ-
9≥10) among the 144 MSM in AURAH who did not report recent anal or vaginal sex was 13.2%. 
This is addressed in Chapter 8 in the context of further exploring the depression profile of men 
reporting different sexual behaviours. 
 
In the sensitivity analyses, results were broadly similar when investigating associations with the 
other measures of depressive symptoms on PHQ-9 (major depressive syndrome and major and 
other depressive syndromes), see Appendix section 11.11 Table 66. There were some 
differences in terms of which adjusted associations were statistically significant, but the pattern 
of associations was very similar.   
 
 
 
139 
 
Table 5: Unadjusted and adjusted associations of socio-demographic and lifestyle factorsf with depressive symptoms on PHQ-9 (score≥10) among 
1340 MSM who reported anal or vaginal sex in the past three months in AURAH 
N=1340 MSM reporting sex in the past 3 months PHQ-9 ≥10 (n=166; 12.4%) 
   N (%) %  p-value
b
 Unadjusted 
PR[95% CI]    
Overall 
p-value 
Adjusted  
PR[95% CI]    
Overall p-
value 
Age (years) <25 
25-29 
30-34 
35-39 
40-44 
45+ 
235 (17.8%) 
344 (26.0%) 
255 (19.3%) 
175 (13.2%) 
125 (9.5%) 
188 (14.2%) 
19.6% 
14.2% 
7.8% 
9.1% 
8.8% 
9.6% 
0.001 
<0.001
c
 
2.04 [1.23, 3.41] 
1.49 [0.89, 2.48] 
0.82 [0.45, 1.51] 
0.95 [0.50, 1.81] 
0.92 [0.45, 1.88] 
1 
0.001 
0.001
c
 
 
1.79 [1.06, 3.01] 
1.57 [0.93, 2.63] 
0.91 [0.50, 1.67] 
1.02 [0.54, 1.95] 
1.02 [0.50, 2.07] 
1 
0.032 
0.006
 c
 
Born in the UK and ethnicity Yes, white 
Yes, BAME 
No, white 
No, BAME 
676 (51.2%) 
86 (6.5%) 
408 (30.9%) 
151 (11.4%) 
12.4% 
17.4% 
10.5% 
11.9% 
0.346 1 
1.40 [0.85, 2.32] 
0.85 [0.60, 1.20] 
0.96 [0.59, 1.55] 
0.336 1 
1.03 [0.60, 1.74] 
0.98 [0.69, 1.39] 
1.08 [0.65, 1.77] 
0.989 
Study region London 
South 
Other 
1017 (75.9%) 
241 (18.0%) 
82 (6.1%) 
11.4% 
13.7% 
20.7% 
0.038 1 
1.20 [0.84, 1.72] 
1.82 [1.15, 2.87] 
0.032 
 
1 
1.16 [0.80, 1.67] 
1.37 [0.84, 2.25] 
0.401 
 
 
University Education Yes 
No/missing
a
 
891 (66.5%) 
449 (33.5%) 
9.3% 
18.5% 
<0.001 1 
1.98 [1.50, 2.63] 
<0.001 1 
1.86 [1.37, 2.51] 
<0.001 
Employment status Employed 
Not employed/ 
missing
a
 
1069 (79.8%) 
271 (20.2%) 
10.1% 
21.4% 
<0.001 1 
2.12 [1.59, 2.83] 
<0.001 1 
1.49 [1.06, 2.09] 
0.020 
Money to cover basic needs 
(financial hardship) 
Always 
Mostly 
At times/no 
958 (71.7%) 
281 (21.0%) 
97 (7.3%) 
7.2% 
16.7% 
49.5% 
<0.001 
<0.001
c
 
1 
2.32 [1.64, 3.28] 
6.87 [5.07, 9.31] 
<0.001 
<0.001
c
 
1 
1.95 [1.36, 2.80] 
5.16 [3.64, 7.30] 
<0.001 
<0.001
c
 
Housing status Home owner 
Renting 
Unstable/other 
369 (27.9%) 
764 (57.8%) 
188 (14.2%) 
3.8% 
13.9% 
21.3% 
<0.001 
<0.001
c
 
1 
3.66 [2.12, 6.30] 
5.61 [3.13, 10.04] 
<0.001 
<0.001
c
 
1 
3.66 [2.07, 6.48] 
4.48 [2.40, 8.36] 
<0.001 
<0.001
c
 
Self-reported sexual identity
e
 Gay 
Bisexual 
Straight 
1190 (89.1%) 
127 (9.5%) 
19 (1.4%) 
11.4% 
22.1% 
5.3% 
0.004
d
 1 
1.74 [1.21, 2.50]
e
 
 
0.003 1 
1.61 [1.11, 2.31]
e
 
 
0.011 
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Table 5: Unadjusted and adjusted associations of socio-demographic and lifestyle factors
f
 with depressive symptoms on PHQ-9 (score≥10) among 
1340 MSM who reported anal or vaginal sex in the past three months in AURAH (continued) 
N=1340 MSM reporting sex in the past 3 months PHQ-9 ≥10 (n=166; 12.4%) 
   N (%) %  p-value
b
 Unadjusted 
PR[95% CI]    
Overall 
p-value 
Adjusted  
PR[95% CI]    
Overall 
p-value 
How many friends know you are 
gay/bisexual/attracted to men  
All/almost all 
Some 
Few/none 
1006 (76.1%) 
250 (18.9%) 
66 (5.0%) 
11.1% 
15.6% 
18.2% 
0.052 
0.016
c
 
1 
1.40 [1.00, 1.96] 
1.63 [0.95, 2.81] 
0.050 
0.013
c
 
1 
1.28 [0.88, 1.88] 
1.16 [0.62, 2.17] 
0.440 
0.317
c
 
How many work colleagues know you 
are gay/bisexual/attracted to men 
All/almost all 
Some 
Few/none 
794 (60.8%) 
277 (21.2%) 
236 (18.1%) 
11.7% 
7.6% 
18.6% 
0.001 
0.044
c
 
1 
0.65 [0.41, 1.02] 
1.59 [1.15, 2.21] 
0.001 
0.055
c
 
1 
0.68 [0.43, 1.09] 
1.47 [0.99, 2.17] 
0.012 
0.192
c
 
How many close family know you are 
gay/bisexual/attracted to men  
All/almost all 
Some 
Few/none 
869 (66.0%) 
205 (15.6%) 
242 (18.4%) 
12.1% 
12.2% 
13.6% 
0.807 
0.547
c
 
1 
1.01 [0.67, 1.52] 
1.13 [0.78, 1.62] 
0.805 
0.547
c
 
1 
0.97 [0.64, 1.47] 
0.87 [0.57, 1.33] 
0.810 
0.535
c
 
‘Out’ to all/almost all friends, work 
colleagues and close family 
Yes 
No 
652 (48.7%) 
688 (51.3%) 
11.5% 
13.2% 
0.338 1 
1.15 [0.86, 1.53] 
0.339 1 
1.15 [0.84, 1.58] 
0.387 
‘Out’ to few/no friends, work colleagues 
and close family 
Yes 
No 
56 (4.2%) 
1284 (95.8%) 
19.6% 
12.1% 
0.092 1.63 [0.94, 2.82] 
1 
0.083 1.10 [0.60, 2.03] 
1 
0.765 
Ongoing relationship Yes 
No/missing
a
 
579 (43.2%) 
761 (56.8%) 
10.5% 
13.8% 
0.073 1 
1.31 [0.97, 1.76] 
0.075 1 
1.27 [0.94, 1.72] 
0.118 
Supportive network 1: High levels 
2 
3 
4 
5: Low levels 
400 (30.1%) 
464 (34.9%) 
284 (21.3%) 
130 (9.8%) 
53 (4.0%) 
4.3% 
6.7% 
17.3% 
33.1% 
49.1% 
<0.001 
<0.001
c
 
1 
1.57 [0.88, 2.80] 
4.06 [2.39, 6.90] 
7.78 [4.60, 13.17] 
11.54 [6.72, 19.81] 
<0.001 
<0.001
c
 
 
1 
1.40 [0.78, 2.51] 
3.84 [2.24, 6.59] 
6.83 [3.96, 11.77] 
10.19 [5.82, 17.83] 
<0.001 
<0.001
c
 
Current smoker Yes 
No/missing
a
 
334 (24.9%) 
1006 (75.1%) 
17.7% 
10.6% 
0.001 1.66 [1.24, 2.23] 
1 
0.001 1.33 [0.98, 1.81] 
1 
0.071 
Higher-risk alcohol consumption Yes 
No/missing
a
 
259 (19.3%) 
1081 (80.7%) 
17.8% 
11.1% 
0.003 1.60 [1.17, 2.19] 
1 
0.003 1.53 [1.11, 2.12] 
1 
0.009 
Recreational drug use (past 3 months) 0/missing
a
 
1 
2-4 
5+ 
579 (43.2%) 
269 (20.1%) 
302 (22.5%) 
190 (14.2%) 
8.8% 
13.8% 
12.9% 
20.5% 
<0.001 
<0.001
c
 
1 
1.56 [1.05, 2.32] 
1.47 [0.99, 2.17] 
2.33 [1.59, 3.42] 
<0.001 
<0.001
c
 
1 
1.52 [1.02, 2.28] 
1.53 [1.02, 2.29] 
2.41 [1.63, 3.57] 
<0.001 
<0.001
c
 
Chemsex-associated  drug use No/missing 
Yes 
1027 (76.6%) 
313 (23.4%) 
11.2% 
16.3% 
0.017 1 
1.46 [1.07, 1.97] 
0.016 1 
1.60 [1.17, 2.19] 
0.003 
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4.4 Discussion 
 
4.4.1 Summary of results 
Among MSM reporting recent sex, the prevalence of depressive symptoms (PHQ-9≥10) was 
12.4%. Half of men with any evidence of current depression reported receiving medical 
treatment or therapy for depression. There was a very strong association between symptoms of 
depression and anxiety: 61% of men who scored positive for depressive symptoms (≥10) also 
scored positive for GAD (≥10). Younger age, markers of lower socio-economic status, and lower 
levels of a supportive network were consistently and strongly associated with depressive 
symptoms (PHQ-9≥10). Reporting depressive symptoms was also associated with identifying as 
bisexual or straight, low levels of disclosure of sexual orientation to work colleagues, higher-risk 
drinking, and greater number of recreational drugs used. 
 
4.4.2 Prevalence of depressive symptoms in studies of MSM 
In AURAH, the prevalence of clinically significant depressive symptoms on the PHQ-9 i.e. a 
score of ≥10, was 12.4% (166/1340) among men who reported recent anal or vaginal sex. Five 
UK studies have investigated depression among MSM. In Natsal-3, the prevalence of 
depressive symptoms on the interviewer-administered PHQ-2 (PHQ-2 score of ≥3), a ‘first step’ 
screen for depression rather than a diagnostic tool, was 8.9% (95% CI: 5.5%, 14.3%, n/N= 
17/190) among all MSM and 6.4% (95% CI: 3.5%, 11.7%, n/N= 7/107) among gay-identified 
MSM 
(342)
. Using the same definition (PHQ-2≥3), the prevalence of depression among MSM who 
reported recent sex in AURAH was 9.3% (95% CI: 7.8%, 10.9%, n/N=124/1340); among all 
MSM in AURAH the comparable prevalence was 9.5% (95% CI: 8.1%, 11.1%, n/N=141/1484). 
Therefore, the prevalence of depressive symptoms found among the large sample of MSM 
attending GUM clinics in AURAH appears comparable to that found in the smaller general 
population sample of MSM from Natsal-3.  
 
In a study of 179 users of a popular geosocial-networking smartphone app for gay, bisexual, 
and other MSM in London (2016), the prevalence of depressive symptoms using the same 
definition (PHQ-2≥3) was twice as high at 22.3% (n=40) 
(416)
. The very high prevalence noted in 
this study may be explained by inclusion of participants living with HIV, among whom the 
prevalence of depression is known to be higher 
(670)
. In total, 11.4% of participants self-reported 
an HIV-positive status. A high proportion of younger participants may also explain the high 
prevalence of depressive symptoms observed since the prevalence of depression is known to 
be higher among younger individuals (see section 4.4.5 below). Seventy percent of participants 
were aged less than 41 years. Furthermore, given the nature of a volunteer sample, it is 
possible that men who elected to partake in this survey were more likely to report symptoms of 
depression. This may be particularly true as the study was advertised as a health and wellbeing 
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survey. It was reported that 1410 app users clicked the advertisement and were taken to the 
survey page, and 202 users completed the survey (14.3%) 
(671)
. On the other hand, it may be 
that men who use dating apps have a higher burden of depressive symptoms. It may be that 
these men are more likely to use recreational drugs or alternatively, are less likely to be 
affiliated to the gay community and have lowers levels of a supportive network. 
 
A similarly high prevalence of depressive symptoms was reported in the Stonewall Gay & 
Bisexual Men’s Health Survey (2011), which was conducted among 5416 gay, bisexual and 
other MSM living in England, Wales, and Scotland. This study collected information on 
depressive symptoms using the PHQ-9 as part of an online survey, using a snowball sampling 
method for study recruitment. The prevalence of depressive symptoms (PHQ-9≥10) was 21.3% 
(1155/5416). As suggested above, the very high prevalence noted may be as a result of 
inclusion of participants living with HIV and/or who are younger in age. Information was not 
collected on HIV status in this study, however, it was reported that 78% of participants were less 
than 45 years of age. Furthermore, there may be problems associated with snowball sampling, 
as it does not always capture a sample that is representative of the target population - gay and 
bisexual communities in the UK.  
 
In the 4 gym project in 2000 (N=739) 
(564)
, 40% (309/772) of men said that they strongly agreed 
or agreed with the statement: ‘generally in the past 6 months I have felt depressed’. Similarly, in 
the AURAH study, 35% of men reported being moderately or extremely anxious or depressed 
when asked about one’s ‘state of health today’. Therefore, the prevalence of self-reported 
depression may be higher than that found via use of symptom questionnaires. Although in 
AURAH, participants were attending a GUM clinic at the time of survey completion and may 
have been awaiting HIV/STI screening and getting symptoms checked. As a result, it is 
reasonable to assume that one may have been feeling anxious or depressed on that particular 
day. In addition, although individuals may perceive themselves to be experiencing depression, 
this may not be of a severity or duration sufficient enough to warrant fulfillment of a clinical 
definition of depression on a symptom questionnaire. Finally, in 1999 a consecutive sample of 
122 MSM attending a GUM clinic in East London was recruited. In total, 13.9% (n=14) of MSM 
were considered to indicate borderline depressive symptoms on HADS and 6.9% (n=8) definite 
symptoms 
(355)
. 
 
When considering alternative definitions based on PHQ-9, the prevalence of a major depressive 
syndrome in AURAH was 6.3% among men who reported recent sex. The prevalence of major 
and other depressive syndromes was 10.2%. Similarly, in the one study identified in review (i) of 
this thesis (Table 1) to investigate depression using PHQ-9 (NHBS 
(363)
), the prevalence of 
major and other depressive syndromes was 13.0% among U.S MSM attending 
community/commercial gay venues in 2014 (N=240).  
 
 
 
 
144 
 
4.4.3 Comparing the prevalence of depressive symptoms between the AURAH study of MSM 
and the general UK population 
There is limited data on the prevalence of depressive symptoms in the general UK population, 
using PHQ-9-based definitions. In the summer of 2007, severe flooding in England prompted 
the Health Protection Agency to investigate the impact of flooding on mental health 
(2007/2008). Survey participants were selected, using probability-based methods, from flooded 
and non-flooded populations. In non-flooded populations, the prevalence of depressive 
symptoms (PHQ-9≥10) was 7.0% and this figure included women, among whom rates of 
depression are most often higher 
(672)
. Comparing this estimate to the AURAH study suggests 
that the prevalence of depressive symptoms may be somewhat higher among MSM compared 
to the general population, but other socio-demographic factors (such as age, socioeconomic 
status, region, and calendar period) may confound this comparison. In Natsal-3, of all 5533 men 
who reported ever having had sex, 8.5% screened positive for depression on PHQ-2 (score of 
≥3) 
(673)
. The equivalent prevalence (PHQ-2 ≥3) for AURAH was 9.3% among MSM who 
reported recent sex and 9.5% among all MSM, suggesting that the prevalence of depressive 
symptoms may be similar or slightly higher among MSM compared to the general population. 
There are a number of other probability-based and general population-based survey studies 
that have collected information on depression among individuals in the UK, none however, have 
incorporated the PHQ-9 
(350, 674-678)
. In AMPS (2007), less than 2% of male participants were 
classified as having a depressive episode (including mild, moderate, and severe) on CIS-R and 
an additional 7% were classified as having a mixed anxiety and depressive disorder 
(350)
. 
 
4.4.4 Comparing the prevalence of depressive symptoms between MSM and their 
heterosexual counterparts, in high-income countries 
There does appear to be consistent evidence that depression prevalence is elevated among 
MSM compared to their heterosexual counterparts in a number of studies in high-income 
countries, mainly the U.S. Evidence comes from a meta-analysis of studies conducted up to 
2005 
(332)
, a recent systematic review of U.S. studies 
(338)
, two recent population-based studies 
in the Netherlands 
(339)
 and France  
(340)
, and from Natsal-3 
(342)
 and AMPS 
(341)
 in the UK. These 
studies are described in detail in section 1.8.1 of Chapter 1. 
 
4.4.5 Association of socio-demographic and lifestyle factors with depressive symptoms 
A number of quantitative studies from high-income countries have investigated factors 
associated with depressive symptoms among samples of MSM including HIV-negative MSM: in 
the UK 
(341, 415, 564)
 (although one study investigated male and female sexual minorities
(341)
), 
Belgium 
(358)
, U.S. 
(41, 346, 347, 354, 356, 364, 365, 368, 370, 371, 606-609, 679-681)
, Australia 
(454)
, and in the iPrEX 
trial spanning multiple countries 
(360)
. Symptoms of depression on symptom questionnaires (and 
self-reported feelings of depression 
(564)
) have been found to be strongly associated with 
markers of lower socio-economic status (unemployment, lower education, and lower income) 
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(346, 347, 354, 356, 364, 371, 415, 454, 606, 681)
, lower levels of a supportive network 
(358, 415, 454)
, and perceived 
discrimination on the basis of sexual orientation 
(341, 346, 347)
. Extensive theoretical research has 
also linked sexual minority stress to poor mental health outcomes 
(209, 210, 226, 227, 229, 235-238, 240, 241, 
245-247, 682)
. Of note, economic hardship has also been established as strongly associated with 
poor mental health in UK general population-based research (the British Household Panel 
Survey (BHPS) 1992-1998, the Whitehall II study 1988, UK Census 2001, and AMPS 2007) 
(348-
351)
. 
 
Furthermore, younger age 
(346, 358, 360, 364, 415, 454, 606-609)
, recreational drug use 
(41, 346, 358, 454, 564, 606-
609)
, describing one’s sexuality as bisexual 
(354, 415, 679, 680)
, and not living with a male partner/not 
being in an ongoing relationship with a partner 
(415, 564)
, have been found to be associated with 
depressive symptoms in previous studies. The association between ethnicity and depressive 
symptoms has been inconsistent 
(347, 356, 415, 564)
. The association of other psychosocial factors, 
including CSA and IPV, with depression is described in section 2.6.3.2 of Chapter 2, and will be 
discussed in detail in Chapter 7 in the context of findings from the PROUD trial. 
 
In line with previous studies, in the AURAH study, markers of socio-economic hardship were 
strongly associated with depressive symptoms as well as other measures of depression on 
PHQ-9, providing further evidence for a critical role of poverty and socio-economic hardship in 
poor mental health among UK MSM. Reporting lower levels of a supportive network was also 
strongly associated with depression measures on PHQ-9 in AURAH. Furthermore, the 
prevalence of depressive symptoms was twice as high in men reporting a bisexual or other 
identity that is not based on attraction to one sex/gender compared to those reporting a gay 
sexual identity in AURAH. In Natsal-3, the prevalence of depressive symptoms (PHQ-2) was 
also higher among all 190 MSM (34 of whom identified as bisexual) than the 107 men who 
identified as gay (8.9% vs. 6.4% respectively) 
(342)
. In addition to an overall mental health 
inequality between the sexual minority and sexual majority, as described in detail in section 
1.8.1, inequalities may also exist within sexual minorities. The same has been found among 
sexual minority women 
(683)
. Perhaps this may reflect higher levels of social support available in 
a more established and potentially cohesive community, such as the gay community. Bisexual 
men may be even more vulnerable to isolation as a sexual minority. 
 
Finally, similar to findings from previous studies in high-income countries, younger age, greater 
number of recreational drugs used, and low levels of disclosure of sexual orientation to work 
colleagues, was associated with depressive symptoms in AURAH. Chemsex-associated drug 
use in the past three months was also found to be associated with depression measures. There 
is emerging evidence from qualitative work suggesting that for some individuals, engagement in 
chemsex is associated with psychological distress including depression 
(579)
, reasons for this are 
explored in detail in section 7.3.8 of Chapter 7. In AURAH, depressive symptoms were also 
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associated with smoking regularly and higher-risk drinking. Having been born in the UK and 
ethnicity was not associated with depressive symptoms in AURAH. 
 
4.4.6  Treatment for depression 
In AURAH, half of those with evidence of current depression reported receiving medical 
treatment/therapy for depression. Although this may suggest some under treatment of 
depression, it is not possible to discern the number of men who had been offered treatment, 
whether treatment had been interrupted, and whether relapse of symptoms had occurred 
following treatment. It is also unclear how this estimate of treatment coverage compares to the 
general UK population, especially given this sample consists of men who are actively engaging 
in health care.  
 
4.4.7 Prevalence of generalized anxiety disorder and suicidal ideation 
In AURAH, the prevalence of GAD on GAD-7 was 10.2% among men who reported recent anal 
or vaginal sex. This may be higher than the estimated 8% lifetime prevalence of GAD among 
men and women in the U.S., Australia, and New Zealand 
(405)
. The majority (74%) of men in the 
AURAH study who scored positive for GAD also scored positive for depressive symptoms on 
PHQ-9 (score of ≥10). This is in line with previous work, which suggests that mental health 
comorbidity is very common among individuals with GAD, and depression is the most common 
comorbidity 
(405)
. Previous studies have also found similar socio-economic associations with 
GAD as those with depression; younger age, lower levels of education, unemployment, and 
lower levels of family income 
(405)
. 
 
In AURAH, the prevalence of suicidal ideation on PHQ-9 was 11.7% among men who reported 
recent anal or vaginal sex. The ‘suicidal ideation’ question on PHQ-9 asks about both suicidal 
ideation (‘Thoughts that you would be better off dead’) and self-harm (‘or of hurting yourself in 
some way’). The life-time prevalence of self-harm is estimated to be around 18.0% in 
adolescence (the time at which it tends to first occur) 
(406)
and the life-time prevalence of suicidal 
ideation is estimated to be around 9.2% among adults 
(407)
. In the AURAH study, the majority 
(57%) of men who scored positive for depressive symptoms (≥10) were considered to indicate 
suicidal ideation and this is in line with findings from previous studies of men and women 
(408, 
409)
. 
 
4.4.8 Limitations 
The general methodological limitations of the AURAH study are discussed in section 3.7.1 of 
Chapter 3. In this specific analysis, it is important to note that the prevalence of depression and 
other mental health measures may have been underestimated if individuals with depressive 
symptoms/other mental health conditions were more likely to be in the 40% of clinic attendees 
approached who did not complete the AURAH questionnaire. Furthermore, it was not possible 
 
 
 
147 
 
to investigate the relationship of internalised homophobia or expectations of rejection, CSA and 
IPV, with depression measures in the AURAH study. Finally, men were asked about the use of 
three recreational drugs commonly used in the context of chemsex, however, men were not 
asked in AURAH whether these drugs had been taken before or during sex.  
 
4.4.9 Summary of discussion 
The prevalence of depressive symptoms among MSM in the setting of UK GUM clinics appears 
to be similar to that found among MSM selected from the British general population, based on 
the small Natsal sample. Consistent evidence suggests that the prevalence of depressive 
symptoms is higher among sexual minority individuals compared to their heterosexual 
counterparts. The majority of these studies were conducted in the U.S. Based on consistent 
findings in the literature and the strong associations found in AURAH, socio-economic status 
and supportive networks appear to be crucial factors linked to depression. Findings from the 
AURAH study also appear to support extensive theoretical, as well as epidemiological, research 
into the link between stress related to sexual minority status and depression. Findings from the 
AURAH study also support evidence that depressive symptoms among MSM are more common 
among younger men, men who use a higher number of recreational drugs, and report higher-
risk alcohol consumption. In line with emerging evidence, the prevalence of depressive 
symptoms among men who reported a bisexual or other plurisexual identity label in the AURAH 
study was twice as high compared to men who identified as gay. Finally, there does appear to 
be some evidence of potential under treatment of possible clinically significant depressive 
conditions. The implications of these findings are discussed in Chapter 9.
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5 Investigating the relationship between depressive symptoms and sexual behaviour 
among gay, bisexual, and other men who have sex with men in the AURAH study 
 
5.1 Introduction 
 
Symptoms of depression have been found to be associated with increased sexual risk 
behaviour (and HIV seroconversion 
(369)
) in studies of MSM 
(353-368)
, mainly in the U.S. Although 
HIV prevention has been a priority among MSM in the UK/Europe, mental health has 
traditionally not been a focus of European studies of risk and prevention, and the role of 
depression in sexual behaviour linked to STI and HIV transmission is not well understood. To 
date, two European cross-sectional studies have investigated the relationship between 
symptoms of depression and sexual behaviour. In a UK GUM clinic sample of 122 MSM in 
1999, a higher prevalence of depressive symptoms (HADS score ≥11) was observed among 
men who reported CLS with an HIV-positive/unknown status partner (Table 1) 
(355)
. In a Belgian 
volunteer and online sample of 591 HIV-negative MSM who reported anal sex with a casual 
partner (2008), depressive symptoms (CES-D >21) were associated with CLS in unadjusted 
analysis (Table 1) 
(358)
.  
 
Given the self-regulation and coping literature on depressive symptoms, it is hypothesized in 
this thesis that among sexual minority men, depressive symptoms would lower self-efficacy for 
sexual safety and increase the chances of sexual risk behaviour, and that this association would 
be partially but not fully confounded by recreational drug use, CSA, and IPV. The aim of this 
chapter was to address this hypothesis and thereby the lack of data on mental health and 
sexual behaviour among MSM at risk of HIV acquisition in the European context. This chapter 
uses data from the AURAH study to investigate among gay, bisexual, and other MSM reporting 
recent sex: (i) the relationship between depressive symptoms and sexual behaviour measures, 
and the potential confounding/moderating effects of recreational drug use, and (ii) a causal 
steps approach to the question of whether low self-efficacy for sexual safety mediates the 
association between depressive symptoms and sexual behaviour measures. Also presented, is 
the association of GAD on GAD-7, and suicidal ideation on PHQ-9, with sexual behaviour 
measures.  
  
5.2 Statistical methods 
 
A detailed description of the variables investigated in analyses presented in this Chapter is 
included in Chapter 3 section 3.3.1. 
 
Chapter 5 
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Analyses are conducted among MSM who reported anal or vaginal sex in the past three 
months. The prevalence of each of the eight sexual behaviour measures defined in section 
3.3.3 of Chapter 3 is presented. The relationship between depressive symptoms (PHQ-9≥10) 
and sexual behaviour measures was assessed using χ
2 
tests, χ
2
 tests for trend, and Fisher’s 
exact test (when expected numbers were small) for univariable analysis, and modified Poisson 
regression with a robust variance estimator in order to produce adjusted PRs 
(645)
. Associations 
are presented unadjusted, adjusted for key socio-demographic factors, and finally adjusted for 
the same key socio-demographic factors plus lifestyle factors (see section 3.6.5), in order to 
assess the extent to which the associations were attenuated when accounting for recreational 
drug use, alcohol use, and smoking. Of note, the relationship between level of PHQ-9 
depressive symptom severity (none/minimal, mild, moderate, moderately severe, or severe) and 
sexual behaviour measures was also investigated adjusted for key socio-demographic factors. 
Findings from this analysis are mentioned in the text for the measure of CLS with one or more 
partners and are summarized for the other sexual behaviour measures. A sensitivity analysis 
was undertaken using different PHQ-9-based definitions of depressive symptoms (major 
depressive syndrome and major and other depressive syndromes [including major depression 
and dysthymia]). The relationship between depressive symptoms (PHQ-9≥10) and sexual 
behaviour measures was also assessed using logistic regression in order to produce adjusted 
ORs. This was in order to compare the magnitude of associations across sexual behaviour 
measures (see section 3.6.2). 
 
Further analyses were performed in order to investigate the potential moderating effects of 
recreational drug use on the relationship between depressive symptoms (PHQ-9≥10) and 
sexual behaviour measures. For the purpose of this analysis, three measures of recreational 
drug use in the past three months were investigated: (i) poly-drug use, (ii) club-drug use, and 
(iii) chemsex-associated drug use 
(578-580)
. Three separate modified Poisson regression models, 
including drug use measures (i), (ii), or (iii) and an interaction term between depressive 
symptoms and the measure of drug use, were investigated, adjusted for key socio-demographic 
and lifestyle factors. The presence of an interaction would indicate the need to present the PR's 
separately for men who reported the measure of drug use and men who did not. 
 
A causal steps approach to mediational analysis 
(639, 640)
 was investigated in this chapter, see 
section 3.4.2. Based on this approach, in addition to investigating the relationship between 
depressive symptoms and sexual behaviour, the following associations were investigated:  
1. The association between depressive symptoms and low self-efficacy measures 
2. The association between low self-efficacy measures and sexual behaviour measures 
3. The association between depressive symptoms and sexual behaviour measures 
adjusted for low self-efficacy measures  
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It is of note that three additional analyses were undertaken in order to explore whether the 
relationship between depressive symptoms (PHQ≥10) and sexual behaviour is different in 
samples of differing sexual risk behaviour profiles: (i) among men who reported anal sex with a 
man in the past three months (N=1304), (ii) among men who reported anal or vaginal CLS in the 
past three months (N=853), and (iii) among men who reported anal CLS in the past three 
months (N=815). Findings are briefly compared to those observed in the main analysis, among 
the 1340 men who reported anal/vaginal sex in the past three months. 
 
The association between depressive symptoms and reasons for non-condom-use among men 
reporting anal or vaginal CLS (N=853) was also investigated. Models are presented unadjusted 
and adjusted for key socio-demographic factors. A number of further investigations were then 
conducted among the 1340 men who reported recent sex. The association of a four category 
variable describing the current presence/absence of depressive symptoms (PHQ-9≥10) and 
medical treatment/therapy for depression (symptoms plus treatment, symptoms no treatment, 
no symptoms with treatment, or no symptoms no treatment) with sexual behaviour measures 
was assessed. Models are presented unadjusted and adjusted for key socio-demographic 
factors. The relationship of suicidal ideation on PHQ-9 and GAD on GAD-7 with sexual 
behaviour measures was also investigated. Models are presented unadjusted, adjusted for key 
socio-demographic factors, and adjusted for the same key socio-demographic factors plus 
lifestyle factors. Finally, the unadjusted association of socio-demographic and lifestyle factors 
with sexual behaviours was assessed.  
 
5.3 Results 
 
5.3.1 Prevalence of sexual behaviour measures 
The prevalence of CLS and other sexual behaviour measures is presented in Table 6. Overall, 
63.7% (n=853) of men reported CLS in the past three months. Of these men, 91.7% (n=782) 
had CLS with men only, 3.9% (n=33) had CLS with both men and women, and 4.5% (n=38) had 
CLS with women only. Of note, of the 782 men who reported CLS with men only in the past 
three months, 27.2% (n=213) reported CLS having occurred with one long-term partner only. Of 
the 38 men who reported CLS with women only in the past three months, 36.8% (n=14) 
reported CLS having occurred with one long-term partner only. Overall, 32.1% of men reported 
CLS with two or more partners and 35.4% had CLS with at least one unknown and/or HIV-
positive status partner (excluding men who reported no CLS partners of unknown HIV status 
and only one HIV-positive CLS partner who was a long-term partner and with whom they 
‘thought the risks of catching HIV were low because their partner was taking ART’). Fourteen 
percent of men had receptive CLS with an unknown status partner.  Thirty-six percent of men 
reported eleven or more new sexual partners in the past year and 37.0% reported group sex in 
the past three months. Thirty-two percent of men reported having been diagnosed with a 
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bacterial STI in the past year and 15.5% of men reported PEP use in the past year. The 
proportion of missing values for each sexual behaviour question was ≤5%, see footnote 
a
 under 
Table 6. 
 
Table 6: Prevalence of sexual behaviour measures
a 
in AURAH 
N=1340 MSM who reported anal/vaginal sex (past three 
months) 
n (%; 95% CI) 
CLS with one or more partners 853 (63.7%; 61.0%, 66.2%) 
CLS with two or more partners (past 3 months) 430 (32.1%; 29.6%, 34.6%) 
CLS with unknown/HIV-positive status partner(s)
b
 (past 3 
months) 
474 (35.4%; 32.9%, 38.0%) 
 
Receptive CLS with an unknown status partner (past 3 
months) 
187 (14.0%; 12.2%, 15.9%) 
Self-reported bacterial STI diagnosis  
(past year) 
423 (31.6%; 29.1%, 34.1%) 
PEP use (past year) 207 (15.5%; 13.6%, 17.5%) 
Eleven or more new sexual partners  
(past year)  
483 (36.0%; 33.5%, 38.7%)
  
Group sex (past 3 months) 496 (37.0%; 34.5%, 39.6%) 
 
 
5.3.2 Relationship between depressive symptoms and sexual behaviour measures  
The prevalence of depressive symptoms on PHQ-9 (≥10) was 12.4% (166/1340), see section 
4.3.1 of Chapter 4. Depressive symptoms were associated with all measures of CLS. Men with 
depressive symptoms were more likely than those without symptoms to report CLS with one or 
more partners (74.7% vs. 62.1%), CLS with two or more partners (44.6% vs. 30.3%), CLS with 
unknown/HIV-positive status partners (50.6% vs. 33.2%), receptive CLS with an unknown 
status partner (22.9% vs. 12.7%), bacterial STI diagnosis (42.2% vs. 30.1%), and PEP use 
(23.5% vs. 14.3%); p<0.01 for all, χ
2
 tests. Among men with depressive symptoms, the 
prevalence of CLS with one or more partners was 70.3% among men with moderate depressive 
symptom severity, 78.0% among men with moderately severe symptoms, and 84.0% among 
men with severe symptoms of depression. Depressive symptoms were not associated with the 
remaining two sexual behaviour measures: the prevalence of depressive symptoms was similar 
among men with and without eleven or more new partners in the past year (39.2% vs. 35.6%; 
p=0.372) and among men reporting and not reporting group sex in the past three months 
(37.5% vs. 33.7%; p=0.350). 
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Figure 11 shows unadjusted and adjusted PRs. After adjusting for key socio-demographic 
factors, depressive symptoms were associated with all measures of CLS partners (≥1 [PR 1.18 
95% CI: 1.06, 1.30; p=0.002], ≥2 [PR 1.42 95% CI: 1.17, 1.74; p=0.001], unknown/HIV-positive 
status [PR 1.43 95% CI: 1.20, 1.71; p<0.001], receptive unknown status [PR 1.60 95% CI: 1.14, 
2.24; p=0.006]), and with bacterial STI diagnosis [PR 1.46 95% CI: 1.19, 1.79; p<0.001] and 
PEP use [PR 1.83 95% CI: 1.33, 2.50; p<0.001]. Adjustment for key socio-demographic factors 
resulted in some attenuation of the associations with CLS measures. This attenuation appears 
to be predominantly driven by the inclusion of university education in the model for each 
measure of CLS. Adjustment for key socio-demographic factors resulted in slightly accentuated 
associations with STI and PEP use, which appeared to be predominantly driven by inclusion of 
age in each model. After adjusting additionally for smoking, alcohol, and recreational drug use, 
all of these associations were attenuated to some extent, but they remained significant (CLS ≥1 
[PR 1.13 95% CI: 1.02, 1.26; p=0.017], CLS ≥2 [PR 1.28 95% CI: 1.05, 1.56; p=0.013], CLS 
unknown/HIV-positive status [PR  1.30 95% CI: 1.09, 1.55; p=0.004], receptive CLS unknown 
status [PR 1.58 95% CI: 1.13, 2.21; p=0.008], bacterial STI diagnosis [PR 1.31 95% CI: 1.07, 
1.60; p=0.009], and PEP use [PR 1.68 95% CI: 1.22, 2.31; p=0.001]). Attenuation appears to be 
predominantly driven by the inclusion of number of recreational drugs used in each model. 
Depressive symptoms were not associated with having eleven or more new sexual partners in 
the past year or with group sex in the past three months, in unadjusted or adjusted analyses. 
 
Figure 11 is repeated with ORs from logistic regression models and presented in Appendix 
section 11.12 (Figure 33). When using ORs as the measure of association, the magnitude of 
associations was very similar across the different measures of CLS (including STI diagnosis and 
PEP use).  
 
Of note, a significant trend was observed when investigating the relationship between level of 
depressive symptom severity and all measures of CLS partners, including bacterial STI 
diagnosis and PEP use, after adjusting for key socio-demographic factors. The relationship was 
in the same direction for all measures of CLS, whereby increasing depressive symptom severity 
was associated with increased CLS, STI, and PEP prevalence. For instance, for the measure of 
CLS with one or more partners, the following estimates were observed: mild depression PR 
1.10 95% CI: 1.00, 1.21; moderate depression PR 1.14 95% CI: 0.98, 1.32; moderately severe 
depression PR 1.28 95% CI: 1.09, 1.49; severe depression PR 1.35 95% CI: 1.10, 1.65; versus 
no/minimal depression, trend test p-value<0.001. Estimates were similar for the other measures 
of CLS, whereby the trend test p-value was ≤0.004 for all measures. Level of depressive 
symptom severity was not associated with report of eleven or more new sexual partners or 
group sex. 
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Figure 11: Unadjusted and adjusted associations of depressive symptoms (PHQ-9≥10) 
with sexual behaviours among 1340 MSM who reported anal or vaginal sex in the past 
three months in AURAH 
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Table 67 (Appendix section 11.12) presents findings from three additional analyses. The pattern 
of associations was identical among the 1304 MSM reporting recent anal sex. When 
considering measures other than CLS with one or more partners, a similar pattern of 
associations was found among the 853 MSM reporting recent anal/vaginal CLS. Although 
associations between depressive symptoms and CLS with two or more partners and CLS with 
an unknown/HIV-positive status partner were considerably attenuated after adjustment for 
smoking, drinking, and recreational drug use. Among the 815 MSM reporting recent anal CLS, 
associations with CLS measures, including bacterial STI diagnosis, were considerably 
attenuated after adjustment for smoking, drinking, and recreational drug use. These findings are 
explored further and their implications are discussed in Chapter 8 in the context of findings from 
the PROUD trial of MSM reporting recent anal CLS. 
 
In the sensitivity analyses, results were broadly similar, although somewhat weaker, when 
investigating associations with the other measures of depressive symptoms on PHQ-9 (a major 
depressive syndrome and major and other depressive syndromes), see Appendix section 11.13 
Table 68 and Table 69.  
 
5.3.2.1 Moderating effects of recreational drug use 
When investigating interactions between depressive symptoms and measures of recreational 
drug use, the association between depressive symptoms and CLS measures, including PEP 
use, appeared somewhat stronger among men who reported the measure of drug use 
compared to men who did not (Table 7). However, most tests of interaction were not significant 
(Table 7), the exception being for the measure of eleven or more new sexual partners in the 
past year. There was some evidence that depressive symptoms were associated with this 
measure among men who reported club-drug use in the past three months, whereas the 
relationship was non-existent among men who did not. A borderline significant interaction was 
also observed for the relationship between depressive symptoms and bacterial STI diagnosis, 
according to club-drug use. The direction of this association was the same in both groups, but 
the association was somewhat stronger among non-club-drug users.  
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Table 7: Association between depressive symptoms (PHQ-9≥10) and sexual behaviour measures according to recreational drug use in the past 
three months, in AURAH 
N=1340  PR [95%CI] for association of depressive symptoms (PHQ-9≥10) with sexual behaviour measures 
Dependent 
variables: 
Poly-drug use 
(n=341) 
 
 
Adjusted
a
 
PR[95% CI] 
No poly-drug 
use (n=999) 
 
 
Adjusted
a
 
PR[95% CI] 
Interaction 
term  
p-value 
Chemsex-drug  
use  (n=313) 
 
 
Adjusted
a
 
PR[95% CI] 
No chemsex-
drug use  
(n=1027) 
 
Adjusted
a
 
PR[95% CI] 
Interaction 
term  
p-value 
Club-drug use 
(n=459) 
 
 
Adjusted
a
 
PR[95% CI] 
No club-drug 
use (n=881) 
 
 
Adjusted
a
 
PR[95% CI] 
Interact-
ion term  
p-value 
CLS with 1+ 
partners 
1.25 [1.11, 1.41] 1.07 [0.93, 1.24] 0.323 1.27 [1.11, 1.46] 1.08 [0.94, 1.24] 0.239 1.19 [1.06, 1.34] 1.08 [0.92, 1.26] 0.718 
CLS with 2+ 
partners 
1.43 [1.13, 1.80] 1.18 [0.88, 1.60] 0.741 1.46 [1.15, 1.87] 1.19 [0.88, 1.60] 0.518 1.44 [1.14, 1.83] 1.14 [0.82, 1.59] 0.508 
CLS with an 
unknown/ 
HIV-positive
 
status partner 
1.51 [1.22, 1.87] 1.19 [0.91, 1.54] 0.558 1.47 [1.17, 1.84] 1.22 [0.95, 1.57] 0.695 1.39 [1.11, 1.74] 1.24 [0.95, 1.63] 0.862 
Receptive CLS 
with an unknown 
status partner 
1.58 [0.91, 2.75] 1.51 [1.00, 2.26] 0.977 1.75 [1.01, 3.03] 1.46 [0.97, 2.20] 0.888 1.47 [0.88, 2.46] 1.63 [1.06, 2.51] 0.537 
STI diagnosis 
(past year) 
1.26 [0.98, 1.63] 1.43 [1.07, 1.92] 0.320 1.16 [0.90, 1.51] 1.49 [1.11, 1.99] 0.153 1.22 [0.94, 1.57] 1.60 [1.17, 2.18] 0.057 
PEP use (past 
year) 
1.79 [1.18, 2.74] 1.54 [0.95, 2.50] 0.807 1.64 [1.10, 2.43] 1.61 [0.97, 2.67] 0.899 1.82 [1.22, 2.70] 1.53 [0.90, 2.61] 0.595 
11+ new sexual 
partners (past 
year) 
1.24 [0.99, 1.55] 0.97 [0.70, 1.34] 0.156 1.31 [1.06, 1.63] 0.97 [0.70, 1.36] 0.076 1.38 [1.10, 1.73] 0.86 [0.59, 1.25] 0.023 
Group sex 0.86 [0.67, 1.10] 0.89 [0.62, 1.29] 0.821 0.96 [0.77, 1.18] 0.76 [0.51, 1.13] 0.289 0.94 [0.74, 1.20] 0.76 [0.49, 1.19] 0.396 
 
 
 
 
 
156 
 
 
5.3.3 Relationship between depressive symptoms and measures of self-efficacy for sexual 
safety  
The prevalence of high self-efficacy for sexual safety was 67.2% (n=900) and 10.6% (n=142) for 
difficulty negotiating condom-use. The prevalence of each individual response option given for 
these measures is presented in Table 8. Of note, of the 900 men who indicated high self-
efficacy for sexual safety, the vast majority (92.2%) did not report difficulty negotiating condom-
use. 
 
Table 8: Prevalence of self-efficacy for sexual safety and difficulty negotiating condom-
use in AURAH 
N=1340 MSM who reported 
recent anal/vaginal sex 
 n (%) 
 ‘I feel confident that, if I want to, I 
can make sure a condom is used 
during sex with any partner, in 
any situation’  
Strongly agree 
Tend to agree 
Undecided/no opinion/not applicable 
Tend to disagree 
Strongly disagree 
900 (67.9%) 
342 (25.8%) 
36 (2.7%) 
38 (2.9%) 
9 (0.7%) 
 ‘I find it difficult to discuss 
condom-use with any new sexual 
partner’ 
Strongly disagree 
Tend to disagree 
Undecided/no opinion/not applicable 
Tend to agree 
Strongly agree 
754 (57.0%) 
346 (26.2%) 
81 (6.1%) 
90 (6.8%) 
52 (3.9%) 
High self-efficacy for sexual safety Yes 
No
a
 
900 (67.2%) 
440 (32.8%) 
Difficulty negotiating condom-use Yes 
No
b
 
142 (10.6%) 
1198 (89.4%) 
 
 
Table 9 presents the unadjusted and adjusted associations between depressive symptoms and 
high self-efficacy for sexual safety and difficulty negotiating condom-use. Men with depressive 
symptoms (PHQ-9≥10) were less likely to report high self-efficacy for sexual safety and more 
likely to report difficulty negotiating condom-use than men without depressive symptoms. 
Adjusted for key socio-demographic factors, depressive symptoms were inversely associated 
with high self-efficacy and were associated with difficulty negotiating condom-use. These 
associations remained with some attenuation, after additional adjustment for smoking, drinking, 
and recreational drug use. 
 
The other depression measures on PHQ-9 were also associated with high self-efficacy for 
sexual safety and again this association remained after adjustment for key socio-demographic 
factors, and additional adjustment for smoking, drinking, and recreational drug use. The other 
depression measures were not however, associated with difficulty negotiating condom-use, in 
unadjusted or adjusted analysis (see Appendix section 11.14 Table 70 and Table 71).
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Table 9: Unadjusted and adjusted associations of depressive symptoms (PHQ-9≥10) with high self-efficacy for sexual safety and difficulty 
negotiating condom-use in AURAH 
N=1340 MSM reporting 
anal/vaginal sex in the past 3 
months 
High self-efficacy for sexual safety (n=900; 67.2%) Difficulty negotiating condom-use (n=142; 10.6%) 
   N (%) %  
p-
value
a
 
Unadjusted 
 
PR[95% CI]    
Overall p-value
b
 
Adjusted
c
 
PR[95% CI]   
Overall p-value
b
  
Adjusted
d
 
PR[95% CI]    
Overall p-value
b
 
%  
p-
value
a
 
Unadjusted 
 
PR[95% CI]    
Overall p-value
b
 
Adjusted
c
 
PR[95% CI]   
Overall p-value
b
  
Adjusted
d
 
PR[95% CI]    
Overall p-value
b
 
Depressive 
symptoms 
(score≥10) 
Yes 
No 
166 (12.4%) 
1174 (87.6%) 
56.6% 
68.7% 
0.002 
0.82 [0.72, 0.95] 
1 
0.006 
0.82 [0.71, 0.94] 
1 
0.006 
0.83 [0.73, 0.96] 
1 
0.011 
18.7% 
9.5% 
<0.001 
1.98 [1.37, 2.84] 
1 
<0.001 
1.77 [1.18, 2.63] 
1 
0.005 
1.76 [1.18, 2.61] 
1 
0.005 
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5.3.4 Relationship between measures of self-efficacy for sexual safety and sexual behaviour 
Men with high self-efficacy for sexual safety were less likely than those without to report CLS 
with one or more partners, CLS with two or more partners, CLS with an unknown/HIV-positive 
status partner, receptive CLS with an unknown status, bacterial STI diagnosis, and PEP use, 
see Table 10. Similarly, men who reported difficulty negotiating condom-use were more likely 
than those who did not to report CLS measures (Table 10). 
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Table 10: Unadjusted associations of high self-efficacy for sexual safety and difficulty negotiating condom-use with sexual behaviour measures in 
AURAH 
N=1340 MSM reporting recent anal/vaginal sex  CLS with 
1+ 
partners 
 
CLS with 
2+ 
partners  
CLS with 
unknown/ 
HIV-positive 
partner 
Receptive CLS 
with unknown 
status partner  
Bacterial 
STI 
diagnosis  
(past year) 
PEP use  
(past 
year) 
11+ new 
sexual 
partners 
(past year)  
Group 
sex  
 
   N (%) %  
p-value
a
 
%  
p-value
a
  
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
High self-efficacy 
for sexual safety 
Yes 
No 
900 (67.2%) 
440 (32.8%) 
55.7% 
80.0% 
<0.001 
24.3% 
48.0% 
<0.001 
26.9% 
52.7% 
<0.001 
10.3% 
21.4% 
<0.001 
29.2% 
36.4% 
0.008 
13.6% 
19.3% 
0.006 
35.4% 
37.3% 
0.513 
35.4% 
40.2% 
0.089 
Difficulty 
negotiating 
condom-use 
Yes 
No 
142 (10.6%) 
1198 (89.4%) 
80.3% 
61.7% 
<0.001 
45.8% 
30.5% 
<0.001 
55.6% 
33.0% 
<0.001 
23.2% 
12.9% 
0.001 
36.6% 
31.0% 
0.171 
19.7% 
14.9% 
0.136 
35.2% 
36.1% 
0.827 
33.1% 
37.5% 
0.307 
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Figure 12 and Figure 13 show unadjusted and adjusted PRs. Adjusted for key socio-
demographic factors and additionally adjusted for smoking, drinking, and recreational drug use, 
high self-efficacy remained associated with lower prevalence of CLS partners, STI diagnosis, 
and PEP use. High self-efficacy was not associated with report of eleven or more new sexual 
partners or group sex, in unadjusted or adjusted analysis. Adjusted for key socio-demographic 
factors and additionally adjusted for smoking, drinking, and recreational drug use, difficulty 
negotiating condom-use remained associated with lower prevalence of CLS partners. Difficulty 
negotiating condom-use was not associated with bacterial STI diagnosis, PEP use, report of 
eleven or more new sexual partners, or group sex, in unadjusted or adjusted analysis. 
 
 In terms of the magnitude of the associations, among men reporting high self-efficacy for 
sexual safety, the prevalence of CLS with two or more partners, CLS with an unknown/HIV-
positive status partner, and receptive CLS with an unknown status partner, was half of that 
observed among men who did not report high self-efficacy. For these measures of CLS, the PR 
of approximately 0.50 remained the same after adjusting for socio-demographic factors and 
additionally adjusting for smoking, drinking, and recreational drug use. For the measures of 
bacterial STI diagnosis and PEP use in the past year, for which the overall prevalence was 
similar to other CLS measures, the difference in prevalence observed between men who 
reported high self-efficacy and men who did not, was not as striking. This resulted in weaker 
PRs of 0.80 for STI diagnosis and 0.70 for PEP use. These estimates remained unchanged 
after adjustment. The largest difference in prevalence was observed for the measure of CLS 
with one or more partners, however, given the high prevalence of this measure overall, the 
resulting PR was 0.70. Again, this estimate remained unchanged after adjustment. 
 
When investigating associations with difficulty negotiating condom-use, for each measure of 
CLS, the PR was weaker than that observed for high self-efficacy for sexual safety. The 
exception being, that the prevalence of receptive CLS with an unknown status partner was still 
twice as high among men who reported difficulty negotiating condom-use. Accordingly, the large 
PR of 2.0 was only observed for the most infrequently reported measure of CLS overall. For all 
measures of CLS, PRs remained unchanged after adjustment.  
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Figure 12: Unadjusted and adjusted associations of high self-efficacy for sexual safety 
with sexual behaviours among 1340 MSM who reported anal or vaginal sex in the past 
three months in AURAH 
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Figure 13: Unadjusted and adjusted associations of finding it difficult to negotiate 
condom-use with sexual behaviours among 1340 MSM who reported anal or vaginal sex 
in the past three months in AURAH 
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5.3.5 Relationship between depressive symptoms and sexual behaviour measures adjusted 
for measures of low self-efficacy for sexual safety  
Adjusting additionally for high self-efficacy attenuated the association between depressive 
symptoms and all sexual behaviours investigated in Table 11. The relationship with CLS with 
one or more partners and CLS with two or more partners disappeared, and the relationship with 
CLS with an unknown/HIV-positive status partner was attenuated to borderline significance. 
Adjusting additionally for difficulty negotiating condom-use (instead of self-efficacy) also 
attenuated the associations found between depressive symptoms and sexual behaviour 
measures, but the degree of attenuation tended to be less than that observed for self-efficacy. 
 
Table 11: Impact of adjusting for high self-efficacy and difficulty negotiating condom-use 
on the relationship between depressive symptoms and CLS measures, STI diagnosis, 
and PEP use, in AURAH 
 PHQ-9 ≥10 (n=166; 12.4%) 
Dependent variables: Adjusted for socio-
demographics
b
 + 
lifestyle factors
c
 
Adjusted for socio-
demographics
b
 + 
lifestyle factors
c
 + 
high self-efficacy 
Adjusted for socio-
demographics
b
 + 
lifestyle factors
c
 + 
difficulty 
negotiating 
condom-use 
 PR[95% CI] 
p-value
a
 
PR[95% CI] 
p-value
a
 
PR[95% CI] 
p-value
a
 
CLS with 1+ partners 
(past 3 months) 
1.13 [1.02, 1.26] 
1 
0.017 
1.08 [0.98, 1.20] 
1 
0.137 
1.11 [1.00, 1.23] 
1 
0.048 
CLS with 2+ partners 
(past 3 months) 
1.28 [1.05, 1.56] 
1 
0.013 
1.18 [0.98, 1.44] 
1 
0.087 
1.23 [1.01, 1.50] 
1 
0.039 
CLS with an 
unknown/HIV-positive 
status partner 
(past 3 months) 
1.30 [1.09, 1.55] 
1 
0.004 
1.19 [1.00, 1.42] 
1 
0.050 
1.23 [1.03, 1.48] 
1 
0.023 
Receptive CLS with an 
unknown status partner 
(past 3 months) 
1.58 [1.13, 2.21] 
1 
0.008 
1.46 [1.04, 2.05] 
1 
0.030 
1.51 [1.07, 2.13] 
1 
0.019 
STI diagnosis (past 
year) 
1.31 [1.07, 1.60] 
1 
0.009 
1.27 [1.04, 1.56] 
1 
0.019 
1.28 [1.05, 1.57] 
1 
0.016 
PEP use (past year) 1.68 [1.22, 2.31] 
1 
0.001 
1.61 [1.78, 2.21] 
1 
0.003 
1.62 [1.16, 2.25] 
1 
0.004 
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5.3.6 Relationship between depressive symptoms and reasons for non-condom-use among 
men reporting recent CLS 
The prevalence of reasons for non-condom-use among the 853 men, who reported anal/vaginal 
CLS in the past three months, is presented in Table 12. More than one reason could be 
selected. The most common reasons were: got carried away/under the influence (n=369; 
43.3%), don’t like/more enjoyable without (n=353; 41.4%), and their/partner’s difficulty in 
keeping an erection/ejaculating (n=205; 24.0%). 
 
Table 12: Prevalence of reasons for non-condom-use among 853 men reporting recent 
CLS in AURAH 
N=853 MSM reporting recent anal/vaginal 
CLS 
 
Reasons for non-condom-use
a
: n (%) 
‘Didn’t think about using a condom or did 
not have a condom’ 
131 (15.4%) 
‘Don’t like using condoms or it’s more 
enjoyable/close without a condom’ 
353 (41.4%) 
‘My partner didn’t want to use a condom’  147 (17.2%) 
‘Felt unable to discuss condom-use’ 37 (4.3%) 
‘Got carried away or was under the 
influence of alcohol or drugs’ 
369 (43.3%) 
‘Difficult for me/partner to keep erection or 
ejaculate when using a condom’ 
205 (24.0%) 
 
 
Table 13 presents the unadjusted associations between depressive symptoms (PHQ-9≥10) and 
reasons for non-condom-use among men reporting recent CLS. Men with depressive symptoms 
were more likely than those without to report having gotten carried away/been under the 
influence, their/their partner’s difficulty in keeping an erection/ejaculating with a condom, and 
also tended to be more likely to report their partner not wanting to use a condom. 
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Table 13: Unadjusted associations of depressive symptoms with reasons reported for non-condom-use in the past three months in AURAH 
N=853 MSM reporting recent anal/vaginal 
CLS  
‘Didn’t think 
about using a 
condom or 
did not have 
a condom’ 
‘Don’t like using 
condoms or it’s 
more 
enjoyable/close 
without a 
condom’ 
‘My partner 
didn’t want to 
use a 
condom’ 
‘Felt unable to 
discuss 
condom-use’ 
‘Got carried 
away or was 
under the 
influence of 
alcohol or 
drugs’ 
‘Difficult for 
me/partner to keep 
erection or ejaculate 
when using a 
condom’ 
   N (%) %  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
Depressive 
symptoms 
(score≥10) 
Yes 
No 
124 (14.5%) 
729 (85.5%) 
14.5% 
15.5% 
0.779 
41.9% 
41.3% 
0.893 
23.4% 
16.2% 
0.050 
6.5% 
4.0% 
0.211 
54.8% 
41.3% 
0.005 
32.3% 
22.6% 
0.020 
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Figure 14 shows unadjusted and adjusted PRs. After adjusting for key socio-demographic 
factors, associations with CLS reasons were similar or slightly attenuated. After adjusting 
additionally for smoking, drinking, and recreational drug use, depressive symptoms remained 
associated with the following reasons for non-condom-use: my partner didn’t want to use a 
condom and difficult for me/partner to keep an erection or ejaculate when using a condom. Not 
surprisingly, the association with reporting ‘got carried away/was under influence of alcohol or 
drugs’ disappeared after additional adjustment for smoking, drinking, and recreational drug use. 
Depressive symptoms were not associated with the following reasons for non-condom-use, in 
unadjusted or adjusted analysis: didn’t think about using a condom or did not have a condom, 
don’t like using condoms or it’s more enjoyable/close without a condom, and felt unable to 
discuss condom-use. Of note, the pattern of associations was very similar when investigating 
the other measures of depression on PHQ-9 (data not shown).  
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Figure 14: Unadjusted and adjusted associations of depressive symptoms on PHQ-9 
(≥10) with reasons for non-condom-use among 853 men who reported recent anal/vaginal 
CLS in AURAH 
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5.3.7 Receiving medical treatment or therapy for depression 
The prevalence of treatment for depression was 51.0% (123/241) among men with any 
evidence of current depression (see section 4.3.2). The prevalence of CLS measures, STI 
diagnosis, and PEP use according to evidence of depression (symptoms and/or treatment), is 
presented in Table 14. Men with any evidence of current depression tended to be more likely to 
report measures of sexual risk than those without evidence of depression. Adjusted PRs for 
associations with CLS with one or more partners, STI diagnosis, and PEP use, were higher for 
men who reported depressive symptoms (with or without treatment) than for those who reported 
treatment but no current symptoms. For the other measures of CLS, prevalence was elevated 
for all depression categories, compared to no depression.  
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Table 14: Unadjusted and adjusted associations of symptoms/treatment for depression 
with CLS measures, STI diagnosis, and PEP use, in AURAH 
N=1340 MSM reporting recent anal/vaginal sex  CLS with one or more partners 
Depressive 
symptoms  
(PHQ-9≥10): 
Receiving 
treatment for 
depression: 
N (%) % 
p-value
a
 
Unadjusted 
PR[95% CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
81.3% 
72.0% 
68.0% 
61.7% 
0.006 
1.32 [1.14, 1.52] 
1.17 [1.03, 1.32] 
1.10 [0.94, 1.30] 
1 
<0.001 
1.26 [1.08, 1.46] 
1.30 [1.02, 1.30] 
1.06 [0.90, 1.24] 
1 
0.006 
  CLS with two or more partners 
Depressive 
symptoms  
(PHQ-9≥10):  
Receiving 
treatment for 
depression: 
N (%) % 
p-value
a
 
Unadjusted 
PR[95% CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
54.2% 
40.7% 
40.0% 
29.7% 
<0.001 
1.83 [1.39, 2.41] 
1.37 [1.08, 1.74] 
1.35 [1.01, 1.81] 
1 
<0.001 
1.65 [1.23, 2.21] 
1.37 [1.08, 1.75] 
1.35 [1.01, 1.80] 
1 
0.001 
  CLS with unknown/HIV-positive status 
partner(s)
c
 
Depressive 
symptoms  
(PHQ-9≥10):  
Receiving 
treatment for 
depression: 
N (%) % 
p-value
a
 
Unadjusted 
PR[95% CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
54.2% 
49.2% 
50.7% 
32.0% 
<0.001 
1.69 [1.29, 2.22] 
1.53 [1.25, 1.88] 
1.58 [1.25, 2.01] 
1 
<0.001 
1.50 [1.11, 2.02] 
1.48 [1.20, 1.82] 
1.57 [1.23, 2.00] 
1 
<0.001 
  Receptive CLS with an unknown status 
partner 
Depressive 
symptoms  
(PHQ-9≥10):  
Receiving 
treatment for 
depression: 
N (%) % 
p-value
a
 
Unadjusted 
PR[95%CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
25.0% 
22.0% 
24.0% 
11.9% 
<0.001 
2.10 [1.25, 3.51] 
1.85 [1.27, 2.69] 
2.01 [1.30, 3.11] 
1 
<0.001 
1.68 [0.94, 2.99] 
1.71 [1.16, 2.52] 
2.08 [1.34, 3.21] 
1 
0.001 
  Self-reported bacterial STI diagnosis (past 
year) 
Depressive 
symptoms  
(PHQ-9≥10):   
Receiving 
treatment for 
depression: 
N (%) 
 
% 
p-value
a
 
Unadjusted 
PR[95% CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
35.4% 
44.9% 
33.3% 
29.9% 
0.009 
1.19 [0.80, 1.76] 
1.50 [1.21, 1.87] 
1.12 [0.80, 1.56] 
1 
0.004 
1.34 [0.91, 1.96] 
1.52 [1.21, 1.92] 
1.12 [0.81, 1.55] 
1 
0.003 
  PEP use (past year) 
Depressive 
symptoms  
(PHQ-9≥10):  
Receiving 
treatment for 
depression: 
N (%) % 
p-value
a
 
Unadjusted 
PR[95% CI]    
p-value
b
 
Adjusted
c
 
PR[95% CI] 
p-value
b
 
Yes 
Yes 
No 
No 
Yes 
No 
Yes 
No 
48 (3.6%) 
118 (8.8%) 
75 (5.6%) 
1099 (82.0%) 
25.0% 
22.9% 
17.3% 
14.1% 
0.018 
1.77 [1.06, 2.96] 
1.62 [1.13, 2.33] 
1.23 [0.73, 2.06] 
1 
0.014 
2.05 [1.21, 3.47] 
1.78 [1.22, 2.58] 
1.28 [0.77, 2.12] 
1 
0.002 
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5.3.8 Generalized anxiety disorder and suicidal ideation 
Compared to depressive symptoms on PHQ-9 (≥10), a similar pattern of associations was found 
for GAD on GAD-7 with sexual behaviour measures, high self-efficacy for sexual safety, and 
difficulty negotiating condom-use (see Appendix section 11.15 Table 72- Table 75). Likewise, 
compared to depressive symptoms on PHQ-9 (≥10), a very similar pattern of associations was 
found for suicidal ideation on PHQ-9 with sexual behaviour measures. However, suicidal 
ideation was not associated with measures of self-efficacy (see Appendix section 11.15 Table 
72- Table 75). In terms of the magnitude of the associations, for each measure of CLS, 
including bacterial STI diagnosis and PEP use, the PRs observed for GAD, were very similar, 
although in each case slightly weaker, than that observed for depressive symptoms (PHQ-
9≥10). The same was true when comparing PRs observed for suicidal ideation and depressive 
symptoms.  
 
5.3.9 Relationship of socio-demographic and lifestyle factors with sexual behaviour measures 
Table 76 in Appendix section 11.16 presents the unadjusted associations of socio-demographic 
and lifestyle factors with sexual behaviour measures. Reporting CLS with multiple partners and 
partners of an unknown or HIV-positive status was associated with older age (albeit of 
borderline significance with the latter CLS measure), attending a study recruitment clinic outside 
of London, a non-university degree level education, financial hardship, not being in an ongoing 
relationship, lower levels of a supportive network, smoking regularly, higher-risk drinking, 
greater number of recreational drugs used, and chemsex-associated drug use. Reporting CLS 
with two or more partners also appeared to be associated with having been born in the UK and 
being BAME, and had a borderline significant association with a self-reported straight sexual 
identity. Reporting CLS with multiple partners and partners of an unknown or HIV-positive status 
was not associated with employment status or housing situation in unadjusted analysis. A 
similar pattern of associations was found with report of CLS with one or more partners, with 
some exceptions. This measure was not associated with age, levels of a supportive network, or 
higher-risk drinking, and was more common among men reporting an ongoing relationship with 
a partner. Reporting receptive CLS with an unknown status partner was associated with 
attending a study recruitment clinic outside of London, a non-university degree level education, 
not being in an ongoing relationship, lower levels of a supportive network, and chemsex-
associated drug use. A borderline significant trend was observed with increasing financial 
hardship. 
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Bacterial STI diagnosis was associated with age 30-34 years (from which point onwards the 
prevalence of STI diagnosis appeared to decrease), non-university degree level education, 
being employed, a self-reported gay sexual identity, greater number of recreational drugs used, 
and chemsex-associated drug use. A borderline significant association was also observed with 
higher-risk drinking. PEP use was associated with lower levels of a supportive network, greater 
number of recreational drugs used, and chemsex-associated drug use. Borderline significant 
associations were also found with not being in an ongoing relationship and attending a study 
recruitment clinic in the South of England.  
 
Reporting eleven or more new sexual partners and group sex was associated with older age, 
higher-risk drinking, greater number of recreational drugs used, and chemsex-associated drug 
use. Reporting eleven or more new partners was also associated with white ethnicity, a more 
stable housing situation, reporting a gay sexual identity, not being in an ongoing relationship, 
and lower levels of a supportive network. Group sex was also associated with being employed, 
in unadjusted analysis. 
 
5.4 Discussion 
 
5.4.1 Summary of results 
As hypothesized in this thesis (see section 1.9.1), depressive symptoms (PHQ-9≥10) were 
associated with all measures of CLS, bacterial STI diagnosis, and PEP use, independently of 
socio-demographic factors and smoking, alcohol, and drug use. Associations were also 
observed among men who did not report (i) poly-drug use, (ii) chemsex-drug use, and (iii) club-
drug use. However, depressive symptoms were not associated with having eleven or more new 
sexual partners or group sex. Depressive symptoms were independently associated with lower 
self-efficacy for sexual safety. High self-efficacy for sexual safety was independently associated 
with all measures of CLS, bacterial STI diagnosis, and PEP use. Adjusting for self-efficacy for 
sexual safety attenuated the association between depressive symptoms and CLS measures. 
Reporting difficulty negotiating condom-use was also independently associated with depression 
and with all CLS measures; adjustment for this measure resulted in some attenuation of the 
association between depression and CLS measures. For some measures of CLS, the adjusted 
prevalence was higher among men who reported depressive symptoms (with or without 
treatment) than men who reported treatment but no current symptoms. The pattern of 
associations described above was very similar when investigating other measures of 
depression on PHQ-9, including suicidal ideation. Associations were also similar when 
investigating GAD on GAD-7 and the implications of these findings are discussed in Chapter 9 
in the context of exploring evidence for a causal association between depressive symptoms and 
sexual risk behaviour.  
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5.4.2 Prevalence of sexual behaviour measures 
AURAH estimates of CLS prevalence appear to be somewhat higher or similar to those 
observed in review (ii) of this thesis (section 2.5.2) for GUM clinic samples and online samples. 
The prevalence of CLS with one or more partners was 63.7% and 35.4% for CLS partners of an 
unknown/HIV-positive status in the past three months among AURAH men who reported recent 
sex. Among all 1484 MSM the prevalence was 57.5% and 31.9% respectively. The prevalence 
of CLS with one or more partners in the past three months was 38.9% and 41.8% in the two 
GUM clinic samples 
(35, 102)
 of review (ii). The prevalence of CLS with unknown/sero-different 
HIV status partners in the past three months was 27.0% and 31.0% in the two online samples 
(no data available from GUM clinics for this CLS measure 
(464, 466, 498, 499)
. Prevalence estimates 
from AURAH appear to reiterate the conclusions of review (i) and (ii), that MSM attending GUM 
clinics may be more likely to report a high prevalence of CLS compared to MSM attending gay 
venues or those selected from the general population, see section 2.5.2. This might be 
expected, since the primary reason for attending a GUM clinic is for screening and/or treatment 
of STIs acquired through CLS. These findings may have implications for HIV prevention 
interventions addressing depression, as described below and discussed in the final conclusion 
chapter of this thesis. 
 
5.4.3 Comparing AURAH findings to other studies investigating depression and CLS among 
MSM in review (i) 
As described in review (i) of this thesis (section 2.4.5.4), in U.S (and Western European) studies 
of MSM the association between depressive symptoms and increased sexual risk behaviour 
may be more consistently demonstrated among samples where all or almost all men reported 
(recent) sexual intercourse (CMDUHS 
(359)
, EXPLORE 
(367-369)
, Project MIX 
(362)
, NHBS 
(363)
, FIP 
(353)
, MAPS 
(357)
, P18 Cohort 
(365)
, Vanden Berghe et al 2014 
(358)
), compared to samples which 
included a higher proportion of men who did not report recent sex (Dudley et al 2004 
(370)
, 
HONOR 
(372)
, Maksut et al 2016 
(373)
), see Table 1. In line with findings from review (i), a strong 
relationship was observed between depressive symptoms and measures of CLS in the AURAH 
study of sexually active GUM clinic attendees. In a sexually active study sample men may be 
more likely to have an externalised response to depressive symptoms such as cognitive 
escape, with implications for sexual risk-taking and substance use, rather than internalised 
response, such as withdrawal 
(362)
. The pairing of depression and externalizing behaviours may 
be a function of genetic predisposition and/or environmental influences (see section 2.6.2.1) 
(307, 
566, 568-573)
. 
 
5.4.4 Comparing AURAH findings to UK studies investigating depression and CLS among the 
general population of men  
Natsal-3 (2010-2012) is the only UK study to have investigated the relationship between 
depressive symptoms (PHQ-2≥3) and sexual risk behaviour among the British general 
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population (N=13507 individuals who reported ever having had sex, N=5533 men). Among men 
who did not report receiving treatment for depression in the past year, and after adjusting for 
age, screening positive for depression (PHQ-2≥3) was associated with greater odds of two or 
more female sexual partners in the past year (AOR 1.45 95% CI: 1.06, 1.97), concurrent 
partnerships in the past five years (AOR 1.39 95% CI: 1.03, 1.89), knowing/perceiving their 
most recent partner to have had sex with somebody else in the past five years (AOR 1.37 95% 
CI: 1.04, 1.82), and ‘quite a lot’ or greater self-perceived risk of STI (AOR 2.09 95% CI: 1.41, 
3.09). Depressive symptoms were not however, associated with report of two or more CLS 
partners in the past year after adjustment for age (AOR 1.29 95% CI: 0.92, 1.81) 
(673)
. Of the 
5533 men in this sample, 91.3% reported at least one sexual partner in the past year 
(5054/5533). Following on from the previous section, the fact that not all men reported sex in 
the past year may explain the apparent lack of association between depressive symptoms and 
CLS among the general UK population. However, comparing these findings to the AURAH 
study may be complicated by the exclusion of men who reported receiving treatment for 
depression in the past year in the Natsal-3 analysis. The relationship may also be unique to 
MSM. Of note, in a recent study of Natsal-3 participants who reported at least one sexual 
partner in the past year (N=4839 men), there was some evidence for an association between 
screening positive for depression (PHQ-2≥3) and lacking interest in sex for a period of three or 
more months in the past year, after adjusting for age (AOR 2.95 95% CI: 2.26, 3.85). Lack of 
interest in sex was strongly related to a lack of recent sexual activity 
(684)
. 
 
5.4.5 Depression, recreational drug use, and sexual behaviour 
Findings from the AURAH study suggest that recreational drug use is strongly associated with 
CLS. Higher levels of drug use among those with depressive symptoms may in part confound 
the link between depression and CLS, but drug use is unlikely to solely explain this relationship. 
Although the association between depression and sexual risk generally appeared weaker in the 
non-drug use groups, there was no statistical evidence to suggest this was the case. 
Depressive symptoms were significantly associated with some sexual behaviour measures 
among men who did not report significant levels of drug use, again suggesting that a 
relationship operates independently of drug use. Furthermore, although reporting symptoms of 
depression was not associated with reporting eleven or more new sexual partners in the past 
year, this relationship was apparent among men who reported club-drug use. With regards to 
partner numbers, and perhaps in the context of sexually orientated settings on the gay scene, it 
may be that it is the combination of depressive symptoms and drug use that is most strongly 
associated with escape tendencies (see section 1.8.3.4), and hence engagement in sex with a 
high number of partners, in line with that described in syndemic theory (see section 2.6.3.2). 
 
Of note, the relationship between recreational drug use and depression is in practice most likely 
bidirectional. For instance, men with depressive symptoms may engage in recreational drug use 
as a form of self-medication and/or in order to induce a state of cognitive release 
(397)
. The 
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complex relationship between depressive symptoms and recreational drug use, and sexual risk 
behaviour, is further addressed in Chapter 6.  
 
5.4.6 Depression, self-efficacy for sexual safety, and sexual behaviour 
Findings from the AURAH study suggest that low self-efficacy for sexual safety and difficulty 
negotiating condom-use may be potential mechanisms through which depression leads to CLS, 
which may explain why a relationship was observed with CLS measures but not higher partner 
numbers. Self-efficacy for sexual safety is a psychological construct that describes one’s 
confidence in one’s ability to produce a certain desired outcome (see section 1.8.3.1), which in 
the context of this thesis, is keeping oneself safe of STI/HIV acquisition. If an individual does not 
perceive that they have the capacity to keep themselves sexually safe, then they may not 
attempt to make it happen. In the AURAH study, condom-use was considered to be the 
behaviour that produces the desired outcome of sexual safety. Condom-use requires exertion of 
control in an interpersonal situation, most likely in the form of discussion and negotiation. It 
therefore follows, that a low self-efficacy for sexual safety via condom-use may be associated 
with increased reporting of CLS, but not necessarily partner numbers.  
 
Among men reporting CLS, depressive symptoms were also independently associated with a 
reason for CLS being that a sexual partner did not want to use a condom, or difficulty/a 
partners’ difficulty in keeping an erection/ejaculating. This may reflect the notion that depression 
can impact on self-assertion in interpersonal relationships and self-protective behaviours. The 
fact that men who reported depressive symptoms were more likely to report PEP use, suggests 
that although depression may impair discussion/negotiation of safe sex practices, there is still 
an overarching desire to be safe and protect oneself after this interaction is over.  
 
5.4.7 Symptoms and treatment for depression in relation to sexual risk 
In the AURAH study, there was no consistent evidence to imply that treatment of depression 
may reduce sexual risk-taking. The extent to which this question can be addressed given the 
cross-sectional design of the study is limited. Inference may be complicated by a number of 
factors including severity of symptoms prior to treatment, type, duration, and frequency of 
treatment, timing of treatment in relation to symptoms, the presence of other psychological 
conditions, and sensitivity of the PHQ-9 in capturing all cases of depressive symptoms.   
 
5.4.8 Socio-demographic and lifestyle factors associated with sexual behaviour 
Unlike in AURAH, in other UK studies of sexual behaviour among MSM (identified in review (ii) 
of this thesis, section 2.5.4) there is some evidence to suggest that younger men are more likely 
to engage in CLS (including with multiple partners and partners of an unknown/sero-different 
HIV status) 
(118, 477, 482, 489, 512, 563)
 
(563)
. There is also some evidence from studies in other high-
income countries, mainly the U.S., for an association between younger age and sexual risk 
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behaviour 
(491, 574-577)
. It is possible that in AURAH the age association with sexual risk may be 
affected by the demographics of people attending GUM clinics.  
 
Furthermore, although a relationship was observed in the AURAH study, alcohol use has not 
been found to be associated with CLS measures in the two other UK studies that have 
investigated this association among MSM 
(478, 509)
. In terms of other factors, findings from the 
AURAH study are similar to other UK studies of sexual behaviour among MSM, in which there is 
some evidence to suggest that being in an ongoing relationship is associated with CLS with one 
or more partners 
(482, 496, 510)
, lower levels of educational attainment are associated with CLS 
(including with multiple partners) 
(510, 512)
, and in which ethnicity and sexual identity have not 
been found to be associated with multiple CLS partners and CLS partners of an unknown/sero-
different HIV status 
(482, 489, 496, 498, 509-512)
. These relationships may not be surprising given that 
the act of CLS will often occur within the context of stable, loving relationships, which foster 
greater assurance of the HIV status of a partner. The possible mechanisms by which lower 
levels of educational attainment are associated with sexual risk behaviour are most likely 
complex. Educational attainment may be a proxy measure for knowledge of HIV (see section 
3.5) and may be associated with socio-economic disadvantage with implications for increased 
levels of depression, recreational drug use, and IPV 
(248, 249)
. It is possible that educational 
attainment may also affect socio-cultural norms and expectations regarding condom-use.  
 
Finally, as in AURAH, in other UK studies of sexual behaviour among MSM, recreational drug 
use has been consistently linked to CLS measures 
(511)
 
(478, 484, 509)
. As described in detail in 
section 2.6.3.2, recreational drug has also been linked to sexual risk behaviour in studies of 
MSM in other high-income countries (one study conducted in the Netherlands, one study in 
Australia, and the remainder in the U.S.) 
(397, 585-600)
. Possible mechanisms of effect are also 
discussed in section 2.6.3.2. 
 
5.4.9 Limitations 
The general methodological limitations of the AURAH study are discussed in section 3.7.1 of 
Chapter 3. In this specific analysis, it is important to note that the prevalence of depression and 
associations with sexual behaviour may have differed among the 40% of individuals 
approached who did not complete a questionnaire. Although it is acknowledged in this thesis 
that CLS should not in itself be pathologized, in the AURAH study of GUM clinic attendees, the 
majority of recent CLS reported did not occur with one long-term partner only, therefore, most 
CLS was CLS with a non-regular partner. It is of note though, that for a small proportion of men 
reporting CLS in AURAH, the act of CLS may occur in the context of loving and mutually 
supportive relationships and carry no risk of HIV/STI transmission. This issue is further 
discussed in the final conclusions chapter (section 9.2.2). Furthermore, as discussed in section 
3.7.1, the cross-sectional methodology used in the AURAH study prohibits us from making 
inferences about causality. In particular, the PHQ-9 enquires about symptoms during the 
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previous two weeks whereas the recall periods for sexual behaviour were longer (past three 
months/past year). However, since depression questionnaires aim to provide a diagnostic 
measure of a chronic mental health condition it is not unreasonable to assume that in many 
cases depression may have preceded the recent sexual behaviour reported. Nevertheless, the 
association between depression and sexual behaviour may operate in both directions (as 
discussed in Chapter 9). 
 
It is important to note that multiple testing took place when investigating whether the relationship 
between depressive symptoms and sexual behaviour measures varied according to poly-, 
chem-, and club-drug use. Since multiple drug measures and multiple sexual behaviour 
measures were investigated, it is inevitable that some significant results will appear just by 
chance. Furthermore, 166 men were classified as having depressive symptoms. Accordingly, 
the numbers investigated become quite small when stratifying by drug use measures, and 
power for interaction tests was limited. 
 
Assessing the extent to which factors such as alcohol use, recreational drug use, or self-efficacy 
measures ‘explain’ the association between depressive symptoms and CLS measures is limited 
by measurement error in those factors. The observed variables may not fully capture all the 
relevant variation in these measures. Therefore, it is important to assess the extent to which 
associations are attenuated, rather than whether they are fully ‘explained’.  
 
Finally, it was hypothesized in this thesis that CSA and IPV may confound the relationship 
between depressive symptoms and sexual behaviour. Unfortunately, AURAH did not collect 
information on CSA or IPV. It was also not possible to investigate certain personality 
characteristics associated with sensation seeking and sexual compulsivity, nor markers of 
cognitive escape, which may also be useful in understanding why some men engage in CLS. 
 
Finally, the infrastructure required to re-contact all sexually active MSM participants to ask them 
for their interpretation of why depressive symptoms may have been linked to measures of CLS 
in the AURAH study, was not set up. Involving patients in the interpretation of findings, via a 
qualitative analysis of verbal or written responses, would have been helpful in better 
understanding the possible mechanisms of effect.  
 
5.4.10 Summary of discussion 
The AURAH study provides further evidence that depressive symptoms are associated with 
CLS measures among samples of MSM reporting recent sex and provides further insight into 
this relationship among MSM in the European context. Furthermore, in line with the hypothesis 
set forth in this thesis, recreational drug use appears to partially but not fully confound the 
association between depressive symptoms and CLS measures in the AURAH study. Reporting 
a greater number of recreational drugs used and chemsex-associated drug use was 
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consistently and strongly associated with measures of sexual risk-taking, in line with previous 
literature, suggesting a critical role of drug use in sexual risk behaviour. Findings also suggest 
that self-efficacy for sexual safety may be on the causal pathway between depression and CLS, 
supporting the hypothesis in this thesis. A more thorough approach to mediational analysis 
(SEM) is described and investigated in the next chapter, in order to determine the statistical 
significance of the indirect effect of self-efficacy. Reporting medical treatment or therapy for 
depression did not appear to consistently reduce the prevalence of sexual risk behaviour 
measures among men with depressive symptoms. However, as noted above, there are a 
number of factors which may distort this investigation, and these findings should be interpreted 
with caution. 
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6 Investigating a conceptual model for the relationship between depression and 
condomless sex among gay, bisexual, and other men who have sex with men in the 
AURAH study 
 
 
6.1 Introduction 
 
Using data from MSM recruited in four U.S. cities for Project MIX between 2004 to 2006, Alvy et 
al (2011) 
(362)
 presented evidence that both lowered self-efficacy for sexual safety and cognitive 
escape tendencies, as well as a composite measure of the two, significantly mediated the 
association between depression and CLS partners of unknown or HIV sero-different status in 
the past three months. These findings were based on an analysis using the distribution of the 
product method, which is similar to approaches described in section 3.4.2 of Chapter 3 that test 
the significance of the mediated effect. There is a lack of recent research into the potential 
mechanisms by which depression might lead to sexual risk-taking, and no UK/European 
studies. The aim of this chapter was to investigate whether data from the AURAH study are 
consistent with the hypothesis that depression is associated with CLS indirectly through lowered 
self-efficacy for sexual safety. This analysis uses the same sample of men as that investigated 
in the previous chapters; gay, bisexual, and other MSM from the AURAH study who reported 
recent anal or vaginal sex (N=1340). Structural equation modelling (SEM) was used to address 
this question. SEM does not circumvent the issue that causal effects cannot be established in 
observational cross-sectional studies. However, it does allow for specification of relationships 
between any variables (including latent variables) and specification of more complex 
relationships in the model, distinguishing between direct and indirect effects 
(652, 653)
.  
 
6.2 Methods 
 
6.2.1 Hypothesized relationship between depression and sexual risk behaviour among sexual 
minority men in the AURAH study 
The DAG shown in Figure 15 presents the hypothesized causal connection between depressive 
symptoms and CLS, whereby self-efficacy for sexual safety was hypothesized to be on the 
casual pathway. In Figure 16, the DAG presents the hypotheses made about causal 
connections of socio-demographic and lifestyle factors collected in the AURAH study with 
depressive symptoms and CLS. All arrows depicted in the DAG were derived from observed 
relationships based either on findings from Chapters 4 and 5 or other previous literature 
presented in Chapters 1 and 2, although such relationships have not been proved to be causal. 
Of note, for each variable shown on the DAG in Figure 16, the category labelled is the non-
Chapter 6 
  
 
 
179 
 
reference category for binary variables and the group furthest from the reference category for 
ordered categorical variables. For instance, the factor ‘financial hardship’ includes categories: (i) 
always enough money (reference category), (ii) mostly enough money, or (iii) at times/never 
enough money, and as a result, is termed financial insecurity in the DAG. This was in order to 
capture the way in which the conceptual model was fitted into the framework of SEM. Therefore, 
the description of factors in Figure 16 does not reflect the direction in which the relationship is 
hypothesized; rather the hypothesized relationships depicted can be either positive or negative. 
For instance, higher educational attainment, a supportive network, and older age are 
hypothesized to lead to lower levels of depressive symptoms, and thus a negative estimate in 
SEM. The remaining postulated relationships are discussed in the context of the results of the 
model. 
 
Figure 15: Directed acyclical graph of causal connection between depressive symptoms 
and CLS among sexual minority men, based on data from AURAH 
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Figure 16: Directed acyclical graph of causal connections* between socio-demographic and lifestyle factors and depressive symptoms, and 
between depression and CLS, among sexual minority men, based on data from AURAH 
 
 
  
 
 
181 
 
 
 
 
 
 
 
 
  
 
 
182 
 
 
6.2.2 Variables investigated in this chapter  
The same measures of CLS as those defined in Chapter 3 section 3.3.3 and investigated in the 
previous chapter, were examined in this chapter. CLS with one or more partners was the main 
measure focused upon when reporting the results. Findings are compared to those observed 
when investigating the other measures of CLS: CLS with two or more partners, CLS with an 
unknown/HIV-positive
xxix
 status partner, and receptive CLS with an unknown status partner. 
However, the definition of other variables investigated differed. Below is a description of the 
variables specific to this chapter that were selected before the analysis since they are related to 
both depressive symptomatology and CLS.  
 
6.2.2.1 Unobserved (latent) variables 
Depressive symptoms, self-efficacy for sexual safety, and supportive networks were considered 
to be unobserved (latent) variables (see section 3.6.3), for which a factor analysis (as described 
below) was incorporated into the SEM model. For depressive symptoms, the nine observable 
items on the PHQ-9 questionnaire (coded 0 to 3) were thought to ‘potentially shadow’ (i.e. 
represent) the construct of depression. For the statements indicating self-efficacy for sexual 
safety and difficulty negotiating condom-use, described in section 3.3.4,  the response options 
were coded as 1 to 5, starting with ‘strongly agree’ (coded as 1) for the first statement and 
‘strongly disagree’ (coded as 1) for the second statement, so that a high score amounts to lower 
self-efficacy for both items. These two observable items were thought to potentially shadow the 
construct of self-efficacy for sexual safety. It is of note, that a latent construct with only two 
‘shadowing’ indicators may be acceptable if the latent construct is specified to be correlated with 
at least one of the other factors in a measurement model 
(653)
, which was the case here.  
 
The five observable items on the Duke-UNC Functional Social Support Questionnaire, 
described in section 3.3.5, were thought to potentially shadow the construct of a supportive 
network. The response options were coded as 1 to 5, starting with ‘much less than I would like’ 
(coded as 1). Of note, having a supportive network may be, to a large extent, a function of 
community affiliation. For plurisexual identified sexual minority men, affiliating one’s self to one 
cohesive community may be more difficult. Therefore, these men may be more likely to 
experience low levels of a supportive network, and thus depressive symptoms. However, sexual 
identity was not included in this model. Due to small numbers, it was not possible to stratify the 
sample and investigate the conceptual model separately for different identities under the 
umbrella of sexual minority status. Furthermore, although it was of interest in this thesis to 
investigate whether sexual minority identities affected the prevalence of depressive symptoms 
reported, it was not the focus of this thesis to examine whether other factors relevant to sexual 
                                                     
xxix
 Men who reported no CLS partners of unknown HIV status and only one HIV-positive CLS partner who 
was a long-term partner and with whom they ‘thought the risks of catching HIV were low because their 
partner was taking ART’ were not counted as positive for this measure. 
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minority men’s sexual and mental health differed between gay- and bisexual-identified men. It 
was deemed inappropriate to include the variable of sexual identity when not fully 
understanding its exact role in the model. Therefore, the model was examined among sexual 
minority men in general, but there may be limitations in assuming all sexual minority identities 
are similar. 
 
6.2.2.2 Observed variables 
Age and number of recreational drugs used were investigated as continuous variables in order 
to increase the degrees of freedom in the SEM and improve power. In the case of recreational 
drug use specifically, it was hypothesized that vulnerability to depression and the chances of 
engaging in CLS would increase with increasing number of drugs used. Given that the weighted 
least squares estimator employed, as described below, does not make distributional 
assumptions about observed variables, the non-normal distribution of age and recreational drug 
use was not considered a major problem 
(685, 686)
. Of note, other measures of age and 
recreational drug use were also investigated in additional analyses in order to determine the 
effect of differing measurements on associations found. Age was investigated in six categories 
(18-24; 25-29; 30-34; 35-39; 40-44; 45+) and as a dichotomous variable (<45; ≥45). Based on a 
previous AURAH analysis 
(687)
, there appears to be a difference in prevalence of recreational 
drug use between men aged less than 45 years and men aged 45 years and older, hence the 
cut-off of age chosen for the dichotomous variable. Four different measures of recreational drug 
use were examined: number of recreational drugs used (0; 1; 2-4; 5+), poly-drug use, chemsex-
drug use, and club-drug use.  
 
The following additional observed variables were investigated: financial security (all of the time, 
most of the time, some of the time, or never), level of educational attainment (no qualifications, 
O levels/GCSEs, A levels, vocational qualifications, or university degree or higher), and 
frequency of attending gay cafes, pubs, bars, nightclubs/discos, or saunas (two or more times a 
month or less than twice a month). Other variables investigated have been defined in section 
3.3.5: born in the UK, ongoing relationship with a partner, poly-drug use, chemsex-drug use, 
club-drug use, and ‘out’ to few/no friends, work colleagues, and close family. Of note, some 
categorical variables (financial security and educational attainment) were not dichotomized in 
this chapter since estimates derived from SEM are more intuitive for associations with ordered 
categorical variables (see section 6.2.3.2). Using categorical instead of derived binary variables 
also allows more information to be incorporated into the model. However, for the other ordered 
categorical variables, frequency of gay scene use and concealment of sexual identity, binary 
measures were derived. These factors were considered to play an important role in the 
conceptual model, as evidenced by most hypothesized indirect pathways operating through 
these two variables (see section 6.2.3.3). As a result, it was deemed necessary to define a cut-
off indicating frequent gay scene use and concealment of sexual identity. 
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A comprehensive measure of sexual minority stress was not investigated in the AURAH study. 
Only one component of the stress, characteristic of sexual minority men, was captured; 
concealment of sexual identity. In this context, it was deemed more appropriate to investigate 
the association of concealment with supportive networks rather than investigating the 
association in the other direction as was shown in the DAG in Chapter 3 (Figure 8), due to the 
importance of disclosure in fostering supportive networks for sexual minority men 
(209, 225, 245-247)
. 
Of note, an arrow is not drawn from concealment to depression in Figure 16 since it was 
investigated whether concealment was associated with depression indirectly via lower levels of 
a supportive network in this chapter. Furthermore, although higher levels of recreational drug 
use were hypothesized to be associated with sexual minority stress (Figure 8), this was not 
thought to be the case when investigating concealment as the only component of minority 
stress. Unlike the phenomenon and sequelae of internalised homophobia and fear of rejection, 
concealment of one’s sexual identity and the stress associated was not thought to lead to 
greater drug use. Men who conceal their sexual identities are thought to be less likely to be 
active on the gay scene where opportunities to ‘cognitively escape’ using drugs are more 
available.  
 
6.2.3 Statistical methods 
 
6.2.3.1 Investigating latent variables via questionnaire items in the AURAH study- 
Measurement model 
A factor analysis was used to obtain estimates of the constructs that cannot be measured 
directly (depression, self-efficacy for sexual safety, and supportive network), by relating them to 
variables that were directly measured. The latent construct should explain differences between 
individuals in their answers to the observable questions asked in the questionnaire. For 
instance, depression itself should explain why some individuals answer ‘yes’ to a lack of interest 
in things and some individuals do not. Although not a primary objective in this chapter, factor 
analysis also allowed the investigation of which observable question item was the most 
important i.e. contributed more weight. The item with the largest factor loading (the link between 
the observed variable and the latent variable) is considered the most important in explaining the 
specific latent variable. 
 
6.2.3.2 Investigating hypothesized causal pathways in the conceptual model- 
Structural model 
An SEM was undertaken in order to investigate the conceptual model depicted in Figure 16. All 
relationships (i.e. regression pathways) hypothesized were specified in MPlus. Since this SEM 
consists of binary, ordered categorical, and continuous outcome measures, a generalized 
weighted least square based robust estimator (the mean and variance-adjusted WLS, WLSMV) 
was used in order to control for heteroscedasticity of the error term. The link function for 
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weighted least square estimators is Probit link 
(653)
, which is the function that has been the most 
commonly used and studied in the estimation of models with categorical outcome measures 
(688-
692)
. The key feature of SEM is to calculate a model fit test. The model estimated variance-
covariance matrix is the proportion of variance accounted for in all dependent measures by the 
set of independent measures specified. The model fit test determines the extent to which the 
variance-covariance matrix differs from the observed sample variance-covariance matrix. If the 
difference is not statistically significant then this provides no evidence against the null 
hypothesis that the model supports the plausibility of postulated relationships among the 
variables 
(653)
.  
 
In order to evaluate the model fit, the following test results were examined in this chapter: The 
χ
2
 p-value, the comparative fit index (CFI), the tucker-lewis index (TLI), and the root mean 
square error of approximation (RMSEA) test. If the χ
2
 p-value is >0.05 then there is considered 
to be no evidence to contradict the model structure, however, the χ
2
 is highly sensitive to 
sample size. If the sample is large then a significant p-value will almost always arise regardless 
of the magnitude of difference between the observed variance-covariance matrix and model 
estimated variance-covariance matrix . The χ
2
 is also sensitive to the number of variables 
specified in the model (it increases when variable number increases). Given the limitations of 
the χ
2
 test, the other model fit indices, described below, were used to guide the conclusion as to 
the model fit 
(653)
.  
 
The CFI and TLI are comparative fit index tests that examine the specified model against the 
null model where nothing is significantly related (i.e. assumes zero covariances between 
observed variables). If values are ≥0.90 then the model is considered to have a satisfactory fit, 
and if the values are ≥0.95 then the model fit is considered to be good. Although the TLI tends 
to produce lower model fit indices to the CFI, the same cut-off values are utilized 
(653)
. The 
RMSEA is a more recently proposed test. It is an absolute index of fit test that examines 
whether the specified model fits the data ‘well-enough’ instead of comparing it to a null model. 
The RMSEA measures the average lack of fit per model degree of freedom by adjusting for the 
degrees of freedom; the error of approximation reflects the lack of fit of the specified model to 
the population. Simulation studies have demonstrated that the model fit indices produced by the 
RMSEA perform better than the other model fit indices described above, and are now the most 
commonly used in applications of SEM 
(693-697)
. If the value of RMSEA is ≤0.08 then the model is 
considered to have an adequate fit and if the value is ≤0.06 then the model fit is considered to 
be good. Additionally, the value of RMSEA is reported with a 90% confidence interval (CI). In a 
well-fitting model, the higher confidence limit should be ≤0.08 
(698)
. Finally, a close-fit test for the 
null hypothesis is reported for the RMSEA, if the p-value is >0.05, the null hypothesis cannot be 
rejected, and as such it can be suggested that the specified model has a ‘close fit’.  
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The coefficients produced by SEM are standardized coefficients i.e. Beta values. The 
standardization of estimates for continuous independent variables was calculated using the 
function ‘STDYX’ and for binary/categorical independent variables using ‘STDY’ in MPlus. The 
Beta coefficients represent the amount of change (in standard deviation units) in a dependent 
variable per one standard deviation change of an independent variable. For a binary 
independent variable the coefficient is interpreted as the change in the dependent variable in 
standard deviation units when the independent variable changes from 0 to 1. Binary dependent 
variables are treated as continuous. In SEM, the interpretive value of the Beta coefficients 
extends only to that of comparing effect sizes in order to determine which factor is of ‘greater 
importance’ to the model; the greater the coefficient the greater the importance. A positive 
coefficient indicates a positive relationship with the dependent variable and a negative 
coefficient indicates the opposite, an inverse relationship with the dependent variable. The p-
values correspond to the estimates adjusted for their standard errors (equivalent to the z score). 
Of note, in MPlus the ‘full information maximum likelihood’ (FIML) approach is used in model 
estimation to deal with missing data. FIML assumes ‘missingness’ to be Missing Completely at 
Random or Missing at Random 
(653)
. Since missingness was <5% in the study for any 
variable/for >1 variable, any bias due to missing data was expected to be low.  
 
6.2.3.3 Investigating whether depression is associated with CLS indirectly via self-
efficacy for sexual safety- Mediational analysis 
In the Poisson model presented in Chapter 5 (Table 11), whereby the association between 
depressive symptoms (PHQ-9≥10) and CLS was investigated adjusted for measures of self-
efficacy (high self-efficacy for sexual safety and difficulty negotiating condom-use), it is 
assumed that all effects are direct- the coefficient for depression includes both the direct and 
the indirect effects. In SEM however, it is possible to derive two estimates; one for the direct 
effect of depressive symptoms on CLS and one for the indirect effect of depressive symptoms 
on CLS via self-efficacy for sexual safety. In order to demonstrate this and compare findings 
from the Poisson model to those from SEM, factor scores from the depression factor analysis 
and self-efficacy factor analysis were imported into Stata to be examined in a modified Poisson 
regression model. A mediator pathway was then specified in MPlus in order to investigate the 
hypothesis that depression causes CLS indirectly through lowered self-efficacy for sexual 
safety.  
 
Additionally, further mediator pathways were specified in order to investigate the hypotheses 
that: (i) concealment of sexual identity causes depression indirectly via less frequent gay venue 
attendance and lower levels of a supportive network, (ii) concealment of sexual identity leads to 
lower levels of recreational drug use via less frequent gay venue attendance, (iii) less frequent 
gay venue attendance leads to less depression via lower levels of recreational drug use, and 
(iv) higher levels of educational attainment lead to less depression via financial security.  
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6.2.3.4 Investigating whether the indirect effect of depression on CLS is similar 
among men who took recreational drugs and men who did not- Testing for 
moderating effects 
The potential moderating effects of recreational drug use were investigated in this chapter in 
two stages. In the first stage, measurement invariance was investigated for the latent construct 
of depression. Determining measurement invariance is as a result of examining whether 
individual items measuring a latent construct in a factor analysis function equivalently. It was 
investigated whether the measure of depression was well specified and captured equivalent 
constructs among: (i) men who reported poly-drug use and men who did not, (ii) men who 
reported chemsex-drug use and men who did not, and (iii) men who reported club-drug use and 
men who did not. 
 
In the second stage, structural invariance was investigated by examining whether the indirect 
association of depression with CLS through lowered self-efficacy for sexual safety was different 
among: (i) men who reported poly-drug use and men who did not, (ii) men who reported 
chemsex-drug use and men who did not, and (iii) men who reported club-drug use and men 
who did not. Of note, this analysis followed on from the finding that the indirect effect of 
depressive symptoms on CLS through self-efficacy for sexual safety was consistent with the 
data. 
 
6.2.3.5 Investigating alternative causal pathways between depressive symptoms and 
CLS with one or more partners- Exploratory analysis 
The main hypothesis upon which this work is based is that symptoms of depression lead to 
CLS. Given the use of DAG to present this hypothesis, which requires strong prior assumptions 
about direction of associations to be made, the possibility that the association may operate in 
the opposite direction (CLS leads to depression) was not investigated, but is discussed when 
considering evidence for causality in Chapter 9 (section 9.2.3).  
 
The main analysis in this chapter assesses support for the hypothesis that depressive 
symptoms lead to CLS via lower self-efficacy, as depicted in Figure 15. However, four 
alternative causal pathways between depressive symptoms and CLS with one or more partners 
were also examined in order to determine whether the overall model fit improved i.e. whether 
alternative pathways appeared to be more consistent with the data. This entailed changing the 
direction of the arrows in the DAG for the link between recreational drug use and depressive 
symptoms and recreational drug use and self-efficacy for sexual safety. Although it is 
acknowledged that this is not the common practice associated with DAG use, it was deemed to 
be of interest in this thesis to examine the extent to which the association between depressive 
symptoms and CLS may also be operating via recreational drug use. The relationship between 
recreational use and depression (and recreational use and self-efficacy for sexual safety) is in 
practice most likely bidirectional. The four alternative pathways investigated included:  
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(i) model without self-efficacy for sexual safety 
(ii) model where symptoms of depression cause CLS indirectly through higher levels of 
recreational drug use (no direct cause between depressive symptoms and CLS) 
(iii) model where symptoms of depression cause CLS indirectly through lowered self-efficacy for 
safety and where symptoms of depression cause CLS indirectly through higher levels of 
recreational drug use 
(iv) model where symptoms of depression cause CLS indirectly via lowered self-efficacy for 
sexual safety and higher levels of recreational drug use. 
 
6.3 Results 
 
6.3.1 Descriptive statistics 
For those variables which were redefined or investigated for the first time in this chapter, the 
prevalence is given here; the prevalence of other factors is presented in Chapters 4 and 5. Of 
the 1340 men who reported recent sex, the median age was 31 (interquartile range [IQR] =13) 
and the mean number of recreational drugs used in the past three months was 1 (IQR=3). Being 
educated to O levels/GCSEs, A levels, vocational qualifications, or university degree level was 
reported by 9.1%, 18.1%, 3.1%, and 67.2% of men respectively, and 2.6% of men reported no 
educational qualifications. Financial security all of the time, most of the time, some of the time, 
or never was reported by 71.7%, 21.0%, 5.2%, and 2.0% of men respectively. Fifty-two percent 
of men reported visiting gay venues two or more times a month. Finally, the proportion of men 
who reported receiving care, love and affection, chances to talk to someone, invitations to go 
out, and help when sick, as much as they would like (indicating higher levels of a supportive 
network), was 66%, 48%, 57%, 57%, and 55% respectively. 
 
6.3.2 Measurement model 
The model (which included depressive symptoms, self-efficacy for sexual safety, and support 
network) terminated normally, with p-values <0.001 for all factor items. Table 15 presents 
findings from the factor analysis of the nine items on the PHQ-9. In the factor analysis, the 
following item on the PHQ-9 appeared to be the most important for depression: ‘feeling down, 
depressed, or hopeless’, this was followed by ‘little interest or pleasure in doing things’, ‘feeling 
bad about yourself-or that you are a failure or have let yourself or your family down’, and 
‘thoughts that you would be better off dead, or of hurting yourself in some way’.  
 
When investigating poly-drug use and club-drug use as potential moderators in the 
measurement model, the mean depression factor analysis score was not significantly different 
between men who reported poly-drug use and men who did not (p=0.075). The depression 
mean was however, found to be different between men who reported club-drug use and men 
  
 
 
189 
 
who did not (p=<0.001). Regardless, when investigating measurement invariance of the 
depression factor analysis, scalar invariance/strong factorial invariance was achieved. In other 
words, the responses to the observable factor items were not significantly different between 
men who reported poly-drug use and men who did not (p=0.093) and men who reported club-
drug use and men who did not (p=0.114). However, the depression mean was significantly 
different between men who reported chemsex-drug use and men who did not (p<0.001) and 
scalar invariance/strong factorial invariance was not achieved (p=0.031). Men who reported 
chemsex-drug use and men who did not may have answered the PHQ-9 depression 
questionnaire in a significantly different way, perhaps giving greater weight to different problem 
items on the scale. On further investigation, although the highest depression factor loading 
among both men who reported chemsex-drug use and men who did not, was for ‘feeling down, 
depressed, or hopeless’  (0.853 and 0.876 respectively), the pattern of factor loading 
importance differed from then onwards. For example, for men who reported chemsex-drug use, 
the second highest factor loading was for ‘little interest or pleasure in doing things’(0.822) and 
the third for ‘poor appetite or overeating’ (0.822), whereas, for men who did not report chemsex-
drug use, the second was for ‘feeling bad about yourself-or that you are a failure or have let 
yourself or your family down’ (0.820), and the third for ‘thoughts that you would be better off 
dead, or of hurting yourself in some way’ (0.814). Of note, findings (i.e. factor loadings, FL) from 
the factor analysis of the items shadowing self-efficacy for sexual safety and supportive network 
are presented in Figure 17. 
 
Table 15: Factor loadings for nine items on the PHQ-9 scale of depression in AURAH 
Individual question items on the PHQ-9 
scale 
Factor loadings 
1. Little interest or pleasure in doing 
things 
0.821 
2. Feeling down, depressed, or 
hopeless 
0.881 
3. Trouble falling or staying asleep, or 
sleeping too much 
0.718 
4. Feeling tired or having little energy 0.772 
5. Poor appetite or overeating 0.753 
6. Feeling bad about yourself-or that 
you are a failure or have let yourself 
or your family down 
0.819 
7. Trouble concentrating on things, 
such as reading the newspaper or 
watching television 
0.757 
8. Moving or speaking so slowly that 
other people could have 
noticed/being so restless that it is 
hard to sit still 
0.746 
9. Thoughts that you would be better off 
dead, or of hurting yourself in some 
way 
0.817 
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6.3.3 Structural model 
The χ
2 
test for the model fit was 1084.478, df. 261, p-value <0.001; given the large size of the 
sample investigated, this significant finding is not unusual and is difficult to interpret. However, 
the RMSEA value was 0.049 (0.046, 0.052; p=0.730), the CFI was 0.961, and the TLI was 
0.955. These model fit indices fall within the category of ‘good’ fit for all tests, as well as ‘close 
fit’ for the RMSEA close-fit test (based on the p-value). Although the conceptual model did not fit 
the data perfectly (as no model usually does), given that the model fit estimates were found to 
be good, it was considered that the model was not substantially inconsistent with the data.  
 
Figure 17 presents the results of the SEM. Below is a description of the adjusted associations 
found in this model, see Figure 17 for sets of adjusted variables. Financial insecurity (Beta= 
0.410; p<0.001) and greater number of recreational drugs used (Beta= 0.182; p<0.001) was 
associated with higher levels of depressive symptoms. Older age (Beta= -0.151; p<0.001), 
higher educational attainment (Beta= -0.079; p=0.039), no ongoing relationship with a partner 
(Beta= -0.138; p<0.001), and higher levels of a supportive network (Beta= -0.597; p<0.001) was 
associated with lower levels of depressive symptoms. Higher levels of depressive symptoms 
were associated with low self-efficacy for sexual safety (Beta= 0.300; p<0.001) and low self-
efficacy for sexual safety (Beta= 0.524; p<0.001) was associated with CLS. Furthermore, 
greater number of recreational drugs used (Beta= 0.176; p<0.001) was associated with CLS. 
Report of no ongoing relationship with a partner was inversely associated with CLS (Beta= -
0.183; p<0.001) i.e. being in an ongoing relationship was associated with CLS. Of note, in line 
with the hypothesis set forth in this thesis, the Beta value for the association between self-
efficacy and CLS was larger than that for the other factors (number of recreational drugs used 
and ongoing relationship status), indicating its greater relevance to CLS in the conceptual 
model. 
 
In terms of the other relationships, older age was associated with concealment of sexual identity 
(Beta= 0.133; p=0.001), and report of no ongoing relationship with a partner was inversely 
associated with concealment of sexual identity (Beta= -0.169; p=0.002) i.e. being in an ongoing 
relationship was associated with concealment. Concealment of sexual identity was associated 
with less frequent visits to gay venues (Beta= 0.702; p<0.001), and this relationship produced 
the largest Beta value in the model. Reporting no ongoing relationship with a partner (Beta= -
0.374; p<0.001) and less frequent visits to gay venues (Beta= -0.140; p<0.001) was associated 
with lower levels of a supportive network. Less frequent visits to gay venues was associated 
with lower levels of recreational drugs used (Beta= -0.115; p=0.001). Finally, older age was 
inversely associated with report of no ongoing relationship with a partner (Beta= -0.109; 
p=0.008) i.e. younger age was associated with not being in an ongoing relationship, having 
been born outside of the UK was associated with higher educational attainment (Beta= 0.261; 
p=0.003), and higher educational attainment was associated with less financial insecurity 
(Beta= -0.312; p<0.001). 
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Age was not associated with CLS or number of recreational drugs used. Number of recreational 
drugs used was not associated with self-efficacy for sexual safety. These non-significant 
pathways were not removed from the model since these relationships were hypothesized a 
priori, and the model fit for this conceptual model was good. However, these non-significant 
pathways were further explored in two ways. First, other categorizations of age and recreational 
drug use were investigated. Neither a categorical nor dichotomous version of age groups was 
associated with CLS with one or more partners (0.017; p=0.423, and 0.057; p=0.571 
respectively) or levels of recreational drugs use (-0.006; p=0.713, and -0.084; p=0.316 
respectively). All other model estimates remained the same and the model fit was unchanged. 
The association with self-efficacy for sexual safety remained non-significant when investigating 
the number of recreational drugs used in four categories, poly-drug use, chemsex-drug use, and 
club-drug use. The model estimates for the association with depressive symptoms and CLS with 
one or more partners in Figure 17 did not appear particularly sensitive to changes in 
recreational drug use measures. All other model estimates remained the same, although older 
age was inversely associated with club-drug use (-0.137; p<0.001), and the model fit was 
unchanged. Second, two additional indirect pathways that were hypothesized prior to model 
refitting were investigated. Findings are described in the mediational analysis section below.
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Figure 17: Structural equation model of the link between depression and CLS with one or more partners in AURAH 
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6.3.4 Mediational analysis 
When investigating factor scores from the depression factor analysis and self-efficacy factor 
analysis in a modified Poisson regression model in Stata, in an unadjusted model, the PR for 
the association between depression scores and CLS with one or more partners was 1.03 (95% 
CI: 1.01, 1.06) with a p-value of 0.002. In an unadjusted SEM with only the depression factor 
analysis and a link specified between depression and CLS with one or more partners, the p-
value was <0.001 (Beta= 0.141). After adjusting for self-efficacy scores in the Poisson model, 
the association between depression scores and CLS with one or more partners was 1.00 (95% 
CI: 0.98, 1.02) with a p-value of 0.916. Similarly, including self-efficacy for sexual safety in the 
SEM with a link specified between depression and self-efficacy and self-efficacy and CLS, the 
p-value for the direct effect of depression on CLS with one or more partners was 0.496 (Beta= 
0.028). Therefore, both the Poisson model and SEM indicate that after adjusting for self-efficacy 
for sexual safety there is no direct association between depression and CLS with one or more 
partners, suggesting that self-efficacy confounds this association. This causal steps approach to 
mediation, as investigated in the previous chapter, can go no further. SEM however, provides 
us with an additional piece of information, which gives evidence as to whether self-efficacy is on 
the causal pathway i.e. whether self-efficacy mediates this association (see Chapter 3 section 
3.4.2). The p-value for the indirect effect of depression on CLS with one or more partners was 
<0.001 (Beta= 0.113).  
 
When investigating the hypothesis-driven model depicted in Figure 16, depression was 
associated with CLS indirectly through lowered self-efficacy for sexual safety (Beta= 0.163 95% 
CI: 0.113, 0.213, S.E. 0.025, z-score=Est/S.E. 6.387, p<0.001). It is of note, that when including 
an additional direct link between depression and CLS in the model, the p-value for the indirect 
effect remained the same (Beta= 0.162) and the p-value for the direct effect was 0.970 (Beta= 
0.002).  
 
In addition, concealment of sexual identity was associated with depression indirectly through 
less frequent visits to gay venues and lower levels of a supportive network (0.059 95% CI: 
0.022, 0.096, S.E. 0.019, Est/S.E. 3.107, p=0.002). Less frequent visits to gay venues was also 
associated with less depression indirectly through lower levels of recreational drug use (-0.021 
95% CI: -0.035, -0.007, S.E. 0.007, Est/S.E. -2.959, p=0.003). Higher educational attainment 
was associated with less depression indirectly through greater financial security (-0.128 95% CI: 
-0.167, -0.089, S.E. 0.020, Est/S.E. -6.451, p<0.001). Of note, in an additional analysis, older 
age (continuous variable) was associated with lower levels of recreational use via concealment 
of sexual identity and less frequent visits to gay venues (-0.011 95% CI: -0.021, -0.002, S.E. 
0.005, Est/S.E. -2.337, p=0.019) and to be inversely associated with CLS with one or more 
partners via concealment of sexual identity, less frequent visits to gay venues, and lower levels 
of recreational drug use (-0.002 95% CI: -0.004, <0.001, S.E. 0.001, Est/S.E. -2.074, p=0.038). 
The model fit was unchanged in this additional analysis. 
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As shown in Table 16, for each CLS measure, the conceptual model fit the data well and low 
self-efficacy for sexual safety was found to significantly mediate the association with 
depression. For each CLS measure, the pattern of associations was similar and each 
meditational analysis was significant. The differences observed were as follows: older age and 
not being in an ongoing relationship was associated with all three CLS measures and greater 
number of recreational drugs used had a borderline association with report of receptive CLS 
with an unknown status partner. Figure 18 presents findings for CLS with two or more partners. 
 
 Table 16: Goodness of fit and mediational analysis findings when including other CLS 
measures in the conceptual model, in AURAH 
CLS-related activity in the past 
three months 
RMSEA CFI TLI Estimate 95% CI; 
S.E.; Est./S.E.;  
p-value for indirect 
effect of 
depression on 
CLS, mediated by 
low self-efficacy 
for sexual safety 
CLS with two or more partners 0.049 [0.046, 0.052]; 
p=0.764 
0.961 0.955 0.158 95% CI 
0.106, 0.211; 0.027; 
5.893; <0.001 
CLS with an unknown/HIV+ status 
partner
a
 
0.049 [0.046, 0.052]; 
p=0.713 
0.960 0.955 0.190 95% CI: 
0.134, 0.247; 0.029; 
6.639; <0.001 
Receptive CLS with an unknown 
status partner 
0.049 [0.046, 0.052]; 
p=0.712 
0.960 0.954 0.168 95% CI 
0.105, 0.231; 0.032; 
5.260; <0.001 
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Figure 18: Structural equation model of the link between depression and CLS with two or more partners in AURAH 
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6.3.5 Testing for moderating effects 
When investigating CLS with one or more partners, CLS with two or more partners, and CLS 
with an unknown/HIV-positive status partner, there was a significant indirect effect for men who 
did not report poly-drug use and for men who did report poly-drug use, and the difference in 
strength for the indirect effect was not significant between groups (Table 17). The same pattern 
was found when stratifying by men who reported chemsex-drug use and men who did not, and 
by men who reported club-drug use and men who did not. When investigating receptive CLS 
with an unknown status partner, there was a significant indirect effect for men who did not report 
poly-drug use, but not for men who did report poly-drug use, although the difference in strength 
for the indirect effect was not significant between groups. The same pattern was found when 
stratifying by chemsex-drug use, and a significant indirect effect was found for men who did 
report club-drug use. The indirect effect of depressive symptoms on CLS through self-efficacy 
for sexual safety did not appear to be different among men who took recreational drugs and 
men who did not.  
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Table 17: Indirect effect of depression on CLS among men who reported recreational drug use and men who did not, in AURAH 
CLS-related 
activity in the past 
three months 
No poly- 
drug use 
 
 
 
Parameter 
p-value 
Poly-drug 
use  
 
 
 
Parameter 
p-value 
Difference 
in strength 
for indirect 
effect 
 
 
p-value 
No 
chemsex-
drug  use 
 
 
Parameter 
p-value 
Chemsex-
drug use 
 
 
 
Parameter 
p-value 
Difference 
in strength 
for indirect 
effect 
 
 
p-value 
No club- 
drug use 
 
 
 
Parameter 
p-value 
Club-drug 
use  
 
 
 
Parameter 
p-value 
Difference 
in strength 
for indirect 
effect 
 
 
p-value 
CLS with one or 
more partners 
0.115 
<0.001 
0.195 
0.005 
-0.080 
0.272 
0.125 
<0.001 
0.192 
0.004 
-0.067 
0.347 
0.121 
<0.001 
0.207 
0.001 
-0.085 
0.217 
CLS with two or 
more partners 
0.119 
<0.001 
0.142 
0.008 
-0.022 
0.711 
0.128 
<0.001 
0.183 
0.003 
-0.055 
0.417 
0.112 
<0.001 
0.196 
0.002 
-0.084 
0.224 
CLS with an 
unknown/HIV+ 
status partner
a
 
0.162 
<0.001 
0.168 
0.008 
-0.005 
0.939 
0.162 
<0.001 
0.226 
0.003 
-0.064 
0.448 
0.159 
<0.001 
0.224 
0.001 
-0.065 
0.406 
Receptive CLS 
with an unknown 
status partner 
0.169 
<0.001 
0.069 
0.089 
0.100 
0.098 
0.159 
<0.001 
0.091 
0.070 
0.068 
0.309 
0.167 
0.001 
0.114 
0.024 
0.053 
0.446 
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6.3.6 Exploratory analysis 
Figure 19 presents the four alternative causal pathways between depressive symptoms and 
CLS with one or more partners investigated. In exploratory model (i), higher levels of depressive 
symptoms were associated with CLS directly (0.164; p<0.001). In exploratory model (ii), higher 
levels of recreational drug use were associated with low self-efficacy for sexual safety (0.379; 
p<0.001), and higher levels of depressive symptoms were associated with CLS indirectly via 
higher levels of recreational drug use (0.047 95% CI: 0.011, 0.083, S.E. 0.018, Est/S.E. 2.543, 
p=0.011). In exploratory model (iii), higher levels of depressive symptoms were associated with 
CLS indirectly via low self-efficacy for sexual safety (0.156 95% CI: 0.107, 0.205, S.E. 0.025, 
Est/S.E. 6.229, p<0.001) and at the same time, indirectly via higher levels of recreational drug 
use (0.032 95% CI: 0.014, 0.051, S.E. 0.009, Est/S.E. 3.476, p=0.001). In exploratory model 
(iv), low self-efficacy for sexual safety was associated with higher levels of recreational drug use 
(0.453; p<0.001), and higher levels of depressive symptoms were associated with CLS 
indirectly via low self-efficacy for sexual safety and higher levels of recreational drug use (0.072 
95% CI: 0.046, 0.099, S.E. 0.013, Est/S.E. 5.391, p<0.001).  
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Figure 19: Exploratory models with altered causal pathways between depressive 
symptoms and CLS with one or more partners
a
, based on data from AURAH 
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Table 18 presents a comparison of the model fit indices between the hypothesis-driven 
conceptual model, depicted in Figure 16, and exploratory models (i) to (iv), whereby model (iii) 
(Figure 19c) appeared to be marginally more consistent with the data.   
 
Table 18: Comparing model fit indices of models with differing causal pathways between 
depressive symptoms and CLS with one or more partners, in AURAH 
Models (in order of better model fit)
a
 RMSEA CFI TLI 
Exploratory model (iii) (Figure 19c) 0.048 [0.045, 0.051]; p=0.875 0.962 0.957 
Hypothesis-driven model (Figure 16) 0.049 [0.046, 0.052]; p=0.730 0.961 0.955 
Exploratory model (i) (Figure 19a) 0.051 [0.048, 0.054]; p=0.341 0.963 0.958 
Exploratory model (ii) (Figure 19b) 0.054 [0.051, 0.057]; p=0.011 0.951 0.945 
Exploratory model (iv) (Figure 19d) 0.054 [0.051, 0.057]; p=0.007 0.951 0.944 
 
It is of note, based on findings from this exploratory analysis, higher levels of recreational drug 
use were associated with low self-efficacy for sexual safety only in models not adjusted for 
depression (exploratory models (ii) and (iv)). It appears that depression may confound this 
association. Accordingly, it was investigated, in the hypothesis-driven model (Figure 16), 
whether higher levels of recreational drug use were associated with low self-efficacy for sexual 
safety indirectly via depression. The indirect effect was significant (0.052 95% CI: 0.030, 0.074, 
S.E. 0.011, Est/S.E. 4.621, p<0.001; the model fit was the same as that in Figure 17. 
 
6.4 Discussion 
 
6.4.1 Summary of results 
The conceptual model investigated in this chapter, using SEM, was found to be consistent with 
AURAH data. Findings provide support for the thesis hypothesis that depression is associated 
with CLS (including CLS with multiple partners and partners of an unknown/HIV-positive status, 
and receptive CLS with unknown status partners) indirectly via lowered self-efficacy for sexual 
safety. When exploring the effects of altering the causal pathway, the model fit was marginally 
improved when depression was considered to lead to CLS indirectly via higher levels of 
recreational drug use as well as indirectly via low self-efficacy for sexual safety. Removing the 
indirect effect via low self-efficacy for sexual safety reduced the model fit. The indirect 
association was also apparent among men who did not report poly-, chemsex-, and club-drug 
use. These findings suggest that the indirect effect is not primarily due to higher levels of 
recreational drug use. Although low self-efficacy and recreational drug use may both play a role 
in the causal pathway between depression and CLS, specifying an indirect effect via low self-
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efficacy and then higher levels of recreational drug use, reduced the model fit (although the 
indirect effect remained significant). These findings suggest that there are in fact two distinct 
indirect effects whereby depression is associated with CLS either by lowering one’s self-efficacy 
for sexual safety or by leading to higher levels of recreational drug use. These results add to the 
analysis described in Chapter 5, as indirect effects could not be directly tested using Poisson 
regression analysis.  
 
6.4.2 Comparing AURAH findings to other studies investigating the indirect effect of 
depression on CLS through self-efficacy for sexual safety  
As described in Chapter 2 section 2.4.8, one high-income country study has investigated 
whether the relationship between depression and CLS is mediated by other psychological 
vulnerabilities and dysfunctional coping processes, using baseline data from Project MIX (see 
section 2.4.1.3) 
(362)
. In all analyses, age, income, education level, ethnicity, HIV status and 
research site were adjusted for. The investigators found that higher levels of depression were 
associated with higher cognitive escape tendencies
xxx
 (F=152.96, p<0.001), higher levels of 
avoidant coping
xxxi
 (F=396.42, p<0.001), and lower levels of self-efficacy for sexual safety
xxxii
 
(F=32.12, p<0.001). Furthermore, low self-efficacy for sexual safety (F=41.71, p<0.001) and 
cognitive escape tendencies (F=6.69, p<0.05) were associated with higher numbers of CLS 
partners of unknown or HIV sero-different status in the past three months, when adjusting 
additionally for depression. In order to investigate the significance of mediation, the authors 
used the PRODCLIN program, which computes tables of critical values to create asymmetrical 
confidence intervals based on the distribution of the product of two factors 
(652)
, a method similar 
to the difference of coefficients method and the product of coefficients method described in 
section 3.4.2 of Chapter 3. This mediational analysis did not take place in the framework of 
SEM. Consistent with findings in this chapter however, low self-efficacy for sexual safety and 
cognitive escape tendencies were found to mediate the association between depression and 
sexual risk behaviour- the confidence intervals produced in PRODCLIN did not include the 
value 0.  
 
In Project MIX, a composite measure of low self-efficacy for sexual safety and/or cognitive 
escape tendencies was also investigated and found to significantly mediate the association. 
When controlling for this composite measure in the model, depression was no longer associated 
with CLS 
(362)
. Similarly, in this chapter, the total effect of depressive symptoms on CLS with one 
or more partners was equal to the indirect effect since the direct effect was equal to 0. Although 
it was not possible as part of the AURAH study to investigate markers of cognitive escape 
tendencies, recreational drug use was also found to mediate the association between 
                                                     
xxx
 On a 7-item scale previously developed by the authors to specifically assess the use of drugs and sex 
to cognitively escape i.e. ‘When I am high or drunk I am more likely to want to have anal sex with a man’. 
xxxi
 Mean score on the Behavioural Disengagement subscale of COPE. 
xxxii
 On a 7-item scale designed to investigate participants’ confidence in their ability to practice safer sex 
i.e. ‘I am confident that I can have safer sex even if my partner doesn’t want to; disagreeing that they could 
be ‘sexually safe’ on four or more items was considered to indicate low self-efficacy for sexual safety. 
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depression and CLS. As described in section 2.6.3.2, recreational drug use may directly lead to 
sexual risk-taking via autonomic or central nervous system mechanisms that increase sexual 
arousal and disinhibition, or indirectly by inducing a state of cognitive release and escape from 
rational self-awareness 
(397, 597)
. 
 
It is of note, in another study, self-efficacy
xxxiii
 has also been found to partially mediate the 
association between depressive symptoms (CES-D>16) and CLS in the past six months among 
MSM residing in one of seven Cape Town townships in South Africa (N=316). A Sobel test (see 
section 3.4.2) was used and was controlled for age, income and education. The sample 
reported high levels of alcohol and drug use and a high number of sexual partners 
(699)
. The fact 
that results are consistent in different geographical settings is re-assuring in terms of trying to 
establish a causal link. 
 
6.4.3 Comparing AURAH findings to other studies investigating depression among MSM 
using SEM  
One U.S. and one UK study have previously employed SEM to study depression among sexual 
minority individuals. In a SEM using data from the Bareback Project (see section 2.4.1.4), it was 
hypothesized that depression was directly and indirectly associated with sexual risk behaviour 
via attitudes toward condom-use (based on a modified version of Brown’s 1984 scale). The 
model was said to fit the data well. The direct effect of depression on sexual risk behaviour was 
not significant (coefficient not reported; p=0.246). However, depression was significantly 
associated with more negative attitudes towards condom-use (-0.15; p=0.005) and more 
positive attitudes towards condom-use were significantly associated with a greater proportion of 
sexual acts that were protected by a condom in the past month (0.29; p<0.001). Results from 
the meditational analysis were not reported perhaps due to the small sample size (N=332). The 
authors stated that they used applicable items from Brown’s (1984) scale 
(700)
, which may 
include for example, the following statements: ‘I would be comfortable suggesting that my 
partner and I use a condom’, ‘Condoms are unreliable’, and ‘Condoms are pleasant to use’. 
Lower scores across items used indicated lower interest in using condoms to keep one’s self 
sexually safe. Since higher levels of depression were associated with lower condom attitude 
scores, which was in turn associated with more sexual risk behaviour, these findings appear to 
be similar to those found in the AURAH study.  
 
The Avon Longitudinal Study of Parents and Children recruited a consecutive sample of 
pregnant women attending care in Avon (N=3710) and collected data from their children up to 
age 18. In a SEM, it was hypothesized that sexual minority status was associated with problem 
alcohol use indirectly via depressive symptoms (on the Short Mood and Feelings 
                                                     
xxxiii
 Based on scores from the following statements: ‘Someone can talk me out of using condoms by telling 
me they love me’, ‘I find it difficult to tell a male sex partner that I want to use condoms’, ‘Someone can talk 
me out of using condoms by telling me they are HIV-negative’, and ‘I find it difficult to insist that condoms 
are used if I have very strong feelings for the man I am going to have sex with’. 
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Questionnaire). This indirect mechanism was significant (Z=3.2, p=0.001). Although sexual 
minority status may be associated with depression (see section 1.8.1), evidence from AURAH 
suggests that, among MSM specifically, concealment of sexual identity is also associated with 
depression indirectly through less frequent visits to gay venues and lower levels of a supportive 
network. Depressive symptoms were also associated with recreational drug use in the AURAH 
study. 
 
6.4.4 Other socio-demographic and psychosocial factors associated with sexual behaviour 
Based on findings from review (ii) of this thesis (section 2.5.4) 
(118, 477, 482, 489, 512, 563)
 
(563)
 and 
other studies in high-income countries 
(491, 574-577)
, it was hypothesized that younger age would 
be associated with CLS measures among sexual minority men in the AURAH study. Similar to 
findings from univariable analysis in the previous chapter, age (continuous, categorical, and 
dichotomous measures) was not associated with CLS with one or more partners in a SEM 
adjusted for relationship status, recreational drug use, and self-efficacy. However, upon further 
investigation younger age was found to be associated with CLS indirectly via a greater tendency 
to be ‘out’ with one’s sexual orientation, be active on the gay scene and be using higher levels 
of recreational drugs. Again, similar to the previous chapter, older age was found to be directly 
associated with CLS with two or more partners, CLS with partners of an unknown/HIV-positive 
status, and receptive CLS with unknown status partners in SEM. Differences between studies 
may reflect different recruitment sites, inter-city differences, and different measures of sexual 
behaviour. 
 
Furthermore, as in the previous chapter, in the SEM, not being in an ongoing relationship with a 
partner was associated with less CLS, and this is in line with that previously observed in the UK 
(482, 496, 510)
. In the SEM, not being in an ongoing relationship was associated with CLS with 
multiple partners. This association has been investigated in one other UK study of MSM 
(512)
, 
which failed to find a link in unadjusted analysis. 
 
Finally, as has been previously observed in the UK 
(511)
 
(478, 484, 509)
 and other high-income 
countries 
(397, 585-600)
, higher levels of recreational drug use were associated with CLS measures 
in the SEM (as in Poisson models in the previous chapter). Based on the Beta standardized 
estimates, however, low self-efficacy for sexual safety was a more ‘important’ factor for CLS 
than drug use. 
 
6.4.5 Socio-demographic and pscyhosocial factors associated with depressive symptoms 
The same associations with depression as that observed in the previous Poisson analysis 
presented in Chapter 4 and in previous studies (including theoretical studies of sexual minority 
stress) of MSM in high-income countries (see sections 1.6 and 2.6.3.1- 2.6.3.2) were also found 
in the SEM in this chapter. The exception to this was the association observed with ongoing 
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relationship with a partner in SEM. Although not being in an ongoing relationship with a partner 
was associated with lower levels of a supportive network, which was in turn associated with 
more depression, there also appeared to be a direct association between no ongoing 
relationship with a partner and less depression. Unfortunately, it was not possible to investigate 
whether the association between ongoing relationship with a partner and depressive symptoms 
was different among men with a supportive network and men without, since supportive network 
was an unobserved variable and testing for moderation in SEM requires the effect-modifier to 
be an observed categorical variable. Using data from the same sample of men, by use of 
standard interaction χ
2
 tests, it was investigated whether the association between ongoing 
relationship with a partner and depressive symptoms (PHQ-9≥10) was different among men 
who reported higher levels of a supportive network (total score across the five questions was 
20-25) and men who did not (total score<20). Although the p-values were not significant, among 
men with higher levels of a supportive network, men with no ongoing relationship with a partner 
appeared to report more depressive symptoms than men with an ongoing partner (6.3% vs. 
4.8%; p=0.330). Among men with lower levels of a supportive network, men with no ongoing 
relationship with a partner appeared to report less depressive symptoms than men with an 
ongoing partner (23.6% vs. 29.2%; p=0.208). These findings suggest that men with low levels of 
social support despite having an ongoing stable partner may suffer worse depressive 
symptomatology than men with low levels of social support and no stable partner, due to the 
profound burden associated with an unhappy partnership. Another possibility is that IPV may be 
occurring within the context of an ongoing relationship, which may in turn lead to depression (as 
suggested in the literature 
(41, 605)
). 
 
Findings from the SEM also extended those observed in Chapter 4, whereby concealment of 
sexual identity was associated with depression indirectly through less frequent visits to gay 
venues and lower levels of a supportive network. Less frequent visits to gay venues was also 
associated with less depression indirectly through lower levels of recreational drug use, and 
finally, higher educational attainment was associated with less depression indirectly through 
greater financial security. Furthermore, it appeared that in men who reported chemsex-drug 
use, anhedonia (decrease in pleasure in everyday life) and poor appetite/overeating were some 
of the most important factors explaining the presence of depression, perhaps reflecting the 
direct psychological and physical effects of drug use itself. 
 
Of note, of factors investigated to be directly associated with depressive symptoms, the largest 
Beta coefficient was observed for the inverse association with higher levels of a supportive 
network, in line with that observed in Chapter 4, and the second largest was for financial 
insecurity. These two factors had a considerably greater estimate of effect compared to each of 
the other factors included in the model (including recreational drug use). The largest Beta 
coefficient in the model for direct effects was that observed for the association between 
concealment of sexual identity and less frequent visits to gay venues.  
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6.4.5.1 Other hypothesized relationships 
Higher levels of recreational drug use were hypothesized to lead to low self-efficacy for sexual 
safety, however, no such association was found in the SEM. In the AURAH study, men were 
asked about their current attitudes towards condom-use and use of recreational drugs in the 
past three months. Unlike depression, which may be chronic and affect every aspect of one’s 
life, the psychoactive effects of drug use may be immediate and short-lived. It may be that 
although at the time of taking drugs one’s (perceived) ability to maintain sexual safety was 
diminished, it was not possible to capture this phenomenon based on the measure of current 
attitudes towards condom-use in AURAH. However, findings from the exploratory analysis also 
shed light on the lack of association observed; higher levels of recreational drug use may be 
associated with low self-efficacy for sexual safety indirectly via depression. This finding reflects 
the importance of the role that depression most likely plays in self-efficacy for sexual safety.   
 
Younger age was hypothesized to lead to higher levels of recreational drug use, but no such 
association was found in the SEM. However, based on findings from an additional analysis, 
younger age was associated with higher levels of recreational drug use via less concealment of 
sexual identity and more frequent visits to gay venues. Findings from the model where club-
drug use was investigated as the measure of recreational drug use reiterate these findings, as 
younger age was directly associated with club-drug use. Of note, this is in line with that found in 
a study of U.S. MSM of black ethnicity (recruited online 2012-2014), whereby younger MSM 
(≤29 years of age) were more likely than older MSM (≥30 years of age) to identify as gay, 
homosexual, same gender loving, or bisexual 
(373)
.  
 
Furthermore, although not hypothesized, reporting no ongoing relationship with a partner was 
associated with less concealment of sexual identity, even after adjusting for age. This is a 
surprising finding, which may reflect the fact that the gender of the partner was not specified. 
Perhaps men who reported a female partnership were less likely to disclose being gay, bisexual 
and/or attracted to men. However, there may certainly be other interpretations, for instance, 
being in an ongoing partnership with a man may for some individuals create an additional 
psychological barrier to coming out as it entails not only disclosure of one’s sexual orientation 
but also one’s life choices.  
 
Finally, contrary to what was hypothesized, having been born outside of the UK was associated 
with higher educational attainment. This may not be surprising however, given that the majority 
of men were residing in London (75.9%) and may represent a select group of migrants of higher 
socio-economic status who were seeking job opportunities in London.  
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6.4.6 Limitations 
The general methodological limitations of the AURAH study are discussed in section 3.7.1 of 
Chapter 3. In this specific analysis, it is important to note that depression was treated as an 
unobserved variable, however, there is evidence to suggest that the PHQ-9 measures 
depression quite accurately (see section 3.3.2.1). Nevertheless, there are many different scales 
to measure symptoms of depression (see section 2.4.2). Therefore, despite the possible 
limitations, depressive symptoms were considered to be latent.  
 
Issues surrounding temporality in cross-sectional study designs are discussed in section 5.4.9. 
DAGs represent so-called ‘recursive models’, which use unidirectional arrows to show the 
direction of causation. Bidirectional relationships (including feedback loops) are not 
conventionally depicted, and if they were, this model would then be considered ‘non-recursive’.  
Although non-recursive models may be theoretically plausible, they most often produce 
estimation problems in the framework of SEM, and in many cases are simply inestimable. 
Interest in using DAGs in epidemiology began to rise in the early 21
st
 Century due to their use in 
formalizing certain types of biases and ease in representing recursive models for SEM. 
However, there are limitations that come hand-in-hand with the rule-bound nature of DAGs 
(701)
. 
It is often only the use of scientific theories which are used to conceptualise the causal 
relationships hypothesized. DAGs cannot themselves provide insight into whether a 
phenomenon is conceptualized appropriately. Therefore, it is possible, especially in the social 
and behavioural sciences, that the hypothesized causal sequence may operate in the other 
direction, with implications for intervention 
(701)
. The DAGs presented in this Chapter assume 
one direction but see Chapter 3 section 3.5 for a description of which associations are assumed 
to be bidirectional. 
 
AURAH did not collect information on markers of cognitive escape coping and as such it was 
not possible to assess the role of this psychological construct in the causal pathways leading to 
CLS. Finally, there will inevitably be measurement error when attempting to capture 
psychosocial phenomenon on the AURAH questionnaire. Measurement error may have affected 
the estimated strength of the associations and as a result, the relative magnitude of one 
association versus another. However, it is reassuring that similar associations were found in 
other studies which investigated measures of self-efficacy for sexual safety. 
 
6.4.7 Summary of discussion 
Presented in this chapter is the first SEM to investigate a conceptual model of hypothesized 
causal links between socio-demographic, psychosocial, and sexual behaviour measures among 
sexual minority men. It is also the first analysis in the UK to investigate possible mechanisms of 
effect for the relationship between depressive symptoms and sexual risk behaviour. Findings 
support evidence from three studies (Project MIX 
(362)
, study of Cape Town MSM 
(699)
, the 
Bareback Project 
(346)
) that depressive symptoms are associated with CLS indirectly via low self-
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efficacy for sexual safety. Findings from AURAH also suggest that depressive symptoms may 
additionally be associated with CLS indirectly via higher levels of recreational drug use- albeit to 
a lesser extent, since low self-efficacy for sexual safety appears to be a more ‘important’ factor 
leading to CLS. 
 
Using Poisson regression models in the previous chapter, recreational drug use was 
consistently associated with CLS measures, in line with that found in other high-income country 
studies of MSM. In addition, using SEM in this chapter, younger age was associated with CLS 
indirectly via a greater tendency to be ‘out’ with one’s sexual orientation, be active on the gay 
scene and be using higher levels of recreational drugs.  
 
Using Poisson regression models in the previous chapter, younger age, non-university degree 
education, financial insecurity, lower levels of a supportive network, and greater number of 
recreational drugs used were strongly associated with depressive symptoms, in line with that 
found in other high-income country studies of MSM. In addition, using SEM in this chapter, the 
type of depressive symptoms reported by men who engaged in chemsex-drug use and men 
who did not was found to differ. Furthermore, although a sexual minority status may be 
stressful, findings from the SEM suggest that higher levels of disclosure of one’s sexual 
orientation may be protective against mental health problems. Concealment of sexual identity 
was found to be associated with depression indirectly through less frequent visits to gay venues 
and lower levels of a supportive network. At the same time, however, less frequent visits to gay 
venues was also found to be associated with less depression indirectly through lower levels of 
recreational drug use. Younger age was found to be associated with higher levels of 
recreational drug use via less concealment of sexual identity and more frequent visits to gay 
venues. Finally, findings also suggest that being in an ongoing relationship with a partner may 
lead to higher or lower levels of depressive symptoms, depending on the reported level of 
support from other individuals in one’s life. A supportive network may be the most ‘important’ 
factor for depression, alongside socio-economic disadvantage.  
 
The implications of these complex pathways for possible intervention are discussed in the final 
conclusion chapter of this thesis. 
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7 Prevalence of depressive symptoms and associated factors among gay, bisexual, 
and other men who have sex with men in the PROUD trial 
 
7.1 Introduction  
 
The PROUD trial enrolled HIV-negative men who reported CLS in the previous three months 
and were of the opinion that they would have CLS in the next three months. In order to measure 
depressive symptoms, the PHQ-9 scale was incorporated into the baseline and annual 
questionnaires. It was of interest in this thesis to see whether an investigation of depressive 
symptoms on PHQ-9 among men in the PROUD trial would elicit similar findings to the AURAH 
study, given the somewhat differing behavioural profiles of these studies. As a longitudinal 
study, PROUD also provides the opportunity to investigate changes in depression prevalence 
over time. Furthermore, unlike in AURAH, as part of the annual PROUD questionnaire, 
psychosocial data, including that on internalized homophobia, age at anal sex debut (sex at a 
very young age may include experiences of childhood sexual abuse [CSA]), and intimate 
partner violence (IPV), was collected. Therefore, PROUD additionally allows an investigation 
into the association between a marker of internalized homophobia, a very young age at anal sex 
debut, and IPV with depressive symptoms, factors which are considered to be of importance 
with regards to mental health among sexual minority men. The aim of this chapter was to 
investigate the prevalence of depressive symptom measures on PHQ-9 and socio-
demographic, lifestyle, and psychosocial factors associated with depressive symptoms across 
study time-points in the PROUD trial.  
 
7.2 Statistical methods 
 
A detailed description of the variables investigated for analyses presented in this Chapter is 
included in Chapter 3 section 3.3.6. 
 
The prevalence of each individual PHQ-9 symptom is presented for PROUD participants at 
baseline, month-12 and month-24. The prevalence of depressive symptoms according to PHQ-
9 criteria (≥10, major depressive syndrome, major and other depressive syndromes [including 
major depression and dysthymia] and suicidal ideation) was investigated in each PROUD trial 
arm and time-point. Prevalence was compared across trial arms at each time-point using χ
2 
tests and across time-points using McNemar’s χ
2 
test to account for correlated responses. The 
prevalence of antidepressant use at baseline was also assessed (see section 3.3.7.1). In order 
to more accurately present the prevalence of men with depression who were receiving 
antidepressant medication, men with either depressive symptoms (PHQ-9≥10) or who reported 
Chapter 7 
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antidepressant use at baseline were considered to account for all men with any evidence of 
current depression at baseline, since treatment in the absence of symptoms may indicate 
successfully treated depression.  
 
The cross-sectional association of socio-demographic and lifestyle factors (see section 3.3.10) 
with depressive symptoms (PHQ-9≥10) at baseline was assessed using χ
2 
tests, χ
2
 tests for 
trend, and Fisher’s exact test (when expected numbers were small) for univariable analysis, and 
modified Poisson regression with a robust variance estimator in order to produce adjusted 
prevalence ratios 
(645)
. Associations were adjusted for key socio-demographic factors (see 
section 3.6.8). The cross-sectional association of psychosocial factors with depressive 
symptoms (PHQ-9≥10) at the 12- and 24-month questionnaires was assessed using χ
2 
tests, χ
2
 
tests for trend, and Fisher’s exact test. Adjusted associations were not investigated since many 
psychosocial measures had very small cell counts. 
 
Poisson GEEs were also used in this Chapter (see section 3.6.7) to assess the cross-sectional 
association of factors with depressive symptoms, including all data points from the baseline, 12- 
and 24-month questionnaire, allowing for correlation between responses across time-points for 
each individual. The main advantage of this approach is that power is increased, as all data 
points are utilised in a single model. In GEE models, depressive symptoms (PHQ-9≥10) were 
investigated as the main time-varying dependent variable. For a description of the way in which 
values at each time-point were used for independent variables in GEE models, see section 
3.6.8. Associations are presented unadjusted and adjusted for key socio-demographic factors 
(see section 3.6.8); including study time-point due to the observed change in depressive 
symptom prevalence over time in PROUD. A sensitivity analysis was undertaken using different 
PHQ-9-based definitions of depressive symptoms (major depressive syndrome and major and 
other depressive syndromes) as time-varying dependent variables in GEE models.  
 
The final section of this chapter was dedicated to assessing the association of factors with the 
change in prevalence of depressive symptoms from baseline to the 12-month questionnaire. 
Four analyses were performed. In the first analysis, unadjusted associations between socio-
demographic, lifestyle, and psychosocial factors with change in depression scores from 
baseline to the 12-month questionnaire were investigated. The distribution of change in 
depression scores was approximately normal, it was therefore decided that comparing mean 
change scores between groups was appropriate and had more interpretative value than 
medians. A two-sample t-test, specifying unequal variances where necessary, was performed. 
In the second analysis, unadjusted associations between socio-demographic, lifestyle, and 
psychosocial factors with incidence of depressive symptoms (PHQ-9≥10) at the 12-month 
questionnaire among men who scored <10 on the PHQ-9 at baseline, were investigated. 
Associations were assessed using χ
2 
tests, χ
2
 tests for trend, and Fisher’s exact test. During the 
process of discussing findings with the PROUD study team, it became apparent that after the 
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enrolment date of April 2013, participants were asked to disclose their response to the suicidal 
ideation question on the PHQ-9 (‘Thoughts that you would be better off dead, or of hurting 
yourself in some way’) to their enrolling clinician. This was as a result of one man taking his life 
during the course of study. Due to this change in reporting policy, in the third analysis, it was 
examined whether the prevalence of suicidal ideation and depressive symptoms (PHQ-9≥10) 
changed significantly after April 1
st
 2013. 
 
Finally, given the findings of this chapter and the common practice of Patient and Public 
Involvement (PPI) in aiding the interpretation of PROUD findings, a short PPI survey was 
designed and distributed to PROUD participants. The survey presented key findings and asked 
participants to help us interpret the data through the lens of their experience. The advantage of 
being able to ask participants to give their views on study results is that they are able to 
comment having had direct experience of being enrolled in the study and using PrEP. The link 
to the PPI survey (via survey monkey) was incorporated into an email, which explained the 
findings and the purpose of the survey, see Appendix section 11.19 Textbox 7, and was sent to 
all PROUD participants who voluntarily signed up to the mailing list (N=157; 28.9%). The survey 
asked for comments on different sets of findings, see Appendix 11.19 Textbox 8; the first 
concerned the change in prevalence of depressive symptoms over the first year of the study, 
and the final two concerned the relationship found between depressive symptoms and 
measures of sexual behaviour. The latter two questions will be presented and described in 
detail in Chapter 8. A thematic analysis approach was used to analyse and summarize PPI 
responses. A thematic analysis method involves sorting each response into different groups 
(numerically coded) that more succinctly describe the data. The different codes are then 
analysed and themes/patterns are searched for, whereby a theme should reflect some level of 
meaning and (preferably) pattern within the data in relation to the research question 
(702)
. 
Eventually, the different codes are sorted into overarching themes and sub-themes. In this 
analysis, the themes were identified within the explicit meaning of the data, without looking 
beyond what the participant had written, often referred to as a semantic approach. The social 
science lead of the PROUD trial, Dr Gafos, independently reviewed the participants’ responses 
and checked whether the codes, themes, and sub-themes suggested appeared appropriate. 
Any discrepancies were discussed and resolved by Dr Gafos and myself. After the responses 
had been organised to show themes and sub-themes in the semantic content of the data, these 
themes were summarized and an attempt was made to theorise the significance and 
implications of the themes. The purpose of PPI is not to ascertain responses that are 
representative of all men who participated in PROUD, but to add to the researcher’s perspective 
when interpreting findings.  
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7.3 Results 
 
7.3.1 Prevalence of depressive symptom measures across trial arms and time-points 
Table 19 presents the prevalence of the nine depressive symptoms on PHQ-9 for each time-
point. The proportion of individuals who did not respond to each question is presented as a 
footnote under Table 19. As described in section 3.3.11 of Chapter 3, missing responses were 
considered to indicate that the symptom was not present. Identical to that reported in the 
AURAH study (Table 3), the most commonly experienced symptom, for at least several days 
over the past two weeks, was ‘feeling tired or having little energy’, followed by ‘trouble falling or 
staying asleep, or sleeping too much’, and ‘feeling down, depressed, or hopeless’, for all time-
points.  
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Table 19: Prevalence of PHQ-9 depressive symptoms in PROUD 
 Baseline [N=540] Month-12 [N=410] Month-24 [N=333] 
 Not at 
all
a
 
% 
Several 
days 
% 
> half 
the days 
% 
Nearly 
every 
day 
% 
Not at 
all
a
 
% 
Several 
days 
% 
> half 
the days 
% 
Nearly 
every 
day 
% 
Not at 
all
a
 
% 
Several 
days 
% 
> half 
the days 
% 
Nearly 
every 
day 
% 
PHQ-9 1) Little interest or 
pleasure in doing things 
70.2% 
 
23.7% 
 
3.9% 
 
2.2% 
 
66.1% 
 
23.2% 
 
7.3% 
 
3.4% 
 
66.4% 23.7% 5.4% 4.5% 
PHQ-9 2) Feeling down, 
depressed, or hopeless 
66.7% 
 
25.7% 
 
5.4% 
 
2.2% 
 
60.7% 
 
28.8% 
 
6.6% 
 
3.9% 
 
61.3% 27.9% 6.0% 4.8% 
PHQ-9 3) Trouble falling or 
staying asleep, or sleeping too 
much 
54.8% 
 
31.1% 
 
9.1% 
 
5.0% 
 
47.8% 
 
35.4% 
 
10.5% 
 
6.3% 
 
49.3% 31.8% 11.7% 7.2% 
PHQ-9 4) Feeling tired or having 
little energy 
51.5% 
 
39.3% 
 
5.7% 
 
3.5% 
 
47.3% 
 
38.5% 
 
10.2% 
 
3.9% 
 
42.6% 41.1% 8.4% 7.8% 
PHQ-9 5) Poor appetite or 
overeating 
73.2% 
 
20.4% 
 
3.7% 
 
2.8% 
 
66.3% 
 
20.5% 
 
9.0% 
 
4.2% 
 
69.1% 18.6% 7.8% 4.5% 
PHQ-9 6) Feeling bad about 
yourself-or that you are a failure 
or have let yourself or your family 
down 
70.6% 
 
19.4% 
 
7.6% 
 
 
2.4% 
 
67.3% 
 
22.7% 
 
4.6% 
 
5.4% 
 
68.2% 20.7% 6.0% 5.1% 
PHQ-9 7) Trouble concentrating 
on things, such as reading the 
newspaper or watching television 
78.3% 
 
14.3% 
 
4.3% 
 
3.2% 
 
68.8% 
 
21.0% 
 
5.9% 
 
4.4% 
 
70.0% 19.8% 5.7% 4.5% 
PHQ-9 8) Moving or speaking so 
slowly that other people could 
have noticed/being so restless 
that it is hard to sit still 
89.1% 
 
8.0% 
 
1.9% 
 
1.1% 
 
84.6% 
 
9.8% 
 
3.4% 
 
2.2% 
 
87.4% 8.4% 2.1% 2.1% 
PHQ-9 9) Thoughts that you 
would be better off dead, or of 
hurting yourself in some way 
89.1% 
 
8.5% 
 
1.7% 
 
0.7% 
 
88.8% 
 
6.8% 
 
2.9% 
 
1.5% 
 
84.4% 11.7% 1.8% 2.1% 
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In PROUD, among the 540 men at baseline, the prevalence of depressive symptoms (PHQ-
9≥10) was 9.1% (49/540). Among the 410 men at the 12-month questionnaire, the prevalence 
was 14.4% (59/410), and among the 333 men at the 24-month questionnaire, the prevalence 
was also 14.4% (48/333). The prevalence of depressive symptoms did not differ significantly 
between men who were randomized to immediate PrEP and men who were randomized to 
deferred PrEP, at any time-point, see Figure 20. There was also no difference in the prevalence 
of depressive symptoms at the 12-month questionnaire between men who were prescribed 
PrEP before the 12-month questionnaire visit (includes all men in the immediate arm and 25 
men in the deferred arm) and men who were not (15.8% vs. 12.4%; Pearson χ
2
 test p=0.343). 
 
Figure 20: Prevalence of depressive symptoms (PHQ-9≥10) by trial arm and timepoint, 
among all men with data at each time-point in PROUD 
 
 
 
Among the 410 men who completed the 12-month questionnaire, the prevalence of depressive 
symptoms increased significantly from baseline to month-12, see Figure 21. Of the 38 men 
(9.3%) who reported depressive symptoms at baseline, 57.9% (n=22) also reported depressive 
symptoms at the 12-month questionnaire (i.e. persistent depressive symptoms). Of the 372 men 
who did not report depressive symptoms at baseline, 37 (10.0%) reported depressive symptoms 
at the 12-month questionnaire. 
 
Among the 333 men who completed the 24-month questionnaire, the prevalence increased 
significantly from baseline to month-24. Among the 307 men who completed the 12- and 24-
10.6% 
7.5% 
16.7% 
11.9% 
16.5% 
11.9% 
0%
5%
10%
15%
20%
25%
Baseline [N=540]                      12-month follow-up [N=410]                  24-month follow-up [N=333] 
p=0.205 
p-value by Pearson χ
2 
test 
p=0.166 p=0.238 
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month questionnaire, the prevalence of depressive symptoms was not significantly different 
between month-12 and 24, see Figure 21. 
 
Figure 21: Changes in prevalence of depressive symptoms (PHQ-9≥10) over time among 
men with data at both time-points (randomized groups are combined) in PROUD 
 
The prevalence of a major depressive syndrome on PHQ-9 was 5.0% at baseline, 9.0% at the 
12-month questionnaire, and 8.7% at the 24-month questionnaire. The prevalence of major 
depression was not significantly different across trial arms at any time-point, see Table 20. The 
pattern of increase over time in depressive symptoms, was also observed for the measure of 
major depressive syndrome on PHQ-9, see Table 21. The prevalence of major and other 
depressive syndromes on PHQ-9 was 8.9% at baseline, 12.4% at the 12-month questionnaire, 
and 8.7% at the 24-month questionnaire. The prevalence of major and other depressive 
syndromes on PHQ-9 did not differ significantly across trial arms at any time-point, see Table 
20. Although prevalence for this measure tended to be higher at month-12- and 24 compared to 
baseline, the changes were not statistically significant, see Table 21.  
 
The prevalence of suicidal ideation on PHQ-9 was 10.9% at baseline, 11.2% at the 12-month 
questionnaire, and 15.6% at the 24-month questionnaire. The prevalence of suicidal ideation 
was significantly higher among men in the immediate PrEP arm than men in the deferred PrEP 
arm at the 12-month questionnaire, but this was not the case at the 24-month questionnaire, 
see Table 20. Among the 307 men who completed the 12- and 24-month questionnaires, the 
prevalence of suicidal ideation increased significantly from month-12 to 24, see Table 21. When 
investigating whether the prevalence of suicidal ideation increased significantly from the 12-
9.3% 
14.4% 
9.6% 
14.4% 
14.0% 14.7% 
0%
5%
10%
15%
20%
25%
p-value by McNemar’s χ2 test 
p=0.004 p=0.036 
p=0.789 
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month questionnaire to the 24-month questionnaire among men in the immediate PrEP arm and 
men in the deferred PrEP arm separately, suicidal ideation increased significantly at month-24 
in the deferred arm (McNemar’s χ
2 
test p=0.012) but not in the immediate arm (McNemar’s χ
2 
test p=0.297). The prevalence of depressive symptoms according to categories of severity is 
presented in Table 20 and Table 21. 
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Table 20: Prevalence of other PHQ-9 depression measures across trial arms among all men with data at each time-point in PROUD 
 Baseline [N=540] 12-month [N=410] 24-month [N=333] 
 Immediate 
[N=273] 
n (%) 
 
Deferral 
[N=267] 
n (%) 
 
p-value
a
 Immediate 
[N=216] 
n (%) 
Deferral 
[N=194] 
n (%) 
 
p-value
a
 Immediate 
[N=182] 
n (%) 
 
Deferral 
[N=151] 
n (%) 
 
p-value
a
 
Depression severity: 
None/minimal 
Mild 
Moderate 
Moderately severe 
Severe 
 
198 (72.5%) 
46 (16.9%) 
14 (5.1%) 
11 (4.0%) 
4 (1.5%) 
 
203 (76.0%) 
44 (16.5%) 
13 (4.9%) 
5 (1.9%) 
2 (0.8%) 
 
0.559
b
 
 
148 (68.5%) 
32 (14.8%) 
16 (7.4%) 
14 (6.5%) 
6 (2.8%) 
 
134 (69.1%) 
37 (19.1%) 
11 (5.7%) 
6 (3.1%) 
6 (3.1%) 
 
0.404 
 
121 (66.5%) 
31 (17.0%) 
16 (8.8%) 
8 (4.4%) 
6 (3.3%) 
 
103 (68.2%) 
30 (19.9%) 
10 (6.6%) 
5 (3.3%) 
3 (2.0%) 
 
0.796
b
 
Major depressive 
syndrome 
17 (6.2%) 10 (3.8%) 0.186 23 (10.7%) 14 (7.2%) 0.226 20 (11.0%) 
 
9 (6.0%) 0.105 
Major and other 
depressive syndromes 
28 (10.3%) 20 (7.5%) 0.259 31 (14.4%) 20 (10.3%) 0.216 27 (14.8%) 14 (9.3%) 0.124 
Suicidal ideation  33 (12.1%) 26 (9.7%) 0.381 34 (15.7%) 12 (6.2%) 0.002 31 (17.0%) 21 (13.9%) 0.434 
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Table 21: Changes in prevalence of other PHQ-9 depression measures over time among men with data at both time-points (randomized groups are 
combined) in PROUD 
 Baseline 
N=410] 
 
12-month 
[N=410] 
Proportion 
difference 
between 
baseline and 
12-month 
[N=410] 
Baseline 
[N=333] 
24-month 
[N=333] 
Proportion 
difference 
between 
baseline and 
24-month 
[N=333] 
12-month 
[N=307] 
24-month 
[N=307] 
Proportion 
difference 
between 12- 
and 24-
month 
[N=307] 
 n (%) 
 
n (%) 
 
p-value
a
 n (%) 
 
n (%) 
 
p-value
a
 n (%) 
 
n (%) 
 
p-value
a
 
Depression 
severity: 
None/minimal 
Mild 
Moderate 
Moderately severe 
Severe 
 
 
301 (73.4%) 
71 (17.3%) 
22 (5.4%) 
12 (2.9%) 
4 (1.0%) 
 
 
282 (68.8%) 
69 (16.8%) 
27 (6.6%) 
20 (4.9%) 
12 (2.9%) 
/  
 
241 (72.3%) 
60 (18.0%) 
18 (5.4%) 
10 (3.0%) 
4 (1.2%) 
 
 
224 (67.2%) 
61 (18.3%) 
26 (7.8%) 
13 (3.9%) 
9 (2.7%) 
/  
 
210 (68.4%) 
54 (17.6%) 
22 (7.2%) 
13 (4.2%) 
8 (2.6%) 
 
 
206 (67.1%) 
56 (18.2%) 
23 (7.5%) 
13 (4.2%) 
9 (2.9%) 
/ 
Major depressive 
syndrome 
20 (4.9%) 37 (9.0%) 0.004 16 (4.8%) 29 (8.7%) 0.024 27 (8.8%) 29 (9.5%) 0.739 
Major and other 
depressive 
syndromes 
38 (9.3%) 51 (12.4%) 
 
0.085 34 (10.2%) 41 (12.3%) 0.336 40 (13.0%) 39 (12.7%) 0.886 
Suicidal ideation  44 (10.7%) 46 (11.2%) 0.777 39 (11.7%) 52 (15.6%) 0.102 33 (10.8%) 49 (16.0%) 0.014 
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7.3.2 Receiving antidepressant medication at baseline 
Overall, the proportion of men who reported antidepressant use at baseline was 8.5% (46/540). 
Antidepressant use was reported by 20.4% (n=10) of the 49 men with depressive symptoms 
(PHQ-9≥10) and 7.3% (n=36) of the 491 men without. Among the 85 men with any evidence of 
current depression (PHQ-9≥10 and/or receiving antidepressant medication), 54.1% (n=46) were 
receiving antidepressant medication. 
 
7.3.3 Prevalence of other psychosocial factors 
The prevalence of socio-demographic factors at baseline is described in Chapter 3 section 
3.2.4.1 and is presented below in Table 22. The prevalence of lifestyle/psychosocial factors is 
presented in Table 23 and Table 24. Of the 540 men at baseline (Table 23), 72.5% reported 
recent recreational drug use; the prevalence of reporting 0, 1, 2-4, or 5 or more recreational 
drugs in the past three months was 27.4%, 16.1%, 29.4%, and 27.0% respectively. The 
prevalence of chemsex-associated drug use was 42.8%. Higher-risk alcohol consumption was 
reported by 32.0% of men. Of the 410 men who completed the 12-month questionnaire (Table 
24), the prevalence of sexualized drug use (see section 3.3.10) was 54.6%. The prevalence of 
anal sex debut with a male before the age of 13 years was 5.6%. In total, the prevalence of any 
IPV victimization and perpetration was 44.9% and 19.5% respectively. Overall, the prevalence 
of reporting negative views about gay sexuality, taken as a marker of internalized homophobia, 
was 41.7%. Finally, 48.4% of men reported having disclosed their sexual orientation to all or 
almost all of their close family, friends, and work colleagues, whereas, 2.3% reported having 
disclosed to few or none of these individuals. Similar proportions were observed among the 333 
men who completed the 24-month questionnaire (Table 24). 
 
7.3.4 Association of socio-demographic and lifestyle factors with depressive symptoms (PHQ-
9≥10) at baseline 
Table 22 presents the unadjusted and adjusted associations of socio-demographic factors with 
depressive symptoms at baseline. In unadjusted analysis, younger men (particularly those aged 
<25) and those who did not report being employed were more likely to report depressive 
symptoms. There was also some evidence that the prevalence of depressive symptoms was 
higher among men who reported not being in an ongoing relationship compared to men who 
did. Adjusting for key socio-demographic factors, younger age and not being employed 
remained associated with depressive symptoms. In adjusted analysis, the association between 
on-going relationship status and depressive symptoms was attenuated. 
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Table 22: Unadjusted and adjusted associations of socio-demographic factors
h
 with depressive symptoms at baseline in PROUD 
N=540 men at baseline   Depressive symptoms (PHQ-9≥10) 
   N (%) %  p-value
b
 Unadjusted 
PR [95% CI] 
p-value
e
 
Adjusted
f
 
PR [95% CI] 
p-value
e
 
Age 
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
22.2% 
8.3% 
12.3% 
6.2% 
3.7% 
6.1% 
0.003 
0.002
c
 
3.63 [1.44, 9.13] 
1.36 [0.49, 3.78] 
2.01 [0.80, 5.02] 
1.01 [0.34, 3.03] 
0.60 [0.16, 2.35] 
1 
0.006 
0.003
c
 
3.49 [1.38, 8.84] 
1.25 [0.44, 3.54] 
1.95 [0.76, 5.01] 
1.01 [0.33, 3.09] 
0.60 [0.15, 2.40] 
1 
0.007 
0.006
 c
 
Born in the UK and white ethnicity Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
9.1% 
14.3% 
6.6% 
12.5% 
0.315
d
 1 
1.58 [0.65, 3.84] 
0.73 [0.36, 1.47] 
1.38 [0.65, 2.91] 
0.368 
1 
1.05 [0.48, 2.32] 
0.75 [0.35, 1.60] 
1.38 [0.61, 3.10] 
0.635 
Self-reported sexual identity
g
 Gay 
Bisexual 
Straight 
513 (95.7%) 
17 (3.2%) 
6 (1.1%) 
9.0% 
13.0% 
0.457
 d
 1 
1.45 [0.49, 4.33] 
0.501 
1 
1.35 [0.53, 3.44] 
0.524 
University Education Yes 
No/missing
a
 
327 (60.6%) 
213 (39.4%) 
8.9% 
9.4% 
0.837 1 
1.06 [0.61, 1.82] 
0.837 
1 
0.93 [0.53, 1.64] 
0.799 
Employed Yes 
No/missing
a
 
439 (81.3%) 
101 (18.7%) 
6.8% 
18.8% 
<0.001 1 
2.75 [1.62, 4.69] 
<0.001 
1 
2.44 [1.36, 4.37] 
0.003 
Ongoing relationship Yes 
No/missing
a
 
246 (45.6%) 
294 (54.4%) 
6.5% 
11.2% 
0.057 1 
1.73 [0.97, 3.06] 
0.062 
1 
1.56 [0.89, 2.75] 
0.121 
Study region London 
Outside London 
375 (69.4%) 
165 (30.6%) 
9.3% 
8.5% 
0.752 1 
0.91 [0.50, 1.64] 
0.753 
1 
0.81 [0.41, 1.60] 
0.541 
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Table 23 presents the unadjusted and adjusted associations of lifestyle factors with depressive 
symptoms at baseline. Depressive symptoms were not associated with higher-risk drinking, 
number of recreational drugs used in the past three months, or chemsex-associated drug use. 
There does, however, appear to be a pattern in terms of report of the number of recreational 
drugs used, whereby men who reported no drug use and men who reported five or more drugs 
used, had a higher prevalence of depressive symptoms compared to men reporting 1and 2-4 
drugs. When investigating whether the individual recreational drugs asked about in PROUD 
were associated with depressive symptoms (see section 3.3.10), men who reported crystal 
methamphetamine use in the past three months were more likely to report depressive 
symptoms than men who did not (15.3% versus 7.7%; p=0.018). This was the only drug found 
to be associated with depressive symptoms. This association remained after adjustment for key 
socio-demographic factors (PR 2.02 95% CI: 1.11, 3.66; p=0.021).
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Table 23: Unadjusted and adjusted associations of lifestyle factorsg with depressive symptoms at baseline in PROUD 
N=540 men at baseline   Depressive symptoms (PHQ-9≥10) 
   N (%) %  p-value
b
 Unadjusted 
PR [95% CI] 
p-value
e
 
Adjusted
f
 
PR [95% CI] 
p-value
e
 
Higher-risk drinking Yes 
No/missing
a
 
173 (32.0%) 
367 (68.0%) 
10.4% 
8.5% 
0.460 1.23 [0.71, 2.14] 
1 
0.460 
1.18 [0.65, 2.13] 
1 
0.591 
Recreational drug use (past 3 months) 0/missing
a
 
1 
2-4 
5+ 
148 (27.4%) 
87 (16.1%) 
159 (29.4%) 
146 (27.0%) 
10.1% 
4.6% 
6.9% 
13.0% 
0.114 
0.399
 c
 
 
1 
0.45 [0.16, 1.32] 
0.68 [0.32, 1.44] 
1.28 [0.68, 2.43] 
0.133 
0.445
c
 
1 
0.48 [0.17, 1.32] 
0.76 [0.34, 1.69] 
1.33 [0.70, 2.50] 
0.151 
0.362
 c
 
Chemsex-associated  drug use No 
Yes 
309 (57.2%) 
231 (42.8%) 
 
8.1% 
10.4% 
0.357 1 
1.28 [0.75, 2.19] 
0.359 
1 
1.33 [0.77, 2.27] 
0.304 
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7.3.5 Association of psychosocial factors with depressive symptoms at the 12- and 24-month 
questionnaire 
Table 24 presents the unadjusted associations of psychosocial factors with depressive 
symptoms (PHQ-9≥10) at the 12- and 24-month questionnaires. Men who reported having 
experienced fear of, emotional abuse or control from, physical violence, and sexual abuse from 
an intimate partner, and perhaps specifically from a former partner within the past year, were 
more likely to report depressive symptoms at both month-12 and 24, compared to those who 
had not had such experiences. Although the numbers are extremely small, some of these 
proportions are quite striking. For instance, at both months 12 and 24, of the men who said they 
had been ‘hit, slapped, kicked or otherwise physically hurt’ by a former partner within the past 
year, about 40% reported depressive symptoms. When investigating the composite measure of 
any IPV victimization, at both months 12 and 24, men who reported ever having been a victim of 
partner abuse were twice as likely to report clinically significant depressive symptoms. The 
difference in prevalence of depressive symptoms was even greater when comparing men who 
reported any IPV victimization in the past year to those who did not. 
 
The proportion of men reporting depressive symptoms is again striking among those who 
indicated having behaved in a way that has made a former partner within the past year feel 
frightened, at 61.5% at month-12 and 40.0% at month-24. The remaining IPV perpetration 
questions were not associated with depressive symptoms, although a borderline association 
was observed between ‘asking a partners’ permission’ and depressive symptoms at month-12. 
It was not possible to investigate questions concerning sexual IPV perpetration, given that only 
one man across both time-points gave a response other than never. When investigating the 
composite measure of any IPV perpetration (emotional/psychological and/or physical) at both 
months 12 and 24, men who reported ever having been a perpetrator of partner abuse were 
almost three times as likely to report depressive symptoms. The difference in prevalence of 
depressive symptoms was again greater when considering any IPV perpetration in the past 
year.  
 
When examining the series of statements about attitudes towards one’s sexuality, the 
proportion of men reporting depressive symptoms was higher among men who indicated a more 
negative attitude towards gay sexuality than those who did not at the 12-month questionnaire. 
For instance, almost half of men who disagreed with the statement that they feel comfortable 
being a transgender/gay man reported depressive symptoms. When investigating a composite 
measure of these statements, depressive symptom prevalence was twice as high among men 
who indicated internalised homophobia compared to men who did not at the 12-month 
questionnaire (21.6% vs. 9.2%). A similar pattern was observed at the 24-month questionnaire, 
though differences tended to be somewhat smaller and not statistically significant.  
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Measures of sexual orientation disclosure to family, friends, and work colleagues were not 
associated with depressive symptoms at the 12-month questionnaire. However, a lower level of 
disclosure to work colleagues was associated with depressive symptoms at month-24, and a 
significant trend was also observed for lower levels of disclosure to friends. At the 24-month 
questionnaire, men who reported that they were not ‘out’ to all or almost of their friends, work 
colleagues, and close family, reported a depressive symptom prevalence twice that of men who 
did report being ‘out’ to all or almost all of these individuals.  
 
Sexualized drug use was not associated with depressive symptoms at the 12- or 24-month 
questionnaire. Anal sex debut with a male, before age 15 years and 13 years, as well as the 
time from any sexual contact to intercourse with a male, was not associated with depressive 
symptoms at month-12 or 24. Age at first anal intercourse as a continuous variable was also 
investigated in a Poisson model with depressive symptoms- there was no association at the 12-
month (PR 0.99 95% CI: 0.94, 1.04) or 24-month questionnaire (PR 1.01 95% CI: 0.97, 1.05). 
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Table 24: Unadjusted associations of psychosocial factorsg with depressive symptoms at 
the 12- and 24-month questionnaire in PROUD 
  12-month [N=410] 24-month [N=333] 
   N (%) % 
PHQ-9≥10 
p-value
 a
 
N (%) % 
PHQ-9≥10 
p-value
 a
 
Sexualized drug 
use  
(past 3 months) 
Yes 
No 
224 (54.6%) 
186 (45.4%) 
15.2% 
13.4% 
0.618 
159 (47.8%) 
174 (52.3%) 
17.6% 
11.5% 
0.112 
Age≤15 years at 
anal sex debut   
Yes 
No 
88 (22.3%) 
307 (77.7%) 
19.3% 
13.4% 
0.164 
70 (21.8%) 
251 (78.2%) 
15.7% 
14.3% 
0.774 
Age<13 years at 
anal sex debut 
Yes 
No 
22 (5.6%) 
373 (94.4%) 
9.1% 
15.0% 
0.755
c
 
19 (5.9%) 
302 (94.1%) 
10.5% 
14.9% 
0.601
c
 
Time between 
any sexual 
contact and 
intercourse with a 
male 
Same time 
1-2 years 
3-4 years 
5+ years 
163 (41.3%) 
90 (22.8%) 
47 (11.9%) 
95 (24.1%) 
15.3% 
11.1% 
19.2% 
14.7% 
0.632 
0.894
b
 
146 (45.5%) 
67 (20.9%) 
33 (10.3%) 
75 (23.4%) 
13.0% 
10.5% 
18.2% 
20.0% 
0.347 
0.133
b
 
Frightened of the 
behaviour of a 
partner 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
237 (60.6%) 
104 (26.6%) 
29 (7.4%) 
21 (5.4%) 
11.0% 
14.4% 
37.9% 
28.6% 
0.001
c
 
209 (65.1%) 
71 (22.1%) 
20 (6.2%) 
21 (6.5%) 
9.6% 
16.9% 
25.0% 
47.6% 
<0.001
c
 
Needed to ask a 
partner’s 
permission (for 
work, shopping, 
visit relatives/ 
friends) 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
347 (88.1%) 
30 (7.6%) 
9 (2.3%) 
8 (2.0%) 
13.3% 
26.7% 
33.3% 
25.0% 
0.041
c
 
286 (89.1%) 
26 (8.1%) 
3 (0.9%) 
6 (1.9%) 
14.0% 
11.5% 
66.7% 
33.3% 
0.057
c
 
Been physically 
hurt by a partner 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
 
297 (75.6%) 
72 (18.3%) 
10 (2.5%) 
14 (3.6%) 
12.1% 
20.8% 
40.0% 
28.6% 
0.010
 c
 
244 (76.3%) 
54 (16.9%) 
13 (4.1%) 
9 (2.8%) 
11.1% 
16.7% 
38.5% 
55.6% 
<0.001
 c
 
Forced to have 
sex/ engage in 
some sexual 
activity 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
329 (83.9%) 
52 (13.3%) 
8 (2.0%) 
3 (0.8%) 
12.2% 
28.9% 
25.0% 
0.0% 
0.013
c
 
270 (84.6%) 
35 (11.0%) 
8 (2.5%) 
6 (1.9%) 
12.6% 
22.9% 
37.5% 
33.3% 
0.030
c
 
Forced to have 
sex without a 
condom  
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
356 (90.4%) 
32 (8.1%) 
6 (1.5%) 
0 (0.0%) 
12.6% 
37.5% 
33.3% 
/ 
0.001
c
 
295 (92.1%) 
22 (6.9%) 
3 (0.9%) 
0 (0.0%) 
13.6% 
22.7% 
66.7% 
/ 
0.019
c
 
Any IPV 
victimization 
No/missing
d
 
Yes 
226 (55.1%) 
184 (44.9%) 
8.4% 
21.7% 
<0.001 
199 (59.8%) 
134 (40.2%) 
9.6% 
21.6% 
0.002 
Any IPV 
victimization in 
the past year 
No/missing
d
 
Yes 
346 (84.4%) 
64 (15.6%) 
11.6% 
29.7% 
<0.001 
284 (85.3%) 
49 (14.7%) 
10.6% 
36.7% 
<0.001 
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Table 24: Unadjusted associations of psychosocial factors
g
 with depressive symptoms at 
the 12- and 24-month questionnaire in PROUD (continued) 
  12-month [N=410] 24-month [N=333] 
   N (%) % 
PHQ-9≥10 
p-value
 a
 
N (%) % 
PHQ-
9≥10 
p-value
 a
 
Behaved in a 
manner that made a 
partner feel 
frightened 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
333 (85.0%) 
32 (8.2%) 
13 (3.3%) 
14 (3.6%) 
11.7% 
12.5% 
61.5% 
50.0% 
<0.001
c
 
274 (85.6%) 
28 (8.8%) 
5 (1.6%) 
13 (4.1%) 
11.3% 
28.6% 
40.0% 
46.2% 
<0.001
 c
 
Partner needed to 
ask your permission 
to work, go 
shopping, visit 
relatives, or visit 
friends  
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
387 (98.5%) 
2 (0.5%) 
0 (0.0%) 
4 (1.0%) 
14.5% 
50.0% 
/ 
50.0% 
0.058
c
 
317 (98.8%) 
2 (0.6%) 
1 (0.3%) 
1 (0.3%) 
14.5% 
50.0% 
0.0% 
0.0% 
0.471
 c
 
Hit, slapped, kicked 
or otherwise 
physically hurt a 
partner 
Never 
>1 yr ago 
Last yr, former partner 
Last yr, current partner 
346 (87.8%) 
36 (9.1%) 
2 (0.5%) 
10 (2.5%) 
13.6% 
22.2% 
50.0% 
30.0% 
0.078
c
 
280 (87.2%) 
32 (10.0%) 
4 (1.3%) 
5 (1.6%) 
13.9% 
18.8% 
0.0% 
40.0% 
0.276
 c
 
Any IPV 
perpetration
e
 
No/missing
d
 
Yes 
330 (80.5%) 
80 (19.5%) 
10.3% 
31.3% 
<0.001 
273 (82.0%) 
60 (18.0%) 
11.4% 
28.3% 
0.001 
Any IPV 
perpetration in the 
past year 
No/missing
d
 
Yes 
378 (92.2%) 
32 (7.8%) 
11.4% 
50.0% 
<0.001 
310 (93.1%) 
23 (6.9%) 
12.9% 
34.8% 
0.009
c
 
‘Obviously 
effeminate 
homosexual men 
make me feel 
uncomfortable’ 
No
f
 
Yes  
 
326 (79.5%) 
84 (20.5%) 
 
12.9% 
20.2% 
0.087 
262 (78.7%) 
71 (21.3%) 
 
13.4% 
18.3% 
0.292 
‘I feel comfortable in 
gay bars’ 
Yes
f
 
No 
 
370 (90.2%) 
40 (9.8%) 
13.2% 
25.0% 
0.044 
301 (90.4%) 
32 (9.6%) 
12.6% 
31.3% 
0.004 
‘Social situations 
with 
transgender/gay 
men make me feel 
uncomfortable’ 
No
f
 
Yes 
 
383 (93.4%) 
27 (6.6%) 
 
12.5% 
40.7% 
<0.001
c
 
308 (92.5%) 
25 (7.5%) 
 
14.3% 
16.0% 
0.500
c
 
‘I feel comfortable 
being seen in public 
with an obviously 
transgender/gay 
person’ 
Yes
f
 
No 
358 (87.3%) 
52 (12.7%) 
14.0% 
17.3% 
0.521 
287 (86.2%) 
46 (13.8%) 
15.0% 
10.9% 
0.461 
‘I feel comfortable 
discussing 
homosexuality in a 
public situation’ 
Yes
f
 
No  
385 (93.9%) 
25 (6.1%) 
12.5% 
44.0% 
<0.001
c
 
307 (92.2%) 
26 (7.8%) 
13.7% 
23.1% 
0.153
c
 
‘I feel comfortable 
being a 
transgender/gay 
man’ 
Yes
f
 
No  
387 (94.4%) 
23 (5.6%) 
12.4% 
47.8% 
<0.001
c
 
322 (96.7%) 
11 (3.3%) 
14.0% 
27.3% 
0.201
c
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Table 24: Unadjusted associations of psychosocial factors
g
 with depressive symptoms at 
the 12- and 24-month questionnaire in PROUD (continued) 
  12-month [N=410] 24-month [N=333] 
   N (%) % 
PHQ-9≥10 
p-value
 a
 
N (%) % 
PHQ-9≥10 
p-value
 a
 
‘Homosexuality is morally 
acceptable to me’ 
Yes
f
 
No 
404 (98.5%) 
6 (1.5%) 
14.1% 
33.3% 
0.208
 c
 
325 (97.6%) 
8 (2.4%) 
14.2% 
25.0% 
0.324
c
 
‘Even if I could change 
my sexual orientation I 
wouldn’t’ 
Yes
f
 
No 
380 (92.7%) 
30 (7.3%) 
12.6% 
36.7% 
0.001
 c
 
312 (93.7%) 
21 (6.3%) 
13.8% 
23.8% 
0.169
c
 
Any negative views about 
gay sexuality (marker of 
internalised homophobia) 
No/missing
  
Yes
 
 
239 (58.3%) 
171 (41.7%) 
9.2% 
21.6% 
<0.001 
195 (58.6%) 
138 (41.4%) 
11.8% 
18.1% 
0.106 
How many friends know 
you are gay/ transgender/ 
have sex with men 
All/almost all 
Some 
Few 
None 
331 (83.0%) 
51 (12.8%) 
14 (3.5%) 
3 (0.8%) 
14.5% 
15.7% 
14.3% 
33.3% 
0.650
c
 
0.601
b
 
265 (80.8%) 
42 (12.8%) 
18 (5.5%) 
3 (0.9%) 
13.2% 
16.7% 
22.2% 
66.7% 
0.063
c
 
0.032
b
 
How many work 
colleagues know you are 
gay/ transgender/ have 
sex with men 
All/almost all 
Some 
Few 
None 
241 (62.3%) 
89 (23.0%) 
35 (9.0%) 
22 (5.7%) 
12.9% 
19.1% 
17.1% 
18.2% 
0.439
c
 
0.237
b
 
205 (64.5%) 
69 (21.7%) 
23 (7.2%) 
21 (6.6%) 
10.2% 
20.3% 
26.1% 
28.6% 
0.010
c
 
0.002
b
 
How many close family 
know you are gay/ 
transgender/ have sex 
with men 
All/almost all 
Some 
Few 
None 
292 (73.4%) 
56 (14.1%) 
34 (8.5%) 
16 (4.0%) 
12.7% 
19.6% 
23.5% 
18.8% 
0.174
c
 
0.068
b
 
229 (70.0%) 
58 (17.7%) 
26 (8.0%) 
14 (4.3%) 
12.2% 
17.2% 
23.1% 
28.6% 
0.124
c
 
0.025
b
 
‘Out’ to all/almost all 
friends, work colleagues 
and close family 
Yes 
No 
206 (51.6%) 
193 (48.4%) 
12.6% 
17.1% 
0.208 
166 (50.6%) 
162 (49.4%) 
8.4% 
21.0% 
0.001 
‘Out’ to few/no friends, 
work colleagues and 
close family 
Yes 
No 
9 (2.3%) 
390 (97.7%) 
22.2% 
14.6% 
0.627
c
 
9 (2.7%) 
319 (97.3%) 
 
14.7% 
11.1% 
0.611
c
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7.3.6 Association of socio-demographic, lifestyle, and psychosocial factors with depression 
measures on PHQ-9 at baseline and the 12- and 24-month questionnaire 
When investigating the association between socio-demographic factors (assessed at baseline) 
and depressive symptoms (PHQ-9≥10) (using data from baseline, month-12, and month-24), 
540 individuals (at most) and 1283 questionnaire responses were included in GEE models, see 
Table 25. The following factors were found to be associated with depressive symptoms in 
unadjusted analyses and analyses adjusted for socio-demographic factors (including study 
time-point): study time-point (with 50-60% higher prevalence of symptoms at follow-up 
compared to baseline) and not being employed (prevalence of symptoms was twice as high in 
men not employed compared to employed men). Although in unadjusted and adjusted analysis, 
the overall association and test of trend of age with depressive symptoms was not significant, 
there was some evidence of variation according to age. The prevalence of symptoms was lower 
in the 35 to 44 age group compared to all other age groups. There was also some suggestion of 
higher prevalence of symptoms in the small group of men with bisexual/straight identity, though 
not statistically significant in unadjusted or adjusted analysis. When investigating the 
association between psychosocial factors (assessed at month-12 and 24) and depressive 
symptoms, 436 individuals
xxxiv
 and 743 questionnaire responses were included in GEE models, 
see Table 25. The following factors were strongly associated with depressive symptoms in 
unadjusted and adjusted analyses, whereby the prevalence of symptoms was two to three fold 
higher: report of any IPV victimization (including in the past year), report of any IPV perpetration 
(including in the past year), internalised homophobia, and not being ‘out’ to all/almost all friends, 
work colleagues, and family. 
 
In the sensitivity analyses, results were similar when investigating associations with the other 
measures of depressive symptoms on PHQ-9 (a major depressive syndrome and major and 
other depressive syndromes), see Appendix section 11.17 Table 77 and Table 78. In addition, 
younger age was associated with both measures and non-university education was associated 
with major and other depressive syndromes on PHQ-9, in unadjusted and adjusted analysis. 
                                                     
xxxiv
 Twenty-six men completed a 24-month questionnaire but did not complete a 12-month questionnaire. 
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Table 25: Unadjusted and adjusted associations of socio-demographic and psychosocial factors with depressive symptoms using baseline, 12-, 
and 24-month PROUD questionnaire data in GEE models  
     Depressive symptoms (PHQ-9≥10) 
N=540 men  
(using data from baseline and follow-ups 
in GEE models) 
 Baseline  
[N=540] 
n(%) 
12-month  
[N=410]  
n(%) 
24-month  
[N=333] 
n(%) 
Unadjusted 
PR [95% CI] 
 
Overall 
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall p-
value
a
 
Study time-point 
N=540
d
, Obs=1283
e 
; N=536
f
, Obs=1273
g
 
Baseline 
12-month  
24-month  
/ / / 1 
1.57 [1.14, 2.18] 
1.58 [1.12, 2.23] 
0.009 
0.006
 c
 
1 
1.60 [1.15, 2.23] 
1.63 [1.14, 2.32] 
0.007 
0.004
c
 
Randomized to study trial arm  
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Immediate arm 
Deferred arm 
/ 216 (52.7%) 
194 (47.3%) 
182 (54.7%) 
151 (45.4%) 
1.40 [0.92, 2.15] 
1 
0.121 1.44 [0.94, 2.21] 
1 
0.095 
Age 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
27 (6.6%) 
56 (13.7%) 
87 (21.2%) 
78 (19.0%) 
70 (17.1%) 
92 (22.4%) 
11 (3.3%) 
35 (10.5%) 
73 (21.9%) 
66 (19.8%) 
55 (16.5%) 
93 (27.9%) 
1.11 [0.57, 2.15] 
0.87 [0.49, 1.53] 
1.02 [0.62, 1.68] 
0.60 [0.33, 1.09] 
0.39 [0.19, 0.80] 
1 
0.061 
0.374
c
 
1.16 [0.58, 2.31] 
0.94 [0.53, 1.66] 
1.08 [0.66, 1.77] 
0.65 [0.36, 1.18] 
0.40 [0.20, 0.83] 
1 
0.082 
0.318
c
 
Born in the UK and white ethnicity 
N=538
d
, Obs=1279
 e
 ; N=534
f
, Obs=1269
g
 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
223 (54.7%) 
22 (5.4%) 
114 (27.9%) 
49 (12.0%) 
184 (55.3%) 
17 (5.1%) 
88 (26.4%) 
44 (13.2%) 
1 
1.57 [0.80, 3.09] 
0.83 [0.52, 1.34] 
1.26 [0.72, 2.20] 
0.317 1 
1.41 [0.70, 2.83] 
0.83 [0.50, 1.35] 
1.18 [0.66, 2.12] 
0.506 
Self-reported sexual identity 
N=536
d
, Obs=1273
e
 ; N=536
f
, Obs=1273
g
 
Gay 
Bisexual/straight 
513 (95.7%) 
23 (4.3%) 
388 (95.6%) 
18 (4.4%) 
315 (95.2%) 
16 (4.8%) 
1 
1.75 [0.85, 3.59] 
0.130 1 
1.73 [0.84, 3.59] 
0.140 
University Education 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
327 (60.6%) 
213 (39.4%) 
256 (62.4%) 
154 (37.6%) 
204 (61.3%) 
129 (38.7%) 
0.85 [0.58, 1.25] 
1 
0.414 0.86 [0.58, 1.28] 
1 
0.451 
Employed 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
439 (81.3%) 
101 (18.7%) 
332 (81.0%) 
78 (19.0%) 
276 (82.3%) 
57 (17.1%) 
1 
1.89 [1.26, 2.86] 
0.002 1 
1.80 [1.18, 2.77] 
0.007 
Study region 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
London 
Outside London 
375 (69.4%) 
165 (30.6%) 
289 (70.5%) 
121 (29.5%) 
228 (68.5%) 
105 (31.5%) 
1 
0.90 [0.59, 1.37] 
0.610 1 
0.81 [0.52, 1.27] 
0.356 
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Table 25: Unadjusted and adjusted associations of socio-demographic and psychosocial factors with depressive symptoms using baseline, 12-, 
and 24-month PROUD questionnaire data in GEE models (continued) 
     Depressive symptoms (PHQ-9≥10)  
N=540 men  
 
 Baseline  
[N=540] 
n(%) 
12-month  
[N=410]  
n(%) 
24-month  
[N=333] 
n(%) 
Unadjusted 
PR [95% CI] 
Overall  
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall  
p-value
a 
 
Sexualized drug use (past 3 months) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Yes 
No 
/ 224 (54.6%) 
186 (45.4%) 
159 (47.8%) 
174 (52.3%) 
1.38 [0.93, 2.06] 
1 
0.108 1.34 [0.89, 2.00] 
1 
0.157 
Age≤15 years at anal sex debut  
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Yes 
No 
/ 88 (22.3%) 
307 (77.7%) 
70 (21.8%) 
251 (78.2%) 
1.27 [0.80, 2.02] 
1 
0.306 1.20 [0.75, 1.93] 
1 
0.451 
Age<13 years at anal sex debut
 
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Yes 
No 
 
/ 22 (5.6%) 
373 (94.4%) 
19 (5.9%) 
302 (94.1%) 
0.71 [0.26, 1.94] 
1 
0.507 0.71 [0.26, 1.94] 
1 
0.499 
Time between sexual contact and 
intercourse with a male 
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Same time 
1-2 years 
3-4 years 
5+ years 
/ 163 (41.3%) 
90 (22.8%) 
47 (11.9%) 
95 (24.1%) 
146 (45.5%) 
67 (20.9%) 
33 (10.3%) 
75 (23.4%) 
1 
0.74 [0.42, 1.30] 
1.26 [0.69, 2.30] 
1.23 [0.75, 2.00] 
0.373 
0.310
 c
 
1 
0.74 [0.42, 1.31] 
1.24 [0.68, 2.27] 
1.27 [0.77, 2.10] 
0.350 
0.268
 c
 
Any IPV victimization 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 226 (55.1%) 
184 (44.9%) 
199 (59.8%) 
134 (40.2%) 
1 
2.45 [1.63, 3.67] 
<0.001 1 
2.57 [1.71, 3.86] 
<0.001 
Any IPV victimization in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
 g
 
No 
Yes 
/ 346 (84.4%) 
64 (15.6%) 
284 (85.3%) 
49 (14.7%) 
1 
2.82 [1.88, 4.22] 
<0.001 1 
2.93 [1.96, 4.40] 
<0.001 
Any IPV perpetration
 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 330 (80.5%) 
80 (19.5%) 
273 (82.0%) 
60 (18.0%) 
1 
2.83 [1.89, 4.22] 
<0.001 1 
2.87 [1.91, 4.32] 
<0.001 
Any IPV perpetration in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 378 (92.2%) 
32 (7.8%) 
310 (93.1%) 
23 (6.9%) 
1 
3.40 [2.13, 5.41] 
<0.001 1 
3.47 [2.13, 5.64] 
<0.001 
Any negative views about gay sexuality 
(marker of internalised homophobia)
 
N=436
d
, Obs=743
e 
; N=432
f
, Obs=737
g
 
No/missing
  
Yes
 
 
/ 239 (58.3%) 
171 (41.7%) 
195 (58.6%) 
138 (41.4%) 
1 
1.92 [1.30, 2.83] 
0.001 1 
1.91 [1.29, 2.83] 
0.001 
‘Out’ to all/almost all friends, work 
colleagues and close family 
N=434
d
, Obs=727
e 
; N=431
f
, Obs=722
g
 
Yes 
No 
/ 206 (51.6%) 
193 (48.4%) 
166 (50.6%) 
162 (49.4%) 
1 
1.75 [1.17, 2.62] 
0.007 1 
1.75 [1.16, 2.65] 
0.008 
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7.3.7 Factors associated with changes over time in screening positive for clinically significant 
depressive symptoms by PHQ-9:  
7.3.7.1 Factors associated with change in depression scores from baseline to the 12-
month questionnaire 
The distribution of change in PHQ-9 depression score from baseline to the 12-month 
questionnaire is presented in Appendix section 11.18 Figure 34. Change scores were generated 
by subtracting the PHQ-9 depression score at baseline from the score at month-12; a positive 
change score signifies an increase in depressive symptoms over time. Overall, the mean 
change in depression scores was 1 (SD=4.9). The mean change in scores was higher among 
men aged ≥25 years compared to men aged <25 years (1 vs. -2), and among men who reported 
any IPV victimization in the past year (3 vs. 1), any IPV perpetration (2 vs. 0), any IPV 
perpetration in the past year (4 vs. 1), and internalized homophobia (1 vs. 0), compared to men 
who did not, see Appendix section 11.18 Table 79.  
 
7.3.7.2 Factors associated with incidence of clinically significant depressive 
symptoms at the 12-month questionnaire among men with no symptoms at 
baseline 
In total, 372 men did not meet the criteria for moderate, moderately severe, or severe 
depressive symptoms (i.e. scored <10 on the PHQ-9) at baseline. Of these men, 10.0% scored 
10 or more on the PHQ-9 at the 12-month questionnaire. The proportion of men reporting new 
depressive symptoms at month-12 appeared to be significantly higher among men aged 45 
years or older and men who reported anal sex debut with a male at age 15 years or younger, 
although the associations were of borderline significance. Furthermore, men who reported any 
IPV victimization (15.6% vs. 5.7%), any IPV victimization in the past year (25.5% vs. 7.3%), any 
IPV perpetration (22.4% vs. 7.2%), any IPV perpetration in the past year (7.8% vs. 41.7%), and 
internalised homophobia (14.4% vs. 7.1%), appeared to be more likely to report new depressive 
symptoms compared to men who did not, at month-12 in unadjusted analysis, see Appendix 
section 11.18 Table 80.  
 
7.3.7.3 PHQ-9 responses after April 1
st
 2013 
The prevalence of suicidal ideation on PHQ-9 was significantly higher among men who 
completed their baseline questionnaire before April 1
st
 2013 (n=71) compared to men who 
completed their baseline questionnaire on or after April 1
st
 2013 (n=469) (19.7% vs. 9.6%; 
Pearson χ
2 
test p=0.011). Similarly, the prevalence of depressive symptoms (PHQ-9≥10) was 
significantly higher among men who completed their baseline questionnaire before April 1
st
 
2013 (21.1% vs. 7.3%; Pearson χ
2 
test p<0.001). When further investigating whether the 
prevalence of depressive symptoms (PHQ-9≥10) increased significantly from baseline to the 12-
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month questionnaire among (i) the 57 men who completed their baseline questionnaire before 
April 1
st
 2013 and had 12-month data, and (ii) the 353 men who completed their baseline 
questionnaire after April 1
st
 2013 and had 12-month data, there was evidence of an increase 
only for those with baseline completion in the later time period (McNemar’s χ
2 
test p-values 
0.366 and <0.001 respectively). 
 
7.3.8 Participant involvement in the interpretation of findings: summary of PPI responses  
In total, 13 men commented on the finding that depression prevalence increased over the first 
year of the study. The way in which the responses were organised into themes in the semantic 
content of the data is shown in Figure 22. 
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Figure 22: Organization of PROUD PPI responses into codes, themes, and sub-themes 
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Two overarching themes were apparent, the first was that the prevalence of depression was 
found to increase since the amount of men experiencing depression did indeed increase over 
the study and the second was that the increase was found since the amount of men reporting 
rather than experiencing symptoms of depression increased. These views were not necessarily 
exclusive, as some individuals cited the possibility that both factors may explain the findings. 
Within the first theme that depression increased, four sub-themes were identified; structural 
factors, risk-taking, study setting, and experience with PrEP. The second theme that reporting 
depression increased, consisted of one main concept, that of the study setting. 
 
Within the first theme, the sub-theme of structural factors (reported by three participants) was 
defined by the recurrent expression that concurrent political/economic instability in the UK may 
have resulted in an increase in depressive symptoms. Similarly, it was cited that social isolation, 
presumably as a sexual minority individual, within the context of the socio-political climate at the 
time of the study, might have resulted in an increase in depressive symptoms.  
 
Describing structural factors as the reason underlying the increase in depressive symptoms 
observed, is an interesting concept as socio-economic hardship has consistently and strongly 
been found to be associated with depressive symptoms in samples of MSM 
(346, 347, 354, 356, 364, 371, 
415, 454, 606, 681)
 including in AURAH and PROUD, and in general UK population samples 
(348-350)
.  It 
seems possible therefore, that a downturn in the economy may have increased the prevalence 
of depression in general in the UK. Given the lack of data on PHQ-9 responses among the UK 
population between 2013-2015 it is very difficult to investigate these suggestions further. 
 
Within the sub-theme of risk-taking (reported by four participants), the discussion of CLS was 
predominantly linked to chemsex-drug use. It was never explicitly stated that occurrence of CLS 
or use of chems may have increased after study enrolment. It was, however, acknowledged that 
taking PrEP was used as a means to reduce the risk of HIV during episodes of sexual risk, 
especially chemsex, and a link was consistently drawn between chem use and CLS, and chem 
use and depression. 
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Again, such discourse is not surprising given that mephedrone and crystal methamphetamine 
use is known to cause acute symptoms of anxiety and paranoia in some individuals 
(524, 579)
. 
Based on recent data from in-depth interviews of 30 men resident in London, it was suggested 
that chemsex-drug use may cause longer-term mental health problems, including depression, 
anxiety, and psychosis, in some individuals 
(579)
. Chemsex-associated drug use (past three 
months) was associated with depressive symptoms among men in the AURAH study (Chapter 4 
Table 5), and the type of depressive symptoms reported by men who engaged in chemsex-drug 
use and men who did not was found to differ somehwat (Chapter 6 section 6.3.2). Although 
chemsex-associated drug use (past three months) was not associated with depressive 
symptoms among men in the PROUD trial at baseline, use of crystal methamphetamine was 
found to be associated. Sexualized drug use (report of sex after recreational drug use in the 
past three months) was not associated with depressive symptoms at the 12- or 24-month 
questionnaire in unadjusted analysis. Unfortunately, it was not possible to investigate 
methamphetamine use (or the measure of chemsex-associated drug use), at the 12- or 24-
month questionnaire. It is possible that one or more chemsex-associated drugs may have been 
linked to depression at the follow-up time-points in PROUD, as the measure of sex after drug 
use may capture a wide-range of practices/experiences that do not necessarily embody the 
documented phenomenon of chemsex, which includes specific drugs and often occurs in group 
sex settings 
(578-582)
.  
 
Reflected in the participants’ comments presented above, it is not only the immediate and long-
term effects of the drugs themselves which may lead to depression, but also the engagement in 
sexual risk-taking, with potentially multiple partners, that often goes hand-in-hand with chem 
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use, and may affect one’s psychological wellbeing. Although previous studies have 
predominantly investigated the association between depression and sexual behaviour (Table 1), 
it is theoretically plausible that sexual risk-taking leads to or exacerbates depression. Reasons 
for this may include feelings of shame as well as a sense of loss of intimacy with a sexual 
partner whilst using chemsex-associated drugs 
(578-584)
. The PROUD sample of men reported 
high levels of CLS partners, perhaps an association was not found between the measure of 
chemsex-associated drug use and depression since most participants were engaging in CLS 
with multiple partners and therefore, the prevalence of depression was similar among non-
chemsex-drug users.  
 
The sub-theme of study setting appears under both of the main themes (depression increased, 
n=2 and reporting depression increased, n=4). As a result of the clinical trial set-up and 
infrastructure, two men suggested that depressive symptoms might have increased due to 
greater awareness of risk-taking during regular survey completion and STI screening.  
 
As described above, it is possible that sexual risk-taking leads to/exacerbates depression. 
Greater confrontation with one’s sexual practices on a regular basis may impact on well-being.  
 
Four men suggested that the burden of depression might have remained the same, but that 
reporting of depressive symptoms may have increased due to greater familiarity with the 
questionnaire and/or staff, and as a result of being a part of a clinical trial. Partaking in a trial 
may be one of the processes that helps individuals recognize/acknowledge their own 
depression in an environment where access to support is provided.  
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Given the somewhat lower prevalence of depressive symptoms among men in PROUD at 
baseline compared to the AURAH study (9.1% compared to 12.4%), and similar prevalence 
observed at month-12 and 24, it seems plausible that the reporting of depressive symptoms 
may have increased over the first year of the study, as suggested by the participants, due to 
familiarity with staff and access to support. Although not cited by participants in this survey, 
another interpretation that was put forth from a researchers point of view was that participants 
may have been reluctant to divulge information on mental health at baseline due to fear of study 
exclusion. Since the PROUD trial adhered to an inclusion criteria, it may be that fear of 
exclusion prevented some men from reporting (greater frequency of) symptoms. Alternatively, 
men who enrol in a trial such as PROUD are most likely at a point in their lives when they are 
not experiencing clinically significant depression, as the symptoms of depression may 
prevent/deter some individuals from active participation. The increase in depression prevalence 
observed may then reflect a regression to the mean effect. 
 
Finally, the sub-theme of experience with PrEP (reported by four participants), was defined by 
three concepts; side effects, fear of loss of access, and stigma. Although it was stated that 
depression was not different among men in the immediate compared to deferred PrEP arm, in 
the initial email and the PPI survey, it is not surprising given the increase in depressive 
symptoms in the context of a PrEP trial that participants brought up concepts surrounding 
experiences with PrEP. One participant suggested that side effects of the drug itself might 
cause depression.  
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Efavirenz in antiretroviral treatment of HIV-positive individuals has been linked to 
neuropsychiatric morbidity, suicidal ideation, and mental health diagnoses 
(703)
. Oral FTC/TDF 
PrEP use has not however, been found to produce such sequelae 
(360)
. 
 
The concept of fear of loss of access to PrEP is not surprising given that PrEP remained 
unavailable on the NHS in England over the course of the PROUD trial
xxxv
. This is despite the 
introduction of a subsidized programme in France in 2015, authorization by the European 
Medicines Agency in 2016, and availability on the NHS in Scotland in 2017. 
 
The extent to which a delayed PrEP programme in England may have resulted in increased 
symptoms of depression is difficult to say. Cheaper generic versions of the drug online from 
overseas was not available until October 2015 
(87)
. 
 
Although the concept of stigma attached to PrEP use was only brought up by two individuals in 
this PPI survey, it is one that has received a lot of attention in research on PrEP acceptance 
and adherence.  
 
In section 1.5.3 of Chapter 1, the safe sex ethos that took hold of gay communities in the early 
1980s is described. Against the backdrop of HIV, condom-protected sex took on greater social 
symbolic meaning beyond that of a barrier method to prevent STIs 
(704)
. Individuals to whom this 
                                                     
xxxv
 PrEP remained unavailable on the NHS in England at the time of submitting this thesis in December 
2017. 
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social practice was associated, were considered to be ‘sexual citizens’ of the gay community, 
‘good’ and responsible men 
(705)
. These notions remain somewhat entrenched in the community 
(704)
. Accordingly, it has been suggested that disassociating PrEP use from the stigma attached 
to CLS has been challenging, given symbolic community virtues attached to condom-use 
(704)
. In 
fact, three recent studies of PrEP acceptability and adherence in San Francisco 
(706)
, Thailand 
(707)
, and Kenya 
(708)
, found that PrEP-related stigma was the most commonly reported social 
harm to arise from PrEP research participation, and was negatively associated with acceptance 
and adherence. Although it is certainly plausible that PrEP-related stigma may be associated 
with psychological distress, as described above, being randomized to PrEP prescription in a 
clinical trial, has not been found to be associated with depressive symptoms on validated 
questionnaire instruments, neither in the PROUD trial itself, nor the iPrEX trial 
(360)
. It may be 
that those individuals who experience PrEP-related stigma do not adhere to the medication and 
associated psychological distress may dissipate as a result. Investigating the relationship 
between PrEP-related stigma and depression may be complex. 
 
7.4 Discussion  
 
7.4.1 Summary of results 
Among PROUD participants, depressive symptoms (PHQ-9≥10) were found to increase 
significantly from baseline (9.3%) to the 12-month questionnaire (14.4%). Younger men, those 
who were not employed, and those who reported crystal methamphetamine use in the past 
three months, were more likely to report depressive symptoms. There was some suggestion of 
association with report of no ongoing relationship, bisexual/straight-identity, higher-risk drinking, 
greater number of recreational drugs used, and chemsex-drug use, although findings were not 
statistically significant.  Furthermore, no association was found with UK born/ethnicity, university 
education, or study region. Measures of IPV, internalised homophobia, and concealment of 
sexual identity, were strongly associated with depressive symptoms. 
 
7.4.2 Prevalence of depressive symptoms 
In PROUD, the prevalence of depressive symptoms (PHQ-9≥10) was 9.1% (49/540) at 
baseline, 14.4% (59/410) at the 12-month questionnaire, and 14.4% (48/333) at the 24-month 
questionnaire. Although depression prevalence tended to be higher in the immediate PrEP arm 
at baseline and throughout the study, prevalence did not differ significantly between trial arms at 
any time-point, which was in line with that reported in the iPrEX trial 
(360)
.  
 
The prevalence of depressive symptoms on PHQ-9 at the 12- and 24-month questionnaire in 
PROUD was very similar to that among men who reported recent CLS with a man in the 
AURAH study (15.0%; n=122/815), and twice that observed in the general UK population in 
2007/2008 (7% reported PHQ-9≥10) 
(672)
. Natsal-3 (2010-2012) investigated the PHQ-2 and 
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found the prevalence to be 8.9% (95% CI: 5.5%, 14.3%, n/N= 17/190) among all MSM and 
6.4% (95% CI: 3.5%, 11.7%, n/N= 7/107) among gay-identified MSM 
(342)
. Using the same 
definition (PHQ-2≥3), the prevalence of depression in PROUD was 9.1% at baseline, 12.9% at 
the 12-month questionnaire, and 12.3% at the 24-month questionnaire. The prevalence of 
depression (PHQ-2≥3) in AURAH was 10.9% among MSM who reported recent anal CLS with a 
man. The prevalence of depressive symptoms may be: (i) elevated among MSM compared to 
the general population, and (ii) elevated among MSM engaging in recent CLS compared to the 
general MSM population. It is possible however, that other socio-demographic factors may 
confound this comparison and the number of MSM participating in Natsal-3 was small (n=190).  
 
The prevalence of other depression measures on PHQ-9 at the 12- and 24-month questionnaire 
in PROUD appears to be similar to that among men who reported recent CLS in the AURAH 
study. For instance, the prevalence of a major depressive syndrome on PHQ-9 was 9.0% at the 
12-month questionnaire in PROUD and 7.7% among men who reported recent CLS with a man 
in AURAH. The prevalence of suicidal ideation was 11.2% at the 12-month questionnaire in 
PROUD and 14.1% among men who reported recent CLS with a man in AURAH. 
 
7.4.3 Receiving antidepressant medication at baseline 
In the PROUD trial, the prevalence of men with depression who were receiving antidepressant 
medication at baseline was 54.1%
xxxvi
. In the AURAH study, the prevalence of men with 
depression who were receiving medical treatment or therapy for depression was 51.0%. In both 
studies there appears to be some evidence of potential under treatment of possible clinically 
significant depressive conditions, see section 4.4.6 for a discussion of possible under treatment.  
 
7.4.4 Socio-demographic and lifestyle factors associated with depressive symptoms 
In the PROUD trial, younger men, those who did not report being employed, and those who 
reported methamphetamine use in the past three months were significantly more likely to report 
depressive symptoms at baseline. Markers of socio-economic hardship (not being employed 
and non-university education) were associated with measures of depressive symptoms on 
PHQ-9 in GEE models combining data from all three time-points.  
 
Younger age 
(346, 358, 360, 364, 415, 454, 606-609)
, markers of lower socio-economic status 
(346, 347, 354, 356, 
364, 371, 415, 454, 606, 681)
, lower levels of a supportive network 
(358, 415, 454)
, reporting a bisexual identity 
(354, 415, 679, 680)
, and recreational drug use 
(41, 346, 358, 454, 564, 606-609)
 appear to be important factors 
for depression in the MSM literature, and this is also what was found to be the case in the 
AURAH study (Table 5 and Figure 17). Findings from the general UK population also suggest a 
                                                     
xxxvi
 However, it should be noted that the prevalence of depressive symptoms at baseline may have been 
underreported. This may have resulted in an overestimation of receipt of treatment, but since the measure 
of treatment did not include therapies other than pharmacological ones, the true prevalence of treatment is 
likely to be higher. 
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critical role of socio-economic hardship in poor mental health 
(348-350)
. Although the pattern of 
associations was very similar in the PROUD trial, some of the differences observed (i.e. 
between sexual identities and number of recreational drugs used) were not significant. Of note, 
the non-significant associations observed with chemsex-associated drug use at baseline and 
report of sexualized drug use at follow-up in PROUD, is discussed in detail in section 7.3.8 
above, in the context of participant interpretations of the increase in depression. It may be that 
due to the limited sample size of the PROUD trial, differences that may exist were not detected. 
It is also important to note that PROUD consisted of a unique sample of men who all reported 
high levels of CLS and agreed to participate in an RCT.  
 
Findings from the SEM in Chapter 6 also suggest that being in an ongoing relationship with a 
partner may lead to lower levels of depressive symptoms via higher levels of a supportive 
network. At the same time, however, there is some evidence to suggest that being in an 
ongoing relationship may also lead to higher levels of depressive symptoms among men who 
do not feel supported by their partner.  
 
7.4.5 Psychosocial factors associated with depressive symptoms 
In section 2.5.3.2 of Chapter 2, psychological theories are described, which posit that exposure 
to abuse as a child and re-victimization/re-enactment in adulthood may distort one’s perception 
of self, particularly one’s sense of worthiness, and ability to influence important outcomes in 
one’s life. In two systematic reviews of studies, mainly in the U.S., conducted from 1985-1997 
(709)
 and 1966-2008 
(710)
, markers of CSA were consistently linked to depression measures 
among the general male population 
(709)
. There is some evidence to suggest, as described in 
section 2.6.3.2, that CSA is associated with depression 
(41, 368, 610)
 and suicidality 
(610)
 among 
MSM. In the PROUD trial, reporting anal intercourse at age 12 or younger was investigated 
since this measure may include experiences of CSA. A young age at anal sex debut was not 
associated with measures of depression on PHQ-9. This may be as a result of lack of power 
and/or this measure may not reflect or pick up all sexual abuse experienced, as some 
participants may not have experienced forced/coerced sex and some CSA may occur at an 
older age.  
 
However, strong associations were found between IPV victimization and perpetration and 
depression measures in the PROUD trial. As described in section 2.6.3.2, evidence from a 
recent meta-analysis suggests that IPV is associated with depression among MSM 
(605)
. One UK 
study has investigated the link between IPV and depressive symptoms among MSM 
(711)
. In this 
cross-sectional survey (2010-2011) of men attending a GUM clinic in London, the same IPV 
questions as those included in PROUD were asked about (with the exclusion of ‘forced to have 
sex without a condom’). In the London study, among self-identified gay or bisexual men, 33.9% 
(176/519) reported any IPV victimization and 16.3% (83/510) reported any IPV perpetration 
(711)
. 
Current depression was measured using HADS (≥8), the prevalence was 12%. Men who 
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reported IPV perpetration in the past year were twice as likely to report current depression 
compared to men who did not (20.7% vs. 11.5%). After adjusting for age, income, education, 
and ethnicity, the association was attenuated to borderline significance (OR 3.7 95% CI: 1.0, 
14.6; p=0.060). Associations with other measures of IPV were not significant in unadjusted or 
adjusted analysis. Compared to this clinic sample of MSM in London, men in the PROUD trial 
reported a higher prevalence of IPV and there were more consistent associations with 
depressive symptoms.  
 
In terms of IPV in the general population, in the APMS (see section 1.8.1), which collected a 
multistage random sample of adults living in private households in England in 2007 (n=7047), 
23.4% (18.7% of men and 27.8% of women) reported any IPV victimization (physical and/or 
emotional/psychological), and 5.9% reported any IPV victimization in the past year. After 
adjusting for socio-demographic factors, any IPV victimization (overall OR 2.8 95% CI: 2.4, 3.3; 
men OR 2.8 95% CI: 2.2, 3.6; women OR 2.8 95% CI: 2.4, 3.5) and IPV victimization in the past 
year (overall OR 3.3 95% CI: 2.5, 4.3; men OR 2.7 95% CI: 2.5, 4.3; women OR 3.8 95% CI: 
2.7, 5.2) was associated with a composite measure of common mental health disorders
xxxvii
 on 
the CIS-R 
(712)
. Given these findings and that of PROUD, it is surprising that an association with 
IPV victimization was not found in the London GUM clinic sample of MSM described above. 
However it is of note, that in the clinic sample the pattern of associations with each individual 
IPV question, although not statistically significant, was equivalent to that found in PROUD. 
Perhaps IPV is not as strongly associated with a mild depressive mood as captured on 
HADS≥8. However, all measures of IPV were associated with major and other depressive 
syndromes on PHQ-9 in the PROUD trial. Perhaps the small sample size of the clinic study 
(N=519) prevented the detection of an association. In addition, in the clinic sample, models 
were adjusted for socio-demographic factors including income. In a recent qualitative study, 
dyadic inequalities (including education and income differentials) increased the risk of 
experiencing control and abuse from a partner 
(713)
, therefore adjustment for income may have 
obscured the association between IPV and depressive symptoms. Unfortunately, it was not 
possible in the PROUD trial to investigate the confounding effect of income/financial security. 
 
Results from PROUD (at month-12 and in GEE models), showed that negative attitudes towards 
gay sexuality (potentially indicative of internalised homophobia), were associated with all 
measures of depression on PHQ-9. Furthermore, there was some evidence from month-24 and 
GEE analyses that lower levels of disclosure of sexual orientation were associated with 
depressive symptom measures. As described in detail in Chapter 1, extensive theoretical 
(209, 210, 
226, 227, 229, 235-238, 240, 241, 245-247)
 and epidemiological research 
(341, 346, 347)
 has linked stress related 
to sexual minority status to poor mental health outcomes.  
 
                                                     
xxxvii
 This includes depressive episodes, mixed anxiety/depression, GAD, panic disorder, phobia, and/or 
OCD. 
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Although it was not possible to investigate measures of internalised homophobia in the AURAH 
study, disclosure of sexual orientation to few/no work colleagues was also associated with 
depressive symptoms (Table 5 in Chapter 4). In addition, findings from the SEM in Chapter 6 
extend AURAH and PROUD findings and suggest that concealment of sexual identity may be 
associated with depression indirectly through less frequent visits to gay venues and lower levels 
of a supportive network.  
 
7.4.6 Change in depression over the PROUD trial 
Although strong associations were found of psychosocial factors (including IPV and internalised 
homophobia) with an increase in depression score and incidence of depressive symptoms (from 
baseline to month-12), there was no evidence to suggest that the increase in depressive 
symptoms was explained by an increasing prevalence of adverse psychosocial factors over the 
first year of study. Further evidence for this comes from responses to a question asked after 
enquiry about IPV; ‘If you answered yes in the last year to any question above, do you think 
joining PROUD has influenced these behaviours?’ Of the 70 men who reported IPV in the past 
year at the 12-month questionnaire, 72.9% said joining PROUD had not influenced these 
behaviours and 21.4% said ‘yes in a positive way’ (5.7% had a missing response and no men 
responded ‘yes in a negative way’). Proportions were similar at the 24-month questionnaire. 
This also implies that IPV did not increase over the time of the study. 
 
Based on findings, it is possible that social-desirability bias and fear of study ineligibility may 
have accounted for the lower prevalence of suicidal ideation and depressive symptoms 
observed among the 353 men who completed enrolment after April 2013 and were asked to 
disclose to study personnel whether they had suicidal thoughts. The assurance of study 
participation at month-12 and greater familiarity with study staff may explain the observed 
increase. This interpretation of findings may also be useful in understanding the lower 
prevalence of suicidal ideation observed among men in the deferred PrEP arm compared to 
men in the immediate PrEP arm at the 12-month questionnaire. Perhaps men in the deferred 
arm were hesitant to disclose suicidal thoughts prior to being prescribed PrEP, again for fear of 
further deferral or study exclusion. This may be reflected in the fact that the prevalence of 
suicidal ideation increased significantly from the 12- to 24-month questionnaire among men in 
the deferred arm. 
 
Possible reasons for the increase in reporting of depressive symptoms at the 12-month 
questionnaire were also given by a small group of participants themselves as part of a PPI 
survey on PROUD findings. These reasons have been discussed in results section 7.3.8. 
Briefly, participants identified four main reasons why depression might have increased. The first 
was that economic instability in the UK may have accounted for the increase in depressive 
symptoms observed. The second was that risk-taking may be an important determinant of 
depression in general. Emphasis was often placed on the role that chemsex and associated 
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CLS may play in mental health, including anxiety and depression. None of the participants 
specifically theorized that engagement in chemsex increased over the study, thereby explaining 
the increase in depressive symptoms, however, chemsex was a clear feature in discourse on 
depression. The third reason was that depressive symptoms may have increased from the time 
of enrolment since participants were regularly confronted with their recent sexual activity and 
possible risk-taking due to frequent STI screening and questionnaire taking. Despite reporting 
that depressive symptoms increased overall among study participants and that no difference 
was observed between the immediate and deferred PrEP groups, the fourth main reason given 
concerned experiences with PrEP. This included possible side-effects, stigma attached to using 
PrEP, and fear of loss of access to PrEP after study completion. Of the PrEP related issues 
brought up in the context of depression, the concept of stigma was predominantly cited. Finally, 
participants also suggested that reporting depressive symptoms may have been easier as the 
study progressed due to greater familiarity with the questionnaire and study staff, and as a 
result of being a part of the clinical trial process, where access to support was available. 
 
7.4.7 Limitations 
The general methodological limitations of the PROUD trial are discussed in section 3.7.2 of 
Chapter 3. In this specific analysis, it is important to note that the measure of higher-risk 
drinking was based on the first two questions of the WHO AUDIT-C questionnaire, however, the 
prevalence may be slightly overestimated since the categories included in the PROUD 
questionnaire for the first WHO AUDIT-C question are 1 frequency lower (see section 3.3.10). 
Men were asked about the use of three recreational drugs commonly used in the context of 
chemsex, however, men were not asked in PROUD whether these drugs had been taken before 
or during sex. In addition, reporting anal intercourse at a very young age was investigated since 
this measure may include experiences of CSA. However, since it was not known whether the 
male sexual debut partner with whom the participant referred was an adult/significantly older 
and if they felt forced, there was most likely measurement error when attempting to capture 
experiences of CSA among PROUD participants. 
 
In addition, socio-demographic and lifestyle factors, including the number and type of 
recreational drugs used in the past three months and report of higher-risk drinking, were only 
collected at the baseline questionnaire, even though these factors may change over time. It was 
deemed inappropriate to investigate relationship status and lifestyle factors in GEE models, 
which would have necessitated carrying forward the baseline value to month-12/24 (see section 
3.6.8). It was also only possible to investigate the association between psychosocial factors and 
depressive symptoms in GEE models among the 436 men with data at the 12- and/or 24-month 
questionnaire. Furthermore, information on financial security and levels of a supportive network 
was not collected in the PROUD trial. These factors have been found to be important in the 
context of depression among MSM. Based on the SEM in Chapter 6, a supportive network was 
found to be the most ‘important’ factor for depression in the model. It is also of note, that cross-
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sectional associations were investigated in this chapter, prohibiting us from making inferences 
about causality. Finally, when interpreting findings presented in Appendix section 11.18 Table 
79, based on the change in depression score from baseline to month-12, it is important to note 
that the differences between some scores on the PHQ-9 may not be clinically meaningful. 
Therefore, although a significant difference in means may be detected, this does not necessarily 
translate into changes of clinical importance.  
 
7.4.8 Summary of discussion 
The prevalence of depressive symptoms at month-12 and 24 in the PROUD trial of men, who 
were required to report CLS in the past three months at enrolment, was similar to that reported 
by men in the AURAH study who reported recent CLS with a man. Although strong associations 
were found between psychosocial factors and depressive symptoms, there was no evidence 
(based on data available) to suggest that these measures increased over the course of the first 
year of study, thereby explaining an increase in depressive symptoms from baseline. The 
finding that report of suicidal ideation at enrolment decreased after April 2013 lends support to 
the notion that some men may have underreported depressive symptoms at baseline. Greater 
familiarity with the study over time may explain the increase in prevalence of symptoms at 
month-12, as reiterated by some PROUD participants when asked for their interpretation. Other 
participant interpretations included socio-economic hardship, chemsex and CLS, and PrEP-
related stigma.
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8 Investigating the relationship between depressive symptoms and sexual behaviour 
among gay, bisexual, and other men who have sex with men in the PROUD trial 
 
8.1 Introduction 
 
Symptoms of depression have been found to be associated with increased sexual risk 
behaviour (and HIV seroconversion 
(369)
) in a number of studies of MSM 
(353-368)
, mainly in the 
U.S. Three European studies have investigated this relationship. The first was conducted in 
1999 among a UK GUM clinic sample of 122 MSM 
(355)
 and the second in 2008 among a 
Belgian volunteer and online sample of 591 HIV-negative MSM 
(358)
. Depressive symptoms were 
associated with CLS measures in both studies. The third is the AURAH study, under 
investigation in this thesis, and for which the findings are presented in detail in Chapters 4, 5, 
and 6. Depressive symptoms were found to have moderate to strong associations with 
measures of CLS in the past three months and with bacterial STI diagnosis and PEP use in the 
past year, including after adjustment for socio-demographic factors and additional adjustment 
for smoking, higher-risk drinking and recreational drug use. Low self-efficacy for sexual safety 
was found to mediate this association. Further analyses using SEM (chapter 6) supported this, 
and found evidence that higher levels of recent recreational drug use also mediate this 
association in a separate pathway, albeit to a lesser extent. The extent to which the relationship 
between depression and sexual risk is present in different samples of UK/European MSM still 
remains unclear. The aim of this chapter was to investigate the relationship between depressive 
symptoms and levels of CLS, and other aspects of sexual behaviour, among men in the 
PROUD trial. The analyses presented here are similar to those conducted among MSM in the 
AURAH study, in Chapter 5. However, there is an important difference due to the sample under 
study. The AURAH analyses compared men having condom-protected sex to men having CLS. 
The PROUD sample consists solely of men who reported anal CLS with a man in the past three 
months at enrolment and that it was likely in their opinion that they would have CLS in the next 
three months. The PROUD analysis therefore addresses a different question in that it compares 
men having higher levels of CLS to men having lower levels of CLS, in other words, assesses 
the role of depressive symptoms among a group of men with a higher sexual risk profile.  
 
8.2 Statistical methods 
 
A detailed description of the variables investigated for analyses presented in this Chapter is 
included in Chapter 3 section 3.3.6. 
 
The prevalence of each derived sexual behaviour measure is presented for PROUD participants 
at baseline, month-12, and month-24 (see section 3.3.8). The proportion of missing responses 
to each sexual behaviour measure is also presented. 
Chapter 8 
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The cross-sectional association of depressive symptoms (PHQ≥10) with sexual behaviours at 
baseline and at the 12- and 24-month questionnaire, was assessed using χ
2 
tests, χ
2
 tests for 
trend, and Fisher’s exact test (when expected numbers were small) for univariable analysis, and 
modified Poisson regression with a robust variance estimator in order to produce adjusted 
prevalence ratios 
(645)
. At baseline, associations were adjusted for key socio-demographic 
factors and then additionally adjusted for lifestyle factors (see section 3.6.8). At the 12- and 24-
month questionnaires, key socio-demographic factors, with the exception of ongoing 
relationship, were adjusted for. Lifestyle factors were not adjusted for at the 12- or 24-month 
questionnaire (see section 3.6.8). At each time-point, adjusted estimates of those associations 
that were found to be significant in univariable analysis (p≤0.05) are presented in tables. 
Sensitivity analyses were undertaken using different PHQ-9-based definitions of depressive 
symptoms (major depressive syndrome and major and other depressive syndromes), including 
suicidal ideation. The association between antidepressant use at baseline and sexual behaviour 
measures was also described. Of note, although baseline associations are presented in this 
chapter, findings from Chapter 7, as discussed in section 7.4.6, do suggest that symptoms of 
depression on PHQ-9 were underreported at the baseline questionnaire. It may, therefore, be 
necessary to interpret the baseline findings with caution.  
 
Poisson GEE models (see section 3.6.7) were also used to assess the association of 
depressive symptoms with sexual behaviour measures pooled across time-points. Each sexual 
behaviour measure was investigated as a time-varying dependent variable in separate GEE 
models. Information on PEP use and rectal STI diagnosis in the past year was only collected at 
baseline, therefore these variables were not investigated in the GEE analysis. Associations are 
presented unadjusted, adjusted for key socio-demographic factors, and adjusted for key socio-
demographic factors and psychosocial factors (see section 3.6.8). Of note, given the observed 
increase in depressive symptoms over the first year of PROUD (see section 7.3.1), it was 
investigated whether adjusting additionally for study time-point affected the socio-demographic 
adjusted associations between depressive symptoms and sexual behaviour measures in GEEs. 
A sensitivity analysis was undertaken using different PHQ-9-based definitions of depressive 
symptoms, including suicidal ideation, as time-varying independent variables in GEE models. 
Associations are presented unadjusted and adjusted for key socio-demographic factors. 
 
It was considered whether, in the immediate PrEP arm, CLS may no longer be the sexual risk 
activity, and that instead, ‘risk’ would shift to PrEP adherence. It was therefore, thought to be 
possible that a relationship between depression and CLS may not be observed in the immediate 
PrEP arm, but may be observed in the deferred PrEP arm. Accordingly, it was investigated 
whether the study trial arm (immediate versus deferred PrEP) significantly moderated the 
association between depressive symptoms (PHQ-9≥10) and sexual behaviour measures at 
month-12 and 24 using modified Poisson regression, and in GEE models combining data from 
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month-12 and 24. At the 12-month questionnaire, it was also investigated whether PrEP 
prescription (includes all men randomized to the immediate PrEP arm and 25 men in the 
deferred PrEP arm) moderated the association. The potential moderating effects of recreational 
drug use (poly-drug use, chemsex-associated drug use, and club-drug use) at baseline (using 
modified Poisson models) and reporting any IPV victimization and age <13 years at anal sex 
debut, at month-12 and 24 (using GEEs) was also investigated. The presence of an interaction 
would indicate the need to present separate findings. 
 
In order to put the PROUD findings into context, a number of additional analyses from AURAH 
are included in this chapter. Unadjusted and adjusted associations of depressive symptoms with 
sexual behaviour measures in AURAH are presented specifically among the group of men who 
reported anal CLS with a man in the past three months (N=815), as well as the whole sample of 
1340 men reporting recent anal or vaginal sex. For these analyses, logistic regression was used 
in order to produce ORs. Although PRs offer greater ease of interpretation, ORs have the 
advantage that the magnitude can more easily be compared across the different AURAH 
subgroups (see section 3.6.2). In addition, the prevalence of depressive symptoms (PHQ-9≥10) 
in AURAH was examined according to the amount of sex/CLS men reported. Presenting these 
findings in a scatter plot provides a visual representation of the relationship between depression 
and increasing sexual risk behaviour. 
 
The association of depression symptoms (PHQ-9≥10) with high self-efficacy for sexual safety, 
difficulty saying no to unwanted sex, and happiness with one’s sex life, and the association of 
these self-efficacy measures with sexual behaviours was investigated at month-12 and/or 24 in 
the PROUD sample. Findings from modified Poisson regression are presented unadjusted and 
adjusted for key socio-demographic factors at each time-point. Findings from GEE models are 
presented unadjusted, adjusted for key socio-demographic factors, and adjusted for key socio-
demographic factors and psychosocial factors (see section 3.6.8), using measures pooled 
across each time-point. Sensitivity analyses were undertaken using different PHQ-9-based 
definitions of depressive symptoms, including suicidal ideation, at month-12 and 24. Of note, 
based on the results of this chapter, the causal steps approach to mediational analysis was not 
investigated further and an SEM was not carried out. 
 
The association of depressive symptoms (PHQ-9≥10) with reasons reported for non-condom-
use at last CLS was investigated at baseline, month-12, and month-24 in unadjusted analysis, 
and in GEE models combining data from all three time-points. GEE models are presented 
unadjusted and adjusted for key socio-demographic factors (see section 3.6.8).  
 
The cross-sectional association of socio-demographic and lifestyle factors with sexual 
behaviours at baseline was assessed in unadjusted analysis. The associations of IPV measures 
and age at anal sex debut with sexual behaviours, were investigated at month-12 and 24 using 
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modified Poisson regression, and in GEE models combining data from month-12 and 24. GEE 
models are presented unadjusted and adjusted for key socio-demographic factors. 
 
Finally, as part of the PPI survey described in detail in Chapter 7 section 7.2, participants were 
asked to help us interpret PROUD findings on the relationship between depressive symptoms 
and measures of sexual behaviour. When reviewing participant responses to this survey, a 
thematic analysis approach was taken. A summary of responses is given in this chapter.  
 
 
8.3 Results 
 
8.3.1 Prevalence of sexual behaviour measures 
The prevalence of each sexual behaviour measure according to questionnaire time-point is 
presented in Table 26. Among the 540 men at baseline, based on a recall period of three 
months; 75.9% reported CLS with two or more partners, 40.9% reported CLS with five or more 
partners, 12.0% reported CLS with an HIV-positive partner not known to be on HIV treatment, 
6.5% reported receptive CLS with an HIV-positive partner not known to be on treatment, 27.0% 
reported an unknown or HIV-positive partner not known to be on treatment at last CLS, 37.0% 
reported ten or more new sex partners, and 32.4% of men reported receptive anal sex with ten 
or more partners. Furthermore, 34.1% of men reported PEP use and 37.0% reported rectal STI 
diagnosis in the past year. Prevalence of CLS measures and partner numbers were broadly 
similar at the 12- and 24-month time-points compared to baseline. At the 12- (N=410) and 24-
month (N=33) follow-ups, 34.6% and 49.0% of men reported group sex in the past three months 
respectively.  
 
With the exception of the rectal STI diagnosis questions, the proportion of missing values for 
each sexual behaviour question across all time-points, was ≤5% (the proportion of missing 
values for PEP use at baseline was very slightly higher at 5.6%), see Appendix section 11.20 
Table 81. Overall 9.3% of men had a missing response to rectal chlamydia, rectal gonorrhoea, 
syphilis, and LGV. The high proportion of missing values for the rectal STI diagnosis questions 
may not be surprising given the layout of the main STI question: ‘In the past 12 months have 
you been diagnosed with any of the following?’, a list of STIs with yes/no boxes was then 
provided. It may have been a common pattern, as was considered to be the case with 
depressive symptoms on PHQ-9, for participants to only identify and tick those STIs that they 
recognized or had been diagnosed with. It was therefore, deemed appropriate to consider a 
non-response to indicate no STI diagnosis.  
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Table 26: Prevalence of sexual behaviour measuresb at baseline and the 12- and 24-
month questionnaires in PROUD 
 Baseline 
[N=540] 
12-month 
[N=410] 
24-month 
[N=333] 
 n (%) n (%) n (%) 
CLS with 2+ partners (past three months) 410 (75.9%) 303 (73.9%) 249 (74.8%) 
CLS with 5+ partners (past three months) 221 (40.9%) 189 (46.1%) 172 (51.7%) 
CLS with HIV+ partner
a 
(past three months) 65 (12.0%) 44 (10.7%) 42 (12.6%) 
Receptive CLS with HIV+ partner
a 
(past three 
months) 
35 (6.5%) 26 (6.3%) 29 (8.7%) 
Unknown/HIV+ partner
a
 at last CLS (past three 
months) 
146 (27.0%) 100 (24.4%) 67 (20.1%) 
10+ new sex partners (past three months) 200 (37.0%) 119 (29.0%) 95 (28.5%) 
Receptive anal sex with 10+ partners (past 
three months) 
175 (32.4%) 118 (28.8%) 98 (29.4%) 
Group sex (past three months) / 224 (34.6%) 163 (49.0%) 
PEP use (past year) 184 (34.1%) / / 
Rectal STI diagnosis (past year) 200 (37.0%) / / 
 
 
8.3.2 Relationship between depressive symptoms and sexual behaviour measures  
Table 27 presents the unadjusted associations between depressive symptom measures on 
PHQ-9 and sexual behaviour measures at baseline. Depressive symptoms (PHQ-9≥10) were 
not significantly associated with any of the CLS measures in unadjusted analysis, although 
there was some suggestion that men with depressive symptoms were more likely to report an 
unknown status or HIV-positive untreated partner at last CLS and receptive anal sex with ten or 
more partners in the past three months. Depressive symptoms were however, associated with 
PEP use in the past year, whereby men with depressive symptoms were more likely to report 
PEP use in the past year compared to men without depressive symptoms. This association 
remained, with some attenuation, after adjustment for key socio-demographic factors and 
additional adjustment for higher-risk drinking and number of recreational drugs used, Table 28. 
Of note, men who reported CLS with an HIV-positive partner not known to be on treatment, 
receptive CLS with an HIV-positive partner not known to be on treatment, ten or more new anal 
sex partners, and receptive anal sex with ten or more partners, were more likely to report PEP 
use than men who did not (50.8% vs. 31.8%; 57.1% vs. 32.5%; 48.5% vs. 25.6%; 50.9% vs. 
26.0%; all χ
2 
p-values ≤0.003, respectively). 
 
The relationship between depressive symptoms and sexual behaviour measures was not 
significantly different among: (i) men who reported poly-drug use and men who did not, (ii) men 
who reported chemsex-associated drug use and men who did not, and (iii) men who reported 
club-drug use and men who did not, in unadjusted or adjusted analysis. The interaction p-values 
were not significant for any of the sexual behaviour measures (p>0.05). 
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In the sensitivity analyses, the measure of major and other depressive syndromes on PHQ-9 
was also associated with PEP use in the past year in unadjusted (Table 27) and adjusted 
analysis (Table 28). Major depressive syndrome and suicidal ideation on PHQ-9 had a 
borderline significant association with PEP use in unadjusted (Table 27) and adjusted analysis 
(Table 28). In addition, major depressive syndrome and suicidal ideation was associated with 
report of an unknown or HIV-positive status partner (not known to be on treatment) at last CLS 
in unadjusted (Table 27) and adjusted analysis (Table 29). Finally, antidepressant use at 
baseline was not associated with sexual behaviour measures in unadjusted analysis (e.g. 
37.0% of men reporting antidepressant use and 41.3% of men not reporting antidepressant use, 
reported ≥5CLS partners; Pearson χ
2
 test p=0.567).
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Table 27: Unadjusted associations of depressive symptom measures on PHQ-9 with sexual behaviour measures in the past three months at 
baseline in PROUD 
N=540   CLS with 2+ 
partners 
[n=410;75.9%] 
 
 
 
 
% 
p-value
a
 
CLS with 5+ 
partners 
[n=221;40.9%] 
 
 
 
 
% 
p-value
a
 
CLS with 
HIV+ partner 
not treated  
[n=65;12.0%] 
 
 
 
% 
p-value
a
 
Receptive 
CLS with 
HIV+ 
partner not 
treated  
[n=35;6.5%] 
 
% 
p-value
a
 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=146;27.0%] 
 
 
% 
p-value
a
 
10+ new sex 
partners 
[n=200;37.0%] 
 
 
 
 
% 
p-value
a
 
Receptive 
anal sex with 
10+ partners  
[n=175;32.4%] 
 
 
 
% 
p-value
a
 
PEP use (past 
year) 
[n=184;34.1%] 
 
 
 
 
% 
p-value
a
 
Rectal STI 
diagnosis 
(past year) 
[n=200;37.0%] 
 
 
 
% 
p-value
a
 
Depressive 
symptoms  
(PHQ9≥10) 
Yes 
No 
73.5% 
76.2% 
0.673 
44.9% 
40.5% 
0.553 
10.2% 
12.2% 
0.679 
8.2% 
6.3% 
0.546
b
 
34.7% 
26.3% 
0.206 
38.8% 
36.9% 
0.792 
42.9% 
31.4% 
0.101 
51.0% 
32.4% 
0.009 
38.8% 
36.9% 
0.792 
Major 
depressive 
syndrome  
Yes 
No 
77.8% 
75.8% 
0.817 
51.9% 
40.4% 
0.236 
7.4% 
12.3% 
0.760
b
 
7.4% 
6.4% 
0.692
b
 
44.4% 
26.1% 
0.037 
44.4% 
36.7% 
0.413 
40.7% 
32.0% 
0.343 
51.9% 
33.1% 
0.046 
44.4% 
36.7% 
0.413 
Major & 
other 
depressive 
syndromes  
Yes 
No 
77.1% 
75.8% 
0.844 
52.1% 
39.8% 
0.100 
10.4% 
12.2% 
0.718 
10.4% 
6.1% 
0.225
b
 
35.4% 
26.2% 
0.171 
43.8% 
36.4% 
0.313 
37.5% 
31.9% 
0.430 
47.9% 
32.7% 
0.034 
47.9% 
36.0% 
0.102 
Suicidal 
ideation  
Yes 
No 
83.1% 
75.1% 
0.175 
45.8% 
40.3% 
0.423 
13.6% 
11.9% 
0.703 
8.5% 
6.2% 
0.571
b
 
39.0% 
25.6% 
0.029 
35.6% 
37.2% 
0.808 
33.9% 
32.2% 
0.795 
45.8% 
32.6% 
0.045 
39.0% 
36.8% 
0.743 
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Table 28: Unadjusted and adjusted associations of depressive symptom measures on 
PHQ-9 with PEP use at baseline of PROUD 
N=540 men  PEP use in the past year [n=184; 34.1%] 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Adjustedc  
PR [95% CI] 
p-valuea 
Depressive symptoms 
(PHQ-9≥10) 
1.58 [1.16, 2.13] 
0.003 
1.50 [1.10, 2.03] 
0.010 
1.47 [1.08, 1.98] 
0.013 
Major depressive 
syndrome  
1.56 [1.07, 2.30] 
0.022 
1.47 [0.99, 2.18] 
0.055 
1.47 [0.98, 2.20] 
0.062 
Major & other 
depressive syndromes 
1.46 [1.06, 2.02] 
0.020 
1.40 [1.01, 1.93] 
0.043 
1.41 [1.02, 1.94] 
0.038 
Suicidal ideation 1.40 [1.03, 1.90] 
0.031 
1.35 [0.98, 1.87] 
0.062 
1.35 [0.99, 1.84] 
0.055 
 
Table 29: Unadjusted and adjusted associations of depressive symptom measures on 
PHQ-9 with last CLS with an unknown/HIV-positive status partner (not believed to be on 
treatment) at baseline of PROUD 
N=540 men  Unknown/HIV+ partner not treated at last CLS [n=146; 27.0%] 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Adjustedc  
PR [95% CI] 
p-valuea 
Major depressive 
syndrome 
1.70 [1.09, 2.66] 
0.020 
1.84 [1.17, 2.89] 
0.008 
1.89 [1.19, 2.98] 
0.007 
Suicidal ideation  1.52 [1.07, 2.17] 
0.020 
1.52 [1.06, 2.18] 
0.023 
1.51 [1.05, 2.17] 
0.026 
 
 
The relationship between depressive symptoms (PHQ-9≥10) and sexual behaviour measures 
was similar at the 12-month questionnaire, see Table 30. There were fewer numbers of men at 
follow-up, but still no evidence of an association with measures of CLS and partner numbers in 
unadjusted analysis. In the sensitivity analyses, patterns of association were similar for the 
other depressive symptom measures on PHQ-9, including suicidal ideation.  
 
The relationship between depressive symptoms (PHQ-9≥10) and sexual behaviour measures 
was again, similar at the 24-month questionnaire, Table 31. In the sensitivity analyses, similar to 
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the baseline investigation, a major depressive syndrome on PHQ-9 was associated with report 
of an unknown or HIV-positive status partner (not known to be on treatment) at last CLS at the 
24-month questionnaire, in unadjusted (Table 31) and adjusted analysis (Table 32). 
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Table 30: Unadjusted associations of depressive symptom measures on PHQ-9 with sexual behaviour measures in the past three months at the 12-
month questionnaire in PROUD 
N=410   CLS with 2+ 
partners 
[n=303;73.9%] 
 
 
 
% 
p-valuea 
CLS with 5+ 
partners  
[n=189;46.1%] 
 
 
 
% 
p-valuea  
CLS with 
HIV+ partner 
not treated 
[n=44;10.7%] 
 
 
% 
p-valuea  
Receptive CLS 
with HIV+ 
partner not 
treated  
[n=26; 6.3%] 
 
% 
p-valuea  
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=100; 24.4%] 
 
% 
p-valuea  
10+ new sex 
partners 
[n=119;29.0%] 
 
 
 
% 
p-valuea  
Receptive anal 
sex with 10+ 
partners  
[n=118;28.8%] 
 
 
% 
p-valuea  
Group sex  
[n=224; 54.6%] 
 
 
 
 
% 
p-valuea  
Depressive 
symptoms  
(PHQ-9≥10) 
Yes 
No 
71.2% 
74.4% 
0.608 
42.4% 
46.7% 
0.535 
6.8% 
11.4% 
0.289 
1.7% 
7.1% 
0.150 
23.7% 
24.5% 
0.898 
28.8% 
29.1% 
0.969 
30.5% 
28.5% 
0.751 
50.9% 
55.3% 
0.528 
Major depressive 
syndrome  
Yes 
No 
75.7% 
73.7% 
0.797 
46.0% 
46.1% 
0.985 
2.7% 
11.5% 
0.158b 
0.0% 
7.0% 
0.152b 
21.6% 
24.7% 
0.681 
29.7% 
29.0% 
0.921 
32.4% 
28.4% 
0.607 
51.4% 
55.0% 
0.674 
Major & other 
depressive 
syndromes  
Yes 
No 
78.4% 
73.3% 
0.431 
54.9% 
44.9% 
0.178 
5.9% 
11.4% 
0.232 
2.0% 
7.0% 
0.228 
31.4% 
23.4% 
0.215 
29.4% 
29.0% 
0.948 
37.3% 
27.6% 
0.153 
56.9% 
54.3% 
0.733 
Suicidal ideation Yes 
No 
71.7% 
74.2% 
0.723 
52.2% 
45.3% 
0.380 
4.4% 
11.5% 
0.204 
0.0% 
7.1% 
0.098b 
26.1% 
24.2% 
0.776 
32.6% 
28.6% 
0.570 
32.6% 
28.3% 
0.543 
54.4% 
54.7% 
0.967 
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Table 31: Unadjusted associations of depressive symptom measures on PHQ-9 with sexual behaviour measures in the past three months at the 24-
month questionnaire in PROUD 
N=333  CLS with 2+ 
partners 
[n=249; 74.8%] 
 
 
 
%  
p-valuea 
CLS with 5+ 
partners  
[n=172; 51.7%] 
 
 
 
% 
p-valuea 
CLS with 
HIV+ partner 
not treated 
[n=42;12.6%] 
 
 
% 
p-valuea 
Receptive CLS 
with HIV+ 
partner not 
treated  
[n=29; 8.7%] 
 
% 
p-valuea 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=67; 20.1%] 
 
% 
p-valuea 
10+ new sex 
partners 
[n=95; 28.5%] 
 
 
 
% 
p-valuea 
Receptive anal 
sex with 10+ 
partners  
[n=98; 29.4%] 
 
 
% 
p-valuea 
Group sex  
[n=163; 49.0%] 
 
 
 
 
% 
p-valuea 
Depressive 
symptoms  
(PHQ-9≥10) 
Yes 
No 
68.8% 
75.8% 
0.299 
39.6% 
53.7% 
0.071 
12.5% 
12.6% 
0.980 
8.3% 
8.8% 
0.591b 
27.1% 
19.0% 
0.193 
29.2% 
28.4% 
0.916 
27.1% 
29.8% 
0.700 
52.1% 
48.4% 
0.639 
Major depressive 
syndrome 
 
Yes 
No 
69.0% 
75.3% 
0.451 
41.4% 
52.6% 
0.247 
10.3% 
12.8% 
0.488b 
6.9% 
8.9% 
0.526b 
41.4% 
18.1% 
0.003 
27.6% 
28.6% 
0.906 
24.1% 
29.9% 
0.513 
51.7% 
48.7% 
0.754 
Major & other 
depressive 
syndromes  
Yes 
No 
68.3% 
75.7% 
0.307 
39.0% 
53.4% 
0.084 
9.8% 
13.0% 
0.556 
7.3% 
8.9% 
0.509b 
29.3% 
18.8% 
0.119 
24.4% 
29.1% 
0.531 
29.3% 
29.5% 
0.981 
56.1% 
48.0% 
0.328 
Suicidal ideation Yes 
No 
75.0% 
74.7% 
0.968 
48.1% 
52.3% 
0.574 
11.5% 
12.8% 
0.800 
9.6% 
8.5% 
0.801 
25.0% 
19.2% 
0.339 
38.5% 
26.7% 
0.084 
34.6% 
28.5% 
0.372 
51.9% 
48.4% 
0.640 
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Table 32: Unadjusted and adjusted associations of a major depressive syndrome on 
PHQ-9 with last CLS with an unknown/HIV-positive status partner (not believed to be on 
treatment) at the 24-month questionnaire in PROUD 
N=333  Unknown/HIV+ partner not treated at last CLS [n=67; 
20.1%] 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Major depressive 
syndrome 
2.29 [1.39, 3.75] 
0.001 
2.24 [1.32, 3.81] 
0.003 
 
 
These associations were also investigated when combining data from baseline and the 12- and 
24-month questionnaire in GEE models, see Figure 23. Depressive symptoms (PHQ-9≥10) 
were not associated with any of the sexual behaviour measures investigated at each time-point, 
in unadjusted
xxxviii
 or adjusted analysis
xxxix
. There did appear to be a slight attenuation in the PR 
after adjusting for any IPV victimization and age <13 years at anal sex debut in addition to 
socio-demographics, for a number of sexual behaviours. Of note, adjusting additionally for study 
time-point in the socio-demographic adjusted models had no impact on associations observed 
in Figure 23. In the sensitivity analyses, when investigating the other depressive symptom 
measures on PHQ-9, including suicidal ideation, in GEE models, the pattern of associations 
was identical, Appendix section 11.21 Table 82. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
xxxviii
 540 individuals contributing 1283 questionnaire responses to the model. 
xxxix
 536 and 429 individuals contributing 1273 and 710 questionnaire responses to adjusted models (i) and 
(ii) respectively. 
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Figure 23: Unadjusted and adjusted associations of depressive symptoms (PHQ-9≥10) 
with sexual behaviours in the past three months using baseline, 12-, and 24-month 
PROUD questionnaire data in GEE models 
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Of note, the relationship between depressive symptoms (PHQ-9≥10) and sexual behaviour 
measures was not different in the two study trial arms at month-12 or 24, nor was the 
relationship found to be different between trial arms in GEE models combining data from both 
follow-up time-points (see Table 33). When investigating whether the relationship between 
depressive symptoms and sexual behaviours was different at the 12-month time-point, between 
men who were prescribed PrEP before the 12-month questionnaire and men who were not, the 
interaction p-values were not significant for any of the sexual behaviours. The relationship 
between depressive symptoms and sexual behaviour measures was also not different among: 
(i) men who reported any IPV victimization and men who did not, and (ii) men who reported their 
anal sex debut with a man before 13 years of age and men who did not, in GEE models. 
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Table 33: Unadjusted associations of depressive symptoms with sexual behaviour measures in the past three months separately among men 
randomized to the immediate PrEP arm and men randomized to the deferred PrEP arm at the 12- and/or 24-month questionnaires in PROUD 
 PR 95% CI for depressive symptoms (PHQ-9≥10) 
 12- month questionnaire [N=410] 24-month questionnaire [N=333] 12- and 24-month questionnaires in GEE models 
[N=436 men; Obs=743
c
] 
 
 
 
 
Dependent 
variables: 
Immediate PrEP 
arm [N=216] 
 
 
PR [95% CI] 
p-value
a
 
Deferred PrEP 
arm [N=194] 
 
 
PR [95% CI] 
p-value
a
 
Interaction 
term  
p-value 
Immediate PrEP 
arm [N=182] 
 
 
PR [95% CI] 
p-value
a
 
Deferred PrEP 
arm [N=151] 
 
 
PR [95% CI] 
p-value
a
 
Interaction 
term  
p-value 
Immediate PrEP 
arm [N=233; 
Obs=398] 
 
PR [95% CI] 
p-value
b
 
Deferred PrEP 
arm [N=203; 
Obs=345] 
 
PR [95% CI] 
p-value
b
 
Interaction 
term  
p-value 
CLS with 2+ 
partners 
1.04 [0.85, 1.26] 
 
0.83 [0.59, 1.16] 0.255 0.98 [0.77, 1.24] 0.80 [0.54, 1.17] 0.370 1.02 [0.76, 1.38] 0.81 [0.54, 1.23] 0.402 
CLS with 5+ 
partners  
0.92 [0.64, 1.34] 0.83 [0.46, 1.49] 0.753 0.71 [0.45, 1.12] 0.77 [0.42, 1.41] 0.820 0.82 [0.55, 1.21] 0.78 [0.46, 1.32] 0.899 
CLS with HIV+ 
partner not treated 
0.63 [0.20, 1.97] 0.46 [0.06, 3.36] 0.799 0.80 [0.25, 2.54] 1.30 [0.42, 4.03] 0.553 0.75 [0.33, 1.72] 0.97 [0.35, 2.66] 0.574 
Receptive CLS with 
HIV+ partner not 
treated
e
 
/ / / 0.46 [0.06, 3.45] 1.58 [0.50, 5.00] 
 
0.296 0.59 [0.18, 2.01] 1.01 [0.33, 3.15] 0.455 
Unknown/HIV+ 
partner not treated 
at last CLS  
0.80 [0.41, 1.54] 1.24 [0.59, 2.62] 0.388 1.75 [0.95, 3.20] 0.89 [0.30, 2.65] 0.287 1.16 [0.70, 1.94] 1.05 [0.52, 2.14] 0.829 
10+ new sex 
partners 
1.09 [0.65, 1.82] 0.79 [0.35, 1.79] 0.512 0.97 [0.50, 1.85] 1.14 [0.56, 2.31] 0.738 0.99 [0.62, 1.60] 0.91 [0.49, 1.68] 0.829 
Receptive anal sex 
with 10+ partners  
1.18 [0.73, 1.93] 
 
0.83 [0.36, 1.87] 0.460 0.84 [0.45, 1.60] 1.00 [0.45, 2.21] 0.747 1.08 [0.69, 1.69] 0.90 [0.47, 1.72] 0.661 
Group sex [N=436]
c
 0.94 [0.67, 1.32] 0.88 [0.56, 1.38] 0.814 1.07 [0.72, 1.59] 1.10 [0.70, 1.73] 0.922 1.00 [0.69, 1.45] 0.99 [0.64, 1.55] 0.969 
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8.3.3 Comparing findings from the AURAH study 
 
8.3.3.1 Restricted AURAH sample of men who reported anal CLS 
Table 34 presents the original AURAH findings from the 1340 men who reported anal or vaginal 
sex in the past three months, and the findings from the restricted analysis of 815 men reporting 
CLS with a man in the past 3 months (the group more comparable to the PROUD sample). 
Associations are presented as ORs, unadjusted and adjusted for key socio-demographic 
factors. Among MSM in AURAH who reported CLS, there remained evidence of an association 
between depressive symptoms (PHQ-9≥10) and CLS with two or more partners, CLS with an 
unknown or HIV-positive status partner, and bacterial STI diagnosis, but the association was 
weaker compared to the original analysis of all MSM reporting sex. Similar to the PROUD trial, 
there remained a strong association between depressive symptoms and PEP use in the 
restricted analysis, with only slight attenuation compared to the original AURAH analysis. 
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Table 34: Unadjusted and adjusted associations of depressive symptoms with sexual 
behaviour measures among AURAH men who reported recent sex and AURAH men who 
reported recent CLS with a man 
Association of depressive symptoms  
(PHQ-9 ≥10) with sexual behaviour measures 
Original AURAH 
analysis: men 
reporting recent 
anal/vaginal sex 
[N=1340] 
Restricted 
AURAH analysis: 
men reporting 
recent anal CLS 
[N=815] 
Dependent variables (past 
three months): 
 Odds Ratio [95% CI] 
p-value
c
 
Odds Ratio [95% 
CI] 
p-value
c
 
CLS with two or more (male) 
partners  
Unadjusted  1.85 [1.33, 2.57] 
p<0.001  
1.54 [1.04, 2.27]  
p=0.031  
Adjusted
b
 1.80 [1.27, 2.56] 
p=0.001 
1.60 [1.04, 2.45] 
 p=0.032  
CLS with an unknown/HIV+ 
(male) partner
a
 
Unadjusted 2.06 [1.48, 2.86] 
p<0.001  
1.72 [1.14, 2.58]  
p=0.009 
Adjusted
b
 1.92 [1.35, 2.71] 
p<0.001  
1.62 [1.04, 2.52]  
p=0.034  
Receptive CLS with an 
unknown status (male) partner 
Unadjusted 2.04 [1.37, 3.05] 
p<0.001 
1.65 [1.08, 2.52] 
p=0.020 
Adjusted
b
 1.80 [1.18, 2.75] 
p=0.007 
1.45 [0.92, 2.28] 
p=0.111 
Bacterial STI diagnosis (past 
year) 
Unadjusted 1.70 [1.22, 2.36] 
p=0.002 
1.56 [1.06, 2.30] 
p=0.024 
Adjusted
b
 1.85 [1.30, 2.62] 
p=0.001 
1.75 [1.16, 2.65] 
p=0.008 
PEP use (past year) Unadjusted 1.84 [1.24, 2.73] 
p=0.002  
1.78 [1.15, 2.75]  
p=0.010 
Adjusted
b
 2.13 [1.40, 3.22] 
p<0.001  
2.06 [1.29, 3.27]  
p=0.002  
 
 
 
8.3.3.2 Prevalence of depressive symptoms according to sexual behaviour among all 
1484 MSM in the AURAH study 
 Figure 24 presents the relationship from the opposite perspective, examining the prevalence of 
depressive symptoms (PHQ-9≥10) according to anal CLS category and level. There appears to 
be a U-shaped relationship, whereby the prevalence of depressive symptoms is higher among 
men who reported no anal sex and men who reported an anal CLS partner, and lower among 
men who reported condom-protected anal sex
xl
. The prevalence of depressive symptoms 
                                                     
xl
 This same U-shaped relationship has also been observed in a previous study of HIV-positive MSM 714.
 Lampe F, Speakman A, Sherr L, Phillips A, Collins S, Gilson R, et al. Psychological and physical 
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increases with greater number of anal CLS partners. In the original AURAH analysis, among the 
sample of men who reported recent anal or vaginal sex, the vast majority of men fall within the 
section highlighted in light blue (i.e. most men reported either condom-protected sex or one 
CLS partner). The vast majority of men in the AURAH analysis restricted to men reporting 
recent anal CLS are falling within the section highlighted in dark blue. Since the vast majority of 
men in the PROUD trial reported anal CLS with two or more partners, the PROUD sample 
mainly falls within the section highlighted in yellow. When comparing anal CLS with five or more 
partners to anal CLS with two to four partners, the relative increase in prevalence of depressive 
symptoms (17.4%; 19.57%/16.67%) is not so pronounced as when comparing two to four anal 
CLS partners with one anal CLS partner (32.4%; 16.67%/12.59%), or comparing one anal CLS 
partner with condom-protected sex (54.3%; 12.59%/8.16%). As such, there is some suggestion 
that the association between level of anal CLS and depression is less pronounced at higher 
levels of CLS.  
 
                                                                                                                                                           
symptoms and sexual behaviour among HIV-diagnosed MSM in the UK.  19th Annual Conference of the 
British HIV Association; 16-19 April; Manchester, UK2013. 
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Figure 24: Proportion of 1458
a
 MSM reporting depressive symptoms (PHQ-9≥10) according to sexual activity (with a man) in the past three months 
in the AURAH study  
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8.3.4 Relationship between depressive symptoms and measures of self-efficacy for sexual 
safety at the 12- and 24-month questionnaires 
High self-efficacy for sexual safety was reported by 21.5% of men at the 12-month 
questionnaire and 27.6% of men at the 24-month questionnaire. Difficulty saying no to 
unwanted sex was reported by 11.5% of men at the 12-month questionnaire and 8.1% of men 
at the 24-month questionnaire. Of note, of the 88 men at month-12 and 92 men at month-24 
who indicated high self-efficacy for sexual safety, the vast majority (96.6% and 96.7% 
respectively) did not report difficulty saying no to unwanted sex. At the 12- and 24-month 
questionnaires, 18.8% and 20.7% of men reported being unhappy with their sex lives 
respectively. The prevalence of each individual response option given for these measures is 
presented in Table 35. 
 
Table 35: Prevalence of self-efficacy for sexual safety, difficulty saying no to unwanted 
sex, and happiness with one’s sex life
d 
in the PROUD trial  
  12-month 
questionnaire 
[N=410] 
24-month 
questionnaire 
[N=333] 
  n (%) n (%) 
‘The sex I have is always as safe as I 
want it to be’ 
Strongly agree 
Agree 
Neutral/uncertain 
Disagree 
Strongly disagree 
88 (22.3%) 
125 (31.7%) 
89 (22.5%) 
79 (20.0%) 
14 (3.5%) 
92 (28.5%) 
132 (40.9%) 
59 (18.3%) 
36 (11.2%) 
4 (1.2%) 
‘I find it easy to say ‘no’ to sex I don’t 
want’ 
Strongly agree 
Agree 
Neutral/uncertain 
Disagree 
Strongly disagree 
135 (34.2%) 
165 (41.8%) 
48 (12.2%) 
40 (10.1%) 
7 (1.8%) 
130 (40.5%) 
129 (40.2%) 
35 (10.9%) 
24 (7.5%) 
3 (0.9%) 
‘I am happy with my sex life’ Strongly agree 
Agree 
Neutral/uncertain 
Disagree 
Strongly disagree 
109 (27.5%) 
148 (37.3%) 
64 (16.1%) 
62 (15.6%) 
14 (3.5%) 
91 (28.2%) 
117 (36.2%) 
46 (14.2%) 
54 (16.7%) 
15 (4.6%) 
High self-efficacy for sexual safety Yes 
No
a
 
88 (21.5%) 
322 (78.5%) 
92 (27.6%) 
241 (72.4%) 
Difficulty saying no to unwanted sex Yes 
No
b
 
47 (11.5%) 
363 (88.5%) 
27 (8.1%) 
306 (91.9%) 
Unhappy with one’s sex life Yes 
No
c
 
77 (18.8%) 
333 (81.2%) 
69 (20.7%) 
264 (79.3%) 
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Table 36 presents the unadjusted associations between depressive symptom measures on 
PHQ-9 and high self-efficacy for sexual safety, difficulty saying no to unwanted sex and 
happiness with one’s sex life, at the 12- and 24-month questionnaires. At the 12-month 
questionnaire, men with depressive symptoms (PHQ-9≥10) were much less likely to report high 
self-efficacy for sexual safety, compared to men without depressive symptoms. This association 
remained after adjustment for key socio-demographic factors (PR 0.43 95% CI: 0.20, 0.92; 
p=0.029). At the 24-month questionnaire however, depressive symptoms were not associated 
with self-efficacy for sexual safety, and this association did not change after adjustment. In the 
sensitivity analyses, the other depressive symptom measures on PHQ-9, including suicidal 
ideation, were also not associated with self-efficacy for sexual safety, at the 12- or 24-month 
questionnaire, and again this association did not change after adjustment for key socio-
demographic factors.  
 
Men with depressive symptoms tended to be more likely to report difficulty in saying no to 
unwanted sex (Table 36), this association was of borderline statistical significance at the 24-
month questionnaire only (PR adjusted for socio-demographic factors: 2.42 95% CI: 1.04, 5.63; 
p=0.040), see Table 37. In the sensitivity analyses, similar patterns were apparent for the other 
measures of depressive symptoms, although the associations tended to be stronger (Table 36 
and Table 37). Suicidal ideation was also associated with difficulty saying no to unwanted sex at 
month-24 (Table 36 and Table 37).  
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Table 36: Unadjusted associations of depressive symptom measures on PHQ-9 with measures of self-efficacy for safety at the 12- and 24-month 
questionnaires in PROUD 
  12-month questionnaire [N=410] 24-month questionnaire [N=333] 
N=410 men  High self-efficacy 
for sexual safety  
[n=88; 21.5%] 
 
% 
p-value
a
 
Difficulty saying no 
to unwanted sex 
[n=47; 11.5%] 
 
% 
p-value
a
 
Unhappy with 
sex life 
 [n=77; 18.8%] 
 
% 
p-value
a
 
High self-efficacy 
for sexual safety  
[n=92; 27.6%] 
 
% 
p-value
a
 
Difficulty saying no 
to unwanted sex 
[n=27; 8.1%] 
 
% 
p-value
a
 
Unhappy with 
sex life 
 [n=69; 20.7%] 
 
% 
p-value
a
 
Depressive symptoms 
(PHQ-9≥10) 
Yes 
No 
10.2% 
23.4% 
0.022 
15.3% 
10.8% 
0.323 
52.5% 
13.1% 
<0.001 
20.8% 
28.8% 
0.255 
14.6% 
7.0% 
0.075
b
 
52.1% 
15.4% 
<0.001 
Major depressive 
syndrome  
Yes 
No 
13.5% 
22.3% 
0.217 
21.6% 
10.5% 
0.055
b
 
62.2% 
14.5% 
<0.001 
27.6% 
27.6% 
0.996 
20.7% 
6.9% 
0.021
b
 
65.5% 
16.5% 
<0.001 
Major & other 
depressive syndromes  
Yes 
No 
13.7% 
22.6% 
0.150 
19.6% 
10.3% 
0.051 
56.9% 
13.4% 
<0.001 
31.7% 
27.1% 
0.533 
14.6% 
7.2% 
0.097
b
 
56.1% 
15.8% 
<0.001 
Suicidal ideation Yes 
No 
15.2% 
22.3% 
0.273 
13.0% 
11.3% 
0.721 
52.2% 
14.6% 
<0.001 
19.2% 
29.2% 
0.140 
17.3% 
6.4% 
0.014
b
 
46.2% 
16.0% 
<0.001 
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Table 37: Unadjusted and adjusted associations of depressive symptom measures on 
PHQ-9 with difficulty saying no to unwanted sex at the 12 and 24-month questionnaires 
in PROUD 
 12-month questionnaire [N=410] 24-month questionnaire [N=333] 
 Difficulty saying no to unwanted sex 
[n=47; 11.5%] 
 
Difficulty saying no to unwanted sex 
[n=27; 8.1%] 
 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Depressive symptoms 
(PHQ-9≥10) 
1.41 [0.72, 2.76] 
0.318 
1.37 [0.72, 2.61] 
0.330 
2.08 [0.93, 4.65] 
0.075 
2.42 [1.04, 5.63] 
0.040 
Major depressive 
syndrome  
2.07 [1.05, 4.09] 
0.037 
1.87 [0.96, 3.63] 
0.067 
3.00 [1.31, 6.83] 
0.009 
3.16 [1.27, 7.85] 
0.013 
Major & other 
depressive syndromes  
1.90 [1.01, 3.59] 
0.047 
1.75 [0.94, 3.24] 
0.077 
2.03 [0.87, 4.75] 
0.100 
2.25 [0.90, 5.62] 
0.082 
Suicidal ideation  1.16 [0.52, 2.58] 
0.720 
1.22 [0.55, 2.75] 
0.624 
2.70 [1.28, 5.69] 
0.009 
2.95 [1.31, 6.63] 
0.009 
 
 
Men reporting measures of depression on PHQ-9 were approximately four times more likely to 
report being unhappy with their sex lives, in fact half or just over half of men with depression 
measures reported being unhappy with their sex lives (Table 36). These strong associations 
remained, with little or no attenuation, after adjustment for key socio-demographic factors, Table 
38. 
 
Table 38: Unadjusted and adjusted associations of depressive symptom measures on 
PHQ-9 with happiness with one’s sex life at the 12 and 24-month questionnaires in 
PROUD 
 12-month questionnaire [N=410] 24-month questionnaire [N=333] 
  Unhappy with sex life 
 [n=77; 18.8%] 
 
Unhappy with sex life 
 [n=69; 20.7%] 
 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Depressive symptoms 
(PHQ-9≥10) 
4.01 [2.79, 5.76] 
<0.001 
4.03 [2.81, 5.79] 
<0.001 
3.37 [2.30, 4.96] 
<0.001 
3.37 [2.28, 4.99] 
<0.001 
Major depressive 
syndrome  
4.29 [3.02, 6.11] 
<0.001 
4.25 [2.98, 6.05] 
<0.001 
3.98 [2.76, 5.75] 
<0.001 
3.98 [2.68, 5.89] 
<0.001 
Major & other 
depressive syndromes  
4.25 [2.98, 6.07] 
<0.001 
4.20 [2.93, 6.02] 
<0.001 
3.56 [2.44, 5.21] 
<0.001 
3.60 [2.43, 5.33] 
<0.001 
Suicidal ideation  3.58 [2.47, 5.20] 
<0.001 
3.73 [2.55, 5.44] 
<0.001 
2.88 [1.94, 4.29] 
<0.001 
2.83 [1.88, 4.26] 
<0.001 
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In GEE models, depressive symptoms were associated with difficulty saying no to unwanted 
sex, including after adjustment for key socio-demographic factors and additional adjustment for 
age <13 years at anal sex debut. Likewise, depressive symptoms were associated with being 
unhappy with one’s sex life, in all adjusted models. Although not statistically significant, there 
was also evidence of an association of depressive symptoms with lower self-efficacy for sexual 
safety, see Table 39. 
 
Table 39: Unadjusted and adjusted associations of depressive symptoms with measures 
of self-efficacy for sexual safety using 12- and 24-month PROUD questionnaire data in 
GEE models 
 Depressive symptoms (PHQ-9≥10)  
N=436 men  
(using data from 
month-12 and 24 in 
GEE models) 
 
Dependent variables: 
Unadjusted 
PR [95% CI]
d
 
p-value
a
 
Adjusted
b
 
PR [95% CI]
d
 
p-value
a
 
Adjusted
c
 
PR [95% CI]
d
 
p-value
a
 
High self-efficacy for 
sexual safety 
 
0.65 [0.40, 106] 
0.084 
0.64 [0.40, 1.04] 
0.073 
0.63 [0.39, 1.02] 
0.062 
Difficulty saying no to 
unwanted sex 
 
1.80 [1.05, 3.08] 
0.032 
1.82 [1.05, 3.17] 
0.033 
1.80 [1.03, 3.15] 
0.038 
Unhappy with sex life 
 
3.37 [2.39, 4.75] 
<0.001 
3.30 [2.33, 4.66] 
<0.001 
3.25 [2.29, 4.61] 
<0.001 
 
 
8.3.5 Relationship between measures of self-efficacy for sexual safety and sexual behaviour 
at the 12- and 24-month questionnaires 
Reporting high self-efficacy for sexual safety, difficulty saying no to unwanted sex, and being 
unhappy with one’s sex life was not significantly associated with any of the sexual behaviour 
measures investigated at the 12-month questionnaire, although there was a borderline 
association between high self-efficacy for sexual safety and group sex, see Table 40. After 
adjusting for key socio-demographic factors, this latter relationship was significant, see Table 
42.  
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At the 24-month questionnaire, lower self-efficacy for sexual safety and difficulty saying no to 
unwanted sex was associated with report of an unknown or HIV-positive status partner (not 
known to be on treatment) at last CLS, and there appeared to be a borderline association 
between difficulty saying no to unwanted sex and group sex, see Table 41. After adjusting for 
key socio-demographic factors, the former associations remained but difficulty saying no to 
unwanted sex was no longer associated with group sex, see Table 42. 
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Table 40: Unadjusted associations of measures of self-efficacy for sexual safety with sexual behaviour measures in the past three months at the 
12-month questionnaire in PROUD 
N=410   CLS with 2+ 
partners  
[n=303; 73.9%] 
 
 
 
% 
p-value
a
 
CLS with 5+ 
partners  
[n=189; 46.1%] 
 
 
 
% 
p-value
a
 
CLS with HIV+ 
partner not 
treated  
[n=44; 10.7%] 
 
 
% 
p-value
a
 
Receptive 
CLS with 
HIV+ partner 
not treated  
[n=26; 6.3%] 
 
% 
p-value
a
 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=100; 24.4%] 
 
% 
p-value
a
 
10+ new sex 
partners 
[n=119; 29.0%] 
 
 
 
% 
p-value
a
 
Receptive anal 
sex with 10+ 
partners  
[n=118; 28.8%] 
 
 
% 
p-value
a
 
Group sex  
[n=224; 54.6%] 
 
 
 
 
% 
p-value
a
 
High self-
efficacy for 
sexual 
safety 
Yes 
No 
69.3% 
75.2% 
0.269 
45.5% 
46.3% 
0.891 
11.4% 
10.6% 
0.829 
8.0% 
5.9% 
0.484 
17.1% 
26.4% 
0.070 
26.1% 
29.8% 
0.501 
21.6% 
30.8% 
0.093 
63.6% 
52.2% 
0.056 
Difficulty 
saying no to 
unwanted 
sex 
Yes 
No 
80.9% 
73.0% 
0.249 
46.8% 
46.0% 
0.917 
6.4% 
11.3% 
0.306 
2.1% 
6.9% 
0.339
b
 
27.7% 
24.0% 
0.579 
25.5% 
29.5% 
0.575 
25.5% 
29.2% 
0.601 
59.6% 
54.0% 
0.470 
Unhappy 
with sex life 
Yes 
No 
74.0% 
73.9% 
0.978 
42.9% 
46.9% 
0.527 
5.2% 
12.0% 
0.082 
3.9% 
6.9% 
0.441
b
 
24.7% 
24.3% 
0.948 
28.6% 
29.1% 
0.923 
29.9% 
28.5% 
0.815 
59.7% 
53.5% 
0.318 
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Table 41: Unadjusted associations of measures of self-efficacy for sexual safety with sexual behaviour measures in the past three months at the 
24-month questionnaire in PROUD 
N=333   CLS with 2+ 
partners  
[n=249; 74.8%] 
 
 
 
% 
p-value
a
 
CLS with 5+ 
partners  
[n=172; 51.7%] 
 
 
 
% 
p-value
a
 
CLS with HIV+ 
partner not 
treated  
[n=42; 12.6%] 
 
 
% 
p-value
a
 
Receptive 
CLS with 
HIV+ partner 
not treated  
[n=29; 8.7%] 
 
% 
p-value
a
 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=67; 20.1%] 
 
% 
p-value
a
 
10+ new sex 
partners 
[n=95; 28.5%] 
 
 
 
% 
p-value
a
 
Receptive anal 
sex with 10+ 
partners  
[n=98; 29.4%] 
 
 
% 
p-value
a
 
Group sex  
[n=163; 49.0%] 
 
 
 
 
% 
p-value
a
 
High self-
efficacy 
for sexual 
safety 
Yes 
No 
69.6% 
76.8% 
0.176 
48.9% 
52.7% 
0.537 
8.7% 
14.1% 
0.183 
6.5% 
9.5% 
0.382 
13.0% 
22.8% 
0.047 
29.4% 
28.2% 
0.838 
28.3% 
29.9% 
0.773 
51.1% 
48.1% 
0.630 
Difficulty 
saying no 
to 
unwanted 
sex 
Yes 
No 
74.1% 
74.8% 
0.930 
40.7% 
52.6% 
0.237 
14.8% 
12.4% 
0.451
b
 
11.1% 
8.5% 
0.425
 b
 
40.7% 
18.3% 
0.005 
33.3% 
28.1% 
0.564 
33.3% 
29.1% 
0.642 
66.7% 
47.4% 
0.055 
Unhappy 
with sex 
life 
Yes 
No 
72.5% 
75.4% 
0.620 
42.0% 
54.2% 
0.072 
15.9% 
11.7% 
0.349 
10.1% 
8.3% 
0.635 
23.2% 
19.3% 
0.475 
30.4% 
28.0% 
0.694 
27.5% 
29.9% 
0.698 
53.6% 
47.7% 
0.383 
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Table 42: Unadjusted and adjusted associations of high self-efficacy for sexual safety and difficulty saying no to unwanted sex with sexual 
behaviour measures at the 12 and 24-month questionnaires in PROUD 
 12-month questionnaire [N=410] 24-month questionnaire [N=333] 12-month questionnaire [N=410] 24-month questionnaire [N=333] 
  Unknown/HIV+ partner not treated 
at last CLS [n=100; 24.4%] 
Unknown/HIV+ partner not treated at 
last CLS [n=67; 20.1%] 
Group sex (past 3 months) 
[n=224; 54.6%] 
Group sex (past 3 months) 
[n=163; 49.0%] 
 Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
Unadjusted 
PR [95% CI] 
p-valuea 
Adjustedb 
PR [95% CI] 
p-valuea 
High self-efficacy 
for sexual safety 
0.65 [0.39, 1.06] 
0.084 
0.62 [0.37, 1.04] 
0.067 
0.57 [0.32, 1.02] 
0.058 
0.53 [0.31, 0.92] 
0.024 
1.22 [1.01, 1.47] 
0.040 
1.25 [1.03, 1.53] 
0.027 
1.06 [0.84, 1.35] 
0.626 
1.08 [0.85, 1.37 
0.532 
Difficulty saying 
no to unwanted 
sex 
1.15 [0.70, 1.90] 
0.573 
1.16 [0.71, 1.91] 
0.554 
2.23 [1.33, 3.72] 
0.002 
1.99 [1.14, 3.47] 
0.015 
1.10 [0.86, 1.42] 
0.448 
1.14 [0.89, 1.45] 
0.309 
1.41 [1.05, 1.88] 
0.022 
1.29 [0.96, 1.72] 
0.087 
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In GEE models combining data from the 12- and 24-month questionnaires, high self-efficacy for 
sexual safety was inversely associated with report of an unknown or HIV-positive status partner 
(not known to be on treatment) at last CLS (PR 0.63 95% CI: 0.42, 0.95), including after 
adjustment for socio-demographic factors (PR 0.60 95% CI: 0.40, 0.91) and additional 
adjustment for age <13 years at anal sex debut (PR 0.62 95% CI: 0.41, 0.94), Figure 25. 
Neither high self-efficacy for sexual safety nor difficulty saying no to unwanted sex was 
associated with any of the (other) sexual behaviour measures investigated in unadjusted or 
adjusted analysis, see Figure 25 and Figure 26. 
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Figure 25: Unadjusted and adjusted associations of high self-efficacy for sexual safety 
with sexual behaviour measures in the past three months using 12- and 24-month 
PROUD questionnaire data in GEE models 
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Figure 26: Unadjusted and adjusted associations of difficulty saying no to unwanted sex 
with sexual behaviour measures in the past three months using 12- and 24-month 
PROUD questionnaire data in GEE models 
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8.3.6 Relationship between depressive symptoms and reasons reported for last CLS 
The prevalence of reasons for non-condom-use at last CLS by time-point is presented in Table 
43. The most commonly reported reason was; ‘It is more enjoyable without a condom’, followed 
by ‘I don’t like using condoms’, and ‘He doesn’t like using condoms’ (at baseline), and ‘I lose 
erections with condoms’ (at the 12- and 24-month questionnaires). 
 
Table 43: Prevalence of reasons for non-condom-use at last CLS, at baseline and the 12- 
and 24-month questionnaires in PROUD 
 Baseline [N=540]
a
 12-month 
questionnaire 
[N=410]
b
 
24-month 
questionnaire 
[N=333]
c
 
Reasons for non-
condom-use at last 
CLS:  
n (%) n (%) n (%) 
‘I don’t like using 
condoms’ 
268 (49.6%) 240 (58.5%) 212 (63.7%) 
‘He doesn’t like 
using condoms’ 
178 (33.0%) 145 (35.4%) 124 (37.2%) 
‘Condoms weren’t 
discussed’  
140 (25.9%) 122 (29.8%) 93 (27.9%) 
‘We don’t use 
condoms with each 
other but do with 
other partners’ 
86 (15.9%) 64 (15.6%) 31 (9.3%) 
‘Neither of us had 
any condoms’ 
36 (6.7%) 16 (3.9%) 11 (3.3%) 
‘I didn’t consider 
myself at risk of HIV’ 
115 (21.3%) 91 (22.2%) 115 (34.5%) 
‘I was under the 
influence of alcohol’ 
113 (20.9%) 54 (13.2%) 36 (10.8%) 
‘I was under the 
influence of drugs’ 
128 (23.7%) 86 (21.0%) 61 (18.3%) 
‘I am faithful to him’ 39 (7.2%) 32 (7.8%) 27 (8.1%) 
‘He is faithful to me’ 32 (5.9%) 36 (8.8%) 26 (7.8%) 
‘It is more enjoyable 
without a condom’ 
349 (64.6%) 255 (62.2%) 212 (63.7%) 
‘I was only dipping’ 97 (18.0%) 31 (7.6%) 11 (3.3%) 
‘I lose erections with 
condoms’
d
 
/ 146 (35.6%) 137 (41.1%) 
‘Other’ reason  57 (10.6%) 36 (8.8%) 21 (6.3%) 
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Table 44 presents the unadjusted associations between depressive symptoms (PHQ-9≥10) and 
reasons for non-condom-use at last CLS at baseline and the 12- and 24-month questionnaires. 
At baseline, men with depressive symptoms compared to men without were more likely to report 
a reason for last CLS being ‘under the influence of drugs’ and ‘other’ (than the options 
provided). When investigating the association between depressive symptoms and being under 
the influence of drugs as a reason for last CLS, the relationship remained after adjusting for key 
socio-demographic factors (PR 1.53 95% CI: 1.02, 2.30; p=0.041). However, not surprisingly, 
this relationship disappeared after additionally adjusting for higher-risk drinking and number of 
recreational drugs used in the past three months (PR 1.29 95% CI: 0.90, 1.84; p=0.168). 
 
At the 12-month questionnaire, the pattern was somewhat different. Men with depressive 
symptoms compared to men without were more likely to report a reason for last CLS being 
‘neither of us had any condoms’ and ‘under the influence of alcohol’. Both associations 
remained after adjusting for key socio-demographic factors (excluding ongoing relationship with 
a partner): PRs were 4.68 (95% CI: 1.83, 11.95; p=0.001) and 2.23 (95% CI: 1.30, 3.79; 
p=0.003) respectively. At the 24-month questionnaire, depressive symptoms were not 
associated with any of the reasons for last CLS in unadjusted analysis.  
 
The pattern of associations was very similar when investigating the other measures of 
depressive symptoms on PHQ-9 (data not shown).  
 
In GEE models, combining data across all three time-points, depressive symptoms (PHQ-9≥10) 
were associated with report of not liking condoms (PR 1.27 95% CI: 1.04, 1.54) and being under 
the influence of alcohol (PR 1.46 95% CI: 1.02, 2.10) as reasons for non-condom-use at last 
CLS, including after adjustment for key socio-demographic factors (PR 1.27 95% CI: 1.04, 1.54 
and PR 1.47 95% CI: 1.02, 2.11, respectively), see Figure 27. 
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Table 44: Unadjusted associations between depressive symptoms and reasons for non-condom-use at last CLS at baseline and the 12- and 24-
month questionnaires in PROUD 
 Depressive symptoms (PHQ-9≥10) 
 Baseline [N=540] 12-month questionnaire [N=410] 24-month questionnaire [N=333] 
Dependent variables (reasons for non-
condom-use at last CLS): 
Yes 
[N=49] 
No 
[N=491] 
p-value
a 
 
Yes 
[N=59] 
No 
[N=351] 
p-value
a
 Yes 
[N=48] 
No 
[N=285] 
p-value
a
 
% ‘I don’t like using condoms’ 57.1% 48.9% 0.270 61.0% 58.1% 0.676 68.8% 62.8% 0.428 
% ‘He doesn’t like using condoms’ 28.6% 33.4% 0.493 45.8% 33.6% 0.071 37.5% 37.2% 0.968 
% ‘Condoms weren’t discussed’  36.7% 24.9% 0.070 33.9% 29.1% 0.451 31.3% 27.4% 0.579 
% ‘We don’t use condoms with each other 
but do with other partners’ 
12.2% 16.3% 0.460 17.0% 15.4% 0.759 8.3% 9.5% 0.801 
% ‘Neither of us had any condoms’ 10.2% 6.3% 0.219
b
 11.9% 2.6% 0.004
b
 2.1% 3.5% 0.512
b
 
% ‘I didn’t consider myself at risk of HIV’ 22.5% 21.2% 0.479
b
 18.6% 22.8% 0.478 31.3% 35.1% 0.605 
 % ‘I was under the influence of alcohol’ 28.6% 20.2% 0.168 23.7% 11.4% 0.010 14.6% 10.2% 0.363 
 % ‘I was under the influence of drugs’ 36.7% 22.4% 0.024 28.8% 19.7% 0.110 20.8% 17.9% 0.626 
 % ‘I am faithful to him’ 8.2% 7.1% 0.481
b
 5.1% 8.3% 0.400 8.3% 8.1% 0.566
b
 
 % ‘He is faithful to me’ 4.1% 6.1% 0.429
b
 10.2% 8.6% 0.684 6.3% 8.1% 0.467
b
 
 % ‘It is more enjoyable without a condom’ 59.2% 65.2% 0.246
b
 61.0% 62.4% 0.840 56.3% 64.9% 0.248 
 % ‘I was only dipping’ 22.5% 17.5% 0.391 11.9% 6.8% 0.177 0.0% 3.9% 0.175
b
 
 % ‘I lose erections with condoms’
c
 / / / 40.7% 34.8% 0.380 50.0% 39.7% 0.178 
% ‘Other’ reason  20.4% 9.6% 0.019 6.8% 9.1% 0.557 10.4% 5.6% 0.169 
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Figure 27: Unadjusted and adjusted associations of depressive symptoms with reasons 
for non-condom-use at last CLS using baseline, 12-month, and 24-month PROUD 
questionnaire data in GEE models 
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8.3.7 Relationship of socio-demographic and lifestyle factors with sexual behaviour measures 
at baseline 
Table 83 and Table 84 in Appendix section 11.22 present the unadjusted associations of socio-
demographic and lifestyle factors with sexual behaviour measures at baseline. Men who did not 
report an ongoing relationship with a partner were more likely to report CLS with two or more 
partners, CLS with five or more partners, and anal sex with ten or more new sexual partners in 
the past three months (Table 83), and slightly more likely to report a rectal STI diagnosis in the 
past year (Table 84). Men who reported using a greater number of recreational drugs and 
chemsex-associated drug use in the past three months were more likely to report CLS with two 
or more partners, CLS with five or more partners, anal sex with ten or more new sexual 
partners, and receptive CLS with ten or more partners in the past three months (Table 83), as 
well as PEP use and rectal STI diagnosis in the past year (Table 84). Compared to men who 
identified as gay, the prevalence of anal sex with ten or more new sexual partners was twice as 
high among men who reported a bisexual or straight sexual identity, Table 83.  Men whose 
study clinic site was in London appeared to report a higher prevalence of PEP use in the past 
year (Table 84), but lower prevalence of having an unknown or HIV-positive status partner not 
known to be on treatment the last time they had CLS (Table 83). Finally, there appeared to be a 
borderline significant trend between younger age and rectal STI diagnosis in the past year, 
Table 84. All of the associations described above remained after adjustment for key socio-
demographic factors, with the exception of relationship status with rectal STI diagnosis, and 
study clinic region with PEP use. The following factors were not associated with any of the 
sexual behaviour measures at baseline: born in the UK and ethnicity, university education, 
employment, and higher-risk drinking (Table 83 and Table 84). 
 
8.3.8 Relationship between measures of IPV and age at sexual debut with sexual behaviour 
measures at the 12- and/or 24-month questionnaires 
When investigating the association of IPV measures with each sexual behaviour measure in 
modified Poisson regression models at each time-point, no associations were found at the 24-
month questionnaire in unadjusted analysis or analysis adjusted for key socio-demographic 
factors. However, at the 12-month questionnaire, any IPV victimization was associated with 
receptive CLS with an HIV-positive partner not known to be on treatment (adjusted PR 2.84 
95% CI: 1.27, 6.36; p=0.011) and any IPV victimization in the past year and any IPV 
perpetration was associated with group sex (adjusted PR 1.32 95% CI: 1.09, 1.60; p=0.004 and 
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adjusted PR 1.40 95% CI: 1.16, 1.69; p<0.001, respectively). In GEEs, measures of lifetime IPV 
victimization and perpetration were not associated with any of the sexual behaviour measures 
investigated, in unadjusted or adjusted analyses (see Appendix section 11.23 Figure 35 and  
Figure 36). However, any IPV victimization within the past year was associated with group sex 
(adjusted PR 1.37 95% CI: 1.06, 1.76; p=0.015). Measures of IPV within the past year were not 
associated with the other sexual behaviour measures. 
 
At the 12-month questionnaire, no associations were found of anal sex debut before age 13 and 
at age 15 years or younger with sexual behaviour measures, in unadjusted analysis or analysis 
adjusted for key socio-demographic factors. At the 24-month questionnaire, both measures of 
sexual debut were associated with report of CLS with five or more partners (adjusted PR 1.68 
95% CI: 1.28, 2.22; p<0.001 and adjusted PR 1.34 95% CI: 1.06, 1.69; p=0.015, respectively). 
In GEEs, no associations were observed, in unadjusted or adjusted analyses. 
 
8.3.9 Participant involvement in the interpretation of findings: summary of PPI responses 
In total, 12 men commented on the finding that men who were depressed did not report a higher 
number of sexual partners, or more sex without a condom, than men who were not depressed. 
The way in which the responses were organized into themes in the semantic content of the data 
is shown in Figure 28.
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Figure 28: Organization of PROUD PPI responses into codes, themes, and sub-themes 
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Based on a thematic analysis approach, three overarching themes were identified. The first was 
that men disagreed with the finding and suggested that depression was indeed associated with 
increased sexual risk-taking. The second was that men agreed with the finding that depression 
was not associated with increased sexual risk-taking and the third was that the association 
under investigation was not relevant to the PROUD sample of men. The views expressed by 
each individual were exclusive to one of the three themes. Within the first, second, and third 
theme described above, the following sub-themes are described: underreporting of sex, 
depression leads to less sexual activity, and do not detect a difference between depressed and 
non-depressed men, respectively.  
 
Within the sub-theme of underreporting of sex (n=1), one man suggested that shame and an 
inability to recall past sexual practices, may prevent individuals from accurately reporting their 
recent sexual behaviour history on questionnaires. This man cited an inability to recall sexual 
risk-taking specifically in the context of chemsex and group sex.  
 
Although it was not explicitly stated, given the question for which this response was provided, it 
may be possible that this man was referring in particular to those who may experience 
depression. For instance, men with depressive symptoms may be less likely to remember, 
perhaps as a result of the link between depressive symptoms and recreational drug use, or 
allow themselves to be cognitively aware of past sexual practices. Poly-drug use and chemsex-
drug use have been found to be associated with depressive symptoms in the AURAH study 
(Table 5 in Chapter 4 and sections 6.3.2- 6.3.3 in Chapter 6), and use of methamphetamine has 
been found to be associated with depressive symptoms at baseline of the PROUD trial (section 
7.3.4). The link between recreational drugs and depressive symptoms has also been observed 
in other studies of MSM 
(41, 346, 358, 454, 564, 606-609)
. Furthermore, findings from the SEM in Chapter 
6 suggest that in some men with depression, CLS may occur as a result of recreational drug 
use (section 6.3.6). In the self-regulation and coping literature, there is consistent evidence that 
those who experience depressive symptoms are more likely to engage in avoidant coping 
(362, 
403, 715)
 and cognitive escape 
(401-404)
, coping strategies which both involve escaping self-
awareness. If men with depressive symptoms were less likely to be able to recall past sexual 
behaviour and underreported any sexual risk-taking, this could provide some insight into why an 
association was not found between depression and increased sexual behaviour.  
 
The sub-theme of depression leading to less sexual activity (n=4), was defined by responses 
that depressive symptoms (or treatment for depression) lead to lowered libido and social 
withdrawal.  
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Although depressive symptoms were not associated with increased sexual risk-taking in the 
PROUD trial, the opposite, that depression leads to reduced sexual behaviour, was also not 
found to be the case. These notions, however, do reflect the suggestion by Crepaz and Marks 
(352)
 that in some individuals, current depressive symptoms may result in lowered libido/interest 
in sex and no sexual activity. In the AURAH study there was some suggestion that men with 
depressive symptoms were more likely to report no recent sex compared to condom-protected 
sex (as well as being more likely to report recent CLS) (see section 8.3.3). 
 
The sub-theme of not detecting a difference between depressed and non-depressed men (n=4), 
was defined by the suggestion that the PROUD study cohort consisted of men who were all 
taking risks (engaging in CLS). This sentiment was expressed by four men in various ways, 
including that all men in PROUD were simply having sex and that gay men are greater risk 
takers in general, that all men included in PROUD had to have disclosed recent CLS, and that 
all men in PROUD were aware of and already had insight into the reasons for engagement in 
CLS. 
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In the context of the question asked, these statements may indicate that an association was not 
observed between depressive symptoms and levels of CLS, since all men in PROUD were 
engaging in CLS, and were aware that they would likely continue to do so. Therefore, a 
difference was not detected between depressed and non-depressed men. 
 
Finally, 11 men commented on the finding that depressive symptoms were associated with 
report of PEP use in the past year at baseline. Six men responded to this question; two men 
gave responses ‘n/a’ and ‘Don’t know’, two men commented on PEP use whilst taking PrEP 
(since the finding was based on baseline data, these responses were not reviewed), and one 
man did not comment on the link between depression and PEP. All six men who responded to 
the question stated that PEP use is linked to sexual risk-taking, and two men brought up 
chemsex-drug use in the context of taking PEP.  
 
Chemsex-associated drug use was associated with all sexual behaviour measures investigated 
in the AURAH study (see Appendix section 11.16 and section 6.3.3 in Chapter 6). In PROUD, 
chemsex-drug use was associated with CLS with multiple partners (two or more and five or 
more), reporting ten or more new sexual partners, receptive anal sex with ten or more partners, 
PEP use, and rectal STI diagnosis, at baseline. Furthermore, qualitative work (2013-2014) 
among a volunteer sample of MSM suggests that a number of men whose last HIV test was 
negative had unintentional CLS as a direct result of ‘chem’ use 
(579, 580, 583)
.  
 
With regards to the link found between depressive symptoms and PEP use, two main themes 
were identified. Four men suggested that depression may lead to sexual risk-taking, in 
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particular, three men indicated that it may be a lack of self-care that results in risk-taking, and 
one man cited ‘emotional issues’ as a predictor.  
 
These suggestions appear to be in line with that hypothesized in this thesis, see section 1.9.1, 
that feeling unable (low self-efficacy) leads to lack of self-care and regulation (escape 
tendencies characterised by fatalistic beliefs), increasing the chances of sexual risk behaviour. 
Alternatively, two men suggested that sexual risk-taking, which is associated with PEP use, may 
lead to depression. One of these men suggested that chemsex may lead to depression, and 
that it is the effect of the ‘chems’ themselves that specifically result in depression.  
 
As discussed in detail in section 7.3.8, chemsex has been linked to depression 
(524, 579)
, including 
in the AURAH study (Table 5 in Chapter 4 and sections 6.3.2- 6.3.3 in Chapter 6). Although 
chemsex-associated drug use (past three months) was not associated with depressive 
symptoms among men in the PROUD trial at baseline, methamphetamine use was found to be 
associated. The other man highlighted the role that ‘self-recrimination and guilt’ following sexual 
risk may play in triggering depression, and even suggested a possible cycle involving sexual 
risk-taking and depression.  
 
The possibility of cyclical causation of depression and CLS is discussed in more detail in the 
thesis conclusion (Chapter 9). 
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8.4 Discussion  
 
8.4.1 Summary of results 
There was little support from the data for an association of depressive symptoms with CLS 
measures and partner numbers in the PROUD sample of men who, at enrolment, were required 
to report CLS in the past three months. The study trial arm was not found to moderate the 
association. There was also no evidence to suggest that antidepressant use was associated 
with sexual behaviour measures at baseline. Depressive symptoms were, however, associated 
with use of PEP in the past year at baseline, including after adjustment for socio-demographic 
factors and additional adjustment for higher-risk drinking and number of recreational drugs 
used. This relationship was also observed amongst men who did not report: (i) poly-drug use, 
(ii) chemsex-drug use, and (iii) club-drug use. It was not possible to investigate associations 
with PEP use at subsequent time-points. However, associations with PEP were broadly 
consistent across different definitions of depressive symptoms on PHQ-9.  
 
There was some evidence to suggest that depressive symptoms were associated with lower 
self-efficacy for sexual safety. Depressive symptoms were independently associated with 
difficulty saying no to unwanted sex and unhappiness with one’s sex life, as well with the 
following reasons for non-condom-use at last CLS; being under the influence of drugs/alcohol, 
not having any condoms, and not liking condoms. Finally, there was some evidence to suggest 
that lower self-efficacy for sexual safety and difficulty saying no to unwanted sex was 
associated with report of an unknown or HIV-positive status partner at last CLS. Measures of 
self-efficacy for sexual safety were not associated with any of the (other) sexual behaviour 
measures. 
 
8.4.2 Prevalence of sexual behaviour 
Given the inclusion criteria for enrolment in the PROUD trial, the prevalence of CLS measures 
found was much higher compared to the 68 surveys of sexual behaviour among UK MSM 
identified in review (ii) of this thesis (section 2.5.2). For instance, the prevalence of CLS with two 
or more partners in the past three months at baseline of the PROUD trial was 75.9%, and 
among UK studies identified in review (ii), the highest prevalence observed of CLS with two or 
more partners in the past year was 38.1% 
(144)
. 
 
8.4.3 Depressive symptoms and sexual behaviour 
For the main measure of depressive symptoms used in this thesis, no associations were found 
between depressive symptoms and higher levels of CLS, or partner numbers, in the PROUD 
trial of MSM at high-risk for HIV acquisition, despite the evidence for a relationship in AURAH 
(Chapters 5 and 6) and other studies of HIV-negative MSM (see section 2.4.5 of Chapter 2). 
The following sections consider possible explanations for this.  
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8.4.3.1 Participant involvement in PROUD study findings: depression not associated 
with sexual behaviour 
Participants identified three main reasons why an association between depressive symptoms 
and report of a higher number of sexual partners or more sex without a condom may not have 
been found. The first was that past sexual behaviour may have been underreported on study 
questionnaires, either as a result of embarrassment or an inability to recall sexual practices. 
Emphasis was placed on the effect chemsex and group sex may have on one’s ability to 
accurately recall sexual risk behaviour. Responses may have implied that if past sexual risk-
taking had been more accurately reported, and perhaps particularly by men with depressive 
symptoms, an association may have been detected. The second was that depression may 
actually lead to less sexual activity, rather than increased sexual risk-taking. The third was that 
a difference was not detected between men reporting depressive symptoms and men who did 
not, in terms of sexual risk behaviour, since all men enrolled in PROUD were reporting CLS.  
 
8.4.3.1 Depression, self-efficacy, drug use, and CLS: comparing PROUD findings to AURAH, 
and other studies investigating depression and CLS in review (i) 
In this section, possible interpretations as to why depressive symptoms were not found to be 
associated with sexual risk behaviours in PROUD are further explored. The following reasons 
given take into account the causal pathways between depression and CLS that were found to 
be consistent with AURAH data, see Figure 19c in Chapter 6.  
 
In PROUD, the prevalence of self-efficacy for sexual safety was low and the prevalence of 
recreational drug use was high, mirroring the high prevalence of multiple CLS partners reported 
by all men. However, this was not reflected by an equivalently high prevalence of depressive 
symptoms, thus depression does not appear to fit in to the hypothesized conceptual model 
when looking at PROUD data. The increase in depressive symptoms observed from baseline of 
PROUD (see section 7.3.1) may indicate a problem with the measurement of depression in this 
trial setting. Furthermore, the prevalence and impact of depression may differ in a PrEP trial 
population compared to an observational study. In addition to depression, other psychosocial 
factors may also explain recreational drug use (e.g. ‘outness’, minority stress, frequency of gay 
scene use, CSA, and IPV) and low self-efficacy for sexual safety (e.g. drug use, CSA, and IPV), 
and these factors may be particularly relevant to the PROUD RCT, for which men with 
depression may not choose to participate in.  
 
Furthermore, in the AURAH study, 27% of all MSM and 32% of MSM reporting recent sex 
reported CLS with two or more partners in the past three months. In AURAH, depressive 
symptoms were associated with all measures of CLS. The PROUD trial included a unique self-
selecting sample of men who reported high levels of CLS partners. Around three-quarters of 
men reported CLS with two or more partners in the past three months, across time-points, a 
much higher proportion than AURAH. Unlike in AURAH, in PROUD, levels of recreational drug 
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use rather than self-efficacy appeared to more consistently explain differences in high versus 
lower levels of CLS (as discussed in section 8.4.6 below). This may also explain why an 
association was not observed in PROUD, since findings from AURAH suggest that the main 
mechanism of effect between depressive symptoms and CLS is low self-efficacy for sexual 
safety. It may be that recreational drug use, and other factors with greater disinhibiting effects 
(including personality traits associated with sexual compulsivity/sensation seeking), better 
explain sexual behaviour among a sample of men predominantly reporting multiple CLS 
partners. Of note, of the studies presented in Table 1 of review (i) that have investigated the 
association between depressive symptoms and sexual risk behaviour (including those that 
found such an association), the vast majority were based on samples that reported much lower 
levels of CLS than in PROUD; levels that were comparable to that in AURAH. There is some 
support from AURAH for the theory that the association between depression and level of CLS is 
diminished when considering very high levels of CLS versus lower levels of CLS. In AURAH, the 
association was somewhat weaker among the subgroup of men who reported recent CLS than 
among the larger subgroup who reported recent sex. Similarly, although the prevalence of 
depressive symptoms appeared to increase with increasing report of CLS partners, the relative 
increase was smaller at higher levels of CLS in AURAH. However, it may also be worth 
considering that the PROUD trial may have lacked power to detect a smaller difference between 
depressed and non-depressed men, as reflected in the width of the confidence intervals. 
 
8.4.4 Depressive symptoms and PEP use 
In the PROUD trial, depressive symptoms were independently associated with use of PEP in 
the past year at baseline, as was found to be the case in the AURAH study (see section 5.3.2). 
 
8.4.4.1 Participant involvement in PROUD study findings: depression was associated 
with PEP use 
Although a link between depression and CLS was not explicitly observed in PROUD, an 
association with PEP use was found. Some respondents clearly interpreted this as a link with 
CLS, either that depression leads to CLS (resulting in PEP use) or that CLS (resulting in PEP 
use) leads to depression. In this context the following interpretations were given; depression is 
associated with a lack of self-care and regulation that leads to CLS, sexualized drug use leads 
to depression, and a possible cycle involving depression and CLS. The notion that the 
relationship between depressive symptoms and CLS may be cyclical is discussed in the context 
of the findings of this thesis in the final conclusion chapter. 
 
8.4.4.2 Depression, self-efficacy, CLS, and PEP use 
There are further explanations for understanding the association between depressive symptoms 
and PEP use in PROUD, in light of the contradictory finding that depression was not associated 
with high levels of CLS. It may be that some individuals who engage in high-risk sexual 
behaviour, depending on personality type and the type of coping mechanism they employ, are 
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more likely to become anxious and depressed as a result of their behaviour, which may 
consequently result in more PEP use. Alternatively, reasons for sexual risk among depressed 
men may be different to men who are not depressed. If this is the case, subsequent attitudes to 
and perceptions of CLS and therefore subsequent PEP use, may differ. Some support for this 
comes from PROUD findings on self-efficacy and reasons for non-condom-use at last CLS. 
Compared to men who did not have depressive symptoms, those who did were more likely to 
report low self-efficacy and tended to be more likely to give alcohol/drugs as reasons for non-
condom-use. This may suggest that the occurrence of CLS among men with depression tends 
to be more situational than intentional. Unplanned sexual risk-taking may be more likely to result 
in PEP use.  
 
Finally, it is possible that the relationship observed between depression and PEP use operates 
in the opposite direction; i.e. PEP use itself leads to depression. There is no evidence to 
suggest a biological effect of the antiretrovirals used in PEP on depression (see section 7.3.8). 
However, there may be unmeasured mediators such as confrontation with one’s sexual risk-
taking history during the process of PEP prescription or stigma attached to PEP use. This was 
suggested by PROUD participants as to why depression prevalence increased over the course 
of the first year of the study, see section 7.3.8.  
 
8.4.5 Socio-demographic factors associated with sexual behaviour 
Although not established in the UK MSM literature identified in review (ii) of this thesis 
(509, 510, 
512)
, there appears to be some evidence from the PROUD and AURAH studies, that not being in 
an ongoing relationship and reporting a bisexual or straight identity was associated with CLS 
with multiple partners (section 6.3.4 in Chapter 6 and Appendix Table 50 and Table 76). 
Although not observed in the PROUD trial, there does appear to be some evidence from 
AURAH (Appendix section 11.16 Table 76) and other UK studies identified in review (ii) 
(510, 512)
 
that lower levels of educational attainment are associated with CLS with multiple partners.  
 
8.4.6 Psychosocial factors associated with sexual behaviour 
Findings from the PROUD trial suggest that use of recreational drugs, including chemsex-
associated drug use in the past three months, may (at least) in part explain high levels of recent 
CLS and partner numbers, and as a result, PEP use and rectal STI diagnosis. This was also 
found to be the case in the AURAH study (Table 76 in Appendix section 11.16 and section 6.3.3 
in Chapter 6), in other UK studies of MSM 
(478, 484, 509, 511, 515)
, and in high-income country studies 
of MSM 
(397, 585-600)
. Higher-risk drinking was not associated with measures of CLS or partner 
numbers, nor PEP use or rectal STI diagnosis in the PROUD trial, in line with UK studies 
identified in review (ii) 
(478, 509)
. However, higher-risk drinking has been found to be associated 
with CLS measures in the AURAH study (Appendix section 11.16 Table 76). 
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A meta-analysis of studies from 1980-2011 has been conducted, which pooled ORs from 
studies measuring HIV status and/or sexual risk behaviour among adult MSM with and without 
experiences of CSA. In fixed-effects meta-analyses of 4367 and 7796 MSM, CSA was 
associated with recent CLS (pooled OR: 1.85 95% CI: 1.36, 2.51) and HIV seropositivity (pooled 
OR: 1.54 95% CI: 1.22, 1.95) respectively 
(604)
. Furthermore, a meta-analysis of studies 
published up to November 2013 pooled ORs from studies which measured IPV together with 
HIV status and/or sexual risk behaviour among samples including HIV-negative gay, bisexual 
and/or other MSM adults 
(605)
. In random-effects meta-analyses of 4447 and 8835 MSM, 
exposure to any kind of IPV was associated with anal CLS (pooled OR: 1.72 95% CI: 1.44, 
2.05) and HIV seropositivity (pooled OR: 1.46 95% CI: 1.26, 1.69) respectively. 
 
In the PROUD trial, measures of IPV were associated with report of receptive CLS with an HIV-
positive status partner not known to be on treatment and group sex at the 12-month 
questionnaire, including after adjustment for socio-demographic factors. Furthermore, reporting 
anal intercourse at age 12 or younger, which may include experiences of CSA, was associated 
with report of CLS with five or more partners at the 24-month questionnaire, including after 
adjustment for socio-demographics. However, with the exception of IPV victimization in the past 
year and group sex, these relationships were not observed in GEE models combining data from 
both follow-up time-points and incorporating greater statistical power. It may be that exposure to 
abuse in childhood and adulthood (in the context of an intimate partnership) is also not an 
effective means of distinguishing between individuals who report a higher number of CLS 
partners and individuals who report a lower number of CLS partners. In addition, a young age at 
anal sex debut may not reflect or pick up all sexual abuse experienced, as some participants 
may not have experienced forced/coerced sex and some CSA may occur at an older age. 
Unfortunately, it was not possible to investigate certain personality characteristics associated 
with sensation seeking and sexual compulsivity, as these factors may also be useful in 
understanding why some men who engage in CLS report a higher number of partners. 
 
8.4.7 Limitations 
The general methodological limitations of the PROUD trial are discussed in section 3.7.2 of 
Chapter 3. In this specific analysis, it is important to note that information on relationship status, 
the number and type of recreational drugs used in the past three months, higher-risk drinking, 
and PEP use and rectal STI diagnosis in the past year, was only available at the baseline 
questionnaire. It was not deemed appropriate to consider that these factors did not change over 
the course of the study. Accordingly, it was not possible to investigate these factors in GEE 
models, or even adjust for them at the 12- or 24-month questionnaires. It was also only possible 
to investigate group sex, self-efficacy for sexual safety, reasons for last CLS, and psychosocial 
factors in GEE models among the 436 men with data at the 12- and/or 24-month questionnaire, 
since information on these measures was not collected at baseline. Limitations with regards to 
the variable higher-risk drinking and extent to which age <13 years at anal sex debut may 
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indicate CSA, is described in detail in section 7.4.7. The proportion of missing responses 
recorded for rectal chlamydia, rectal gonorrhoea, syphilis, and LGV exceeded 5%. It was 
however, considered appropriate to continue to investigate these measures (and not apply 
multiple imputation techniques), given that the layout of the STI diagnosis question may have 
prompted participants to tick only those STIs that applied to them. Cross-sectional associations 
were investigated in this chapter, prohibiting us from making inferences about causality. Finally, 
as discussed in section 3.7.3, a large number of statistical tests were performed using PROUD 
data, due to analysis at each time-point. One measure of depression was positively associated 
with one CLS measure, but this was an isolated finding at one time-point, no associations were 
observed in any other analyses. Therefore, such a result could be due to chance.  
 
8.4.8 Summary of discussion 
Based on AURAH study findings and other studies in the literature, it appears that gay, 
bisexual, and other MSM with clinically significant depressive symptoms are more likely to 
engage in CLS than condom-protected sex even after adjusting for recreational drug use. 
However, based on PROUD trial findings and other studies in the literature, it appears that 
depressive symptoms do not explain why some men who engage in CLS have a high number of 
CLS partners (or a higher prevalence of more risky CLS). Higher levels of recreational and 
chemsex-drug use may better explain higher versus lower levels of CLS.  
 
Depressive symptoms were associated with PEP use at baseline, even after adjusting for 
higher-risk drinking and number of recreational drugs used. It may be that some individuals who 
engage in sexual risk-taking develop symptoms of depression and/or anxiety, which then leads 
to PEP use. On the other hand, evidence from the PROUD trial suggests that sexual risk-taking 
among men with depression tends to be more situational than intentional, leading to more PEP 
use. Findings from AURAH support this notion, whereby the main mechanism through which 
depression might lead to sexual risk behaviour was lowered self-efficacy for sexual safety.
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9 Implications of thesis findings and final conclusions 
 
9.1 Summary of thesis background, hypothesis, and structure 
 
Depression is a psychological construct that is used to describe the co-occurrence of a number 
of symptoms, including feelings of worthlessness and hopelessness, anhedonia, sleep and 
appetite disturbance, and suicidal thoughts, which may be rooted in traumatic events (perhaps 
early on in life) 
(252, 257-266)
, and may reflect impaired neural functioning 
(265, 270-313)
. This thesis 
addressed how these symptoms might affect sexual behaviour. The question was studied 
among gay- and, to a lesser extent, bisexual-identified men, and other MSM. In Chapter 1, the 
background to and rationale for this thesis was presented. Theoretical and epidemiological 
research was presented that suggests that the study of depression is particularly relevant 
among individuals of a sexual minority status as such status may induce high levels of stress as 
a result of a discriminatory social environment, which may lead to depression 
(211, 223-225, 227, 235-
239, 242)
. Epidemiological trends in HIV in the UK were presented, which suggest that HIV 
transmission remains ongoing among MSM 
(43)
. Therefore, the hypothesis to investigate 
whether symptoms of depression are associated with sexual behaviour linked to increased risk 
of STI and HIV acquisition (in particular CLS) among sexual minority men in the UK was 
developed. 
 
There was considerable evidence from the literature review presented in Chapter 2 of this 
thesis, for an association between depressive symptoms and increased sexual risk behaviour 
(and HIV seroconversion 
(369)
) in high-income country studies of MSM (1996-2014) 
(353-368)
. It 
was theorized in studies identified from the literature review that depressive symptoms may lead 
either to increased sexual risk-taking or to lowered libido/interest in sex and sexual inactivity. 
The direction of the association may depend on the severity of the symptoms and/or the type of 
coping mechanism employed by the individual. For instance, individuals who experience severe 
symptoms of depression may be more likely to withdraw from social and sexual activity, 
whereas, individuals who experience moderate symptoms may be more likely to engage in 
sexual risk behaviour 
(352)
. Alternatively, more recent research suggests that it may be  genetic 
and environmental influences that determine response to depression; some individuals may 
cope with depression with more externalizing responses such as substance use and sexual 
risk-taking, whereas, others may cope with more internalizing responses such as social 
withdrawal and other regressive behaviours 
(307, 362, 566, 568-573)
. Theoretically, when studying the 
association between depression and sexual risk in a study sample, an overall lack of 
association may be due to opposing associations: depression linked to sexual risk but also to 
lack of sexual activity. Of the studies identified in the literature review, those that investigated a 
Chapter 9 
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sexually active sample appeared to consistently find an association between depressive 
symptoms and increased sexual risk-taking. An association was consistently found regardless 
of where the sample of men was recruited from, if the analysis was restricted to men who 
reported recent sex. Understanding at which recruitment sites men may be more likely to be 
engaging in sexual activity, may have implications for intervention. It was identified in the 
literature review that men attending sexual health clinics, as well as men recruited online, may 
report a higher prevalence of sexual risk behaviour compared to men recruited elsewhere (from 
community/commercial gay venues or the general population). Therefore, HIV prevention 
interventions focused on depression and targeted at sexual health clinic attendees (or possibly 
men using certain websites) may be more relevant and cost-effective. The vast majority of 
studies reviewed were conducted in the U.S. The implications of these findings in the 
UK/European context were unclear.  
 
The hypothesized mechanism by which depressive symptoms lead to sexual risk behaviour, 
conceptualised in this thesis, was derived from findings in the literature review. Depressive 
symptoms were hypothesized to be associated with CLS indirectly via lowered self-efficacy for 
sexual safety. Self-efficacy is another psychological construct that, in a sexual context, is used 
to describe a perceived inability to exert control and keep oneself sexually safe (for example by 
condom-use). The association between depressive symptoms and sexual risk behaviour was 
also hypothesized to be partially confounded by recreational drug use, childhood sexual abuse 
(CSA), and intimate partner violence (IPV). The hypothesis was investigated in this thesis using 
data from the AURAH and PROUD studies of HIV-negative gay, bisexual, and other MSM in 
England. AURAH is an observational cross-sectional study that recruited men attending 20 
GUM clinics. Analyses in this thesis were restricted to men in the AURAH sample who reported 
recent sex. PROUD recruited men who volunteered to participate in a randomised trial of PrEP 
efficacy, for which eligibility required that men reported ongoing CLS. The methodology of these 
studies was presented in Chapter 3 of this thesis. 
 
In Chapter 4, using data from AURAH, the prevalence of depressive symptoms was examined 
and the association of demographic, socio-economic, and lifestyle factors with depressive 
symptoms was assessed. In Chapter 5, the thesis hypothesis was investigated. Chapter 6 
extended the analyses presented in Chapters 4 and 5 by investigating in a single conceptual 
model, key hypothesized relationships with higher levels of depressive symptoms and CLS 
measures (including a number of complex mediational chains). In this chapter, the hypothesis 
that depressive symptoms would be associated with CLS indirectly via lowered self-efficacy for 
sexual safety was examined in more detail.  
 
Using data from PROUD, Chapter 7 investigated the prevalence of depressive symptoms and 
associated factors. In Chapter 8, among the unique self-selecting sample of high-risk MSM in 
PROUD, the thesis hypothesis was investigated. Chapters 7 and 8 extended the AURAH 
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analyses, since information on age at anal sex debut (sex at a very young age may include 
experiences of CSA) and IPV, as well as other important psychosocial factors (markers of 
minority stress) was collected in PROUD. 
 
Each of the results chapters provided a summary and interpretation of findings, in the context of 
existing literature, and assessed limitations of the analyses. 
 
The findings presented in this thesis represent the largest study of the role of depression in 
sexual behaviour linked to STI/HIV transmission among sexual minority men in the UK to date. 
This final chapter draws together the results and considers implications for the epidemiological 
study of the link between depressive symptoms and sexual behaviour, as well as for clinical 
practice, and for possible interventions for HIV prevention.  
 
9.2 Depression and sexual behaviour: interpretation of results 
 
9.2.1 Link between depression and sexual behaviour in different samples of men 
The relationship between depressive symptoms and sexual behaviour may be complex. It has 
been theorized that the prevalence of depressive symptoms may be elevated both among men 
who do not report recent sexual intercourse and men who report recent CLS, and lower among 
men who report condom-protected sex- creating a U-shaped relationship. Findings from the 
AURAH study (presented in Chapters 5, 6, and 8) support this theory. As described above, it is 
possible that some individuals may cope with depression with internalizing responses, whereas, 
others may cope with externalizing responses.  
 
Among MSM reporting recent anal/vaginal sex in the AURAH study, in line with that 
hypothesized, symptoms of depression were strongly associated with markers of sexual risk: 
multiple CLS partners, unknown/HIV-positive status CLS partners, receptive CLS with unknown 
HIV status partners, bacterial STI diagnosis, and PEP use. Associations remained, although 
most were somewhat attenuated, after adjustment for regular smoking, higher-risk drinking, and 
number of recreational drugs used. The observed associations were also present among men 
who did not report drug use. Unfortunately, it was not possible to investigate the role of CSA 
and IPV in these relationships. However, AURAH findings in the UK add to substantial evidence 
(mainly from the U.S.) that sexually active men with depressive symptoms are more likely to 
engage in CLS versus condom-protected sex than are sexually active men without depressive 
symptoms, even after adjusting for recreational drug use.  
 
In the PROUD trial of MSM reporting high levels of CLS, symptoms of depression were not 
associated with measures of CLS, including rectal STI diagnosis. It may be that symptoms of 
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depression do not distinguish between men reporting higher levels of CLS partners and lower 
levels of CLS partners- creating a plateauing effect in the U-shaped relationship. An additional 
exploration of data from AURAH provides some support for this theory: the association between 
depressive symptoms and higher levels of CLS appeared weakened among the subgroup of 
men with at least one CLS partner, although the association did remain. It may be that high 
levels of CLS partners are better explained by factors with greater disinhibiting effects and 
capacity for sexual arousal, such as personality traits associated with sensation seeking/sexual 
compulsivity and recreational drug use. This is supported by findings from the PROUD trial 
(Chapter 8), in which a higher number of recreational drugs used and chemsex-associated drug 
use were the only measures (for which data was available) found to be consistently associated 
with higher levels of CLS and partner numbers.  
 
9.2.2 Mechanisms of association 
In the AURAH study of sexually active men, depressive symptoms were associated with CLS 
measures indirectly via lowered self-efficacy for sexual safety (Chapter 6). In addition, reporting 
a higher number of recreational drugs used appeared to be another, distinct, pathway through 
which depressive symptoms might lead to CLS. However, in line with the hypothesis set forth in 
this thesis, self-efficacy appeared to be the most important factor leading to CLS in the SEM 
presented in Chapter 6. This is reflected by the fact that the link between depression and CLS 
measures was attenuated but remained after adjusting for drug use in modified Poisson 
regression models in Chapter 5. There was a greater degree of attenuation after adjusting for 
self-efficacy in regression models, most likely because the main indirect path was blocked.  
 
It was assumed in this thesis that in order for men with depression to engage in CLS (have an 
externalized response to symptoms) a process of cognitive escape would most likely have to be 
enacted. Cognitive escape is a theoretical process whereby individuals turn their attention away 
from threatening cues in order to engage in a desired behaviour such as sex. Cognitive escape 
may take two forms: thought suppression or fatalistic beliefs. It was hypothesized in this thesis, 
that a perceived inability to maintain sexual safety (low self-efficacy) would for some individuals 
lead to fatalistic beliefs about HIV, with implications for sexual risk-taking. It was also 
hypothesized that recreational drug use may lead to CLS directly or indirectly via engagement in 
cognitive escape processes. Unfortunately, it was not possible to investigate the role of 
cognitive escape on the two causal pathways identified, since a measure of cognitive escape 
was not collected in AURAH or PROUD. 
 
The finding that self-efficacy for sexual safety via condom-use, which requires exertion of 
control through discussion/negotiation in an interpersonal situation, may play an important role 
on the causal pathway between depression and CLS, may explain why a relationship was 
observed with CLS measures but not higher partner numbers in the AURAH study (Chapter 5). 
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Furthermore, there was some evidence to suggest that recreational drug use plays a role in the 
link between depression and high partner numbers.  
 
In PROUD, although depressive symptoms were not associated with high levels of CLS, they 
were associated with PEP use (Chapter 8). When investigating reasons for non-condom-use, 
patterns of association suggested that men with depressive symptoms may be more likely to 
report measures of low self-efficacy for sexual safety and less likely to report CLS because they 
were intentionally seeking it and did not consider it placing them at risk. This may explain the 
observed relationship with PEP use. These findings lend some support to the conclusion that 
self-efficacy may be an important mechanism through which depression leads to CLS. 
 
In addition to management of depressive symptoms, reducing sexual risk-taking among sexual 
minority men with depression may require interventions that address self-regulatory skills for 
sexual safety (including negotiation of condom-use) and integrate or offer referral to substance 
use services.  
 
To conclude this section, it is necessary to acknowledge that CLS with a partner should not in 
itself be pathologized. The act of CLS will often occur within the context of loving and mutually 
supportive relationships. Strategies may also be used to try and reduce any perceived risk of 
HIV transmission such as use of PrEP, serosorting and seropositioning, or knowledge that an 
HIV-positive partner has a stably suppressed viral load. In the AURAH study, men who reported 
an ongoing relationship with a partner were more likely to report CLS, as has been found in 
other UK studies of MSM 
(482, 496, 510)
. In AURAH, most CLS was CLS with a non-regular partner. 
The link found between depression and the act of CLS, may occur primarily within the context of 
non-regular partnerships. This may be supported by the finding that depressive symptoms were 
associated with CLS with two or more partners, CLS with an unknown/HIV-positive status 
partner (excluding reports of one long-term HIV-positive partner on ART), and receptive CLS 
with an unknown HIV status partner. These associations were mediated by low self-efficacy for 
sexual safety. CLS with one or more partners was the outcome focused upon in the SEM in this 
thesis, since depressive symptoms were hypothesized to lead to non-condom-use in itself. 
However, additional analyses suggested the same pattern of results for other CLS measures. 
The other measures of CLS described above could be considered to be the most important in 
terms of HIV prevention, as these in particular may confer more significant risk of HIV infection.  
 
9.2.3 Temporality of association: investigating criteria for causality 
The Bradford Hill Criteria for causality are presented in Chapter 3 (section 3.4.4). Each of the 
nine criteria are briefly evaluated based on findings from this thesis, in order to infer whether the 
  
 
 
303 
 
observed association between depressive symptoms and CLS measures (in the context of 
samples in which condom-protected sex and CLS is reported) is likely to be causal. 
 
In terms of the consistency and strength of the association (criteria 1 and 2), the majority (68%) 
of studies that have investigated the link between depressive symptoms and measures of CLS 
among MSM samples including HIV-negative MSM, in high-income countries, have found a 
statistically significant positive association, including after adjusting for recreational drug use. 
Although it is unclear what the effect of adjusting for CSA and IPV might be. In particular, the 
association has been consistently demonstrated in samples of sexually active men, across 
geographical locations and study years, samples of differing age and ethnic profiles, and 
statistical methodologies. In this thesis, the association was consistently demonstrated in 
analyses based on AURAH, but not in those based on PROUD, possibly due to the selected 
high-risk sample recruited into the trial. In terms of strength of association, it is difficult to 
comment on the general magnitude of association given the investigation of different depression 
and sexual behaviour measures, using various statistical techniques, across studies. Logistic 
regression was the most common statistical technique utilized and reported ORs (adjusted for 
socio-demographics, alcohol, and drug use) ranged from 1.3 to 5.72. ORs adjusted for socio-
demographics, for the association across different measures of sexual risk in the AURAH study, 
ranged from 1.80 to 2.13, suggesting a moderate to strong association. The finding of a 
statistically significant association in a number of studies (n=7) consisting of a small sample size 
(≤240 men) provides some further evidence in favour of a strong, and therefore perhaps more 
likely causal, relationship between depressive symptoms and sexual risk behaviour. 
 
In addition, specificity (criterion 3) may be inferred by the apparent association between 
depressive symptoms and CLS measures, but not measures of high partner numbers in the 
AURAH study. These findings are in line with the hypothesized mechanism (reduced self-
efficacy for sexual safety) leading to sexual risk behaviour set forth in this thesis. 
 
In terms of criterion 4, temporality, evidence is limited, as most studies have been cross-
sectional, with depression and CLS measured at the same time. It is not possible to comment 
on criterion 4 based on findings from AURAH and PROUD in this thesis, as AURAH was a 
cross-sectional study and the PROUD data were analyzed as cross-sectional. As all men in 
PROUD reported ongoing CLS at baseline, it was not possible to assess ‘incidence’ of CLS, 
and power was insufficient to analyze incident HIV infections. However, there does appear to be 
some evidence from U.S. studies for the temporality of the association. Two longitudinal studies 
have investigated the association between depressive symptoms and HIV incidence, whereby 
an association was observed in EXPLORE 
(367-369)
 but not MACS 
(361, 431)
. However, in the latter 
study depressive symptoms did predict a higher sexual risk trajectory.  
 
  
 
 
304 
 
In terms of criterion 5, biological gradient, the prevalence of CLS increased with increasing 
severity of depressive symptoms in the AURAH study, as was the case in U.S. studies 
investigating categories of depressive symptom severity 
(357, 359, 360, 365, 367-369)
. Furthermore, in 
terms of biological plausibility and coherence (criteria 6 and 7), evidence from across disciplines 
suggest that depression (or at least greater vulnerability towards depression) may precede the 
onset of risky sexual behaviour. Evidence from cognitive psychology suggests that depression 
may have strong roots in childhood and early adolescence. Its precursor is the meaning 
assigned to early/formative experiences and the subsequent formation of a systematic cognitive 
bias in the information processing system, which may affect responses to negative stimuli later 
on in life 
(252, 257-266)
. Evidence from genetic and neurophysiological studies reiterate these 
findings 
(265, 270-313)
 and suggest that some individuals with depression react to symptoms with 
externalizing responses such as substance use and sexual risk-taking 
(307, 566, 568-573)
.  
Furthermore, in the self-regulation and coping literature, social cognitive theory 
(256, 262, 381-387)
 
has postulated that depressive symptoms may lead to a perceived inability to produce a desired 
outcome. This is particularly accurate in the context of interpersonal interactions extending to 
sexual situations. In addition, cognitive escape theory 
(396-399, 401-404)
 
(397, 400)
 posits that symptoms 
of depression may lead to the notion that acquiring HIV is inevitable, with implications for sexual 
risk-taking. In the AURAH study, low self-efficacy for sexual safety was found to mediate the 
association between depressive symptoms and CLS, as has been observed in previous studies 
of sexually active U.S. MSM 
(362)
 and South African MSM 
(699)
. In addition, in the AURAH study, 
high levels of recreational drug use were also found to mediate the association between 
depressive symptoms and CLS. Although this association was primarily investigated in the 
opposite direction in this thesis, in the cognitive escape model, men with depressive symptoms 
may engage in recreational drug use as a form of self-medication and/or in order to induce a 
state of cognitive release 
(397)
. Recreational drug use may directly lead to sexual risk-taking via 
autonomic or central nervous system mechanisms which increase sexual arousal and 
disinhibition, or indirectly by inducing a state of cognitive release and escape from rational self-
awareness 
(397, 597)
.  
 
Further evidence in favour of a ‘coherent story’ comes from the associations observed between 
different measures of depressive symptoms, including suicidal ideation, with measures of CLS 
in the AURAH study. In addition to the associations observed between depressive symptoms 
and CLS, treatment for depression was also associated with CLS measures in AURAH, again 
providing some evidence in favour of coherence. However, the fact that, for some measures, 
CLS was elevated even among men who reported receiving treatment for depression and no 
current symptoms of depression, suggests that the effect on CLS was not reversed with the 
removal of symptoms as a result of treatment. Therefore, there is less support for criterion 8 of 
experimental manipulation- that reducing the exposure would reduce the occurrence of the 
outcome. However, as discussed in Chapter 5, the measure for treatment of depression may 
not capture all the necessary information. Criterion 9 (analogy) may be met, since symptoms of 
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generalized anxiety disorder (GAD), a common mood disorder for which there is overlap with 
depressive symptoms, were also associated with CLS measures in the AURAH study, and 
associations were found to be of a similar, albeit slightly weaker, magnitude. 
 
Using the Bradford Hill Criteria to evaluate findings in this thesis provides some support in 
favour of a causal association between depressive symptoms and measures of CLS, but does 
not conclusively demonstrate that causation operates in one direction only. It is also plausible, 
however, that CLS may further perpetuate depression, perhaps making the symptoms worse, 
prolonging episodes, or even triggering the onset of depression. CLS may for some individuals 
reinforce a perceived inability to exert control in sexual situations, thereby lowering self-efficacy 
for sexual safety. It is theorized in social cognitive theory that low self-efficacy triggers 
depression and then depression further triggers low self-efficacy. Perhaps it is possible that 
depressive symptoms lead to CLS indirectly via low self-efficacy for sexual safety, which then 
leads to a cycle of associations, possibly involving self-efficacy. The interpretation of findings 
given by some of the PROUD participants supports this theory. 
 
9.3 Implications for analysis of data from epidemiological studies investigating 
depression and sexual behaviour 
 
Findings from this thesis suggest that when investigating the link between depression and 
sexual behaviour among sexual minority men in epidemiological studies, the behavioural profile 
of samples is important in explaining the presence/absence of an association. The U-shaped 
relationship between levels of sexual behaviour and depressive symptoms (see section 8.3.3.2) 
should, therefore, be taken into account when investigating the role of depression in sexual 
behaviour linked to STI/HIV acquisition. In other words, when investigating associations 
between depression and CLS, rather than comparing CLS to ‘no CLS’, it is important to 
separate out the group of men reporting condom-protected sex from those not reporting sex. At 
the same time, it is important to consider that the prevalence of depressive symptoms may 
begin to plateau among individuals reporting very high levels of CLS partners. Therefore, the 
relationship between depressive symptoms and increased sexual risk behaviour may be weaker 
among men reporting high levels of CLS. Among samples of men at high-risk of HIV infection, 
recreational drug use may be a more effective predictor of increased sexual risk-taking.  
 
Furthermore, it may be beneficial to examine hypothesized relationships in a SEM framework, in 
order to assess possible indirect effects and better understand the mechanism of effect.  SEM is 
also useful in allowing an investigation into whether alternative hypotheses are more consistent 
with the data, thereby generating further hypotheses. In the AURAH study, an alternative 
hypothesis, whereby depressive symptoms lead to CLS indirectly via low self-efficacy for sexual 
safety as well as indirectly via recreational drug use, was found to be slightly more consistent 
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with the data. These causal pathways should be investigated in epidemiological studies, 
together with alternative pathways via for instance IPV, in order to shed further light on the 
association between depression and sexual risk behaviour.  
 
9.4 Implications of a possible causal link between depression and sexual risk 
behaviour for sexual health clinical practice  
 
Clinical psychology service provision within GUM was introduced in the UK in the early 1980s in 
response to the onset of the HIV epidemic. The British Psychological Society dictates that the 
primary role of clinical psychologists within GUM settings is to address the psychological needs 
of individuals whose lives are affected by sexual health problems, including HIV infection, 
genital herpes, and genital warts 
(716)
. In a recent survey conducted by the BASHH Special 
Interest Group in sexual dysfunction, some but not all of the 273 UK GUM clinics incorporated 
psychological interventions, including brief counselling, CBT, psychosexual therapy, integrated 
therapy, and hypnosis, into service provision (exact proportion not reported; 25% incorporated 
psychosexual therapy). The major barrier to integrating psychological interventions into GUM 
settings was reported to be funding 
(717)
. The 2012 BASHH guidelines suggest that in order to 
reduce sexual risk-taking; intensive, multi-session, evidence-based behaviour change 
interventions, which may encompass safer sex advice and strategies to enhance 
communication skills and motivation to adopt safe sex practices
xli
, should be offered either by 
trained clinic staff or by referral in all UK GUM clinics (where resources are available) 
(718)
. It is 
recommended that interventions should be provided to attendees at greatest risk of STI/HIV 
transmission, including those with a history of bacterial STI diagnosis or substance abuse. 
BASHH states that although poor mental health may be useful in identifying individuals at high-
risk of poor sexual health outcomes, there is not enough evidence to conclude an elevated risk 
of STI/HIV infection among those with psychological conditions 
(718)
. Therefore, UK guidelines 
regarding GUM service provision have emphasized the need to address mental health in the 
context of the emotive significance attached to acquiring STIs and the lack of evidence, 
particularly among MSM, that those who disclose/screen positive for a mental health condition 
should be targeted for a sexual risk reduction intervention.  
 
                                                     
xli
 It is suggested that behaviour change interventions could take the form of motivational interviewing, 
which consists of a “collaborative, person-centred form of guidance aimed at eliciting and strengthening an 
individual’s motivation for change”. It is also suggested that behaviour change interventions should be 
incorporated within a combination approach to prevention, which may include referral to group and 
community-based behavioural interventions, as well as offering biomedical interventions (PEP, PrEP, and 
TasP). It is also suggested that computer assisted interventions should be considered as an alternative or 
adjunct to clinical staff delivered interventions, for instance videos shown in waiting rooms  
718. Clutterbuck D, Flowers P, Barber T, Wilson H, Nelson M, Hedge B, et al. UK National Guidelines 
on safer sex advice. The Clinical Effectiveness Group of the British Association for Sexual Health and HIV 
(BASHH) and the British HIV Association (BHIVA). United Kingdom: British Association for Sexual Health 
and HIV (BASHH) and the British HIV Association (BHIVA), 2012.. 
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In AURAH and PROUD, of HIV-negative MSM attending GUM clinics and/or reporting high 
levels of CLS and interest in PrEP, around half of those with evidence of current depression 
reported receiving medical treatment or therapy for depression. Although it is not known how 
many of those who were untreated had been offered treatment, the findings suggest that there 
is unmet need in terms of depression among MSM attending GUM clinics. Findings from this 
thesis suggest the need for a more integrated sexual health approach. This includes screening 
for depressive symptoms using brief instruments, such as the PHQ-9, which may be useful in 
identifying individuals who could be offered referral for interventions with proven efficacy such 
as psychotherapy and/or anti-depressant medication 
(719, 720)
. In parallel, integration of 
substance use services or referral to such services could be used to the same effect- to 
alleviate symptoms and potentially reduce future sexual risk-taking.
(721)
 Given the finding in this 
thesis that men attending GUM clinics may be more likely to cope with depressive symptoms 
with externalizing responses, due to their somewhat unique behavioural profile, it may be 
beneficial to offer attendees with depression referral to an HIV prevention intervention that 
specially addresses sexual risk-taking as a result of depressive symptomatology. A number of 
suggestions for developing an intervention addressing depression and sexual behaviour among 
sexual minority men are given below. A suggestion is given for a two stage group intervention. 
In the first stage, possible roots of depression among sexual minority men could be addressed 
and attempts made to ameliorate symptoms. In the second stage, attempts could be made to 
improve self-efficacy for sexual safety, potentially reducing sexual risk-taking. 
 
9.4.1 Implications for intervention to ameliorate effects of depression among sexual minority 
men 
In the PROUD trial, markers of internalized homophobia and concealment of one’s sexual 
orientation to close family, friends, and work colleagues was strongly associated with 
depressive symptoms, including after adjustment for socio-demographic factors. In the AURAH 
study, concealment of sexual orientation was associated with higher levels of depressive 
symptoms indirectly via a strong association with less frequent visits to gay venues and lower 
levels of a supportive network. At the same time, reporting less frequent visits to gay venues 
was associated with lower levels of depressive symptoms via lower levels of recreational drug 
use. Throughout this thesis, recreational drug use was found to be associated with depressive 
symptomatology. In AURAH, the symptoms that predominate in depressive episodes differed 
between men who reported chemsex-drug use and men who did not. For men who reported 
chemsex-drug use, anhedonia and poor appetite/overeating were among the most important 
factors that explained the presence of depression, perhaps reflecting the direct psychological 
and physical effects of the drugs themselves. Furthermore, in PROUD, reporting IPV 
victimization and IPV perpetration was very strongly associated with depressive symptoms.  
 
These findings lend support to the notion that addressing the potential root of mental health 
disorders among sexual minority individuals may be important in order to foster greater 
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community affiliation and support, and curtail stress. At the same time however, actively 
providing help to men, who may want it, who are active on the gay scene and may be using 
recreational drugs is vital as well in ameliorating the effects of depressive symptoms.  
 
Although it is important to be cognizant of the unique forms of stress experienced by sexual 
minority men, it should not be forgotten that one’s stress is often framed within one’s socio-
economic context. Therefore, emphasis on alleviating economic hardship together with efforts to 
promote self-acceptance and pride towards one’s sexual orientation should be considered 
together when addressing depression among sexual minority men. In addition, addressing the 
damaging effect unhappy relationships may have on one’s mental health may play an important 
role. Referral to services which provide individuals with the skills and advice needed to create 
and maintain successful relationships, and that encompass culturally appropriate structures set 
up to address IPV among same-sex male couples, may be useful.   
 
Furthermore, in AURAH, older age was associated with being in an ongoing relationship with a 
partner and concealment of sexual identity. Younger age was associated with higher levels of 
recreational drug use via a greater tendency to be ‘out’ with one’s sexual orientation and be 
active on the gay scene. These findings may suggest the need for separate interventions for 
younger and older sexual minority men. It may be that interventions focused on younger men 
should address recreational drug use on the scene and interventions focused on older men 
should address relationship counselling, community participation, and social support. 
 
Care should be taken not to treat sexual minority men as a homogenous group, as gay-
identified and plurisexual-identified men may have different needs. There is a growing body of 
evidence to suggest that bisexual-identified men experience a greater burden of depressive 
symptomatology than do gay-identified men 
(354, 415, 679, 680)
, as was found to be the case in the 
AURAH study, and for which there was some suggestion in PROUD. It is important to be 
cognizant of the heterogeneities present between sexual minority men and to tailor and target 
interventions carefully. Care should be taken to include bisexual and other men whose sexual 
identity is not based on attraction to one sex/gender, in efforts to promote social support and 
manage symptoms of depression. 
 
Of note, although age at anal sex debut (sex at a very young age may include experiences of 
CSA) was incorporated into the PROUD questionnaire, reporting anal intercourse at age 12 or 
younger was not found to be associated with depressive symptoms. It is possible that this 
measure may not have fully captured experiences of CSA. There is some evidence to suggest 
that sexual abuse in childhood is associated with depressive symptomatology later on in life 
(41, 
368, 610)
. Addressing CSA associated trauma may be better conducted in one-to-one sessions 
with a psychotherapist. Finally, the above suggestions for intervention are given for ameliorating 
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symptoms of depression in adulthood. It is acknowledged that intervening with sexual minority 
individuals at a young age i.e. in schools and/or in LGBTQA youth groups, most likely will have 
positive effects on preventing the onset of mental health problems later on in life 
(343)
. Public 
health emphasis should be placed both on preventing depression among sexual minority youth 
and ameliorating symptoms among sexual minority adults.  
 
9.4.2 Implications for intervention to improve sexual safety 
As described above, improved screening and referral of individuals with depressive symptoms 
to appropriate interventions is of public health importance. In the context of considering an 
intervention to improve sexual safety by managing depression, it is important however, to 
recognize the fact that treating/curing depression is challenging. Treatment most often requires 
therapy to re-wire faulty information processing and/or pharmacological intervention. The lack of 
ease of access (due to waiting times and financial constraints) to talk therapies, including 
various forms of psychotherapy and CBT, and lack of efficacy of anti-depressant medication 
add to the challenge that is treating depression. There is little dispute, if any, that lacking 
confidence in one’s ability to produce a desired outcome goes hand-in-hand with depression. In 
order to reduce sexual risk-taking, what may be possible to suggest, given the findings of this 
thesis, together with those of Alvy et al (2011) 
(362)
, is to intervene upon beliefs of self-efficacy 
for sexual safety among individuals with depression, for which there does appear to be some 
evidence to suggest that self-regulatory programmes can greatly improve (see section 1.8.3.3 of 
Chapter 1). 
 
Seminal work by Kelly (1995) 
(388)
 demonstrated the effectiveness of self-regulatory 
programmes for improved self-efficacy for sexual safety in the U.S. Similarly, Mpowerment, a 
community-level intervention that utilized a similar technique to Kelly and colleagues, was 
evaluated and found to be efficacious in reducing CLS among young U.S. sexual minority men 
in the 1990s 
(722)
.  Mpowerment encompassed peer-led meetings whereby the following topics 
were discussed: clearing up misconceptions about safer sex, eroticizing safer sex, promoting 
condom-use, and learning verbal and non-verbal safer sex strategies. This intervention has 
recently been re-evaluated among young BAME MSM in three CDC-funded community-based 
organizations (N=298) 
(723)
. After adjusting for level of intervention exposure and socio-
demographic factors, self-efficacy for sexual safety was found to increase significantly from 
baseline to the three and six month follow-up. The prevalence of CLS was found to decrease in 
the short-term but not longer-term. A control group was not included in this study. The authors 
suggested that a booster intervention would be needed to sustain behavioural changes in the 
long-term. Findings from Kelly (1995) 
(388)
 and the Mpowerment study 
(723)
 may be promising in 
terms of developing interventions that address self-regulatory skills among men with symptoms 
of depression, among whom self-efficacy for sexual safety may be lowered. It is of note, 
improving self-efficacy for sexual safety may also help in ameliorating symptoms of depression, 
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and hence have wider health benefits, especially if CLS does contribute to depressive 
symptoms in a cyclical manner involving self-efficacy, as discussed above in section 9.2.3. 
 
It appears vital to remain aware and focus efforts on drug use, and chemsex-drug use in 
particular, in terms of reducing very high levels of sexual risk-taking. Furthermore, although the 
suggestions for intervention given are for GUM clinic attendees, they may also be useful for 
MSM who do not attend these services. Findings from the literature review in this thesis also 
suggest that men recruited online may be more likely to cope with depression with more 
externalizing responses, with implications for sexual risk-taking, given the levels of sexual risk 
behaviour noted among online samples. Recruitment of men online for intervention and/or 
online interventions may reach a broad cross-section of men, including individuals with little or 
no community attachment. However, it is of note that it is difficult to generalize about men 
recruited online since the sample depends on how exactly men were recruited i.e. via 
advertisement on dating apps/websites or on Facebook/social media.  
 
9.5 Conclusions 
 
In conclusion, findings from this thesis suggest that among sexually active men, management of 
depression alongside interventions surrounding self-efficacy for sexual safety may play an 
important role in HIV/STI prevention. A combination of efforts that address stress related to 
sexual minority status and socio-economic hardships common to the general population may be 
needed to alleviate depressive symptomatology. In particular, having a supportive network, 
which may be intricately linked to disclosure of one’s sexual identity and community affiliation, 
appears to play an important protective role with regards to depression among sexual minority 
men. At the same time, in order to provide individuals with the tools needed to exercise self-
protective control over interpersonal sexual situations, it may be useful to offer a guided self- 
enablement programme that simulates experiences of mastery in the exercise of personal 
control 
(256, 388)
. Finally, addressing recreational drug use in both the context of mental health 
and sexual health remains an important issue. Integration of substance use services into GUM 
clinics or referral to such services may be useful in potentially reducing depressive 
symptomatology and future sexual risk-taking. 
 
9.6 Recommendations for future research 
 
Based on work conducted in this thesis, five manuscripts/reports have been published and three 
additional papers are in preparation at the time of submission (December 2017). Further work 
required is discussed below. 
 
To date, there have been no UK survey studies of mental health and sexual behaviour that are 
tailored to sexual minority men at risk of HIV acquisition. Such a study would include a 
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comprehensive measure of sexual minority stress, religiosity, HIV-related worry, CSA, IPV, 
markers of sensation-seeking/sexual compulsivity, detailed substance use behaviour, frequency 
of gay scene use, and markers of self-efficacy for sexual safety and cognitive escape coping. 
This could be collected together with information on general factors known to be associated with 
poor mental health outcomes and sexual risk-taking (social support, socio-economic status, 
age, and relationship status). Future survey studies would be useful in investigating the 
conceptual model suggested in this thesis (Figure 8). Furthermore, respondent driven sampling 
(RDS), see section 2.2.4.2, has not been used to recruit gay, bisexual, and other MSM for 
survey participation in the field of sexual health in the UK. This method can be used to 
approximate a probability sample and may be useful for recruiting larger numbers of sexual and 
gender minority individuals, who may be difficult to reach through other sampling strategies. 
RDS may become especially useful in an era of social networking online, where it is easier for 
individuals to reach out to others in their network, and for researchers to get an idea of how 
many people are in the participant’s network. 
 
In addition, there have been no longitudinal studies in high-income countries that are designed 
and powered to investigate depression and sexual behaviour among MSM. Future longitudinal 
analyses would be useful in investigating the suggested causal pathways in this thesis. In 
particular, it would be useful to investigate in a randomized trial, the effect of an intervention to 
enhance depression treatment service provision on CLS measures and STI/HIV acquisition.  
 
With the currently available evidence on efficacy of PrEP in preventing HIV transmission and 
with increasing use of PrEP among MSM, future studies of sexual risk behaviour in sexual 
minority men will need to account for PrEP use, rather than solely focusing on CLS. Condom-
use is investigated as the preventative measure of HIV acquisition in this thesis. Whether an 
association between depression and (HIV) unprotected CLS is mediated by low self-efficacy for 
consistent PrEP use is very difficult to extrapolate, given the emphasis in this thesis on the link 
between depression and a behaviour (non-condom-use) that requires exertion of control in 
interpersonal interactions. In a sub-study of 334 MSM and transgender women in iPrEx OLE (an 
open-label extension to iPrEx), compared to men who reported no/mild symptoms of depression 
on CES-D, men who reported moderate levels of depressive symptoms were more likely to 
have protective levels of PrEP, and men who reported severe levels of symptoms were less 
likely to have protective levels of PrEP in dried blood spots 
(724)
. However, the authors 
suggested that severe symptoms of depression did not play a major role in non-adherence to 
PrEP. Further investigation into the role of depression in PrEP adherence among sexual 
minority men in the UK is required. 
 
Finally, it is important that future studies also address the role of depression in lowered libido 
and sexual inactivity among MSM, and investigate the complex role that antidepressants may 
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play in this relationship. There is a tendency of MSM studies to focus on risk behaviour when 
investigating the intersection of mental health and sexual behaviour, but outcomes related to 
personal wellbeing are also relevant.  
 
In conclusion, the research agenda for 2018 onwards is clear. Mental health among sexual 
minorities in the UK needs to be more actively addressed. In 2015, Public Health England laid 
out a number of initiatives to develop the data sources needed to support the public health 
system in reducing mental ill health among sexual minorities, including the collection of sexual 
orientation data in mental health services and monitoring of homophobic incidents in schools 
(725)
. In 2017, more attention has been given to the health and wellbeing of sexual and gender 
minorities in mainstream media. However, the scientific evidence base still urgently needs to be 
built up in the UK and elsewhere in Europe in order to inform interventions and prevention 
programmes.
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Thomas’), Christine Brewer, Richard Evans, Jan Gravely, Charles Lacey, Gary Lamont, Fabiola 
Martin, Georgina Morris, Sarah Russell-Sharpe, John Wightman (York), Anthony Bains, Gill 
Bell, Christine Bowman, Terry Cox, Claire Dewsnap, Charlie Hughes, Hannah Loftus, Naomi 
Sutton, Debbie Talbot, Vince Tucker (Sheffield). 
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Sarah Banbury, Elizabeth Brodnicki, Christina Chung, David Dolling, David Dunn, Keith 
Fairbrother, Mitzy Gafos, Sajad Khan, Shabana Khan, Sheena McCormack, Brendan Mauger, 
Yinka Sowunmi, Susan Spencer, Ellen White, Gemma Wood, Michelle Gabriel, and Annabelle 
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Social Science Team: 
Gill Bell, Caroline Rae, Michael Rayment, Will Nutland, and Sonali Wayal. 
 
Public Health England: 
Monica Desai, Sarika Desai, Nigel Field, Noel Gill, Kate Hyland, Anthony Nardone, and Parnam 
Seyan. 
 
Gilead Sciences: 
Rich Clarke and Jim Rooney. 
 
11.4  Appendix 4: Prevalence of recreational drug use and intimate partner violence 
among sexual minority men and evidence for a link with sexual minority stress 
 
11.4.1 Studies comparing the prevalence of recreational drug use between sexual minorities 
and their heterosexual counterparts in high-income countries 
There is evidence to suggest that the prevalence of recreational drug use is elevated among 
sexual minority men compared to their heterosexual counterparts in high-income countries. 
In the National Well Being Study conducted in England and Wales between 2000 and 2002, 
described in section 1.8.1, the reported prevalence of recreational drug use in the past month 
was higher among gay-identified men compared to heterosexual-identified men (52% vs. 45%; 
χ
2 
test p-value<0.05) 
(726)
. In the national Crime Survey for England and Wales 2013/2014, gay- 
and bisexual-identified men were the group most likely to report having taken any illicit drug in 
the past year (at 33%) 
(727)
. Similarly, in a recent systematic review of mostly U.S. samples, 
described in section 1.8.1, the vast majority of included studies (93%) reported an increased 
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risk of recent illicit drug use and drug dependency among lesbian-, gay- and bisexual-identified 
individuals compared to heterosexual-identified individuals. Elevated risk was observed across 
different orientations for both men and women 
(338)
.  
 
In a random-effects meta-analysis of studies conducted from 1996-2005, gay, bisexual and 
other MSM (N=209) were found to report a higher prevalence of drug dependence in the past 
year compared to men who identified as heterosexual and did not report sexual attraction to or 
sex with men (N=7471), across three U.S. nationally representative household surveys (1996 
National Household Survey of Drug Abuse, National Comorbidity Survey, McArthur Foundation 
National Survey of Midlife Development in the United States): pooled RR 2,41 95% CI: 1.48, 
3.92 
(332)
.  
 
11.4.1.1 Recreational drug use on the gay ‘scene’: escape from minority stress 
For many gay (and bisexual) men, the gay scene is an important social nexus and can 
represent a culturally-endorsed ‘time-out’ from stresses common to the gay community  
(601, 728)
. 
Drug use often plays a key role in escaping self-awareness of social and sexual norms. Sexual 
minority men’s use of drugs is potentially part of coping with minority stress 
(210, 229)
. Of note, 
certain personality traits related to sensation-seeking and sexual compulsivity may be 
associated with the use of drugs, and one’s ability to disengage from self-awareness 
(371, 612-614)
.  
 
11.4.2 Studies comparing the prevalence of intimate partner violence between sexual 
minorities and their heterosexual counterparts in high-income countries 
Evidence suggests that the prevalence of IPV is higher for men in same-sex couples than for 
men in opposite-sex couples and similar for same-sex male couples and women in opposite-sex 
couples. Four U.S. population-based studies have investigated the comparative prevalence 
among these population groups. In the 1995-1996 National Violence Against Women Survey, 
whereby 65 men and 79 women who reported a current or past same-sex cohabiting 
relationship were compared to randomly selected sub-samples of 300 men and 300 women 
who reported a current or past cohabitating relationship with an opposite sex partner (and no 
cohabitation with same-sex partner), lifetime IPV prevalence was significantly higher for men in 
same-sex cohabitating relationships compared to men in opposite-sex cohabitating 
relationships in unadjusted analysis (15.4% [95% CI: 10.9%, 19.9%] versus 7.7% [95% CI: 
6.2%, 9.2%]). Lifetime IPV prevalence did not differ significantly for men in same-sex 
cohabitating relationships compared to women in opposite-sex cohabiting relationships in 
unadjusted analysis (15.4% [95% CI: 10.9%, 19.9%] versus 20.3% [95% CI: 18.0%, 22.6%]) 
(729)
.  
 
In the UMHS, described in section 2.4.1.1, prevalence estimates of IPV in the past five years 
(39.2% 95% CI: 37.0%, 41.5%) were higher than those reported for men in opposite-sex 
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couples in the literature and as high, or higher, than those reported for women in opposite-sex 
couples. This comparative review was, however, limited by several factors including the differing 
IPV measures and recall periods, and the fact that the differences observed may have been 
confounded by socio-demographic factors, as only unadjusted analyses were presented (as 
was the case for the National Violence Against Women Survey) 
(730)
.  
 
In the 2007-2008 California Health Interview Survey (N=13447 heterosexual-identified men, 415 
gay-identified men, 135 bisexual-identified men, and another 92 MSM), after adjusting for socio-
demographic, lifestyle, and psychological factors, the prevalence of lifetime IPV and IPV in the 
past year was found to be higher among gay, bisexual and other MSM compared to 
heterosexual-identified men who did not report sexual attraction to/sex with men, but the 
difference was only statistically significant for gay-identified men versus heterosexual-identified 
men (OR 2.68 [95% CI: 1.75, 4.11]; OR 2.41 [95% CI: 1.32, 4.40] respectively) 
(731)
.  
 
In the 2010 National Intimate Partner & Sexual Violence Survey (N=9086 women and 7421 
men), bisexual-identified men (N=89) reported a higher lifetime prevalence of rape, physical 
violence and/or stalking by an intimate partner compared to heterosexual-identified men (37.3% 
vs. 29.0%). Gay-identified men (N=148) reported a similar prevalence to heterosexual men 
(26.0%). Gay-identified men reported a higher prevalence of psychological IPV (specifically 
expressive aggression including name calling, insulting, or humiliating) compared to both 
bisexual-identified men and heterosexual-identified men (44.5%, 32.4%, 24.4% respectively) 
(732)
.   
 
11.4.2.1 Minority stress and intimate partner violence 
In line with the exosystem factor theory described in Textbox 4, the social pressure faced by 
sexual minority individuals to conform to heteronormative behaviours and the ensuing stress 
associated with homophobic discrimination and shaming, may trigger, depending on one’s 
personal history, episodes of abuse in intimate partnerships. Evidence is gathering which 
suggests that among UK (N=398
(733)
), U.S. (N=1575 
(734)
, N=750 
(735)
), and Canadian (N=186 
(736)
) samples of MSM, markers of internalized homophobia are associated with physical IPV 
perpetration
(733, 736)
, emotional/psychological IPV perpetration
(736)
, sexual IPV perpetration 
(734)
, 
physical IPV victimization 
(733)
, sexual IPV victimization 
(733)
, any IPV perpetration 
(735)
, and any 
IPV victimization 
(735)
, in unadjusted analysis 
(734, 736)
, and after adjusting for socio-demographic 
and lifestyles factors 
(733, 735)
.  
 
It is of note, there is also some evidence to suggest that the prevalence of CSA is higher among 
gay, bisexual, and other MSM compared to heterosexual-identified men, including after 
adjustment for age and ethnicity 
(737)
. In the ‘Growing Up Today Study’ (2005-2007 wave), a 
U.S. population-based longitudinal study of 16882 children (born of mothers who were enrolled 
in the Nurses’ Health Study II), sexual minority individuals were more likely to screen positive for 
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a measure of childhood gender nonconformity. This measure included questions on favourite 
games and toys in childhood, which television characters were admired/imitated and feelings of 
masculinity or femininity. Gender nonconformity was found to partly explain the differences 
observed in CSA prevalence between gay, bisexual, and other MSM and heterosexual-
identified men who did not report sexual attraction to/sex with men. 
  
11.5 Appendix 5: Location of literature for thesis literature reviews 
 
Table 45: Identification of publications for literature review 
Database MeSH terms- MSM sexual lifestyles/behaviour search Limits 
Pubmed ("men who have sex with men"[All Fields] AND ("HIV 
acquisition"[All Fields] OR "unsafe sex"[MeSH Terms] OR 
"HIV testing"[All Fields] OR "Pre-Exposure 
Prophylaxis"[All Fields] OR "Post-Exposure 
Prophylaxis"[All Fields])) AND (("1996/01/01"[PDAT] : 
"3000/12/31"[PDAT]) AND "humans"[MeSH Terms] AND 
English[lang] AND "male"[MeSH Terms] AND (AIDS[sb] 
OR systematic[sb]) AND "adult"[MeSH Terms]) 
Publication date 
from 1996/01/01, 
Humans, English, 
Male 
Cochrane 
Database of 
Systematic 
Reviews 
"men who have sex with men" or gay next men or 
homosexual next men or bisexual next men or [mh 
"homosexuality male"] AND (HIV near acquisition or HIV 
near diagnos?s or positive HIV-test* or [mh "aids 
serodiagnosis"] OR high-risk sex* behaviour or condom-
less next sex or unprotected next sex or unprotected next 
intercourse or "sex without a condom" or unsafe next sex 
or high-risk next sex or [mh "unsafe sex"] OR HIV next 
test* or late diagnos?s of HIV or delayed diagnos?s of HIV 
OR PrEP or "Pre-Exposure Prophylaxis" OR PEP or 
"Post-Exposure Prophylaxis" 
/ 
Cochrane 
Central Register 
of Controlled 
Trials 
"men who have sex with men" or gay next men or 
homosexual next men or bisexual next men or [mh 
"homosexuality male"] AND (HIV near acquisition or HIV 
near diagnos?s or positive HIV-test* or [mh "aids 
serodiagnosis"] OR high-risk sex* behaviour or condom-
less next sex or unprotected next sex or unprotected next 
intercourse or "sex without a condom" or unsafe next sex 
or high-risk next sex or [mh "unsafe sex"] OR HIV next 
test* or late diagnos?s of HIV or delayed diagnos?s of HIV 
OR PrEP or "Pre-Exposure Prophylaxis" OR PEP or 
"Post-Exposure Prophylaxis" 
/ 
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11.6 Appendix 6: Prevalence of CLS across UK recruitment settings 
Figure 29 presents the prevalence of CLS with two or more partners in the past year. The 
Natsal-3 estimate appears relatively high at 19.9%. However, as stated in section 2.5.2 of 
Chapter 2, the confidence interval is wide, reflecting the small sample size for MSM and 
therefore, relative imprecision of the prevalence. A similar pattern to that described for the 
measure of CLS with one or more partners in the past year (section 2.5.2) appears evident; on 
the whole, men recruited online appear to report a higher prevalence of multiple CLS partners in 
the past year (range from: 21.5%-28.8%) compared to men recruited from community and 
commercial gay venues (range form: 8.4%-38.1%). There are three exceptions to this pattern, 
where prevalence estimates from the GMSHS in England in 1996, 1997, and 1998 appear to be 
higher (32.0%, 35.7%, and 38.1% respectively). It is possible that differences observed between 
prevalence estimates may (in addition) reflect changes overtime, including city specific changes 
overtime. 
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Figure 29: Proportion of MSM reporting anal CLS with two or more male partners in the 
past year, from UK studies
a
 which include HIV-negative men (1996-2014) and according 
to study recruitment site
b 
 
 
a 
In the GMSHS England 2011, the prevalence estimate pertains to men resident in London only. 
b 
Studies that encompassed mixed approaches to sampling (i.e. from commercial venues, clinics, and 
online) were placed in the recruitment site category from which the largest proportion of the sample was 
selected. 
c 
Binomial 95% confidence intervals using Wald test. 
 
Key, prevalence estimates with 
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c
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Figure 30 presents the prevalence of CLS with an unknown or sero-different HIV status partner 
in the past year. It was not possible to include an estimate for this measure of CLS from Natsal. 
Once again, a similar pattern may be evident; men recruited online appear to report a higher 
prevalence of CLS with an unknown/sero-different HIV status partner in the past year (39.5%) 
compared to men recruited from community and commercial gay venues (range from: 15.4%-
32.6%). Unfortunately, for this measure of CLS it was only possible to compare the prevalence 
estimate from one online recruited sample. The seemingly higher prevalence reported in studies 
which recruited men from Pride events (30.7% and 32.6%), and lower prevalence of CLS with 
two or more partners in studies which recruited from Pride events (Figure 29), compared to 
bars, clubs, and saunas (range from: 15.4%-32.3%), may not be surprising. As suggested in 
section 2.5.2 of Chapter 2, the festive and temporary nature of Pride events may possibly 
facilitate risky sex with a partner, which may then be captured on a survey. As described in 
section 2.5.2, the high estimate and wide confidence interval observed for the SM sex Study 
may not be surprising given the sample size of this unique self-selecting sample. 
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Figure 30: Proportion of MSM reporting anal CLS with an unknown or HIV sero-different 
status partner
a
 in the past year, from UK studies which include HIV-negative men (1996-
2014) and according to study recruitment site
b 
 
 
 
a 
In the GMSHS England 1999 and MYPC 2010, the prevalence estimate consists of men who reported 
CLS with a casual and/or unknown and/or HIV-positive status partner in the past year. Furthermore, in 
GMSHS England 2000-2013, the prevalence estimate pertains to men resident in London only. 
Key, prevalence estimates with 
95% CIs
c
 from studies which 
recruited from: 
 
       Community/commercial 
gay venues  
       Online 
       Demarcates prevalence 
estimates below and above 
25%, no test of significance is 
implied 
 
* HIV negative by Orasure 
saliva test 
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b 
Studies that encompassed mixed approaches to sampling (i.e. from commercial venues, clinics, and 
online) were placed in the recruitment site category from which the largest proportion of the sample was 
selected. 
c 
Binomial 95% confidence intervals using Wald test. 
 
Figure 31 presents the prevalence of CLS with one or more partners in the past three months. 
In line with that observed for CLS measures reported in the past year, the reported prevalence 
of CLS in the past three months appears to be similar between GUM clinic samples (38.9% and 
41.8%) and online samples (41.0% and 43.0%), and higher compared to 
community/commercial gay venue samples, excluding the somewhat difficult to compare 
estimate from the SM sex Study (19.6% and 24.9%). 
 
 
Figure 31: Proportion of MSM reporting anal CLS with one or more male partners in the 
past three months, from UK studies which include HIV-negative men (1996-2014) and 
according to study recruitment site
a 
 
 
Key, prevalence estimates with 
95% CIs
b
 from studies which 
recruited from: 
 
        
       GUM clinics 
       Community/commercial 
gay venues  
       Online 
       Demarcates prevalence 
estimates below and above 
50%, no test of significance is 
implied 
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a 
Studies that encompassed mixed approaches to sampling (i.e. from commercial venues, clinics and 
online) were placed in the recruitment site category from which the largest proportion of the sample was 
selected. 
b 
Binomial 95% confidence intervals using Wald test. 
 
 
Finally, Figure 32 presents the prevalence of CLS with an unknown or HIV sero-different status 
partner in the past three months. This final figure again depicts that observed; the prevalence 
estimates of this CLS measure appear to be higher in studies of men recruited online (27.0% 
and 31.0%) versus from bars, clubs, saunas, or gyms (excluding SM sex Study, range from: 
10.5%-23.7%). The confidence intervals are narrow for all online recruited samples, shown in 
each figure, given the large sample sizes of these studies. Within the community/commercial 
gay venue recruitment category, men recruited from gyms (most of which were reported to 
consist almost entirely of gay-identified male cliental 
(482-484)
) appeared to report a higher 
prevalence (range from: 16.8%-23.7%) compared to men recruited from bars, clubs, and 
saunas (10.5%). However, only one study of commercial gay venues was available for 
comparison. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
377 
 
Figure 32: Proportion of MSM reporting anal CLS with an unknown or HIV sero-different 
status partner in the past three months, from UK studies which include HIV-negative men 
(1996-2014) and according to study recruitment site
a 
 
 
 
a 
Studies that encompassed mixed approaches to sampling (i.e. from commercial venues, clinics, and 
online) were placed in the recruitment site category from which the largest proportion of the sample was 
selected. 
b 
Binomial 95% confidence intervals using Wald test. 
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b
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11.7 Appendix 7: Relationship between socio-demographic and psychosocial factors 
with CLS measures among MSM in the UK 
 
11.7.1 Age 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 66 collected data on age (Table 2). The association between age and common 
measures of CLS was investigated in nine publications, some of which combined a number of 
repeated surveys (across different studies) (Table 46) 
(118, 477, 482, 489, 509-512, 563)
. In all nine 
studies, age was investigated in categories (of around five to ten year bands) and as a binary 
variable in two studies (using a cut-off of mid-twenties). Eight studies recruited men from 
community/commercial gay venues (including one gym sample and three Pride event samples) 
and the remaining study recruited men online. Four studies investigated CLS with one or more 
partners (with recall periods of three months in one study and the past year in three studies) 
and five studies investigated CLS with two or more partners in the past year as well as CLS with 
a partner of unknown/sero-different HIV status in the past year in two of these studies. Two 
studies found that the prevalence of CLS decreased with increasing age 
(482, 489)
 and two studies 
found no significant association in unadjusted analysis 
(510, 511)
. One study investigated the 
association adjusted for relationship status and found that the significant unadjusted association 
remained 
(482)
. Similarly, four studies found that older age was associated with lower levels of 
CLS with two or more partners in unadjusted analysis 
(512)
 and in adjusted analysis (for socio-
demographic factors) 
(118, 477, 563)
. One study investigated the association in unadjusted and 
adjusted analysis and did not find an association 
(509)
. One study found that older age was 
associated with lower odds of CLS with a partner of unknown/sero-different HIV status adjusted 
for socio-demographic factors 
(563)
 and one study found that older age was associated with 
higher odds of this CLS measure in unadjusted analysis 
(509)
. However, this latter association 
disappeared after adjusting for socio-demographic factors and recreational drug use.
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Table 46: Unadjusted and adjusted associations found between age and sexual behaviour measures in UK studies of MSM (including HIV-negative 
MSM), by measure of CLS 
 
 Largest % 
recruited via: 
Measure 
of age 
groups: 
Measure of 
CLS 
Unadjusted association Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
Gym-based 
intervention 
baseline 
1997 
(N=1004)
(482)
 
 
Gyms 
(N=1004) 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
CLS with 
1+ partner  
(past 3 
months) 
χ
2 
test for 
a linear 
trend 
Lower 
CLS with 
older age 
35.0% 
29.0% 
26.5% 
23.9% 
19.1% 
14.3% 
p<0.01 
OR per 5 
year 
increase in 
age 
Lower 
CLS with 
older age 
0.80 [0.70, 0.90] 
p<0.001 
Relationship status 
GMSS 1998 
(N=5065
a
)
(51
0)
 
 
Pride events 
(n=6315) 
 
<20 
20s 
30s 
40s 
50+ 
CLS with 
1+ partner  
(past year) 
χ
2 
test None 48.1% 
48.9%
 
 
45.7% 
43.7%
 
 
44.8%
 
 
p>0.05 
/ / / / 
GMSS 1999 
(N=4025
a
)
(51
1)
 
Pride events 
(n=6612) 
<20 
20s 
30s 
40s 
50+  
CLS with 
1+ partner  
(past year) 
χ
2 
test None 58.4% 
56.4% 
53.9% 
52.3% 
51.9% 
p>0.05 
/ / / / 
GMSS 2000 
(N=9789)
(489)
 
Pride events 
(n=6624) 
<20 
20s 
30s 
40s 
50+ 
CLS with 
1+ partner  
(past year) 
χ
2 
test Lower 
CLS with 
older age 
49.0% 
50.3% 
43.9% 
39.0% 
34.5% 
p<0.05 
/ / / / 
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Table 46: Unadjusted and adjusted associations found between age and sexual behaviour measures in UK studies of MSM (including HIV-negative 
MSM), by measure of CLS (continued) 
 Largest % 
recruited via: 
Measure 
of age 
groups: 
Measure of 
CLS 
Unadjusted association Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
GMSS 2008 
(N=7461)
(512)
 
Online 
(N=4364) 
<20 
20s 
30s 
40s 
50+ 
CLS with 
2+ partners  
(past year) 
χ
2 
test Lower 
CLS with 
older age 
24.6% 
24.1% 
24.3% 
23.8%  
17.8% 
p<0.05 
/ / / / 
GMSHS 
Scotland 
1996-2002 
(N=6448)
(118)
 
Gay bars 
(N=6448) 
<26  
26+  
CLS with 
2+ partners  
(past year) 
/ / / OR Lower 
CLS with 
older age 
1 
0.70 [0.58, 0.84] 
Social class, 
education, area of 
residence, 
frequency of gay 
bar use, HIV 
optimism 
GMSHS 
England  
2003-2004 & 
GMSHS 
Scotland 
2005 
(N=3046)
(563)
  
Commercial 
gay venues 
(N=3046) 
15-25 
26-35 
36-45 
46+ 
CLS with 
2+ partners  
(past year) 
/ / / OR Lower 
CLS with 
older age 
1 
0.83 [0.65, 1.07] 
0.64 [0.48, 0.85] 
0.57 [0.38, 0.85] 
p=0.003 
Education, 
employment status, 
HIV testing history 
GMSHS 
Scotland 
1996-2008, 
and Testing 
Barriers 
2000-2003 
(N=10223)
(47
7)
 
Commercial 
gay venues 
(N=10223) 
<25  
25+ 
CLS with 
2+ partners  
(past year) 
/ / / OR Lower 
CLS with 
older age 
1 
0.69 [0.60, 0.78]  
p<0.001 
Survey year 
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Table 46: Unadjusted and adjusted associations found between age and sexual behaviour measures in UK studies of MSM (including HIV-negative 
MSM), by measure of CLS (continued) 
a 
Men who reported anal sex with a man in the past year. 
b
 Men who reported CLS with one or more partners in the past year, and did not have any missing data on any of the alcohol or drug use questions. 
 Largest % 
recruited via: 
Measure 
of age 
groups: 
Measure of 
CLS 
Unadjusted association Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
16-25 
26-35 
36-45 
45+ 
CLS with 
2+ partners  
(past year) 
OR None 1 
0.90 [0.59, 1.36] 
0.97 [0.60, 1.58] 
1.52 [0.84, 2.73] 
p=0.392 
OR None 1 
0.96 [0.61, 1.52] 
0.90 [0.51, 1.59] 
1.46 [0.74, 2.89] 
p=0.582 
Sexual orientation, 
area of residence, 
frequency of gay 
scene use, HIV/STI 
testing, HIV status, 
alcohol, popper, 
stimulant/recreatio-
nal/illicit drug, 
Viagra use 
GMSHS 
England  
2003-2004 & 
GMSHS 
Scotland 
2005 
(N=3046)
(563)
  
Commercial 
gay venues 
(N=3046) 
15-25 
26-35 
36-45 
46+ 
CLS with 
unknown/ 
sero-
different 
partner 
(past year) 
 
/ / / OR Lower 
CLS with 
older age 
1 
0.81 [0.66, 1.00] 
0.66 [0.52, 0.83] 
0.50 [0.35, 0.70] 
p<0.001 
Education, 
employment status, 
HIV testing history 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
16-25 
26-35 
36-45 
45+ 
CLS with 
unknown/ 
sero-
different 
partner 
(past year) 
 
OR Higher 
CLS with 
older age 
1 
0.93 [0.65, 1.35] 
1.50 [0.96, 2.35] 
1.93 [1.07,3.48] 
p=0.029 
OR None 1 
0.89 [0.61, 1.32] 
1.38 [0.85, 2.24] 
1.78 [0.94, 3.37] 
p=0.101 
Sexual orientation, 
area of residence, 
frequency of gay 
scene use, HIV/STI 
testing, HIV status, 
alcohol, popper, 
stimulant/recreatio-
nal/illicit drug, 
Viagra use 
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11.7.2 Ethnicity 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 52 collected data on ethnicity (Table 2). The association between ethnicity and common 
measures of CLS was investigated in seven publications (Table 47) 
(482, 489, 496, 498, 499, 510-512)
. 
Four studies recruited men from community/commercial gay venues (including one gym sample 
and four Pride event samples) and three studies recruited men online. Ethnicity was not found 
to be associated with CLS with one or more partners or two or more partners, or partners of an 
unknown/sero-different HIV status in unadjusted analysis 
(482, 489, 496, 498, 510-512)
. One study 
investigated the association between two measures of ethnicity with report of CLS with 
unknown/sero-different HIV status partners in the past three months adjusted for socio-
demographic factors and recreational drug use, and found that the association remained non-
significant 
(498)
.
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Table 47: Unadjusted and adjusted associations found between ethnicity and sexual behaviour measures in UK studies of MSM (including HIV-
negative MSM), by measure of CLS 
 Largest % 
recruited 
via: 
Measure of 
ethnicity: 
Measure 
of CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure of 
effect size 
Relation-
ship 
Estimate Measure 
of effect 
size 
Relation-
ship 
Estimate Factors 
adjusted 
for 
Gym-based 
intervention 
baseline 
1997 
(N=1004)
(482)
 
Gyms 
(N=1004) 
White 
Non-white 
CLS with 
1+ 
partner  
(past 
3months) 
χ
2 
test  None It was reported: “There was no significant 
univariate association between UAI and 
ethnicity” (pg 1409). No estimate given 
/ / / / 
GMSS 1998 
(N=5065
a
) 
(510)
 
 
Pride 
events 
(n=6315) 
 
White  
Black 
Asian
b
 
Other  
CLS with 
1+ 
partner  
(past 
year) 
χ
2 
test None 46.4%
 
45.3%
  
48.0%
  
52.9%
 
p>0.05 
/ / / / 
GMSS 1999 
(N=4025
a
) 
(511)
 
Pride 
events 
(n=6612) 
White
e
,UK 
White
f
 
Black
g  
Asian
h
 
Other 
CLS with 
1+ 
partner  
(past 
year) 
χ
2 
test None 54.7%
  
54.4% 
53.9% 
54.1%
 
0.7%
 
p>0.05 
/ / / / 
GMSS 2000 
(N=9789)
(489)
 
Pride 
events 
(n=6624) 
White
e
,UK 
White
f
 
Black
g  
Asian
h
 
Other 
CLS with 
1+ 
partner  
(past 
year) 
χ
2 
test None 44.7% 
44.2% 
49.2% 
47.0% 
43.6% 
p>0.05 
/ / / / 
GMSS 2006 
(N=12155) 
(496)
 
Online 
(n=8286) 
White
e
,UK 
White
f
 
Black Asian 
Mixed 
Other 
CLS with 
1+ 
partner  
(past 
year) 
OR None It was reported: “no ethnic group was 
more or less likely to have had UAI than 
the White British men”  
(pg 28). No estimate given 
/ / / / 
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Table 47: Unadjusted and adjusted associations found between ethnicity and sexual behaviour measures in UK studies of MSM (including HIV-
negative MSM), by measure of CLS (continued) 
a 
Men who reported anal sex with a man in the past year. 
b 
South Asian. 
 Largest % 
recruited via: 
Measure 
of 
ethnicity: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relatio-
nship 
Estimate Measure 
of effect 
size 
Relatio-
nship 
Estimate Factors adjusted 
for 
GMSS 2008 
(N=7461)
(512)
 
Online 
(N=4364) 
White
e
,UK 
White
f
 
Black 
Asian 
Mixed 
Other 
CLS with 
2+ partners  
(past year) 
χ
2 
test None 23.0% 
25.5% 
26.4% 
22.4% 
20.8% 
23.8% 
p>0.05 
/ / / / 
MESH 
2007-2008 
(N=13278) 
(498)
 
Online 
(N=12494) 
White
e
,UK 
Minorities  
SCA
c
 
CEE
c
 
CLS with 
unknown/ 
sero-
different 
partner 
(past 3 
months)
d
 
 
OR None 1 
0.95 [0.82, 1.10] 
0.95 [0.63, 1.43] 
0.96 [0.69, 1.34] 
OR None 1 
0.99 [0.84, 1.16] 
0.95 [0.62, 1.45] 
0.91 [0.64, 1.29] 
Age, place of 
residence, place 
of birth, 
education, 
employment, HIV 
treatment 
optimism, 
recreational drug 
use, HIV status 
MESH 
2007-2008 
(N=13278) 
(498)
 
Online 
(N=12494) 
White
e
,UK 
Black  
Asian
h
 
Chinese 
Asian
i
 
Arab 
Other  
SCA
c
 
CEE
c
 
CLS with 
unknown/ 
sero-
different 
partner 
(past 3 
months)
d
 
 
OR None 1 
0.98 [0.75, 1.27] 
1.01 [0.77, 1.31] 
0.82 [0.54, 1.22] 
0.87 [0.58, 1.30] 
0.92 [0.48, 1.77] 
1.15 [0.66, 2.02] 
0.95 [0.63, 1.43] 
0.96 [0.69, 1.34] 
OR None 1 
1.00 [0.76, 1.31] 
1.03 [0.78, 1.35] 
0.97 [0.64, 1.47] 
0.94 [0.62, 1.43] 
0.97 [0.49, 1.91] 
0.94 [0.53, 1.67] 
0.95 [0.62, 1.45] 
0.91 [0.64, 1.29] 
Age, place of 
residence, place 
of birth, 
education, 
employment, HIV 
treatment 
optimism, 
recreational drug 
use, HIV status 
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c 
Men who were born in this region (SCA= South/Central America; CEE= Central/Eastern Europe) 
d
 Includes men who reported CLS and had never tested for HIV. 
e
 White British. 
f
 Other white. 
g
 Black or black British. 
h
 Asian or Asian British. 
i 
Asian other. 
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11.7.3 Sexual identity 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 30 collected data on sexual identity (Table 2). The association between sexual identity 
(gay- versus bisexual-identity) and common measures of CLS was investigated in two 
publications of data collected from men attending Pride events 
(510)
 or commercial gay venues 
(509)
 (Table 48). Sexual identity was not found to be associated with CLS with one or more 
partners or CLS with a partner of unknown/sero-different HIV status in the past year in 
unadjusted analysis 
(509, 510)
. Bisexual men were more likely to report CLS with two or more 
partners in the past year in unadjusted analysis 
(509)
. However, this association was investigated 
adjusted for socio-demographic factors and recreational drug use, and a significant relationship 
was no longer observed.
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Table 48: Unadjusted and adjusted associations found between sexual identity and sexual behaviour measures in UK studies of MSM (including 
HIV-negative MSM), by measure of CLS 
 Largest % 
recruited via: 
Measure 
of sexual 
identity: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
GMSS 1998 
(N=5065
a
) 
(510)
 
 
Pride events 
(n=6315) 
 
Gay 
Bisexual 
CLS with 
1+ partner  
(past year) 
χ
2 
test None 46.9%
 
40.3%
 
p>0.05 
/ / / / 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Gay 
Bisexual 
CLS with 
2+ partners  
(past year) 
OR Bisexual 
men more 
likely to 
report 
CLS 
1 
2.11 [1.05, 4.25] 
p=0.037 
OR None 1 
1.81 [0.85, 3.86] 
p=0.124 
Age, area of 
residence, 
frequency of gay 
scene use, HIV/STI 
testing, HIV status, 
alcohol, popper, 
stimulant/ 
recreational/illicit 
drug, Viagra use 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Gay 
Bisexual 
CLS with 
unknown/ 
sero-
different 
partner 
(past year) 
 
OR None 1 
1.33 [0.66, 2.71] 
p=0.429 
/ / / / 
a 
Men who reported anal sex with a man in the past year. 
b
 Men who reported CLS with one or more partners in the past year, and did not have any missing data on any of the alcohol or drug use questions.  
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11.7.4 Education 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 53 collected data on levels of educational attainment (Table 2). The association 
between educational levels and common measures of CLS was investigated in eight 
publications, some of which combined a number of repeated surveys (across different studies) 
(Table 49) 
(118, 482, 489, 496, 509, 510, 512, 563)
. Six studies recruited men from community/commercial 
gay venues (including one gym sample and two Pride event samples) and the remaining two 
studies recruited men online. Four studies investigated CLS with one or more partners (with 
recall periods of three months in one study and the past year in three studies) and four studies 
investigated CLS with two or more partners in the past year as well as CLS with a partner of 
unknown/sero-different HIV status in the past year in two of these studies. One study found that 
the prevalence of CLS decreased with higher educational levels 
(510)
 and two studies found no 
significant association in unadjusted analysis 
(482, 489)
. Another study only investigated the 
association adjusted for HIV status and found no association 
(496)
. Similarly, one study found 
that the prevalence of CLS with two or more partners decreased with higher educational levels 
(512)
, however, another study did not 
(509)
, in unadjusted analysis. Two studies only investigated 
the association adjusted for socio-demographic factors, and again found no association 
(118, 563)
. 
Educational attainment was not found to be associated with CLS with an unknown/sero-different 
HIV status partner in unadjusted or adjusted analysis 
(509, 563)
.
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Table 49: Unadjusted and adjusted associations found between education and sexual behaviour measures in UK studies of MSM (including HIV-
negative MSM), by measure of CLS 
 Largest % 
recruited via: 
Measure 
of 
education 
levels: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure 
of effect 
size 
Relation-
ship 
Estimate Factors 
adjusted 
for 
Gym-based 
intervention 
baseline 
1997 
(N=1004)
(482)
 
 
Gyms 
(N=1004) 
Univserity 
educated: 
Yes 
No 
CLS with 
1+ partner  
(past 3 
months) 
χ
2 
test  None It was reported: 
“No significant 
univariate 
association 
between UAI and 
education” (pg 
1409). No 
estimate given 
/ / / / 
GMSS 1998 
(N=5065
a
)
(51
0)
 
 
Pride events 
(n=6315) 
 
O-level
b
 
A-level 
Degree 
CLS with 
1+ partner  
(past year) 
χ
2 
test Lower 
CLS with 
higher 
levels of 
education 
53.9%
 
46.1%
  
42.1%
  
p<0.01 
/ / / / 
GMSS 2000 
(N=9789)
(489)
 
Pride events 
(n=6624) 
Low 
Medium 
High 
CLS with 
1+ partner  
(past year) 
χ
2 
test None 47.8% 
48.3%  
40.4% 
p>0.05 
/ / / / 
GMSS 2006 
(N=12155)
(49
6)
 
Online 
(n=8286) 
Low 
Medium 
High 
CLS with 
1+ partner  
(past year) 
/ / / OR None It was reported: “No differences in 
UAI across the education groups” (pg 
28). No estimate given 
Tested 
HIV-
positive 
GMSS 2008 
(N=7461)
(512)
 
Online 
(N=4364) 
Low 
Medium 
High 
CLS with 
2+ partners  
(past year) 
χ
2 
test Lower 
CLS with 
higher 
levels of 
education 
27.5% 
24.0% 
21.3% 
p<0.05 
/ / / / 
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Table 49: Unadjusted and adjusted associations found between education and sexual behaviour measures in UK studies of MSM (including HIV-
negative MSM), by measure of CLS (continued) 
a 
Men who reported anal sex with a man in the past year. 
 Largest % 
recruited via: 
Measure of 
education 
levels: 
Measure of CLS Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure 
of effect 
size 
Relation-
ship 
Estimate Factors adjusted for 
GMSHS 
Scotland 
1996-2002 
(N=6448)
(118)
 
Gay bars 
(N=6448) 
2ry
c
 
Further
d
 
Higher
e
 
CLS with 2+ 
partners  
(past year) 
/ / / OR None 1 
0.94 [0.74, 1.20] 
0.94 [0.73, 1.21] 
Social class, education, 
area of residence, 
frequency of gay bar 
use, HIV optimism 
GMSHS 
England  
2003-2004 & 
GMSHS 
Scotland 
2005 
(N=3046)
(563)
  
Commercial 
gay venues 
(N=3046) 
2ry
c
 
Higher
e
 
CLS with 2+ 
partners  
(past year) 
/ / / OR None 1 
0.98 [0.75, 1.28] 
p=0.310 
 
Age, employment 
status, HIV testing 
history 
GMSHS 
Scotland 
2011 
(N=639
f
)
(509)
 
Commercial 
gay venues 
(N=1515) 
2ry
c
 
Further
d
 
Higher
e
 
CLS with 2+ 
partners  
(past year) 
OR None 1.06 [0.62, 1.80] 
1.37 [0.93, 2.02] 
1 
p=0.441 
/ / / / 
GMSHS 
England  
2003-2004 & 
GMSHS 
Scotland 
2005 
(N=3046)
(563)
  
Commercial 
gay venues 
(N=3046) 
2ry
c
 
Higher
e
 
CLS with 
unknown/ sero-
different partner  
(past year) 
 
/ / / OR None 1 
0.88 [0.70, 1.10] 
p=0.454 
Age, employment 
status, HIV testing 
history 
GMSHS 
Scotland 
2011 
(N=639
f
)
(509)
 
Commercial 
gay venues 
(N=1515) 
2ry
c
 
Further
d
 
Higher
e
 
CLS with 
unknown/ sero-
different partner  
(past year) 
OR None 1.04 [0.65, 1.66] 
1.13 [0.80, 1.61] 
1 
p=0.240 
/ / / / 
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b 
O-level or no formal education. 
c 
Secondary school. 
d 
Post-secondary schooling (including vocational training). 
e 
Higher educational attainment (Degree/post-graduate). 
f
 Men who reported CLS with one or more partners in the past year, and did not have any missing data on any of the alcohol or drug use questions.  
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11.7.5 Relationship status 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 28 collected data on relationship status (Table 2). The association between relationship 
status and common measures of CLS was investigated in four publications (Table 50) 
(482, 496, 510, 
512)
. Two studies recruited men from community/commercial gay venues and two studies 
recruited men online. Being in an ongoing relationship was found to be associated with CLS 
with one or more partners (in the past year and the past three months) in unadjusted analysis in 
three studies 
(482, 496, 510)
, one of which also investigated the association adjusted for age and 
found that the relationship remained 
(482)
. However, relationship status was not associated with 
CLS with two or more partners in the past year in unadjusted analysis 
(512)
.
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Table 50: Unadjusted and adjusted associations found between relationship status and sexual behaviour measures in UK studies of MSM 
(including HIV-negative MSM), by measure of CLS 
a 
Men who reported anal sex with a man in the past year. 
b 
No regular partner. 
c 
Length of regular partnership.
 Largest % 
recruited via: 
Measure 
of 
relations-
hip status: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
GMSS 1998 
(N=5065
a
)
(51
0)
 
 
Pride events 
(n=6315) 
 
None
b
  
<1 year
c
 
>1 year
c
 
CLS with 
1+ partner  
(past year) 
χ
2 
test Men in a 
relations-
hip more 
likely to 
report 
CLS 
34.8%
 
51.9%  
55.2%
 
p<0.01 
/ / / / 
GMSS 2006 
(N=12155)
(49
6)
 
Online 
(n=8286) 
None
b
 
Partnered 
CLS with 
1+ partner  
(past year) 
OR Men in a 
relations-
hip more 
likely to 
report 
CLS 
1 
2.29 [2.12, 2.47] 
/ / / / 
Gym-based 
intervention 
baseline 
1997 
(N=1004)
(482)
 
 
Gyms 
(N=1004) 
None
b
 
Partnered 
CLS with 
1+ partner  
(past three 
months) 
χ
2 
test  Men in a 
relations-
hip more 
likely to 
report 
CLS 
16.3% 
32.1% 
p<0.05 
OR  Men in a 
relations-
hip more 
likely to 
report 
CLS 
1 
2.50 [1.80, 3.40] 
p<0.001 
Age 
GMSS 2008 
(N=7461)
(512)
 
Online 
(N=4364) 
None
b
 
Partnered 
CLS with 
2+ partners  
(past year) 
χ
2 
test None 23.5% 
23.1% 
p>0.05 
/ / / / 
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11.7.6 Recreational drug use 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 19 collected data on recreational drug use (Table 2). The association between 
recreational drug use and common measures of CLS was investigated in five publications, all of 
which recruited men from community/commercial gay venues (including two gym samples and 
one Pride event sample) (Table 51) 
(478, 484, 487, 509, 511)
. Measures of recreational drug use 
investigated include: (i) any drug use, (ii) anabolic steroid use, (iii) use of poppers (inhaled drug 
consisting of nitrites, usually sold as cleaning products, with euphoria-inducing effects), (iv) 
Viagra use, (v) marijuana use, (vi) party drug use (ecstasy, LSD, amphetamine, and cocaine), 
and (vii) alcohol, poppers, marijuana, or any other recreational drug use. With the exception of 
one study 
(487)
, all studies found associations between measures of recreational drug use and 
measures of CLS, in unadjusted and/or adjusted analysis 
(478, 484, 509, 511)
. In one study, use of 
any recreational drugs was found to be associated with CLS with two or more partners in the 
past year in unadjusted and adjusted analysis 
(509)
. However, in the same study, recreational 
drug use was not found to be associated with report of CLS with a partner of unknown/sero-
different HIV status in the past year in unadjusted analysis or adjusted for socio-demographic 
factors, alcohol, poppers, and Viagra use 
(509)
. In this same study, use of poppers was 
associated with CLS with two or more partners and CLS with an unknown/sero-different HIV 
status partner (in the past year) in unadjusted analysis, but the association disappeared for both 
measures of CLS after adjusting for socio-demographic factors, alcohol use, and use of other 
recreational drugs (as well as Viagra) 
(509)
. Similarly, in the same study, an identical pattern of 
associations was found with Viagra use 
(509)
. Furthermore, in the two gym samples investigated, 
anabolic steroid use was found to be associated with CLS with one or more partners in the past 
three months in on study 
(484)
 but not the other, in unadjusted analysis 
(487)
. In another study, use 
of marijuana, nitrites, and party drugs (in three separate measures) by either or both partners 
before or during sex in the past three months (during an episode of CLS with an unknown/sero-
different status partner or during the last sexual encounter) was strongly associated with CLS 
with an unknown/sero-different HIV status partner (past three months) in unadjusted analysis 
(478)
. In the final study, men who reported alcohol use, and recreational drug use, especially 
drugs other than poppers and cannabis, were more likely to report CLS with one or more 
partners in the past year compared to men who did not report alcohol or drug use, in unadjusted 
analysis 
(511)
.  
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Table 51: Unadjusted and adjusted associations found between recreational drug use and sexual behaviour measures in UK studies of MSM 
(including HIV-negative MSM), by measure of CLS
 
 Largest % 
recruited via: 
Measure 
of drug 
use: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
Gym-based 
intervention 
baseline 
1997 
(N=1004)
(484)
  
Gyms 
(N=1004) 
Anabolic 
steroids: 
Never 
Current 
user 
CLS with 
1+ partner  
(past three 
months) 
χ
2 
test Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
22.2% 
42.6% 
p<0.001 
/ / / / 
4 gym 
project 
2000 
(N=477
e
)
(487)
 
Gyms 
(N=477) 
Anabolic 
steriods
 h
: 
 
No 
Yes 
CLS with 
1+ partner  
(past three 
months) 
χ
2 
test None  
 
34.8% 
33.8% 
p=1.000 
/ / / / 
GMSS 1999 
(N=4025
a
)
(51
1)
 
Pride events 
(n=6612) 
None 
Alcohol
f 
Poppers 
Cannabis 
Any other 
CLS with 
1+ partner  
(past year) 
χ
2 
test Men who 
drink/use
drugs 
more 
likely to 
report 
CLS 
50.0%
 
53.0%
  
54.0%
 
49.9%
 
59.6%
 
p<0.001 
/ / / / 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
poppers: 
No 
Yes 
CLS with 
2+ partners  
(past year) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
1.86 [1.31, 2.65] 
p=0.001 
OR None  
 
1 
1.44 [0.96, 2.14] 
p=0.076 
Age, sexual 
orientation, area of 
residence, 
frequency of gay 
scene use, HIV/STI 
testing, HIV status, 
alcohol, stimulant/ 
recreational/illicit 
drugs, Viagra use 
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Table 51: Unadjusted and adjusted associations found between recreational drug use and sexual behaviour measures in UK studies of MSM 
(including HIV-negative MSM), by measure of CLS (continued) 
 Largest % 
recruited via: 
Measure 
of drug 
use: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure 
of effect 
size 
Relation-
ship 
Estimate Factors adjusted for 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
drugs
 g
:
 
No 
Yes 
CLS with 
2+ partners  
(past year) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
3.20 [2.16, 4.73] 
p<0.001 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
2.75 [1.74, 4.34] 
p<0.001 
Age, sexual orientation, area 
of residence, frequency of 
gay scene use, HIV/STI 
testing, HIV status, alcohol, 
poppers, Viagra use 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
Viagra: 
No 
Yes 
CLS with 
2+ partners  
(past year) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
2.49 [1.58, 3.94] 
p<0.001 
OR None  
 
1 
1.70 [0.97, 2.98] 
p=0.062 
Age, sexual orientation, area 
of residence, frequency of 
gay scene use, HIV/STI 
testing, HIV status, alcohol, 
poppers,  stimulant/ 
recreational/illicit drugs, 
Community-
based 
survey 
1998 
(N=506)
(478)
 
Commercial 
gay venues 
(N=506) 
Marijuana 
before 
last (high-
risk) sex
c
: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past three 
months) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
 
 
1 
2.60 [1.24, 5.45] 
 
/ / / / 
Community-
based 
survey 
1998 
(N=506)
(478)
 
Commercial 
gay venues 
(N=506) 
Nitrites 
before 
last (high-
risk) sex
c
: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past three 
months) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
 
 
1 
3.56 [1.78,7.13] 
 
/ / / / 
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Table 51: Unadjusted and adjusted associations found between recreational drug use and sexual behaviour measures in UK studies of MSM 
(including HIV-negative MSM), by measure of CLS (continued) 
 Largest % 
recruited via: 
Measure 
of drug 
use: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
Community-
based 
survey 
1998 
(N=506)
(478)
 
Commercial 
gay venues 
(N=506) 
Party 
drugs
d
 
before 
last (high-
risk) sex
c
: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past three 
months) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
 
 
 
1 
2.93 [1.18, 7.28] 
/ / / / 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
poppers: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past year) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
1.44 [1.04, 2.00] 
p=0.029 
OR None  
 
1 
1.27 [0.89, 1.82] 
p=0.184 
Age, sexual orientation, 
area of residence, 
frequency of gay scene 
use, HIV/STI testing, HIV 
status, alcohol, stimulant/ 
recreational/illicit drugs, 
Viagra use 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
drugs
 g
:
 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past year) 
OR None  
 
1 
1.44 [0.98, 2.11] 
p=0.062 
OR None  
 
1 
1.23 [0.79, 1.89] 
p=0.359 
Age, sexual orientation, 
area of residence, 
frequency of gay scene 
use, HIV/STI testing, HIV 
status, alcohol, poppers, 
Viagra use 
GMSHS 
Scotland 
2011 
(N=639
b
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Used 
Viagra: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past year) 
OR Men who 
use drugs 
more 
likely to 
report 
CLS 
 
 
1 
1.98 [1.23, 3.19] 
p=0.005 
OR None  
 
1 
1.58 [0.92, 2.72] 
p=0.097 
Age, sexual orientation, 
area of residence, 
frequency of gay scene 
use, HIV/STI testing, HIV 
status, alcohol, poppers,  
stimulant/ 
recreational/illicit drugs 
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a 
Men who reported anal sex with a man in the past year. 
b
 Men who reported CLS with one or more partners in the past year, and did not have any missing data on any of the alcohol or drug use questions.  
c 
Intake of marijuana/nitrites/party drugs by either or both partners immediately before sex, during sex or less than two hours before sex, during episode of CLS with an 
unknown or HIV sero-different partner in the past three months or at last sexual encounter in the past three months. 
d 
Ecstasy, LSD, amphetamine, and cocaine. 
e 
HIV-negative men. 
f 
Alcohol use only. 
g
 Stimulants, recreational drugs and/or illicit drugs. 
h
 In the past year. 
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11.7.7 Alcohol use 
Of the 68 UK studies (if repeated surveys are considered as separate studies) identified in this 
review, 10 collected data on alcohol use (Table 2). The association between alcohol use and 
common measures of CLS was investigated in two publications, both of which recruited men 
from community/commercial gay venues (Table 52) 
(478, 509)
. Neither being drunk on alcohol 
(always/sometimes) nor alcohol use before/during sex was found to be associated with CLS 
with two or more partners in the past year or CLS with an unknown/sero-different HIV status 
partner (past year or past three months) 
(478, 509)
. The associations remained non-significant after 
adjustment for socio-demographic factors and recreational drug use in one study 
(509)
. 
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Table 52: Unadjusted and adjusted associations found between drinking alcohol and sexual behaviour measures in UK studies of MSM (including 
HIV-negative MSM), by measure of CLS
 
a
 Men who reported CLS with one or more partners in the past year and did not have any missing data on any of the alcohol or drug use questions.  
b 
Intake of alcohol by either or both partners immediately before sex, during sex, or less than two hours before sex, during episode of CLS with an unknown or HIV sero-different 
partner in the past three months or at last sexual encounter in the past three months. 
c 
Always/sometimes.
 Largest % 
recruited via: 
Measure 
of alcohol 
use: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors adjusted for 
GMSHS 
Scotland 
2011 
(N=639
a
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Drunk on 
alcohol: 
Never 
Yes
c 
 
CLS with 
2+ partners  
(past year) 
OR None  
 
1 
1.25 [0.81, 1.91] 
p=0.312 
OR None  
 
1 
0.81 [0.49, 1.33] 
p=0.397 
Age, sexual orientation, 
area of residence, 
frequency of gay scene 
use, HIV/STI testing, HIV 
status, popper, stimulant/ 
recreational/illicit drug and 
Viagra use 
Community-
based 
survey 
1998 
(N=506)
(478)
 
Commercial 
gay venues 
(N=506) 
Alcohol 
before 
last (high-
risk) sex
b
: 
No 
Yes 
CLS with 
unknown/ 
sero-
different 
partner  
(past three 
months) 
OR None  
 
 
 
1 
1.02 [0.58, 1.80] 
 
/ / / / 
GMSHS 
Scotland 
2011 
(N=639
a
)
(509)
 
Commercial 
gay venues 
(N=1515, 
whole 
sample) 
Drunk on 
alcohol: 
Never 
Yes
c 
 
CLS with 
unknown/ 
sero-
different 
partner  
(past year) 
OR None  
 
1 
1.13 [0.77, 1.64] 
p=0.538 
OR None  
 
1 
1.10 [0.73, 1.66] 
p=0.652 
Age, sexual orientation, 
area of residence, 
frequency of gay scene 
use, HIV/STI testing, HIV 
status, popper, stimulant/ 
recreational/illicit drug and 
Viagra use 
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11.7.8 CSA and IPV 
Although the association between CSA and common measures of CLS was not investigated (as 
measures of CSA have not been explicitly collected), it was investigated whether sexual assualt 
and non-consensual sex in childhood and adulthood was associated with CLS with with one or 
more partners in the past year in two studies (Table 2 and Table 53) 
(355, 510)
. Both studies 
investigated unadjusted associations only, one study finding that men who reported sexual 
assualt in childhood and/or adulthood were more likely to report CLS 
(510)
, and the other finding 
no association with non-consensual sex 
(355)
. No UK studies of sexual behaviour among MSM 
have collected data on IPV (Table 2). 
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Table 53: Unadjusted and adjusted associations found between markers of CSA and sexual behaviour measures in UK studies of MSM (including 
HIV-negative MSM), by measure of CLS
 
 Largest % 
recruited via: 
Measure 
of CSA: 
Measure of 
CLS 
Unadjusted association 
 
Adjusted association 
Study:    Test/ 
measure 
of effect 
size 
Relation-
ship 
Estimate Measure of 
effect size 
Relation-
ship 
Estimate Factors 
adjusted for 
GMSS 1998 
(N=5065
a
) 
(510)
 
 
Pride events 
(n=6315) 
 
Sexual 
assault: 
Never 
<16 years 
≥16 years  
Both
b
 
CLS with 
1+ partner  
(past year) 
χ
2 
test Men who 
report 
sexual 
assault in 
childhood 
and/or 
adulthood 
more 
likely to 
report 
CLS 
 
 
45.1%
  
46.7%
  
55.1%
  
60.4%
 
p<0.01 
/ / / / 
Clinic survey 
1999 
(N=122)
(355)
 
GUM clinic 
(N=122) 
Non-
consens-
ual sex in 
childhood/ 
adulthood 
No 
Yes 
CLS with 
1+ partner  
(past year) 
χ
2 
test None  
 
 
 
 
62.2% 
59.4% 
p=0.71 
/ / / / 
a 
Men who reported anal sex with a man in the past year. 
b
 Experienced sexual assualt both before & since the age of 16.
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11.8 Appendix 8: Design and methods of the AURAH study 
 
11.8.1 Identification of the sample population in AURAH 
The AURAH study nurse coordinator (Janey Sewell) identified 15 clinical centres (comprising of 
20 GUM clinic sites, see Table 54) for study participation based on previously successful 
research collaborations and on the understanding that the centre could facilitate access to large 
numbers of HIV-negative MSM and black African men and women.  
 
Table 54: Number of MSM recruited from 20 GUM clinical sites for the AURAH study 
Clinical centre N=1340 MSM 
who reported 
anal/vaginal 
sex in the past 
three months  
n(%) 
South East 
Claude Nicol Centre at Royal Sussex County Hospital (Brighton and Sussex 
University Hospitals NHS Trust) 
173 (12.9%) 
Florey Unit (Royal Berkshire NHS Foundation Trust) 32 (2.4%) 
South West 
Brecon Unit at Southmead Hospital (North Bristol NHS Trust) 36 (2.7%) 
London region 
Sydenham Centre at Barking Hospital (Barking, Havering and Redbridge 
University Hospitals NHS Trust) 
8 (0.6%) 
Barts Sexual Health Centre (Barts Health NHS Trust) 11 (0.8%) 
Ambrose King Centre at The London Hospital (Barts Health NHS Trust) 10 (0.8%) 
Greenway Centre at Newham Hospital (Barts Health NHS Trust) 7 (0.5%) 
Whipps Cross Hospital (Barts Health NHS Trust) 6 (0.5%) 
56 Dean Street (Chelsea and Westminster Hospital NHS Foundation Trust) 478 (35.7%) 
John Hunter Clinic (Chelsea and Westminster Hospital NHS Foundation Trust) 43 (3.2%) 
West London Centre for Sexual Health (Chelsea and Westminster Hospital 
NHS Foundation Trust) 
90 (6.7%) 
Clifden Centre (Homerton University Hospital NHS Foundation Trust) 33 (2.5%) 
King’s College Hospita (King’s College Hospital NHS Foundation Trust) 29 (2.2%) 
The Mortimer Market Centre (Central and North West London NHS Foundation 
Trust) 
240 (17.9%) 
Marlborough Clinic (Royal Free Hospital NHS Foundation Trust) 27 (2.0%) 
Courtyard Clinic (St George’s Healthcare NHS Trust) 35 (2.6%) 
West Midlands 
Birmingham Heartlands Hospital (Heart of England NHS Foundation Trust) 7 (0.5%) 
City of Coventry Healthcare Centre (Coventry and Warwickshire Partnership 
NHS Trust) 
27 (2.0%) 
East Midlands 
Leicester Royal Infirmary (University Hospitals of Leicester NHS Trust) 5 (0.4%) 
Yorkshire and the Humber 
Princess Royal Community Health Centre (Calderdale and Huddersfield NHS 
Foundation Trust) 
43 (3.2%) 
 
11.8.2 Method of sample selection in AURAH 
Recruitment to the study took place between June 2013 and November 2014 at different 
periods in the 20 clinic sites. At study start, all sites were asked to identify specific clinics each 
week for recruitment. Clinic attendees were consecutively sampled. After five months of 
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consecutive sampling, it became clear that the proportion of the populations of interest (MSM 
and black African men and women) was not reaching the targets set for analytic purposes. 
Accordingly, sampling switched to disproportionate quota purposive methods, in order to ‘over 
represent’ and recruit until the required proportion of the populations of interest were enrolled. 
Clinic staff was asked to identify and recruit only MSM or individuals of black ethnicity.  Once 
the target sample population of 1000 MSM had been achieved, after ten months of recruitment, 
the five clinic sites that had recruited the highest numbers of MSM were asked to continue 
sampling and to focus solely upon the recruitment of MSM who were willing to participate in a 
follow-up longitudinal study commencing November 2014. The remaining 15 clinic sites were 
asked to focus solely upon the recruitment of men and women of black African ethnicity for a 
fixed period of four months before recruitment end.  
 
11.8.3 Sample power calculation for the AURAH study 
Determining the appropriate sample size for a particular research question, often requires a 
balance between accepting the limitations of resources available and the need to avoid error 
when concluding support for a null hypothesis: type I error is a false positive finding and type II 
error is a false-negative finding. A maximum probability of making a type I error, called alpha, is 
assigned. Alpha is usually set at 0.05, indicating that there is no greater than a 5% chance of 
making a type I error. A maximum probability for making a type II error, called beta, is assigned 
and referred to as the statistical power of the study. Statistical power depends on sample size. 
The larger the sample size the higher the level of statistical power. Beta is usually set at 20%, 
which means there is at least 80% chance of rejecting a false null hypothesis. 
 
For the AURAH study, estimating the prevalence of the following three measures, was deemed 
vital: (i) CLS in the past three months with a partner of unknown or HIV-positive status and that 
one of the reasons for this was ‘I knew there was a risk of acquiring HIV but I am not so 
concerned about having the disease that it made me want to have sex using a condom’ (where 
the denominator was all participants or all participants reporting CLS), (ii) CLS in the past three 
months with a positive partner who give a reason as ‘I thought the risks of catching HIV were 
low because my partner was taking anti-retroviral therapy’, and (iii) current depressive 
symptoms on the PHQ-9 scale, where the denominator was all MSM, heterosexual men and 
women, and black African men and women. 
 
It was calculated that with a recruitment target of 2000 total sample size, 1000 MSM and 1000 
heterosexuals (500 men and 500 women), of whom 600 are black African, the study would have 
sufficient power to estimate the three measures described above. This sample size enabled the 
estimation of proportions relating to measure (i), with the precision shown in Table 55, for 
estimated response proportions of 5%, 10%, 15%, and 20%, within the demographic 
subgroups.   
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Table 55: Precision for 95% confidence intervals for a single proportion according to 
major demographic subgroups, for the AURAH study 
 
 
Target 
number in 
AURAH 
 
95% 
Confidence 
interval for 
prevalence of 
5% 
95% Confidence 
interval for 
prevalence of  
 
10% 
95% 
Confidence 
interval for 
prevalence of 
15% 
95% 
Confidence 
interval for 
prevalence of 
20% 
MSM 1000 +/- 1.35 +/- 1.86 +/- 2.22 +/- 2.48 
All 
heterosexual 
men 
500 +/- 1.90 +/- 2.63 +/- 3.15 +/- 3.51 
Black African 
heterosexual 
men 
300 +/-2.45 +/- 3.40 +/- 4.05 +/- 4.53 
 
All women 500 +/- 1.90 +/- 2.63 +/- 3.15 +/- 3.51 
Black African 
women 
300 +/-2.45 +/- 3.40 +/- 4.05 +/- 4.53 
 
For measure (ii), the denominator was the number of subjects who report CLS in the past three 
months (estimated to be 50% of the total number), and the estimated proportion was expected 
to be lower than for (i). Precision is shown in Table 56 for proportions of 5% and 10%. For 
measure (iii), the study has 80% power to detect the differences in prevalence of depression 
shown in Table 57 for the demographic subgroups, with a 2-sided alpha level set at 0.05. 
 
Table 56: Precision for 95% confidence intervals for a single proportion according to 
major demographic subgroups
a
, for the AURAH study 
 
 
Target 
number in 
AURAH 
 
95% Confidence 
interval for 
prevalence of 5% 
95% Confidence interval for 
prevalence of 10% 
MSM 500 +/- 1.90 +/- 2.63 
All Heterosexual men 250 +/-2.70 +/- 3.7 
Black African heterosexual 
men 
150 +/- 3.50 +/- 4.8 
All women 250 +/-2.70 +/- 3.7 
Black African women 150 +/- 3.50 +/- 4.8 
a
 These estimates are based on Normal approximations but exact methods will be used to 
calculate 95% confidence intervals for proportions when the numerator is < 20. 
 
Table 57: Differences between two proportions detectable with 80% power at 2-sided 5% 
significance level, according to major demographic subgroups, for the AURAH study 
 Estimated 
final 
numbers in 
ASTRA 
Target 
number in 
AURAH 
 
Difference in prevalence of depression 
that could be detected, comparing 
HIV+ve with HIV-ve individuals, 
assuming 25% prevalence in HIV+ve 
people (in all groups) 
MSM 2250 1000 4.5% 
All Heterosexual men 400 500 7.5% 
Black African 
heterosexual men 
200 300 10.0% 
All women 700 500 6.8% 
Black African women 450 300 8.5% 
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11.8.4 AURAH questionnaire 
An initial questionnaire was piloted at one study site in June 2013, using the recruitment 
procedures described above. Following feedback from participants and research staff, some 
revisions were made to the final questionnaire. These changes were submitted as amendments 
for ethical approval and were incorporated into the final version employed during the main 
recruitment period, which commenced in June 2013. The statement of ethical approval is 
presented in the following section.  
 
The final questionnaire consisted of a printed A5 booklet, with versions for men (24 page 
questionnaire) and women (20 page questionnaire). The questionnaire sought detailed 
information on socio-demographic factors, health and well-being, lifestyle factors, HIV-related 
information, and sexual risk behaviour. A description of all questions asked is presented below. 
Of note, participants were made aware that their participation included supplying information on 
the results of any STI or HIV tests that took place in the clinic on the day they were enrolled in 
the study. Participants were given an envelope and asked to seal the completed questionnaire 
in it to ensure that their answers were kept confidential from clinic staff. Completed 
questionnaires were collected in the clinic and transferred regularly to the study management 
centre. If participants took the questionnaire off site to complete outside of the clinic area, they 
were supplied with a postage paid envelope to return the questionnaire to the study 
management centre.  
 
Socio-demographic factors: Age, or year of birth, gender, ethnicity (white British, Irish or other, 
black African, Caribbean or other, Indian, Pakistani, Bangladeshi or Asian other, white and 
black African, white and black Caribbean, white and Asian or mixed other, or Chinese or any 
other ethnic group), born in the UK, when moved to the UK (born in the UK, moved >5 years 
ago, moved 1-5 years ago, or moved <1 year ago), education (no qualifications, O 
levels/GCSEs, A levels, university degree, or other), employment (employed full- or part-time, 
student, unemployed on benefits or not, permanently or temporarily sick, care, or other), 
housing (own home, renting from council or private, temporary accommodation, staying with 
someone, homeless, or other), enough money to cover basic needs (all of the time, most of the 
time, some of the time, or never), relationship status and HIV status of partner (HIV-negative 
stable partner, HIV-positive stable partner, unknown status stable partner, or no stable partner), 
any children and sexuality (straight/heterosexual, gay/homosexual, bisexual, or other) and 
disclosure of ‘MSM status’ (what proportion of the following groups (i) close family, (ii) friends 
and (iii) workmates, know that you are gay/bisexual/attracted to men [all/almost all, more than 
half, about half, less than half or few/none]). 
 
Health and well-being: Psychological and physical symptoms (modified version of Memorial 
Symptom Assessment Scale Short-Form) 
(738, 739)
, Depression (PHQ-9) 
(443)
, Anxiety (GAD-7) 
(629)
, Health-related quality of life (EuroQoL 5D) 
(628)
, Social support (modified version of the 
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Duke–UNC Functional Social Support Questionnaire – FSSQ) 
(631)
, ever been told that you have 
any major health condition (cancer, diabetes, stroke, heart disease, high cholesterol, epilepsy, 
high blood pressure, mental health, or other), receiving medical treatment or therapy for 
depression, or any other mental health condition, diagnosed chronic Hepatitis B or C, diagnosed 
STI in the past year (with 11 individual options including other), symptoms of STI (discharge, 
pain, or sores/rash), and finally, women were asked about being pregnant and men about 
circumcision.  
 
Lifestyle factors: regular cigarette smoking, frequency of drinking alcohol (never, monthly or 
less, 2-4 times a month, 2-3 times a week, or 4, or more times a week), usual alcohol intake in 
units on a typical day (1-2, 3-4, 5-6, 7-9 or 10, or more), evidence of alcohol dependency (the 
CAGE questionnaire) 
(740)
, recent use of recreational drugs (with 19 individual drug options 
including other), recent use of injecting drugs, and gay scene frequency (how often do you go to 
gay cafes, pubs, bars, nightclubs/discos [often, sometimes, occasionally, rarely, or never]).  
 
HIV related information: HIV-positive status (no or don’t know), HIV test on the day of the study, 
history of any HIV tests (within the last six months, >six months and up to two years ago, >two 
years and up to five years ago, or >five years ago), beliefs about transmission risk in relation to 
ART and undetectable viral load (‘I worry about getting HIV’, ‘If I had HIV and was being treated 
with modern HIV drugs I would expect to have a normal lifespan’, ‘If a person with HIV has an 
undetectable HIV VL this makes them less infectious to a sexual partner than if they had a high 
VL’, ‘when HIV VL is undetectable, a condom is not needed to prevent HIV transmission’ 
[strongly agree, tend to agree, undecided/not relevant to me/no opinion, tend to disagree, or 
strongly disagree]), knowledge and any history of post exposure prophylaxis (PEP) and pre-
exposure prophylaxis (PREP), interest in PrEP, and attitudes to HIV self-testing and clinic 
based tests. 
 
Sexual behaviour: Men were asked about anal sex with men, and anal or vaginal sex with 
women, in the past three months. Women were asked about anal or vaginal sex with a man in 
the past three months. Subsequent questions asked about condomless sex; the number of 
partners with whom they had condomless sex (one, 2-4, 5-10, or >10) and whether this partner 
or one of these partners were their long-term partner (yes, no, or I don’t have a long-term 
partner). If men reported condomless anal sex with a man, they were asked whether they had 
always been the receptive partner, always been the insertive partner or both. Regardless of the 
gender of the condomless sex partner, participants were further asked the reasons for non-
condom-use (‘Didn’t think about using a condom/did not have one’,’ Don’t like using a 
condom/more pleasurable without’, ‘Partner didn’t want to use a condom’, ‘Felt unable to 
discuss condom-use’, ‘Got carried away/under the influence of alcohol or drugs’, ‘Difficult to 
keep erection for me or my partner’, and just for sex with women; ‘Trying for pregnancy’), 
whether they considered the risks of HIV infection (‘I thought there was a very low risk of being 
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infected with HIV’ and/or ‘I knew there was a risk of getting HIV but I am not so concerned about 
HIV that it made me want to have sex using a condom’), whether they knew the HIV status of all 
of their partners (no, yes all, or yes some), whether they had condomless sex with a person 
they knew had HIV, the number of HIV-positive condomless sex partners, whether this positive 
partner or one of these positive partners was their long-term partner (yes, no, or I don’t know) 
and whether they agreed with the statement ‘I thought the risks of catching HIV were low 
because my partner was taking anti-retroviral therapy’. All participants were also asked about 
use of the Internet to find sexual partners, different sex practices (fisting or use of sex toys) and 
group sex, attitudes to disclosure of HIV status to sexual partners and negotiation of condom-
use (‘I find it difficult to discuss condom-use with any new sexual partner’, ‘I am less likely to use 
a condom with a casual partner’, ‘I would expect a new partner to tell me if they’re HIV-positive 
before we have sex’, ‘I’d expect to ask any new partner their HIV status before we have sex’, 
and ‘I feel confident that, if I want to, I can make sure a condom is used during sex with any 
partner, in any situation’ (strongly agree, tend to agree, undecided/not relevant to me/no 
opinion, tend to disagree, or strongly disagree)), and the number of new sexual partners in the 
past year. 
 
A study website was set up (http://www.astra-study.org/aurah) providing access to full contact 
details, progress updates, background information, all the study documents and future results. 
PDF copies of the questionnaires are available on request from the study website 
(http://www.astra-study.org/aurah).  
 
11.8.4.1 Statement of ethical approval for the AURAH study 
The research protocol and all versions of the study documents (information sheet, consent form, 
questionnaires and insert) were approved by the designated research ethics committee (NRES 
committee London-Hampstead, ref: 13/LO/0246).  Based on these documents, the study 
subsequently received permission for clinical research at all participating National Health 
Service sites. 
 
11.8.4.2 Data processing in the AURAH study 
An external data processing contractor digitised questionnaires received at the management 
centre. Each paper questionnaire was checked for legibility, digitally scanned and the resulting 
images were used as the source for two manual data entry rounds with subsequent quality 
checking. The completed data entry batches delivered by the contractor were checked for 
accuracy at the study management centre by fully examining a 5% sample. The original 
pseudonymised study datasets, including scanned images of the questionnaires were stored at 
the study management centre in encrypted digital form. They were preserved by being 
duplicated and stored on managed servers with regular backup and professional administration.  
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11.8.5 Data management in the AURAH study 
 
11.8.5.1 Checking AURAH data for errors and inconsistencies 
The data was checked for errors and inconsistences using the ‘assert’ command in Stata. The 
assert command allows automation of the process of data checking within do-files. After the 
assert command a logical expression that should always be true of the data is described. For 
instance, the ‘assert inlist(a3_ethnic,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,.u)’ command and 
logical expression will be true if the variable ethnicity had values 1 to 16 or unknown (.u), and 
will be false otherwise. Furthermore, the ‘assert a4_bornother==.n if a4_bornuk==1’ command 
and logical expression will be true when the response to ‘having been born in the UK’ is Yes (1) 
and the response to ‘which other country were you born in’ is Not applicable (.n), and will be 
false otherwise i.e. if a4_bornuk is coded as 1 (yes), then a4_bornother should always be coded 
as .n (not applicable). When the assert command fails the do-file stops and produces an error 
message describing the number of individuals in the dataset for whom the assertion has failed. 
Of note, as described below, local macros can be used to control how the assert command 
functions 
(616)
. Where necessary a local macro (called ‘run’ and set to rc0) was used to 
determine whether the do-file should continue or stop upon encountering a false assertion. 
When an expression was followed by the option ‘run’, the do-file continued to run even if there 
was a false assertion. Table 58 and Table 59 outline the various assertions created.
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Table 58: Strategy for creating assertions - individual variables and skip questions (data-management in the AURAH study) 
For individual 
variables 
For skip question variables
a
 with 
one sub-group question 
For skip question variables
a
 with more than one sub-group 
question
b
 
For skip question variables
a
 with more than one 
false/true sub-group question
c
 
1. Created one 
assertion 
based on the 
range of 
possible 
values/categor
ies as 
indicated by 
the code book 
and ‘all 
participants’ 
study log. 
1. Created one assertion which 
checked whether the sub-group 
variable is always .n if the skip 
question response renders the 
participant ineligible for the sub-
group question (usually ‘No’). 
1.Created two assertions for each sub-group question, the 
first checked whether the sub-group variable is always .n 
if the skip question response renders the participant 
ineligible for the sub-group question (usually ‘No’) and the 
second checked the reverse, whether the skip question 
response is always ‘No’ if the sub-group variable is coded 
as .n. 
1.Created two assertions for each sub-group question, 
the first checked whether the sub-group variable is 
always .n if the skip question response renders the 
participant ineligible for the sub-group question (usually 
‘No’) and the second checked the reverse, whether the 
skip question response is always ‘No’ if the sub-group 
variable is coded as .n. 
 2. Created one assertion which 
checked whether the skip 
question response is always the 
eligible response (usually ‘Yes’) if 
the sub-group variable has a 
value i.e. is not missing (.u/.n). 
This second assertion was not 
included when the skip question 
was a scale of questions. 
2. Created one assertion for each sub-group question, 
which checked whether the skip question response is 
always the eligible response (usually ‘Yes’) if the sub-
group variable has a value i.e. is not missing (.u/.n). 
2. Created one assertion for each sub-group question, 
which checked whether the skip question response is 
always the eligible response (usually ‘Yes’) if the sub-
group variable has a value i.e. is not missing (.u/.n). 
   3. Created two assertions for each sub-group question, 
the first checked whether the sub-group variable is 
always .u if the skip question is coded as .u. The second 
checked the reverse, whether the skip question is 
always .u if the sub-group question is coded as .u. 
a
 Where a participant was asked to move to the next question if their response to this particular question was ‘No’. 
b
 If I recoded missing (i.e. coded as 0 in the raw dataset) on a variable into .n (not applicable) or a new category based on a skip question, then I checked to see whether there 
was more than one sub-group question following the skip question. If there was more than one, I included an additional assertion to pick up any changes from No to Yes. One 
of the sub-group variables may be coded as .n since they had a missing value and had ticked No for the skip question, however, if another sub-group variable contains a value 
that suggests that the skip question should be changed from No to Yes, then the previous sub-group would need to be recoded from .n into .u. A second assertion was needed 
to pick this up, asserting that the sub-group is always .n if the skip question is No was no longer enough, I needed to know whether the skip question was always coded as No if 
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the sub-group was coded as .n. Of note, if the .n category on a sub-group variable was based on gender, then a second assertion was not required since gender cannot be 
changed, regardless of the values on any of the sub-group variables. Of note, unlike all other skip questions in the questionnaire, insert variable categories (to attain further 
information on preferences for HIV testing) dictated whether participants should have values for the sub-group questions i.e. if someone had been placed in the completed 
insert category, then they should have at least one value for all questions in the insert i.e. they should not have all .u (whereas, this is not the case for other skip questions, 
where answering Yes and being eligible for the sub-group questions did not translate into having to have at least one value and not having all unknown). To account for this an 
extra assertion was created for the testing options variables, which checked whether the insert variable is always blank or no insert if the value for each testing option is greater 
than 4 i.e. was missing. 
c
 Two additional assertions were required for false/true variables in this context, in order to take into account the fact that the sub-groups are coded 0 (false) and 1 (true) i.e. if 
someone had ticked Yes to the skip question and was eligible for the sub-group options, they would be coded as 0 if they did not tick a sub-group option and not .u. Therefore, it 
is necessary to assert here that the sub-group option is always .u if the skip question is .u and that the skip question is always .u if the sub-group option is .u, again this final 
assertion is used to pick up any changes from .u to Yes. 
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Table 59: Strategy for creating assertions- skip questions with multiple sub-group questions and implausible combinations of variables (data-
management in the AURAH study) 
For more than one skip question variable
a
 with more than one 
sub-group question 
For ‘Other please specify’ variables For implausible combinations of variables 
1. If gender is a skip question and the sub-group question is a skip 
question and again (although there might not always have been 
this third level or there might even have been more) its sub-group 
question is a skip question for multiple sub-group questions, then 
only gender was coded as .n for all these variables. For the 
remaining skip questions, the ineligible response was included as 
a new category in the sub-group variables i.e. two extra 
categories would have been added to the final level of sub-group 
questions, accounting for the two skip questions and the ineligible 
gender would have been coded as .n. Under these circumstances: 
Created assertions for each previous skip question until gender 
with each sub-group variable
b
. 
1. Created two assertions for each sub-group variable, the first 
checked whether the sub-group question is always .n if gender is 
male/female (as appropriate). The second checked whether 
gender is always male/female if the sub-group question has a 
value i.e. is not missing (although .u would also be appropriate, 
but these assertions together cover the information we need). 
1. Created one assertion which checked 
whether the categorical variable which 
included other please specify) always has 
a value i.e. is not missing (.u) if the 
encoded comments variable has a value 
i.e. is not missing. 
1. Created two assertions, the first checked 
whether one variable is always a certain 
value if another variable is a certain value. 
The second checked whether the second 
variable is always a certain value if the first 
is a certain value. 
2.Created two assertions for each sub-group variable, the first 
checked whether the sub-group question is always coded as a 
new category if the skip question response is ineligible i.e. usually 
‘No’. The second checked whether the skip question response is 
always ‘No’ if the sub-group question is coded as a new category 
(these two assertions would be repeated if there were more than 
one skip question following gender). 
 2. Created one assertion which checked 
whether a variable is .n if gender is 
male/female (as appropriate). 
3.Created one assertion for each sub-group variable, which 
checked whether the skip question response is always the eligible 
response (usually ‘Yes’) if the sub-group variable has a value that 
does not include the new category (this assertion would be 
repeated if there were more than one skip question following 
gender). 
  
a
 Where a participant was asked to move to the next question if their response to this particular question was ‘No’. 
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b
 Since all of these variables are linked and a change in one needs to be captured in all subsequent variables.
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11.8.5.2 Correcting errors and inconsistencies in AURAH data 
If errors in the range of variable categories were detected, where data entry personnel had 
coded a participant as 99 for a particular variable, indicating multiple responses, this was dealt 
with by investigating the participants’ original scanned questionnaire and recoding using the 
criteria described in Table 60. 
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Table 60: Dealing with multiple responses (data-management in the AURAH study) 
Likert scale 
variables 
Yes/No & Don’t 
know variables 
Yes & No 
variables 
Education levels Ethnicity  
Take the upper limit response i.e. if ticked 
quite a bit distressed and very much 
distressed, recode into very much. For 
frequency categories i.e. once, twice etc. 
if someone ticked once and twice, they 
were recoded into twice. If the scale 
includes undecided/not relevant to me in 
the middle either side of agree and 
disagree and someone ticked undecided 
and agree, then they were recoded into 
agree. If someone ticked tend to agree 
and strongly agree, they were coded as 
strongly agree, the same is true if 
someone wrote tend to agree and 
strongly disagree, they were recoded as 
the latter. If someone ticked tend to agree 
and tend to disagree, they were coded 
into undecided. If someone ticked almost 
all and more than half of a group knows 
you are gay, then they were recoded into 
almost all.  
If ticked Yes & 
Don’t know, recode 
as Don’t know (do 
the same for No & 
Don’t know). 
If ticked Yes and No, 
create a new category 
that is Don’t know/no 
preference. However, 
for treatment for 
depression and 
condomless sex, if 
someone had ticked 
yes & no, they were 
recoded into yes. If 
someone ticked I am 
an ex-smoker and I 
have never smoked, 
they were recoded as I 
am an ex-smoker. 
Take the upper limit 
response i.e. if 
ticked O levels and 
A levels, recode 
into A levels 
If ticked two ethnic 
groups, recode into 
the appropriate mixed 
category. If one of the 
two categories ticked 
includes a mixed 
group, recode into 
mixed other. If 
someone had ticked 
black African and 
another category or 
white and black 
African and another 
category, then they 
were kept in the 
category that included 
black African, since 
whoever ticked black 
African (regardless of 
whether it was mixed 
with white) are of 
interest. 
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Furthermore, if someone ticked No to a skip question (i.e. where a participant was asked to 
move to the next question if their response to this particular question was ‘No’) and was no 
longer eligible to answer the following question(s) but had ticked a response to at least one 
question, their sub-group questions were investigated. The following criteria were set out in 
order to deal with the various skip questions included: 
1. If someone had only ticked No/Never to these questions, they were not recoded into 
Yes for the original skip question. Their values for the following variables were recoded 
into ‘not applicable’ (.n).  
2. If someone had ticked No for the skip question and had ticked Yes/number of 
times/frequency to at least one question following, they were recoded into Yes for the 
original skip question and their values for the following variable(s) were changed 
accordingly, i.e. from not applicable to unknown (.u).  
3. If someone had no values for the skip question but had indicated Yes/number of 
times/frequency to at least one question following, they were recoded into Yes for the 
original skip question.  
4. If someone had no values for the skip question and had ticked No/Never only (and there 
is no other helpful information relating to these questions), they were not recoded, the 
skip question remained as unknown (a local macro was incorporated here to allow the 
Stata do-file to continue to run i.e. the file did not terminate once the assertion term 
relating to this variable failed but continued to check the data for errors). 
5. If someone had ticked No to the skip but had ticked at least one false/true question 
following (i.e. one in which more than one option is possible), they were recoded into 
Yes for the original skip question and False to any false/true question that was not 
ticked.  
 
Of note, if someone had ticked Yes to having been born in the UK but had values for the 
following questions, to which they were not eligible, they were recoded into Not applicable for 
these following questions. If someone had not ticked anything for born in the UK and had ticked 
that they had moved to the UK 1-5 years ago or less and had ticked an ethnicity other than 
white British, they were recoded into not born in the UK. However, if they had ticked white 
British ethnicity and had ticked having moved to the UK more than 5 years ago (or had not 
ticked this at all), they were recoded into born in the UK. If someone had ticked an ethnicity 
other than white British and they had ticked moved to the UK more than 5 years ago, they were 
kept as unknown for born in the UK and country born in. 
 
11.8.5.3 Dealing with inconsistent responses to sexual behaviour in the AURAH study 
The sexual lifestyle section in the AURAH questionnaire contained thirteen questions (for 
female and male partners separately), with an overall skip question ‘In the past three months, 
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have you had sex (vaginal/anal sex) with a man/woman’, and a number of subsequent 
questions to be answered if the response to the previous question was positive, including ‘If 
Yes, did any of the sex within the last 3 months take place without a condom’. Unlike most other 
sections of the questionnaire, sexual behaviour is subject to social desirability bias. This was, 
however, probably limited by the AURAH study’s attempt to assure participants of confidentiality 
of responses and data security issues. Instead of recoding individuals’ responses as a matter of 
error and inconsistency, as described in the previous section, a different approach to 
highlighting and dealing with inconsistent responses was required.  
 
Individuals who gave a positive response to a sub-group question(s) were not recoded into Yes 
for CLS if participants had said No to sex and/or CLS, instead they were recoded into a 
category called ‘Possible’. In total, of MSM who reported anal/vaginal sex in the past three 
months and reported not having had CLS in the past three months, 3.3% (44/1340) and 0.03% 
(34/1340) were categorized as having ‘possible CLS’ with a man and woman respectively. The 
inclusion criteria for the ‘Possible’ group are described below. Of note, men who were placed in 
the ‘possible’ category of CLS were included in the ‘no CLS’ category for all analyses presented 
in this thesis. 
 
 
1. If someone ticked No to the sub-skip question ‘IF YES, did any of the sex within the last 
three months take place without a condom?’ and was no longer eligible to answer the 
following questions but had ticked Yes/number of times/True (including any anal 
position) to at least one question following, they were recoded into ‘Possible’ in the 
original sub-skip question (For condomless sex with a man n=43, and for condomless 
sex with a woman n=9). If they had missing values for one of the questions following, 
they were recoded into unknown. 
2. If someone had ticked No to any sex in the past three months skip question and had no 
values for the CLS sub-skip question (i.e. they would have been coded as No sex), then 
if they ticked No/Never only for the questions following, their following questions were 
coded into No sex. If they had ticked at least one Yes/number of times/True to the 
questions following, then they were recoded into ‘Possible’ (For condomless sex with a 
man n=1, and for condomless sex with a woman n=25).  
3. If someone had ticked Yes to any sex in the past three months skip question or had no 
values and if they had no values for the CLS sub-skip question (i.e. they would have 
been coded as unknown), then if they had ticked Yes/number of times/True to at least 
one question following, they were coded into Yes to the CLS sub-skip question. If they 
had ticked No/Never on a question following that was phrased as ‘In the last three 
months, when you had sex without a condom...’, they would be recoded into ‘Possible’, 
however, no one met this criteria. If someone had ticked No/Never on a question 
following that was not phrased in this way (including ‘In the past three months, did you 
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have anal sex with a woman without a condom’ and ‘In the past three months, did you 
have sex without a condom with a woman you knew was HIV-positive’), they were not 
recoded into ‘Possible’, their value for the CLS sub-skip question remained as unknown 
and their value for the question following remained as No/Never (again, a local macro 
was incorporated here to allow the do-file to continue to run). 
 
Further criteria were set forth to resolve other inconsistencies in the sexual lifestyle section. For 
instance, some participants had ticked ‘Yes, I knew the HIV status of some of my partner(s)’ and 
had ticked one CLS partner. If someone had reported the profile of a partner that matched to 
their stable ongoing HIV-positive/negative status partner that they had reported, or if they had 
reported the profile of a partner whose status they knew to be positive and who they clearly 
stated was not their stable ongoing partner, then it was assumed that due to the wording of the 
status question, these people may have ticked ‘Some’ instead of ‘All’. The wording of the ‘some 
partners’ option is confusing since partner(s) is specified instead of partners. The criteria for 
recoding these participants into ‘Yes, I knew the HIV status of all of my partners’ are described 
in more detail below: 
1. If they had reported being in a current stable relationship with an HIV-negative partner, 
and in the sexual behaviour section they had ticked ‘Long-term CLS partner’ and ‘No’ to 
having had an HIV-positive partner. 
2. If they had reported being in a current stable relationship with an HIV-positive partner, 
and in the sexual behaviour section they had ticked ‘Long-term CLS partner’, ‘Yes’ to 
having had an HIV-positive partner, ‘One’ positive partner(s) and ‘Yes’ to long-term 
positive partner.  
3. Regardless of whether they had reported being in a current stable relationship (HIV-
positive, HIV-negative, Don’t Know status or missing response) or having no current 
stable partner, if they had ticked ‘No’ to long-term partner, ‘Yes’ to having had an HIV-
positive status partner, ‘One’ positive partner and ‘No’ to long-term positive partner.  
 
Of note, for participants who had ticked no current stable partner, this included people who had 
ticked ‘I don’t have a long-term partner’, ‘Yes’ to having had an HIV-positive partner, ‘One’ 
positive partner and ‘I don’t have a long-term partner’. Participants who did not meet these 
criteria were recoded into 2-4 CLS partners if they had indicated elsewhere that 2-4 partners is 
an appropriate assumption by looking at group sex, seeking sex on the Internet, acquisition of 
STIs, money or drugs for sex and number of new sexual partners. If someone had ticked group 
sex, they were recoded into 2-4 partners (regardless of what else they had ticked). If someone 
had not ticked group sex but they had ticked two or more new sexual partners and ‘Yes’ to at 
least one of the following; STI diagnosis, seeking sex on the Internet, or Money/drugs for sex, 
then they were again recoded into 2-4 partners. Those who had not were kept as they were.  
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11.8.5.4 Variables derived for analysis in AURAH 
In short, date of birth and study clinic attendance date, which were originally stored as string 
variables (i.e. character variables, which permit storage of any combination of numbers and 
characters) in Stata, were converted into date variables. Stata stores each date as the number 
of days from January 1
st
 1960 (an arbitrary value), to facilitate calculations of the amount of time 
that has elapsed between two dates 
(616)
. This made it possible to compute missing values for 
age by subtracting birth date from study clinic attendance date, see Table 61. In order to make 
the dates easier to read, I used the %td format, in order to produce variables with a two-digit 
day, three-letter month, and four-digit year. 
 
Table 61: Dealing with date and other string variables (data-management in the AURAH 
study) 
Date 
variable 
Genuine string variable 
 ‘Other, please specify’ ‘Please specify’ on a binary 
variable 
1. 
Changed 
variable 
from str to 
td 
1. The comments of participant’s, who ticked 
the Other category of a categorical variable, 
were examined. 
1. Created a sub-group 
variable, making sure, based 
on the comments, that 
participants were placed in 
the appropriate category of 
the original variable. 
 2. New distinct categories were created from 
the comments (if appropriate) or participants 
were recoded into another category of the 
variable (if the comment clearly indicated 
another category should have been ticked). If 
neither of the above was appropriate, then 
participants were kept in Other. 
2. No assertion was needed, 
since it was created. 
 3. Created an assertion to check that everyone 
who has given a comment, has ticked a box 
i.e. a participant should not have a missing 
value if they wrote a comment. 
 
 
Furthermore, where appropriate, I distinguished between missing values (coded as .u ; 
“Unknown”) and values which were not applicable i.e. when an individual had answered a 
previous question in such a way that they were not eligible for further questioning of this subject, 
their missing values should not be coded as unknown but as not applicable (.n), see Table 62. 
This was important in order to be able to clearly distinguish the proportion of individuals who 
had missing responses to questions. 
 
A number of questions in the AURAH questionnaire included an ‘Other, please specify’ option, 
which included an allocated space for individuals to write their own response. In addition, a 
section was included at the end of the questionnaire which encouraged participants to write any 
comments/raise any issues. These responses were entered in the dataset, and as such, when 
imported in Stata, they were stored as string variables. It was necessary to convert these string 
variables into numeric variables in order to be able to utilize (i.e. code with) these variables 
when allocating individuals with certain responses into an appropriate category (be it of the 
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original variable asked or a new derived variable), see Table 61. In order to do this, I used the 
‘encode’ command in Stata to produce numeric variables that had value labels indicating which 
values correspond to which category. Of note, the variable pertaining to study clinic site was not 
entered into the original dataset and had to be imported from the clinic study log, as such it was 
imported as a string variable, and again had to be converted into a numeric variable in order for 
it to be included in analysis (i.e. as a predictor in a regression model). Each individuals specific 
study ‘idcode’ was also entered into the original dataset and as such was stored as a string 
variable in Stata, idcode was encoded into a numeric variable (this was vital during the data 
correcting stage, since errors were corrected based on idcode). 
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Table 62: Dealing with variables with missing values (data-management in the AURAH 
study) 
Applicable to 
all participants 
Applicable only to a sub-group of 
participants 
Applicable only to a sub-group of 
participants (please tick all that apply) 
1.Missing (i.e. 
0) was 
recoded as .u. 
1. Missing was dealt with making 
sure that only people who did not 
answer the sub-group question i.e. 
had a value of 0 (were missing) were 
recoded into .u/.n based on the 
original skip question. If someone 
was eligible for the sub-group 
question and had not answered it, 
they were recoded into .u 
(Unknown). If someone was not 
eligible for the sub-group question 
and had not answered it, they were 
recoded as .n (NA). 
1.Missing was dealt with much in the 
same way as those questions which were 
not false/true (i.e. true if ticked and false 
otherwise), with the following exceptions: 
a) Participants who had ticked at least one 
option provided but had not specified 
yes/no on the original skip question, were 
recoded into yes. 
b) People who were eligible for the sub-
group question and had not ticked an 
option were recoded from 0 (false) into 2. 
The remaining participants with a value of 
0 for this option were recoded as .u. 
These people had not ticked yes or no for 
the skip question nor did they tick any of 
the sub-group options provided and were 
thus, unknowns. Two was recoded into 0 
again and these people made up the false 
category. 
2. No 
assertion was 
needed. 
2. An assertion was included for 
each sub-group question of a skip 
variable that checked whether all 
participants who were not eligible 
had a value of .n for the sub-group 
question and that if someone had a 
value for the sub-group question, 
they were coded as Yes for the skip 
question. 
2. An assertion was included for each sub-
group option of a skip variable that 
checked whether all participants who were 
not eligible had a value of .n for the sub-
group question and that if someone had a 
value for the sub-group question, they 
were coded as Yes for the skip question. It 
also checked whether all participants who 
were .u for the skip question had a value 
of .u for the sub-group options. 
  3.If all the options were covered i.e. the 
sub-group options included other, then if 
someone had all 0 for all options provided, 
they were recoded into .u. Of note, the 
same coding here was also used for 
‘please tick all that apply’ variables that 
were applicable to all participants. In that 
case, if everyone should give an answer 
(i.e. reason for attending clinic but not 
have you received a diagnosis of a major 
condition) and all options were covered, 
then again if someone had all 0 for each 
option provided then they were coded as 
.u. 
 
Variables were then renamed (and derived variables labelled), values were labelled and 
variables were re-ordered appropriately in Stata. I also checked to see if someone had written a 
comment about having condomless sex/a broken condom (i.e. explicit comment about 
condomless sex), with a suggestion of it being within the past three months and an indication of 
the gender of their partner(s), for the reasons attending clinic variable. In anticipation, the 
following criteria for recoding were set forth: If a participant had made such a comment and had 
not said yes to CLS (in the sexual behaviour section of the questionnaire), then they were 
recoded. In addition, if a participant had written a comment about PEP use without indicating 
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the need for information or follow-up, then they were also recoded if appropriate (and if the 
gender of the partner was possible to deduce). Although a small number of participants had 
written that a condom had broken, no one specified a time frame and the gender of the partner. 
One male participant who did specify ‘yesterday’ had ticked yes to condomless anal sex. 
Another male participant specified a ‘guy’ but had not ticked condomless anal sex, but it would 
not have been appropriate to recode this participant into yes since it is possible that the broken 
condom occurred greater than three months ago and now they are here to screen (which may 
be synonymous with the HIV testing window period). Furthermore, I also checked all comments 
made throughout the questionnaires (these were documented in the original excel spread 
sheets). Of note, information on the results of an HIV test carried out on the day of the study 
questionnaire was imported into Stata from the study log.  
 
11.8.5.5 Appending AURAH datasets  
Finally, in order to append the 8 data batches together (each batch was cleaned individually), 
the following measures were taken: (i) I made sure that the order of the variables in all data 
batches were the same, (ii) I converted the encoded numeric variables back into string 
variables, so that upon appending they would fit into the right categories with the appropriate 
labels, (iii) I appended the datasets, using the most recent batch as the master dataset and the 
earlier batch as the using dataset, (iv) I generated a variable ‘datasrc’ that uniquely identifies 
which batch an idcode was from, (v) I checked whether there were any duplicates (specifically 
for idcode and then the remaining variables as well), and (vi) I encoded each of the string 
variables which had previously been decoded. 
 
11.8.6 AURAH participants 
 
11.8.6.1 Investigating response bias in the AURAH study 
It appears that refusal to consent to study participation was significantly more common among 
attendees of London clinics, and to a lesser extent among clinic attendees in Yorkshire and the 
Humber region (sees Table 63). There could be a multitude of reasons for this; from living in a 
more busy/pressurized life in London, or being more overwhelmed by health promotion 
messages/requests for study participation, to the possibility that more staff in London create 
quicker ‘in-and-out’ services, and as such less time to focus upon a survey. There were 
however, a small number of attendees of clinics outside of London. Refusal to consent to study 
participation did not differ significantly by gender. Among those consenting however, men were 
more likely to not return a (usable) questionnaire compared to women. Furthermore, not 
returning a (usable) questionnaire was most common among participants attending a clinic in 
the East Midlands, followed by London, again however, the number of individuals participating 
in the East Midlands was small (n=66).  
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In total, 19 consenting individuals undertook an HIV test on the day of the questionnaire and 
received a positive HIV diagnosis (18 men and one woman). Participants who took an HIV test 
on the day of consenting to study participation and received a positive test result were more 
than twice as likely to not return a (usable) questionnaire, compared to participants who did not 
have an HIV test or received a negative test result (see Table 64). Of note, of the nine 
individuals who received an HIV-positive diagnosis and did not return a (usable) questionnaire, 
eight took the questionnaire offsite to be posted at their convenience, but never returned the 
questionnaire, leaving one individual who returned an unusable questionnaire (blank/no 
answers). Not all individuals who were aware (we can assume as a result of point-of-care 
screening) of an HIV-positive diagnosis, did not return a posted questionnaire (two individuals 
did so), however, it is more than understandable that the majority of these individuals did not 
return a questionnaire, as they would of course be entirely occupied by their diagnosis, and 
linkage to care. Although postage return questionnaires may have been a study limitation in this 
respect, as response bias would be introduced if all individuals who received a positive HIV 
diagnosis did not subsequently  participate in the study, a study that primarily investigates 
behaviours that can lead to HIV acquisition, it must be emphasized that participants were asked 
to fill in the questionnaire and return it in the clinic- reflected in the fact that of the 10 participants 
who received a positive HIV test result and returned a (usable) questionnaire, eight did so in the 
clinic, we can justifiably assume prior to the consultation. It is also important to consider this 
significant result in terms of the small number of individuals who did receive a positive test result 
(n=19). 
 
Table 63: Unadjusted associations of gender and study clinic region with refusal to 
consent to participation in the AURAH study  
N=4380 GUM clinic attendees approached  Refusal to consent to study 
participation (n=1040; 23.7%) 
   N %  p-value by 
χ
2 
test 
Gender Female 
Male 
1043 (24.0%) 
3301 (76.0%) 
21.8% 
23.5% 
0.236 
Study clinic 
region 
South East  
South West 
London 
West Midlands 
East Midlands 
Yorkshire & the Humber 
325 (7.4%) 
59 (1.4%) 
3526 (80.5%) 
309 (7.1%) 
69 (1.6%) 
92 (2.1%) 
3.1% 
1.7% 
28.7% 
1.3% 
4.4% 
10.9% 
<0.001 
 
 
 
 
 
 
 
 
 
 
  
 
 
424 
 
Table 64: Unadjusted associations of gender, study clinic region, and HIV/STI information 
with unusable/unreturned questionnaires in the AURAH study 
N=3340 clinic attendees consenting to study participation Questionnaire not 
returned/unusable
a
 (n=710; 21.3%) 
   N %  p-value χ
2 
test 
Gender Female 
Male 
816 (24.4%) 
2524 (75.6%) 
17.2% 
22.6% 
0.001 
Study clinic 
region 
South East  
South West 
London 
West Midlands 
East Midlands 
Yorkshire & the Humber 
315 (9.4%) 
58 (1.7%) 
2514 (75.3%) 
305 (9.1%) 
66 (2.0%) 
82 (2.5%) 
4.1% 
5.2% 
25.5% 
8.5% 
27.3% 
11.0% 
<0.001 
HIV test 
undertaken on 
the day 
Yes 
No 
2546 (76.3%) 
791 (23.7%) 
20.7% 
22.8% 
0.225 
HIV test result No HIV test 
Negative result 
Positive result 
791 (23.7%) 
2527 (75.7%) 
19 (0.6%) 
22.8% 
20.5% 
47.4% 
0.012
 b
 
STI test 
undertaken on 
the day 
Yes 
No 
2281 (87.0%) 
341 (13.0%) 
20.2% 
23.5% 
0.161 
a 
Of note, 692 consenting individuals did not return a questionnaire, and 18 consenting individuals returned 
a questionnaire that did not contain any usable information (blank/no answers). 
b 
p-value by Fisher’s exact test. 
 
 
11.9 Appendix 9: Design and methods of the PROUD trial  
 
11.9.1 Identification of the PROUD sample population 
The PROUD trial was coordinated by the Medical Research Council (MRC) Clinical Trials Unit 
(CTU) at University College London.Thirteen GUM clinics in England (eight in London [N=375, 
69%] and five outside [Birmingham, Brighton, Manchester, Sheffield and York, N=165, 31%]) 
were identified for study participation.  
 
11.9.2 Method of PROUD sample selection 
Recruitment to the PROUD trial took place between November 2012 and April 2014. Men, and 
transgender women, aged 18 years or older who were attending the clinic for a routine visit and 
reported CLS on more than one occasion with a man in the past three months, were provided 
with information sheets on the PROUD trial if they were interested in PrEP. Furthermore, 
posters and electronic screens in participating GUM clinics, advertisements on social media, 
and distribution of business cards and leaflets by community organizations during outreach 
activities were also used to promote the study. Individuals who were interested (and recognized 
that they were eligible) in the study could download the information sheet from the study 
website. Potential participants were asked to make a note of their sexual behaviour and 
condom-use in preparation for enrolment. At the enrolment visit, HIV/STI test results and sexual 
behaviour were reviewed in order to confirm an HIV-negative status (confirmation was 
necessary within four weeks prior to or on the day of enrolment) and report of CLS on more 
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than one occasion within the past three months, and likely in the opinion of the participant, that 
CLS will occur in the next three months. Participants with an acute viral illness that could be due 
to HIV seroconversion, any contraindications to Truvada, treatment for Hepatitis B infection 
indicated or ongoing, and who were unlikely according to the opinion of the investigator, to 
comply with the randomized allocation, were not eligible.  
 
11.9.3 Sample power calculation, randomization, and amendment to the PROUD study design 
The purpose of the PROUD trial was to determine the feasibility of conducting a large trial to 
determine whether inclusion of PrEP as part of an HIV risk reduction package for MSM who are 
at risk of acquiring HIV is clinically effective and cost-effective. The PROUD trial was primarily 
designed to investigate the outcome of time to accrual of 500 participants and retention; the 
secondary outcomes consisted of: (i) HIV infection (ii) safety of PrEP, (iii) adherence to PrEP, 
and (iv) risk compensation as a result of PrEP use.  
 
The PROUD trial was originally designed with an anticipated target sample size of 5000 
participants (2500 per arm) in mind. Based on an estimated incidence of 3/100 person-years 
during the first 12 months in participants who were waiting to access PrEP and a 50% reduction 
in incidence in those offered PrEP; a sample size of 5000 would be adequately powered to 
detect a reduction in HIV incidence from 2.5 to 1.25 infections per 100 person-years. The initial 
pilot study used an arbitrary 10% target sample size of 500- a pragmatic choice which was to 
provide guidance as to whether 5000 participants could be enrolled over a two year study 
period. However, in April 2014, due to the very high incidence of HIV infection in the deferral 
arm of the study, it became apparent that a larger trial was not needed in order to investigate 
the effectiveness of PrEP on HIV incidence, and an Independent Data Monitoring Committee 
(IDMC) was set up to monitor key study outcomes 
(80)
. 
 
11.9.4 PROUD questionnaire 
Participants were asked to self-complete a paper questionnaire during clinic visits at baseline 
and on an annual basis thereafter. This was to occur in a private space. Participants were then 
asked to place the questionnaire in a sealed envelope, and hand it in to study clinic staff. 
Deferral of PrEP was initially set until the 12 month point, however, an unexpectedly high 
number of HIV infections were observed during the deferral period, which led to a 
recommendation from the Trial Steering Committee in October 2014 that all participants should 
be offered PrEP. Therefore, even participants who were still within the first 12 months of the 
study were asked to fill out their 12-month questionnaire and those in the deferred arm were 
offered PrEP. Of note, 25 men in the deferred arm were prescribed PrEP prior to completing 
their 12-month questionnaire. The surveys sought detailed information on socio-demographic 
and psychosocial factors, HIV/STI related information, and sexual behaviour. A description of all 
questions asked at each time-point is presented below. The statement of ethical approval is 
given in the following section.  
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Socio-demographic factors: At baseline only; date of birth, sexual identity (gay/homosexual, 
straight/heterosexual, bisexual, or other), ethnicity (white, Irish, Irish traveler, Chinese, Indian, 
Pakistani, Bangladeshi, black African, black Caribbean, black other, mixed ethnic group, or 
other), born in the UK, education (no qualifications, O levels/GCSEs, A levels, university degree 
or above, still in full-time education, vocational training, or other qualifications), employment 
(employed full- or part-time, student, unemployed , retired, or other), and relationship status 
(yes, I am in a relationship and living with my partner; yes, I am in a relationship but not living 
with my partner, or; no, I am not currently in an ongoing relationship with a partner). At follow-up 
only; disclosure of ‘MSM status’ (what proportion of the following groups (i) friends, (ii) work 
colleagues and (iii) close family, know that you are gay/transgender/have sex with men 
[all/almost all, more than half, less than half, few, or none]). 
 
Health and well-being: At baseline only; diagnosed STI in the past year (with 13 individual STI 
options), and circumcision. At follow-up only; depression (PHQ-9) 
(443)
, and intimate partner 
violence (experienced the following behaviours in relationships (i) Have you ever felt frightened 
of the behaviour of a partner, (ii) Have you ever needed to ask a partner’s permission to work, 
go shopping, visit relatives, or visit friends i.e. beyond the usual of being considerate to and 
checking with a partner, (iii) Have you ever been hit, slapped, kicked or otherwise physically 
hurt by a partner, (iv) Have you ever been forced to have sex or made to engage in some 
sexual activity when you did not want to, (v) Have you ever been forced to have sex without a 
condom when you did not want to, (vi) Have you ever behaved in a manner that has made a 
partner feel frightened, (vii) Has a partner ever needed to ask your permission to work, go 
shopping, visit relatives, or visit friends i.e. beyond the usual of being considerate to and 
checking with a partner, (viii) Have you ever hit, slapped, kicked or otherwise physically hurt a 
partner, (ix) Have you ever forced a partner to have sex or engage in some sexual activity when 
he did not want to, (x) Have you ever forced a partner to have sex without a condom when he 
did not want to [never, yes-more than 1 year ago, yes within the last year with former partner, or 
yes within the last year with current partner]), attitudes towards sexuality (‘Obviously effeminate 
homosexual men make me feel uncomfortable’, ‘I feel comfortable in gay bars’, ‘Social 
situations with transgender/gay men make me feel uncomfortable’, ‘I feel comfortable being 
seen in public with an obviously transgender/gay person’, ‘I feel comfortable discussing 
homosexuality in a public situation’, ‘I feel comfortable being a transgender/gay man’, 
‘Homosexuality is morally acceptable to me’, ‘Even if I could change my sexual orientation I 
wouldn’t’ [strongly agree, agree, neutral or uncertain, disagree, strongly disagree]). 
 
Lifestyle factors: At baseline only; frequency of alcohol drinking in the past three months (daily, 
nearly every day, 3 or 4 times a week, once or twice a week, 2 or 3 times a month, once, or 
never), usual alcohol intake in units on a typical day, recent use of recreational drugs (with 19 
individual drug options including other), and at follow-up only; met new sexual partners in (i) gay 
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community centres, organisations, events or social groups, (ii) gay cafes, pubs and/or bars, (iii) 
gay nightclubs/discos, (iv) gay saunas, (v) backrooms, sex clubs or gay party, (vi) bareback 
parties, (vii) cruising areas were men meet for sex with men, (viii) gay social networking 
websites eg. Gay.com, gaydar.com, grindr, Manhunt, GayRomeo etc (within the last 4 weeks, 
within the last 3 months, within the last 6 months, more than 6 months ago, or never). 
 
HIV/STI related information: At baseline only; frequency of HIV testing at a sexual health clinic 
in the past year, frequency of STI testing at a sexual health clinic in the past year, frequency of 
PEP use in the past year, and beliefs about future PrEP adherence (I will find it easy to 
remember to take my drug daily, I might forget to take my pill at my scheduled time but will 
remember to take it within a few hours, I might occasionally forget to take a dose, I might forget 
to take my drug once or twice a week, I will remember to take my pill if I know I am going to be 
having sex in a couple of days, or I will find a daily dosing schedule very difficult to follow).  At 
follow-up only; concerns about transmission risk if having sex with a man whose HIV status was 
unknown and (i) no condom or PrEP was used during receptive anal sex, (ii) no condom or 
PrEP was used during insertive anal sex, (iii) no condom or PrEP was used but PEP was used 
after receptive anal sex, (iv) no condom was used during receptive anal sex but PrEP was being 
taken every day, (v) same as previous but tablets of PrEP were missed in the previous days, (vi) 
same as previous but several tablets were missed that week, and (vii) no condom or PrEP was 
used during receptive anal sex with a positive man who is on ART (very worried, somewhat 
worried, or not worried), and use of PrEP before the study from (i) the Internet or elsewhere, (ii) 
someone else’s Truvada, and (iii) someone else’s antiretroviral tablets (more than once, once, 
or never). 
 
Sexual behaviour: Men were asked about number of sexual partners in the previous three 
months (with how many different men have you been bottom [passive] and/or top [active] during 
anal sex in the last 90 days), the number of these partners with whom a condom was not used 
(‘with how many were you bottom without using a condom’ and ‘with how many were you top 
without using a condom’; separate questions for receptive and insertive partners), the number of 
these partners who were known to be HIV-positive and known to be on treatment (‘how many 
did you know were HIV-positive’ and ‘how many did you know were on HIV treatment’; separate 
questions for receptive and insertive partners), number of new anal sex partners in the past 
three months, perception of partner HIV status at last CLS act (I don’t know, I thought he was 
HIV-negative, I thought he was HIV-positive and on treatment, I thought he was HIV-positive 
and not on treatment, or I thought he was HIV-positive and did not consider whether he was on 
treatment), reasons for non-condom-use (‘I don’t like using condoms’, ‘He doesn’t like using 
condoms’, ‘Condoms weren’t discussed’, ‘We don’t use condoms with each other but do with 
other partners’, ‘Neither of us had any condoms’, ‘I didn’t consider myself at risk of HIV’, ‘I was 
under the influence of alcohol’, ‘I was under the influence of drugs’, ‘I am faithful to him’, ‘He is 
faithful to me’, ‘It is more enjoyable without a condom’, ‘I was only dipping’, ‘I lose erections with 
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condoms’ [only asked in the follow-up questionnaire] and ‘Other’), and extent of feeling at risk 
when you have CLS (not applicable, no risk, a little risk, somewhat at risk, large risk, or very 
large risk). At follow-up only; age at first sexual contact with a male, age at first act of anal 
intercourse with a male, attitudes towards ones sex life (‘I am happy with my sex life’, ‘I am as 
sexually confident as I want to be’, ‘I find it easy to say ‘no’ to sex I don’t want’, ‘The sex I have 
is always as safe as I want it to be’, ‘I would like to have more sex’, ‘I am usually sexually 
satisfied after sex’, ‘I would like to have a, or more, steady partner(s)’, ‘I would like to have a, or 
more, non-steady partner(s), ‘I would like more intimacy in my life’, ‘I would like more love in my 
life’ [strongly agree, agree, neutral or uncertain, disagree, or strongly disagree]), sexualized 
drug use (within the last 4 weeks, within the last 3 months, within the last 6 months, more than 6 
months ago, or never), participated in group sex (within the last 4 weeks, within the last 3 
months, within the last 6 months, more than 6 months ago, or never), and received (i) money, 
(ii) drugs, or (iii) something else (such as a place to stay) for having sex (within the last 4 weeks, 
within the last 3 months, within the last 6 months, more than 6 months ago, or never). 
 
Of note, HIV and STI testing (urethral, rectal and pharyngeal swabs for chlamydia trachomatis 
and Neisseria gonorrhoea, serology for syphilis and Hepatitis C [when indicated]), was 
conducted on a three monthly basis. Hepatitis C screening was also conducted if the participant 
reported injecting or snorting drugs, fisting, or the use of sex toys. Serum creatinine was 
checked on an annual basis or more frequently if more than a trace of protein was detected by 
urine dipstick and could not be explained by infection. Finally, in depth interviews were also 
conducted as part of the PROUD trial. 
 
A study website was set up (http://www.proud.mrc.ac.uk) providing access to full contact details, 
progress updates, background information, all study documents, and future results.  
 
11.9.4.1 Statement of ethical approval for the PROUD trial 
The study was reviewed and approved by London Bridge Research Ethics Committee. 
 
11.9.4.2 Data processing in the PROUD trial 
Details of all interested individuals were added to a pre-screening log. The log contained the 
names and GUM clinic numbers of all patients invited to participate in the study. This 
information together with sealed envelopes of the behavioural questionnaires was transferred 
securely to the MRC CTU for data entry. A computer generated randomization list with variable 
block sizes (of four, six, and eight; stratified by clinical site) was prepared by one of the trial 
statisticians, and incorporated into a database held securely at the coordinating centre. 
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11.9.5 Data management in the PROUD trial 
 
11.9.5.1 Checking PROUD data for errors and inconsistencies  
Variables of interest in this thesis were checked for errors and inconsistencies.  
 
11.9.5.2 Correcting errors and inconsistencies in PROUD 
In general, the policy adopted in PROUD analyses was to focus on the questions of interest and 
take what participants had reported for these questions, even if it was not completely in line with 
the other questions asked. Of note, this was only relevant for the sexual behaviour section, the 
question of recreational drug use and the subsequent drug options displayed, and the question 
of having been born in the UK and if not the subsequent ‘which country born in’ question. In 
addition, there were very few men who reported any inconsistencies.  
 
11.9.5.3 Dealing with inconsistent responses to sexual behaviour in the PROUD trial 
The sexual lifestyle sections in the PROUD questionnaires contained twelve questions. The first 
question asked participants to provide the number of men with whom they had had either 
receptive or insertive anal sex in the past three months. The subsequent questions were split 
into separate sets of questions regarding receptive and insertive partners, whether a condom 
was used with these partners, and the HIV and treatment status of these partners. Questions 
were phrased in such a way that participants were asked to write down a numerical response. 
Accordingly, inconsistencies could arise if a participant reported a higher number than 
previously recorded i.e. a higher number of receptive CLS partners than receptive anal sex 
partners. Previous PROUD data analyses have investigated given responses to the CLS 
questions 
(80, 615, 741-743)
. As a result, the same was carried in this thesis; all responses to the CLS 
questions were analysed as they were, and changing an erroneous previous anal sex question 
response was not considered necessary.  
 
Although imputing a ‘correct’ value for the anal sex questions is not possible since this value 
could be any higher number than that reported for the CLS questions, I have changed the 
responses to anal sex to be equal to that reported for CLS (only where a value was provided for 
the former i.e. the value for anal sex was not missing) in order to achieve consistency in the 
data. This was only relevant for a very small number of men (n=2 at baseline and n=0 at the 12-
and 24-month questionnaires).  
 
Of note, it was not necessary to solve any inconsistencies between report of CLS partners and 
report of HIV-positive CLS partners, since the sexual behaviour measures considered for 
analysis which included reporting an HIV-positive CLS partner, only required that one such 
partner be reported. Therefore, regardless of whether the number for HIV-positive CLS partners 
exceeded that for CLS partners did not affect which category the participant was placed in. No 
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men reported one HIV-positive (receptive or insertive) CLS partner and zero CLS (receptive or 
insertive) partners. 
 
11.9.5.4 Variables derived for analysis in the PROUD trial 
I derived a set of variables. Variables and their values were labelled and re-ordered as 
appropriate, comments made in the ‘Other (please specify)’ for sexuality were requested from 
the data managers and examined.  
 
11.9.5.5 Merging PROUD datasets  
I selected a set of derived variables of interest (together with the study identification number, 
date of randomization, trial arm, and date of follow-up visit) from the baseline and follow-up 
questionnaire datasets and created new, separate datasets. I then performed a 1:1 merge. The 
data were reshaped from a wide to long format, whereby Stata was informed which variable 
were time varying and time constant, in preparation for analysis.
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11.10 Appendix 10: Socio-demographic and lifestyle factors associated with depressive symptoms (PHQ-9≥10) among all MSM in the AURAH study 
 
Table 65: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with depressive symptoms on PHQ-9 (≥10) among all 
1484 MSM in the AURAH study 
N=1484 MSM participating in the AURAH study PHQ-9 ≥10 (n=185; 12.5%) 
   N (%) %  p-value
b
 Unadjusted 
PR[95% CI]    
Overall 
p-value 
Adjusted models 
PR[95% CI]    
Overall p-
value 
Age (years) <25 
25-29 
30-34 
35-39 
40-44 
45+ 
254 (17.4%) 
372 (25.4%) 
277 (18.9%) 
193 (13.2%) 
143 (9.8%) 
225 (15.4%) 
19.7% 
14.3% 
8.3% 
9.8% 
7.7% 
9.8% 
<0.001 
<0.001
c
 
2.01 [1.26, 3.22] 
1.46 [0.91, 2.33] 
0.85 [0.49, 1.48] 
1.01 [0.56, 1.80] 
0.79 [0.39, 1.57] 
1 
<0.001 
0.001
c
 
1.72 [1.06, 2.79] 
1.53 [0.95, 2.46] 
0.95 [0.54, 1.65] 
1.09 [0.61, 1.95] 
0.88 [0.45, 1.74] 
1 
0.033 
0.005
c
 
Born in the UK and white ethnicity Yes, white 
Yes, BAME 
No, white 
No, BAME 
759 (51.8%) 
97 (6.6%) 
437 (29.8%) 
172 (11.7%) 
12.8% 
17.5% 
10.3% 
11.6% 
0.228 1 
1.37 [0.86, 2.19] 
0.81 [0.58, 1.12] 
0.91 [0.58, 1.43] 
0.222 1 
0.89 [0.53, 1.51] 
0.91 [0.65, 1.29] 
0.99 [0.62, 1.59] 
0.942 
Study region London 
South 
Other 
1112 (74.9%) 
276 (18.6%) 
96 (6.5%) 
11.5% 
13.0% 
21.9% 
0.012 1 
1.13 [0.80, 1.60] 
1.90 [1.26, 2.87] 
0.009 
 
1 
1.07 [0.74, 1.53] 
1.38 [0.88, 2.15] 
0.380 
 
 
University Education Yes 
No/missing
a
 
990 (66.7%) 
494 (33.3%) 
9.1% 
19.2% 
<0.001 1 
2.12 [1.62, 2.76] 
<0.001 1 
2.00 [1.50, 2.66] 
<0.001 
Employment status Employed 
Not employed/ 
missing
a
 
1182 (79.7%) 
302 (20.4%) 
10.2% 
21.5% 
<0.001 1 
2.12 [1.61, 2.79] 
<0.001 1 
1.52 [1.11, 2.09] 
0.010 
Money to cover basic needs (financial 
hardship) 
Always 
Mostly 
At times/no 
1062 (71.8%) 
311 (21.0%) 
107 (7.2%) 
7.3% 
16.7% 
50.5% 
<0.001 
<0.001
c
 
1 
2.31 [1.66, 3.20] 
6.96 [5.23, 9.26] 
<0.001 
<0.001
c
 
1 
1.95 [1.39, 2.74] 
5.17 [3.71, 7.20] 
<0.001 
<0.001
c
 
Housing status Home owner 
Renting 
Unstable/other 
421 (28.8%) 
832 (56.9%) 
210 (14.4%) 
4.0% 
13.9% 
21.4% 
<0.001 
<0.001
c
 
1 
3.45 [2.10, 5.67] 
5.31 [3.11, 9.04] 
<0.001 
<0.001
c
 
1 
3.34 [1.99, 5.61] 
4.05 [2.29, 7.17] 
<0.001 
<0.001
c
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Table 65: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with current depressive symptoms on PHQ-9 (≥10) 
among all 1484 MSM in the AURAH study (continued) 
N=1484 MSM participating in the AURAH study PHQ-9 ≥10 (n=185; 12.5%) 
   N (%) %  p-value
b
 Unadjusted 
PR[95% CI]    
Overall 
p-value 
Adjusted models 
PR[95% CI]    
Overall 
p-value 
Self-reported sexual identity Gay 
Bisexual 
Straight 
1313 (88.8%) 
141 (9.5%) 
25 (1.7%) 
11.7% 
20.6% 
4.0% 
0.004
d
 1 
1.55 [1.09, 2.22]
g
 
0.016 1 
1.45 [1.01, 2.07]
g
 
 
0.042 
How many friends know you are 
gay/bisexual/attracted to men  
All/almost all 
Some 
Few/none 
1107 (76.1%) 
271 (18.6%) 
77 (5.3%) 
11.3% 
15.9% 
16.9% 
0.059 
0.022
c
 
1 
1.41 [1.02, 1.94] 
1.50 [0.89, 2.52] 
0.057 
0.018
c
 
1 
1.36 [0.96, 1.93] 
1.18 [0.66, 2.11] 
0.230 
0.188
c
 
How many work colleagues know you are 
gay/bisexual/attracted to men 
All/almost all 
Some 
Few/none 
863 (60.1%) 
308 (21.4%) 
266 (18.5%) 
12.1% 
8.1% 
17.7% 
0.002 
0.098
c
 
1 
0.67 [0.44, 1.02] 
1.47 [1.07, 2.01] 
0.003 
0.113
c
 
1 
0.70 [0.45, 1.09] 
1.40 [0.97, 2.00] 
0.016 
0.232
c
 
How many close family know you are 
gay/bisexual/attracted to men  
All/almost all 
Some 
Few/none 
954 (65.7%) 
226 (15.6%) 
273 (18.8%) 
12.1% 
13.3% 
13.6% 
0.751 
0.464
c
 
1 
1.10 [0.76, 1.60] 
1.12 [0.80, 1.59] 
0.751 
0.461
c
 
1 
1.05 [0.72, 1.54] 
0.91 [0.61, 1.34] 
0.819 
0.703
c
 
‘Out’ to all/almost all friends, work colleagues and 
close family 
Yes 
No 
709 (47.8%) 
775 (52.2%) 
13.0% 
11.9% 
0.490 1 
1.10 [0.84, 1.44] 
0.491 1 
1.10 [0.82, 1.48] 
0.527 
‘Out’ to few/no friends, work colleagues and close 
family 
Yes 
No 
65 (4.4%) 
1419 (95.6%) 
18.5% 
12.2% 
0.135 1.51 [0.89, 2.57] 
1 
0.125 1.13 [0.63, 2.01] 
1 
0.684 
Ongoing relationship Yes 
No/missing
a
 
640 (43.1%) 
844 (56.9%) 
10.6% 
13.9% 
0.062 1 
1.30 [0.99, 1.73] 
0.063 1 
1.27 [0.95, 1.69] 
0.107 
Supportive network 1: High levels 
2 
3 
4 
5: Low levels 
440 (29.9%) 
510 (34.7%) 
317 (21.6%) 
142 (9.7%) 
62 (4.2%) 
4.3% 
7.3% 
17.0% 
31.7% 
48.4% 
<0.001 
<0.001* 
1 
1.68 [0.98, 2.88] 
3.94 [2.39, 6.52] 
7.34 [4.44, 12.12] 
11.21 [6.73, 18.65] 
<0.001 
<0.001
c
 
 
1 
1.49 [0.86, 2.58] 
3.77 [2.27, 6.28] 
6.54 [3.89, 10.98] 
9.78 [5.77, 16.60] 
<0.001 
<0.001
c
 
Current smoker Yes 
No/missing
a
 
364 (24.5%) 
1120 (75.5%) 
18.4% 
10.5% 
<0.001 1.75 [1.33, 2.30] 
1 
<0.001 1.39 [1.04, 1.87] 
1 
0.027 
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Table 65: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with current depressive symptoms on PHQ-9 (≥10) 
among all 1484 MSM in the AURAH study (continued) 
N=1484 MSM participating in the AURAH study PHQ-9 ≥10 (n=185; 12.5%) 
   N (%) %  p-value
b
 Unadjusted 
PR[95% CI]    
Overall 
p-value 
Adjusted models 
PR[95% CI]    
Overall 
p-value 
Higher-risk alcohol consumption Yes 
No/missing
a
 
288 (19.4%) 
1196 (80.6%) 
11.3% 
17.4% 
0.005 1.54 [1.14, 2.07] 
1 
0.005 1.44 [1.05, 1.96] 
1 
0.023 
Recreational drug use (past 3 months) 0/missing
a
 
1 
2-4 
5+ 
672 (45.3%) 
300 (20.2%) 
319 (21.5%) 
193 (13.0%) 
9.4% 
13.3% 
13.2% 
20.7% 
<0.001 
<0.001
c
 
1 
1.42 [0.98, 2.06] 
1.40 [0.97, 2.03] 
2.21 [1.54, 3.18] 
<0.001 
<0.001
c
 
1 
1.45 [0.99, 2.11] 
1.49 [1.02, 2.18] 
2.32 [1.60, 3.37] 
<0.001 
<0.001
c
 
Chemsex-associated  drug use No 
Yes 
1160 (78.2%) 
324 (21.8%) 
11.3% 
16.7% 
0.010 1 
1.60 [1.19, 2.17] 
0.002 1 
1.48 [1.10, 1.98] 
0.009 
a 
University Education: 0.3% (n=4) missing. Employed: 1.4% (n=20) missing. Ongoing relationship: 0.3% (n=4) missing. Smoke regularly: 0.4% (n=6) missing. Heavy drinking: 
1.2% (n=18) missing. Recreational drug use: 1.3% (n=19) missing. 
b 
Pearson χ
2 
test 
c
 Test for trend. 
d 
Fisher’s exact test. 
Adjusted models: Each factor included in a separate model and adjusted for: age (included as four categories: <25, 25-29, 30-39, 40+), UK born (yes or no/missing), sexual 
identity (gay or bisexual/straight), university education, ongoing relationship status and study region. 
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11.11 Appendix 11: Socio-demographic and lifestyle factors associated with other measures of depressive symptoms on PHQ-9 in AURAH 
 
Table 66: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with other depression measures on PHQ-9 in AURAH 
N=1340 MSM reporting sex in the past 3 months Major depressive syndrome on PHQ-9 (n=85; 
6.3%) 
Major and other depressive syndromes on PHQ-9 
(n=136; 10.2%) 
   N (%) %  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
%  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
Age (years) <25 
25-29 
30-34 
35-39 
40-44 
45+ 
235 (17.8%) 
344 (26.0%) 
255 (19.3%) 
175 (13.2%) 
125 (9.5%) 
188 (14.2%) 
13.6% 
7.3% 
3.1% 
3.4% 
5.6% 
2.7% 
<0.001 
<0.001
c
 
5.12 [2.03, 12.89] 
2.73 [1.06, 7.02] 
1.18 [0.39, 3.55] 
1.29 [0.40, 4.15] 
2.11 [0.68, 6.49] 
1 
<0.001 
<0.001
c
 
4.22 [1.65, 10.8] 
2.99 [1.16, 7.72] 
1.36 [0.45, 4.11] 
1.42 [0.44, 4.63] 
2.46 [0.81, 7.48] 
1 
0.004 
0.001
c
 
18.7% 
11.1% 
6.7% 
6.9% 
8.8% 
5.9% 
<0.001 
<0.001
c
 
3.20 [1.70, 6.02] 
1.89 [0.99, 3.61] 
1.14 [0.55, 2.38] 
1.17 [0.53, 2.59] 
1.50 [0.67, 3.36] 
1 
<0.001 
<0.001
c
 
2.77 [1.46, 5.25] 
2.00 [1.04, 3.85] 
1.27 [0.60, 2.66] 
1.16 [0.51, 2.62] 
1.69 [0.76, 3.75] 
1 
0.003 
0.001
c
 
Born in the UK and ethnicity Yes, white 
Yes, BAME 
No, white 
No, BAME 
676 (51.2%) 
86 (6.5%) 
408 (30.9%) 
151 (11.4%) 
6.5% 
10.5% 
4.7% 
7.3% 
0.195 
1 
1.61 [0.81, 3.18] 
0.72 [0.42, 1.21] 
1.12 [0.59, 2.12] 
0.200 
1 
1.08 [0.52, 2.22] 
0.90 [0.53, 1.53] 
1.42 [0.72, 2.77] 
0.678 
10.7% 
12.8% 
8.3% 
10.6% 
0.501 
1 
1.20 [0.66, 2.17] 
0.78 [0.53, 1.15] 
0.99 [0.60, 1.66] 
0.506 
1 
0.85 [0.46, 1.58] 
0.89 [0.60, 1.33] 
1.16 [0.68, 1.97] 
0.784 
Study region London 
South 
Other 
1017 (75.9%) 
241 (18.0%) 
82 (6.1%) 
5.5% 
7.1% 
14.6% 
0.004 
1 
1.28 [0.76, 2.16] 
2.66 [1.49, 4.75] 
0.004 
1 
1.13 [0.66, 1.94] 
1.67 [0.86, 3.24] 
0.314 
9.2% 
11.2% 
18.3% 
0.028 
1 
1.21 [0.81, 1.82] 
1.98 [1.20, 3.25] 
0.024 
1 
1.13 [0.75, 1.70] 
1.41 [0.83, 2.41] 
0.431 
University Education Yes 
No/missing
a
 
891 (66.5%) 
449 (33.5%) 
3.9% 
11.1% 
<0.001 
1 
2.83 [1.87, 4.30] 
<0.001 
1 
2.48 [1.58, 3.91] 
<0.001 
7.4% 
15.6% 
<0.001 
1 
2.10 [1.53, 2.89] 
<0.001 
1 
1.88 [1.34, 2.64] 
<0.001 
Employment status Employed 
Not employed/ 
missing
a
 
1069 (79.8%) 
271 (20.2%) 
5.0% 
11.8% 
<0.001 
1 
2.38 [1.57, 3.62] 
<0.001 
1 
1.43 [0.88, 2.32] 
0.150 
8.3% 
17.3% 
<0.001 
1 
2.08 [1.50, 2.89] 
<0.001 
1 
1.44 [0.99, 2.10] 
0.057 
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Table 66: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with other depression measures on PHQ-9 in AURAH 
(continued) 
N=1340 MSM reporting sex in the past 3 months Major depressive syndrome (n=85; 6.3%) Major & other depressive syndromes (n=136; 10.2%) 
   N (%) %  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
%  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
Money to cover basic 
needs (financial 
hardship) 
Always 
Mostly 
At times/no 
958 (71.7%) 
281 (21.0%) 
97 (7.3%) 
3.3% 
8.2% 
29.9% 
<0.001 
<0.001
c
 
1 
2.45 [1.46, 4.12] 
8.95 [5.67, 14.1] 
<0.001 
<0.001
c
 
1 
1.91 [1.11, 3.27] 
5.94 [3.54, 9.94] 
<0.001 
<0.001
c
 
6.8% 
12.8% 
34.0% 
<0.001 
<0.001
c
 
1 
1.89 [1.28, 2.77] 
5.01 [3.49, 7.21] 
<0.001 
<0.001
c
 
1 
1.60 [1.08, 2.37] 
3.71 [2.46, 5.58] 
<0.001 
<0.001
c
 
Housing status Home owner 
Renting 
Unstable/ 
other 
369 (27.9%) 
764 (57.8%) 
188 (14.2%) 
1.9% 
6.7% 
13.3% 
<0.001 
<0.001
c
 
1 
3.52 [1.61, 7.68] 
7.01 [3.09, 15.91] 
<0.001 
<0.001
c
 
1 
2.84 [1.26, 6.41] 
3.86 [1.52, 9.82] 
0.017 
0.005
c
 
5.2% 
11.0% 
16.0% 
<0.001 
<0.001
c
 
1 
2.14 [1.32, 3.46] 
3.10 [1.79, 5.36] 
<0.001 
<0.001
c
 
1 
1.73 [1.04, 2.89] 
1.87 [1.00, 3.48] 
0.088 
0.058
c
 
Self-reported sexual 
identity 
Gay 
Bisexual 
Straight 
1190 (89.1%) 
127 (9.5%) 
19 (1.4%) 
6.0% 
9.5% 
5.3% 
0.302
d
 
1 
1.49 [0.85, 2.63]
f
 
0.166 
1 
1.34 [0.77, 2.34]
f
 
0.301 
9.6% 
14.2% 
10.5% 
0.219 
1 
1.43 [0.92, 2.23]
f
 
0.114 
 
1 
1.34 [0.87, 2.07]
f
 
0.183 
How many friends know 
you are 
gay/bisexual/attracted 
to men  
All/almost all 
Some 
Few/none 
1006 (76.1%) 
250 (18.9%) 
66 (5.0%) 
5.6% 
8.4% 
9.1% 
0.130
d 
0.064
c
 
1 
1.53 [0.99, 2.39]f 
0.057 
1 
1.51 [0.93, 2.44]f 
0.094 
9.2% 
13.2% 
12.1% 
0.154 
0.090
c
 
1 
1.43 [0.98, 2.07] 
1.31 [0.67, 2.58] 
0.151 
0.078
c
 
1 
1.38 [0.94, 2.03] 
1.14 [0.53, 2.46] 
0.256 
0.263
c
 
How many work 
colleagues know you 
are 
gay/bisexual/attracted 
to men 
All/almost all 
Some 
Few/none 
794 (60.8%) 
277 (21.2%) 
236 (18.1%) 
5.9% 
3.3% 
10.2% 
0.005 
0.098
c
 
1 
0.55 [0.27, 1.11] 
1.72 [1.07, 2.75] 
0.006 
0.124
c
 
1 
0.63 [0.32, 1.27] 
1.73 [1.02, 2.94] 
0.020 
0.138
c
 
9.8% 
6.9% 
14.0% 
0.027 
0.213
c
 
1 
0.70 [0.43, 1.13] 
1.42 [0.97, 2.08] 
0.028 
0.233
c
 
1 
0.73 [0.45, 1.20] 
1.41 [0.91, 2.20] 
0.086 
0.294
c
 
How many close family 
know you are 
gay/bisexual/attracted 
to men  
All/almost all 
Some 
Few/none 
869 (66.0%) 
205 (15.6%) 
242 (18.4%) 
6.0% 
5.9% 
7.9% 
0.548 
0.345
c
 
1 
0.98 [0.53, 1.80] 
1.31 [0.79, 2.18] 
0.547 
0.351
c
 
1 
0.92 [0.52, 1.65] 
1.13 [0.65, 1.98] 
0.855 
0.742
c
 
9.0% 
11.7% 
13.2% 
0.114 
0.039
c
 
1 
1.30 [0.85, 2.01] 
1.47 [1.00, 2.17] 
0.113 
0.036
c
 
1 
1.28 [0.83, 1.97] 
1.31 [0.85, 2.01] 
0.327 
0.160
c
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Table 66: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with other depression measures on PHQ-9 in AURAH 
(continued) 
N=1340 MSM reporting sex in the past 3 months Major depressive syndrome on PHQ-9 (n=85; 6.3%) Major and other depressive syndromes on PHQ-9 (n=136; 10.2%) 
   N (%) %  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
%  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
‘Out’ to all/almost all 
friends, work colleagues 
and close family 
Yes 
No 
652 (48.7%) 
688 (51.3%) 
5.5% 
7.1% 
0.230 
1 
1.29 [0.85, 1.96] 
0.231 
1 
1.40 [0.90, 2.17] 
0.135 
8.9% 
11.3% 
0.139 
1 
1.27 [0.92, 1.76] 
0.141 
1 
1.35 [0.96, 1.89] 
0.089 
‘Out’ to few/no friends, 
work colleagues and 
close family 
Yes 
No 
56 (4.2%) 
1284 (95.8%) 
8.9% 
6.2% 
0.279
d
 
/
 e
 /
 e
 10.7% 
10.1% 
0.886 
1.06 [0.49, 2.29] 
1 
0.886 
0.82 [0.36, 1.87] 
1 
0.641 
Ongoing relationship Yes 
No/missing
a
 
579 (43.2%) 
761 (56.8%) 
4.8% 
7.5% 
0.048 
1 
1.55 [1.00, 2.40] 
0.051 
1 
1.41 [0.90, 2.20] 
0.135 
7.8% 
12.0% 
0.012 
1 
1.54 [1.09, 2.16] 
0.013 
1 
1.40 [1.00, 1.98] 
0.052 
Supportive network 1: High levels 
2 
3 
4 
5: Low levels 
400 (30.1%) 
464 (34.9%) 
284 (21.3%) 
130 (9.8%) 
53 (4.0%) 
1.0% 
2.6% 
9.2% 
19.2% 
34.0% 
<0.001
d
 
<0.001
c
 
1 
7.98 [4.69, 13.59]
f
 
<0.001 
 
1 
7.19 [4.21, 12.28]
f
 
<0.001 
 
2.5% 
6.3% 
13.7% 
26.9% 
43.4% 
<0.001 
<0.001
c
 
1 
2.5 [1.23, 5.07] 
5.49 [2.79, 10.82] 
10.77 [5.49, 21.14] 
17.36 [8.75, 34.44] 
<0.001 
<0.001
c
 
1 
2.33 [1.15, 4.74]  
5.06 [2.53, 10.10] 
9.31 [4.65, 18.64] 
13.96 [6.71, 29.02] 
<0.001 
<0.001
c
 
Current smoker Yes 
No/missing
a
 
334 (24.9%) 
1006 (75.1%) 
8.7% 
5.6% 
0.043 
1.56 [1.01 2.40] 
1 
0.043 
1.13 [0.72, 1.77] 
1 
0.607 
14.1% 
8.9% 
0.006 
1.59 [1.14 2.22] 
1 
0.006 
1.30 [0.92, 1.84] 
1 
0.135 
Higher-risk alcohol 
consumption 
Yes 
No/missing
a
 
259 (19.3%) 
1081 (80.7%) 
9.3% 
5.6% 
0.032 
1.64 [1.04, 2.58] 
1 
0.032 
1.41 [0.87, 2.28] 
1 
0.165 
14.7% 
9.1% 
0.007 
1.62 [1.14, 2.29] 
1 
0.007 
1.47 [1.03, 2.10] 
1 
0.033 
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Table 66: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with other depression measures on PHQ-9 in AURAH 
(continued) 
N=1340 MSM reporting sex in the past 3 months Major depressive syndrome on PHQ-9 (n=85; 6.3%) Major and other depressive syndromes on PHQ-9 (n=136; 10.2%) 
   N (%) %  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
%  
p-value
b
 
Unadjusted 
PR[95% CI] 
Overall p-value    
Adjusted models 
PR[95% CI] 
Overall p-value    
Recreational drug use 
(past 3 months) 
0/missing
a
 
1 
2-4 
5+ 
579 (43.2%) 
269 (20.1%) 
302 (22.5%) 
190 (14.2%) 
5.2% 
6.7% 
6.0% 
10.0% 
0.126 
0.048
c
 
1 
1.29 [0.73, 2.28] 
1.15 [0.65, 2.03] 
1.93 [1.11, 3.35] 
0.128 
0.053
c
 
1 
1.19 [0.68, 2.09] 
1.08 [0.60, 1.95] 
1.81 [1.03, 3.18] 
0.201 
0.105
c
 
8.5% 
8.2% 
10.3% 
17.9% 
0.001 
0.001
c
 
1 
0.97 [0.60, 1.56] 
1.21 [0.79, 1.86] 
2.11 [1.41, 3.17] 
0.001 
0.002
c
 
1 
0.94 [0.58, 1.51] 
1.21 [0.78, 1.87] 
2.11 [1.39, 3.22] 
0.002 
0.003
c
 
Chemsex-associated  
drug use 
No 
Yes 
1027 (76.6%) 
313 (23.4%) 
6.0% 
7.4% 
0.405 
1 
1.22 [0.77, 1.93] 
0.404 
1 
1.27 [0.79, 2.06] 
0.325 
8.9% 
14.4% 
0.005 
1 
1.62 [1.16, 2.27] 
0.005 
1 
1.74 [1.23, 2.45] 
0.002 
Adjusted models: Each factor included in a separate model and adjusted for: age (included as four categories: <25, 25-29, 30-39, 40+), UK born (yes or no/missing), sexual 
identity (gay or bisexual/straight), university education, ongoing relationship status and study region.  
a 
University Education: 0.3% (n=4) missing. Employed: 1.4% (n=19) missing. Ongoing relationship: 0.2% (n=3) missing. Smoke regularly: 0.4% (n=5) missing. Heavy drinking: 
1.2% (n=16) missing. Recreational drug use: 0.8% (n=11) missing. 
b 
Pearson χ
2 
test 
c
 Test for trend. 
d 
Fisher’s exact test. 
e
 It was not possible to investigate this association due to small numbers. 
f
 A Fisher’s exact test p-value is presented for univariable comparison of the categories presented, however, in unadjusted and adjusted Poisson analyses; a dichotomized 
version of self-reported sexual identity (gay or bisexual/straight), disclosure of sexual orientation to friends (all/almost all or some/few/none), and social support score (highest 
score or otherwise) is investigated due to small numbers. 
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11.12 Appendix 12: Relationship between depressive symptoms and sexual behaviour 
measures in the AURAH study 
 
Figure 33: Unadjusted and adjusted associations of depressive symptoms (PHQ-9≥10) 
with sexual behaviours among 1340 MSM who reported anal or vaginal sex in the past 
three months in AURAH using logistic regression  
 
 
 
a
 Men who reported no CLS partners of unknown HIV status, and only one HIV-positive CLS partner who 
was a long-term partner and with whom they ‘thought the risks of catching HIV were low because their 
partner was taking ART’ were not counted as positive for this measure.  
b
 The model was fitted to include age in four categories (<25; 25-29; 30-39; 40+) and dichotomous UK 
born and self-reported sexual identity.
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Table 67: Unadjusted and adjusted associations of depressive symptoms (PHQ-9≥10) with sexual behaviour measures among different samples of 
AURAH MSM according to report of recent sexual behaviour, in three sensitivity analyses 
 PHQ-9 ≥10 n=166; 12.4% (independent variable) 
Dependent variables:  Modified Poisson 
models: 
N=1304 MSM reporting anal 
sex in the past 3 months 
N=853 MSM reporting anal/vaginal 
CLS in the past 3 months 
N=815 MSM reporting anal 
CLS in the past 3 months 
PR[95% CI]
a
; p-value
b
 PR[95% CI]
a
; p-value
b
 PR[95% CI]
a
; p-value
b
 
CLS with 1+ partners (past 
3 months) 
Unadjusted 1.24 [1.12, 1.37]; <0.001 / / 
Adjusted model (i)
c
 1.22 [1.10, 1.36]; <0.001 / / 
Adjusted model (ii)
d
 1.18 [1.07, 1.31]; 0.002 / / 
CLS with 2+ partners (past 
3 months) 
Unadjusted 1.48 [1.21, 1.80]; <0.001 1.22 [1.04, 1.44]; 0.016 1.19 [1.00, 1.41]; 0.046 
Adjusted model (i)
c
 1.46 [1.19, 1.80]; <0.001 1.22 [1.03, 1.43]; 0.020 1.20 [1.01, 1.43]; 0.038 
Adjusted model (ii)
d
 1.32 [1.07, 1.62]; 0.008 1.14 [0.97, 1.34]; 0.122 1.11 [0.93, 1.33]; 0.228 
CLS with unknown/HIV-
positive status partners
e 
(past 3 months) 
Unadjusted 1.55 [1.30, 1.84]; <0.001 1.27 [1.10, 1.46]; 0.001 1.25 [1.08, 1.44]; 0.002 
Adjusted model (i)
c
 1.45 [1.21, 1.74]; <0.001 1.23 [1.06, 1.41]; 0.005 1.20 [1.04, 1.38]; 0.014 
Adjusted model (ii)
d
 1.31 [1.09, 1.57]; 0.003 1.15 [1.00, 1.33]; 0.047 1.12 [0.97, 1.29]; 0.131 
Receptive CLS with an 
unknown status partner 
(past 3 months) 
Unadjusted 1.80 [1.31, 2.47]; <0.001 1.50 [1.11, 2.03]; 0.008 1.45 [1.07, 1.96]; 0.015 
Adjusted model (i)
c
 1.55 [1.11, 2.17]; 0.010 1.37 [1.00, 1.88]; 0.049 1.30 [0.95, 1.78]; 0.103 
Adjusted model (ii)
d
 1.54 [1.10, 2.15]; 0.012 1.41 [1.03,1.93]; 0.033 1.33 [0.97, 1.81]; 0.076 
Bacterial STI diagnosis 
(past year) 
Unadjusted 1.41 [1.16, 1.72]; 0.001 1.31 [1.06, 1.62]; 0.014 1.30 [1.05, 1.61]; 0.016 
Adjusted model (i)
c
 1.45 [1.18, 1.77]; <0.001 1.39 [1.12, 1.74]; 0.003 1.37 [1.10, 1.71]; 0.004 
Adjusted model (ii)
d
 1.30 [1.07, 1.58]; 0.010 1.26 [1.01, 1.57]; 0.036 1.24 [1.00, 1.53]; 0.050 
PEP use (past year) Unadjusted 1.64 [1.20, 2.22]; 0.002 1.61 [1.17, 2.22]; 0.004 1.55 [1.13, 2.14]; 0.007 
Adjusted model (i)
c
 1.79 [1.30, 2.45]; <0.001 1.79 [1.29, 2.48]; 0.001 1.71 [1.23, 2.37]; 0.001 
Adjusted model (ii)
d
 1.64 [1.19, 2.26]; 0.002 1.62 [1.16, 2.28]; 0.005 1.55 [1.10, 2.17]; 0.011 
11+ new sexual partners 
(past year) 
Unadjusted 1.09 [0.89, 1.34]; 0.412 1.13 [0.90, 1.42]; 0.285 1.09 [0.87, 1.38]; 0.447 
Adjusted model (i)
c
 1.19 [0.97, 1.46]; 0.088 1.24 [1.00, 1.54]; 0.054 1.20 [0.97, 1.50]; 0.096 
Adjusted model (ii)
d
 1.08 [0.89, 1.30]; 0.433 1.09 [0.89, 1.33]; 0.408 1.06 [0.86, 1.29]; 0.587 
Group sex (past 3 months) Unadjusted 0.91 [0.73, 1.14]; 0.408 0.95 [0.75, 1.21]; 0.695 0.96 [0.76, 1.22]; 0.737 
Adjusted model (i)
c
 0.99 [0.79, 1.24]; 0.928 1.05 [0.83, 1.33]; 0.679 1.07 [0.84, 1.35]; 0.595 
Adjusted model (ii)
d
 0.84 [0.68, 1.04]; 0.113 0.88 [0.71, 1.10]; 0.279 0.89 [0.71, 1.11]; 0.313 
a
 Prevalence ratio associated with depressive symptoms on PHQ-9 (independent variable). 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
  
 
 
440 
 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
e
 Men who reported no CLS partners of unknown HIV status and only one HIV-positive CLS partner who was a long-term partner and with whom they ‘thought the risks of 
catching HIV were low because their partner was taking ART’ were not counted as positive for this measure. 
 
11.13 Appendix 13: Relationship between other depressive symptom measures on PHQ-9 and sexual behaviour measures in the AURAH study 
 
Table 68: Unadjusted associations of other depression measures on PHQ-9 with sexual behaviour measures in AURAH 
N=1340 MSM reporting sex in the past three months CLS 
with 1+ 
partners 
 
CLS with 
2+ 
partners  
CLS with 
unknown/
HIV-
positive 
partner
b
 
Receptive 
CLS with 
unknown 
status 
partner  
Bacterial 
STI 
diagnosis 
(past 
year) 
PEP use  
(past 
year) 
11+ new 
sexual 
partners 
(past 
year) 
Group 
sex  
(past 3 
months) 
   N (%) %  
p-value
a
 
%  
p-value
a
 
 %  
p-value
a
 
%  
p-value
a
 
 %  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
Major depressive 
syndrome on PHQ-9 
(6.3%; n=85) 
Yes 
No 
85 (6.3%) 
1255 (93.7%) 
76.5% 
62.8% 
0.011 
44.7% 
31.2% 
0.010 
54.1% 
34.1% 
<0.001 
21.2% 
13.5% 
0.047 
34.1% 
31.4% 
0.601 
22.4% 
15.0% 
0.069 
34.1% 
36.2% 
0.702 
32.9% 
37.3% 
0.422 
Major and other 
depressive syndromes on 
PHQ-9 
(10.2%; n=136) 
Yes 
No 
136 (10.2%) 
1204 (89.9%) 
75.7% 
62.3% 
0.002 
45.6% 
30.6% 
<0.001 
50.7% 
33.6% 
<0.001 
16.9% 
13.6% 
0.294 
39.7% 
30.7% 
0.031 
22.1% 
14.7% 
0.024 
37.5% 
35.9% 
0.709 
34.6% 
37.3% 
0.531 
a
 Pearson χ
2 
test 
b
 Men who reported no CLS partners of unknown HIV status and only one HIV-positive CLS partner who was a long-term partner and with whom they ‘thought the risks of 
catching HIV were low because their partner was taking ART’ were not counted as positive for this measure. 
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Table 69: Unadjusted and adjusted associations of other depression measures on PHQ-9 with sexual behaviour measures in AURAH 
N=1340 MSM reporting sex in the past three months Major depressive syndrome 
(6.3%; n=85) 
Major & other depressive 
syndromes (10.2%; n=136) 
Dependent variables:   PR[95% CI]
a
; p-value
b
 PR[95% CI]
a
; p-value
b
 
CLS with 1+ partners (past 3 months) Unadjusted 1.22 [1.07, 1.38]; 0.002 1.22 [1.09, 1.35]; <0.001 
Adjusted model (i)
c
 1.18 [1.03, 1.35]; 0.014 1.20 [1.08, 1.34]; 0.001 
Adjusted model (ii)
d
 1.15 [1.01, 1.32]; 0.034 1.16 [1.04, 1.29]; 0.009 
CLS with 2+ partners (past 3 months) Unadjusted 1.43 [1.11, 1.84]; 0.005 1.49 [1.22, 1.83]; <0.001 
Adjusted model (i)
c
 1.33 [1.03, 1.73]; 0.030 1.46 [1.18, 1.80]; <0.001 
Adjusted model (ii)
d
 1.24 [0.96, 1.61]; 0.098 1.31 [1.06, 1.60]; 0.012 
CLS with unknown/HIV-positive status partners
e 
(past 3 months) 
Unadjusted 1.59 [1.29, 1.96]; <0.001 1.51 [1.26, 1.81]; <0.001 
Adjusted model (i)
c
 1.43 [1.15, 1.79]; 0.001 1.42 [1.18, 1.72]; <0.001 
Adjusted model (ii)
d
 1.34 [1.07, 1.67]; 0.010 1.29 [1.07, 1.56]; 0.007 
Receptive CLS with an unknown status partner 
(past 3 months) 
Unadjusted 1.57 [1.02, 2.43]; 0.041 1.24 [0.83, 1.85]; 0.288 
Adjusted model (i)
c
 1.30 [0.84, 2.03]; 0.242 1.07 [0.71, 1.62]; 0.730 
Adjusted model (ii)
d
 1.30 [0.83, 2.03]; 0.247 1.05 [0.70, 1.59]; 0.798 
Bacterial STI diagnosis (past year) Unadjusted 1.09 [0.80, 1.48]; 0.595 1.30 [1.04, 1.62]; 0.023 
Adjusted model (i)
c
 1.13 [0.82, 1.55]; 0.452 1.33 [1.06, 1.67]; 0.015 
Adjusted model (ii)
d
 1.04 [0.77, 1.41]; 0.781 1.19 [0.95, 1.49]; 0.121 
PEP use (past year) Unadjusted 1.49 [0.98, 2.27]; 0.060 1.50 [1.06, 2.12]; 0.021 
Adjusted model (i)
c
 1.63 [1.04, 2.55]; 0.034 1.62 [1.14, 2.31]; 0.008 
Adjusted model (ii)
d
 1.54 [0.97, 2.43]; 0.066 1.45 [1.02, 2.07]; 0.041 
11+ new sexual partners (past year) Unadjusted 0.94 [0.70, 1.28]; 0.706 1.05 [0.83, 1.32]; 0.707 
Adjusted model (i)
c
 1.03 [0.76, 1.40]; 0.826 1.14 [0.91, 1.43]; 0.259 
Adjusted model (ii)
d
 0.96 [0.73, 1.26]; 0.766 1.03 [0.84, 1.27]; 0.792 
Group sex (past 3 months) Unadjusted 0.88 [0.65, 1.21]; 0.436 0.93 [0.73, 1.18]; 0.539 
Adjusted model (i)
c
 1.02 [0.74, 1.39]; 0.923 1.04 [0.82, 1.32]; 0.764 
Adjusted model (ii)
d
 0.92 [0.68, 1.23]; 0.560 0.89 [0.71, 1.12]; 0.315 
a
 Prevalence ratio associated with a major depressive syndrome on PHQ-9 or major and other depressive syndromes on PHQ-9 (independent variables). 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
e
 Men who reported no CLS partners of unknown HIV status, and only one HIV-positive CLS partner who was a long-term partner and with whom they ‘thought the risks of 
catching HIV were low because their partner was taking ART’ were not counted as positive for this measure. 
  
 
 
442 
 
11.14 Appendix 14: Relationship between other depression measures on PHQ-9 and measures of self-efficacy for sexual safety in the AURAH 
study 
 
Table 70: Unadjusted and adjusted associations of other depression measures on PHQ-9 with high self-efficacy for sexual safety in AURAH 
N=1340 MSM reporting anal/vaginal sex in 
the past 3 months 
High self-efficacy for sexual safety (n=900; 67.2%) 
   N (%) %  p-value
a
 Unadjusted 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model (i)
c
 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model (ii)
d
 
PR[95% CI]    
Overall 
p-value
b
 
Major depressive 
syndrome  
Yes 
No 
85 (6.3%) 
1255 (93.7%) 
51.8% 
68.2% 
0.002 0.76 [0.62, 0.94] 
1 
0.010 0.75 [0.61, 0.92] 
1 
0.007 0.76 [0.61, 0.93] 
1 
0.009 
Major and other 
depressive 
syndromes  
Yes 
No 
136 (10.2%) 
1204 (89.9%) 
55.9% 
68.4% 
0.003 0.82 [0.70, 0.95] 
1 
0.010 0.81 [0.70, 0.95] 
1 
0.009 0.82 [0.70, 0.96] 
1 
0.015 
a
 Pearson χ
2 
test 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
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Table 71: Unadjusted and adjusted associations of other depression measures on PHQ-9 with difficulty negotiating condom-use in AURAH 
N=1340 MSM reporting anal/vaginal sex in the 
past 3 months 
Difficulty negotiating condom-use (n=142; 10.6%) 
   N (%) %  p-value
a
 Unadjusted 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model 
(i)
c
 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model 
(ii)
d
 
PR[95% CI]    
Overall p-
value
b
 
Major depressive 
syndrome 
Yes 
No 
85 (6.3%) 
1255 (93.7%) 
14.1% 
10.4% 
0.276 1.36 [0.79, 2.36] 
1 
0.269 1.24 [0.71, 2.17] 
1 
0.452 1.22 [0.70, 2.12] 
1 
0.480 
Major and other 
depressive 
syndromes 
Yes 
No 
136 (10.2%) 
1204 (89.9%) 
14.0% 
10.2% 
0.178 1.37 [0.87, 2.14] 
1 
0.172 1.30 [0.83, 2.05] 
1 
0.253 1.29 [0.82, 2.03] 
1 
0.264 
a
 Pearson χ
2 
test 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
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11.15 Appendix 15: Relationship of generalized anxiety disorder and suicidal ideation 
with sexual behaviour measures in the AURAH study 
 
The prevalence of GAD on GAD-7 (≥10) was 10.2% (137/1340), see section 4.3.3.1 of Chapter 
4. Compared to depressive symptoms on PHQ-9 (≥10) a similar pattern of associations was 
found between GAD on GAD-7 and sexual behaviour measures. Men with GAD were more 
likely than men without to report CLS with two or more partners, CLS with an unknown/HIV-
positive status partner, receptive CLS with an unknown HIV status partner, and PEP use. Men 
with GAD were slightly less likely than men without to report eleven or more new sexual 
partners in the past year (Table 72). After adjusting for socio-demographic factors, all 
associations remained, with the exception of that with eleven or more new sexual partners. After 
adjusting additionally for smoking, drinking, and recreational drug use, associations with CLS 
measures and PEP use were attenuated but remained significant. GAD was not associated with 
CLS with one or more partners (although the unadjusted PR did appear to be of at least 
borderline significance), bacterial STI diagnosis, or group sex, in unadjusted or adjusted 
analysis (Table 73). Furthermore, men with GAD were less likely to report high self-efficacy for 
sexual safety and more likely to report difficulty negotiating condom-use than men without GAD 
(Table 74). Adjusted for key socio-demographic factors, GAD was inversely associated with 
high self-efficacy, and was associated with difficulty negotiating condom-use. These 
associations remained with some attenuation, after additional adjustment for smoking, alcohol, 
and recreational drug use (Table 75). GAD on GAD-7 was not associated with any reason for 
non-condom-use presented, in unadjusted or adjusted analysis (data not shown). 
 
The prevalence of suicidal ideation on PHQ-9 was 11.7% (157/1340), see section 4.3.1 of 
Chapter 4. Compared to depressive symptoms on PHQ-9 (≥10) a similar pattern of associations 
was found between suicidal ideation on PHQ-9 with sexual behaviour measures. Men who 
reported suicidal ideation were more likely than men who did not to report all measures of CLS, 
as well as PEP use. Men who reported suicidal ideation were also slightly more likely than men 
who did not to report bacterial STI diagnosis (Table 72). After adjusting for socio-demographic 
factors, associations with all CLS measures, STI diagnosis, and PEP use remained. After 
adjusting additionally for smoking, drinking, and recreational drug use, most associations were 
attenuated but remained significant, with the exception of that with STI diagnosis, which was no 
longer associated with suicidal ideation. Suicidal ideation was not associated with report of 
eleven or more new sexual partners or group sex, in unadjusted or adjusted analysis. Suicidal 
ideation was not associated with high self-efficacy for sexual safety, in unadjusted or adjusted 
analysis (Table 73). Men who reported suicidal ideation were more likely to report difficulty 
negotiating condom-use than men who did not report suicidal ideation (Table 74). However, this 
relationship disappeared after adjustment (Table 75). Finally, indicating suicidal ideation on 
PHQ-9 was found to have a borderline association with a reason for non-condom-use being; my 
partner didn’t want to use a condom, in unadjusted analysis, however, the association 
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disappeared after adjustment. Suicidal ideation on PHQ-9 was not associated with any of the 
other reasons for non-condom-use, in unadjusted or adjusted analysis (data not shown). 
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Table 72: Unadjusted associations of GAD and suicidal ideation with sexual behaviour measures in AURAH 
N=1340 MSM reporting sex in the past three months CLS 
with 1+ 
partners 
 
CLS with 
2+ 
partners  
CLS with 
unknown/
HIV-
positive 
partner
b
 
Receptive 
CLS with 
unknown 
status 
partner  
Bacterial 
STI 
diagnosis 
(past 
year) 
PEP use  
(past 
year) 
11+ new 
sexual 
partners 
(past 
year) 
Group 
sex  
(past 3 
months) 
   N (%) %  
p-value
a
 
%  
p-value
a
 
 %  
p-value
a
 
%  
p-value
a
 
 %  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
%  
p-value
a
 
Generalized anxiety 
disorder on GAD-7 (score 
of ≥10) 
Yes 
No 
137 (10.2%) 
1203 (89.8%) 
70.8% 
62.8% 
0.066 
43.1% 
30.8% 
0.004 
48.2% 
33.9% 
0.001 
22.6% 
13.0% 
0.002 
32.9% 
31.4% 
0.734 
22.6% 
14.6% 
0.014 
28.5% 
36.9% 
0.051 
30.7% 
37.7% 
0.104 
Suicidal ideation on PHQ-
9 (final question) 
Yes 
No 
157 (11.7%) 
1183 (88.3%) 
77.1% 
61.9% 
<0.001 
45.2% 
30.4% 
<0.001 
52.9% 
33.1% 
<0.001 
25.5% 
12.4% 
<0.001 
38.2% 
30.7% 
0.056 
22.3% 
14.5% 
0.012 
38.9% 
35.7% 
0.435 
36.3% 
37.1% 
0.845 
a
 Pearson χ
2 
test 
b
 Men who reported no CLS partners of unknown HIV status and only one HIV-positive CLS partner who was a long-term partner and with whom they ‘thought the risks of 
catching HIV were low because their partner was taking ART’ were not counted as positive for this measure. 
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Table 73: Adjusted associations of GAD and suicidal ideation with sexual behaviour measures in AURAH 
N=1340 MSM reporting sex in the past three months GAD (GAD-7≥10) Suicidal ideation on PHQ-9 
Dependent variables:   PR[95% CI]
a
; p-value
b
 PR[95% CI]
a
; p-value
b
 
CLS with 1+ partners (past 3 months) Unadjusted 1.13 [1.00, 1.27]; 0.044 1.25 [1.13, 1.37]; <0.001 
Adjusted model (i)
c
 1.11 [0.99, 1.25]; 0.079 1.21 [1.09, 1.33]; <0.001 
Adjusted model (ii)
d
 1.08 [0.96, 1.22]; 0.182 1.16 [1.06, 1.28]; 0.002 
CLS with 2+ partners (past 3 months) Unadjusted 1.40 [1.13, 1.72]; 0.002 1.49 [1.23, 1.81]; <0.001 
Adjusted model (i)
c
 1.39 [1.12, 1.74]; 0.003 1.40 [1.14, 1.71]; 0.001 
Adjusted model (ii)
d
 1.31 [1.05, 1.62]; 0.015 1.27 [1.04, 1.56]; 0.019 
CLS with unknown/HIV-positive status partners
b 
(past 3 months) 
Unadjusted 1.42 [1.17, 1.72]; <0.001 1.60 [1.35, 1.89]; <0.001 
Adjusted model (i)
c
 1.36 [1.12, 1.67]; 0.002 1.48 [1.24, 1.76]; <0.001 
Adjusted model (ii)
d
 1.28 [1.05, 1.55]; 0.015 1.35 [1.13, 1.61]; 0.001 
Receptive CLS with an unknown status partner 
(past 3 months) 
Unadjusted 1.74 [1.24, 2.46]; 0.001 2.05 [1.51, 2.79]; <0.001 
Adjusted model (i)
c
 1.52 [1.05, 2.20]; 0.025 1.81 [1.31, 2.49]; <0.001 
Adjusted model (ii)
d
 1.52 [1.05, 2.21]; 0.026 1.80 [1.30, 2.48]; <0.001 
Bacterial STI diagnosis (past year) Unadjusted 1.05 [0.81, 1.35]; 0.732 1.25 [1.00, 1.55]; 0.047 
Adjusted model (i)
c
 1.10 [0.86, 1.42]; 0.441 1.35 [1.09, 1.67]; 0.007 
Adjusted model (ii)
d
 1.05 [0.82, 1.34]; 0.709 1.23 [0.99, 1.51]; 0.061 
PEP use (past year) Unadjusted 1.55 [1.10, 2.17]; 0.012 1.53 [1.11, 2.12]; 0.010 
Adjusted model (i)
c
 1.74 [1.23, 2.47]; 0.002 1.68 [1.21, 2.33]; 0.002 
Adjusted model (ii)
d
 1.71 [1.20, 2.43]; 0.003 1.57 [1.13, 2.18]; 0.008 
11+ new sexual partners (past year) Unadjusted 0.77 [0.59, 1.02]; 0.065 1.09 [0.88, 1.34]; 0.427 
Adjusted model (i)
c
 0.84 [0.64, 1.11]; 0.228 1.19 [0.97, 1.46]; 0.105 
Adjusted model (ii)
d
 0.80 [0.62, 1.04]; 0.099 1.09 [0.89, 1.33]; 0.425 
Group sex (past 3 months) Unadjusted 0.81 [0.62, 1.06]; 0.120 0.98 [0.79, 1.22]; 0.846 
Adjusted model (i)
c
 0.90 [0.69, 1.17]; 0.438 1.04 [0.83, 1.29]; 0.741 
Adjusted model (ii)
d
 0.83 [0.65, 1.06]; 0.133 0.90 [0.73, 1.10]; 0.302 
a
 Prevalence ratio associated with a major depressive syndrome on PHQ-9 or major and other depressive syndromes on PHQ-9 (independent variables). 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
d
 Adjusted models (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
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Table 74: Unadjusted and adjusted associations of GAD and suicidal ideation with high self-efficacy for sexual safety in AURAH 
N=1340 MSM reporting anal/vaginal sex in 
the past 3 months 
High self-efficacy for sexual safety (n=900; 67.2%) 
   N (%) %  p-value
a
 Unadjusted 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model (i)
c
 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model (ii)
d
 
PR[95% CI]    
Overall 
p-value
b
 
Generalized 
anxiety disorder 
on GAD-7 (score 
of ≥10) 
Yes 
No 
137 (10.2%) 
1203 (89.8%) 
54.0% 
68.7% 
0.001 0.79 [0.67, 0.92] 
1 
0.003 0.78 [0.67, 0.92] 
1 
0.002 0.79 [0.67, 0.92] 
1 
0.003 
Suicidal ideation 
on PHQ-9 (final 
question) 
Yes 
No 
157 (11.7%) 
1183 (88.3%) 
61.2% 
68.0% 
0.087 0.90 [0.79, 1.03] 
1 
0.113 0.92 [0.80, 1.04] 
1 
0.192 0.93 [0.81, 1.06] 
1 
0.276 
a
 Pearson χ
2 
test 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
 
Table 75: Unadjusted and adjusted associations of GAD and suicidal ideation with difficulty negotiating condom-use in AURAH 
N=1340 MSM reporting anal/vaginal sex in the 
past 3 months 
Difficulty negotiating condom-use (n=142; 10.6%) 
   N (%) %  p-value
a
 Unadjusted 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model 
(i)
c
 
PR[95% CI]    
Overall 
p-value
b
 
Adjusted model 
(ii)
d
 
PR[95% CI]    
Overall p-
value
b
 
Generalized anxiety 
disorder on GAD-7 
(score of ≥10) 
Yes 
No 
137 (10.2%) 
1203 (89.8%) 
18.3% 
9.7% 
0.002 1.88 [1.27, 2.78] 
1 
0.002 1.62 [1.06, 2.48] 
1 
0.027 1.62 [1.06, 2.49] 
1 
0.027 
Suicidal ideation on 
PHQ-9 (final 
question) 
Yes 
No 
157 (11.7%) 
1183 (88.3%) 
16.6% 
9.8% 
0.010 1.69 [1.14, 2.50] 
1 
0.009 1.46 [0.97, 2.17] 
1 
0.067 1.45 [0.97, 2.16] 
1 
0.067 
a
 Pearson χ
2 
test 
b
 p-value by Wald test using modified Poisson models. 
c
 Adjusted model (i): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, and study region. 
  
 
 
449 
 
d
 Adjusted model (ii): Age in four categories (<25; 25-29; 30-39; 40+), UK born (yes or no/missing), sexual identity (gay or bisexual/straight), university education, ongoing 
relationship status, study region, smoking, higher-risk drinking, and recreational drug use. 
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11.16 Appendix 16: Relationship of socio-demographic and lifestyle factors with sexual behaviour measures in the AURAH study 
 
Table 76: Unadjusted associations of socio-demographic and lifestyle factors with sexual behaviour measures (past three months) among 1340 
MSM in AURAH who reported anal or vaginal sex in the past three months 
N=1340 MSM reporting sex in the past 3 months CLS 
with 1+ 
partners 
CLS with 
2+ 
partners  
CLS with 
unknown/HIV-
positive partner 
l
 
Receptive CLS 
with unknown 
status partner  
Bacterial STI 
diagnosis 
(past year) 
PEP use  
(past 
year) 
11+ new sex 
partners 
(past year) 
Group 
sex 
   N (%) %  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
Age (years) <25 
25-29 
30-34 
35-39 
40-44 
45+ 
235 (17.8%) 
344 (26.0%) 
255 (19.3%) 
175 (13.2%) 
125 (9.5%) 
188 (14.2%) 
65.5% 
59.6% 
65.5% 
64.0% 
64.0% 
65.4% 
0.631 
0.565
c
 
28.5% 
26.2% 
32.6% 
37.7% 
36.8% 
37.2% 
0.023 
0.002
c
 
34.9% 
29.7% 
34.9% 
37.1% 
38.4% 
43.6% 
0.046 
0.006
c
 
15.3% 
11.9% 
11.8% 
17.1% 
15.2% 
14.9% 
0.499 
0.483
c
 
24.3% 
35.8% 
37.7% 
32.0% 
33.6% 
22.9% 
0.001 
0.407
c
 
14.5% 
14.0% 
17.7% 
20.0% 
13.6% 
13.8% 
0.396 
0.859
c
 
29.4% 
29.4% 
40.4% 
38.3% 
48.0% 
41.0% 
<0.001 
<0.001
c
 
28.1% 
30.2% 
39.2% 
46.9% 
45.6% 
44.2% 
<0.001 
<0.001
c
 
Born in the UK 
and ethnicity 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
676 (51.2%) 
86 (6.5%) 
408 (30.9%) 
151 (11.4%) 
66.3% 
68.6% 
57.1% 
66.2% 
0.012 
33.6% 
40.7% 
26.0% 
35.1% 
0.010 
37.7% 
34.9% 
31.9% 
34.4% 
0.273 
15.1% 
10.5% 
13.0% 
13.3% 
0.577 
30.5% 
29.1% 
35.8% 
26.5% 
0.123 
14.8% 
12.8% 
16.2% 
17.9% 
0.674 
36.8% 
27.9% 
39.5% 
28.5% 
0.037 
39.8% 
31.4% 
36.0% 
31.8% 
0.150 
Study region London 
South 
Other 
1017 (75.9%) 
241 (18.0%) 
82 (6.1%) 
60.4% 
73.4% 
75.6% 
<0.001 
29.3% 
40.7% 
41.5% 
0.001 
32.2% 
44.4% 
48.8% 
<0.001 
12.6% 
15.4% 
26.8% 
0.001 
31.2% 
35.3% 
25.6% 
0.229 
14.6% 
20.3% 
12.2% 
0.058 
37.0% 
35.3% 
26.8% 
0.177 
37.0% 
39.4% 
30.5% 
0.351 
University 
Education 
Yes 
No/missing
a
 
891 (66.5%) 
449 (33.5%) 
60.5% 
69.9% 
0.001 
29.5% 
37.2% 
0.004 
32.0% 
42.1% 
<0.001 
12.4% 
17.2% 
0.017 
29.0% 
36.8% 
0.004 
16.2% 
14.0% 
0.308 
37.2% 
33.9% 
0.236 
36.9% 
37.2% 
0.923 
Employment 
status 
Employed 
Not employed/ 
missing
a
 
1069 (79.8%) 
271 (20.2%) 
63.1% 
66.1% 
0.359 
31.1% 
36.2% 
0.108 
34.7% 
38.0% 
0.310 
13.5% 
15.9% 
0.309 
32.9% 
26.2% 
0.033 
15.3% 
16.2% 
0.688 
36.5% 
34.3% 
0.507 
38.4% 
31.7% 
0.044 
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Table 76: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with sexual behaviour measures (past three months) 
among 1340 MSM in AURAH who reported anal or vaginal sex in the past three months (continued) 
N=1340 MSM reporting sex in the past 3 months CLS 
with 1+ 
partners 
 
CLS with 
2+ 
partners  
CLS with 
unknown/HIV-
positive partner
 l
  
Receptive CLS 
with unknown 
status partner  
Bacterial STI 
diagnosis 
(past year) 
PEP use  
(past 
year) 
11+ new sex 
partners 
(past year) 
Group 
sex 
   N (%) %  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
Money to 
cover basic 
needs 
(financial 
hardship) 
Always 
Mostly 
At times/no 
958 (71.7%) 
281 (21.0%) 
97 (7.3%) 
61.2% 
68.0% 
76.3% 
0.003 
0.001
c
 
30.2% 
34.2% 
45.4% 
0.007 
0.003
c
 
33.1% 
38.1% 
50.5% 
0.002 
0.001
c
 
12.9% 
15.3% 
19.6% 
0.149 
0.055
c
 
29.9% 
36.3% 
34.0% 
0.106 
0.078
c
 
15.2% 
13.9% 
22.7% 
0.109 
0.245
c
 
37.0% 
35.2% 
29.9% 
0.366 
0.181
c
 
37.9% 
35.2% 
34.0% 
0.585 
0.309
c
 
Housing status Home owner 
Renting 
Unstable/other 
369 (27.9%) 
764 (57.8%) 
188 (14.2%) 
65.6% 
62.0% 
67.0% 
0.306 
0.955
c
 
33.6% 
30.4% 
35.6% 
0.284 
0.929
c
 
36.9% 
34.0% 
38.3% 
0.437 
0.991
c
 
13.3% 
13.6% 
16.5% 
0.543 
0.367
c
 
28.2% 
32.9% 
33.0% 
0.258 
0.158
c
 
17.3% 
14.9% 
14.4% 
0.512 
0.286
c
 
42.3% 
34.6% 
29.8% 
0.006 
0.002
c
 
41.2% 
35.9% 
34.6% 
0.161 
0.077
c
 
Self-reported 
sexual identity 
Gay 
Bisexual 
Straight 
1190 (89.1%) 
127 (9.5%) 
19 (1.4%) 
63.1% 
64.6% 
94.7% 
0.017 
31.8% 
30.7% 
57.9% 
0.050 
35.0% 
37.0% 
52.6% 
0.258 
13.8% 
15.8% 
15.8% 
0.731
d
 
32.6% 
27.6% 
0.0% 
0.006 
16.1% 
11.0% 
5.3% 
0.200
d
 
38.0% 
22.8% 
5.3% 
<0.001 
37.9% 
30.7% 
26.3% 
0.174 
Ongoing 
relationship 
Yes 
No/missing
a
 
579 (43.2%) 
761 (56.8%) 
70.6% 
58.3% 
<0.001 
27.3% 
35.7% 
0.001 
30.7% 
38.9% 
0.002 
10.2% 
16.8% 
0.001 
29.0% 
33.5% 
0.080 
13.3% 
17.1% 
0.058 
27.3% 
42.7% 
<0.001 
34.9% 
38.6% 
0.160 
Supportive 
network 
1: High levels 
2 
3 
4 
5: Low levels 
400 (30.1%) 
464 (34.9%) 
284 (21.3%) 
130 (9.8%) 
53 (4.0%) 
63.5% 
61.0% 
64.8% 
66.2% 
71.7% 
0.494 
0.222
c
 
27.3% 
29.1% 
36.3% 
41.5% 
49.1% 
<0.001 
<0.001
c
 
29.0% 
34.9% 
37.7% 
43.1% 
52.8% 
0.001 
<0.001
c
 
10.3% 
12.7% 
16.2% 
17.7% 
32.1% 
<0.001 
<0.001
c
 
30.3% 
30.8% 
30.3% 
37.7% 
39.6% 
0.341 
0.104
c
 
11.3% 
13.2% 
16.9% 
26.2% 
32.1% 
<0.001 
<0.001
c
 
31.5% 
36.0% 
37.0% 
46.2% 
41.5% 
0.038 
0.004
c
 
35.0% 
37.9% 
37.3% 
37.7% 
43.4% 
0.769 
0.290
c
 
Current 
smoker 
Yes 
No/missing
a
 
334 (24.9%) 
1006 (75.1%) 
71.9% 
60.9% 
<0.001 
40.1% 
29.4% 
<0.001 
46.7% 
31.6% 
<0.001 
15.3% 
13.5% 
0.424 
33.2% 
31.0% 
0.450 
14.7% 
15.7% 
0.650 
33.5% 
36.9% 
0.270 
40.7% 
35.8% 
0.106 
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Table 76: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with sexual behaviour measures (past three months) 
among 1340 MSM in AURAH who reported anal or vaginal sex in the past three months (continued) 
N=1340 MSM reporting sex in the past 3 months CLS 
with 1+ 
partners 
 
CLS with 
2+ 
partners  
CLS with 
unknown/HIV-
positive partner
 l
  
Receptive CLS 
with unknown 
status partner  
Bacterial STI 
diagnosis 
(past year) 
PEP use  
(past 
year) 
11+ new sex 
partners 
(past year) 
Group 
sex 
   N (%) %  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
%  
p-value
b
 
Higher-risk 
alcohol 
consumption 
Yes 
No/missing
a
 
259 (19.3%) 
1081 (80.7%) 
64.5% 
63.5% 
0.759 
39.0% 
30.4% 
0.008 
42.1% 
33.8% 
0.012 
15.4% 
13.6% 
0.441 
36.7% 
30.3% 
0.049 
18.9% 
14.6% 
0.085 
44.8% 
34.0% 
0.001 
44.0% 
35.3% 
0.009 
Recreational 
drug use  
(past 3 
months) 
0/missing
a
 
1 
2-4 
5+ 
579 (43.2%) 
269 (20.1%) 
302 (22.5%) 
190 (14.2%) 
58.4% 
60.2% 
68.5% 
76.8% 
<0.001 
<0.001
c
 
25.6% 
25.3% 
36.1% 
55.3% 
<0.001 
<0.001
c
 
27.6% 
32.0% 
39.4% 
57.4% 
<0.001 
<0.001
c
 
12.8% 
12.3% 
16.6% 
15.8% 
0.316 
0.123
c
 
22.6% 
29.7% 
34.4% 
56.8% 
<0.001 
<0.001
c
 
12.1% 
11.2% 
18.5% 
26.8% 
<0.001 
<0.001
c
 
24.9% 
34.9% 
39.7% 
65.8% 
<0.001 
<0.001
c
 
20.4% 
32.0% 
50.0% 
74.2% 
<0.001 
<0.001
c
 
Chemsex-
associated  
drug use 
No 
Yes 
1027 (76.6%) 
313 (23.4%) 
60.7% 
73.5% 
<0.001 
26.9% 
49.2% 
<0.001 
30.4% 
51.8% 
<0.001 
12.9% 
17.6% 
0.035 
24.4% 
55.0% 
<0.001 
11.0% 
30.0% 
<0.001 
29.1% 
58.8% 
<0.001 
26.9% 
70.3% 
<0.001 
a 
University Education: 0.3% (n=4) missing. Employed: 1.4% (n=19) missing. Ongoing relationship: 0.2% (n=3) missing. Smoke regularly: 0.4% (n=5) missing. Heavy drinking: 
1.2% (n=16) missing. Recreational drug use: 0.8% (n=11) missing. 
b 
Pearson χ
2 
test 
c
 Test for trend. 
d 
Fisher’s exact test.
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11.17 Appendix 17: Socio-demographic, lifestyle, and psychosocial factors associated with other depressive symptom measures on PHQ-9 at 
baseline, and the 12- and 24-month questionnaire in the PROUD trial 
 
Table 77: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with a measure of major depression on PHQ-9 using 
baseline, 12-month follow-up, and 24-month follow-up data among all 540 men who participated in PROUD 
     Major depression on PHQ-9 
N=540 men  
 
 Baseline  
[N=540] 
n(%) 
12-month  
[N=410]  
n(%) 
24-month  
[N=333] 
n(%) 
Unadjusted 
PR [95% CI] 
Overall  
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall  
p-value
a 
 
Study time-point 
N=540
d
, Obs=1283
e 
; N=536
f
, Obs=1273
g
 
Baseline 
12-month  
24-month  
/ / / 1 
1.79 [1.17, 2.73] 
1.76 [1.12, 2.77] 
0.014 
0.010
 c
 
1 
1.82 [1.17, 2.81] 
1.82 [1.14, 2.91] 
0.013 
0.009
c
 
Randomized to study trial arm  
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Immediate arm 
Deferred arm 
/ 216 (52.7%) 
194 (47.3%) 
182 (54.7%) 
151 (45.4%) 
1.64 [0.93, 2.88] 
1 
0.086 1.72 [0.97, 3.04] 
1 
0.061 
Age 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
27 (6.6%) 
56 (13.7%) 
87 (21.2%) 
78 (19.0%) 
70 (17.1%) 
92 (22.4%) 
11 (3.3%) 
35 (10.5%) 
73 (21.9%) 
66 (19.8%) 
55 (16.5%) 
93 (27.9%) 
1.00 [0.45, 2.22] 
0.71 [0.35, 1.43] 
0.80 [0.43, 1.46] 
0.33 [0.14, 0.77] 
0.18 [0.06, 0.58] 
1 
0.017 
0.721
c
 
0.97 [0.44, 2.14] 
0.72 [0.36, 1.43] 
0.85 [0.46, 1.56] 
0.36 [0.15, 0.84] 
0.20 [0.06, 0.62] 
1 
0.031 
0.803
c
 
Born in the UK and white ethnicity 
N=538
d
, Obs=1279
 e
 ; N=534
f
, Obs=1269
g
 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
223 (54.7%) 
22 (5.4%) 
114 (27.9%) 
49 (12.0%) 
184 (55.3%) 
17 (5.1%) 
88 (26.4%) 
44 (13.2%) 
1 
1.97 [0.88, 4.40] 
0.80 [0.43, 1.51] 
1.13 [0.53, 2.42] 
0.261 1 
1.63 [0.70, 3.77] 
0.78 [0.41, 1.50] 
1.02 [0.46, 2.23] 
0.506 
Self-reported sexual identity
d
 
N=536
d
, Obs=1273
e
 ; N=536
f
, Obs=1273
g
 
Gay 
Bisexual/straight 
513 (95.7%) 
23 (4.3%) 
388 (95.6%) 
18 (4.4%) 
315 (95.2%) 
16 (4.8%) 
1 
2.27 [0.98, 5.28] 
0.057 1 
2.25 [0.97, 5.24] 
0.060 
University Education 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
327 (60.6%) 
213 (39.4%) 
256 (62.4%) 
154 (37.6%) 
204 (61.3%) 
129 (38.7%) 
0.68 [0.41, 1.12] 
1 
0.126 0.68 [0.41, 1.14] 
1 
0.141 
Employed 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
439 (81.3%) 
101 (18.7%) 
332 (81.0%) 
78 (19.0%) 
276 (82.3%) 
57 (17.1%) 
1 
2.58 [1.57, 4.23] 
<0.001 1 
2.36 [1.41, 3.94] 
0.001 
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Table 77: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with a measure of major depression on PHQ-9 using 
baseline, 12-month follow-up, and 24-month follow-up data among all 540 men who participated in PROUD (continued) 
     Major depression on PHQ-9 
N=540 men  
 
 Baseline  
[N=540] n(%) 
12-month  
[N=410] n(%) 
24-month  
[N=333] n(%) 
Unadjusted 
PR [95% CI] 
Overall  
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall  
p-value
a 
 
Study region 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
London 
Outside London 
375 (69.4%) 
165 (30.6%) 
289 (70.5%) 
121 (29.5%) 
228 (68.5%) 
105 (31.5%) 
1 
0.78 [0.44, 1.37] 
0.385 1 
0.62 [0.34, 1.12] 
0.113 
Had sexualized drug use (past three months) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Yes 
No 
/ 224 (54.6%) 
186 (45.4%) 
159 (47.8%) 
174 (52.3%) 
1.25 [0.76, 2.08] 
1 
0.377 1.20 [0.72, 2.00] 
1 
0.479 
Age≤15 years at anal sex debut  
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Yes 
No  
/ 88 (22.3%) 
307 (77.7%) 
70 (21.8%) 
251 (78.2%) 
1.78 [1.02, 3.12] 
1 
0.042 1.71 [0.96, 3.06] 
1 
0.068 
Age<13 years at anal sex debut
  
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g 
Yes 
No 
/ 22 (5.6%) 
373 (94.4%) 
19 (5.9%) 
302 (94.1%) 
0.95 [0.30, 2.95] 
1 
0.927 0.95 [0.30, 3.00] 
1 
0.937 
Time between any sexual contact and intercourse 
with a male N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Same time 
1-2 years 
3-4 years 
5+ years 
/ 163 (41.3%) 
90 (22.8%) 
47 (11.9%) 
95 (24.1%) 
146 (45.5%) 
67 (20.9%) 
33 (10.3%) 
75 (23.4%) 
1 
0.74 [0.38, 1.44] 
0.79 [0.33,1.85] 
0.85 [0.44, 1.63] 
0.815 
0.564
c
 
1 
0.76 [0.39, 1.47] 
0.75 [0.31, 1.77] 
0.84 [0.43, 1.65] 
0.813 
0.548
c
 
Any IPV victimization 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 226 (55.1%) 
184 (44.9%) 
199 (59.8%) 
134 (40.2%) 
1 
2.02 [1.22, 3.35] 
0.006 1 
2.15 [1.29, 3.58] 
0.003 
Any IPV victimization in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
 g
 
No 
Yes 
/ 346 (84.4%) 
64 (15.6%) 
284 (85.3%) 
49 (14.7%) 
1 
3.08 [1.86, 5.10] 
<0.001 1 
3.18 [1.91, 5.29] 
<0.001 
Any IPV perpetration
 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 330 (80.5%) 
80 (19.5%) 
273 (82.0%) 
60 (18.0%) 
1 
2.29 [1.35, 3.89] 
0.002 1 
2.24 [1.31, 3.84] 
0.003 
Any IPV perpetration in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 378 (92.2%) 
32 (7.8%) 
310 (93.1%) 
23 (6.9%) 
1 
3.08 [1.68, 5.67] 
<0.001 1 
3.07 [1.63, 5.78] 
0.001 
Bidirectional IPV (victimization and perpetration) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 341 (83.2%) 
69 (16.8%) 
277 (83.2%) 
56 (16.8%) 
1 
2.23 [1.29, 3.82] 
0.004 1 
2.24 [1.29, 3.90] 
0.004 
Unidirectional IPV victimization (no reported 
perpetration) N=436
d
, Obs=743
e
 ; N=432
f
,Obs=737
g
 
No 
Yes 
/ 295 (72.0%) 
115 (28.1%) 
255 (76.6%) 
78 (23.4%) 
1 
1.18 [0.70, 2.01] 
0.536 1 
1.28 [0.75, 2.19] 
0.357 
Any negative views about gay sexuality (marker of 
internalised homophobia)
 
N=436
d
, Obs=743
e 
; 
N=432
f
, Obs=737
g 
No/missing
  
Yes
 
 
/ 239 (58.3%) 
171 (41.7%) 
195 (58.6%) 
138 (41.4%) 
1 
2.01 [1.22, 3.31] 
0.006 1 
2.02 [1.22, 3.36] 
0.006 
‘Out’ to all/almost all friends, work colleagues and 
close family N=434
d
, Obs=727
e 
; N=431
f
, Obs=722
g
 
Yes 
No 
/ 206 (51.6%) 
193 (48.4%) 
166 (50.6%) 
162 (49.4%) 
1 
2.22 [1.29, 3.79] 
0.004 1 
2.24 [1.29, 3.88] 
0.004 
a
 p-value by Wald test using GEE models. 
  
 
 
455 
 
b
 Age (included as four categories: <25, 25-29, 30-39, 40+), born in the UK, sexual identity (gay or bisexual/straight), university education, and London study clinic site. 
c 
Test for trend. Of note, findings were almost identical when adjusting additionally for study time-point. 
d
 Number of men contributing observations to the unadjusted model. 
e
 Number of observations examined in the unadjusted model. 
f
 Number of men contributing observations to the adjusted model. 
g
 Number of observations examined in the adjusted model. 
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Table 78: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with major & other depressive syndromes on PHQ-9 
using baseline, 12-month follow-up, and 24-month follow-up data among all 540 men who participated in PROUD 
     Major & other depressive syndromes on PHQ-9  
N=540 men  
 
 Baseline  
[N=540] 
n(%) 
12-month  
[N=410]  
n(%) 
24-month  
[N=333] 
n(%) 
Unadjusted 
PR [95% CI] 
Overall  
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall  
p-value
a 
 
Study time-point 
N=540
d
, Obs=1283
e 
; N=536
f
, Obs=1273
g
 
Baseline 
12-month  
24-month  
/ / / 1 
1.38 [0.98, 1.95] 
1.33 [0.92, 1.93] 
0.141 
0.100
 c
 
1 
1.39 [0.98, 1.98] 
1.36 [0.93, 1.99] 
0.134 
0.089
c
 
Randomized to study trial arm  
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Immediate arm 
Deferred arm 
/ 216 (52.7%) 
194 (47.3%) 
182 (54.7%) 
151 (45.4%) 
1.50 [0.93, 2.40] 
1 
0.094 1.51 [0.94, 2.42] 
1 
0.085 
Age 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
27 (6.6%) 
56 (13.7%) 
87 (21.2%) 
78 (19.0%) 
70 (17.1%) 
92 (22.4%) 
11 (3.3%) 
35 (10.5%) 
73 (21.9%) 
66 (19.8%) 
55 (16.5%) 
93 (27.9%) 
1.13 [0.57, 2.24] 
0.69 [0.37, 1.31] 
1.05 [0.63, 1.76] 
0.36 [0.17, 0.75] 
0.53 [0.27, 1.03] 
1 
0.018 
0.621
c
 
1.08 [0.55, 2.13] 
0.69 [0.37, 1.29] 
1.09 [0.65, 1.81] 
0.38 [0.18, 0.79] 
0.56 [0.29, 1.08] 
1 
0.025 
0.736
c
 
Born in the UK and white ethnicity 
N=538
d
, Obs=1279
 e
 ; N=534
f
, Obs=1269
g
 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
223 (54.7%) 
22 (5.4%) 
114 (27.9%) 
49 (12.0%) 
184 (55.3%) 
17 (5.1%) 
88 (26.4%) 
44 (13.2%) 
1 
1.60 [0.78, 3.29] 
0.90 [0.55, 1.49] 
1.39 [0.78, 2.47] 
0.345 1 
1.41 [0.67, 2.96] 
0.90 [0.54, 1.51] 
1.36 [0.75, 2.46] 
0.518 
Self-reported sexual identity
d
 
N=536
d
, Obs=1273
e
 ; N=536
f
, Obs=1273
g
 
Gay 
Bisexual/straight 
513 (95.7%) 
23 (4.3%) 
388 (95.6%) 
18 (4.4%) 
315 (95.2%) 
16 (4.8%) 
1 
1.81 [0.85, 3.82] 
0.122 1 
1.76 [0.84, 3.72] 
0.136 
University Education 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
327 (60.6%) 
213 (39.4%) 
256 (62.4%) 
154 (37.6%) 
204 (61.3%) 
129 (38.7%) 
0.66 [0.44, 0.99] 
1 
0.043 0.66 [0.44, 0.99] 
1 
0.046 
Employed 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
Yes 
No/missing 
439 (81.3%) 
101 (18.7%) 
332 (81.0%) 
78 (19.0%) 
276 (82.3%) 
57 (17.1%) 
1 
1.97 [1.28, 3.02] 
0.002 1 
1.81 [1.16, 2.81] 
0.009 
Study region 
N=540
d
, Obs=1283
e
 ; N=536
f
, Obs=1273
g
 
London 
Outside London 
375 (69.4%) 
165 (30.6%) 
289 (70.5%) 
121 (29.5%) 
228 (68.5%) 
105 (31.5%) 
1 
0.83 [0.53, 1.30] 
0.422 1 
0.70 (0.44, 1.14] 
0.151 
Had sexualized drug use (past three 
months) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
Yes 
No 
/ 224 (54.6%) 
186 (45.4%) 
159 (47.8%) 
174 (52.3%) 
1.52 [0.99, 2.35] 
1 
0.057 1.48 [0.95, 2.29] 
1 
0.080 
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Table 78: Unadjusted and adjusted associations of socio-demographic and lifestyle factors with major & other depressive syndromes on PHQ-9 
using baseline, 12-month follow-up, and 24-month follow-up data among all 540 men who participated in PROUD (continued) 
     Major & other depressive syndromes on PHQ-9 on PHQ-9 
N=540 men  
 
 Baseline  
[N=540] 
n(%) 
12-month  
[N=410]  
n(%) 
24-month  
[N=333] 
n(%) 
Unadjusted 
PR [95% CI] 
Overall  
p-value
a
 
Adjusted
b
 
PR [95% CI] 
Overall  
p-value
a 
 
Age≤15 years at anal sex debut  
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Yes 
No  
/ 88 (22.3%) 
307 (77.7%) 
70 (21.8%) 
251 (78.2%) 
1.40 [0.85, 2.29] 
1 
0.184 1.36 [0.82, 2.26] 
1 
0.240 
Age<13 years at anal sex debut
 
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Yes 
No 
/ 22 (5.6%) 
373 (94.4%) 
19 (5.9%) 
302 (94.1%) 
1.03 [0.41, 2.61] 
1 
0.944 1.02 [0.41, 2.58] 
1 
0.962 
Time between any sexual contact and 
intercourse with a male 
N=433
d
, Obs=716
e
 ; N=429
f
, Obs=710
g
 
Same time 
1-2 years 
3-4 years 
5+ years 
/ 163 (41.3%) 
90 (22.8%) 
47 (11.9%) 
95 (24.1%) 
146 (45.5%) 
67 (20.9%) 
33 (10.3%) 
75 (23.4%) 
1 
0.72 [0.41, 1.28] 
0.89 [0.45,1.79] 
0.88 [0.50, 1.53] 
0.734 
0.640
c
 
1 
0.75 [0.42, 1.33] 
0.90 [0.45, 1.80] 
0.88 [0.50, 1.55] 
0.803 
0.656
c
 
Any IPV victimization 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 226 (55.1%) 
184 (44.9%) 
199 (59.8%) 
134 (40.2%) 
1 
2.02 [1.32, 3.11] 
0.001 1 
2.18 [1.42, 3.34] 
<0.001 
Any IPV victimization in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
 g
 
No 
Yes 
/ 346 (84.4%) 
64 (15.6%) 
284 (85.3%) 
49 (14.7%) 
1 
2.93 [1.91, 4.51] 
<0.001 1 
3.04 [1.97, 4.69] 
<0.001 
Any IPV perpetration
 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 330 (80.5%) 
80 (19.5%) 
273 (82.0%) 
60 (18.0%) 
1 
2.20 [1.40, 3.44] 
0.001 1 
2.21 [1.40, 3.49] 
0.001 
Any IPV perpetration in the past year 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 378 (92.2%) 
32 (7.8%) 
310 (93.1%) 
23 (6.9%) 
1 
3.12 [1.87, 5.21] 
<0.001 1 
3.28 [1.92, 5.60] 
<0.001 
Bidirectional IPV (victimization and 
perpetration) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 341 (83.2%) 
69 (16.8%) 
277 (83.2%) 
56 (16.8%) 
1 
2.26 [1.43, 3.57] 
<0.001 1 
2.33 [1.46, 3.71] 
<0.001 
Unidirectional IPV victimization (no reported 
perpetration) 
N=436
d
, Obs=743
e
 ; N=432
f
, Obs=737
g
 
No 
Yes 
/ 295 (72.0%) 
115 (28.1%) 
255 (76.6%) 
78 (23.4%) 
1 
1.16 [0.74, 1.82] 
0.514 1 
1.25 [0.80, 1.97] 
0.331 
Any negative views about gay sexuality 
(marker of internalised homophobia)
 
N=436
d
, Obs=743
e 
; N=432
f
, Obs=737
g
 
No/missing
  
Yes
 
 
/ 239 (58.3%) 
171 (41.7%) 
195 (58.6%) 
138 (41.4%) 
1 
2.05 [1.34, 3.14] 
0.001 1 
2.07 [1.35, 3.18] 
0.001 
‘Out’ to all/almost all friends, work colleagues 
and close family 
N=434
d
, Obs=727
e 
; N=431
f
, Obs=722
g
 
Yes 
No 
/ 206 (51.6%) 
193 (48.4%) 
166 (50.6%) 
162 (49.4%) 
1 
1.76 [1.13, 2.72] 
0.012 1 
1.75 [1.11, 2.74] 
0.015 
a
 p-value by Wald test using GEE models. 
  
 
 
458 
 
b
 Age (included as four categories: <25, 25-29, 30-39, 40+), born in the UK, sexual identity (gay or bisexual/straight), university education, and London study clinic site. Of note, 
findings were almost identical when adjusting additionally for study time-point. 
c 
Test for trend. 
d
 Number of men contributing observations to the unadjusted model. 
e
 Number of observations examined in the unadjusted model. 
f
 Number of men contributing observations to the adjusted model. 
g
 Number of observations examined in the adjusted model. 
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11.18 Appendix 18: Changes overtime in screening positive for clinically significant 
depressive symptoms by PHQ-9 in the PROUD trial 
 
Figure 34: Distribution of change in PHQ-9 depression score from baseline to the 12-
month questionnaire in PROUD 
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Table 79: Unadjusted associations of socio-demographic, lifestyle, and psychosocial 
factors with change in depression score from baseline to the 12-month questionnaire in 
PROUD 
N=410 men with baseline 
and 12-month questionnaire 
data 
  Change in depression 
score [mean 
change=1, SD=4.9] 
   N (%) Mean 
change 
scores 
[SD] 
p-value
a
 
Data collected at baseline: 
Age
c
 <25 
25+ 
 
32 (7.8%) 
378 (92.2%) 
-2 [5.7] 
1 [4.7] 
0.013
b
 
Born in the UK
e
 Yes 
No 
245 (59.8%) 
165 (40.2%) 
1 [4.9] 
1 [4.9] 
0.715 
Self-reported sexual identity Gay 
Bisexual/straight 
388 (95.6%) 
18 (4.4%) 
1 [4.9] 
1 [5.4] 
0.927
 b
 
University Education Yes 
No/missing 
256 (62.4%) 
154 (37.6%) 
1 [4.9] 
1 [4.8] 
0.223 
Employed Yes 
No/missing 
332 (81.0%) 
78 (19.0%) 
1 [4.8] 
0 [5.2] 
0.231
 b
 
Ongoing relationship Yes 
No/missing 
182 (44.4%) 
228 (55.6%) 
1 [4.5] 
1 [5.2] 
0.819
 b
 
Study region London 
Outside London 
289 (70.5%) 
121 (29.5%) 
1 [5.1] 
1 [4.4] 
0.441
 b
 
Higher-risk drinking Yes 
No/missing 
129 (31.5%) 
281 (68.5%) 
0 [4.4] 
1 [5.1] 
0.109
 b
 
Recreational drug use (past 
3 months)
e
 
0/missing 
1+ 
106 (25.9%) 
304 (74.2%) 
1 [4.6] 
1 [5.0] 
0.909 
Data collected on/before 12-month questionnaire: 
Randomized to study trial 
arm  
Immediate arm 
Deferred arm 
216 (52.7%) 
194 (47.3%) 
1 [5.0] 
1 [4.7] 
0.316 
Prescribed PrEP before 12-
month questionnaire 
completion
d
 
Yes  
No 
241 (58.8%) 
169 (41.2%) 
1 [4.7] 
1 [5.0] 
0.583 
Age≤15 years at anal sex 
debut   
Yes 
No 
88 (22.3%) 
307 (77.7%) 
2 [6.2] 
1 [4.4] 
0.215
 b
 
Age<13 years at anal sex 
debut
 
Yes 
No 
22 (5.6%) 
373 (94.4%) 
2 [5.9] 
1 [4.8] 
0.480
 b
 
Any IPV victimization No/missing 
Yes 
226 (55.1%) 
184 (44.9%) 
1 [4.1] 
1 [5.7] 
0.118
 b
 
Any IPV victimization past 
year 
No/missing 
Yes 
346 (84.4%) 
64 (15.6%) 
1 [4.3] 
3 [6.9] 
0.017
 b
 
Any IPV perpetration No/missing 
Yes 
330 (80.5%) 
80 (19.5%) 
0 [4.3] 
2 [6.4] 
0.014
 b
 
Any IPV perpetration past 
year 
No/missing 
Yes 
378 (92.2%) 
32 (7.8%) 
1 [4.5] 
4 [7.4] 
0.032
 b
 
Any negative views about 
gay sexuality (marker of 
internalised homophobia) 
No/missing
  
Yes
 
 
239 (58.3%) 
171 (41.7%) 
0 [4.4] 
1 [5.5] 
0.047
 b
 
‘Out’ to all/almost all friends, 
work colleagues and close 
family 
Yes 
No 
206 (51.6%) 
193 (48.4%) 
1 [4.9] 
1 [4.8] 
0.496 
‘Out’ to few/no friends, work 
colleagues and close family 
Yes 
No 
9 (2.3%) 
390 (97.7%) 
1 [6.4] 
1 [4.8] 
0.971
 b
 
a 
Two-sided p-value using two-sample t-test. 
b 
Two-sample t-test with unequal variances. 
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c 
The choice of categories (<25; 25+) was driven by a previous examination of age in six categories (<25; 
25-29; 30-34; 35-39; 40-44; 45+) in a one-way ANOVA, whereby it was clear that the mean change in 
depression score was different in the youngest age group. Due to the significant Bartlett’s p-value, age 
was dichotomized was shown above and examined in a two-sample t-test with unequal variances. 
d
Twenty-five men were prescribed PrEP before the 12-month questionnaire. 
e
 Due to a significant Bartlett’s test p-value (indicating unequal variances) in a one-way ANOVA with 
change in depression score, this variable was dichotomized i.e. from UK born and ethnicity to UK born and 
from number of recreational drugs used to any drug use. 
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Table 80: Unadjusted associations of socio-demographic, lifestyle, and psychosocial 
factors with incidence of clinically significant depressive symptoms at the 12-month 
questionnaire in PROUD 
N=372 men who scored <10 on the PHQ-9 at baseline PHQ-9≥10 at month-
12 [n=37; 10.0%] 
   N (%) % p-value
a
 
Data collected at baseline: 
Age <25 
25-29 
30-34 
35-39 
40-44 
45+ 
21 (5.7%) 
62 (16.7%) 
74 (19.9%) 
73 (19.6%) 
59 (15.9%) 
83 (22.3%) 
4.8% 
12.9% 
12.2% 
6.9% 
1.7% 
15.7% 
0.055
c 
0.774
 b
 
Born in the UK and white ethnicity Yes, white 
Yes, BAME 
No, white 
No, BAME 
204 (55.1%) 
18 (4.9%) 
105 (28.4%) 
43 (11.6%) 
9.8% 
22.2% 
7.6% 
11.6% 
0.286
c
 
Self-reported sexual identity Gay 
Bisexual/straight 
353 (95.9%) 
15 (4.1%) 
10.2% 
6.7% 
0.543
 c
 
University Education Yes 
No/missing 
232 (62.4%) 
140 (37.6%) 
9.1% 
11.4% 
0.458 
Employed Yes 
No/missing 
308 (82.8%) 
64 (17.2%) 
9.7% 
10.9% 
0.771 
Ongoing relationship Yes 
No/missing 
172 (46.2%) 
200 (53.8%) 
8.1% 
11.5% 
0.280 
Study region London 
Outside London 
259 (69.6%) 
113 (30.4%) 
11.2% 
7.1% 
0.222 
Higher-risk drinking Yes 
No/missing 
115 (30.9%) 
257 (69.1%) 
7.8% 
10.9% 
0.361 
Recreational drug use (past 3 months) 0/missing 
1 
2-4 
5+ 
95 (25.5%) 
58 (15.6%) 
119 (32.0%) 
100 (26.9%) 
13.7% 
10.3% 
5.9% 
11.0% 
0.283 
0.338
b
 
Data collected on/before 12-month questionnaire: 
Randomized to study trial arm  Immediate arm 
Deferred arm 
194 (52.2%) 
178 (47.9%) 
11.3% 
8.4% 
0.348 
Prescribed PrEP before 12-month 
questionnaire completion
d
 
Yes  
No 
217 (58.3%) 
155 (41.7%) 
10.1% 
9.7% 
0.884 
Age≤15 years at anal sex debut   Yes 
No 
76 (21.2%) 
282 (78.8%) 
15.8% 
8.5% 
0.061 
Age<13 years at anal sex debut
 
 Yes 
No 
20 (5.6%) 
338 (94.4%) 
10.0% 
10.1% 
0.675
c
 
Any IPV victimization No/missing 
Yes 
212 (57.0%) 
160 (43.0%) 
5.7% 
15.6% 
0.001 
Any IPV victimization past year No/missing 
Yes 
317 (85.2%) 
55 (14.8%) 
7.3% 
25.5% 
<0.001 
Any IPV perpetration No/missing 
Yes 
305 (82.0%) 
67 (18.0%) 
7.2% 
22.4% 
<0.001 
Any IPV perpetration past year No/missing 
Yes 
348 (93.6%) 
24 (6.5%) 
7.8% 
41.7% 
<0.001
c
 
Any negative views about gay sexuality 
(marker of internalised homophobia) 
No/missing
  
Yes
 
 
226 (60.8%) 
146 (39.3%) 
7.1% 
14.4% 
0.022 
‘Out’ to all/almost all friends, work 
colleagues and close family 
Yes 
No 
192 (53.0%) 
170 (47.0%) 
10.4% 
10.0% 
0.896 
‘Out’ to few/no friends, work colleagues 
and close family 
Yes 
No 
8 (2.2%) 
354 (97.8%) 
12.5% 
10.2% 
0.582
 c
 
a
 Pearson χ
2 
test 
b
 Test for trend. 
c
 Fisher’s exact test. 
  
 
 
463 
 
d 
Twenty-five men were prescribed PrEP before the 12-month questionnaire. 
 
11.19 Appendix 19: Patient and Public Involvement survey for PROUD participants 
 
Textbox 7: Request for PROUD participants to comment on the prevalence and correlates 
of depression found during the study 
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Textbox 8: Layout of survey monkey questions about the PROUD study findings 
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11.20 Appendix 20: Prevalence of sexual behaviour measures in PROUD 
 
Table 81: Proportion of missing values for sexual behaviour questions in PROUD 
 Baseline 
[N=540] 
12-month 
[N=410] 
24-month 
[N=333] 
 n (%) 
missing 
n (%) 
missing 
n (%) 
missing 
‘With how many different men have you 
been bottom (passive) during anal sex in 
the last 90 days?’ 
20 (3.7%) 6 (1.5%) 3 (0.9%) 
‘With how many were you bottom without 
using a condom?’
e
 
5 (1.0%)
a
 1 (0.3%)
a
 0 (0.0%)
a
 
‘How many did you know were HIV-
positive’
f
 
19 (4.4%)
a
 8 (2.5)
a
 1 (0.4%)
a
 
‘How many did you know were on HIV 
treatment?’
g
 
3 (1.5%)
a
 1 (0.6%)
a
 0 (0.0%)
a
 
‘With how many different men have you 
been top (active) during anal sex in the last 
90 days?’ 
20 (3.7%) 12 (2.9%)
 
 8 (2.4%) 
‘With how many were you top without using 
a condom?’
e
 
3 (0.6%)
a
 3 (0.9%)
a
 1 (0.4%)
a
 
‘How many did you know were HIV-
positive’
f
 
22 (5.1%)
a
 10 (3.2%)
a
 2 (0.8%)
a
 
‘How many did you know were on HIV 
treatment?’
g
 
0 (0.0%)
a
 1 (0.6%)
a
 0 (0.0%)
a
 
‘Of the men you’ve been either top or 
bottom with during anal sex in the last 90 
days, how many were new partners?’ 
23 (4.3%) 6 (1.5%) 3 (0.9%) 
‘Think of the last time you had anal sex with 
a man without a condom. What was his HIV 
status?’ 
9 (1.7%) 11 (2.7%) 6 (1.8%) 
Rectal Chlamydia diagnosis in the past 
year
b
 
70 (13.0%) / / 
Rectal gonorrhoea diagnosis in the past 
year
b
 
62 (11.5%) / / 
Syphilis diagnosis in the past year
b
 67 (12.4%) / / 
LGV diagnosis in the past year
b
 82 (15.2%) / / 
PEP use in the past year
b
 30 (5.6%) / / 
Participated in group sex (sex with  more 
than one other person on the same 
occasion)
c
 
/ 16 (3.9%) 14 (4.2%) 
a 
The denominator is the number of men who responded to the previous question, providing a response 
greater than 0.  
b
 Information on this measure was not collected at the 12- or 24-month questionnaire.  
c 
Information on this measure was not collected at the baseline questionnaire. 
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11.21 Appendix 21: Relationship between other depressive symptom measures on PHQ-9 
and sexual behaviour measures in the PROUD trial 
 
Table 82: Unadjusted and adjusted associations of other depression measures with 
sexual behaviour measures in the past three months using baseline, 12- and 24-month 
questionnaire data among all 540 men who participated in PROUD 
N=540 men  
(using data from baseline and 
follow-ups in GEE models) 
 
Dependent variables: 
Major 
depressive 
syndrome on 
PHQ-9 
Major & other 
depressive 
syndromes on 
PHQ-9 
Suicidal ideation 
on PHQ-9  
CLS with two or more partners 
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
0.98 [0.77, 1.26] 
0.896 
0.99 [0.77, 1.26] 
0.910 
 
1.00 [0.82, 1.23] 
0.999 
1.01 [0.82, 1.23] 
0.962 
 
1.04 [0.86, 1.26] 
0.691 
1.04 [0.86, 1.26] 
0.697 
CLS with five or more partners  
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
1.04 [0.77, 1.42] 
0.794 
1.03 [0.76, 1.41] 
0.831 
 
1.11 [0.86, 1.42] 
0.423 
1.10 [0.86, 1.41] 
0.445 
 
1.10 [0.87, 1.40] 
0.417 
1.20 [0.86, 1.40] 
0.444 
CLS with HIV+ partner not 
treated 
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
 
0.54 [0.24, 1.22] 
0.139 
0.54 [0.24, 1.24] 
0.145 
 
 
0.72 [0.40, 1.29] 
0.269 
0.72 [0.40, 1.30] 
0.275 
 
 
0.87 [0.52, 1.47] 
0.607 
0.88 [0.52, 1.48] 
0.619 
Receptive CLS with HIV+ 
partner not treated  
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
 
0.67 [0.26, 1.75] 
0.413 
0.66 [0.25, 1.73] 
0.394 
 
 
0.99 [0.50, 1.93] 
0.968 
0.98 [0.50, 1.94] 
0.965 
 
 
0.93 [0.48, 1.79] 
0.826 
0.93 [0.48, 1.80] 
0.825 
Unknown/HIV+ partner not 
treated at last CLS  
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
 
1.35 [0.93, 1.97] 
0.119 
1.38 [0.94, 2.02] 
0.096 
 
 
1.27 [0.92, 1.75] 
0.154 
1.29 [0.93, 1.78] 
0.131 
 
 
1.12 [0.81, 1.56] 
0.494 
1.11 [0.80, 1.54] 
0.524 
Ten or more new sex partners 
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI]
d
 
p-value
a
 
 
 
0.99 [0.69, 1.43] 
0.966 
1.00 [0.69, 1.45] 
0.984 
 
 
0.97 [0.72, 1.32] 
0.870 
0.99 [0.73, 1.34] 
0.935 
 
 
1.04 [0.78, 1.39] 
0.786 
1.04 [0.78, 1.39] 
0.785 
Receptive anal sex with ten or 
more partners  
PR [95% CI]
c
 
p-value
a 
Adjusted PR
b
 [95% CI
d
 
p-value
a
 
 
 
1.07 [0.75, 1.54] 
0.699 
1.08 [0.75, 1.56] 
0.664 
 
 
1.18 [0.89, 1.58] 
0.256 
1.20 [0.90, 1.60] 
0.221 
 
 
1.13 [0.85, 1.50] 
0.413 
1.13 [0.85, 1.50] 
0.416 
Group sex 
PR [95% CI]
 e
 
p-value
a 
Adjusted PR
b
 [95% CI]
e
 
p-value
a
 
 
0.97 [0.68, 1.38] 
0.860 
0.99 [0.69, 1.41] 
0.935 
 
1.12 [0.84, 1.49] 
0.456 
1.13 [0.84, 1.52] 
0.413 
 
1.04 [0.78, 1.40] 
0.777 
1.04 [0.77, 1.40] 
0.812 
a
 p-value by Wald test using GEE models. 
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b
 Age (included as four categories: <25, 25-29, 30-39, 40), UK born (yes or no/missing), sexual identity 
(gay or bisexual/straight), university education (yes or no/missing), and London study clinic site (London or 
outside London). 
c
 The number of men contributing observations to the unadjusted model was 540;  The number of 
observations examined in the unadjusted model was 1283. 
d 
The number of men contributing observations to the adjusted model was 536;  The number of 
observations examined in the adjusted model was 1273. 
e 
Men were asked whether they had engaged in group sex at the 12-month and 24-month follow-up 
questionnaires only. There were 104 men who did not fill out a questionnaire at either of these follow-up 
time-points, and therefore, 104 men for whom the question group sex had a missing value (since group 
sex was coded as yes; no or missing, everyone who filled out a questionnaire had a value). It is therefore 
of note, that the number of men contributing observations to the unadjusted model was 436; The number 
of observations examined in the unadjusted model was 743 and the number of men contributing 
observations to the adjusted model was 432;  The number of observations examined in the adjusted model 
was 737.
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11.22 Appendix 22: Relationship between socio-demographic and lifestyle factors with sexual behaviour measures at baseline of the PROUD trial 
 
Table 83: Unadjusted associations of socio-demographic and lifestyle factors with sexual behaviour measures in the past three months at baseline 
of PROUD 
N=540 men at baseline        
   N (%) CLS with 2+ 
partners 
[n=410;75.9%] 
 
 
 
% 
p-value
a
 
CLS with 5+ 
partners 
[n=221;40.9%] 
 
 
 
% 
p-value
a
 
CLS with 
HIV+ partner 
not treated  
[n=65;12.0%] 
 
 
% 
p-value
a
 
Receptive 
CLS with 
HIV+ partner 
not treated  
[n=35;6.5%] 
 
% 
p-value
a
 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=146;27.0%] 
 
% 
p-value
a
 
10+ new sex 
partners 
[n=200;37.0%] 
 
 
 
% 
p-value
a
 
Receptive anal 
sex with 10+ 
partners  
[n=175;32.4%] 
 
 
% 
p-value
a
 
Age 
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
77.8% 
76.0% 
74.6% 
67.0% 
76.5% 
84.7% 
0.127 
0.315
b
 
33.3% 
41.7% 
39.5% 
35.1% 
48.2% 
45.9% 
0.352 
0.125
b
 
11.1% 
8.3% 
13.2% 
8.3% 
13.6% 
17.4% 
0.355 
0.118
b
 
7.4% 
5.2% 
7.0% 
6.2% 
7.4% 
6.1% 
0.989
c 
0.967
b
 
22.2% 
28.1% 
26.3% 
21.7% 
25.9% 
35.7% 
0.312 
0.172 
31.5% 
44.8% 
37.7% 
34.0% 
32.1% 
38.8% 
0.471 
0.687
b
 
31.5% 
39.6% 
30.7% 
34.0% 
28.4% 
29.6% 
0.624 
0.274 
Born in the 
UK and white 
ethnicity 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
78.1% 
77.1% 
71.1% 
78.1% 
0.410 
42.2% 
37.1% 
39.5% 
42.2% 
0.906 
12.2% 
14.3% 
14.5% 
4.7% 
0.192
c
 
7.3% 
5.7% 
7.9% 
0.0% 
0.079
c
 
25.1% 
25.7% 
29.6% 
31.3% 
0.645 
36.9% 
34.3% 
36.8% 
39.1% 
0.973 
35.2% 
22.9% 
34.2% 
21.9% 
0.115 
Self-reported 
sexual 
identity
i
 
Gay 
Bisexual/ 
straight
g
 
513 (95.7%) 
23 (4.3%) 
75.4% 
87.0% 
0.206 
40.6% 
56.5% 
0.128 
12.3% 
8.7% 
0.456
c
 
6.6% 
4.4% 
0.548
c
 
26.5% 
39.1% 
0.183 
36.1% 
60.9% 
0.016 
32.8% 
30.4% 
0.817 
University 
Education 
Yes 
No/missing
a
 
327 (60.6%) 
213 (39.4%) 
77.4% 
73.7% 
0.331 
42.2% 
39.0% 
0.455 
10.4% 
14.6% 
0.147 
6.1% 
7.0% 
0.669 
26.6% 
27.7% 
0.780 
39.1% 
33.8% 
0.209 
34.9% 
28.6% 
0.131 
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Table 83: Unadjusted associations of socio-demographic and lifestyle factors with sexual behaviour measures in the past three months at baseline 
of PROUD (continued) 
N=540 men at baseline        
   N (%) CLS with 2+ 
partners 
[n=410;75.9%] 
 
 
 
 
% 
p-value
a
 
CLS with 5+ 
partners 
[n=221;40.9%] 
 
 
 
 
% 
p-value
a
 
CLS with 
HIV+ partner 
not treated  
[n=65;12.0%] 
 
 
 
% 
p-value
a
 
Receptive 
CLS with 
HIV+ partner 
not treated  
[n=35;6.5%] 
 
 
% 
p-value
a
 
Unknown/HIV+ 
partner not 
treated at last 
CLS  
[n=146;27.0%] 
 
 
% 
p-value
a
 
10+ new sex 
partners 
[n=200;37.0%] 
 
 
 
 
% 
p-value
a
 
Receptive anal 
sex with 10+ 
partners  
[n=175;32.4%] 
 
 
 
% 
p-value
a
 
Employed Yes 
No/missing
a
 
439 (81.3%) 
101 (18.7%) 
75.6% 
77.2% 
0.734 
40.1% 
44.6% 
0.411 
12.1% 
11.9% 
0.957 
6.8% 
5.0% 
0.488 
27.6% 
24.8% 
0.566 
36.5% 
39.6% 
0.554 
32.6% 
31.7% 
0.863 
Ongoing 
relationship 
Yes 
No/missing
a
 
246 (45.6%) 
294 (54.4%) 
65.9% 
84.4% 
<0.001 
33.7% 
46.9% 
0.002 
12.2% 
11.9% 
0.918 
7.3% 
5.8% 
0.471 
24.8% 
28.9% 
0.284 
30.9% 
42.2% 
0.007 
30.1% 
34.4% 
0.291 
Study region London 
Outside 
London 
375 (69.4%) 
165 (30.6%) 
76.8% 
73.9% 
0.474 
42.1% 
38.2% 
0.390 
11.7% 
12.7% 
0.744 
6.9% 
5.5% 
0.520 
24.3% 
33.3% 
0.029 
38.4% 
33.9% 
0.323 
33.6% 
29.7% 
0.372 
Higher-risk 
drinking
g
 
Yes 
No/missing
a
 
173 (32.0%) 
367 (68.0%) 
79.2% 
74.4% 
0.223 
41.0% 
40.9% 
0.970 
13.3% 
11.4% 
0.537 
6.9% 
6.3% 
0.768 
26.6% 
27.3% 
0.872 
40.5% 
35.4% 
0.258 
37.0% 
30.3% 
0.118 
Recreational 
drug use 
(past 3 
months) 
0/missing
a
 
1 
2-4 
5+ 
148 (27.4%) 
87 (16.1%) 
159 (29.4%) 
146 (27.0%) 
67.6% 
69.0% 
74.8% 
89.7% 
<0.001 
<0.001
b
 
32.4% 
31.0% 
34.0% 
63.0% 
<0.001 
<0.001
b
 
10.8% 
10.3% 
10.1% 
16.4% 
0.269 
0.187
b
 
6.8% 
4.6% 
5.0% 
8.9% 
0.477 
0.510
b
 
27.0% 
28.7% 
31.5% 
21.2% 
0.242 
0.406
b
 
23.7% 
24.1% 
33.3% 
62.3% 
<0.001 
<0.001
b
 
18.9% 
26.4% 
27.0% 
55.5% 
<0.001 
<0.001
b
 
Chemsex-
associated  
drug use 
No 
Yes 
309 (57.2%) 
231 (42.8%) 
 
69.9% 
84.0% 
<0.001 
32.0% 
52.8% 
<0.001 
11.3% 
13.0% 
0.557 
5.5% 
7.8% 
0.285 
28.5% 
25.1% 
0.383 
25.9% 
52.0% 
<0.001 
23.3% 
44.6% 
<0.001 
a
 Pearson χ
2 
test 
b
 χ
2 
test for trend. 
c
 Fisher’s exact test. 
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Table 84: Unadjusted associations of socio-demographic and lifestyle factors with PEP 
use and rectal STI diagnosis in the past year at baseline of PROUD 
N=540 men at 
baseline 
    
   N (%) PEP use  
[n=184;34.1%] 
 
 
 
 
% 
p-value
a
 
Rectal STI 
diagnosis
c
 
[n=200;37.0%] 
 
 
 
% 
p-value
a
 
Age 
 
<25 
25-29 
30-34 
35-39 
40-44 
45+ 
54 (10.0%) 
96 (17.8%) 
114 (21.1%) 
97 (18.0%) 
81 (15.0%) 
98 (18.2%) 
37.0% 
37.5% 
34.2% 
39.2% 
29.6% 
27.6% 
0.493 
0.114
b
 
35.2% 
44.8% 
38.6% 
39.2% 
38.3% 
25.5% 
0.131 
0.050
b
 
Born in the UK 
and white 
ethnicity 
Yes, white 
Yes, BAME 
No, white 
No, BAME 
287 (53.4%) 
35 (6.5%) 
152 (28.3%) 
64 (11.9%) 
31.7% 
31.4% 
35.5% 
43.8% 
0.305 
34.5% 
37.1% 
40.8% 
37.5% 
0.634 
Self-reported 
sexual identity
i
 
Gay 
Bisexual/ 
straight
g
 
 
513 (95.7%) 
17 (3.2%) 
6 (1.1%) 
33.9% 
39.1% 
0.606 
37.4% 
26.1% 
0.270 
University 
Education 
Yes 
No/missing
a
 
327 (60.6%) 
213 (39.4%) 
35.8% 
31.5% 
0.300 
38.8% 
34.3% 
0.283 
Employed Yes 
No/missing
a
 
439 (81.3%) 
101 (18.7%) 
37.6% 
33.3% 
0.404 
37.1% 
36.6% 
0.926 
Ongoing 
relationship 
Yes 
No/missing
a
 
246 (45.6%) 
294 (54.4%) 
31.7% 
36.1% 
0.288 
32.5% 
40.8% 
0.047 
Study region London 
Outside 
London 
375 (69.4%) 
165 (30.6%) 
37.1% 
27.3% 
0.027 
39.2% 
32.1% 
0.117 
Higher-risk 
drinking
g
 
Yes 
No/missing
a
 
173 (32.0%) 
367 (68.0%) 
35.8% 
33.2% 
0.553 
37.6% 
36.8% 
0.860 
Recreational 
drug use (past 3 
months) 
0/missing
a
 
1 
2-4 
5+ 
148 (27.4%) 
87 (16.1%) 
159 (29.4%) 
146 (27.0%) 
23.7% 
25.3% 
41.5% 
41.8% 
<0.001 
<0.001
b
 
27.7% 
28.7% 
37.7% 
50.7% 
<0.001 
<0.001
b
 
Chemsex-
associated drug 
use 
No 
Yes 
309 (57.2%) 
231 (42.8%) 
 
25.2% 
45.9% 
<0.001 
28.8% 
48.1% 
<0.001 
a
 Pearson χ
2 
test 
b
 χ
2 
test for trend. 
c 
Rectal Chlamydia, rectal gonorrhoea, syphilis and/or LGV. 
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11.23 Appendix 23: Association between measures of IPV and sexual risk behaviour in 
the PROUD trial  
 
Figure 35: Unadjusted and adjusted associations of any IPV victimization with sexual 
behaviours in the past three months among 436 men who participated in PROUD  
 
 
a
 Not known to be on HIV treatment. 
b
 The model was fitted to include age in four categories (<25; 25-29; 30-39; 40+), dichotomous UK born 
and self-reported sexual identity. 
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Figure 36: Unadjusted and adjusted associations of any IPV perpetration with sexual 
behaviours in the past three months among 436 men who participated in PROUD  
 
a
 Not known to be on HIV treatment. 
b
 The model was fitted to include age in four categories (<25; 25-29; 30-39; 40+), dichotomous UK born 
and self-reported sexual identity. 
